Citrus Sinensis ID: 040398
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 732 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FXF2 | 1021 | Probable LRR receptor-lik | yes | no | 0.989 | 0.709 | 0.564 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.978 | 0.701 | 0.518 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.990 | 0.714 | 0.525 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.964 | 0.740 | 0.5 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.979 | 0.690 | 0.513 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.980 | 0.693 | 0.508 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.980 | 0.704 | 0.510 | 0.0 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.946 | 0.671 | 0.423 | 1e-160 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.957 | 0.678 | 0.418 | 1e-159 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.303 | 0.259 | 0.540 | 1e-64 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 879 bits (2270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/790 (56%), Positives = 547/790 (69%), Gaps = 66/790 (8%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT 64
LPGTLP QIV LPYL +D AYNY++G++PREWAS L +IS+ NRLSG IP GN +
Sbjct: 112 LPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISLLVNRLSGEIPKEFGN-S 169
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
SLTYLDLE N FSGTIP+ELGNLV+L+ L LSSN+L G LP L +L+N+TDFRIND
Sbjct: 170 SLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRINDLQL 229
Query: 125 NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMT 184
+G+ P +IQ+W QL RLE+ SGL GPIP IS L L LRISD++GP Q FP L+N+T
Sbjct: 230 SGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSLKNVT 289
Query: 185 GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL-MFIR 243
GLT+IIL+NCNI+G+IP Y+ +K L LDLSFN+L G +P A +L+F + +
Sbjct: 290 GLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPSFAQAENLRFIILAGNMLE 349
Query: 244 G------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNNF 297
G + + ++DLSYNN WQSPE ACR NLNLNLF+S+S + + PC +F
Sbjct: 350 GDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIKDF 409
Query: 298 TCHRYWHSLHINCGGGNVKVNDST----FEGDAGVGGGAATYHLLDGTNWGISSTGDFTD 353
C RY LH+NCGG ++ V + +EGD V GGAA Y L NWG SSTGDF D
Sbjct: 410 KCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMD 469
Query: 354 DDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKT 413
D++ QNT + +S S+LY ARI+P+SLTY CLENGNY++ L FAEI+FTND+
Sbjct: 470 DNNFQNTRFTMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDEN 529
Query: 414 YKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGKGTT 473
Y LGRR+FDIYIQ+KLV KDFNI EA G P+ +P TA V+NH L IR WAGKGTT
Sbjct: 530 YNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTT 589
Query: 474 AIPIGGVYGPLISAISV------------------------------------------- 490
IP GVYGP+ISAIS+
Sbjct: 590 RIPTRGVYGPIISAISIVSDSKPCERPKTGMSPGAYIAIGIGAPCLIIFILGFLWICGCL 649
Query: 491 --------DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIA 542
DP E E + +FTL+QI+ AT +F+P NKIGEGGFG V+KG L DG ++A
Sbjct: 650 PRCGRQRKDPYEE--ELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVA 707
Query: 543 VKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF 602
VK LSSKSRQGNREFLNEIG ISCLQHPNLVKL+G C+E QL+L YEY+ENNSL+ ALF
Sbjct: 708 VKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALF 767
Query: 603 GGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662
++ Q+ ++W R KIC GIA+GLAFLHEES K VHRDIKATN+LLD+DL PKISDFG
Sbjct: 768 SPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFG 827
Query: 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722
LA+LDEEEKTHIST+VAGTIGYMAPEYALWGYLT+KADVYSFGV+ LEIV+G N +++
Sbjct: 828 LARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMG 887
Query: 723 DSNCTCPLDW 732
+ C L++
Sbjct: 888 AGDSVCLLEF 897
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/802 (51%), Positives = 515/802 (64%), Gaps = 86/802 (10%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT 64
L G+LP + LP+L+ +D NYL+GSIP EW + L IS+ NR+SG+IP LGN+T
Sbjct: 99 LQGSLPTDLSGLPFLQELDLTRNYLNGSIPPEWGASSLLNISLLGNRISGSIPKELGNLT 158
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
+L+ L LE NQ SG IP ELGNL NL+ L LSSN L G +P KL LTD RI+DN F
Sbjct: 159 TLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQF 218
Query: 125 NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMT 184
G+ PDFIQ+W L +L IQ SGL GPIP +I L L LRI+DL GP FP LRNMT
Sbjct: 219 TGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMT 278
Query: 185 GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG 244
+ +ILRNCN+ G++P Y+ + L+ LDLSFN+L+G +P A + L + F
Sbjct: 279 SMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIP--ATYSGLSDVDFIYFTSN 336
Query: 245 VYEHQ----------SLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSS--VENNFGVFP 292
+ Q ++D++YNNF+ E+ C++K ++N F S+S V NN
Sbjct: 337 MLNGQVPSWMVDQGDTIDITYNNFSKDKTEE--CQQK---SVNTFSSTSPLVANNSSNVS 391
Query: 293 CTNNFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTN-WGISSTGDF 351
C + +TC + ++ LHINCGG + N++ ++ D G Y+ D N W S+TG+F
Sbjct: 392 CLSKYTCPKTFYGLHINCGGNEITSNETKYDADTWDTPG---YY--DSKNGWVSSNTGNF 446
Query: 352 TDDDDE-------QNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFA 404
DDD N++ + + SS LY AR+S +SLTY CL GNY+V LHFA
Sbjct: 447 LDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFA 506
Query: 405 EIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIR 464
EI F Y LGRR FDIY+Q K KDFNI EA GV K V + F V+N LEIR
Sbjct: 507 EIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIR 566
Query: 465 FQWAGKGTTAIPIGGVYGP----------------------------------------- 483
QWAGKGT AIP+ GVYGP
Sbjct: 567 LQWAGKGTQAIPVRGVYGPLISAVSVDPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFL 626
Query: 484 --LISAI-----------SVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPV 530
LI I ++ + + L+FQ SSF+L+QI+ AT NFDP NKIGEGGFGPV
Sbjct: 627 VLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPV 686
Query: 531 YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590
+KG +TDGT+IAVK LS+KS+QGNREFLNEI IS LQHP+LVKLYGCC+EGDQL+LVYE
Sbjct: 687 HKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYE 746
Query: 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650
YLENNSLA ALFG + +Q+ LNW +RQKIC+GIARGLA+LHEESR KIVHRDIKATNVLL
Sbjct: 747 YLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLL 806
Query: 651 DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALE 710
D++LNPKISDFGLAKLDEEE THISTRVAGT GYMAPEYA+ G+LT KADVYSFGVVALE
Sbjct: 807 DKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALE 866
Query: 711 IVSGKNNMSYVPDSNCTCPLDW 732
IV GK+N S ++ LDW
Sbjct: 867 IVHGKSNTSSRSKADTFYLLDW 888
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 749 bits (1935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/797 (52%), Positives = 526/797 (65%), Gaps = 72/797 (9%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT 64
L G +PP+ L +L+ +D + N L GSIP+EWASM+L+ +S NRLSG P L +T
Sbjct: 102 LTGIVPPEFSKLRHLKVLDLSRNSLTGSIPKEWASMRLEDLSFMGNRLSGPFPKVLTRLT 161
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
L L LE NQFSG IP ++G LV+LE L L SN G L +L LKNLTD RI+DNNF
Sbjct: 162 MLRNLSLEGNQFSGPIPPDIGQLVHLEKLHLPSNAFTGPLTEKLGLLKNLTDMRISDNNF 221
Query: 125 NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMT 184
G PDFI +WT++ +L++ G GL+GPIP SIS+L L LRISDL G +FP L+N+
Sbjct: 222 TGPIPDFISNWTRILKLQMHGCGLDGPIPSSISSLTSLTDLRISDLGGKPSSFPPLKNLE 281
Query: 185 GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP---DVAVPADLKFTQILMF 241
+ +ILR C I G IP+YI +K L+ LDLSFN L+GE+P + AD +
Sbjct: 282 SIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFENMKKADFIYLTGNKL 341
Query: 242 IRG-----VYEHQSLDLSYNNFTWQS--PEQPACREKPNLNLNLFRSSSVENNFGVF--- 291
G V ++++D+S+NNFT +S P R NL + + F
Sbjct: 342 TGGVPNYFVERNKNVDVSFNNFTDESSIPSHDCNRVTSNLVESFALGNKSHKGSTCFLQR 401
Query: 292 -PCTNNFTCHRYWHSLHINCGGGNVKVNDS-TFEGDAGVGGGAATYHLLDGTNWGISSTG 349
PC + H Y L+INCGGG VKV+ T++ D GA+ Y L W +SSTG
Sbjct: 402 MPCVHPKRYHLY--KLYINCGGGEVKVDKEITYQAD-DEPKGASMYVLGANKRWALSSTG 458
Query: 350 DFTDDDDE------QNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHF 403
+F D+DD+ QNT+ ++ + SS LY AR+SPLSLTY G CL NGNY+V LHF
Sbjct: 459 NFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLSLTYYGICLGNGNYTVNLHF 518
Query: 404 AEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEI 463
AEI FT+D T +LG+R+FDIY+QD+LV K+FNI+ A G KP+ + F NV++H L+I
Sbjct: 519 AEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKSFLVNVTDHTLKI 578
Query: 464 RFQWAGKGTTAIPIGGVYGPLISAISVDPN------------------------------ 493
+WAGKGTT IPI GVYGP+ISAISV+PN
Sbjct: 579 GLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVYYDTKDIILKVGVPVAAATLLLFII 638
Query: 494 -----------------LEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT 536
L GL+ Q +FTL+QI+AAT NFD KIGEGGFG VYKG+L+
Sbjct: 639 VGVFWKKRRDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELS 698
Query: 537 DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596
+G +IAVK LS+KSRQGNREF+NEIG IS LQHPNLVKLYGCC+EG+QL+LVYEYLENN
Sbjct: 699 EGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNC 758
Query: 597 LAHALFGG-ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655
L+ ALFG E+S+LKL+WS R+KI LGIA+GL FLHEESR KIVHRDIKA+NVLLD+DLN
Sbjct: 759 LSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLN 818
Query: 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
KISDFGLAKL+++ THISTR+AGTIGYMAPEYA+ GYLT KADVYSFGVVALEIVSGK
Sbjct: 819 AKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGK 878
Query: 716 NNMSYVPDSNCTCPLDW 732
+N ++ P + LDW
Sbjct: 879 SNTNFRPTEDFVYLLDW 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/790 (50%), Positives = 502/790 (63%), Gaps = 84/790 (10%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNI 63
+L G+LP ++V LP L+ +D + NYL+GSIP EW + L I + NRL+G IP GNI
Sbjct: 74 NLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNRLTGPIPKEFGNI 133
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
T+LT L LE NQ SG +P ELGNL N++ + LSSN G +P KL L DFR++DN
Sbjct: 134 TTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQ 193
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+G+ PDFIQ WT+L RL IQ SGL GPIP +I++L +L LRISDL GP FP LRN+
Sbjct: 194 LSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFPQLRNI 253
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243
+ +ILRNCN+ G++P+Y+ I + +FLDLSFN+L+G +P+ + +L+ + F
Sbjct: 254 KKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYI--NLRDGGYIYFTG 311
Query: 244 G----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPC 293
V + +DLSYNNF+ P C+ NN V C
Sbjct: 312 NMLNGSVPDWMVNKGYKIDLSYNNFS-VDPTNAVCK---------------YNN--VLSC 353
Query: 294 TNNFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTD 353
N+ C + +++LHINCGG + +N + +E D + Y +G W ++ G F D
Sbjct: 354 MRNYQCPKTFNALHINCGGDEMSINGTIYESDK-YDRLESWYESRNG--WFSNNVGVFVD 410
Query: 354 DDD-EQNTNYIANSQSSGISE--LYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTN 410
D + +NS + + LY ARIS +SLTY CLENGNY+V LHFAEI F
Sbjct: 411 DKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNG 470
Query: 411 DKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGK 470
+ Y++LGRR FDIYIQ KL KDFNI EA V V + F + + LEIR WAG+
Sbjct: 471 NNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGR 530
Query: 471 GTTAIPIGGVYGPLISAISVD--------------------------------------- 491
GTT IP VYGPLISAISVD
Sbjct: 531 GTTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVILSIFIVFLVFGTLWKKG 590
Query: 492 ---------PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIA 542
+ + LE +SF+L+QI+ AT+NFD N+IGEGGFGPVYKG+L DGTIIA
Sbjct: 591 YLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIA 650
Query: 543 VKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF 602
VK LS+ S+QGNREFLNEIG IS L HPNLVKLYGCC+EG QL+LVYE++ENNSLA ALF
Sbjct: 651 VKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALF 710
Query: 603 GGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662
G + +QL+L+W R+KIC+G+ARGLA+LHEESR KIVHRDIKATNVLLD+ LNPKISDFG
Sbjct: 711 GPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFG 770
Query: 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722
LAKLDEE+ THISTR+AGT GYMAPEYA+ G+LT KADVYSFG+VALEIV G++N
Sbjct: 771 LAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERS 830
Query: 723 DSNCTCPLDW 732
+N +DW
Sbjct: 831 KNNTFYLIDW 840
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/799 (51%), Positives = 503/799 (62%), Gaps = 82/799 (10%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
FSLPG PP+ NL L +D + N+L+G+IP + + L+ +SV NRLSG P LG+
Sbjct: 100 FSLPGIFPPEFGNLTRLREIDLSRNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPPQLGD 159
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
IT+LT ++LE N F+G +PR LGNL +L+ L LS+N G +P L LKNLT+FRI+ N
Sbjct: 160 ITTLTDVNLETNLFTGPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGN 219
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ-TFPMLR 181
+ +G PDFI +WT L RL++QG+ +EGPIPPSIS L L +LRI+DL+G +FP LR
Sbjct: 220 SLSGKIPDFIGNWTLLERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLR 279
Query: 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241
N+ + R++LRNC I G IPEYI + L+ LDLS N LTG +PD D F MF
Sbjct: 280 NLMKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLD-AFN--FMF 336
Query: 242 IRG-----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRS-SSVENNFG 289
+ + ++LDLS NNFT QP L++NL S SV +N
Sbjct: 337 LNNNSLTGPVPQFIINSKENLDLSDNNFT-----QPPTLSCNQLDVNLISSYPSVTDNSV 391
Query: 290 VFPCTNNFTCHR--YWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISS 347
+ C SL INCGG +K+ T+ D G +T+ + WG SS
Sbjct: 392 QWCLREGLPCPEDAKQSSLFINCGGSRLKIGKDTYTDDLN-SRGQSTFSSV-SERWGYSS 449
Query: 348 TGDFTDDDDEQNTNYIANSQSSGIS----ELYNDARISPLSLTYIGYCLENGNYSVALHF 403
+G + +D Y+A + + I+ E Y AR+SP SL Y G CL G+Y + LHF
Sbjct: 450 SGVWLGKED---AGYLATDRFNLINGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHF 506
Query: 404 AEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFT-ANVSNHILE 462
AEI F+ND+T+ +LGRRIFDIY+Q L+E+DFNI A GV KP R V+ LE
Sbjct: 507 AEIMFSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLE 566
Query: 463 IRFQWAGKGTTAIPIGGVYGPLISAISVDPN----------------------------- 493
I QW GKGT IP GVYGPLISAI++ PN
Sbjct: 567 IHLQWTGKGTNVIPTRGVYGPLISAITITPNFKVDTGKPLSNGAVAGIVIAACAVFGLLV 626
Query: 494 --------------------LEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKG 533
L GL+ Q SFTLKQI+ AT+NFDP NKIGEGGFGPVYKG
Sbjct: 627 LVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKG 686
Query: 534 QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593
L DG IAVK LSSKS+QGNREF+ EIG IS LQHPNLVKLYGCCIEG +L+LVYEYLE
Sbjct: 687 VLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLE 746
Query: 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653
NNSLA ALFG E +L L+WS R KIC+GIA+GLA+LHEESR KIVHRDIKATNVLLD
Sbjct: 747 NNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLS 806
Query: 654 LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
LN KISDFGLAKL+++E THISTR+AGTIGYMAPEYA+ GYLT KADVYSFGVV LEIVS
Sbjct: 807 LNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVS 866
Query: 714 GKNNMSYVPDSNCTCPLDW 732
GK+N +Y P LDW
Sbjct: 867 GKSNTNYRPKEEFVYLLDW 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 725 bits (1871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/798 (50%), Positives = 499/798 (62%), Gaps = 80/798 (10%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
F+L G +PP+ NL L +D N+L G+IP + + L+ ++V NRLSG P LG
Sbjct: 98 FNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPPQLGQ 157
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
IT+LT + +E N F+G +P LGNL +L+ L +SSN + G +P L LKNLT+FRI+ N
Sbjct: 158 ITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRIDGN 217
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
+ +G PDFI +WT+L RL++QG+ +EGPIP SIS L L +LRI+DL+GP FP L+N
Sbjct: 218 SLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFPDLQN 277
Query: 183 MTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVPAD-LKFT---- 236
MT + R++LRNC I IPEYI + L+ LDLS N L G +PD + F
Sbjct: 278 MTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNN 337
Query: 237 -----QILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRS-SSVENNFGV 290
+ FI + Q++DLSYNNFT QP L++NL S SV NN
Sbjct: 338 NSLTGPVPQFI--LDSKQNIDLSYNNFT-----QPPTLSCNQLDVNLISSYPSVTNNSVQ 390
Query: 291 FPCTNNFTCHRYWH--SLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISST 348
+ + C H SL INCGG +KV+ + D GA+T+ + WG SS+
Sbjct: 391 WCLRKDLPCPGDAHHSSLFINCGGNRLKVDKDEYADDLN-KRGASTFSSV-SERWGYSSS 448
Query: 349 GDFTDDDDEQNTNYIA----NSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFA 404
G + +D Y+A N + E Y AR++ SL Y G C+ G+Y V L+FA
Sbjct: 449 GAWLGND---GATYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFA 505
Query: 405 EIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPF-TANVSNHILEI 463
EI F+ND+TY +LGRR+FDIY+Q L+E+DFNI A GV KP R V+ LEI
Sbjct: 506 EIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEI 565
Query: 464 RFQWAGKGTTAIPIGGVYGPLISAISVDPN------------------------------ 493
+W GKGT IP GVYGPLISAI+V PN
Sbjct: 566 HLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGVVAGIVIAACVAFGLLVL 625
Query: 494 -------------------LEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQ 534
L GL+ Q SFTLKQI+ AT+NFDP NKIGEGGFGPVYKG
Sbjct: 626 VILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGV 685
Query: 535 LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594
L DG IAVK LSSKS+QGNREF+ EIG IS LQHPNLVKLYGCCIEG +L+LVYEYLEN
Sbjct: 686 LADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLEN 745
Query: 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654
NSLA ALFG E +L L+WS R K+C+GIA+GLA+LHEESR KIVHRDIKATNVLLD L
Sbjct: 746 NSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSL 805
Query: 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
N KISDFGLAKLDEEE THISTR+AGTIGYMAPEYA+ GYLT KADVYSFGVV LEIVSG
Sbjct: 806 NAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSG 865
Query: 715 KNNMSYVPDSNCTCPLDW 732
K+N +Y P LDW
Sbjct: 866 KSNTNYRPKEEFIYLLDW 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/796 (51%), Positives = 513/796 (64%), Gaps = 78/796 (9%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLG 61
SL G LPP++ LPYL++++ NYL G+IP EWA M L ISV AN LSGN+P+ L
Sbjct: 104 MSLRGKLPPELTKLPYLKSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQ 163
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
N +LT+L +E NQFSG IP ELGNL +L L L+SN+ G LP L +L NL RI D
Sbjct: 164 NFKNLTFLGVEGNQFSGPIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICD 223
Query: 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLR 181
NNF G P +I +WT+L +L + SGL GPIP ++ L+ L +L +SD G ++FP L
Sbjct: 224 NNFTGIIPAYIGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGI-KSFPNLS 282
Query: 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVA-VPADLKFTQILM 240
+ GL R+ILRN ++G IP YIW + +L+ LDLSFN+L G + V P ++ T L+
Sbjct: 283 S-KGLKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNGIVQGVQNPPKNIYLTGNLL 341
Query: 241 FIR----GVYEHQS-LDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNF-GVFPCT 294
G+ QS +DLSYNNF+W S Q +N ++SS +NN G+ PC
Sbjct: 342 SGNIESGGLLNSQSYIDLSYNNFSWSSSCQKGS------TINTYQSSYSKNNLTGLPPCA 395
Query: 295 NNFTCHRYWHSLHINCGGGNVKVNDS----TFEGDAGVGGGAATYHLLDGTNWGISSTGD 350
C +Y LHINCGG V + +S T++ D AA+ D WG+S+TGD
Sbjct: 396 VPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFD--YWGVSNTGD 453
Query: 351 FTDDDDEQNTNYIAN--SQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQF 408
FTDD+ + + Y + + S +LY AR S LSL Y +CLENGNY+V LHF EIQF
Sbjct: 454 FTDDNSDHDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVKLHFMEIQF 513
Query: 409 TNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWA 468
++ + Y LGRRIFD+Y+Q KL +DFNI EA+G +KPV + A V+NH+LEIR WA
Sbjct: 514 SDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHMLEIRLYWA 573
Query: 469 GKGTTAIPIGGVYGPLISAISVDPNLE---GLE--------------------------- 498
GKGTT IP G YGPLISAIS+ + E G+E
Sbjct: 574 GKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIVLLAVG 633
Query: 499 ----------------------FQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT 536
Q F+ +Q++ AT+NFD NK+GEGGFG V+KG+L+
Sbjct: 634 IYARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELS 693
Query: 537 DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596
DGTIIAVK LSSKS QGNREF+NEIG IS L HPNLVKLYGCC+E DQL+LVYEY+ENNS
Sbjct: 694 DGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNS 753
Query: 597 LAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656
LA ALF G+NS LKL+W+ RQKIC+GIARGL FLH+ S ++VHRDIK TNVLLD DLN
Sbjct: 754 LALALF-GQNS-LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNA 811
Query: 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716
KISDFGLA+L E E THIST+VAGTIGYMAPEYALWG LT KADVYSFGVVA+EIVSGK+
Sbjct: 812 KISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKS 871
Query: 717 NMSYVPDSNCTCPLDW 732
N +++ ++W
Sbjct: 872 NTKQQGNADSVSLINW 887
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 564 bits (1454), Expect = e-160, Method: Compositional matrix adjust.
Identities = 338/799 (42%), Positives = 451/799 (56%), Gaps = 106/799 (13%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITS 65
G +PP++ L YL ++ N L GS+P ++ ++++++ N LSG +P +G +T
Sbjct: 113 GPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTD 172
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L L + N FSG+IP E+G L+ + + S+ L G +P+ L L I D
Sbjct: 173 LRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVT 232
Query: 126 GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTG 185
PDFI WT+L L I G+GL GPIP S S L L +LR+ D+ + + +++M
Sbjct: 233 DQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKS 292
Query: 186 LTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG- 244
L+ ++LRN N+ G IP I +LR +DLSFN+L G +P + +Q+ G
Sbjct: 293 LSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP----ASLFNLSQLTHLFLGN 348
Query: 245 --------VYEHQSL---DLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFG---- 289
+ QSL D+SYN+ S P+ P+L LNL V NNF
Sbjct: 349 NTLNGSFPTQKTQSLRNVDVSYNDL---SGSLPSWVSLPSLKLNL-----VANNFTLEGL 400
Query: 290 ---VFPCTN----NFTCHR---YWHSLHINCGGGNVK-VNDSTFEGDAGVGGGAATYHLL 338
V P N NF C+R + INCGG + V + FE + G A++ +
Sbjct: 401 DNRVLPGLNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFERE-DEDFGPASFFVS 459
Query: 339 DGTNWGISSTGDFTDDDDEQNTNYIANSQSSGI----SELYNDARISPLSLTYIGYCLEN 394
G W SS G F N YIA SQS + SEL+ AR+S S+ Y G LEN
Sbjct: 460 AGQRWAASSVGLFA---GSSNNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLEN 516
Query: 395 GNYSVALHFAEIQF--TNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEA-HGVLKPVTRP 451
G Y+V L FAEIQ + T+K LGRR FDIY+Q +LVEKDF++ A ++ V R
Sbjct: 517 GGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRV 576
Query: 452 FTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPN------------------ 493
+ ANVS + LE+ WAGKGT IPI G YGPLISA+S P+
Sbjct: 577 YKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTG 636
Query: 494 -----------------------------------LEGLEFQASSFTLKQIRAATSNFDP 518
L G++ + FT ++++AT +FDP
Sbjct: 637 TIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDP 696
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
NK+GEGGFGPVYKG L DG ++AVKLLS SRQG +F+ EI IS + H NLVKLYGC
Sbjct: 697 SNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGC 756
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
C EG+ MLVYEYL N SL ALFG + L L+WS R +ICLG+ARGL +LHEE+ +I
Sbjct: 757 CFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRI 814
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
VHRD+KA+N+LLD L P+ISDFGLAKL +++KTHISTRVAGTIGY+APEYA+ G+LT K
Sbjct: 815 VHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 874
Query: 699 ADVYSFGVVALEIVSGKNN 717
DVY+FGVVALE+VSG+ N
Sbjct: 875 TDVYAFGVVALELVSGRPN 893
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 561 bits (1447), Expect = e-159, Method: Compositional matrix adjust.
Identities = 331/791 (41%), Positives = 446/791 (56%), Gaps = 90/791 (11%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITS 65
G++P Q+ L YL ++ N L GS+P ++ ++++++ N LSG IP +G +T
Sbjct: 112 GSIPQQLWTLEYLTNLNLGQNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTD 171
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L L + N FSG+IP E+G L+ + + S+ L G LP+ L L I D
Sbjct: 172 LRLLSISSNNFSGSIPDEIGRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELT 231
Query: 126 GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTG 185
G PDFI WT+L L I G+GL GPIP S S L L +LR+ D+ N + +++M
Sbjct: 232 GQIPDFIGDWTKLTTLRILGTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKS 291
Query: 186 LTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG- 244
L+ ++LRN N+ G IP I +LR LDLSFN+L G +P + Q+ G
Sbjct: 292 LSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIP----ASLFNLRQLTHLFLGN 347
Query: 245 --------VYEHQSL---DLSYNNFTWQSPEQPACREKPNLNLNL-FRSSSVENNF--GV 290
+ QSL D+SYN+ + P + + F ++N G+
Sbjct: 348 NTLNGSLPTQKGQSLSNVDVSYNDLSGSLPSWVSLPNLNLNLVANNFTLEGLDNRVLSGL 407
Query: 291 FPCTNNFTCHR---YWHSLHINCGGGNVK-VNDSTFEGDAGVGGGAATYHLLDGTNWGIS 346
NF C+R + INCGG ++ V ++ FE + G A++ + G W S
Sbjct: 408 NCLQKNFPCNRGKGIYSDFSINCGGPEIRSVTEAVFERE-DEDLGPASFVVSAGQRWAAS 466
Query: 347 STGDFTDDDDEQNTNYIANSQSSGI----SELYNDARISPLSLTYIGYCLENGNYSVALH 402
S G F N YI+ SQS + SEL+ AR+S SL Y G LENG Y+V L
Sbjct: 467 SVGLFAGS---SNNIYISTSQSQFVNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQ 523
Query: 403 FAEIQF--TNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEA-HGVLKPVTRPFTANVSNH 459
FAEIQ + T++ LGRR FDIY+Q +LVEKDF++ A ++ V R + ANVS +
Sbjct: 524 FAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQN 583
Query: 460 ILEIRFQWAGKGTTAIPIGGVYGPLISAISV----------------------------- 490
LEI WAGKGT IPI G YGPLISA+
Sbjct: 584 HLEIHLFWAGKGTCCIPIQGAYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVG 643
Query: 491 ------------------------DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGG 526
D + ++ + +FT ++++AT +FDP NK+GEGG
Sbjct: 644 VGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGG 703
Query: 527 FGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586
FGPVYKG+L DG +AVKLLS SRQG +F+ EI IS +QH NLVKLYGCC EG+ +
Sbjct: 704 FGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRL 763
Query: 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKAT 646
LVYEYL N SL ALFG L L+WS R +ICLG+ARGL +LHEE+R +IVHRD+KA+
Sbjct: 764 LVYEYLPNGSLDQALFG--EKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKAS 821
Query: 647 NVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGV 706
N+LLD L PK+SDFGLAKL +++KTHISTRVAGTIGY+APEYA+ G+LT K DVY+FGV
Sbjct: 822 NILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 881
Query: 707 VALEIVSGKNN 717
VALE+VSG+ N
Sbjct: 882 VALELVSGRPN 892
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 121/224 (54%), Positives = 165/224 (73%), Gaps = 2/224 (0%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREF 557
E + ++ + AT NF NK+G+GGFG VYKG+L DG IAVK LS S QG EF
Sbjct: 510 ELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEF 569
Query: 558 LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
+NE+ I+ LQH NLV++ GCCIEGD+ ML+YEYLEN SL LF G+ + KLNW+ R
Sbjct: 570 MNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLF-GKTRRSKLNWNERF 628
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST- 676
I G+ARGL +LH++SRF+I+HRD+K +N+LLD+++ PKISDFG+A++ E ++T +T
Sbjct: 629 DITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTM 688
Query: 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720
+V GT GYM+PEYA++G + K+DV+SFGV+ LEIVSGK N +
Sbjct: 689 KVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGF 732
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 732 | ||||||
| 224116760 | 1024 | predicted protein [Populus trichocarpa] | 0.987 | 0.706 | 0.645 | 0.0 | |
| 255562540 | 2046 | kinase, putative [Ricinus communis] gi|2 | 0.990 | 0.354 | 0.640 | 0.0 | |
| 224079009 | 1030 | predicted protein [Populus trichocarpa] | 0.987 | 0.701 | 0.625 | 0.0 | |
| 359483540 | 1066 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.670 | 0.612 | 0.0 | |
| 449520451 | 987 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.991 | 0.735 | 0.583 | 0.0 | |
| 449459314 | 1019 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.708 | 0.581 | 0.0 | |
| 297851398 | 1023 | hypothetical protein ARALYDRAFT_473178 [ | 0.990 | 0.708 | 0.567 | 0.0 | |
| 224078996 | 942 | predicted protein [Populus trichocarpa] | 0.939 | 0.730 | 0.588 | 0.0 | |
| 359483546 | 917 | PREDICTED: probable LRR receptor-like se | 0.920 | 0.735 | 0.572 | 0.0 | |
| 357519155 | 1039 | ATP-binding/protein serine/threonine kin | 0.991 | 0.698 | 0.551 | 0.0 |
| >gi|224116760|ref|XP_002317385.1| predicted protein [Populus trichocarpa] gi|222860450|gb|EEE97997.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2608), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/788 (64%), Positives = 594/788 (75%), Gaps = 65/788 (8%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
FSL G LPP++ LPYLE++D +YNYL+GSIP EWA +QLK I++ ANRLSGNIPS+LGN
Sbjct: 92 FSLAGELPPELNQLPYLESIDLSYNYLNGSIPSEWAPLQLKSIALLANRLSGNIPSYLGN 151
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
+TSLTYLDLE NQFSG IP ELG LVNL+TL LSSN+L GNLPMEL KL+NLTDFRINDN
Sbjct: 152 LTSLTYLDLELNQFSGMIPHELGKLVNLKTLILSSNKLDGNLPMELSKLRNLTDFRINDN 211
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NFNGS PDF+++W QL RLE+ SGLEGPIP SISAL+ L LRI+D+ +Q+FP L N
Sbjct: 212 NFNGSIPDFVENWKQLKRLEMVASGLEGPIPSSISALETLTDLRITDITSTDQSFPDLSN 271
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT------ 236
+TGLTR++LR CNI+GEIP YIW + LR LDLSFN+L GELP+ L F
Sbjct: 272 ITGLTRLLLRGCNISGEIPLYIWEMSKLRILDLSFNKLRGELPNAITTETLVFIFLSGNL 331
Query: 237 ---QILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPC 293
I MF +G+ ++DLSYNNF+ QS QPAC+++ ++ LNLFRSSS+ N+ G C
Sbjct: 332 LTGNIPMFRKGM----TVDLSYNNFSEQSTGQPACQQRTDVTLNLFRSSSMGNDLG-GAC 386
Query: 294 TNNFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTD 353
++ C +YWHSL+INCGG NV++N ST+EGDA V GGA ++ WG+SSTGDF D
Sbjct: 387 MDDLKCDQYWHSLYINCGGQNVQINGSTYEGDAAVSGGAGLFY-QSADEWGLSSTGDFMD 445
Query: 354 DDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKT 413
D+D QN Y N S I+ELY ARISP+SLTY CLENGNY+V+LHFAEI+FTND T
Sbjct: 446 DNDFQNRAYTENVPSLNINELYQTARISPISLTYYRRCLENGNYTVSLHFAEIRFTNDNT 505
Query: 414 YKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGKGTT 473
+ +LGRR+FDIYIQ+ LVEKDFNIE +A GV KPVT A V+N+ILEIR WAGKGT
Sbjct: 506 FNSLGRRLFDIYIQNNLVEKDFNIEVQAAGVAKPVTEIHNAIVTNNILEIRLFWAGKGTR 565
Query: 474 AIPIGGVYGPLISAISVDPN---------------------------------------- 493
IP+ GVYGPLISAISVDPN
Sbjct: 566 RIPVSGVYGPLISAISVDPNFKPRFSREEKTKTVPIIVGVVVGFCLIFSVLAIFWWRCCF 625
Query: 494 ---------LEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVK 544
LEG+E Q SFTLKQI+AAT NFDP NKIGEGGFGPVYKG L DGT+IAVK
Sbjct: 626 RINKKRRKGLEGIEIQTVSFTLKQIKAATDNFDPANKIGEGGFGPVYKGLLPDGTVIAVK 685
Query: 545 LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGG 604
LSSKS QGNREFLNEIG ISC+QHP+LVKL+GCCIEGDQL+LVYEY+ENNSL+ ALFG
Sbjct: 686 QLSSKSSQGNREFLNEIGVISCMQHPHLVKLHGCCIEGDQLLLVYEYMENNSLSRALFGP 745
Query: 605 ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
E+ QL L+W RQKIC+GIA+GLAFLHEESR KIVHRDIK TNVLLD+DLNPKISDFGLA
Sbjct: 746 EH-QLHLDWKTRQKICVGIAKGLAFLHEESRLKIVHRDIKVTNVLLDKDLNPKISDFGLA 804
Query: 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDS 724
KLDE EKT ISTRVAGT+GYMAPEYALWG LTYKADVYSFG+VALEIVSGK NMS P++
Sbjct: 805 KLDEREKTFISTRVAGTVGYMAPEYALWGRLTYKADVYSFGIVALEIVSGKYNMSCGPEN 864
Query: 725 NCTCPLDW 732
+C LDW
Sbjct: 865 QYSCLLDW 872
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562540|ref|XP_002522276.1| kinase, putative [Ricinus communis] gi|223538529|gb|EEF40134.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2545), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/785 (64%), Positives = 587/785 (74%), Gaps = 60/785 (7%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
FSLPG LPP++V L +LE +DFAYNYL+GSIPREWAS+ LK+ISV ANRLSGNIP+HL N
Sbjct: 91 FSLPGELPPELVQLSFLEHIDFAYNYLNGSIPREWASIPLKFISVLANRLSGNIPTHLEN 150
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
T+LT LDLE NQFSG +PRELG LVNL L+LSSN+L GNLP+EL +L+NLTDFRINDN
Sbjct: 151 FTNLTSLDLELNQFSGNVPRELGKLVNLRILKLSSNKLSGNLPVELAELRNLTDFRINDN 210
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NF GS PD IQ+W QL RLE+QGSGLEGPIP S+S L+KL LRISD+ NQ FP L N
Sbjct: 211 NFTGSIPDSIQNWRQLGRLEMQGSGLEGPIPSSVSILEKLTDLRISDINVTNQAFPDLIN 270
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM-- 240
+TGL+R+ILRNC I+G IP YIW + LR LDLSFN L GELP+ + I +
Sbjct: 271 ITGLSRLILRNCKISGNIPSYIWTMSRLRVLDLSFNNLHGELPNAITTETNRLLYIFLNG 330
Query: 241 -FIRGVYEHQS----LDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTN 295
F+ GV S +DLSYNNFT Q +QPACR+ ++ LNLFRSSS+ N+ G C
Sbjct: 331 NFLSGVIPFFSSGLNIDLSYNNFTRQ--DQPACRQT-DIRLNLFRSSSMGNDIG-GACAK 386
Query: 296 NFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDD 355
+F C R+WHSL+INCGG N++VN +T+EGD VGGGA+T++ WG SSTGDF DDD
Sbjct: 387 SFDCDRHWHSLYINCGGENMEVNGNTYEGDGDVGGGASTFY-PSNNGWGFSSTGDFMDDD 445
Query: 356 DEQNTNYIANSQSSGISE-LYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKTY 414
D N YIA S SS IS LY ARI+PLSLTY CL +GNY+V+LHFAEIQFTND TY
Sbjct: 446 DFLNEAYIAESPSSLISNGLYRTARIAPLSLTYYRQCLIDGNYTVSLHFAEIQFTNDSTY 505
Query: 415 KTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGKGTTA 474
+LGRR+F+IYIQ+ +VE++FNI EA+GV + + + A V+N+ILEIR WAGKGTT
Sbjct: 506 NSLGRRLFNIYIQNDMVEQNFNIADEANGVATLIKKMYNATVTNNILEIRLSWAGKGTTR 565
Query: 475 IPIGGVYGPLISAISVDP------------------------------------------ 492
IP GVYGPLISAIS+DP
Sbjct: 566 IPDSGVYGPLISAISIDPHFKPPSGGGNTKIAPIIVGVLGSCLIILALGLIVWKRYFRAK 625
Query: 493 -----NLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLS 547
+ EGLE Q SFTLKQI+ AT+NF P NKIGEGGFGPVYKG L D T+IAVK LS
Sbjct: 626 NGRQKDFEGLEIQTVSFTLKQIKTATNNFAPANKIGEGGFGPVYKGLLADNTVIAVKQLS 685
Query: 548 SKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENS 607
SKS QGNREFLNEIG ISC+QHPNLVKL+GCCIEG+QL+LVYEY+ENNSLAH L G E+
Sbjct: 686 SKSNQGNREFLNEIGVISCMQHPNLVKLHGCCIEGNQLLLVYEYMENNSLAHTLLGPEDR 745
Query: 608 QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667
LKL+W RQ+IC+GIA+GLA+LHEES KIVHRDIKATNVLLD+ LNPKISDFGLAKLD
Sbjct: 746 CLKLDWQTRQRICVGIAKGLAYLHEESTLKIVHRDIKATNVLLDKHLNPKISDFGLAKLD 805
Query: 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCT 727
EEKTHISTRVAGTIGYMAPEYALWGYLTYKAD+YSFG+VALEIVSGK+NMS P+SN
Sbjct: 806 SEEKTHISTRVAGTIGYMAPEYALWGYLTYKADIYSFGIVALEIVSGKHNMSRGPESNFG 865
Query: 728 CPLDW 732
C LDW
Sbjct: 866 CLLDW 870
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079009|ref|XP_002305716.1| predicted protein [Populus trichocarpa] gi|222848680|gb|EEE86227.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2509), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/811 (62%), Positives = 588/811 (72%), Gaps = 88/811 (10%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
FSL G LPP+++ L YLE++D +YN L GSIP +WAS+QLK I++ ANRLSGNIPS+LGN
Sbjct: 60 FSLAGELPPELIQLRYLESIDLSYNELGGSIPSQWASLQLKMIALLANRLSGNIPSYLGN 119
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
TSL YLDLE NQFSG IPRELGNLVNLETL LSSN+L GNLP EL +LKNLTDFRINDN
Sbjct: 120 FTSLAYLDLELNQFSGMIPRELGNLVNLETLILSSNKLDGNLPKELAELKNLTDFRINDN 179
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NFNGS PDF+Q+W QL RLE+ SGLEGPIP SISAL L LRI+D+ NQ+FP L N
Sbjct: 180 NFNGSIPDFVQNWKQLKRLEMVASGLEGPIPSSISALKTLTDLRITDINFTNQSFPDLSN 239
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT------ 236
+ GLTR++LRNCNI+GEIP YIW + LR LDLSFN+L G LP+ L F
Sbjct: 240 IVGLTRLLLRNCNISGEIPPYIWEMSKLRILDLSFNKLHGNLPNAITTEALVFIFLSGNR 299
Query: 237 ---QILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPC 293
I MF +G+ S+DLSYNNF+ QS QPAC++ ++ LNLFRSSS+ N+ G C
Sbjct: 300 LTGNIPMFRKGM----SVDLSYNNFSQQSSGQPACQQGMDVTLNLFRSSSMGNDIG-GAC 354
Query: 294 TNNFTCHRY------------------------WHSLHINCGGGNVKVNDSTFEGDAGVG 329
++ TC + WHS++INCGG NVK N ST+EGDA
Sbjct: 355 MDDLTCDKCKYVILRFNVNSLYRSIVVLFLLADWHSMYINCGGQNVKTNGSTYEGDAAAS 414
Query: 330 GGAATYHLLDGTNWGISSTGDFTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIG 389
GAA ++ + WGISSTGDF DD+D QN YI N S I+ELY AR+SP+SLTY
Sbjct: 415 SGAAIFYRSE-DEWGISSTGDFMDDNDFQNRAYIENMPSLNINELYQTARVSPISLTYYH 473
Query: 390 YCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVT 449
CLENGNY+V+LHFAEI+F ND TY +LGRR+FD+YIQ+ LVEKDFNIE EA GV KPVT
Sbjct: 474 RCLENGNYTVSLHFAEIRFKNDNTYNSLGRRLFDVYIQNNLVEKDFNIEVEAAGVAKPVT 533
Query: 450 RPFTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPN---------------- 493
+ A V+N+IL+I WAGKGTT IP+ GVYGPLISAISV PN
Sbjct: 534 KIHNATVTNNILDIHLYWAGKGTTRIPVSGVYGPLISAISVYPNFKPRFSGGGKTKTVPI 593
Query: 494 --------------------------------LEGLEFQASSFTLKQIRAATSNFDPMNK 521
LEG+E Q SFTLKQI+AAT NF+P NK
Sbjct: 594 ILGVVGFCLVFSALAIFWWKCYFRVQKKRQKGLEGIEIQTVSFTLKQIKAATGNFNPANK 653
Query: 522 IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581
IGEGGFGPVYKG L DGT+IAVK LSSKS QGNREFLNEIG ISC+QHP+LVKL+GCCIE
Sbjct: 654 IGEGGFGPVYKGLLPDGTVIAVKQLSSKSSQGNREFLNEIGVISCMQHPHLVKLHGCCIE 713
Query: 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHR 641
GDQL+LVYEY+ENNSL+ ALFG EN QL L+W RQKIC+GIA+GL+FLHEESR KIVHR
Sbjct: 714 GDQLLLVYEYMENNSLSRALFGPEN-QLHLDWKTRQKICIGIAKGLSFLHEESRLKIVHR 772
Query: 642 DIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADV 701
DIK TNVLLD+DLNPKISDFGLAKLDE EKT+ISTRVAGT+GYMAPEYALWG LTYKADV
Sbjct: 773 DIKVTNVLLDKDLNPKISDFGLAKLDEREKTYISTRVAGTVGYMAPEYALWGRLTYKADV 832
Query: 702 YSFGVVALEIVSGKNNMSYVPDSNCTCPLDW 732
YSFG+VALEIVSGK+N S PD +C LDW
Sbjct: 833 YSFGIVALEIVSGKHNKSCGPDDQFSCLLDW 863
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483540|ref|XP_002264878.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RFK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2422), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/803 (61%), Positives = 563/803 (70%), Gaps = 88/803 (10%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
+LPGTLPP++ NL YL+ +DFAYNYL+GSIP +WASM L IS+ ANRLSG IP +GN
Sbjct: 102 LNLPGTLPPELANLTYLQNIDFAYNYLNGSIPTQWASMPLINISLLANRLSGEIPKEIGN 161
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
+L+YL LE NQFSG +P E+G LVNL TL LSSN+L LP EL L +L D INDN
Sbjct: 162 FANLSYLSLEANQFSGPVPSEIGKLVNLHTLILSSNQLSETLPKELGGL-DLRDL-INDN 219
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NFNG+ PDFIQ+W QL RLE+ SGL+GPIP +IS L LNQLRISD+ G NQ FP+L N
Sbjct: 220 NFNGTIPDFIQNWIQLTRLEMHASGLQGPIPSNISVLKNLNQLRISDINGTNQPFPVLDN 279
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
+ L R++LRNCNI+GEIP IW + NLR LDLSFN+LTGELP LKF +F+
Sbjct: 280 IKSLRRLVLRNCNISGEIPSIIWRMTNLRVLDLSFNKLTGELPTAISSDSLKF----IFL 335
Query: 243 RG-----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVF 291
G + + ++DLSYNNFTWQSPEQPAC N F S
Sbjct: 336 TGNLLSGNISGSFLKDGVTIDLSYNNFTWQSPEQPACD---NYKYQTFISDLS------L 386
Query: 292 PCTNNFTCHRYW----------HSLHINCGGGNVKVNDS----TFEGDAGVGGGAATYHL 337
C C W HSL++NCGG VKVN+ T+EGD A Y+L
Sbjct: 387 TCLAWPLCLSLWCLLVKLRGDGHSLYVNCGGEKVKVNEDKRSITYEGDTARDNSDAKYYL 446
Query: 338 -LDGTNWGISSTGDFTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGN 396
D NWG SS+GDF DD++E N +YI S+S LYN ARISPLSLTY YCL+NG+
Sbjct: 447 SADNNNWGFSSSGDFMDDNNELNKDYIITSKSQISETLYNTARISPLSLTYFRYCLQNGS 506
Query: 397 YSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANV 456
YSV LHFAEI+FTND TY +LG+R+FDIY QD+LV+KDFNIE A G LKP T PF A V
Sbjct: 507 YSVRLHFAEIEFTNDSTYGSLGKRMFDIYAQDELVKKDFNIEDHAKGALKPYTLPFNATV 566
Query: 457 SNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPNLE--------------------- 495
+N++LEIRF +AG+GTT IP GVYGPLISAISVDPN
Sbjct: 567 TNNVLEIRFYFAGRGTTRIPQRGVYGPLISAISVDPNFTPPSEGGKTKTAPIIIGVVAAC 626
Query: 496 --------------------------GLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGP 529
GL+ SFTLKQI+AAT+NFD +N+IGEGGFGP
Sbjct: 627 LICLALGIFWWRVNLRTKNGREKDFGGLDVHIGSFTLKQIKAATNNFDSLNQIGEGGFGP 686
Query: 530 VYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589
VYKG L DGT IAVK LSSKS QGNREFLNEIG ISCLQHPNLVKL+GCCIEG+QL+LVY
Sbjct: 687 VYKGLLPDGTAIAVKQLSSKSTQGNREFLNEIGMISCLQHPNLVKLHGCCIEGNQLLLVY 746
Query: 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
EY+ENNSLA AL G EN QLKL+W RQKIC+GIARGLAFLHEESR KIVHRDIK TNVL
Sbjct: 747 EYMENNSLARALLGPENCQLKLDWPTRQKICVGIARGLAFLHEESRLKIVHRDIKGTNVL 806
Query: 650 LDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVAL 709
LD DLNPKISDFGLAKL EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVAL
Sbjct: 807 LDGDLNPKISDFGLAKLHEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVAL 866
Query: 710 EIVSGKNNMSYVPDSNCTCPLDW 732
EIVSGK+NMSY P ++C C LDW
Sbjct: 867 EIVSGKHNMSYQPKNDCACLLDW 889
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520451|ref|XP_004167247.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase RFK1-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/800 (58%), Positives = 561/800 (70%), Gaps = 74/800 (9%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNI 63
+LPG LPP+IV LPYL+ VDFAYNYLHG+IPREWAS +L IS+ NRL+G IP L NI
Sbjct: 64 NLPGVLPPEIVKLPYLKEVDFAYNYLHGNIPREWASTRLTTISLLVNRLTGEIPDALWNI 123
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
T+LT L+LE NQF+G IP +LG L NL+ L LSSN+ G +P LKNLTDFRINDNN
Sbjct: 124 TTLTSLNLEGNQFTGAIPSQLGRLSNLQYLLLSSNQFNGTIPTTFAGLKNLTDFRINDNN 183
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
NGS P+FI++W L RLE+ SGL+GPIP IS L L +LRISD+ GP Q FP L NM
Sbjct: 184 LNGSIPEFIKNWILLKRLELHASGLQGPIPSKISILRNLQELRISDINGPKQDFPELTNM 243
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM--F 241
TG+ R++LRNCNIAG+IP Y+W + + LD+SFNQLTGE+P+ ++F +L
Sbjct: 244 TGMVRLVLRNCNIAGKIPSYVWKLPAMEMLDVSFNQLTGEIPEDISMERIRFLXLLTGNM 303
Query: 242 IRG------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGV-FPCT 294
+ G + + ++DLSYNN WQ P ACR+ N+NLNLFRSSS N PC
Sbjct: 304 LSGNLPESILMDGTNVDLSYNNLKWQGPGHHACRKNLNMNLNLFRSSSNSNTLQENLPCL 363
Query: 295 NNFTCHRYWHSLHINCGGGN--VKVNDST--FEGDAGVGGGAATYHLLDGTNWGISSTGD 350
+ C +Y +N GG + ++VN+ + GDA + GG A +++ + WG+SSTGD
Sbjct: 364 KDSICSKYSKCWFVNSGGNDLTMEVNNRNILYNGDADIEGGTAKFYIDQDSYWGLSSTGD 423
Query: 351 FTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTN 410
F DD D QNT Y + SS +SELY+ AR SP++LTY CLENGNYSV LHFAE+QFTN
Sbjct: 424 FMDDFDHQNTRYTLSLSSSNLSELYSTARRSPITLTYFHRCLENGNYSVTLHFAELQFTN 483
Query: 411 DKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFT-ANVSNHILEIRFQWAG 469
DKTYK+LGRR FDIYIQD+LV ++F+I+ +A G KP F +V NH+LEIRF WAG
Sbjct: 484 DKTYKSLGRRKFDIYIQDRLVLENFDIDEKAGGAQKPTEMQFAYISVFNHVLEIRFYWAG 543
Query: 470 KGTTAIPIGGVYGPLISAISVDPNLE---------------------------------- 495
KGTT IP GVYGPLISAISV +L+
Sbjct: 544 KGTTRIPERGVYGPLISAISVYSDLKYCPIRESSKKKTVALVVGITVGLLCLATIIIVGL 603
Query: 496 -----------------GLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG 538
G+E Q FTLKQI+AAT++FD NKIGEGGFGPVYKGQL DG
Sbjct: 604 LWWKGSLKVIRRSKGGTGIEVQTGIFTLKQIKAATNHFDSCNKIGEGGFGPVYKGQLVDG 663
Query: 539 TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598
TI+A+K LSSKSRQGNREFLNEIG ISCLQHPNLVKL+GCCIEGDQL+LVYEYLENNSLA
Sbjct: 664 TIVAIKQLSSKSRQGNREFLNEIGMISCLQHPNLVKLHGCCIEGDQLLLVYEYLENNSLA 723
Query: 599 HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658
ALFG +L L+W R +IC+GIA+GLA+LHEES KIVHRDIKATNVLLD +LNPKI
Sbjct: 724 RALFG---CRLNLDWPTRLRICIGIAKGLAYLHEESSLKIVHRDIKATNVLLDGELNPKI 780
Query: 659 SDFGLAKLDEEEKTHISTRVAGTI------GYMAPEYALWGYLTYKADVYSFGVVALEIV 712
SDFGLAKL++EEKTHI+TRVAGT+ GYMAPEYALWGYLTYKADVYSFGVVALEI+
Sbjct: 781 SDFGLAKLNDEEKTHITTRVAGTMYVIVLSGYMAPEYALWGYLTYKADVYSFGVVALEII 840
Query: 713 SGKNNMSYVPDSNCTCPLDW 732
G++N YVP C C LDW
Sbjct: 841 GGRSNNDYVPSETCVCLLDW 860
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459314|ref|XP_004147391.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RFK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/803 (58%), Positives = 561/803 (69%), Gaps = 81/803 (10%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNI 63
+LPG LPP+IV LPYL+ VDFAYNYLHG+IPREWAS +L IS+ NRL+G IP L NI
Sbjct: 97 NLPGVLPPEIVKLPYLKEVDFAYNYLHGNIPREWASTRLTTISLLVNRLTGEIPDALWNI 156
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
T+LT L+LE NQF+G IP +LG L NL+ L LSSN+ G +P LKNLTDFRINDNN
Sbjct: 157 TTLTSLNLEGNQFTGAIPSQLGRLSNLQYLLLSSNQFNGTIPTTFAGLKNLTDFRINDNN 216
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
NGS P+FI++W L RLE+ SGL+GPIP IS L L +LRISD+ GP Q FP L NM
Sbjct: 217 LNGSIPEFIKNWILLKRLELHASGLQGPIPSKISILRNLQELRISDINGPKQDFPELTNM 276
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243
TG+ R++LRNCNIAG+IP Y+W + + LD+SFNQLTGE+P+ ++F +F+
Sbjct: 277 TGMVRLVLRNCNIAGKIPSYVWKLPAMEMLDVSFNQLTGEIPEDISMERIRF----LFLT 332
Query: 244 G-----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGV-F 291
G + + ++DLSYNN WQ P ACR+ N+NLNLFRSSS N
Sbjct: 333 GNMLSGNLPESILMDGTNVDLSYNNLKWQGPGHHACRKNLNMNLNLFRSSSNSNTLQENL 392
Query: 292 PCTNNFTCHRYWHSLHINCGGGN--VKVNDST--FEGDAGVGGGAATYHLLDGTNWGISS 347
PC + C +Y +N GG + ++VN+ + GDA + GG A +++ + WG+SS
Sbjct: 393 PCLKDSICSKYSKCWFVNSGGNDLTMEVNNRNILYNGDADIEGGTAKFYIDQDSYWGLSS 452
Query: 348 TGDFTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQ 407
TGDF DD D QNT Y + SS +SELY+ AR SP++LTY CLENGNYSV LHFAE+Q
Sbjct: 453 TGDFMDDFDHQNTRYTLSLSSSNLSELYSTARRSPITLTYFHRCLENGNYSVTLHFAELQ 512
Query: 408 FTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFT-ANVSNHILEIRFQ 466
FTNDKTYK+LGRR FDIYIQD+LV ++F+I+ +A G KP F +V NH+LEIRF
Sbjct: 513 FTNDKTYKSLGRRKFDIYIQDRLVLENFDIDEKAGGAQKPTEMQFAYISVFNHVLEIRFY 572
Query: 467 WAGKGTTAIPIGGVYGPLISAISVDPNLE------------------------------- 495
WAGKGTT IP GVYGPLISAISV +L+
Sbjct: 573 WAGKGTTRIPERGVYGPLISAISVYSDLKYCPIRESSKKKTVALVVGITVGLLCLATIII 632
Query: 496 --------------------GLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQL 535
G+E Q FTLKQI+AAT++FD NKIGEGGFGPVYKGQL
Sbjct: 633 VGLLWWKGSLKVIRRSKGGTGIEVQTGIFTLKQIKAATNHFDSCNKIGEGGFGPVYKGQL 692
Query: 536 TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595
DGTI+A+K LSSKSRQGNREFLNEIG ISCLQHPNLVKL+GCCIEGDQL+LVYEYLENN
Sbjct: 693 VDGTIVAIKQLSSKSRQGNREFLNEIGMISCLQHPNLVKLHGCCIEGDQLLLVYEYLENN 752
Query: 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655
SLA ALFG +L L+W R +IC+GIA+GLA+LHEES KIVHRDIKATNVLLD +LN
Sbjct: 753 SLARALFG---CRLNLDWPTRLRICIGIAKGLAYLHEESSLKIVHRDIKATNVLLDGELN 809
Query: 656 PKISDFGLAKLDEEEKTHISTRVAGTI------GYMAPEYALWGYLTYKADVYSFGVVAL 709
PKISDFGLAKL++EEKTHI+TRVAGT+ GYMAPEYALWGYLTYKADVYSFGVVAL
Sbjct: 810 PKISDFGLAKLNDEEKTHITTRVAGTMYVIVLSGYMAPEYALWGYLTYKADVYSFGVVAL 869
Query: 710 EIVSGKNNMSYVPDSNCTCPLDW 732
EI+ G++N YVP C C LDW
Sbjct: 870 EIIGGRSNNDYVPSETCVCLLDW 892
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297851398|ref|XP_002893580.1| hypothetical protein ARALYDRAFT_473178 [Arabidopsis lyrata subsp. lyrata] gi|297339422|gb|EFH69839.1| hypothetical protein ARALYDRAFT_473178 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/790 (56%), Positives = 552/790 (69%), Gaps = 65/790 (8%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT 64
LPGTLP QIV LPYL +D AYNY++G++PREWAS L +IS+ NRLSG IP GN +
Sbjct: 113 LPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISLLVNRLSGEIPKEFGNSS 171
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
+LTYLDLE N+FSGTIP+ELGNLV+L+ L LSSN+L G LP L +L+N+TDFRIND
Sbjct: 172 TLTYLDLESNEFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRINDLQL 231
Query: 125 NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMT 184
+G+ P ++Q+W QL RLE+ SGL GPIP IS L L LRISD++GP Q FP L+N+T
Sbjct: 232 SGTIPSYLQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSLKNVT 291
Query: 185 GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL-MFIR 243
GL ++IL+NCNI+G+IP Y+ +K L LDLSFN+L G +P A +L+F + +
Sbjct: 292 GLVKLILKNCNISGQIPTYLSNLKELETLDLSFNKLVGGIPSFAQAENLRFIILAGNMLE 351
Query: 244 G------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNNF 297
G + + +LDLSYNN WQSPE ACR NLNLNLF+S+S + + PC +F
Sbjct: 352 GDAPDELLRDGITLDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIKDF 411
Query: 298 TCHRYWHSLHINCGGGNVKVNDST----FEGDAGVGGGAATYHLLDGTNWGISSTGDFTD 353
C RY LH+NCGG ++ V + +EGD V GGAA Y L NWG SSTGDF D
Sbjct: 412 KCPRYSSCLHVNCGGSDIYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMD 471
Query: 354 DDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKT 413
D++ QNT + +S +S+LY ARI+P+SLTY CLENGNY++ L FAE++FTND+
Sbjct: 472 DNNFQNTRFTMFVPASNLSDLYKSARIAPVSLTYFHACLENGNYTINLDFAEMRFTNDEN 531
Query: 414 YKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGKGTT 473
Y LGRR+FDIYIQ+KLV KDFNI EA G P+ +PFTA VSNH L IR WAGKGTT
Sbjct: 532 YSRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPFTAYVSNHFLTIRLSWAGKGTT 591
Query: 474 AIPIGGVYGPLISAISV------------------------------------------- 490
IP GVYGPLISAIS+
Sbjct: 592 RIPTRGVYGPLISAISIVSDSKPCERPKTGMSPGAYIAVGVGAPCLIIFIVGILWMCGCL 651
Query: 491 --------DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIA 542
DP E E + +FTL+QI+ AT +F+P NKIGEGGFGPV+KG L DG ++A
Sbjct: 652 PRCGQRRKDPYEE--ELPSGTFTLRQIKFATDDFNPTNKIGEGGFGPVFKGVLADGRVVA 709
Query: 543 VKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF 602
VK LSSKSRQGNREFLNEIG ISCLQHPNLVKL+G C+E QL+LVYEY+ENNSL+ ALF
Sbjct: 710 VKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLVYEYMENNSLSSALF 769
Query: 603 GGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662
++ Q+ ++WS R KIC GIA+GLAFLHEES K VHRDIKATN+LLD+DL PKISDFG
Sbjct: 770 SPKHKQIPMDWSTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFG 829
Query: 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722
LA+LDEEEKTHIST+VAGTIGYMAPEYALWGYLT+KADVYSFGV+ LEIV+G N +++
Sbjct: 830 LARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMG 889
Query: 723 DSNCTCPLDW 732
+ C L++
Sbjct: 890 AGDSVCLLEF 899
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078996|ref|XP_002305711.1| predicted protein [Populus trichocarpa] gi|222848675|gb|EEE86222.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/797 (58%), Positives = 550/797 (69%), Gaps = 109/797 (13%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
++LPG LP Q+V LP L+ DFAYNYL+G++PREWASMQL ISV NRLSG IP LGN
Sbjct: 64 YNLPGVLPTQLVKLPRLQRSDFAYNYLNGTLPREWASMQLTSISVLVNRLSGEIPKELGN 123
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
IT+LT L LE NQF GTIP +LG L+NL+ L LSSN L GNLP+ L NLTDFRINDN
Sbjct: 124 ITTLTTLSLEANQFYGTIPPDLGKLINLQALGLSSNHLSGNLPVSFAGLINLTDFRINDN 183
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NF+G+ P FIQ+W +L RLE+ +GLEGPIP +IS L+ L +LRISDL GP Q FPML N
Sbjct: 184 NFSGTIPIFIQNWKKLKRLEMHATGLEGPIPSNISLLNNLAELRISDLNGPTQGFPMLSN 243
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
MTG+ ++ LRNCNI+G++P Y+W +K+L LD+SFN+L G++PD L+F +F+
Sbjct: 244 MTGMIKLTLRNCNISGKLPAYLWTMKSLEALDVSFNKLVGKIPDTITADRLRF----VFL 299
Query: 243 RG-----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVF 291
G + + ++DLSYNNF Q PEQPAC+E
Sbjct: 300 TGNLLSGDVPDSILKDGSNVDLSYNNFELQGPEQPACQE--------------------- 338
Query: 292 PCTNNFTCHRYWHSLHINCGGGNV--KVNDSTF--EGDAGVGGGAATYHLLDGTNWGISS 347
N GG +V K N +TF EGD GGAA Y + + + WG SS
Sbjct: 339 -----------------NIGGKDVIIKENKTTFSYEGDGQEEGGAAKYFVNEQSFWGFSS 381
Query: 348 TGDFTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQ 407
+GDF DD+D QNT Y + QSS + ELY+ ARISP+SLTY YCLENGNY+V LHFAEIQ
Sbjct: 382 SGDFMDDNDYQNTRYTVSMQSSTLPELYSTARISPISLTYFHYCLENGNYTVNLHFAEIQ 441
Query: 408 FTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKP-VTRPFTANVSNHILEIRFQ 466
FTND TYK+LGRRIFDIY+Q FNIE + KP V + +V+N++LEIRF
Sbjct: 442 FTNDLTYKSLGRRIFDIYVQVCSYTNKFNIEDQVGSAEKPLVKQVLNVSVTNNMLEIRFY 501
Query: 467 WAGKGTTAIPIGGVYGPLISAISVDPNL-------------------------------- 494
+AGKGTT P GVYGP+IS ISV +L
Sbjct: 502 FAGKGTTRTPDRGVYGPIISGISVFSDLKPCSSGKKKGTVYAVAGAVVASCLIAIILGIL 561
Query: 495 ----------------EGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG 538
EGL F +F+LKQIRAAT +FDP NKIGEGGFGPVYKGQL DG
Sbjct: 562 WWKDYLPGKWCRKKDAEGLNFPNGTFSLKQIRAATDDFDPSNKIGEGGFGPVYKGQLPDG 621
Query: 539 TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598
T+IAVK LSSKSRQGNREFLNE+G ISCLQHPNLVKL+GCCIE DQL+LVYEY+ENNSLA
Sbjct: 622 TVIAVKQLSSKSRQGNREFLNEMGIISCLQHPNLVKLHGCCIESDQLLLVYEYMENNSLA 681
Query: 599 HALFG--GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656
ALFG E +Q L+W R KIC+GIARGLAFLHEESRFKIVHRDIKATNVLLD DLN
Sbjct: 682 RALFGECHEINQPNLDWPSRLKICIGIARGLAFLHEESRFKIVHRDIKATNVLLDGDLNA 741
Query: 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716
KISDFGLA+LDEEEK+HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN
Sbjct: 742 KISDFGLARLDEEEKSHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 801
Query: 717 NMSYVP-DSNCTCPLDW 732
N +Y+P D+NC C LDW
Sbjct: 802 NNNYMPSDNNCVCLLDW 818
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483546|ref|XP_002264679.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RFK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/793 (57%), Positives = 544/793 (68%), Gaps = 119/793 (15%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
+SLPG LPP++V L YL +DFAYNYL G+IP EWAS QL IS+ ANRLSG IP LGN
Sbjct: 55 YSLPGMLPPELVELQYLREIDFAYNYLGGTIPHEWASTQLNSISLLANRLSGEIPKELGN 114
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
I SLTYL+LE N+FSG +P ELG+L+NL+TL LSSN+ GNLP L L N+TDFRINDN
Sbjct: 115 IASLTYLNLEANKFSGVLPPELGDLINLKTLMLSSNQFFGNLPTTLAGLINITDFRINDN 174
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
NF+G PD+IQ+W QL R+E+Q SGLEGPIP SIS LDKL +LRISD+ G +Q FP+L N
Sbjct: 175 NFSGPIPDYIQNWKQLTRIEMQASGLEGPIPLSISLLDKLTELRISDMTGKSQGFPLLNN 234
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL--M 240
MTG+ ++LRNCNI+GEIP YIW +K L LD+SFN+L GE VP+DL + L +
Sbjct: 235 MTGIINLVLRNCNISGEIPAYIWKMKELEMLDVSFNKLVGE-----VPSDLSLAKALNYI 289
Query: 241 FIRG-----------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNF- 288
++ G + + S+DLSYNNF+WQ PEQPAC+E NLN+NL+RSSS+ENN
Sbjct: 290 YLSGNLLSGNIPDLFLKKGSSIDLSYNNFSWQGPEQPACQENMNLNVNLYRSSSMENNLR 349
Query: 289 GVFPCTNNFTCHRYWHSLHINCGGGNVKVNDST----FEGDAGVGGGAATYHLLDGTNWG 344
V PC+ N C +Y S H+NCGG ++ + +S +EGDA V GG A Y + WG
Sbjct: 350 AVLPCSKNDNCPQYACSFHVNCGGDDLTIKESKRKVFYEGDAEVEGGTAKYFRSKNSYWG 409
Query: 345 ISSTGDFTDDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFA 404
+SSTGDF DD+++QN YI S IS +Y AR+SPLSLTY GYCLENG+Y++ LHFA
Sbjct: 410 LSSTGDFMDDNNDQNMRYIETLSSGNISGVYTTARLSPLSLTYFGYCLENGDYTLQLHFA 469
Query: 405 EIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIR 464
EI FTNDKTY +LG+R+FDIYIQ++LV KDFNIE EA G KPV + F +V+N++LEIR
Sbjct: 470 EIYFTNDKTYDSLGKRLFDIYIQEQLVHKDFNIEDEARGARKPVMKQFNTSVTNNVLEIR 529
Query: 465 FQWAGKGTTAIPIGGVYGPLISAISVDPNLE----------------------------- 495
F WAGKGTT IP GVYGPLISAISV PN +
Sbjct: 530 FYWAGKGTTRIPSRGVYGPLISAISVHPNFKSCSSSGKKGMTAYIIGGVVGLCIILLILG 589
Query: 496 ----------------GLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGT 539
GL+ Q SSFTLKQI+ AT+NFD NKIGEGGFGPV+KG L+DGT
Sbjct: 590 FLQWKGCLRGRKREEKGLDLQTSSFTLKQIKNATNNFDSANKIGEGGFGPVFKGLLSDGT 649
Query: 540 IIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAH 599
+AVK LSS SRQGNREFLNEIG ISCLQHPNLV+L+GCC+EGDQL+L
Sbjct: 650 TVAVKQLSSGSRQGNREFLNEIGMISCLQHPNLVELHGCCVEGDQLLL------------ 697
Query: 600 ALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659
IVHRDIKATNVLLDRDLNPKIS
Sbjct: 698 --------------------------------------IVHRDIKATNVLLDRDLNPKIS 719
Query: 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719
DFGLA+LD+ K+HISTR+AGTIGYMAPEYAL GYLTYKADVYSFG+V LEIVSGKNN
Sbjct: 720 DFGLARLDDGGKSHISTRIAGTIGYMAPEYALRGYLTYKADVYSFGIVVLEIVSGKNN-D 778
Query: 720 YVPDSNCTCPLDW 732
Y+P ++C C LDW
Sbjct: 779 YMPSNSCFCLLDW 791
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519155|ref|XP_003629866.1| ATP-binding/protein serine/threonine kinase [Medicago truncatula] gi|355523888|gb|AET04342.1| ATP-binding/protein serine/threonine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/852 (55%), Positives = 567/852 (66%), Gaps = 126/852 (14%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
++LPGTLPPQ+V LPYL+ VDFA NYL+G+IP+EWAS +L IS+F NRLSG IP LGN
Sbjct: 67 YNLPGTLPPQLVKLPYLKEVDFALNYLNGTIPKEWASTELTSISLFVNRLSGEIPKELGN 126
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
IT+L YL+LE NQFSG +P ELG L NL+TL LSSN+L GNLP +L++L DFRI+DN
Sbjct: 127 ITTLRYLNLEANQFSGLVPSELGVLFNLQTLILSSNQLSGNLPGTFAQLQSLIDFRISDN 186
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
+FNG P FIQ+W QL RLE+ GSGLEGPIP +IS L ++QL+ISD+ GP+Q FP+L N
Sbjct: 187 SFNGKIPSFIQNWKQLQRLEMLGSGLEGPIPSNISLLSNVSQLKISDINGPSQNFPILSN 246
Query: 183 MTGLTRIILRNCNIAGEIPEYIWG----------------------IKNLR-------FL 213
MTG+ R+ILRNCNI GE+P Y +KN+ +
Sbjct: 247 MTGMIRLILRNCNITGEVPSYFLDNEAIGNVFLKHAQYVQRHKHILVKNVSLYYFFNLYR 306
Query: 214 DLSFNQLTGELPDVAVPADLKF-------------TQILMFIRGVY-------------E 247
DLSFN L GE+P + L+F ILM VY
Sbjct: 307 DLSFNNLFGEIPAIVHVGHLRFLFLTGNKLSGNVADSILMSGSNVYVSYLNHFNFNIAKY 366
Query: 248 HQSLDLSYNNFTWQSPEQPACRE---KPNLNLNLFRS--SSVENNFGVFPCTNNFTCHRY 302
+ LDLSYNNFT+Q P + AC + + L ++ S S + G+ PC+NNF C RY
Sbjct: 367 YHLLDLSYNNFTYQGPGKSACGDYLYEHGLLHDITDSPFSLILERQGMLPCSNNFKCPRY 426
Query: 303 WHSLHINCGGGNVKVNDS----TFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDDDEQ 358
LH+NCGG +++V ++ + GD V GGAA Y+ +WG SSTGDF DD D Q
Sbjct: 427 SSCLHVNCGGKDIQVKENGENILYIGDGDVVGGAAKYYDDSENHWGFSSTGDFMDDGDYQ 486
Query: 359 NTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLG 418
NT Y + SS + ELY AR SP+SLTY YCLENG Y+V LHFAEIQFTND+TYK+LG
Sbjct: 487 NTRYSRSLSSSNMPELYTTARASPISLTYFHYCLENGKYTVRLHFAEIQFTNDRTYKSLG 546
Query: 419 RRIFDIYIQDKLVEKDFNIEAEAHGVLKP-VTRPFTANVSNHILEIRFQWAGKGTTAIPI 477
+R+FDIYIQ +LV+KD+NIE E+H KP + + V++ ILEIR WAGKGTT IP+
Sbjct: 547 KRLFDIYIQGRLVQKDYNIENESHLAQKPRILSVYNVTVTDGILEIRLYWAGKGTTRIPV 606
Query: 478 GGVYGPLISAISVDPN-------------------------------------------- 493
GVYGPLISA S+ +
Sbjct: 607 SGVYGPLISAFSIVSDSKHCSDQKNGRHKIVVGVGFGVTALCLVLIVVGILWRKGYTKGI 666
Query: 494 ------LEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLS 547
++G +FQ +FTLKQIRAAT F P NK+GEGGFG VYKGQL DGT +AVK LS
Sbjct: 667 IRRQKVIKGQDFQMRTFTLKQIRAATDGFSPANKVGEGGFGSVYKGQLYDGTWVAVKQLS 726
Query: 548 SKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENS 607
SKSRQGNREFLNEIG ISCLQHPNLVKL+GCCIEGDQL+LVYEY+ENNSLA ALF +
Sbjct: 727 SKSRQGNREFLNEIGMISCLQHPNLVKLHGCCIEGDQLILVYEYMENNSLARALF---QN 783
Query: 608 QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667
QLKL+WS R +IC+GIA+GL+FLHEESR KIVHRDIKA NVLLD +LNPKISDFGLA+LD
Sbjct: 784 QLKLDWSSRLRICIGIAKGLSFLHEESRLKIVHRDIKANNVLLDGNLNPKISDFGLARLD 843
Query: 668 EEEKTHISTRVAGT--------IGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719
EEEKTHI+TRVAGT IGYMAPEYALWGYL+YK DVYSFGVV LE VSGK+N +
Sbjct: 844 EEEKTHITTRVAGTMSVLSPLIIGYMAPEYALWGYLSYKVDVYSFGVVVLETVSGKSNNN 903
Query: 720 YVPDSNCTCPLD 731
Y+P NC C LD
Sbjct: 904 YMPSDNCVCLLD 915
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 732 | ||||||
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.662 | 0.475 | 0.562 | 6.3e-236 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.672 | 0.456 | 0.477 | 4.2e-206 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.639 | 0.491 | 0.448 | 2.2e-198 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.657 | 0.464 | 0.435 | 8.6e-197 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.948 | 0.716 | 0.466 | 6.3e-156 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.327 | 0.232 | 0.599 | 9.5e-135 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.327 | 0.229 | 0.574 | 1.3e-131 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.304 | 0.172 | 0.486 | 1.3e-78 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.285 | 0.175 | 0.511 | 2.7e-75 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.307 | 0.236 | 0.463 | 1.2e-73 |
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1422 (505.6 bits), Expect = 6.3e-236, Sum P(2) = 6.3e-236
Identities = 280/498 (56%), Positives = 349/498 (70%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNI 63
+LPGTLP QIV LPYL +D AYNY++G++PREWAS L +IS+ NRLSG IP GN
Sbjct: 111 NLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWASSNLTFISLLVNRLSGEIPKEFGN- 168
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
+SLTYLDLE N FSGTIP+ELGNLV+L+ L LSSN+L G LP L +L+N+TDFRIND
Sbjct: 169 SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRINDLQ 228
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+G+ P +IQ+W QL RLE+ SGL GPIP IS L L LRISD++GP Q FP L+N+
Sbjct: 229 LSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSLKNV 288
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL-MFI 242
TGLT+IIL+NCNI+G+IP Y+ +K L LDLSFN+L G +P A +L+F + +
Sbjct: 289 TGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPSFAQAENLRFIILAGNML 348
Query: 243 RG------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNN 296
G + + ++DLSYNN WQSPE ACR NLNLNLF+S+S + + PC +
Sbjct: 349 EGDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIKD 408
Query: 297 FTCHRYWHSLHINCGGGNVKVNDST----FEGDAGVGGGAATYHLLDGTNWGISSTGDFT 352
F C RY LH+NCGG ++ V + +EGD V GGAA Y L NWG SSTGDF
Sbjct: 409 FKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFM 468
Query: 353 DDDDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDK 412
DD++ QNT + +S S+LY ARI+P+SLTY CLENGNY++ L FAEI+FTND+
Sbjct: 469 DDNNFQNTRFTMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDE 528
Query: 413 TYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGKGT 472
Y LGRR+FDIYIQ+KLV KDFNI EA G P+ +P TA V+NH L IR WAGKGT
Sbjct: 529 NYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGT 588
Query: 473 TAIPIGGVYGPLISAISV 490
T IP GVYGP+ISAIS+
Sbjct: 589 TRIPTRGVYGPIISAISI 606
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 4.2e-206, Sum P(2) = 4.2e-206
Identities = 252/528 (47%), Positives = 335/528 (63%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLG 61
FSLPG LPP+ L YLE +D NYL+GSIP EWAS+ LK ISV ANRL+G+IP LG
Sbjct: 108 FSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKSISVCANRLTGDIPKGLG 167
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
+LT L LE NQFSGTIP+ELGNLVNLE L SSN+L+G +P L +LK LT+ R +D
Sbjct: 168 KFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGVPKTLARLKKLTNLRFSD 227
Query: 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLR 181
N NGS P+FI + ++L RLE+ SGL+ PIP SI L+ L LRISD P++
Sbjct: 228 NRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLIDLRISDTAAGLGQVPLIT 287
Query: 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP-DVAVPADLKFTQIL- 239
+ + L ++LRN N+ G IP +W + NL LDLSFN+LTGE+P D + P K+T +
Sbjct: 288 SKS-LKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPADASAP---KYTYLAG 343
Query: 240 MFIRGVYEH-------QSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFG-VF 291
+ G E ++DLSYNNFTW +C+E+ N N+N + SS N+ +
Sbjct: 344 NMLSGKVESGPFLTASTNIDLSYNNFTWSQ----SCKER-N-NINTYASSRSTNSLTRLL 397
Query: 292 PCTNNFTCHRYWHSLHINCGGGNVKVNDST----FEGDA-GVGGGAATYHLLDGTNWGIS 346
PC+ C Y SLHINCGG +V + +S +EGD G+ G A Y+ G NWG S
Sbjct: 398 PCSAINLCQNYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYY---GKNWGFS 454
Query: 347 STGDFTDDDDEQNTNYIANSQSSGIS---ELYNDARISPLSLTYIGYCLENGNYSVALHF 403
+TGDF DD ++T Y +S+S+ + +LY +AR SPLSL Y C ENG+Y+V LHF
Sbjct: 455 NTGDFMDDAITEDT-YTVSSESAVSAKYPDLYQNARRSPLSLAYFAICFENGSYNVKLHF 513
Query: 404 AEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEI 463
AEIQF++++ + L +R+F+IY+Q KL+ +DF+I EA+G K V + V+++ LEI
Sbjct: 514 AEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEVNTTVTDNTLEI 573
Query: 464 RFQWAGKGTTAIPIGGVYGPLISAISVDPNLE---GLEFQASSFTLKQ 508
R WAGKGTT IP G YG LISAISV P+ E G+ Q T +Q
Sbjct: 574 RLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQ 621
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 2.2e-198, Sum P(2) = 2.2e-198
Identities = 226/504 (44%), Positives = 303/504 (60%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNI 63
+L G+LP ++V LP L+ +D + NYL+GSIP EW + L I + NRL+G IP GNI
Sbjct: 74 NLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNRLTGPIPKEFGNI 133
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
T+LT L LE NQ SG +P ELGNL N++ + LSSN G +P KL L DFR++DN
Sbjct: 134 TTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQ 193
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+G+ PDFIQ WT+L RL IQ SGL GPIP +I++L +L LRISDL GP FP LRN+
Sbjct: 194 LSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFPQLRNI 253
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF-- 241
+ +ILRNCN+ G++P+Y+ I + +FLDLSFN+L+G +P+ + +L+ + F
Sbjct: 254 KKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYI--NLRDGGYIYFTG 311
Query: 242 --IRG------VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPC 293
+ G V + +DLSYNNF+ P C+ NN V C
Sbjct: 312 NMLNGSVPDWMVNKGYKIDLSYNNFS-VDPTNAVCKY---------------NN--VLSC 353
Query: 294 TNNFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTD 353
N+ C + +++LHINCGG + +N + +E D + Y +G W ++ G F D
Sbjct: 354 MRNYQCPKTFNALHINCGGDEMSINGTIYESDK-YDRLESWYESRNG--WFSNNVGVFVD 410
Query: 354 DDD-EQNTNYIANSQSSGISE--LYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTN 410
D + +NS + + LY ARIS +SLTY CLENGNY+V LHFAEI F
Sbjct: 411 DKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNG 470
Query: 411 DKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGK 470
+ Y++LGRR FDIYIQ KL KDFNI EA V V + F + + LEIR WAG+
Sbjct: 471 NNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGR 530
Query: 471 GTTAIPIGGVYGPLISAISVDPNL 494
GTT IP VYGPLISAISVD ++
Sbjct: 531 GTTVIPKERVYGPLISAISVDSSV 554
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 8.6e-197, Sum P(2) = 8.6e-197
Identities = 223/512 (43%), Positives = 305/512 (59%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN 62
F+L G +PP+ NL L +D N+L G+IP + + L+ ++V NRLSG P LG
Sbjct: 98 FNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAVTGNRLSGPFPPQLGQ 157
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
IT+LT + +E N F+G +P LGNL +L+ L +SSN + G +P L LKNLT+FRI+ N
Sbjct: 158 ITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRIDGN 217
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
+ +G PDFI +WT+L RL++QG+ +EGPIP SIS L L +LRI+DL+GP FP L+N
Sbjct: 218 SLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFPDLQN 277
Query: 183 MTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDV--AVPA-DLKFTQ- 237
MT + R++LRNC I IPEYI + L+ LDLS N L G +PD ++ A + +
Sbjct: 278 MTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNN 337
Query: 238 ------ILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRS-SSVENNFGV 290
+ FI + Q++DLSYNNFT P +C + L++NL S SV NN
Sbjct: 338 NSLTGPVPQFI--LDSKQNIDLSYNNFT--QPPTLSCNQ---LDVNLISSYPSVTNNSVQ 390
Query: 291 FPCTNNFTCHRYWH--SLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISST 348
+ + C H SL INCGG +KV+ + D G A+T+ + WG SS+
Sbjct: 391 WCLRKDLPCPGDAHHSSLFINCGGNRLKVDKDEYADDLNKRG-ASTFSSVS-ERWGYSSS 448
Query: 349 GDFTDDDDEQNTNYIA----NSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFA 404
G + +D Y+A N + E Y AR++ SL Y G C+ G+Y V L+FA
Sbjct: 449 GAWLGND---GATYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFA 505
Query: 405 EIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFT-ANVSNHILEI 463
EI F+ND+TY +LGRR+FDIY+Q L+E+DFNI A GV KP R V+ LEI
Sbjct: 506 EIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEI 565
Query: 464 RFQWAGKGTTAIPIGGVYGPLISAISVDPNLE 495
+W GKGT IP GVYGPLISAI+V PN +
Sbjct: 566 HLKWTGKGTNVIPTRGVYGPLISAITVTPNFK 597
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1520 (540.1 bits), Expect = 6.3e-156, P = 6.3e-156
Identities = 353/757 (46%), Positives = 465/757 (61%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWAS-MQLKYISVFANRLSGNIPSHLGNI 63
L G++P + +LPYL+++ N L G IP+ + L + + AN+ SG IP LGN+
Sbjct: 134 LYGSIPMEWASLPYLKSISVCANRLSGDIPKGLGKFINLTLLVLEANQFSGTIPKELGNL 193
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
+L L L NQ G +P+ L L L L LS NRL G++P + KL L + +
Sbjct: 194 VNLQGLGLSSNQLVGGLPKTLAKLTKLTNLHLSDNRLNGSIPEFIGKLPKLQRLELYASG 253
Query: 124 FNGSAPDFIQSWTQLNRLEIQGS--GLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLR 181
G PD I L + I + GL G +P S K LR +L GP T +
Sbjct: 254 LRGPIPDSIFHLENLIDVRISDTVAGL-GHVPQITSTSLKYLVLRNINLSGPIPT--SIW 310
Query: 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241
++ L + L + GEIP Y K + L+ N L+G++ A F
Sbjct: 311 DLPSLMTLDLSFNRLTGEIPAYATAPK---YTYLAGNMLSGKVETGA------------F 355
Query: 242 IRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNL-----NLFRSSSVENNFGVFPCTNN 296
+ ++DLSYNNFTW P C+E+ N+N + R + + + C N
Sbjct: 356 LTA---STNIDLSYNNFTWS----PMCKERKNINTYESSHSKNRLTRLLPCSAIKQC-QN 407
Query: 297 FTCHRYWHSLHINCGGGNVKVNDSTF--EGDA-GVGGGAATYHLLDGTNWGISSTGDFTD 353
++ R H ++ ++ + F EGD G+ G A Y+ NWG S+TGDF D
Sbjct: 408 YS--RSLH-INCGGPDVTIENSRGRFLYEGDNYGLTGSATNYYR---KNWGYSNTGDFMD 461
Query: 354 DDDEQNTNYIANSQSSGIS---ELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTN 410
D ++T Y +S+S+ + +LY +AR SPLSL Y +C ENG+Y+V LHFAEIQF++
Sbjct: 462 DAITEDT-YTVSSESAVSAKYPDLYQNARRSPLSLAYYAFCFENGSYNVKLHFAEIQFSD 520
Query: 411 DKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQWAGK 470
+ Y L +R+F+IYIQ KL+ +DF+I EA+G K V R V+++ LEIR WAGK
Sbjct: 521 VEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIREVNTTVTDNTLEIRLYWAGK 580
Query: 471 GTTAIPIGGVYGPLISAISVDPN--------------LEGLEFQASSFTLKQIRAATSNF 516
GT IP G YG LISA+SV P+ L+G + + SF+L+Q++ AT++F
Sbjct: 581 GTMIIPQRGYYGSLISAVSVCPSSESECGGMKKKISKLKGPDLRTGSFSLRQLKVATNDF 640
Query: 517 DPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
DP+NKIGEGGFG VYKG+L DGT+IAVK LSSKS QGN+EF+NEIG I+CLQHPNLVKLY
Sbjct: 641 DPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGMIACLQHPNLVKLY 700
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
GCC+E +QL+LVYEYLENN L+ ALF G S LKL W R KICLGIARGLAFLHE+S
Sbjct: 701 GCCVEKNQLLLVYEYLENNCLSDALFAGR-SCLKLEWGTRHKICLGIARGLAFLHEDSAV 759
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
KI+HRDIK TNVLLD+DLN KISDFGLA+L E+ ++HI+TRVAGTIGYMAPEYA+ G+LT
Sbjct: 760 KIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLT 819
Query: 697 YKADVYSFGVVALEIVSGKNNMSYVPDSNCTCPL-DW 732
KADVYSFGVVA+EIVSGK+N Y PD C L DW
Sbjct: 820 EKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLDW 856
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 9.5e-135, Sum P(2) = 9.5e-135
Identities = 145/242 (59%), Positives = 182/242 (75%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS 550
D L G++ + FT ++++AT +FDP NK+GEGGFGPVYKG L DG ++AVKLLS S
Sbjct: 669 DEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGS 728
Query: 551 RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK 610
RQG +F+ EI IS + H NLVKLYGCC EG+ MLVYEYL N SL ALFG + L
Sbjct: 729 RQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT--LH 786
Query: 611 LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
L+WS R +ICLG+ARGL +LHEE+ +IVHRD+KA+N+LLD L P+ISDFGLAKL +++
Sbjct: 787 LDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDK 846
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCTCPL 730
KTHISTRVAGTIGY+APEYA+ G+LT K DVY+FGVVALE+VSG+ N + L
Sbjct: 847 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLL 906
Query: 731 DW 732
+W
Sbjct: 907 EW 908
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 717 (257.5 bits), Expect = 1.3e-131, Sum P(2) = 1.3e-131
Identities = 139/242 (57%), Positives = 179/242 (73%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS 550
D + ++ + +FT +++ AT +FD NK+GEGGFG VYKG L DG +AVK LS S
Sbjct: 685 DEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGS 744
Query: 551 RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK 610
RQG +F+ EI IS + H NLVKLYGCC EGD +LVYEYL N SL ALFG ++ L
Sbjct: 745 RQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS--LH 802
Query: 611 LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
L+WS R +ICLG+ARGL +LHEE+ +I+HRD+KA+N+LLD +L PK+SDFGLAKL +++
Sbjct: 803 LDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDK 862
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCTCPL 730
KTHISTRVAGTIGY+APEYA+ G+LT K DVY+FGVVALE+VSG+ N + L
Sbjct: 863 KTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLL 922
Query: 731 DW 732
+W
Sbjct: 923 EW 924
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.3e-78, Sum P(3) = 1.3e-78
Identities = 109/224 (48%), Positives = 144/224 (64%)
Query: 493 NLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR- 551
NL E T I AT NF ++ IG+GGFG VYK L +G +A+K L +
Sbjct: 979 NLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF 1038
Query: 552 QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKL 611
QG+REFL E+ TI ++HPNLV L G C+ GD+ L+YEY+EN SL L ++ L
Sbjct: 1039 QGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEAL 1098
Query: 612 NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671
W R KICLG ARGLAFLH I+HRD+K++N+LLD + P++SDFGLA++ +
Sbjct: 1099 GWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACE 1158
Query: 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
TH+ST +AGT GY+ PEY L T K DVYSFGVV LE+++G+
Sbjct: 1159 THVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGR 1202
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 2.7e-75, Sum P(2) = 2.7e-75
Identities = 108/211 (51%), Positives = 138/211 (65%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTIS 565
L I AT +F N IG+GGFG VYK L +AVK LS QGNREF+ E+ T+
Sbjct: 907 LGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLG 966
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK-LNWSVRQKICLGIA 624
++HPNLV L G C ++ +LVYEY+ N SL H L + L+ L+WS R KI +G A
Sbjct: 967 KVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL-RNQTGMLEVLDWSKRLKIAVGAA 1025
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
RGLAFLH I+HRDIKA+N+LLD D PK++DFGLA+L ++H+ST +AGT GY
Sbjct: 1026 RGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGY 1085
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ PEY T K DVYSFGV+ LE+V+GK
Sbjct: 1086 IPPEYGQSARATTKGDVYSFGVILLELVTGK 1116
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 1.2e-73, Sum P(2) = 1.2e-73
Identities = 108/233 (46%), Positives = 156/233 (66%)
Query: 486 SAISVD-PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVK 544
S S+D P L G A +FT ++++ T NF N +G GG+G VY+G L +G +IA+K
Sbjct: 604 SKSSIDAPQLMG----AKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIK 659
Query: 545 LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGG 604
S QG EF EI +S + H N+V+L G C + ++ MLVYEY+ N SL +L G
Sbjct: 660 RAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSG- 718
Query: 605 ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
S ++L+W+ R KI LG +GLA+LHE + I+HRDIK+ N+LLD +L K++DFGL+
Sbjct: 719 -KSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLS 777
Query: 665 KL-DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716
KL + EKTH++T+V GT+GY+ PEY + LT K+DVY FGVV LE+++G++
Sbjct: 778 KLVGDPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRS 830
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FXF2 | RKF1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5645 | 0.9890 | 0.7091 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XI.3143.1 | hypothetical protein (929 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 732 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 2e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-25 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-06 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-55
Identities = 84/188 (44%), Positives = 101/188 (53%), Gaps = 27/188 (14%)
Query: 304 HSLHINCGGG-NVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDDDEQNTNY 362
L INCGG + + T+E D GG+A Y++ D SS+ T D
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNG---SSSIAGTTDP------- 50
Query: 363 IANSQSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIF 422
ELY R SP S +Y CLENGNY+V LHFAEI F D LGRR+F
Sbjct: 51 ----------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGEDG----LGRRVF 96
Query: 423 DIYIQDKLVEKDFNIEAEAHGVLKPVTRPF-TANVSNHILEIRFQWAGKGTTAIPIGGVY 481
D+Y+Q KLV KDF+I AEA G K + + V++ LEI F WAGKGT IP GVY
Sbjct: 97 DVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVY 156
Query: 482 G-PLISAI 488
G P ISAI
Sbjct: 157 GNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 77/194 (39%), Positives = 110/194 (56%), Gaps = 11/194 (5%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLYGCC 579
+GEGGFG VY + G +A+K++ + E L EI + L HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
+ + L LV EY E SL L + ++ KL+ +I L I GL +LH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 640 HRDIKATNVLLD-RDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-WGYLTY 697
HRD+K N+LLD + K++DFGL+KL +K+ + T V GT YMAPE L GY +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 698 KADVYSFGVVALEI 711
K+D++S GV+ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 78/201 (38%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 521 KIGEGGFGPVYKGQLTD-----GTIIAVK-LLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
K+GEG FG VYKG+L +AVK L S Q EFL E + L HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
L G C E + L +V EY+E L L ++ KL+ S L IARG+ +L +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAPEYALW 692
+HRD+ A N L+ +L KISDFGL++ D++ ++ I +MAPE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177
Query: 693 GYLTYKADVYSFGVVALEIVS 713
G T K+DV+SFGV+ EI +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 75/207 (36%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 520 NKIGEGGFGPVYKGQLTDG----TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVK 574
K+GEG FG VYKG+L T +AVK L S + ++FL E + L HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
L G C E + L LV EY+E L + L+ + IA+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHISTRVAGTIGYMA 686
L + K VHRD+ A N L+ DL KISDFGL++ D+ + ++ I +MA
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP--IRWMA 175
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVS 713
PE G T K+DV+SFGV+ EI +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 78/201 (38%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 521 KIGEGGFGPVYKGQLTDG-----TIIAVK-LLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
K+GEG FG VYKG L +AVK L S Q EFL E + L HPN+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
L G C E + LM+V EY+ L L +N +L+ S L IARG+ +L +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAPEYALW 692
+HRD+ A N L+ +L KISDFGL++ D++ ++ I +MAPE
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178
Query: 693 GYLTYKADVYSFGVVALEIVS 713
G T K+DV+SFGV+ EI +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 72/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLV 573
++ + K+GEG FG VY + G ++A+K++ K + +RE L EI + L+HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LY + D+L LV EY E L L + +L+ + I L +LH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
IVHRD+K N+LLD D + K++DFGLA+ + ++T V GT YMAPE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
D++S GV+ E+++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 79/199 (39%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYG 577
K+G G FG VYK + G I+AVK+L +S + ++ EI + L HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ D L LV EY E L L L+ +KI L I RGL +LH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLT 696
I+HRD+K N+LLD + KI+DFGLAK + + ++T V GT YMAPE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 697 YKADVYSFGVVALEIVSGK 715
K DV+S GV+ E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 75/203 (36%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 521 KIGEGGFGPVYKGQLTD-----GTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVK 574
K+GEG FG VYKG L T +AVK L + + R EFL E + L HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
L G C +G+ L +V EY+ L L KL ++ L IA+G+ +L +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHISTRVAGTIGYMAPEYAL 691
VHRD+ A N L+ +L KISDFGL++ D+ + ++ I +MAPE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP--IKWMAPESLK 177
Query: 692 WGYLTYKADVYSFGVVALEIVSG 714
G T K+DV+SFGV+ EI +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 74/208 (35%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
F+ + KIG+GGFG VYK G +A+K++ +S++ + +NEI + +HPN+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
YG ++ D+L +V E+ SL L +++ L S +C + +GL +LH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY 694
I+HRDIKA N+LL D K+ DFGL+ + T + GT +MAPE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 695 LTYKADVYSFGVVALEIVSGKNNMSYVP 722
YKAD++S G+ A+E+ GK S +P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 77/204 (37%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 520 NKIGEGGFGPVYKGQLTD-GTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+G G FG VY D G ++AVK LS S + EI +S LQHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 577 GCCI--EGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
G E + L + EY+ SL+ L FG KL V +K I GLA+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHS 119
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYAL 691
IVHRDIK N+L+D D K++DFG AK L + E + V GT +MAPE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
AD++S G +E+ +GK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 76/198 (38%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQHPNLVKLYG 577
K+G G FG V+ G T +AVK L + G FL E + L+H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
C E + + +V EY+ SL L GE +L+L V + IA G+A+L ESR
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQIAEGMAYL--ESR-N 123
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+HRD+ A N+L+ +L KI+DFGLA+L D+E + I + APE A +G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRF 181
Query: 696 TYKADVYSFGVVALEIVS 713
T K+DV+SFG++ EIV+
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/202 (35%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 520 NKIGEGGFGPVYKG-QLTDGTIIAVKLLS--SKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+ IG G FG VYKG L G +A+K +S + + + EI + L+HPN+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
G D L ++ EY EN SL + FG L + V Q + +GLA+LHE+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY-VYQ-----VLQGLAYLHEQ- 118
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHISTRVAGTIGYMAPEYALWG 693
++HRDIKA N+L +D K++DFG+A KL++ K V GT +MAPE
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
+ +D++S G +E+++G
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQH 569
+ + KIGEG G VYK G +A+K L ++++ +NEI + +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
PN+V Y + GD+L +V EY++ SL + + +++N +C + +GL +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH ++HRDIK+ N+LL +D + K++DFG A +EK+ ++ V GT +MAPE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187
Query: 690 ALWGYLTYKADVYSFGVVALEIVSG 714
K D++S G++ +E+ G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 70/205 (34%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 520 NKIGEGGFGPVYKG-QLTDGTIIAVKLLS-SKSRQGN-REFLNEIGTISCLQHPNLVKLY 576
NKIG G FG VY L G ++AVK + + +E +E+ + L+HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G + +++ + EY +L L G V + L + GLA+LH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH----VIRVYTLQLLEGLAYLHSH--- 118
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG---YMAPEYALWG 693
IVHRDIK N+ LD + K+ DFG A + T + V G YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 694 YLTYK---ADVYSFGVVALEIVSGK 715
AD++S G V LE+ +GK
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS-SKSRQGNREF-LNEIGTISCLQHPN 571
++ + +IG+G FG VY + +DG + +K + S + RE LNE+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK----------LNWSVRQKICL 621
++K Y E +L +V EY + L+ + Q K L+W V ++CL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFV--QLCL 114
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT 681
L +LH KI+HRDIK N+ L + K+ DFG++K+ T V GT
Sbjct: 115 A----LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT 166
Query: 682 IGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGK 715
Y++PE L Y YK+D++S G V E+ + K
Sbjct: 167 PYYLSPE--LCQNKPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 72/204 (35%), Positives = 109/204 (53%), Gaps = 24/204 (11%)
Query: 522 IGEGGFGPVYKGQLT---DGTIIAVK---LLSSKSRQGNREFLNEIGTISCLQHPNLVKL 575
+G G FG VYKG + I V L S + N+E L+E ++ + HP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 576 YGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
G C+ Q+ L+ + + L H SQ LNW V+ IA+G+++L
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEY 689
EE R +VHRD+ A NVL+ + KI+DFGLAK LD +EK + + I +MA E
Sbjct: 126 -EEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 690 ALWGYLTYKADVYSFGVVALEIVS 713
L T+K+DV+S+GV E+++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 74/219 (33%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 519 MNKIGEGGFGPVYKGQLT------DGTIIAVKLLS-SKSRQGNREFLNEIGTISCLQHPN 571
++GEG FG V+ G+ D ++AVK L + S ++F E ++ QH N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLA--------HALFGGENSQLK--LNWSVRQKICL 621
+VK YG C EGD ++V+EY+E+ L A F L S +I +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT 681
IA G+ +L + F VHRD+ N L+ DL KI DFG+++ + T RV G
Sbjct: 130 QIASGMVYLASQ-HF--VHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGH 183
Query: 682 ----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GK 715
I +M PE ++ T ++DV+SFGVV EI + GK
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 15/194 (7%)
Query: 522 IGEGGFGPVYKGQLTDGTIIAVKLLS--SKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
IG+G FG V G G +AVK L S + Q FL E ++ L+HPNLV+L G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVV 69
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
++G+ L +V EY+ SL L + + + + L + G+ +L E+ V
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVI--TLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 640 HRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKA 699
HRD+ A NVL+ DL K+SDFGLAK E + S ++ + + APE + K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKS 180
Query: 700 DVYSFGVVALEIVS 713
DV+SFG++ EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
FD + K+GEG +G VYK G ++A+K++ + +E + EI + P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
YG + L +V EY S++ + + + L I +GL +LH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-WG 693
K +HRDIKA N+LL+ + K++DFG++ + +T V GT +MAPE G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
Y KAD++S G+ A+E+ GK
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 522 IGEGGFGPVYKGQLT----DGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKLY 576
IG G FG V +G+L +A+K L + S R +FL E + HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G + +M++ EY+EN SL F EN K + GIA G+ +L S
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDK--FLRENDG-KFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG--YMAPEYALWGY 694
VHRD+ A N+L++ +L K+SDFGL++ E+ + +T+ G I + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRK 184
Query: 695 LTYKADVYSFGVVALEIVS 713
T +DV+SFG+V E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-31
Identities = 79/223 (35%), Positives = 114/223 (51%), Gaps = 25/223 (11%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNI 63
L G +P + NL LE + A N L G IPRE M+ LK+I + N LSG IP +G +
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
TSL +LDL N +G IP LGNL NL+ L L N+L G +P + L+ L ++DN+
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+G P+ + L L + + G IP ++++L +L L+
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ----------------- 338
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
L + +GEIP+ + NL LDLS N LTGE+P+
Sbjct: 339 -------LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 519 MNKIGEGGFGPVYKGQLT---DGT--IIAVKLLS-SKSRQGNREFLNEIGTISCLQHPNL 572
+ ++GEG FG V + D T +AVK L+ S Q +F EI + L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 573 VKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
VK G C + G L L+ EYL + SL L + + ++N I +G+ +L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPE 688
+ + +HRD+ A N+L++ + KISDFGLAK+ E+K + + G I + APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 689 YALWGYLTYKADVYSFGVVALEIVS 713
+ +DV+SFGV E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPN 571
S+ + + +G+G G VYK + G I A+K + + R + L E+ T+ + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+VK YG + ++ +V EY++ SLA L K+ V I I +GL +LH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
+ I+HRDIK +N+L++ KI+DFG++K+ E +T V GT+ YM+PE
Sbjct: 117 TKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
+Y AD++S G+ LE GK
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 65/193 (33%), Positives = 106/193 (54%), Gaps = 6/193 (3%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
K+G G FG V++G + T +AVK L + +FL E + L+HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
+ + +V E ++ SL L GG LKL + + +A G+A+L ++ +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQN---YIH 126
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD+ A NVL+ + K++DFGLA++ +E+ I + APE AL+ + K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 701 VYSFGVVALEIVS 713
V+SFG++ EIV+
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 87/250 (34%), Positives = 125/250 (50%), Gaps = 15/250 (6%)
Query: 16 LPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
+P LET+D + N L G IP + S LK + + N L G IP+ L N+TSL +L L N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
Q G IPRELG + +L+ + L N L G +P E+ L +L + NN G P + +
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNC 194
L L + + L GPIPPSI +L KL L +SD + ++ + L + L +
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 195 NIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254
N G+IP + + L+ L L N+ +GE +P +L L LDLS
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGE-----IPKNLGKHNNLTV---------LDLS 364
Query: 255 YNNFTWQSPE 264
NN T + PE
Sbjct: 365 TNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
F K+G G FG V++G + +A+K+L S ++F E+ + L+H +L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L+ C G+ + ++ E +E SL L E L + + + +A G+A+L E+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLEEQ 123
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+HRD+ A N+L+ DL K++DFGLA+L +E+ ++S+ + APE A G
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAASHG 179
Query: 694 YLTYKADVYSFGVVALEIVS 713
+ K+DV+SFG++ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 18/207 (8%)
Query: 514 SNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPN 571
S D KIGEG G V + G +AVK + + +Q RE L NE+ + QHPN
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPN 77
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+V++Y + GD+L +V E+LE +L + + ++N +CL + + L+FLH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLH 132
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRVAGTIGYMAPEYA 690
+ ++HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE-- 185
Query: 691 LWGYLTY--KADVYSFGVVALEIVSGK 715
+ L Y + D++S G++ +E+V G+
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 69/199 (34%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLYGCC 579
KIG+G FG VYKG L T +AVK S + FL E + HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
++ + +V E + SL L +N +L + + ++ L A G+ +L ES+ +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLL--QMSLDAAAGMEYL--ESK-NCI 115
Query: 640 HRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEYALWGYL 695
HRD+ A N L+ + KISDFG+++ EE+ I T G I + APE +G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 696 TYKADVYSFGVVALEIVSG 714
T ++DV+S+G++ E S
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 75/214 (35%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK---SRQGNREFLNEIGTI-SCLQHP 570
++ + K+GEG FG VY + D ++A+K+L+ K + FL EI + S P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
N+VKLY + L LV EY++ SL L + L+ S I I L +L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 631 HEESRFKIVHRDIKATNVLLDRDLN-PKISDFGLAKLDEEEKTHISTR-----VAGTIGY 684
H + I+HRDIK N+LLDRD K+ DFGLAKL + + S GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 685 MAPEYAL---WGYLTYKADVYSFGVVALEIVSGK 715
MAPE L Y + +D++S G+ E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 71/203 (34%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLS-----SKSRQGNREFLNEIGTISCLQHPNLVKL 575
+G G FG VY+G L DG AVK +S ++ ++ EI +S LQHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
G E D L + E + SLA L +G + ++ RQ I GL +LH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT-RQ-----ILLGLEYLHDR 121
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-W 692
VHRDIK N+L+D + K++DFG+AK E S G+ +MAPE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 693 GYLTYKADVYSFGVVALEIVSGK 715
G AD++S G LE+ +GK
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 67/203 (33%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 520 NKIGEGGFGPVYKG--QLTDGTII--AVKLLS-SKSRQGNREFLNEIGTISCLQHPNLVK 574
++G G FG V KG + G + AVK L G +EFL E ++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK--LNWSVRQKICLGIARGLAFLHE 632
L G C +G+ LMLV E L L + + +A G+A+L E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA------HQVAMGMAYL-E 112
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYA 690
F VHRD+ A NVLL KISDFG+++ + AG + + APE
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 691 LWGYLTYKADVYSFGVVALEIVS 713
+G + K+DV+S+GV E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 70/196 (35%), Positives = 108/196 (55%), Gaps = 13/196 (6%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQHPNLVKLYG 577
K+G G FG V+ G T +A+K L +QG+ FL E + LQHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ + + ++ EY+EN SL L E +L +N + + IA G+AF+ ++
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLI--DMAAQIAEGMAFIERKN--- 122
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
+HRD++A N+L+ L KI+DFGLA+L E+ + I + APE +G T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 698 KADVYSFGVVALEIVS 713
K+DV+SFG++ EIV+
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-27
Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 41/312 (13%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGN 62
+L G +P +I L L +D YN L G IP +++ L+Y+ ++ N+LSG IP + +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS------------------------N 98
+ L LDL +N SG IP + L NLE L L S N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISA 158
+ G +P L K NLT ++ NN G P+ + S L +L + + LEG IP S+ A
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 159 LDKLNQLRISDLQGPNQTFPMLRNMTGLTRII---LRNCNIAGEIPEYIWGIKNLRFLDL 215
L ++R LQ + + + T L + + N N+ G I W + +L+ L L
Sbjct: 403 CRSLRRVR---LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 216 SFNQLTGELPDVAVPA-----DLKFTQILMFI----RGVYEHQSLDLSYNNFTWQSPEQ- 265
+ N+ G LPD DL Q + + E L LS N + + P++
Sbjct: 460 ARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 266 PACREKPNLNLN 277
+C++ +L+L+
Sbjct: 520 SSCKKLVSLDLS 531
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 515 NFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPN 571
+F+ +NKIG+G FG V+K + D + A+K LS +R+ E ++E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLN--WSVRQKICLGIARGLAF 629
+++ Y ++ +L +V EY EN L L L + W + + I GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH + KI+HRDIK+ N+ LD N KI D G+AKL + T+ + + GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPEL 172
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
K+DV++ GVV E +GK
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 22/209 (10%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCLQ 568
++ + K+GEG +G VYK + G I+A+K K R N E L EI + L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK----KIRLDNEEEGIPSTALREISLLKELK 56
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HPN+VKL +L LV+EY + + L L + L+ ++ + I + RGLA
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+ H S +I+HRD+K N+L++RD K++DFGLA+ + V T+ Y APE
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168
Query: 689 YALWGYLTY--KADVYSFGVVALEIVSGK 715
L G Y D++S G + E+++GK
Sbjct: 169 -ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 75/218 (34%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 519 MNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPN 571
+ ++GEG FG VYKG+LT T +A+K L + +EF E +S LQHPN
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALF------------GGENSQLKLNWSVRQKI 619
+V L G C + +++EYL + L L G E + L+ S I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ IA G+ +L S VHRD+ A N L+ L KISDFGL++ + + RV
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQ 183
Query: 680 GT----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +M PE L+G T ++D++SFGVV EI S
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 44/249 (17%)
Query: 519 MNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPN 571
+ ++G+G FG VY+G T +A+K ++ + R EFLNE + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHAL------------FGGENSQLKLNWSVRQKI 619
+V+L G G ++V E + L L G Q +
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM------ 124
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRV 678
IA G+A+L + K VHRD+ A N ++ DL KI DFG+ + + E + +
Sbjct: 125 AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-------GKNN---MSYVPDSNC-- 726
+ +MAPE G T K+DV+SFGVV E+ + G +N + +V D
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241
Query: 727 ---TCPLDW 732
CP
Sbjct: 242 LPENCPDKL 250
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 521 KIGEGGFGPVYKGQL------TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
++GEG FG V+ + D ++AVK L S ++F E ++ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 575 LYGCCIEGDQLMLVYEYLENNSL----------AHALFGGENSQL-KLNWSVRQKICLGI 623
YG C EG L++V+EY+ + L A L GGE+ +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTI 682
A G+ +L + VHRD+ N L+ + L KI DFG+++ + + + R I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+M PE L+ T ++D++SFGVV EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 521 KIGEGGFGPVYKGQLTD--GTII--AVKLLSSKSRQGN-REFLNEIGTISCLQHPNLVKL 575
K+G+G FG V +G+ + G +I AVK L S +FL E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
YG + LM+V E SL L + S + IA G+ +L E R
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYL-ESKR 117
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHIST---RVAGTIGYMAPEYAL 691
F +HRD+ A N+LL D KI DFGL + L + E ++ +V + APE
Sbjct: 118 F--IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLR 173
Query: 692 WGYLTYKADVYSFGVVALEIVS 713
++ +DV+ FGV E+ +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNLVKLYGC 578
IG+G FG VYK ++A+K++ + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
++G +L ++ EY S L G KL+ + I + GL +LHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
+HRDIKA N+LL + + K++DFG++ + +T V GT +MAPE K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 699 ADVYSFGVVALEIVSGK 715
AD++S G+ A+E+ G+
Sbjct: 179 ADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLV 573
F+ + IGEG +G VYK + G ++A+K++ + E E + HPN+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIA 66
Query: 574 KLYGC------CIEGDQLMLVYEYLENNS---LAHALFGGENSQLKLNWSVRQKICLGIA 624
YG DQL LV E S L L + +LK W I
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAY--ILRETL 123
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLD-EEEKTHISTRVAGTI 682
RGLA+LHE K++HRDIK N+LL ++ K+ DFG+ A+LD + + GT
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTP 177
Query: 683 GYMAPE-----YALWGYLTYKADVYSFGVVALEIVSGK 715
+MAPE ++DV+S G+ A+E+ GK
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ ++G G FG V+ G+ +A+K++ + +F+ E + L HPNLV+LYG
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 579 CIEGDQLMLVYEYLENNSLAHALF---GGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
C + + +V EY+ N L + L G ++ L+ +C + + +L E +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYL-ESNG 120
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYALWG 693
F +HRD+ A N L+ D K+SDFGLA+ LD++ + T+ + + PE +
Sbjct: 121 F--IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYS 176
Query: 694 YLTYKADVYSFGVVALEIVSG 714
+ K+DV+SFGV+ E+ S
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 69/195 (35%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ K+G G FG V+ G T +AVK L + FL E + L+H LV+LY
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
E + + +V EY+ SL L GE LKL V + +A G+A++ R
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIE---RMNY 123
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
+HRD+++ N+L+ L KI+DFGLA+L E+ + I + APE AL+G T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 699 ADVYSFGVVALEIVS 713
+DV+SFG++ E+V+
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 8e-26
Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
K+G+G FG V+ G T +A+K L + FL E + L+H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
E + + +V EY+ SL L G L+L V + IA G+A++ R VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVE---RMNYVH 125
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD++A N+L+ +L K++DFGLA+L E+ + I + APE AL+G T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 701 VYSFGVVALEIVS 713
V+SFG++ E+ +
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG---NREFLNEIGTISCLQHPNLVKLYG 577
+IG G FG V+ G + +A+K + R+G +F+ E + L HP LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
C E + LV+E++E+ L+ L + K + +CL + G+A+L +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
++HRD+ A N L+ + K+SDFG+ + +++ ST + + +PE + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 698 KADVYSFGVVALEIVSGKNNMSYVPDSN 725
K+DV+SFGV+ E+ S + Y SN
Sbjct: 181 KSDVWSFGVLMWEVFS-EGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 6/195 (3%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ K+G G FG V+ G + T +AVK L + + FL E + LQH LV+LY
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
+ + + ++ EY+ SL L E ++ L + IA G+A++ ++
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKN---Y 124
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
+HRD++A NVL+ L KI+DFGLA++ E+ + I + APE +G T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 699 ADVYSFGVVALEIVS 713
+DV+SFG++ EIV+
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPNLVKLY 576
+ IG G VY L + +A+K + + Q + + L E+ +S HPN+VK Y
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL-----GIARGLAFLH 631
+ GD+L LV YL SL + + + + + +GL +LH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTR--VAGTIGYMAPE 688
+ +HRDIKA N+LL D + KI+DFG+ A L + R GT +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 689 --YALWGYLTYKADVYSFGVVALEIVSGK 715
+ GY +KAD++SFG+ A+E+ +G
Sbjct: 177 VMEQVHGY-DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/193 (35%), Positives = 104/193 (53%), Gaps = 7/193 (3%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
K+G+G FG V+ G T +A+K L + FL E + L+H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
E + + +V E++ SL L G+ LKL V + IA G+A++ R +H
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIE---RMNYIH 125
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD++A N+L+ +L KI+DFGLA+L E+ + I + APE AL+G T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 701 VYSFGVVALEIVS 713
V+SFG++ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+G FG V + D G + A+K+L K R+ L E +S + HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
++L LV EY L L + + + + + I L +LH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLHSL---G 113
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
I++RD+K N+LLD D + K++DFGLAK E + +T GT Y+APE L
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGK 172
Query: 698 KADVYSFGVVALEIVSGK 715
D +S GV+ E+++GK
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNRE-----FLNEIGTISCL 567
+F IGEG F V + A+K+L RQ +E E ++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 568 -QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARG 626
HP ++KLY + + L V EY N L + L+ + I
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLA 114
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA------- 679
L +LH + I+HRD+K N+LLD+D++ KI+DFG AK+ + + S +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 680 ------------GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT Y++PE +D+++ G + ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 521 KIGEGGFGPVYK-GQLTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYG 577
+IGEG G V+K G +A+K ++ + +G + L EI + QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
G +LV EY+ + L+ L + + L + + + +G+A++H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKL-DEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
I+HRD+K N+L+ D KI+DFGLA+L EEE S +VA T Y APE L+G
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPEL-LYGARK 177
Query: 697 YKA--DVYSFGVVALEIVSG 714
Y D+++ G + E+++G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 74/210 (35%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 522 IGEGGFGPVYKGQLTD------GTI-IAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLV 573
+G G FG VY+G TD G I +AVK L + Q +EFL E +S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK---LNWSVRQKICLGIARGLAFL 630
KL G C+ + ++ E +E L L + L ICL +A+G +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 631 HEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG-- 683
E+ F +HRD+ A N L+ D D KI DFGLA+ D + + G +
Sbjct: 123 -EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MAPE L G T ++DV+SFGV+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 79/223 (35%), Positives = 112/223 (50%), Gaps = 31/223 (13%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVK--LLSSKSRQG---NREFLN----EIGTISCLQHPN 571
IG G FG VY G + G ++AVK L S S R L+ EI + LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAF 629
+V+ G ++ D L + EY+ S+A L +G L N+ VRQ I +GL +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQ-----ILKGLNY 121
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA-----GTIGY 684
LH I+HRDIK N+L+D KISDFG++K E T A G++ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCT 727
MAPE T KAD++S G + +E+++GK+ P +CT
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH-----PFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 522 IGEGGFGPVYKG-QLTDGTII----AVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKL 575
+G G FG V+KG + +G I A+K + +S RQ +E + + + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALF---GGENSQLKLNWSVRQKICLGIARGLAFLHE 632
G C G L LV + SL + + Q LNW C+ IA+G+ +L E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYAL 691
++VHR++ A N+LL D +I+DFG+A L ++K + + I +MA E L
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 692 WGYLTYKADVYSFGVVALEIVS 713
+G T+++DV+S+GV E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQG--NREFLNEIGTISCLQHPNLVKL 575
+ KIGEG +G VYK + G I+A+K + + + L EI + L HPN++KL
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
L LV+E+++ + L + ++ Q L S+ + + +GLAF H
Sbjct: 64 LDVFRHKGDLYLVFEFMDTD-LYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTH-ISTRVAGTIGYMAPEYAL 691
I+HRD+K N+L++ + K++DFGLA+ TH + TR Y APE L
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLL 171
Query: 692 W-GYLTYKADVYSFGVVALEIVSGK 715
+ D++S G + E++S +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 522 IGEGGFGPVYKGQL-TDG---TIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKLY 576
IG G FG V++G L G +A+K L + R +FL+E + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
G + M++ EY+EN +L L GE S +L +R GIA G+ +L S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAPEYALW 692
VHRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I + APE +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 693 GYLTYKADVYSFGVVALEIVS 713
T +DV+SFG+V E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
++ + +IG G +G VYK + + G ++A+K++ + EI + +HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 575 LYGCCIEGDQLMLVYEYLENNSLA---HALFGG-ENSQLKLNWSVRQKICLGIARGLAFL 630
+G + D+L +V EY SL G Q+ +C +GLA+L
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYL 117
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDE---EEKTHISTRVAGTIGYMA 686
HE +HRDIK N+LL D + K++DFG+ A+L + K+ I GT +MA
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMA 169
Query: 687 PEYAL----WGYLTYKADVYSFGVVALEIVSGKNNMS 719
PE A GY K D+++ G+ A+E+ + M
Sbjct: 170 PEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK-LLSSKSRQG-NREFLNEIGTISCLQHPNL 572
++ + +IGEG +G VYK + G ++A+K + ++G + EI + L+HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 573 VKLYGCCIEGDQ--LMLVYEYLEN--NSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
V+L + + +V+EY+++ L + ++K S + + GL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEGLQ 114
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST-RVAGTIGYMAP 687
+LH I+HRDIK +N+L++ D K++DFGLA+ + + T RV T+ Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSGKN 716
E L G Y D++S G + E+ GK
Sbjct: 171 EL-LLGATRYGPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 521 KIGEGGFGPVYKGQL------TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
++GEG FG V+ + D ++AVK L S ++F E ++ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHA----LFGGENSQLKLNWSVRQKICLGIAR 625
YG C+EGD L++V+EY+++ L AH L N +L S I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGY 684
G+ +L + VHRD+ N L+ +L KI DFG+++ + + + I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVS 713
M PE ++ T ++DV+S GVV EI +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 65/206 (31%), Positives = 114/206 (55%), Gaps = 25/206 (12%)
Query: 522 IGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLY 576
IG G FG V +G+L +A+K L S + + R+FL+E + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLN---WSVRQKICL--GIARGLAFLH 631
G + +M++ E++EN +L +S L+ N ++V Q + + GIA G+ +L
Sbjct: 72 GVVTKSRPVMIITEFMENGAL--------DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH--ISTRVAGTIG--YMAP 687
E + VHRD+ A N+L++ +L K+SDFGL++ E++ + ++ + G I + AP
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 688 EYALWGYLTYKADVYSFGVVALEIVS 713
E + T +DV+S+G+V E++S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ ++G G FG V G+ +A+K++ S + EF+ E + L H LV+LYG
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 579 CIEGDQLMLVYEYLEN----NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
C + + +V EY+ N N L + SQL ++C + G+A+L ES
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-------LEMCKDVCEGMAYL--ES 118
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYALW 692
+ + +HRD+ A N L+D K+SDFGL++ LD+E + + ++ + + PE L+
Sbjct: 119 K-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLY 175
Query: 693 GYLTYKADVYSFGVVALEIVS-GK 715
+ K+DV++FGV+ E+ S GK
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 60/255 (23%)
Query: 522 IGEGGFGPVYKGQL------TDGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVK 574
IG+G FG V++ + T++AVK+L + S +F E ++ HPN+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 575 LYGCCIEGDQLMLVYEYLE----NNSLAH----------------ALFGGENSQLKLNWS 614
L G C G + L++EY+ N L H G L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP--LSCT 130
Query: 615 VRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA---------K 665
+ I +A G+A+L E K VHRD+ N L+ ++ KI+DFGL+ K
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-------GKNN- 717
E + A I +M PE + T ++DV+++GVV EI S G +
Sbjct: 188 ASEND--------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 718 --MSYVPDSNC-TCP 729
+ YV D N +CP
Sbjct: 240 EVIYYVRDGNVLSCP 254
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 69/225 (30%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 519 MNKIGEGGFGPVYKGQLT----DGTIIAVK---LLSSKSRQGNREFLNEIGTISCLQHPN 571
+ +G G FG VY+G D + V L S S Q +FL E +S H N
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK---LNWSVRQKICLGIARGLA 628
+V+L G E ++ E + L L + L +A+G
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 629 FLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAK-LDEEEKTHISTRVAGTI 682
+L EE+ F +HRDI A N LL R KI+DFG+A+ + R I
Sbjct: 131 YL-EENHF--IHRDIAARNCLLTCKGPGRVA--KIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCT 727
+M PE L G T K DV+SFGV+ EI S + Y+P T
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 522 IGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQGN-REFLNEIGTISCLQHPNLVK 574
+GEG FG V K T +AVK+L + R+ L+E + + HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 575 LYGCCIEGDQLMLVYEYLENNSL------------AHALFGGENSQLKLNWSVRQKICLG 622
LYG C + L+L+ EY + SL ++ G + L+ + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 623 --------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674
I+RG+ +L E K+VHRD+ A NVL+ KISDFGL++ EE +++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 675 STRVAGTI--GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
R G I +MA E T ++DV+SFGV+ EIV+
Sbjct: 185 K-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL 572
+ D KIGEG G V + + G ++AVK + + +Q NE+ + QH N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V++Y + GD+L +V E+LE +L + + ++N +CL + + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHA 134
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRVAGTIGYMAPEYAL 691
+ ++HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE L
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE--L 187
Query: 692 WGYLTY--KADVYSFGVVALEIVSGK 715
L Y + D++S G++ +E+V G+
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCLQH---PNLVKLY 576
IG G +G VY+G + G ++A+K+++ + + + E+ +S L+ PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G ++G +L ++ EY E S+ + G ++ ++ +R+ + L ++H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-----VLVALKYIHKVG-- 121
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YL 695
++HRDIKA N+L+ N K+ DFG+A L + + ST V GT +MAPE G Y
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYY 179
Query: 696 TYKADVYSFGVVALEIVSGKNNMSYVP 722
KAD++S G+ E+ +G S V
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 20/202 (9%)
Query: 522 IGEGGFGPVYKG-QLTDGTII----AVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKL 575
+G G FG VYKG + +G + A+K+L+ + + N EF++E ++ + HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 576 YGCCIEGDQLMLVYEYLENNSL---AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
G C+ + LV + + + L H SQL LNW C+ IA+G+ +L E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-EEKTHISTRVAGTIGYMAPEYAL 691
++VHRD+ A NVL+ + KI+DFGLA+L E +EK + + I +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 692 WGYLTYKADVYSFGVVALEIVS 713
+ T+++DV+S+GV E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 65/207 (31%), Positives = 115/207 (55%), Gaps = 15/207 (7%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPN 571
+F + K+G+G +G VYK + L+D A+K L S S++ + +NEI ++ + HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
++ ++G++L +V EY L+ A+ + + + +I + + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
E+ KI+HRD+K+ N+LL + KI D G++K+ K +++ GT YMAPE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPHYMAPE--V 172
Query: 692 WG---YLTYKADVYSFGVVALEIVSGK 715
W Y +YK+D++S G + E+ +
Sbjct: 173 WKGRPY-SYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHP 570
+ + + ++G G G V K G I+AVK L ++ L E+ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+V YG + + EY++ SL L + Q ++ + KI + + +GL +L
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPE 688
HE + KI+HRD+K +N+L++ K+ DFG++ ++ KT GT YMAPE
Sbjct: 117 HE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----VGTSSYMAPE 169
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
+ K+D++S G+ +E+ +G+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-23
Identities = 58/166 (34%), Positives = 88/166 (53%), Gaps = 2/166 (1%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSI-PREWASMQLKYISVFANRLSGNIPSHLGN 62
S G LP + LP + +D + N L G I R+W L+ +S+ N+ G +P G+
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
L LDL NQFSG +PR+LG+L L L+LS N+L G +P EL K L ++ N
Sbjct: 475 -KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
+G P L++L++ + L G IP ++ ++ L Q+ IS
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
|
Length = 968 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 5e-23
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL 558
L+++R S DP KIG+G G VY + G +A+K ++ + + +
Sbjct: 5 LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
NEI + +HPN+V + GD+L +V EYL SL + ++ ++
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 119
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+C + L FLH +++HRDIK+ N+LL D + K++DFG E++ ST V
Sbjct: 120 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE K D++S G++A+E+V G+
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 521 KIGEGGFGPVYKGQ------LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
++GEG FG V+ + D ++AVK L + ++F E ++ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHA-----LFGGENSQLK--LNWSVRQKICLG 622
YG C +GD L++V+EY+++ L AH L G+ Q K L S I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGT 681
IA G+ +L + VHRD+ N L+ +L KI DFG+++ + + +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
I +M PE ++ T ++DV+SFGV+ EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG---NREFLNEIGTISCLQHPNLVKL 575
M ++G G FG V+ G+ +A+K + +G +F+ E + L HP LV+L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
YG C + L +V E++EN L + L Q KL+ + +C + G+ +L E +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYL-ERNS 120
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAG-TIGYMAPEYALW 692
F +HRD+ A N L+ K+SDFG+ + LD+E + S+ A + + PE +
Sbjct: 121 F--IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNF 175
Query: 693 GYLTYKADVYSFGVVALEIVS-GKNNMSYVPDSN 725
+ K+DV+SFGV+ E+ + GK M + SN
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGK--MPFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-23
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 522 IGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLY 576
IG G FG V G+L +A+K L + + + R+FL+E + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
G + +M+V EY+EN SL L G+ + ++L +R GIA G+ +L S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---S 123
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG--YMAPEYALW 692
VHRD+ A N+L++ +L K+SDFGL+++ E++ T G I + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 693 GYLTYKADVYSFGVVALEIVS 713
T +DV+S+G+V E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 21/287 (7%)
Query: 2 LFS--LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPS 58
LFS G +P + +LP L+ + N G IP+ L + + N L+G IP
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFR 118
L + +L L L N G IP+ LG +L +RL N G LP E KL +
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 119 INDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178
I++NN G L L + + G +P S + +L L +S Q
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQI 238
L +++ L ++ L ++GEIP+ + K L LDLS NQL+G++P F+++
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA-------SFSEM 546
Query: 239 LMFIRGVYEHQSLDLSYNNFTWQSPEQPACRE---KPNLNLNLFRSS 282
+ LDLS N + + P+ E + N++ N S
Sbjct: 547 PVL-------SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586
|
Length = 968 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNL 572
++++GEG G V K +L G I A+K +++ ++ L E+ + P +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 573 VKLYGCCIEGDQLML--VYEYLENNSLAHALFGGENSQ-LKLNWSVRQKICLGIARGLAF 629
VK YG ++ + EY E SL +++ + ++ V KI + +GL++
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH KI+HRDIK +N+LL R K+ DFG++ E ++ GT YMAPE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPER 174
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
+ +DV+S G+ LE+ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNLV 573
F + +IG+G FG VYKG ++A+K++ + + E + EI +S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ YG ++G +L ++ EYL S L G + + +R+ I +GL +LH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILRE-----ILKGLDYLHSE 120
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+ +HRDIKA NVLL + K++DFG+A + + +T V GT +MAPE
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
+KAD++S G+ A+E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 76/206 (36%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 522 IGEGGFGPV--YKGQLT-DGT--IIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKL 575
+GEG FG V Y DGT ++AVK L + Q N + EI + L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 576 YGCCIE-GDQ-LMLVYEYLENNSLAHALFGGENSQLKLNWS----VRQKICLGIARGLAF 629
GCC E G + L L+ EY+ SL L + KLN + Q+IC G+A+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQIC----EGMAY 122
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAP 687
LH + +HRD+ A NVLLD D KI DFGLAK E + R G + + A
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 688 EYALWGYLTYKADVYSFGVVALEIVS 713
E +Y +DV+SFGV E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 46/221 (20%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREF--------LNEIGTISC 566
+ + ++G+G FG VY + G ++A+K + ++F L E+ ++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRK 53
Query: 567 LQ-HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL-------KLNWSVRQK 618
L HPN+VKL E D+L V+EY+E N L+ QL + SV +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGN-----LY-----QLMKDRKGKPFSESVIRS 103
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH---IS 675
I I +GLA +H+ F HRD+K N+L+ KI+DFGLA+ + +S
Sbjct: 104 IIYQILQGLAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS 160
Query: 676 TRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
TR Y APE L + D+++ G + E+ + +
Sbjct: 161 TR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 521 KIGEGGFGPVYKGQLTDG----------------TIIAVKLLSSKSRQGNR-EFLNEIGT 563
K+GEG FG V+ + +G ++AVK+L + + R +FL EI
Sbjct: 12 KLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--------FGGENSQLKLNWSV 615
+S L++PN+++L G C+ D L ++ EY+EN L L F N+ ++ +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHI 674
+ + IA G+ +L + VHRD+ N L+ KI+DFG+++ L + I
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
R I +MA E L G T +DV++FGV E+ +
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNLV 573
F + +IG+G FG V+KG ++A+K++ + + E + EI +S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
K YG ++G +L ++ EYL S L G + ++ +++ I +GL +LH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----ILKGLDYLHSE 120
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
K +HRDIKA NVLL + K++DFG+A + + +T V GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
KAD++S G+ A+E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
+G+G FG VYK Q G A K++ +S + +F+ EI +S +HPN+V LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
++L ++ E+ + +L + E L + +C + L FLH K++H
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT---- 696
RD+KA N+LL D + K++DFG++ ++ T + GT +MAPE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 697 -YKADVYSFGVVALEI 711
YKAD++S G+ +E+
Sbjct: 186 DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDG--TIIAVKLLS---------SKSRQGN-REFLNEIG 562
+ + +G G FG VYK + + ++A+K ++ + R + + ++E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 563 TI-SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG----GENSQLKLNWSVRQ 617
I L+HPN+V+ Y +E D+L +V + +E L + + W++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
++ L L +LH+E R IVHRD+ N++L D I+DFGLAK + E T
Sbjct: 121 QMVLA----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTS 172
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFG-----VVALEIVSGKNNM 718
V GTI Y PE KADV++FG + L+ NM
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 74/210 (35%), Positives = 113/210 (53%), Gaps = 18/210 (8%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS-SKSRQG-NREFLNEIGTISCLQHP 570
+ F+ +N+IGEG +G VY+ + T G I+A+K + R G L EI + L+HP
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 571 NLVKLYGCCIEGDQL---MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
N+V+L + G L LV EY E + LA L +N + S + + L + RGL
Sbjct: 67 NIVELKE-VVVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGL 121
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
+LHE F I+HRD+K +N+LL KI+DFGLA+ ++ +V T+ Y AP
Sbjct: 122 QYLHE--NF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSGK 715
E L G TY D+++ G + E+++ K
Sbjct: 178 EL-LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 522 IGEGGFGPVYKGQL------TDGTIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPNLV 573
+GEG FG V K + + + +AVK+L + + + ++E+ + + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFG----GENSQLKLNWSVRQKI--------CL 621
L G C + L +V EY + +L L GE + + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHISTR 677
+ARG+ FL S+ K +HRD+ A NVL+ D KI+DFGLA+ +D KT T
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---TN 193
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T+++DV+SFGV+ EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQG-NREFLNEIGTISC 566
SN + +G G FG V+ + T++ VK L + EF E+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF---GGENSQLKLNWSVRQK--ICL 621
L H N+V+L G C E + ++ EY + L L + S +QK +C
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT 681
IA G+ L S + VHRD+ A N L+ K+S L+K + +
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ ++APE + K+DV+SFGV+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLS---------SKSRQGNREFLN-EIGTISCLQHP 570
IG+G +G VY +T G ++AVK + ++ + L EI T+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLA 628
N+V+ G + L + EY+ S+ L +G QL + + Q + GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-VRFFTEQ-----VLEGLA 122
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS-TRVAGTIGYMAP 687
+LH + I+HRD+KA N+L+D D KISDFG++K ++ + + G++ +MAP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 688 EYALWGYLTY--KADVYSFGVVALEIVSGK 715
E Y K D++S G V LE+ +G+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 521 KIGEGGFGPV-YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
KIGEG G V + G +AVK++ + +Q NE+ + QH N+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
+ G++L ++ E+L+ +L + SQ +LN +C + + L +LH + ++
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 640 HRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
HRDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 699 ADVYSFGVVALEIVSGK 715
D++S G++ +E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHP 570
+F+ + IG+G FG V Q D + A+K ++ + + R LNE + L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
LV L+ + + + LV + L L + L + ++K + + I L +L
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHISTRVAGTIGYMAPEY 689
H + I+HRDIK N+LLD + I+DF +A K+ + T T +GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEV 170
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
+ D +S GV A E + GK
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 69/217 (31%), Positives = 115/217 (52%), Gaps = 34/217 (15%)
Query: 514 SNFDPMNKIGEGGFGPVYKG-QLTDGTII----AVKLL-SSKSRQGNREFLNEIGTISCL 567
+ F + +G G FG VYKG + +G + A+K L + S + N+E L+E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 568 QHPNLVKLYGCCIEG-----DQLM---LVYEYLENNSLAHALFGGEN--SQLKLNWSVRQ 617
+P++ +L G C+ QLM + +Y+ + +N SQ LNW
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK--------DNIGSQYLLNW---- 114
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHIST 676
C+ IA+G+ +L E ++VHRD+ A NVL+ + KI+DFGLAK L +EK + +
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
I +MA E L T+++DV+S+GV E+++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCLQHPNL 572
NF + K+GEG + VYKG+ T G I+A+K + + +G + EI + L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V+L+ ++LMLV+EY++ + + G L N + + +G+AF HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPN--TVKSFTYQLLKGIAFCHE 118
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
+++HRD+K N+L+++ K++DFGLA+ S V T+ Y AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLL 173
Query: 693 GYLTYKA--DVYSFGVVALEIVSGK 715
G TY D++S G + E+++G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKY-ISVFANRLSGNIPSHLGN 62
SL G +P + L V N G +P E+ + L Y + + N L G I S +
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
+ SL L L N+F G +P G+ LE L LS N+ G +P +L L L ++++N
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
+G PD + S +L L++ + L G IP S S + L+QL +S
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS-------------- 555
Query: 183 MTGLTRIILRNCN-IAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225
N ++GEIP+ + +++L +++S N L G LP
Sbjct: 556 -----------QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-21
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL 558
L+++R+ S DP KIG+G G VY + G +A+K ++ + + +
Sbjct: 5 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
NEI + ++PN+V + GD+L +V EYL SL + ++ ++
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 119
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+C + L FLH +++HRDIK+ N+LL D + K++DFG E++ ST V
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE K D++S G++A+E+V G+
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 521 KIGEGGFGPVYKGQLTD----GTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKL 575
IGEG FG VY+G +AVK + + RE FL E + HP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
G E + + +V E L L + ++ L+ + ++ LA+L ES+
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL--ESK 126
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+ VHRDI A NVL+ K+ DFGL++ E+E + +++ I +MAPE +
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 696 TYKADVYSFGVVALEIVS-GKNNMSYVPDSN 725
T +DV+ FGV EI+ G V +++
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK-LLSSKSRQGNREF-LNEIGTISCLQ---H 569
++ + +IGEG +G VYK + L G +A+K + S +G L EI + L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 570 PNLVKLYGCCI-----EGDQLMLVYEYLENNSLA-----HALFGGENSQLKLNWSVRQKI 619
PN+V+L C +L LV+E+++ + LA G +K +RQ
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIK--DLMRQ-- 115
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ RG+ FLH +IVHRD+K N+L+ D KI+DFGLA++ E T V
Sbjct: 116 ---LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVV 167
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEI 711
T+ Y APE L D++S G + E+
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLS----SKSRQGN--REFLNEIGTISCLQHPNLVK 574
+G G F Y+ + + GT++AVK ++ + S Q EI ++ L HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
+ G E L E++ S++H L +G +V + RGL++LHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA------FKEAVIINYTEQLLRGLSYLHE 121
Query: 633 ESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEEEKT---HISTRVAGTIGYMA 686
+I+HRD+K N+L+D + L +I+DFG A + T ++ GTI +MA
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSGK 715
PE DV+S G V +E+ + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 7/193 (3%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
K+G G FG V+ T +AVK + S FL E + LQH LVKL+ +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
+ + ++ E++ SL L E S+ L + IA G+AF+ + + +H
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRN---YIH 125
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD++A N+L+ L KI+DFGLA++ E+ + I + APE +G T K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 701 VYSFGVVALEIVS 713
V+SFG++ +EIV+
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL 558
++++R S DP KIG+G G V+ + G +A+K ++ + + +
Sbjct: 5 MEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII 64
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
NEI + L++PN+V + GD+L +V EYL SL + ++ ++ +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAA 119
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+C + L FLH +++HRDIK+ NVLL D + K++DFG E++ ST V
Sbjct: 120 VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE K D++S G++A+E+V G+
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
+G+G +G VY + L+ IA+K + + + + EI S L+H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
E + E + SL+ AL + LK N I GL +LH+ +IVH
Sbjct: 76 ENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 641 RDIKATNVLLDRDLNP-KISDFG----LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
RDIK NVL++ KISDFG LA ++ +T GT+ YMAPE G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPEVIDKGPR 186
Query: 696 TY--KADVYSFGVVALEIVSGK 715
Y AD++S G +E+ +GK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK------LLSSKSRQGNREFLNEIGTIS 565
NF KIG+G F VYK L DG ++A+K ++ +K+RQ + L EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625
L HPN++K IE ++L +V E + L+ + + + + K + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYM 685
L +H + +I+HRDIK NV + K+ D GL + + T + V GT YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 686 APEYALWGYLTYKADVYSFGVVALEI 711
+PE +K+D++S G + E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 515 NFDPMNKIGEGGFGP--VYKGQLTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHP 570
++ P+ +G+G FG +Y+ + D +++ K L+ S + R+ LNEI +S LQHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI--CLGIARGLA 628
N++ Y ++ + L++ EY +L + Q + + I ++
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
++H+ I+HRDIK N+ L + K+ DFG++K+ E + T V GT YM+PE
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
+K+D+++ G V E+++ K
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 35/222 (15%)
Query: 521 KIGEGGFGPVY------------KGQLTDG-----TIIAVKLL----SSKSRQGNREFLN 559
K+GEG FG V+ K + ++AVK+L S +R+ +FL
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68
Query: 560 EIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF-------GGENSQLKLN 612
E+ +S L PN+ +L G C L ++ EY+EN L L G + L+
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEK 671
+S + IA G+ +L ES VHRD+ N L+ ++ KI+DFG+++ L +
Sbjct: 129 FSTLLYMATQIASGMRYL--ESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ R I +MA E L G T K+DV++FGV EI++
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 66/195 (33%), Positives = 106/195 (54%), Gaps = 17/195 (8%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
IGEG FG V +G+ T G +AVK + K + FL E ++ L H NLV+L G I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGLAFLHEESRFKI 638
+ L +V E + +L + L ++ + SV Q + L +A G+ +L ES+ K+
Sbjct: 69 LHNGLYIVMELMSKGNLVNFL----RTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KL 121
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
VHRD+ A N+L+ D K+SDFGLA++ ++++ + + APE + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSK 177
Query: 699 ADVYSFGVVALEIVS 713
+DV+S+GV+ E+ S
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 7e-21
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 37/227 (16%)
Query: 521 KIGEGGFGPVYKGQLTD-----------------GTIIAVKLLSSKSRQGNR-EFLNEIG 562
K+GEG FG V+ ++ + ++AVK+L + + R +FL E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 563 TISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQ--------- 608
+S L+ PN+++L G C++ D L ++ EY+EN L +H L E +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 609 -LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-L 666
+++S + L IA G+ +L S VHRD+ N L+ +L KI+DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ I R I +MA E L G T +DV++FGV EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 521 KIGEGGFGPV-YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
KIGEG G V + G +AVK + + +Q NE+ + H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
+ GD+L +V E+LE +L + + ++N +CL + R L++LH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 640 HRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY- 697
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE + L Y
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPE--VISRLPYG 196
Query: 698 -KADVYSFGVVALEIVSGK 715
+ D++S G++ +E++ G+
Sbjct: 197 TEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 521 KIGEGGFGPVY----KGQL-------------TDGTIIAVKLLSSKSRQGNR-EFLNEIG 562
K+GEG FG V+ +G ++AVK+L + + R +FL EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 563 TISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF-------GGENSQLKLNWSV 615
+S L+ PN+++L CI D L ++ EY+EN L L + + +++S
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHI 674
+ IA G+ +L S VHRD+ N L+ ++ KI+DFG+++ L + I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
R I +M+ E L G T +DV++FGV EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 30/210 (14%)
Query: 519 MNKIGEGGFGPVYKG-QLTDGTII----AVKLL-SSKSRQGNREFLNEIGTISCLQHPNL 572
+ +G G FG VYKG + DG + A+K+L + S + N+E L+E ++ + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 573 VKLYGCCIEGD-----QLM---LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
+L G C+ QLM + +Y+ N SQ LNW C+ IA
Sbjct: 72 CRLLGICLTSTVQLVTQLMPYGCLLDYVRENK------DRIGSQDLLNW------CVQIA 119
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIG 683
+G+++L E ++VHRD+ A NVL+ + KI+DFGLA+ LD +E + + I
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MA E L T+++DV+S+GV E+++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 522 IGEGGFGPVYKGQLT--DGTI--IAVKL--LSSKSRQGNREFLNEIGTISCLQHPNLVKL 575
+GEG FG V +GQL+ DG+ +AVK L + EFL+E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 576 YGCCIEGDQL------MLVYEYLENNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGL 627
G C E L M++ ++++ L L L ++ K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT-IGYMA 686
+L S +HRD+ A N +L D+ ++DFGL+K + R+A + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVS 713
E T K+DV++FGV EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTDGT--IIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNL 572
F + KIG+G FG V+KG + + T ++A+K++ + + E + EI +S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
K YG ++ +L ++ EYL S L G + ++ +R+ I +GL +LH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILRE-----ILKGLDYLHS 119
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS-TRVAGTIGYMAPEYAL 691
E + +HRDIKA NVLL K++DFG+A + T I GT +MAPE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
KAD++S G+ A+E+ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 501 ASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGN----- 554
++S + + S + +N+IG G G VYK G + A+K++ GN
Sbjct: 61 SASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTV 115
Query: 555 -REFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613
R+ EI + + HPN+VK + ++ ++ E+++ SL E L
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE---QFLAD 172
Query: 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673
RQ I G+A+LH R IVHRDIK +N+L++ N KI+DFG++++ +
Sbjct: 173 VARQ-----ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 674 ISTRVAGTIGYMAPE-----YALWGYLTYKADVYSFGVVALEIVSGK 715
++ V GTI YM+PE Y Y D++S GV LE G+
Sbjct: 225 CNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREF----LNEIGTISCLQH 569
++ + +GEG +G V K + G I+A+K K + + + L E+ + L+H
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRH 59
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
N+V L +L LV+EY+E L L E S L + + + +A+
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLL-ELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPE 688
H I+HRDIK N+L+ K+ DFG A+ L + ++ VA T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 689 YALWGYLTY--KADVYSFGVVALEIVSG 714
L G Y DV++ G + E++ G
Sbjct: 172 L-LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL 558
L+++R+ S DP KIG+G G VY + G +A++ ++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
NEI + ++PN+V + GD+L +V EYL SL + ++ ++
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 120
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+C + L FLH +++HRDIK+ N+LL D + K++DFG E++ ST V
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE K D++S G++A+E++ G+
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKL-----LSSKSRQGNREFLNEIGTISCLQHPNLVKL 575
+G+G FG VY D G +AVK S ++++ EI + LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK----LNWSVRQKICLGIARGLAFLH 631
YGC + + L + EY+ S+ QLK L +V +K I G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSV--------KDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS--TRVAGTIGYMAPEY 689
IVHRDIK N+L D N K+ DFG +K + + + V GT +M+PE
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
KADV+S G +E+++ K
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQHPN 571
F + +IG G FG VY + ++A+K +S +Q N ++ + E+ + L+HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK-----ICLGIARG 626
++ GC + LV EY G + L+++ Q+ IC G +G
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC---------LGSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
LA+LH R +HRDIKA N+LL K++DFG A L + + GT +MA
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179
Query: 687 PEYALW---GYLTYKADVYSFGVVALEIVSGK------NNMS 719
PE L G K DV+S G+ +E+ K N MS
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 520 NKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+K+G G +G VY+G +AVK L + + EFL E + ++HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
C ++ E++ +L L E ++ ++N V + I+ + +L E+ F
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL-EKKNF-- 125
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALWGYL 695
+HRD+ A N L+ + K++DFGL++L + T AG I + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 696 TYKADVYSFGVVALEIVS 713
+ K+DV++FGV+ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K R+G + LNE + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFG-GEN--SQLKLNWSVRQKICLGIARGLAFLHEES 634
D L LV + L + ++ GE + + + Q IC GL LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC-----GLEHLHQR- 114
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+IV+RD+K NVLLD N +ISD GLA +L +K AGT GYMAPE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGE 169
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
+ D ++ G E+++G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS-SKSRQGNREFL-NEIGTISCLQHPNL 572
++ + IG+G FG V K + +DG I+ K + + ++ L +E+ + L+HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 573 VKLYGCCI--EGDQLMLVYEYLENNSLAHALFGGENSQL-----KLN--------WSVRQ 617
V+ Y I L +V EY E GG+ +QL K W +
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCE---------GGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 618 KICLGIARGLAFLH--EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675
++ L + H + ++HRD+K N+ LD + N K+ DFGLAK+ + +
Sbjct: 113 QLLLALYE----CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
T V GT YM+PE K+D++S G + E+ +
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 519 MNKIGEGGFGPVYKGQ---LTDGT--IIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ ++G+G FG V + L D T ++AVK L + + R+F EI + LQH N+V
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 574 KLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
K G C + L LV EYL SL L + + +L+ I +G+ +L
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEY 689
+ R+ VHRD+ N+L++ + KI DFGL K+ ++K + R G I + APE
Sbjct: 126 SK-RY--VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 690 ALWGYLTYKADVYSFGVVALEIVS 713
+ +DV+SFGVV E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 7/193 (3%)
Query: 522 IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKLYGCCI 580
+G+G FG V+KG L D T +AVK Q + +FL+E + HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
+ + +V E + + + +LK V K L A G+A+L ES+ +H
Sbjct: 63 QRQPIYIVMELVPGGDFL-SFLRKKKDELKTKQLV--KFALDAAAGMAYL--ESK-NCIH 116
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD+ A N L+ + KISDFG+++ +++ S I + APE +G + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 701 VYSFGVVALEIVS 713
V+S+G++ E S
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 512 ATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK-LLSSKSRQGNREF----LNEIGTIS 565
+++ + K+GEG FG VYK Q+ G ++A+K +L + G F L EI +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNS------------LAHALFGG-ENSQLKLN 612
L+HPN+V L + + E + + + H L G EN +KL
Sbjct: 63 KLKHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK- 671
S + L + G+ +LHE I+HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 672 ---------THISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
T T + T Y PE L T D++ G V E+ + +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 522 IGEGGFGPVY--KGQLTDGTIIAVKLLSSKSRQGNREF---LNEIGTISCLQHPNLVKLY 576
I +G +G V+ K + T G I A+K++ + L E +S Q P +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
L LV EYL LA L G L+ V + I L +LH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS------LDEDVARIYIAEIVLALEYLH--- 110
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHIST-----RVAGTIGYMAP 687
I+HRD+K N+L+D + + K++DFGL+K L + R+ GT Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSG 714
E L + D +S G + E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQG-----NREFLNEIGTISCLQ 568
++ K+GEG + VYK G I+A+K + R+ N L EI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HPN++ L + LV+E++E + L + ++ + L + + L RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD-LEKVI---KDKSIVLTPADIKSYMLMTLRGLE 116
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+LH S + I+HRD+K N+L+ D K++DFGLA+ ++ +V T Y APE
Sbjct: 117 YLH--SNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 689 YALWGYLTYKADVYSFGV 706
L + A Y GV
Sbjct: 173 ------LLFGARHYGVGV 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 519 MNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
+ ++G+G FG VYK + + G + A K++ +KS + +++ EI ++ HP +VKL G
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR----QKICLGIARGLAFLHEE 633
+L ++ E+ ++ + L+L+ + Q IC + L +LH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
KI+HRD+KA NVLL D + K++DFG++ + + + + GT +MAPE +
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCE 185
Query: 694 YLT-----YKADVYSFGVVALEI 711
+ YKAD++S G+ +E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLL-SSKSRQ 552
E S +++I +G G FG + +G L +A+ L + S +
Sbjct: 1 ELDNKSIKIERI------------LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK 48
Query: 553 GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLN 612
R FL E T+ H N+V+L G G+ +M+V EY+ N +L L E QL
Sbjct: 49 QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQL--- 104
Query: 613 WSVRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
Q + + G+A G+ +L E VH+ + A VL++ DL KIS F + D+ E
Sbjct: 105 -VAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ + + + APE + + + +DV+SFG+V E++S
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
KIGEG +G VYK + G I+A+K L ++ + EI + L HPN+V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
++L LV+E+L + L + + L+ + + + +G+A+ H S +
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAK---LDEEEKTHISTRVAGTIGYMAPEYALWGY 694
++HRD+K N+L+DR+ K++DFGLA+ + TH V T+ Y APE L G
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE-ILLGS 174
Query: 695 LTYKA--DVYSFGVVALEIVSGK 715
Y D++S G + E+V+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAV-KLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
+ ++G+G FG VYK Q + ++A K++ +KS + +++ EI ++ HPN+VKL
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ L ++ E+ ++ + E L + +C L +LHE K
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY--- 694
I+HRD+KA N+L D + K++DFG++ + + + GT +MAPE +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 182
Query: 695 --LTYKADVYSFGVVALEI 711
YKADV+S G+ +E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 28/226 (12%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTI 564
L +R F+ + +G G +G VYKG+ + G + A+K++ + E EI +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 565 SCL-QHPNLVKLYGCCIE------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
H N+ YG I+ DQL LV E+ S+ + + + LK +W
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDE---EEKTH 673
IC I RGLA LH K++HRDIK NVLL + K+ DFG+ A+LD T
Sbjct: 126 -ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 674 ISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSG 714
I GT +MAPE Y++D++S G+ A+E+ G
Sbjct: 182 I-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVK---LLSSKSRQGNREFLN---EIGTISCLQHPNLV 573
+G+G +G VY G G +IAVK L +S +E+ E+ + L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+ G C++ + + + E++ S++ L FG L V K I G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLH 119
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-----DEEEKTHISTRVAGTIGYMA 686
+VHRDIK NV+L + K+ DFG A+ +++ + GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722
PE K+D++S G E+ +GK ++ +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 522 IGEGGFGPVYKGQLTDG----TIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLY 576
IG+G FG VY G L D AVK L+ + E FL E + HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 577 GCCIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG--IARGLAFLHEE 633
G C+ + ++V Y+++ L + + + N +V+ I G +A+G+ +L +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK 117
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEE-EKTHISTRVAGTIGYMAPEYA 690
K VHRD+ A N +LD K++DFGLA+ D+E H T + +MA E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 691 LWGYLTYKADVYSFGVVALEIVS 713
T K+DV+SFGV+ E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 519 MNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSS-KSRQGNREFLNEIGTISCLQHPNL 572
M ++GE FG +YKG L ++A+K L + Q EF E ++ L HPN+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALF-----------GGENSQLK--LNWSVRQKI 619
V L G + + +++EYL L L E+ +K L+ I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRV 678
+ IA G+ +L S F VH+D+ A N+L+ L+ KISD GL++ + + + +
Sbjct: 130 AIQIAAGMEYL--SSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
I +M PE ++G + +D++SFGVV EI S
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 522 IGEGGFGPVYKGQL-----TDGTI-IAVKLLSSKSRQGNREFL-NEIGTISCL-QHPNLV 573
+G G FG V + +D + +AVK+L + RE L +E+ +S L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG--IARGLAFLH 631
L G C G ++++ EY L + L S L L + +A+G+AFL
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE----DLLSFSYQVAKGMAFLA 158
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI---STRVAGTIGYMAPE 688
++ +HRD+ A NVLL KI DFGLA+ + ++ + R+ + +MAPE
Sbjct: 159 SKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPE 213
Query: 689 YALWGYLTYKADVYSFGVVALEIVS 713
T+++DV+S+G++ EI S
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 509 IRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL 567
+R F+ + +G G +G VYKG+ + G + A+K++ + E EI +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 568 -QHPNLVKLYGCCIE------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620
H N+ YG I+ DQL LV E+ S+ + + + LK W IC
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDE---EEKTHIST 676
I RGL+ LH+ K++HRDIK NVLL + K+ DFG+ A+LD T I
Sbjct: 118 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-- 172
Query: 677 RVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSG 714
GT +MAPE +K+D++S G+ A+E+ G
Sbjct: 173 ---GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK------LLSSKSRQGNREFLNEIGTISC 566
+NF KIG G F VY+ L DG +A+K L+ +K+R + + EI +
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 58
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQL--KLNWSVRQKICLG 622
L HPN++K Y IE ++L +V E + L+ + F + + K W ++C
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC-- 116
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
A H SR +++HRDIK NV + K+ D GL + KT + + GT
Sbjct: 117 ----SALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTP 170
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
YM+PE +K+D++S G + E+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNL 572
++ ++KIGEG +G V+K + + G I+A+K + S + L EI + L+HPNL
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V L +L LV+EY ++ ++ + L E + + + +KI + + F H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDH-TVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHISTRVAGTIGYMAPE 688
+HRD+K N+L+ + K+ DFG A++ ++ +++TR Y APE
Sbjct: 119 H---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 689 YALWGYLTYKA--DVYSFGVVALEIVSG 714
L G Y DV++ G V E+++G
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 516 FDPMNKIGEGGFGPVY-KGQLTDGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQHPN 571
F +++IG G FG VY ++AVK +S +Q N ++ + E+ + L+HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK-----ICLGIARG 626
++ GC ++ LV EY G + L+++ Q+ I G +G
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
LA+LH + ++HRDIKA N+LL K++DFG A + + GT +MA
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMA 185
Query: 687 PEYALW---GYLTYKADVYSFGVVALEIVSGK 715
PE L G K DV+S G+ +E+ K
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 521 KIGEGGFGPVYKG--QLTDGTI-IAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKLY 576
++G G FG V KG ++ I +A+K+L +++ + R E + E + L +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G C E + LMLV E L + G+ ++ ++ V ++ ++ G+ +L E F
Sbjct: 62 GVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVV--ELMHQVSMGMKYL-EGKNF 116
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWGY 694
VHRD+ A NVLL KISDFGL+K + ++ R AG + + APE +
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 695 LTYKADVYSFGVVALEIVS 713
+ ++DV+S+G+ E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 521 KIGEGGFGPVYKG---QLTDGTIIAVKLLSSKSRQG--NREFLNEIGTISCLQHPNLVKL 575
++G G FG V KG +AVK+L + + E L E + L +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK----ICLGIARGLAFLH 631
G C E + MLV E E G N L+ N V +K + ++ G+ +L
Sbjct: 62 IGIC-EAESWMLVMELAE--------LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL- 111
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEY 689
EE+ F VHRD+ A NVLL KISDFGL+K ++ + + G + + APE
Sbjct: 112 EETNF--VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 690 ALWGYLTYKADVYSFGVVALEIVS 713
+ + K+DV+SFGV+ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 9e-18
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQHPN 571
F + +IG G FG VY + + ++A+K +S +Q N ++ + E+ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL-----GIARG 626
++ GC + LV EY G + L+++ Q++ + G +G
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
LA+LH + ++HRDIKA N+LL K++DFG A + + + GT +MA
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMA 189
Query: 687 PEYALW---GYLTYKADVYSFGVVALEIVSGK 715
PE L G K DV+S G+ +E+ K
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPN 571
NF + KIGEG +G VYK + G ++A+K L +++ + EI + L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+VKL ++L LV+E+L + L + S + L + + + +GLAF H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEEEKTHISTRVAGTIGYMAPE 688
+++HRD+K N+L++ + K++DFGLA+ + TH V T+ Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 170
Query: 689 YALWG-YLTYKADVYSFGVVALEIVSGK 715
L Y + D++S G + E+V+ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLTDGT------IIAVKLLSSKSRQGNRE-FLNE 560
+I +T F M ++GE FG VYKG L +A+K L K+ RE F +E
Sbjct: 1 EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 561 IGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL--------AHALFGGENSQLKLN 612
S LQHPN+V L G + L +++ Y ++ L H+ G + +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 613 WSVRQ----KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668
++ I IA G+ FL S +VH+D+ NVL+ LN KISD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172
Query: 669 EEKTHISTRVAGT----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
E ++ G I +M+PE ++G + +D++S+GVV E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 67/193 (34%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 522 IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581
IG+G FG V G G +AVK + K+ + FL E ++ L+H NLV+L G +E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 582 GD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
L +V EY+ SL L S L + + K L + + +L E + F VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYL-EANNF--VH 125
Query: 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKAD 700
RD+ A NVL+ D K+SDFGL K E T + ++ + + APE + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 701 VYSFGVVALEIVS 713
V+SFG++ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 73/225 (32%), Positives = 106/225 (47%), Gaps = 54/225 (24%)
Query: 519 MNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNRE---FLNEIGTI----SCLQHP 570
+ +IG G FG V K GTI+AVK + S +E L ++ + C P
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDC---P 63
Query: 571 NLVKLYGCCI-EGD-----QLM---------LVYEYLENNSLAHALFGGENSQLKLNWSV 615
+VK YG EGD +LM VYE L++ + +
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV---------------IPEEI 108
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHI 674
KI + + L +L EE KI+HRD+K +N+LLDR+ N K+ DFG++ +L +
Sbjct: 109 LGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIA 163
Query: 675 STRVAGTIGYMAPE----YALWGYLTYKADVYSFGVVALEIVSGK 715
TR AG YMAPE A GY ++DV+S G+ E+ +GK
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 20/235 (8%)
Query: 494 LEGL-EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYK-GQLTDGTIIAVKLLSSKSR 551
L GL + +S L+ + T ++ + IG+G +G VYK DG++ AVK+L
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-IS 59
Query: 552 QGNREFLNEIGTISCL-QHPNLVKLYGCCIEGD-----QLMLVYEYLENNSLAHALFGGE 605
+ E E + L HPN+VK YG + D QL LV E S+ + G
Sbjct: 60 DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119
Query: 606 NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
+L+ ++ I G GL LH +I+HRD+K N+LL + K+ DFG++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 666 LDEEEKTHISTRVAGTIGYMAPEYAL----WGYLTYKA--DVYSFGVVALEIVSG 714
+ +T V GT +MAPE + Y +Y A DV+S G+ A+E+ G
Sbjct: 177 QLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDY-SYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQHPN 571
F + +IG G FG VY + + + ++A+K +S +Q N ++ + E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL-----GIARG 626
++ GC + LV EY G + L+++ Q++ + G +G
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
LA+LH + ++HRD+KA N+LL K+ DFG A + + GT +MA
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMA 179
Query: 687 PEYALW---GYLTYKADVYSFGVVALEIVSGK 715
PE L G K DV+S G+ +E+ K
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS-SKSRQGNREF----LNEIGTISCLQ 568
++ +N+I EG +G VY+ + G I+A+K L K ++G F L EI + LQ
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 569 HPNLVKL----YGCCIEGDQLMLVYEYLENNSLAHALFGG-ENSQLKLNWSVRQKICLGI 623
HPN+V + G + D++ +V EY+E H L E + S + + L +
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVE-----HDLKSLMETMKQPFLQSEVKCLMLQL 115
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
G+A LH+ I+HRD+K +N+LL+ KI DFGLA+ T++ T+
Sbjct: 116 LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLW 171
Query: 684 YMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
Y APE L G Y D++S G + E+++ K
Sbjct: 172 YRAPEL-LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSR-QGNREF-LNEIGTISCLQHPN 571
++ + KIGEG +G V+K + + I+A+K + +G L EI + L+H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+V+LY +L LV+EY + + L ++ ++ + + + +GLAF H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
++HRD+K N+L++++ K++DFGLA+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 515 NFDPMNKIGEGGFGPVYK-GQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPN 571
++ + +G G FG V+ + D ++ +K + + ++ NE + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+++ Y +E LM+V EY +LA + NS L I + L LH
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD-----EDTILHFFVQILLALH 115
Query: 632 EESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
I+HRD+K N+LLD+ KI DFG++K+ K+ T V GT Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISPELC 173
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
K+D+++ G V E+ S K
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 522 IGEGGFGPVYKGQLT-DGTII--AVKLLSS-KSRQGNREFLNEIGTISCL-QHPNLVKLY 576
IGEG FG V + + DG + A+K+L S +R+F E+ + L HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL-----------FGGENSQLKLNWSVRQ--KICLGI 623
G C L + EY +L L F E+ + +Q + +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLLQFASDV 128
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
A G+ +L E+ + +HRD+ A NVL+ +L KI+DFGL++ +E R+ +
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VR 183
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MA E + T K+DV+SFGV+ EIVS
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 38/221 (17%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK-LLSSKSRQGNREFLNEIG----TISCLQ 568
+ + + ++G G +G V K + + GTI+AVK + ++ + Q + L ++ ++ C
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC-- 59
Query: 569 HPNLVKLYGCCI-EGD-----QLM-LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
P V YG EGD ++M + L E+ + KI +
Sbjct: 60 -PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPED--------ILGKIAV 110
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVA 679
I + L +LH + ++HRD+K +NVL++R+ K+ DFG++ +D K T A
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TIDA 164
Query: 680 GTIGYMAPE-----YALWGYLTYKADVYSFGVVALEIVSGK 715
G YMAPE GY K+DV+S G+ +E+ +G+
Sbjct: 165 GCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE--F----LNEIGTISC 566
S ++ + KIG+G FG V+K + I+A+K K N + F L EI +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67
Query: 567 LQHPNLVKLYGCCIE--------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
L+H N+V L C LV+E+ E++ LA L N +K S +K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKK 123
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEEEKTH-I 674
+ + GL ++H R KI+HRD+KA N+L+ +D K++DFGLA+ L + K +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 675 STRVAGTIGYMAPEYAL 691
+ RV T+ Y PE L
Sbjct: 181 TNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-17
Identities = 72/237 (30%), Positives = 117/237 (49%), Gaps = 13/237 (5%)
Query: 39 SMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLV-NLETLRLSS 97
S ++ I + +SG I S + + + ++L NQ SG IP ++ +L L LS+
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS 157
N G++P + NL +++N +G P+ I S++ L L++ G+ L G IP S++
Sbjct: 128 NNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 158 ALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217
L L L ++ Q Q L M L I L N++GEIP I G+ +L LDL +
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 218 NQLTGELP-DVAVPADLKFT---------QILMFIRGVYEHQSLDLSYNNFTWQSPE 264
N LTG +P + +L++ I I + + SLDLS N+ + + PE
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCL 567
++ + KIGEG +G VYKG+ G I+A+K K R + E + EI + L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK----KIRLESEEEGVPSTAIREISLLKEL 56
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAH--ALFGGENSQLKLNWSVRQKICLGIAR 625
QHPN+V L ++ +L L++E+L + + +L G+ +L S +I GI
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL- 115
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV----AGT 681
F H +++HRD+K N+L+D K++DFGLA+ I RV T
Sbjct: 116 ---FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVT 164
Query: 682 IGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
+ Y APE L G Y D++S G + E+ + K
Sbjct: 165 LWYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 519 MNKIGEGGFGPVYKGQLTD------GTIIAVKLLS-SKSRQGNREFLNEIGTISCLQHPN 571
+ ++G+G FG VY+G D T +AVK ++ S S + EFLNE + +
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFG----GENSQLKLNWSVRQKICLG--IAR 625
+V+L G +G ++V E + + L L EN+ + ++++ I + IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAG--TIG 683
G+A+L+ + K VHRD+ A N ++ D KI DFG+ + D E + G +
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVR 186
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MAPE G T +D++SFGVV EI S
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 516 FDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNL 572
++ + KIGEG +G VYK + +T+ TI K+ + +G + EI + +QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V+L +L LV+EYL+ + H + N + + I RG+A+ H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHM---DSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 633 ESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEEEKTHISTRVAGTIGYMAPE 688
+++HRD+K N+L+DR N K++DFGLA+ + TH T+ Y APE
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPE 173
Query: 689 YALWGYLTYKA--DVYSFGVVALEIVSGK 715
L G Y D++S G + E+V+ K
Sbjct: 174 ILL-GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 520 NKIGEGGFGPVYKGQLTDGT----IIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKL 575
++IG G FG V G+ G ++ +L +S + FL E+ L HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGG-ENSQLKLNWSVRQKICLGIARGLAFLHEES 634
G CIE +LV E+ L + L V Q++ +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST-RVAGTIGYMAPEYA--- 690
+ +H D+ N L DL+ KI D+GLA E +I+ A + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 691 ----LWGYLTYKADVYSFGVVALEI 711
L T K++++S GV E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 503 SFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIG 562
S T+ I S+ N I G G YKG+ ++ + + N +EI
Sbjct: 682 SITINDI---LSSLKEENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIA 735
Query: 563 TISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
+ LQHPN+VKL G C L++EY+E +L+ L L+W R+KI +G
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIG 788
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
IA+ L FLH +V ++ +++D P + L + K IS+
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS------ 842
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716
Y+APE +T K+D+Y FG++ +E+++GK+
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
|
Length = 968 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVY------KGQLTDGTIIAVKLLSSKSRQGNREFL- 558
LK+IR +GEG FG V +G T G +AVK L +S + L
Sbjct: 6 LKRIR----------DLGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLK 54
Query: 559 NEIGTISCLQHPNLVKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
EI + L H N+VK G C E G+ + L+ E+L + SL L +N K+N +
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN---KINLKQQ 111
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
K + I +G+ +L SR + VHRD+ A NVL++ + KI DFGL K E +K + +
Sbjct: 112 LKYAVQICKGMDYLG--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 677 R--VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ + + + APE + +DV+SFGV E+++
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 522 IGEGGFGPVYKGQLT-DGTII--AVKLLSS-KSRQGNREFLNEIGTISCL-QHPNLVKLY 576
IGEG FG V K ++ DG + A+K + S+ +R+F E+ + L HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHAL-----------FGGENSQLKLNWSVRQ--KICLGI 623
G C L L EY + +L L F NS S +Q +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAADV 121
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
ARG+ +L ++ + +HRD+ A N+L+ + KI+DFGL++ E R+ +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VR 176
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MA E + T +DV+S+GV+ EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 515 NFDPMNKIGEGGFGPVY--KGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
++ + KIGEG FG +Y K + ++ +I L+ + E+ ++ ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC--LGIARGLAF 629
+V + E +L +V EY + L + N Q + +S Q + + I+ GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI----NRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 630 LHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+H+ KI+HRDIK+ N+ L ++ + K+ DFG+A+ + ++ GT Y++PE
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYLSPE 172
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGKN 716
K D++S G V E+ + K+
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 521 KIGEGGFGPVYKGQL-TDGTIIAVK-LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+IG G FG V+ G+L D T +AVK + +FL E + HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
C + + +V E ++ E +LK+ ++ + A G+ +L ES+ I
Sbjct: 62 CTQKQPIYIVMELVQGGDFL-TFLRTEGPRLKVKELIQ--MVENAAAGMEYL--ESKHCI 116
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEYALWGY 694
HRD+ A N L+ KISDFG+++ +EE+ + ST G + + APE +G
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYGR 172
Query: 695 LTYKADVYSFGVVALEIVS 713
+ ++DV+SFG++ E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSK----SRQGNREFLNEIGTISCLQHPNLVKLY 576
+GEG FG V +GQL D +I+ V + + K +R +FL+E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 577 GCCIEGDQL------MLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLA 628
G C++ + +++ ++++ L L + L + K IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT-IGYMAP 687
+L +S +HRD+ A N +L+ ++N ++DFGL+K + R+A + ++A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 688 EYALWGYLTYKADVYSFGVVALEIVS 713
E T K+DV+SFGV EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNL 572
++ + +GEG +G V K + + G I+A+K L S + + + EI + L+H NL
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V L +L LV+E++++ L E L+ S +K I RG+ F H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHISTRVAGTIGYMAPE 688
+ I+HRDIK N+L+ + K+ DFG A+ E +++TR Y APE
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPE 170
Query: 689 YALWGYLTY-KA-DVYSFGVVALEIVSG 714
L G Y +A D+++ G + E+++G
Sbjct: 171 L-LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-16
Identities = 44/151 (29%), Positives = 79/151 (52%)
Query: 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT 64
L G + + ++P L+ + A N G +P + S +L+ + + N+ SG +P LG+++
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
L L L EN+ SG IP EL + L +L LS N+L G +P ++ L+ ++ N
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 125 NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPS 155
+G P + + L ++ I + L G +P +
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK------LLSSKSRQGNREFLNEIGTISC 566
+NF KIG G F VY+ L D +A+K ++ +K+RQ + + EI +
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQ 58
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQL--KLNWSVRQKICLG 622
L HPN++K IE ++L +V E + L+ + F + + + W ++C
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ H SR +++HRDIK NV + K+ D GL + + T + V GT
Sbjct: 119 VE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
YM+PE +K+D++S G + E+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIG------TISCLQ--HPNL 572
I +G FG VY + + G A+K+L ++ + N++ I +Q P +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL----KKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFL 630
KLY D L LV EYL A + GG L +W +Q I + G+ L
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDW-AKQYIA-EVVLGVEDL 113
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
H+ I+HRDIK N+L+D+ + K++DFGL++ E K + GT Y+APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETI 165
Query: 691 LWGYLTYKADVYSFGVVALEIVSG 714
L +D +S G V E + G
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
R +F+ + +IG G +G VYK + + G + A+K++ + + EI + +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL-FGGENSQLKLNWSVRQKICLGIARGL 627
H N+V +G + D+L + E+ SL G S+ ++ + R+ + +GL
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA------GT 681
+LH + + +HRDIK N+LL + + K++DFG++ I+ +A GT
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGT 169
Query: 682 IGYMAPEYALW---GYLTYKADVYSFGVVALEI 711
+MAPE A G D+++ G+ A+E+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGT---ISCLQH--PNL 572
+ +IG G G VYK + G ++AVK + R GN+E I + H P +
Sbjct: 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 573 VKLYGCCIEGDQLMLVYEYLEN--NSLAHALFGG--ENSQLKLNWSVRQKICLGIARGLA 628
VK YG I + + E + + L + G E+ + K+ + I + L
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPED--------ILGKMTVAIVKALH 128
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+L E+ ++HRD+K +N+LLD N K+ DFG++ + K TR AG YMAPE
Sbjct: 129 YLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184
Query: 689 ----------YALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCT 727
Y + +ADV+S G+ +E+ +G+ P NC
Sbjct: 185 RIDPPDPNPKYDI------RADVWSLGISLVELATGQ-----FPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 52/228 (22%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQ-HP 570
+ + KIGEG F V K Q G A+K + + Q N L EI + L HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHP 58
Query: 571 NLVKLYGCCIEGDQL------------MLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
N+++L + D+ M +YE ++ L + ++ + Q
Sbjct: 59 NILRL--IEVLFDRKTGRLALVFELMDMNLYELIKGRK--RPL-----PEKRVKSYMYQ- 108
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKT-HIS 675
+ + L +H R I HRDIK N+L+ D+ K++DFG + + T +IS
Sbjct: 109 ----LLKSLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYIS 160
Query: 676 TRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVS------GKN 716
TR Y APE L GY K D+++ G V EI+S G N
Sbjct: 161 TR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 522 IGEGGFGPVYKGQL-TDGTII--AVKLLSS-KSRQGNREFLNEIGTISCL-QHPNLVKLY 576
IGEG FG V K ++ DG + A+K + S+ +R+F E+ + L HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 577 GCCIEGDQLMLVYEY---------------LENN---SLAHALFGGENSQLKLNWSVRQK 618
G C L L EY LE + ++A++ +SQ L+++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA--- 131
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+ARG+ +L S+ + +HRD+ A N+L+ + KI+DFGL++ E R+
Sbjct: 132 ---DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MA E + T +DV+S+GV+ EIVS
Sbjct: 186 P--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 32/208 (15%)
Query: 522 IGEGGFGPVY---KGQLTD-GTIIAVKLL---SSKSRQGNREFLNEIGTISCLQHPNLVK 574
+G+G FG V+ K D G + A+K+L + K R R E ++ + HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 575 L-YGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARGLA 628
L Y EG +L L+ ++L L +F E+ + L +A L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMA 686
LH I++RD+K N+LLD + + K++DFGL+K +D E+K + GT+ YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSG 714
PE T AD +SFGV+ E+++G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 521 KIGEGGFGPVY----KGQLTDG--TIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLV 573
++G+G FG VY KG + D T +A+K ++ + R EFLNE + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFG----GENSQLKLNWSVRQKICLG--IARGL 627
+L G +G +++ E + L L EN+ ++ S+++ I + IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMA 686
A+L+ K VHRD+ A N ++ D KI DFG+ + + E + + + +M+
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVS 713
PE G T +DV+SFGVV EI +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 52/205 (25%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNL 572
+F+ ++++G G G V K Q G I+A KL+ + + R + + E+ + P +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V YG ++ + E+++ SL L ++ + K+ + + RGLA+L E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYA 690
+ +I+HRD+K +N+L++ K+ DFG++ +D + + TR YM+PE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERL 174
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
+ + ++D++S G+ +E+ G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSS----KSRQGNREFLNEIGTISCLQ 568
+F+ + +G G FG V + G A+K+LS K +Q LNE + ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-NSQLKLNWSVRQKICLGIAR-- 625
HP LV LYG + L LV EY+ GGE S L+ + +AR
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVP---------GGELFSHLR----KSGRFPEPVARFY 106
Query: 626 ------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
L +LH IV+RD+K N+LLD D KI+DFG AK K T +
Sbjct: 107 AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTYT-LC 159
Query: 680 GTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSG 714
GT Y+APE L GY D ++ G++ E+++G
Sbjct: 160 GTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL--NEIGTISC 566
R +++ + ++G G +G VYK + L G + AVK++ K G+ L EI +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVKE 62
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL-FGGENSQLKLNWSVRQKICLGIAR 625
+H N+V +G + ++L + EY SL G S+L++ + R+ + +
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----Q 117
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA------ 679
GLA+LH + + +HRDIK N+LL + + K++DFG+A I+ +A
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFI 167
Query: 680 GTIGYMAPEYALW---GYLTYKADVYSFGVVALEI 711
GT +MAPE A G D+++ G+ A+E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 522 IGEGGFGPVYK-GQLTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+G G G V K + GT++A K + +KS ++ L E+ + + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-RKQILRELQIMHECRSPYIVSFYGA 71
Query: 579 CIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+ + + + E+++ SL G + + KI + + GL +L+ R
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHR- 124
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
I+HRDIK +N+L++ K+ DFG++ E I+ GT YM+PE G T
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 697 YKADVYSFGVVALEIVSGK 715
K+DV+S G+ +E+ GK
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K R+G LNE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSV--RQKICLGIARGLAFLHEESR 635
D L LV + L ++ + + +V +IC G L LH+E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+IV+RD+K N+LLD + +ISD GLA E +T I RV GT+GYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 696 TYKADVYSFGVVALEIVSGKN 716
T+ D ++ G + E+++G++
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 522 IGEGGFGPV-YKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+G+G +G V TDG +K L+ + SR+ + E +S L+HPN+V Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66
Query: 579 CIEGD--QLMLVYEYLENNSLAHALFGGENSQLKLN----WSVRQKICLGIARGLAFLHE 632
EG+ L +V + E L H L + L N W V+ IA L +LHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHE 120
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
+ I+HRD+K NV L R K+ D G+A++ E + ST + GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 693 GYLTYKADVYSFGVVALEIVSGKN 716
YK+DV++ G E+ + K+
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 522 IGEGGFGPVY--------KGQLTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCL-QHPN 571
+GEG FG V K + + +AVK+L + + + + ++E+ + + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ------------KI 619
++ L G C + L ++ EY +L L ++ ++ + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHIS 675
+ARG+ +L + K +HRD+ A NVL+ + KI+DFGLA+ +D +KT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT--- 196
Query: 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
T + +MAPE T+++DV+SFGV+ EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 519 MNKIGEGGFG-PVYKGQLTDGTIIAVK-----LLSSKSRQGNREFLNEIGTISCLQHPNL 572
+ KIGEG FG + DG +K +S K R+ +R+ E+ +S ++HPN+
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPNI 61
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V+ E L +V +Y E L + N+Q + + Q + + LA H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLALKHV 117
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
R KI+HRDIK+ N+ L +D K+ DFG+A++ ++ GT Y++PE
Sbjct: 118 HDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICEN 175
Query: 693 GYLTYKADVYSFGVVALEIVSGKN 716
K+D+++ G V E+ + K+
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----------H 569
+G+G FG V +L + AVK+L ++ + + + C H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAGKH 55
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P L +L+ C D+L V EY+ L + + + + I GL F
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE--IVLGLQF 111
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAP 687
LHE I++RD+K NVLLD + + KI+DFG+ K + T + GT Y+AP
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAP 165
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSGK 715
E + D ++ GV+ E+++G+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLS-SKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
+G G G VYK L I+AVK++ + + ++ ++E+ + P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
+++ + E+++ SL + K+ V +I + + +GL +L KI+
Sbjct: 69 FVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 640 HRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKA 699
HRD+K +N+L++ K+ DFG++ + I+ GT YMAPE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 700 DVYSFGVVALEIVSG--------KNNMSYVPDSNCTCPLD 731
DV+S G+ +E+ G KN S +P C +D
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 510 RAATSNFDPMNK-IGEGGFGPVYKGQLT-DGTIIAVKLLS----SKSRQGNREF------ 557
+ + + +GEG +G V K T G I+A+K + S +R+
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 558 ----LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613
L E+ ++ ++H N++ L +EGD + LV + + ++ L + + +++L
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTE 118
Query: 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA--------- 664
S + I L I GL LH+ +HRD+ N+ ++ KI+DFGLA
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 665 ----KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
K + ++ T T+ Y APE L G Y D++S G + E+++GK
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 522 IGEGGFGPVYKGQLTDGT-IIAVKLLSSKSRQGNREFLNEIGTISCL-----------QH 569
+G+G FG V +L A+K L ++ + E + C +H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAWEH 55
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P L L+ + L V EYL L + S + + + + I GL F
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQF 111
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH++ I++RD+K NVLLD+D + KI+DFG+ K + + ST GT Y+APE
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI 167
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGKN 716
D +SFGV+ E++ G++
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 522 IGEGGFGPVY--------KGQLTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCL-QHPN 571
+GEG FG V K + T +AVK+L S + + + + ++E+ + + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ------------KI 619
++ L G C + L ++ EY +L L ++ ++ Q
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHIS 675
+ARG+ +L + K +HRD+ A NVL+ D KI+DFGLA+ +D +KT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT--- 199
Query: 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
T + +MAPE T+++DV+SFGV+ EI +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 519 MNKIGEGGFGPVYKG-QLTDGTIIAVK-----LLSSKSRQGNREFLNEIGTISCLQHPNL 572
++++G+G +G VYK G +A+K L SK Q + E+ + P +
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYI 61
Query: 573 VKLYGC-CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
V YG IEG M + EY++ SL L+ G + + V ++I + +GL FL
Sbjct: 62 VDFYGAFFIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE--KTHISTRVAGTIGYMAPEY 689
EE I+HRD+K TNVL++ + K+ DFG++ KT+I G YMAPE
Sbjct: 120 EE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPER 172
Query: 690 ----ALWGYLTY--KADVYSFGVVALEIVSGKNNMSYVPDS 724
TY ++DV+S G+ LE+ G+ Y P++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGR--YPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K + G + L E + + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
L LV + L + ++ L++ + I G+ LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA--QITCGILHLHS---MD 115
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
IV+RD+K NVLLD N ++SD GLA ++ KT T+ AGT GYMAPE +Y
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 698 KADVYSFGVVALEIVSGK 715
D ++ G E+V+G+
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K R+G LNE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 578 CCIEGDQLMLVYEYLENNSLAHALF----GGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
D L LV + L ++ G + + + ++ +I G L LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA--EITCG----LEDLHRE 121
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+IV+RD+K N+LLD + +ISD GLA E +T I RV GT+GYMAPE
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNE 176
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
T+ D + G + E++ GK
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-14
Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKL----LSSKSRQGNREFLNEIGTISCLQHP 570
+D + IG+GG G VY +A+K LS R FL E + L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHP 62
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG-----------GENSQLKLNWSVRQKI 619
+V +Y C +GD + Y+E +L L E + + S+ KI
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEEEKTHIST 676
C I ++H S+ ++HRD+K N+LL I D+G A L+EE+ I
Sbjct: 123 CATIE----YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 677 --------------RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
++ GT YMAPE L + D+Y+ GV+ ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 513 TSNFDPMNKIGEGGFGPV--YKGQLTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCLQH 569
T+ + + +G G FG V + QLT + K++ S + E+ + L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 570 PNLVKLYGCCIEG-DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
N++ L I + + V E L L L L Q I RGL
Sbjct: 69 ENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLK 122
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAP 687
++H +VHRD+K +N+L++ + + KI DFGLA++ + + T ++STR Y AP
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 688 EYAL-WGYLTYKADVYSFGVVALEIVSGK 715
E L W + D++S G + E++ GK
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGN-RE-----FLNEIGTISCLQ 568
FD + +IGEG +G VYK + D G ++A+K K R N +E + EI + L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64
Query: 569 HPNLVKLYGCCIEGDQLM----------LVYEYLENNSLAHALFGGENSQL-KLNWSVRQ 617
H N+V L + + LV+EY++ H L G S L + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-----HDLMGLLESGLVHFSEDHIK 119
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+ GL + H+++ +HRDIK +N+LL+ K++DFGLA+L E++ T
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 678 VAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
T+ Y PE L G Y DV+S G + E+ + K
Sbjct: 177 KVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-14
Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 29 LHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87
L G IP + + ++ L+ I++ N + GNIP LG+ITSL LDL N F+G+IP LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 88 VNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRINDN 122
+L L L+ N L G +P L +L + F DN
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 516 FDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQGNREF--LNEIGTISCLQ--- 568
++ + +IGEG +G V+K + G +A+K + ++ + + E+ + L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 569 HPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
HPN+V+L+ C +L LV+E+++ + + + + + + + +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL---DKVPEPGVPTETIKDMMFQL 119
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
RGL FLH ++VHRD+K N+L+ K++DFGLA++ + T V T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 174
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEI 711
Y APE L D++S G + E+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 20/212 (9%)
Query: 511 AATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQ 568
AATS + + K+GEG + VYKG +G ++A+K++S K+ +G + E + L+
Sbjct: 3 AATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF---GGENSQLKLNWSVRQKICLGIAR 625
H N+V L+ + L V+EY+ + LA + GG + ++VR + R
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHP-----YNVRL-FMFQLLR 114
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYM 685
GLA++H + I+HRD+K N+L+ K++DFGLA+ S+ V T+ Y
Sbjct: 115 GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYR 170
Query: 686 APEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
P+ L G Y + D++ G + +E++ G+
Sbjct: 171 PPD-VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 521 KIGEGGFGPVYKGQLTDG---TIIAVK-LLSSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+IG G FG V G++ G + VK L S S Q +FL E LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQ-LKLNWSVRQKICLGIARGLAFLHEESR 635
G C E +LV E+ L L ++ + + + Q++ IA GL LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI-STRVAGTIGYMAPEYA--LW 692
+H D+ N LL DL KI D+GL+ +E ++ ++ + ++APE +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 693 GYL-----TYKADVYSFGVVALEI 711
G L T +++V+S GV E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 522 IGEGGFGPVY--------KGQLTDGTIIAVKLLSSKSRQGN-REFLNEIGTISCL-QHPN 571
+GEG FG V K + +AVK+L + + + ++E+ + + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHAL---------FGGENSQL---KLNWSVRQKI 619
++ L G C + L ++ EY +L L + + +L +L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHIS 675
+ARG+ +L + K +HRD+ A NVL+ D KI+DFGLA+ +D +KT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT--- 193
Query: 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
T + +MAPE T+++DV+SFGV+ EI +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K R+G LNE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSV--RQKICLGIARGLAFLHEESR 635
D L LV + L ++ N + ++ +I G L LH E+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHISTRVAGTIGYMAPEYALWGY 694
V+RD+K N+LLD + +ISD GLA K+ E E I RV GT+GYMAPE
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQR 177
Query: 695 LTYKADVYSFGVVALEIVSGKN 716
T D + G + E++ G++
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 516 FDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREF---------LNEIGTIS 565
++ + IG G +G V G +A+K + + F L EI +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLR 54
Query: 566 CLQHPNLVKLYGCCIEGDQ-----LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620
L+H N++ L + +V E +E + L H + S L Q
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD-L-HKVI---KSPQPLTDDHIQYFL 109
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHISTR 677
I RGL +LH ++HRD+K +N+L++ + + KI DFGLA+ DE+EK ++
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 678 VAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
V T Y APE L T D++S G + E+++ K
Sbjct: 167 VV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 522 IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ---GNREFLNEIGTISC-------LQHPN 571
+G+G FG VY D + L++K Q + E E+ + C LQH
Sbjct: 10 LGQGAFGRVYLCYDVDTG----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 572 LVKLYGCCIE-GDQLMLVY-EYLENNSLAHALFGGENSQLK----LNWSVRQKICLGIAR 625
+V+ YGC + ++ + ++ EY+ S+ QLK L SV +K I
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILE 117
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE---EKTHISTRVAGTI 682
G+++LH IVHRDIK N+L D N K+ DFG +K + T I + V GT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTP 173
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+M+PE KADV+S G +E+++ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 519 MNKIGEGGFGPVYKG--QLTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKL 575
++K+GEG + VYKG +LTD ++A+K + + +G + E+ + L+H N+V L
Sbjct: 11 LDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
+ L LV+EYL+ + L L NS +N + + RGL + H R
Sbjct: 70 HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCH---R 122
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
K++HRD+K N+L++ K++DFGLA+ S V T+ Y P+ L G
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL-GST 180
Query: 696 TY--KADVYSFGVVALEIVSGK 715
Y + D++ G + E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 519 MNKIGEGGFGPVYKG--QLTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKL 575
++K+GEG + V+KG +LT ++A+K + + +G + E+ + L+H N+V L
Sbjct: 10 LDKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
+ L LV+EYL+++ L L N N + + RGL++ H+
Sbjct: 69 HDIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKI---FMFQLLRGLSYCHKR-- 122
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
KI+HRD+K N+L++ K++DFGLA+ S V T+ Y P+ L G
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGST 179
Query: 696 TYKA--DVYSFGVVALEIVSGK 715
Y D++ G + E+ +G+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 32/218 (14%)
Query: 522 IGEGGFGPVYKG-------QLTDGTI-IAVKLLSSKSRQGN-REFLNEIGTISCL-QHPN 571
+GEG FG V + D T+ +AVK+L + + + ++E+ + + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALF------------GGENSQLKLNWSVRQKI 619
++ L G C + L ++ EY +L L + + +L++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHIS 675
+ARG+ +L ESR + +HRD+ A NVL+ D KI+DFGLA+ +D +KT +
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-N 195
Query: 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
R+ + +MAPE T+++DV+SFG++ EI +
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 519 MNKIGEGGFGPVYKG--QLTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKL 575
+ K+GEG + V+KG +LT+ ++A+K + + +G + E+ + L+H N+V L
Sbjct: 11 LEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 576 YGCCIEGDQLMLVYEYLENNSLAH-----ALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+ L LV+EYL+ + + + N ++ L I RGLA+
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAYC 120
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
H R K++HRD+K N+L++ K++DFGLA+ S V T+ Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-V 175
Query: 691 LWGYLTY--KADVYSFGVVALEIVSGK 715
L G Y + D++ G + E+ SG+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 50/205 (24%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 515 NFDPMNKIGEGGFGPVYK-GQLTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNL 572
+F+ ++++G G G V+K G I+A KL+ + + R + + E+ + P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V YG ++ + E+++ SL L ++ + K+ + + +GL +L E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYA 690
+ KI+HRD+K +N+L++ K+ DFG++ +D + + TR YM+PE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERL 174
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
+ + ++D++S G+ +E+ G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L K R+G LNE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSV--RQKICLGIARGLAFLHEESR 635
D L LV + L ++ N ++ ++C G L + R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+IV+RD+K N+LLD + +ISD GLA E +T + RV GT+GYMAPE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKY 178
Query: 696 TYKADVYSFGVVALEIVSGKN 716
T+ D + G + E++ G++
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 522 IGEGGFGP--VYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
+GEG FG + + +D ++ KS + E ++ ++HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA-FKES 66
Query: 580 IEGD-QLMLVYEYLENNSLAHA-------LFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
E D L +V EY + L LF L W V ++CLG+ +H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLF---PEDTILQWFV--QMCLGVQH----IH 117
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
E+ +++HRDIK+ N+ L ++ K+ DFG A+L + T V GT Y+ PE +
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE--I 171
Query: 692 WGYLTY--KADVYSFGVVALEIVSGKN 716
W + Y K+D++S G + E+ + K+
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKH 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQH-P 570
++ + KIGEG +G VYK + G ++A+K L L EI + L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 571 NLVKLYGCCIEG-------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
+V+L +E L LV+EYL+++ G L + +
Sbjct: 62 YIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEEEKTHISTRVA 679
+G+A H+ ++HRD+K N+L+D+ KI+D GL + + + TH
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--- 173
Query: 680 GTIGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSG 714
T+ Y APE L G Y D++S G + E+
Sbjct: 174 -TLWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 23/209 (11%)
Query: 515 NFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNL 572
+++ + K+GEG + VYKG+ +G ++A+K++ + +G + E + L+H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAH--ALFGG---ENSQLKLNWSVRQKICLGIARGL 627
V L+ + L LV+EY+ + + GG EN +L L + RGL
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL---------FQLLRGL 116
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
+++H+ R+ I+HRD+K N+L+ K++DFGLA+ + +H + T+ Y P
Sbjct: 117 SYIHQ--RY-ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPP 172
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSG 714
+ L G Y D++ G + +E++ G
Sbjct: 173 D-VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISC-------LQHPNLV 573
+G G FG VY D G +AVK + ++E E+ + C L+H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDP--DSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 574 KLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLK----LNWSVRQKICLGIARGL 627
+ YGC + ++ L + EY+ S+ QLK L +V ++ I +G+
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQILQGV 119
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE---EKTHISTRVAGTIGY 684
++LH IVHRDIK N+L D N K+ DFG +K + T I + V GT +
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYW 175
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
M+PE KADV+S +E+++ K
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREF---LNEIGTIS-CLQHPNLVKLY 576
+G+G FG V+ +L A+K L + + + E +S +HP L LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+ L V EYL L + S K + I GL FLH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
IV+RD+K N+LLD D + KI+DFG+ K + T GT Y+APE L
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174
Query: 697 YKADVYSFGVVALEIVSGKN 716
D +SFGV+ E++ G++
Sbjct: 175 TSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 36/199 (18%)
Query: 541 IAVKLLSSKSRQGNRE---FLNEIGTISCLQHPNLVKLY--GCCIEGDQLMLVYEYLENN 595
+A+KLL + + + + F E + L HPN+V L G L V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 596 SLAH------ALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
+L AL GE +L L + LA H + IVHRD+K N++
Sbjct: 65 TLREVLAADGALPAGETGRLMLQ----------VLDALACAHNQG---IVHRDLKPQNIM 111
Query: 650 LD-RDLNP--KISDFGLAKL-------DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKA 699
+ + P K+ DFG+ L D T +T V GT Y APE +T +
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT-RTTEVLGTPTYCAPEQLRGEPVTPNS 170
Query: 700 DVYSFGVVALEIVSGKNNM 718
D+Y++G++ LE ++G+ +
Sbjct: 171 DLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 67/205 (32%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 522 IGEGGFGPVYK-GQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGC- 578
IG+G +G V+K +G+ AVK+L + E E + L HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
GDQL LV E S+ + G ++ + I GL LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY-ALWG 693
K +HRD+K N+LL + K+ DFG++ + +T V GT +MAPE A
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 694 YL--TYKA--DVYSFGVVALEIVSG 714
L TY A DV+S G+ A+E+ G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQGNREFLNE---IGTISCLQHPNLVK 574
IG GGFG VY + D G + A+K L K +QG LNE + +S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+ D+L + + + L H +F ++++ + +I LG+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEAEMRFYAA---EIILGLE----- 111
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
H +RF +V+RD+K N+LLD + +ISD GLA ++K H S GT GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 690 ALWGYLTY--KADVYSFGVVALEIVSG 714
G + Y AD +S G + +++ G
Sbjct: 167 LQKG-VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 18/178 (10%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIA---VK-LLSSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+IG G FG V ++ T +A VK L ++ S + EFL + LQHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGE----NSQLKLNWSVRQKICLGIARGLAFLHE 632
G C+E +LV+EY E L L + NSQL L Q++ IA G+ +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMH- 116
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST--RVAGTIGYMAPE 688
+ +H D+ N L DL K+ D+G+ +E +I T + ++APE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQHPNLVKLYG 577
+G GGFG V ++ + A+K + + + +E + HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ + ++ EY L L + + + + +LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLHNRG--- 113
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYALW-GYL 695
I++RD+K N+LLD + K+ DFG AK L +KT T GT Y+APE L GY
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY- 169
Query: 696 TYKADVYSFGVVALEIVSGK 715
+ D +S G++ E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQGNREFLNE---IGTISCLQHPNLVK 574
IG GGFG VY + D G + A+K L K +QG LNE + +S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+ D+L + + + L H +F + + +I LG+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLE----- 111
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
H +RF +V+RD+K N+LLD + +ISD GLA ++K H S GT GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 690 ALWGY-LTYKADVYSFGVVALEIVSG 714
G AD +S G + +++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
+G+GGFG V Q+ G + A K L+ K R+G + E ++ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFG--GEN---SQLKLNWSVRQKICLGIARGLAFLHE 632
L LV + L + ++ EN + + + Q I GL LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS-----GLEHLHQ 115
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYA 690
+I++RD+K NVLLD D N +ISD GLA D + KT AGT G+MAPE
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK---GYAGTPGFMAPELL 169
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
+ D ++ GV E+++ +
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLL------------SSKSRQGNREFLNEIGTISCLQ 568
+G G FG V + G + A+K L S + R F T + +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK--RIFE----TANSER 60
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP LV L+ C D + V EY L + S+ + + + LG L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC-VVLG----LQ 115
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+LHE KIV+RD+K N+LLD + KI+DFGL K ST GT ++APE
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPE 171
Query: 689 YALWGYLTYKADVYSFGVVALEIVSG 714
T D + GV+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 515 NFDPMNKIGEGGFGPVY----KGQLTDGTIIAVKLL----------SSKSRQGNREFLNE 560
NF+ + +G G +G V+ G G + A+K+L +++ + R+ L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 561 IGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620
+ + P LV L+ +L L+ +Y+ L L+ E+ ++
Sbjct: 61 V-----RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVY 110
Query: 621 LG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHIST 676
+ I L LH+ I++RDIK N+LLD + + ++DFGL+K +EEE+ +
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--- 164
Query: 677 RVAGTIGYMAPEYALWGYLTY-KA-DVYSFGVVALEIVSG 714
GTI YMAPE G + KA D +S GV+ E+++G
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSKS--RQGNREFL---NEIGTISCLQHPNLVKL 575
+G+G FG V +L G + AVK+L + + E I +++ HP L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
Y C D+L V E++ L +F + S+ + + + + I L FLH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFLHDKG- 116
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY---ALW 692
I++RD+K NVLLD + + K++DFG+ K ST GT Y+APE L+
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLY 173
Query: 693 GYLTYKADVYSFGVVALEIVSG 714
G D ++ GV+ E++ G
Sbjct: 174 GPSV---DWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLA-HALFGGENSQLKLNWSVRQKICLGIARG 626
++P L LY + L V E+L L H G + + + +C G
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----G 108
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
L FLH + I++RD+K NV+LDRD + KI+DFG+ K + ST GT Y+A
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIA 164
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSGKN 716
PE T+ D +SFGV+ E++ G++
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL-----NEIGTISCLQ- 568
++P+ +IG G +G VYK + G +A+K S Q N + L E+ + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 569 --HPNLVKLYGCC--IEGDQ---LMLVYEYLENN---SLAHALFGGENSQLKLNWSVRQK 618
HPN+V+L C D+ + LV+E+++ + L G ++ + +RQ
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-TIKDLMRQF 117
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS-TR 677
+ GL FLH IVHRD+K N+L+ K++DFGLA++ ++ T
Sbjct: 118 LR-----GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTP 166
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
V T+ Y APE L D++S G + E+ K
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 516 FDPMNKIGEGGFGPVYKGQL---TDGTIIAVKLLSSKSRQG---NREFLNEIGTISCLQH 569
++ IG G +G VYK + DG A+K Q ++ EI + L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 570 PNLVKLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
N+V L +E + L+++Y E++ F + ++ + S+ + + I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKL-DEEEKTHIS-TRVAGT 681
+LH ++HRD+K N+L+ + KI D GLA+L + K V T
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 682 IGYMAPEYALWGYLTY-KA-DVYSFGVVALEIVS 713
I Y APE L G Y KA D+++ G + E+++
Sbjct: 179 IWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 518 PMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLN---------EIGTISCL 567
++ +G G +G V T G +A+K LS R F + E+ + +
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHM 71
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
H N++ L L + L A KL+ Q + I RGL
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMA 686
++H I+HRD+K +N+ ++ D KI DFGLA+ ++E T +++TR Y A
Sbjct: 132 KYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 183
Query: 687 PEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
PE L W + D++S G + E+++GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 524 EGGFGPVYKGQLTDGTI-----IAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLYG 577
EG FG ++ G L D + VK + + + L E + L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 578 CCIE-GDQLMLVYEYLENNSLAHAL----FGGENSQLKLNWSVRQKICLG--IARGLAFL 630
CIE G+ ++Y Y+ +L L G N+ L S +Q + + IA G+++L
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIACGMSYL 133
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---------LDEEEKTHISTRVAGT 681
H + ++H+DI A N ++D +L KI+D L++ L + E +
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------ 184
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MA E + + +DV+SFGV+ E+++
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 40/187 (21%)
Query: 522 IGEGGFGPVYKGQLTDGT----IIAVKLLSS----KSRQGNREFLNEIGTISCLQHPNLV 573
+G+GG+G V++ + G I A+K+L ++++ E + ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-NSQLKLNWSVRQKICLG---------I 623
L G +L L+ EYL GGE L+ R+ I + I
Sbjct: 64 DLIYAFQTGGKLYLILEYLS---------GGELFMHLE-----REGIFMEDTACFYLSEI 109
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGT 681
+ L LH++ I++RD+K N+LLD + K++DFGL K + E TH GT
Sbjct: 110 SLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGT 163
Query: 682 IGYMAPE 688
I YMAPE
Sbjct: 164 IEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 42/224 (18%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD---GTIIAVKLL------SSKSRQGNRE--FLNEIG 562
++ + K+G+G +G V+K D ++A+K + ++ +++ RE FL E+G
Sbjct: 7 RKYEILQKLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG 64
Query: 563 TISCLQHPNLVKLYGCC-IEGDQ-LMLVYEYLENNSLAHALFGGENSQLK---LNWSVRQ 617
HPN+VKL E D+ + LV+EY+E + HA+ ++ L ++
Sbjct: 65 -----DHPNIVKLLNVIKAENDKDIYLVFEYMETD--LHAV-------IRANILEDVHKR 110
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTH 673
I + + L ++H S ++HRD+K +N+LL+ D K++DFGLA+ L+E +
Sbjct: 111 YIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 674 ISTRVAGTIGYMAPEYALWGYLTY-KA-DVYSFGVVALEIVSGK 715
+ T T Y APE L G Y K D++S G + E++ GK
Sbjct: 168 VLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLL--SSKSRQGNRE---FLNEIGTISCLQHPNLVKL 575
+G+G FG VY D G +AVK + +S + ++E EI + L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 576 YGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
YGC + + L + E++ S+ L S L +V +K I G+++LH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE---EKTHISTRVAGTIGYMAPEYA 690
IVHRDIK N+L D N K+ DFG +K + T + + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVI 181
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
KAD++S G +E+++ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKS---RQGNREFLNEIGT-ISCLQHPNLVKLY 576
IG+G FG V + DG AVK+L K+ ++ + + E + ++HP LV L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWS-VRQKICLG-IARGLAFLHEES 634
D+L V +Y+ L L Q + ++ R + IA L +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL------QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY 694
I++RD+K N+LLD + ++DFGL K E ST GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQP 172
Query: 695 LTYKADVYSFGVVALEIVSG 714
D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSS--KSRQGNREFLNEIGTISCLQHPNLVKL--- 575
+G G +G V G +A+K LS +S + E+ + +QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 576 YGCCIEGDQLM---LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
+ + GD+ LV Y++ + + G S+ K+ + V Q +C GL ++H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYAL 691
I+HRD+K N+ ++ D KI DFGLA+ + E T ++ TR Y APE L
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 692 -WGYLTYKADVYSFGVVALEIVSGK 715
W + D++S G + E+++GK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 522 IGEGGFGPVYKGQLT--DGTI--IAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKL 575
+G+G FG V + QL DG+ +AVK+L + S EFL E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 576 YGCCIEGDQL------MLVYEYLENNSLAHALFG---GENSQLKLNWSVRQKICLGIARG 626
G + M++ ++++ L L GE L + + IA G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP-FTLPLQTLVRFMIDIASG 125
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHISTRVAGTI 682
+ +L S +HRD+ A N +L+ ++ ++DFGL+K D + S +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL---PV 179
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
++A E T +DV++FGV EI++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
+F + ++G+GG+G V+ + D G I+A+K + R L E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
LVKL + + L L EY+ L N + R +A
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHAR----FYMAEMFEA 113
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
+ +HRD+K N L+D + K++DFGL+K + V G+ YMAPE
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 690 ALWGYLTYKADVYSFGVVALEIVSG 714
+ D +S G + E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQH------PNLVK 574
IG+G FG VY+ + D I A+K+LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 575 LYGCCIEGDQLMLVYEYLENNSLA-HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L L LV +Y+ L H G S+ + + + + + L LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL-----ALEHLHK- 114
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-- 691
+ IV+RD+K N+LLD + + DFGL+K + + +T GT Y+APE L
Sbjct: 115 --YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 692 WGYLTYKADVYSFGVVALEIVSG 714
GY T D +S GV+ E+ G
Sbjct: 172 KGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 34/159 (21%)
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSL------------AHALFGGENSQLKLNWSVRQ 617
P L +L+ C D+L V EY+ L HA+F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE----------- 109
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
IA GL FLH + I++RD+K NV+LD + + KI+DFG+ K E +TR
Sbjct: 110 -----IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTR 159
Query: 678 V-AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT Y+APE + D ++FGV+ E+++G+
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
I RGL +LH I+HRDIK N+L++ + KI DFGLA+++E +++ T+ T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 683 GYMAPEYALWG--YLTYKADVYSFGVVALEIVSGK 715
Y APE L G + T D++S G + E++ +
Sbjct: 169 YYRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 522 IGEGGFGPVYKG---QLTDG-----TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+G+G F ++KG ++ D T + +K+L R + F +S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
YG C+ GD+ ++V EY++ SL L +N +N S + ++ +A L FL ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK 119
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT------IGYMAP 687
+ H ++ A NVLL R+ + K + KL + IS V I ++ P
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD---PGISITVLPKEILLERIPWVPP 173
Query: 688 E-YALWGYLTYKADVYSFGVVALEIVSGKN 716
E L+ AD +SFG EI SG +
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGD 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 515 NFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCL------ 567
+F+ + +G+G FG V + + A+K+L ++ + + + C
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL-------KKDVVIQDDDVECTMVEKRV 53
Query: 568 -----QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
+ P L +L+ C D+L V EY+ L + + Q + Q +
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI------QQVGKFKEPQAVFYA 107
Query: 623 --IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV-A 679
I+ GL FLH I++RD+K NV+LD + + KI+DFG+ K E ++TR
Sbjct: 108 AEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFC 162
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT Y+APE + D +++GV+ E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 521 KIGEGGFGPVY----KGQLTDGTIIAVKLLSSKSRQGNR--EFLNEIGTISCLQHPNLVK 574
++G+G FG VY K + + + +K + N + E +S L HP +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
+ +E D ++ EY E L L +++ L+ + + + + G+ ++H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL--W 692
+I+HRD+KA N+ L +L KI DFG+++L ++T GT YM+PE AL
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPE-ALKHQ 180
Query: 693 GYLTYKADVYSFGVVALEI 711
GY + K+D++S G + E+
Sbjct: 181 GYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
+P LV L+ C +L LV EY+ L + Q KL + I L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALN 110
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
FLHE I++RD+K NVLLD D + K++D+G+ K ST GT Y+APE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPE 166
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDS 724
+ D ++ GV+ E+++G++ + D+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREF----LNEIGTISCLQ 568
+ F+ + +GEG +G V K + + I+A+K K + N E L E+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
N+V+L +L LV+EY+E N L E + N +K+ I + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-------ELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+H + IVHRDIK N+L+ + K+ DFG A+ E T T Y +PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
L D++S G + E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPN 571
+F+ + ++G G G V K G I+A KL+ + + R + + E+ + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+V YG ++ + E+++ SL L ++ ++ KI + + RGL +L
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLR 116
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEY 689
E+ KI+HRD+K +N+L++ K+ DFG++ +D + + TR YM+PE
Sbjct: 117 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 169
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
+ T ++D++S G+ +E+ G+
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSS--KSRQGNREFLNEIGT 563
K I + ++ +G G +G V G +AVK LS +S + E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL----KLNWSVRQKI 619
+ ++H N++ L L E + L L G + + + KL Q +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRV 678
I RGL ++H I+HRD+K +N+ ++ D KI DFGLA+ ++E T +++TR
Sbjct: 126 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 679 AGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L W + D++S G + E+++G+
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSS---KSRQGNREFL 558
+++++ ++D + IG G FG V QL + + A+KLLS R + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEV---QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQ-LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
E ++ P +V+L+ C + D+ L +V EY+ GG+ L N+ V +
Sbjct: 92 EERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMP---------GGDLVNLMSNYDVPE 141
Query: 618 KIC-LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHIS 675
K A + L ++HRD+K N+LLD+ + K++DFG K+DE
Sbjct: 142 KWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 676 TRVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSG 714
T V GT Y++PE GY + D +S GV E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQ 568
+ + + +G G FG V+ + A+K+++ +Q + NE + +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 569 HPNLVKLYGCCIEGDQ--LMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIA 624
HP +++L+ E DQ L ++ EY+ L L G ++ L ++ I
Sbjct: 60 HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE------IV 111
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST-RVAGTIG 683
L +LH + IV+RD+K N+LLD++ + K++DFG AK K T + GT
Sbjct: 112 CALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPE 163
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
Y+APE D ++ G++ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 515 NFDPMNKIGEGGFGPVY-----KGQLTDGTIIAVKLL----------SSKSRQGNREFLN 559
NF+ + +G G +G V+ G + G + A+K+L +++ + R+ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 560 EIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
I Q P LV L+ +L L+ +Y+ L L SQ + +I
Sbjct: 60 HI-----RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-----SQRERFKEQEVQI 109
Query: 620 CLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
G I L LH + I++RDIK N+LLD + + ++DFGL+K E++ +
Sbjct: 110 YSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166
Query: 679 AGTIGYMAPEYALWGYLTY-KA-DVYSFGVVALEIVSGKNNMSYVPDSN 725
GTI YMAP+ G + KA D +S GV+ E+++G + + + N
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 519 MNKIGEGGFGPV---YKGQLTDGTIIAVKLLSS--KSRQGNREFLNEIGTISCLQHPNLV 573
+ +G G +G V Y +L +AVK LS +S R E+ + ++H N++
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 574 KLYGCCIEGDQLMLVYE-YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
L + E YL N + L Q KL+ Q + + RGL ++H
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS 136
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYAL 691
I+HRD+K +NV ++ D +I DFGLA+ ++E T +++TR Y APE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIML 188
Query: 692 -WGYLTYKADVYSFGVVALEIVSGK 715
W + D++S G + E++ GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP LV L+ C +L V EY+ L + Q KL + I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALN 110
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+LHE I++RD+K NVLLD + + K++D+G+ K + ++ GT Y+APE
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPE 166
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGKNNMSYV-----PDSN 725
+ D ++ GV+ E+++G++ V PD N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 522 IGEGGFGPVYKGQL---TDGTI--------IAVKLLSSKSRQGNREFLNEIGTISCLQHP 570
+G+G F +YKG L +D I + +K+L S R + F +S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+LVKLYG C+ + +M V EY++ L L +N+ + L+W + + +A L +L
Sbjct: 62 HLVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNN-VSLHWKL--DVAKQLASALHYL 117
Query: 631 HEESRFKIVHRDIKATNVLLDR-DLNP------KISDFGLAK--LDEEEKTHISTRVAGT 681
++ K+VH ++ N+L+ R LN K+SD G+ L EE RV
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE------RVE-R 167
Query: 682 IGYMAPEY--ALWGYLTYKADVYSFGVVALEIVSG 714
I ++APE LT AD +SFG LEI S
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 36/225 (16%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL 572
S + + +G G G V+ +D +AVK + Q + L EI I L H N+
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 573 VKLY--------------GCCIEGDQLMLVYEYLEN---NSLAHALFGGENSQLKLNWSV 615
VK+Y G E + + +V EY+E N L E+++L
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL------ 118
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL---DEEEK 671
+ RGL ++H + ++HRD+K NV ++ DL KI DFGLA++ K
Sbjct: 119 ---FMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
++S + T Y +P L T D+++ G + E+++GK
Sbjct: 173 GYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKSRQGNRE----FLNEIGTIS 565
+F+ + IG G FG V L G + A+K+L KS R E ++
Sbjct: 1 DDFEVIKVIGRGAFGEV---WLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILA 56
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC----- 620
P +VKLY + + L LV EY+ GG+ +N +R+ +
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMP---------GGD----LMNLLIRKDVFPEETA 103
Query: 621 -LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------------- 665
IA + L + +HRDIK N+L+D D + K++DFGL K
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 666 --------------LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEI 711
D +++ + GT Y+APE + D +S GV+ E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 712 VSG 714
+ G
Sbjct: 224 LYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHP 570
S + P+ IG G +G V T G +A+K + + L E+ + +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 571 NLVKLYGCCI---------EGDQLMLVYEYLENNSLAHALFGGENSQLKL-NWSVRQKIC 620
N++ I + + +V + +E++ L H + + + + + Q
Sbjct: 65 NII-----AIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEHIRYFLYQ--- 115
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHIST 676
+ RGL ++H ++HRD+K +N+L++ D +I DFG+A+ E K ++
Sbjct: 116 --LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 677 RVAGTIGYMAPE--YALWGYLTYKADVYSFGVVALEIV 712
VA T Y APE +L Y T D++S G + E++
Sbjct: 171 YVA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P L +L+ C D+L V EY+ L + + + + K +V IA GL F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVF--YAAEIAIGLFF 116
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV-AGTIGYMAPE 688
LH + I++RD+K NV+LD + + KI+DFG+ K E ++T+ GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
+ D ++FGV+ E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 29/168 (17%)
Query: 567 LQHPNLVKLYGCCIEGDQLMLV--------YEYLENNSLAHALFGGENSQLKLNWSVRQK 618
+ HP+++++ + G +V Y YL S + Q
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP--------------LPIDQA 159
Query: 619 ICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
+ + I GL +LH + +I+HRD+K N+ ++ I D G A+ +
Sbjct: 160 LIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG- 215
Query: 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDS 724
+AGT+ APE KAD++S G+V E+++ + + P S
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCL----QHPNLVKLY 576
IG+G FG V + +DG+ AVK+L K+ +E + + + L +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG----------IARG 626
++L V +Y+ GGE L + ++++ C +A
Sbjct: 63 YSFQTAEKLYFVLDYVN---------GGE-----LFFHLQRERCFLEPRARFYAAEVASA 108
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
+ +LH + I++RD+K N+LLD + ++DFGL K E + ST GT Y+A
Sbjct: 109 IGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLA 164
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSG 714
PE D + G V E++ G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP LV L+ C +L V E++ L + Q KL + I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALN 110
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
FLHE I++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPE 166
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGKN-----NMSYVPDSN 725
+ D ++ GV+ E+++G++ MS PD N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 522 IGEGGFGPVYKGQL--TDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-----------Q 568
+G+G FG V +L TD + A+K+L ++ + + + C +
Sbjct: 3 LGKGSFGKVMLAELKGTD-EVYAIKVL-------KKDVILQDDDVDCTMTEKRILALAAK 54
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP L L+ C D+L V EY+ L +F + S+ K + + + L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTLALM 110
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
FLH R +++RD+K N+LLD + + K++DFG+ K + +T GT Y+APE
Sbjct: 111 FLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE 166
Query: 689 YALWGYLTYKADV--YSFGVVALEIVSGK 715
+ L Y V ++ GV+ E+++G+
Sbjct: 167 --ILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 515 NFDPMNKIGEGGFGPVY--KGQLTDGTIIAVKLLSSKSRQGNRE----FLNEIGTISCLQ 568
+FD + +G G FG V + + T G I A+K++ KS +E F E +S
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
P + +L + D L LV EY L L E+ + + + Q + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIH 116
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+H+ VHRDIK NVL+DR + K++DFG A K S GT Y+APE
Sbjct: 117 SVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 689 Y--ALWGYL--TY--KADVYSFGVVALEIVSGK 715
+ G TY + D +S GV+A E++ G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 44/127 (34%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 591 YLENNSLAHALFGGENSQL-KLNWSVRQKIC--LGIARGLAFLHEESRFKIVHRDIKATN 647
++E+ SL+ E +L K ++ I +ARG+ FL SR K +HRD+ A N
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--ASR-KCIHRDLAARN 203
Query: 648 VLLDRDLNPKISDFGLAKLDEEEKTHISTRVAG-TIGYMAPEYALWGYLTYKADVYSFGV 706
+LL + KI DFGLA+ ++ ++ A + +MAPE T ++DV+SFGV
Sbjct: 204 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGV 263
Query: 707 VALEIVS 713
+ EI S
Sbjct: 264 LLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 17/180 (9%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSS----KSRQGNREFLNEIGTISCLQ 568
S+F+ +G G FG V + G A+K L K +Q + E + L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELS 76
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP +V + + +++ + E++ + LF + V + +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFV----VGGELFTHLRKAGRFPNDVAKFYHAELVLAFE 132
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+LH + I++RD+K N+LLD + K++DFG AK ++T + GT Y+APE
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT---LCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 22/222 (9%)
Query: 501 ASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTI--IAVKLLSS----KSRQGN 554
++ ++ + +F+ + +G G FG V + +A+K K +Q +
Sbjct: 17 STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 555 REFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGEN-SQLKLNW 613
F +E ++ + HP V LYG + L LV E++ GGE + L+ N
Sbjct: 77 HVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV---------IGGEFFTFLRRNK 126
Query: 614 SVRQKI-CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
+ C A+ + IV+RD+K N+LLD+D K++DFG AK+ +
Sbjct: 127 RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184
Query: 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
+ + GT Y+APE L AD ++ G+ EI+ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGT 681
+ +GL ++H I+HRD+K N+ ++ D KI DFGLA+ + E T ++ TR
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR---- 179
Query: 682 IGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L W + T D++S G + E+++GK
Sbjct: 180 -WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKS---RQGNREFLNEIGTI-SCLQHPNLVKLY 576
IG+G FG V + + AVK+L K+ ++ + ++E + ++HP LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
D+L V +Y+ L + L + + L R IA L +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRAR-FYAAEIASALGYLHS---L 115
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
IV+RD+K N+LLD + ++DFGL K + E ST GT Y+APE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 697 YKADVYSFGVVALEIVSG 714
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQ--GNREFLNEIGTISCLQHP 570
+ ++ IGEG +G V G +A+K +S Q R L EI + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63
Query: 571 NLVKLYGCCIEGD-----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625
N++ + + +V E +E + L + S + + + Q I R
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFLYQ-----ILR 117
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS--TRVAGTIG 683
GL ++H + ++HRD+K +N+LL+ + + KI DFGLA++ + E H T T
Sbjct: 118 GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 684 YMAPEYAL--WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L GY T D++S G + E++S +
Sbjct: 175 YRAPEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFS-----------------------GTIPRELGN 86
NRL NI S L +T+LT LDL+ N + ++P L N
Sbjct: 103 NRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146
L NL+ L LS N L +LP L L NL + ++ N + P I+ + L L++ +
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219
Query: 147 GLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWG 206
+ + S+S L L+ L +S+ + + + N++ L + L N I +
Sbjct: 220 SII-ELLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQI--SSISSLGS 275
Query: 207 IKNLRFLDLSFNQLTGELPD 226
+ NLR LDLS N L+ LP
Sbjct: 276 LTNLRELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 38/94 (40%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI---STRVA 679
+ARG+ FL SR K +HRD+ A N+LL + KI DFGLA+ ++ ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T ++DV+SFGV+ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSS---KSRQGNREFL 558
+ ++R +FD + IG G FG V QL + + A+KLLS R + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQ-LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
E ++ +V+L+ + D+ L +V EY+ GG+ L N+ + +
Sbjct: 92 EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMP---------GGDLVNLMSNYDIPE 141
Query: 618 K----ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKT 672
K + L +H +HRD+K N+LLD+ + K++DFG K+D
Sbjct: 142 KWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 673 HISTRVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSG 714
T V GT Y++PE GY + D +S GV E++ G
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 515 NFDPMNKIGEGGFGPVY----KGQLTDGTIIAVKLLS-------SKSRQGNREFLNEIGT 563
NF+ + +G G +G V+ G + A+K+L +K+ + R N +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGEN-SQLKLNWSVRQKICLG 622
+ Q P LV L+ +L L+ +Y+ + L+ +N S+ ++ + +
Sbjct: 61 VR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE----- 113
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAG 680
I L LH + IV+RDIK N+LLD + + ++DFGL+K L EE++ S G
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCG 168
Query: 681 TIGYMAPEYALWGYLTYKA-DVYSFGVVALEIVSG 714
TI YMAPE KA D +S G++ E+++G
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 522 IGEGGFGPV-YKGQLTDGTIIAVKLLSSKSRQGNREF---LNEIGTISCLQHPNLVKLYG 577
+G+G FG V + G A+K+L + E L E + +HP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG-IARGLAFLHEESRF 636
D+L V EY+ L L S+ ++ R + I L +LH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
KIV+RD+K N++LD+D + KI+DFGL K + + T GT Y+APE
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 697 YKADVYSFGVVALEIVSGK 715
D + GVV E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 516 FDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPNL 572
+ ++K+GEG + VYKG+ LT ++A+K + + +G + E + L+H N+
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
V L+ L LV+EYL+ + L + L ++ +VR + RGLA+ H+
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTD-LKQYM-DDCGGGLSMH-NVRL-FLFQLLRGLAYCHQ 121
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-EEKTHISTRVAGTIGYMAPEYAL 691
+++HRD+K N+L+ K++DFGLA+ KT+ + V T+ Y P+ L
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPD-VL 175
Query: 692 WGYLTYKA--DVYSFGVVALEIVSG 714
G Y D++ G + E+ +G
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 522 IGEGGFGPV--YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLY 576
+G+G FG V K + T G A+K+L + E + + LQ HP L L
Sbjct: 3 LGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG-IARGLAFLHEESR 635
D+L V EY L L S+ ++ R + I L +LH E
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEK- 115
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+V+RD+K N++LD+D + KI+DFGL K ++ + T GT Y+APE
Sbjct: 116 -NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173
Query: 696 TYKADVYSFGVVALEIVSGK 715
D + GVV E++ G+
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTI-SCLQHPNLVKLY 576
IG+G FG V + DG AVK+L K +R+ + + E + ++HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG-IARGLAFLHEESR 635
++L V +++ L L + + R + IA L +LH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
IV+RD+K N+LLD + ++DFGL K + ++ +T GT Y+APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 696 TYKADVYSFGVVALEIVSG 714
D + G V E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 522 IGEGGFGPV-YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLYG 577
+G+G FG V + G A+K+L + E + + LQ HP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG----------IARGL 627
D+L V EY GGE L + + ++ I L
Sbjct: 63 SFQTHDRLCFVMEYAN---------GGE-----LFFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
+LH +V+RD+K N++LD+D + KI+DFGL K + + T GT Y+AP
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 164
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSGK 715
E D + GVV E++ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT- 681
+A+G+ FL ++ +HRD+ A NVLL KI DFGLA+ + ++ V G
Sbjct: 221 VAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 682 ---IGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKN 716
+ +MAPE T ++DV+S+G++ EI S GK+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAG-T 681
+A+G+ FL SR K +HRD+ A N+LL + KI DFGLA+ ++ ++ A
Sbjct: 188 VAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T ++DV+SFGV+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 74/265 (27%), Positives = 98/265 (36%), Gaps = 94/265 (35%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSR----------QGNREFLNEIG 562
+F+ + IG G FG V Q D G I A+K L KS + R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEA- 58
Query: 563 TISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
+P +VKLY + + L L+ EYL GG+ L +
Sbjct: 59 -----DNPWVVKLYYSFQDENYLYLIMEYLP---------GGDMMTLLMKKDT------- 97
Query: 623 IARGLAFLHEESRFKI---------------VHRDIKATNVLLDRDLNPKISDFGL---- 663
F EE+RF I +HRDIK N+LLD + K+SDFGL
Sbjct: 98 ------FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
Query: 664 ------------------AKLDEEEKTHISTRVA---------------GTIGYMAPEYA 690
LD K S R A GT Y+APE
Sbjct: 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF 211
Query: 691 LW-GYLTYKADVYSFGVVALEIVSG 714
L GY + D +S GV+ E++ G
Sbjct: 212 LQTGY-NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 525 GGFGPVYKGQLTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG 582
+ K + T T++AVK L S S++ + EI T LQHPN++ I
Sbjct: 13 LMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 583 DQLMLVYEYLENNSLAHALFGGENSQLK------LNWSVRQKICLGIARGLAFLHEESRF 636
+L +V + +G LK L I + L ++H +
Sbjct: 72 SELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 637 KIVHRDIKATNVLLDRDLNPKISDF----GLAKLDEEEKT-HISTR-VAGTIGYMAPEY- 689
+HR +KA+++LL D +S + K + ++ H + + +++PE
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 690 --ALWGYLTYKADVYSFGVVALEIVSG 714
L GY K+D+YS G+ A E+ +G
Sbjct: 181 QQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 522 IGEGGFGPVYKGQLTDGT-IIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYG 577
IG+G FG V + + D I A+K + SR L E ++ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 578 CCIEGDQLMLVYEYLENNSLAHAL-FGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
++L LV ++ L H L G + + + +C L LH+ F
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC-----ALENLHK---F 112
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
+++RD+K N+LLD + + DFGL KL+ ++ +T GT Y+APE L T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYT 171
Query: 697 YKADVYSFGVVALEIVSG 714
D ++ GV+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 522 IGEGGFGPV-YKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLYG 577
+G+G FG V + G A+K+L + E + + LQ HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG-IARGLAFLHEESRF 636
D+L V EY L L S+ ++ R + I L +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
+V+RDIK N++LD+D + KI+DFGL K + + T GT Y+APE
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 697 YKADVYSFGVVALEIVSGK 715
D + GVV E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ RGL ++H + ++HRD+K +N+LL+ + + KI DFGLA+ EK T T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172
Query: 683 GYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L T DV+S G + E++ K
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSS---KSRQGNREFL 558
++ +R +++ + IG G FG V QL + + A+KLLS R + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
E ++ P +V+L+ + L +V EY+ GG+ L N+ V +K
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMSNYDVPEK 142
Query: 619 IC-LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHIST 676
A + L +HRD+K N+LLD+ + K++DFG K+++E T
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 677 RVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSG 714
V GT Y++PE GY + D +S GV E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSS--KSRQGNREFLNEIGTISCLQHPNL 572
+ + IG G G V T G +AVK LS +++ + E+ + C+ H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 573 VKLYGCCI------EGDQLMLVYEYLENN--SLAHALFGGENSQLKLNWSVRQKICLGIA 624
+ L E + LV E ++ N + H E ++++ + Q +C
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE----RMSYLLYQMLC---- 134
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
G+ LH I+HRD+K +N+++ D KI DFGLA+ + T T Y
Sbjct: 135 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYY 188
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSG 714
APE L D++S G + E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 28/91 (30%), Positives = 49/91 (53%)
Query: 69 LDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSA 128
L L+ G IP ++ L +L+++ LS N + GN+P L + +L ++ N+FNGS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 129 PDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159
P+ + T L L + G+ L G +P ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 27/78 (34%), Positives = 42/78 (53%)
Query: 52 LSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKL 111
L G IP+ + + L ++L N G IP LG++ +LE L LS N G++P L +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 112 KNLTDFRINDNNFNGSAP 129
+L +N N+ +G P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 522 IGEGGFGPVYKGQLT-DGTIIAVKL-------LSSKSRQGNREFLNEIGTISCLQHPNLV 573
IG+G +G V T G +A+K +S +R L EI + L+HP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62
Query: 574 KLYGCCIEGDQ-----LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
++ + + + +V+E +E++ H + + L Q + R L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDD---LTPEHHQFFLYQLLRALK 117
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMA 686
++H + F HRD+K N+L + D KI DFGLA+ ++ T T Y A
Sbjct: 118 YIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 687 PEY--ALWGYLTYKADVYSFGVVALEIVSGK 715
PE + + T D++S G + E+++GK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 491 DPNLEGLEFQASSFT-LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSS- 548
D N +E S+FT LK+ + N P+ +G Y L +A+K LS
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQ----NLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRP 60
Query: 549 -KSRQGNREFLNEIGTISCLQHPNLVKLYGCCI------EGDQLMLVYEYLENNSLAHAL 601
+++ + E+ + C+ H N++ L E + +V E ++ N +
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--V 118
Query: 602 FGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661
E ++++ + Q +C G+ LH I+HRD+K +N+++ D KI DF
Sbjct: 119 IQMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170
Query: 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GLA+ + + T T Y APE L D++S G + E++ G
Sbjct: 171 GLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQLTDGT-IIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
R+ ++ N IG G FG VY+ D + +A+K + + NRE L + L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 569 HPNLVKL----YGCCIEGDQ----LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620
H N++ L Y C + ++ L +V E++ + N+ L + +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH-ALPLFLVKLYS 176
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAK---LDEEEKTHIST 676
+ R LA++H S+F I HRD+K N+L+D K+ DFG AK + ++I +
Sbjct: 177 YQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 677 RVAGTIGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSG 714
R Y APE L G Y D++S G + E++ G
Sbjct: 234 RF-----YRAPELML-GATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT- 681
+A+G++FL ++ +HRD+ A N+LL KI DFGLA+ + ++ V G
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNA 276
Query: 682 ---IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T+++DV+S+G++ EI S
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST-RVAGT 681
+ARG+ FL ++ VHRD+ A NVLL + KI DFGLA+ + ++S
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T +DV+S+G++ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ--- 568
++ + ++G+G +G V + + +A+K ++ F +I L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-------NVFSKKILAKRALRELK 53
Query: 569 -------HPNLVKLYGCCI-EGDQLMLVYEYLE--NNSLAHALFGGENSQLKLNWSVRQK 618
H N+ LY I +Y Y E L + S L + Q
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII----RSGQPLTDAHFQS 109
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEEEKTHI 674
I GL ++H + ++HRD+K N+L++ D KI DFGLA+ E +
Sbjct: 110 FIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 675 STRVAGTIGYMAPEYALWGYLTY-KA-DVYSFGVVALEIVSGK 715
+ VA T Y APE L + +Y KA DV+S G + E++ K
Sbjct: 167 TEYVA-TRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 16/97 (16%)
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL------DEEEKTHISTRVAG 680
LA H S+ ++HRDIK+ N+LL + K+ DFG +K+ D+ +T G
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCG 207
Query: 681 TIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
T Y+APE +W Y KAD++S GV+ E+++ K
Sbjct: 208 TPYYVAPE--IWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 497 LEFQASSFT-LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSS--KSRQG 553
+E S+FT LK+ + N P+ +G Y L +A+K LS +++
Sbjct: 6 VEVGDSTFTVLKRYQ----NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 59
Query: 554 NREFLNEIGTISCLQHPNLVKLYGCCI------EGDQLMLVYEYLENNSLAHALFGGENS 607
+ E+ + C+ H N++ L E + LV E ++ N + E
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMELD 117
Query: 608 QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667
++++ + Q +C G+ LH I+HRD+K +N+++ D KI DFGLA+
Sbjct: 118 HERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-- 167
Query: 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ + T T Y APE L D++S G + E+V K
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNLVKLYGCC 579
K+G G +G VYK + DG L G + EI + L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 580 IEGD--QLMLVYEYLENNSLA----HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ ++ L+++Y E++ H ++L S+ + + I G+ +LH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 634 SRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEEEKTHIS--TRVAGTIGYMA 686
++HRD+K N+L+ + P KI+D G A+L ++ V T Y A
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 687 PEYALWG-YLTYKADVYSFGVVALEIVSGK 715
PE L + T D+++ G + E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHISTRVAG 680
+ LA+LH I+HRD+K N+ LD N + DFG A KLD T +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 681 TIGYMAPEY-ALWGYLTYKADVYSFGVVALEI 711
T+ +PE AL Y K D++S G+V E+
Sbjct: 250 TLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 541 IAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHA 600
+ +K+L R F +S + H +L ++G C+ G + ++V E++E+ L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DV 105
Query: 601 LFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLN 655
E ++ + W + + +A L++L +++ +VH ++ A N+LL R +
Sbjct: 106 CLRKEKGRVPVAWKI--TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTS 160
Query: 656 P--KISDFG--LAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALE 710
P K+SD G L EE+ I ++APE G L+ AD +SFG LE
Sbjct: 161 PFIKLSDPGVSFTALSREERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 711 I 711
I
Sbjct: 214 I 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 538 GTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595
GT++ V++ L + + + + NE+ +HPN++ + G L ++ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA-- 82
Query: 596 SLAHALFGGENSQLK------LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
+G NS LK ++ ++ I G RGL +LH+ +HR+IKA+++L
Sbjct: 83 ------YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 650 LDRDLNPKISDFGLAKLDEEEKTHISTRVA--------GTIGYMAPEYA---LWGYLTYK 698
+ D +S GL+ L + +V + +++PE L+GY K
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVK 190
Query: 699 ADVYSFGVVALEIVSGK 715
+D+YS G+ A E+ +G+
Sbjct: 191 SDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/233 (19%), Positives = 92/233 (39%), Gaps = 23/233 (9%)
Query: 500 QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLL---SSKSRQGNRE 556
++ +K I + + I E +YKG + + ++ +
Sbjct: 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDI 64
Query: 557 FLNEIGTISCLQHPNLVKLYGCCIE-GDQL---MLVYEYLENNSLAHALFGGENSQLKLN 612
NEI + + N++K+YG I+ D L L+ EY L L + + L+
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLS 120
Query: 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
+ + + + +GL L+ ++++ + + L+ + KI GL K+ +
Sbjct: 121 FKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI----LS 174
Query: 673 HISTRVAGTIGYMAPEYAL--WGYLTYKADVYSFGVVALEIVSGK---NNMSY 720
+ + Y + + + T K D+YS GVV EI +GK N++
Sbjct: 175 SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT- 681
+A G+ FL ++ VHRD+ A NVL+ KI DFGLA+ + +IS G+
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 682 ---IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +MAPE T +DV+SFG++ EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 26/167 (15%)
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
+E+ ++ H +VK + D+L+L+ EY L N Q+K R K
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL--------NKQIKQ----RLK 161
Query: 619 ICLGIAR---GLAF------LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDE 668
L GL F L E K++HRD+K+ N+ L K+ DFG +K +
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 669 EEKTHISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVS 713
+++ GT Y+APE LW Y KAD++S GV+ E+++
Sbjct: 222 SVSLDVASSFCGTPYYLAPE--LWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 39/170 (22%)
Query: 568 QHPNLVKLYGCCIEGDQ-LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR- 625
++P +V ++ C E + L +V EY+E GG+ + L N + + +AR
Sbjct: 59 ENPFVVSMF-CSFETKRHLCMVMEYVE---------GGDCATLLKNIG---ALPVDMARM 105
Query: 626 -------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK------------- 665
L +LH + IVHRD+K N+L+ + K++DFGL+K
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 666 -LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
++++ + + +V GT Y+APE L D ++ G++ E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNLVKLYGCC 579
K+G G +G VYK + DG L G + EI + L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 580 IE--GDQLMLVYEYLENNSLA----HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ ++ L+++Y E++ H ++L + + + I G+ +LH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 634 SRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEEEKTHIS--TRVAGTIGYMA 686
++HRD+K N+L+ + P KI+D G A+L ++ V T Y A
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 687 PEYALWG-YLTYKADVYSFGVVALEIVSGK 715
PE L + T D+++ G + E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 30/96 (31%), Positives = 38/96 (39%), Gaps = 18/96 (18%)
Query: 394 NGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFT 453
N Y V LHFAEIQ +L R FDIYI K V D + + + F
Sbjct: 252 NFEYYVYLHFAEIQ--------SLETREFDIYINGKTVYGDVSPK-YLGTDTGALYLDFP 302
Query: 454 ANVS-NHILEIRFQWAGKGTTAIPIGGVYGPLISAI 488
NVS +L I T PL++A+
Sbjct: 303 VNVSGGGLLNISLVPTSGST--------LPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 19/154 (12%)
Query: 522 IGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGT----ISCLQHPNLVKLY 576
I G FG VY G+ + + AVK++ K+ N+ ++++ ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 577 GCCIEGDQLMLVYEYL---ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ + LV EYL + SL H ++G + ++ + K +A L +LH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAV------KYISEVALALDYLH-- 121
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667
R I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 46/168 (27%), Positives = 70/168 (41%), Gaps = 35/168 (20%)
Query: 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPN 571
F + +G+G G V+ +L G + A+K+L K R + L E ++ L HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK-----ICLGIAR- 625
L LY L LV +Y GGE + + Q+ + +AR
Sbjct: 63 LPTLYASFQTETYLCLVMDYCP---------GGEL------FRLLQRQPGKCLSEEVARF 107
Query: 626 -------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666
L +LH IV+RD+K N+LL + +SDF L+K
Sbjct: 108 YAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQ 152
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ R + +LHE I+HRDIKA N+ ++ + + DFG A + + AGTI
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718
APE D++S G+V E+ + +++
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 37/107 (34%), Positives = 46/107 (42%), Gaps = 14/107 (13%)
Query: 384 SLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHG 443
L+Y N NYSV LHFAEI D + G+R+FD+ I KD +I +
Sbjct: 267 DLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGDTAFKDVDIVKMSGE 322
Query: 444 VLKPVTRPFTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISV 490
+ T VS L I Q KGT AI I+AI V
Sbjct: 323 RYTALVLNKTVAVSGRTLTIVLQ-PKKGTHAI---------INAIEV 359
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 49/160 (30%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVK-LLSS---KSRQ-----GNREFLNEIGTI 564
+F + IG+G FG V Q D G I A+K LL S K Q R+ L E +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS- 60
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
P +V LY + L L+ E+L L L + + + L I
Sbjct: 61 -----PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
+H + +HRDIK N+L+DR + K+SDFGL+
Sbjct: 116 A----VH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 28/85 (32%), Positives = 42/85 (49%)
Query: 141 LEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200
L + GL G IP IS L L + +S P L ++T L + L + G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 201 PEYIWGIKNLRFLDLSFNQLTGELP 225
PE + + +LR L+L+ N L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 35/209 (16%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT 115
+PS L + SL L S L NL+ L +L L+ NRL N+ EL++L NLT
Sbjct: 62 LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLT 119
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175
+++NN +I L G + ++ LD L+ +I L P
Sbjct: 120 SLDLDNNNIT----------------DI--PPLIGLLKSNLKELD-LSDNKIESLPSP-- 158
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKF 235
LRN+ L + L +++ ++P+ + + NL LDLS N+++ +P +++
Sbjct: 159 ----LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS------DLPPEIEL 207
Query: 236 TQILMFIRGVYEHQ-SLDLSYNNFTWQSP 263
L + L S +N S
Sbjct: 208 LSALEELDLSNNSIIELLSSLSNLKNLSG 236
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 36/191 (18%)
Query: 541 IAVKLLS------SKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI------EGDQLMLV 588
+A+K LS + +++ RE + + + H N++ L E + LV
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNV 648
E ++ N + + ++++ + Q +C G+ LH I+HRD+K +N+
Sbjct: 100 MELMDAN--LCQVIQMDLDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNI 149
Query: 649 LLDRDLNPKISDFGLAKLDEEEKT---HISTRVAGTIGYMAPEYAL-WGYLTYKADVYSF 704
++ D KI DFGLA+ ++ TR Y APE L GY D++S
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGY-KENVDIWSV 203
Query: 705 GVVALEIVSGK 715
G + E++ G
Sbjct: 204 GCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 1/59 (1%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLG 61
S+ G +PP + ++ LE +D +YN +GSIP + L+ +++ N LSG +P+ LG
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 26/183 (14%)
Query: 544 KLLSSKSRQGNR---EFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE---YLENNSL 597
+L++ + + G+R + NEI + L H N++K+ + +L E Y+
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245
Query: 598 AHALFG---GENSQLK---LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD 651
L+ E K L R I + + ++H++ K++HRDIK N+ L+
Sbjct: 246 DFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 652 RDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-YALWGYLTYKADVYSFGVVALE 710
D + DFG A E+E+ GT+ +PE A GY D++S G++ L+
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLD 360
Query: 711 IVS 713
++S
Sbjct: 361 MLS 363
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 27/155 (17%)
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
+PN +KLY +L+ +Y+++ L F LK + + I R L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F----DLLKKEGKLSEAEVKKIIRQLV 119
Query: 629 F-LHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
L++ + I+H DIK NVL DR + + D+GL K+ + GT+ Y +
Sbjct: 120 EALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFS 174
Query: 687 PE------YALWGYLTYKADVYSFGVVALEIVSGK 715
PE Y D ++ GV+ E+++GK
Sbjct: 175 PEKIKGHNYD------VSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 15/156 (9%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQGNREFLNEIGTISCLQH 569
S F + +G G FG V + D + A+K L K R E ++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC--LGIARGL 627
+V+LY + D L V +Y+ GG+ L + + + IA
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIP---------GGDMMSLLIRMGIFPEDLARFYIAELT 111
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663
+ + +HRDIK N+L+DRD + K++DFGL
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 56/244 (22%), Positives = 96/244 (39%), Gaps = 57/244 (23%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLS-----SKSRQGN----REFLNEIGTI 564
+F+ + IG G FG V Q D G + A+K+L K + G+ R+ L E ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
+VK++ + L L+ E+L + L +K + ++ IA
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-------MKKDTLTEEETQFYIA 108
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL--------------------- 663
+ + + +HRDIK N+LLD + K+SDFGL
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 664 -------------AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALE 710
A+ + + ++ GT Y+APE + D +S GV+ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 711 IVSG 714
++ G
Sbjct: 229 MLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 64/269 (23%), Positives = 94/269 (34%), Gaps = 95/269 (35%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS---RQ------GNREFLNEIGT 563
S F + IG G FG V + D + A+K L R R+ L E
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-- 58
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
+ +VKLY + D L V +Y+ + L I LGI
Sbjct: 59 ----DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-----------------IRLGI 97
Query: 624 ARGLAFLHEESRFKI---------------VHRDIKATNVLLDRDLNPKISDFGL----- 663
F + +RF I +HRDIK N+L+DRD + K++DFGL
Sbjct: 98 -----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152
Query: 664 -------------------------AKLDEEEKTHISTR------------VAGTIGYMA 686
+++D + R + GT Y+A
Sbjct: 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212
Query: 687 PEYALWGYLTYKADVYSFGVVALEIVSGK 715
PE L T D +S GV+ E++ G+
Sbjct: 213 PEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
IA + +H + VHRDIK NVLLD + + +++DFG ++ T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 683 GYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGK 715
Y++PE G + D +S GV E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY--AL- 691
+ VHRDIK NVLLD++ + +++DFG + T S GT Y++PE A+
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 692 --WGYLTYKADVYSFGVVALEIVSGK 715
G + D +S GV E++ G+
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 32/149 (21%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLV-KLYGC 578
+ G VY D + +K+ S+ + +RE E+ + L + V K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
L+ E++E +L E S+ + Q +A LA LH+ +
Sbjct: 62 GESDGWSYLLMEWIEGETL------DEVSEEEKEDIAEQ-----LAELLAKLHQLPLLVL 110
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLD 667
H D+ N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 514 SNFDPMNKIGEGGFGPVY--KGQLTDGTII--AVKLLSSKSRQGNREFLNEIGTISCLQH 569
+ ++ + KIG G FG V+ K + T A+ K R+ + + + E+ + L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIEVNVMRELKH 71
Query: 570 PNLVKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR-- 625
N+V+ + +L ++ E+ + L+ + K+ + + + I R
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI----QKCYKMFGKIEEHAIVDITRQL 127
Query: 626 --GLAFLHE----ESRFKIVHRDIKATNVLLD-------------RDLN----PKISDFG 662
LA+ H + +++HRD+K N+ L +LN KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 663 LAK-LDEEEKTHISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
L+K + E H GT Y +PE L +Y K+D+++ G + E+ SGK
Sbjct: 188 LSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 47/239 (19%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEI-GTISCLQHPN- 571
+F+ + IG G FG V Q D G I A+K+L K+ +E + I L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEADG 60
Query: 572 --LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+VK++ + L L+ E+L + L +K + + IA +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEEATQFYIAETVLA 113
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-------------------------- 663
+ + +HRDIK N+LLD + K+SDFGL
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 664 --------AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
A+ ++ + ++ GT Y+APE + D +S GV+ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 541 IAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHA 600
+ +K+L R + F + + H ++V LYG C+ + ++V E++E L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--D 92
Query: 601 LFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-----DRDLN 655
LF S + L + K+ +A L++L ++ +VH ++ N+LL D +
Sbjct: 93 LFMHRKSDV-LTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG 148
Query: 656 P--KISDFG--LAKLDEEEKTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALE 710
P K+SD G + L +E I ++APE L+ AD +SFG E
Sbjct: 149 PFIKLSDPGIPITVLSRQECVE-------RIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201
Query: 711 I 711
I
Sbjct: 202 I 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 18/60 (30%), Positives = 26/60 (43%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
LK + + NRL+ + +L LDL N + P L +L +L LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 38/147 (25%), Positives = 62/147 (42%), Gaps = 13/147 (8%)
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSL-AHALFGGENSQLKLNWSVRQKICLGIARGLA 628
PN+V L+ + D + LV ++ E L +H L + ++ + L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-----KFLNIPEECVKRWAAEMVVALD 99
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
LH E IV RD+ N+LLD + +++ F + E E + V Y APE
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPE 152
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
T D +S G + E+++GK
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-----G 693
VHRDIK N+L+D + + +++DFG E+ T S+ GT Y++PE G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
+ D +S GV E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-EEKTHISTRVAGTIGYMAP 687
++H E I+HRDIK NVL++ + + DFG A T +AGT+ AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 688 EYALWGYLTYKADVYSFGVVALE 710
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241
N + + I L NI+G+I I+ + ++ ++LS NQL+G +PD D+ T
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD-----DIFTTS---- 117
Query: 242 IRGVYEHQSLDLSYNNFTWQSPEQPA-CREKPNLNLNLFRSSSVENNFGVF 291
+ L+LS NNFT P E +L+ N+ S + N+ G F
Sbjct: 118 ----SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNML-SGEIPNDIGSF 163
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 8/78 (10%)
Query: 522 IGEGGFGPVYK------GQLTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCL-QHPNLV 573
+G G FG V + G+ + +AVK+L + + RE L +E+ +S L QH N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 574 KLYGCCIEGDQLMLVYEY 591
L G C G ++++ EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.004
Identities = 19/37 (51%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
T+L LDL NQ + +P L NL NLETL LS N++
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 62/254 (24%), Positives = 95/254 (37%), Gaps = 61/254 (24%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
S F + +G G FG V D + A+K L K +R E ++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+VKLY + D L V +Y+ GG+ L + V ++
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIP---------GGDMMSLLIRMEVFPEVLARFYIAELT 111
Query: 630 LHEESRFKI--VHRDIKATNVLLDRDLNPKISDFGLA------------------KLDEE 669
L ES K+ +HRDIK N+L+D D + K++DFGL + D
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 670 E-------------------------KTH---ISTRVAGTIGYMAPEYALWGYLTYKADV 701
E K H ++ + GT Y+APE L T D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 702 YSFGVVALEIVSGK 715
+S GV+ E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 732 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.61 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-62 Score=598.94 Aligned_cols=559 Identities=30% Similarity=0.453 Sum_probs=353.2
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+.|.+|+.+.++++|++|++++|.+++.+|..+..+ +|++|+|++|++.+.+|..++.+++|+.|+|++|++++.+|..
T Consensus 296 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~ 375 (968)
T PLN00113 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375 (968)
T ss_pred eccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChh
Confidence 456677777777777777777777777777777666 6777777777777777777777777777777777777666666
Q ss_pred ccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCC
Q 040398 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 163 (732)
+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+
T Consensus 376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 455 (968)
T PLN00113 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455 (968)
T ss_pred HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence 66666666666666666666666666666666666666666666666666666666666666666655555555555555
Q ss_pred eeeccCc-----------------------CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcC
Q 040398 164 QLRISDL-----------------------QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQL 220 (732)
Q Consensus 164 ~L~ls~N-----------------------~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 220 (732)
.|++++| ++.+..+..+..+++|+.|+|++|++.+.+|+.+..+++|+.|+|++|.+
T Consensus 456 ~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 456 MLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 5555554 44444444455555555555555555555555555555555555555555
Q ss_pred cccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCcc-ccCCCCcccccccccCCCCCCcccccccCCCC
Q 040398 221 TGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPA-CREKPNLNLNLFRSSSVENNFGVFPCTNNFTC 299 (732)
Q Consensus 221 ~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~-~~~~~~l~~~~~~~~~~~~~~~~~p~~~~~~c 299 (732)
+|.+|.. +.++++|+.|||++|++++.+|.... +..+..| ..+.+...+.+|..
T Consensus 536 ~~~~p~~--------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l------~ls~N~l~~~~p~~----- 590 (968)
T PLN00113 536 SGQIPAS--------------FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV------NISHNHLHGSLPST----- 590 (968)
T ss_pred cccCChh--------------HhCcccCCEEECCCCcccccCChhHhcCcccCEE------eccCCcceeeCCCc-----
Confidence 5555543 56677777777877777777665321 1112222 22344444555543
Q ss_pred CCcceeEEEecCCCeeeecCceecCCCCCCCCcceeeecCCCCceeccccCCCCCCccccccccccCCCCCchhhhcccc
Q 040398 300 HRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDDDEQNTNYIANSQSSGISELYNDAR 379 (732)
Q Consensus 300 ~~~~~s~~i~c~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (732)
+...++..+.|.||+++||+........+.. .+
T Consensus 591 ------------~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~-----------------------------------~~ 623 (968)
T PLN00113 591 ------------GAFLAINASAVAGNIDLCGGDTTSGLPPCKR-----------------------------------VR 623 (968)
T ss_pred ------------chhcccChhhhcCCccccCCccccCCCCCcc-----------------------------------cc
Confidence 3345677889999999998632110000000 00
Q ss_pred cCccceeEEEEeecCcceeEEEEeeEEEeeccccccccCceeeEEEecceecccccchhhhccCCCCceeeeeeeeeccc
Q 040398 380 ISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNH 459 (732)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 459 (732)
.++.-..+++..+. . .+. +...++.++. .+.....+ . +..... +.
T Consensus 624 ~~~~~~~~~~~~~~--~---~~~--------------~~~~~~~~~~-----~~~~~~~~----~-~~~~~~------~~ 668 (968)
T PLN00113 624 KTPSWWFYITCTLG--A---FLV--------------LALVAFGFVF-----IRGRNNLE----L-KRVENE------DG 668 (968)
T ss_pred ccceeeeehhHHHH--H---HHH--------------HHHHHHHHHH-----HHhhhccc----c-cccccc------cc
Confidence 00000000000000 0 000 0000000000 00000000 0 000000 00
Q ss_pred eEEEEEEEcCCCcccccCCCccCCCccccccCCCccCcccccccccHHHHHHHhCCCcccceecccCceEEEEEEEc-CC
Q 040398 460 ILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DG 538 (732)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g 538 (732)
.|... ..+. .....++++++ ...|...+.||+|+||.||+|+.. ++
T Consensus 669 ------~~~~~------------------~~~~------~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~ 715 (968)
T PLN00113 669 ------TWELQ------------------FFDS------KVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNG 715 (968)
T ss_pred ------ccccc------------------cccc------ccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCC
Confidence 00000 0000 00112333433 345677789999999999999874 78
Q ss_pred eEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHH
Q 040398 539 TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618 (732)
Q Consensus 539 ~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ 618 (732)
+.||||++...... ..+|++++++++|||||+++++|.+++..++||||+++|+|.++++ .++|..+.+
T Consensus 716 ~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~ 784 (968)
T PLN00113 716 MQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRK 784 (968)
T ss_pred cEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHH
Confidence 99999988643322 2346889999999999999999999999999999999999999994 378999999
Q ss_pred HHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCc
Q 040398 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698 (732)
Q Consensus 619 i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k 698 (732)
|+.||++||+|||+.+..+|+||||||+||+++.++..++. ||.+...... ....++..|+|||++.+..++.+
T Consensus 785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~ 858 (968)
T PLN00113 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEK 858 (968)
T ss_pred HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcc
Confidence 99999999999997655679999999999999999888875 6655432211 12357889999999999999999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCC
Q 040398 699 ADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 699 ~DvwSlGvll~elltG~~P~~~ 720 (732)
+|||||||++|||+||+.||+.
T Consensus 859 sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 859 SDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cchhhHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=392.85 Aligned_cols=231 Identities=55% Similarity=0.898 Sum_probs=200.6
Q ss_pred ccccccHHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeE
Q 040398 500 QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579 (732)
Q Consensus 500 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 579 (732)
....|+++++..||++|...+.||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred EeCC-EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 580 IEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 580 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
.+.+ +.+||||||++|+|+++++..... +++|..|.+||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875443 8899999999999999999999998788999999999999999999999
Q ss_pred EeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCcCCCCC
Q 040398 659 SDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCTCPLDW 732 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~~~~~~~~~~w 732 (732)
+|||+|+..+.......+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.........+++|
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 99999976554122222111799999999999999999999999999999999999998886543333335554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.84 Aligned_cols=198 Identities=32% Similarity=0.546 Sum_probs=180.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..+|...+.||+|+||+||+|+++ ++..||||.+... .+...+.+..|+++|+.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 567888888999999999999986 6899999998765 4556677889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC------CCeEEEeeec
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD------LNPKISDFGL 663 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kL~DfGl 663 (732)
|||.||+|.++++. ...+++..++.++.|||.||++||+++ ||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999954 347899999999999999999999996 9999999999999875 4589999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|+...+ .......+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||.
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 998775 444556899999999999999999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.00 Aligned_cols=201 Identities=30% Similarity=0.466 Sum_probs=180.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
..++|++++.||+|+||+||.++.+ +++.||+|++++.. ....+...+|..+|.+++||.||+++..|++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999876 68999999998652 3345678899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|+||+.||.|..+| ..+..+++..++-++..|+.||.|||+++ ||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999 44567899999999999999999999997 999999999999999999999999999854
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ....++||+.|||||++.+..++..+|+|||||++|||++|.+||..
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 43322 23348999999999999999999999999999999999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=341.39 Aligned_cols=198 Identities=30% Similarity=0.499 Sum_probs=176.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-EEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-QLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~ 591 (732)
+.+.++.||+|..|+|||++++ +++.+|+|.+... .....+++.+|+++++..+||+||++|+.|..+. .+.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444578999999999999987 7899999998554 4455688999999999999999999999999998 59999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|++|||++++... .++++....+|+.+|++||.|||+.- +||||||||+|||++..|++||||||.+......
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999998432 56899999999999999999999642 6999999999999999999999999999865543
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
....++||..|||||.+.+..|+.++||||||++++||.+|+.|+...
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 445688999999999999999999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.91 Aligned_cols=200 Identities=29% Similarity=0.486 Sum_probs=181.5
Q ss_pred CCCcccceecccCceEEEEEEE-cCCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..|...+.||+|||+.||+++. .+|+.||+|++... .....+...+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999998 68999999998763 3445677899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|+|..++|..+++ ...++++.+++.++.||+.||.|||+.+ |||||||..|+|+++++++||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999884 4567999999999999999999999996 99999999999999999999999999987764
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+.. .....+||+.|+|||++.....+..+||||+||+||.||+|++||+..
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 432 234589999999999999999999999999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.38 Aligned_cols=207 Identities=27% Similarity=0.444 Sum_probs=181.0
Q ss_pred hCCCcccceecccCceEEEEEEE-cCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeee-eEEeCCE-EEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYG-CCIEGDQ-LML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~l 587 (732)
..+|+++++||+|.||.|||++. .+|..+|.|.+.-. .....+....|+.+|++++|||||++++ .+.++.+ +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34678889999999999999986 48999999987643 3445677899999999999999999998 4555555 899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR-FKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~-~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
|||||..|+|...+...+.....+++..+|+++.|++.||.++|++-+ .-|+||||||.||+++.+|.+||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999998777778889999999999999999999998421 1388999999999999999999999999998
Q ss_pred CCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .....+|||.||+||.+...+|+.|+||||+||++|||..-+.||..
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 765433 33457899999999999999999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.01 Aligned_cols=200 Identities=30% Similarity=0.448 Sum_probs=171.3
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc-------chHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-------GNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++...... ......+|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567788899999999999999764 8999999999754211 1233579999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEe
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISD 660 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~D 660 (732)
+.|+|||||+||.|.+.+-. ...+.+..-+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999998844 334566677889999999999999997 9999999999999766 6699999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY---LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+|+...+ ......++||+.|.|||++.++. +..+.|+||+||+||-+|+|.+||..
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999998764 34445689999999999998653 34478999999999999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.78 Aligned_cols=200 Identities=39% Similarity=0.623 Sum_probs=174.1
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcccccccc--hHHHHHHHHHHhcCCCCceeeeeeeEEeCC-EEEEEEEecCC
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG--NREFLNEIGTISCLQHPNLVKLYGCCIEGD-QLMLVYEYLEN 594 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~ 594 (732)
..+.+|+|+||+||+|.+.....||||++....... .++|.+|+.++.+++|||||+++|+|.++. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999844449999998653322 568999999999999999999999999987 79999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeCCccCce
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~~~~~~~ 673 (732)
|+|.++++.. ....+++..+.++|.|||+||+|||++++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999654 45689999999999999999999999852 99999999999999998 99999999998655432 2
Q ss_pred eeecccCccccccchhcc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYAL--WGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
..+...||+.|||||++. ..+++.|+|||||||++|||+||+.||....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 223367999999999999 5699999999999999999999999998654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=314.72 Aligned_cols=197 Identities=28% Similarity=0.419 Sum_probs=177.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|+.++.||.|+||.|..++.+ +|..||+|+++...- ...+...+|..+|+.+.||.++++++.|.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467889999999999999999976 789999999986532 2345567899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||++||.|.++++ ...++++..++-+|.||+.||+|||+.+ |++|||||+|||+|++|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999994 3457899999999999999999999986 9999999999999999999999999998665
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....|||+.|+|||++...+++..+|+|||||++|||+.|.+||-.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 42 3357899999999999999999999999999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.86 Aligned_cols=203 Identities=29% Similarity=0.444 Sum_probs=178.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLM 586 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 586 (732)
..+.|+.+++||+|+||.||+|++. +|+.||+|++.... .....-..+||.+|++++||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4567888899999999999999865 89999999887654 44456678999999999999999999998876 6899
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+|+|||+. +|.-++. .....|++.++..++.|++.||+|+|++| |+|||||.+|||||.+|.+||+|||+|++
T Consensus 195 lVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 99999976 6776662 34567999999999999999999999997 99999999999999999999999999998
Q ss_pred CCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+........+..+-|.+|.|||.+.|. .|+...|+||.||||.||++|++.|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 877666555566779999999999986 7999999999999999999999888753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=313.70 Aligned_cols=202 Identities=27% Similarity=0.405 Sum_probs=175.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
+.|+.+.++|+|+||+||||+++ +|+.||||+|.... +...+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999987 69999999987543 3345668899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||+..-|++ + +.....++...+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||||||.|+.....
T Consensus 82 ~~dhTvL~e-L---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-L---ERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHH-H---HhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 998754444 3 244556889999999999999999999985 999999999999999999999999999987643
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYVPD 723 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~~~ 723 (732)
....+.++.|.+|.|||.+.+ .+|+...||||+||++.||++|++-|-..++
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 233456788999999999988 5899999999999999999999988876443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.45 Aligned_cols=204 Identities=25% Similarity=0.416 Sum_probs=180.1
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.....+|.+.+.||+|+|++|++|+.+ +++.||||++.+. .....+....|-++|.+| .||.|++++..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455778999999999999999999865 7999999998754 223345567788899999 89999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
+|+|+||+++|+|.++|+. .+.+++...+.+|.+|+.||+|||+.| ||||||||+|||||+|++++|+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999943 467899999999999999999999997 999999999999999999999999999
Q ss_pred eeCCccCce---------e---eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTH---------I---STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~---------~---~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+.+.+.... . ...++||..|.+||++.....++.+|+|+||||+|+|+.|++||..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 876543222 1 1348899999999999999999999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.89 Aligned_cols=197 Identities=29% Similarity=0.486 Sum_probs=179.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ....+.+.+|+++++.++|||||.+++.|++..+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999876 78999999987653 3446678999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+.| +|..++ .....++++.++.++.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9977 999999 45667999999999999999999999985 99999999999999999999999999987654
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.....+...||+.|||||.+.+.+|+..+|+||+||++|||++|++||-
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 3455667889999999999999999999999999999999999999994
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=329.55 Aligned_cols=203 Identities=26% Similarity=0.377 Sum_probs=177.3
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
...++|+.+++||+|+||.||.|+.+ +|+.||+|++++.. ....+....|-.+|...++|+||+++..|.+.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35789999999999999999999876 79999999998753 334566788999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
|||||++||++..+| .....+++..++.++.+++-|++-+|+.| +|||||||+|+|||..|++||+|||++.-
T Consensus 218 LiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999998 34567899999999999999999999997 99999999999999999999999999842
Q ss_pred CCc-----------------------cCc------e-----------------eeecccCccccccchhcccCCCCCchh
Q 040398 667 DEE-----------------------EKT------H-----------------ISTRVAGTIGYMAPEYALWGYLTYKAD 700 (732)
Q Consensus 667 ~~~-----------------------~~~------~-----------------~~~~~~gt~~y~APE~~~~~~~~~k~D 700 (732)
... +.. . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 110 000 0 011247999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q 040398 701 VYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 701 vwSlGvll~elltG~~P~~~ 720 (732)
+||||||+||||.|.+||..
T Consensus 371 wWSLG~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCS 390 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=328.24 Aligned_cols=202 Identities=26% Similarity=0.436 Sum_probs=177.4
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc----cc-cchHHHHHHHHHHhcCC-CCceeeeeeeEEeCC
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK----SR-QGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGD 583 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 583 (732)
.....|.+.+.||+|+||.|+.|+.. +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678899999999999999999865 7899999977653 11 23456678999999999 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeee
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFG 662 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfG 662 (732)
.+++||||+.+|+|.+++.. ..++.+.+++++++|++.|++|+|+.| |+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999943 567888999999999999999999997 9999999999999999 999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCC-CC-CchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGY-LT-YKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 998774 2233344678999999999999866 64 789999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.20 Aligned_cols=199 Identities=33% Similarity=0.555 Sum_probs=180.5
Q ss_pred hCCCcccceecccCceEEEEEEE-cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
...|...++||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34577788999999999999975 47899999999887777677889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|+||+|.|.+ ....+++.++..|++++++||+|||.+| |+|||||++|||++.++.+||+|||.+....+..
T Consensus 352 m~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999988 3445899999999999999999999997 9999999999999999999999999988766655
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....+||++|||||++....|++|.||||||+|+.||+-|++||-.
T Consensus 424 ~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 424 SK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred Cc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 43 3457899999999999999999999999999999999999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.46 Aligned_cols=201 Identities=34% Similarity=0.542 Sum_probs=175.5
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+...+.||+|-||.||.|.++....||+|.++... -..+.|.+|+++|++++|+|||+++++|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34567899999999999999977799999987642 33577899999999999999999999999999999999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
+|.++|.. ..+..+...+...++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...++.....
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999965 23456788899999999999999999985 99999999999999999999999999996555444444
Q ss_pred ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
..-.-+..|.|||.+..+.++.|+|||||||+|+||+| |+.|+..+.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 43344678999999999999999999999999999999 888887544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.46 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=178.1
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
...++|..+++||+|.||+|++++.+ +++.||||++++. ..++.+....|.+++... +||.+++++..|.+++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34678999999999999999999987 7899999999875 344566778888888777 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+.||++..+. ....+++..++-+|..|+.||+|||+++ |||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999955444 3357899999999999999999999996 9999999999999999999999999997
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
-.-... .....++||+.|||||++.+..|+...|+|||||+|||||.|+.||....
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 433222 24557899999999999999999999999999999999999999998533
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.46 Aligned_cols=206 Identities=26% Similarity=0.422 Sum_probs=179.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|+..+.||.|..++||+|+.. .++.||||++..+. ....+.+.+|+..+..++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3678999999999999999999864 68999999998653 333688999999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
.||.+||+.+++...... .+++..+..|.+++++||.|||++| .||||||+.|||++.+|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999765333 3889999999999999999999997 99999999999999999999999998754433
Q ss_pred cCceee---ecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 670 EKTHIS---TRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 670 ~~~~~~---~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... ..+.||++|||||++.. ..|+.|+|||||||+..||.+|..||...+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 322211 45689999999999543 368999999999999999999999998755
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.73 Aligned_cols=199 Identities=29% Similarity=0.419 Sum_probs=173.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.+|...+++|+|.||.||+|++. +|+.||+|+++.... .......+|++.|+.++|+||+.+++.|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999865 899999999886532 234568999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||+. +|+..+++ ....++...+..++.++++|++|||++. |+||||||.|+|++.+|.+||+|||+|+.....
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9965 89998853 4567899999999999999999999996 999999999999999999999999999987654
Q ss_pred CceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... +..+-|.+|.|||.+.|. .|+...||||.||++.||+-|.+-|..
T Consensus 155 ~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 155 NRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred Cccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 4332 233678899999999876 789999999999999999999865654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.14 Aligned_cols=201 Identities=34% Similarity=0.511 Sum_probs=170.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC--EEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD--QLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e 590 (732)
.+|...+.||+|+||.||.+... +|+..|||..........+.+.+|+++|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666788999999999999876 59999999887664434677899999999999999999999855444 6899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCCc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEE 669 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~~ 669 (732)
|+++|||.+.+.... ..+++..++.+++||++||+|||++| ||||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999995422 26999999999999999999999996 999999999999999 79999999999876553
Q ss_pred --cCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 --EKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 --~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..........||+.|||||++..+ ...+++|||||||++.||+||+.||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 222223357799999999999954 344699999999999999999999975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=297.52 Aligned_cols=203 Identities=29% Similarity=0.407 Sum_probs=174.4
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLM 586 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 586 (732)
..++|+.++.|++|+||.||+|+++ +++.||+|+++.... ...-...+|+.+|.+++|||||.+-.+.... +.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3567888999999999999999986 789999999876532 2234568999999999999999999987754 6799
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+|||||+. +|...+.... .++...++.-++.|+++|++|||... |+|||||++|+|+++.|.+||+|||+|+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 99999976 8888885443 57889999999999999999999986 99999999999999999999999999997
Q ss_pred CCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+..... ..+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|...+
T Consensus 227 ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 227 YGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred hcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 765433 23456779999999999876 68999999999999999999998887544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.20 Aligned_cols=204 Identities=30% Similarity=0.471 Sum_probs=170.1
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc----------c----chHHHHHHHHHHhcCCCCceee
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR----------Q----GNREFLNEIGTISCLQHPNLVK 574 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~----------~----~~~~~~~E~~~l~~l~H~nIv~ 574 (732)
....++|++.+.||+|.||.|-+|+.. +++.||+|++.+... . ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345788999999999999999999976 799999999875311 0 1257889999999999999999
Q ss_pred eeeeEEe--CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC
Q 040398 575 LYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 652 (732)
Q Consensus 575 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 652 (732)
++++.-+ .+.+|||+|||..|.+...- .....+++.+++++++++..||+|||.++ ||||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9999876 46899999999998776433 23334999999999999999999999997 999999999999999
Q ss_pred CCCeEEEeeecceeCCccC----ceeeecccCccccccchhcccC----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 653 DLNPKISDFGLAKLDEEEK----THISTRVAGTIGYMAPEYALWG----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 653 ~~~~kL~DfGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|++||+|||.+....... .....+.+||+.|+|||...++ ..+.+.||||+||+||.|+.|+.||..
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999999999987552211 1122346799999999998763 356788999999999999999999964
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.15 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=173.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999876 68999999987532 223456788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999843 346899999999999999999999986 99999999999999999999999999864322
Q ss_pred cCc----------------------------------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC
Q 040398 670 EKT----------------------------------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 670 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~ 715 (732)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 100 0012357999999999999989999999999999999999999
Q ss_pred CCCCC
Q 040398 716 NNMSY 720 (732)
Q Consensus 716 ~P~~~ 720 (732)
.||..
T Consensus 234 ~Pf~~ 238 (363)
T cd05628 234 PPFCS 238 (363)
T ss_pred CCCCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.70 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=178.9
Q ss_pred hCCCcccceecccCceEEEEEEE-cCCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+|++.+.||+|.||.|-+|+. ..|+.||||.++... .++.-.+.+|++++..++||||+.++.+|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788899999999999999975 589999999887653 33445678999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||..+|.|+|++ .....+++.+++.+++||..|+.|+|+++ ++|||||.+|||+|+++++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 44567999999999999999999999985 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. ....+.++|++-|.+||++.+.+| .+..|-|||||+||.|+.|..||+..
T Consensus 205 ~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 205 D--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred c--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 5 334457899999999999998876 47899999999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.47 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=176.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.-|...+.||.|+-|.|-.|++. +|+.+|||++... .......+.+|+-+|+.+.|||+++++++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34667788999999999999875 8999999998765 2233566889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|.|.+++ ...+++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|||..+++||+|||+|.+..+
T Consensus 92 Eyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999998 35567899999999999999999999885 99999999999999999999999999986544
Q ss_pred cCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.......||++.|.|||++.|.+| +.++||||.|||||.||||+.||+.
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 344556799999999999999865 5799999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.94 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=175.3
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
+....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344678999999999999999999986 6889999998642 22334567899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999998843 24788899999999999999999986 999999999999999999999999999
Q ss_pred eeCCccCceeeecccCccccccchhcccC----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWG----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...............||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 86543332222346799999999998754 378899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.85 Aligned_cols=204 Identities=30% Similarity=0.540 Sum_probs=175.3
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
+++.+-.+.+.+.+.||+|.||+||+|++. -.||||++... ..+..+.|+.|+.++++-+|.||+=+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 556666667778899999999999999987 24999998765 44567889999999999999999999999998887
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.||..+|+|.+|+.++|..+ ..+.......||+|||+|+.|||.++ |||||||+.|||+++++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999998654 56888999999999999999999995 999999999999999999999999999
Q ss_pred eeCCccC-ceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 665 KLDEEEK-THISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 665 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.....-. ..-..-..|...|||||+++. .++++.+|||||||++|||+||..||.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 6432211 111122347889999999874 479999999999999999999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=318.30 Aligned_cols=200 Identities=27% Similarity=0.381 Sum_probs=173.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 68999999987532 233456788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 335899999999999999999999986 99999999999999999999999999864322
Q ss_pred cCce-------------------------------------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHH
Q 040398 670 EKTH-------------------------------------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIV 712 (732)
Q Consensus 670 ~~~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ell 712 (732)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999889999999999999999999
Q ss_pred cCCCCCCC
Q 040398 713 SGKNNMSY 720 (732)
Q Consensus 713 tG~~P~~~ 720 (732)
+|+.||..
T Consensus 234 ~G~~Pf~~ 241 (364)
T cd05599 234 VGYPPFCS 241 (364)
T ss_pred cCCCCCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.43 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=179.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+.++|++.+.||+|-||.||.|+.+ ++..||+|++... ..+...++.+|+++-..++||||+++|++|.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4678999999999999999999865 7889999998654 33445778999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
++||.+.|++...|.+. ...++++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+|++|||.+...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999643 2345778888999999999999999885 999999999999999999999999998644
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+ .......+||..|.+||.+.+...+.+.|+|++||+.||++.|.+||+..
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 3 22334578999999999999999999999999999999999999999853
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=306.81 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=172.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999876 78999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998843 346889999999999999999999986 99999999999999999999999999875433
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 234689999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.30 Aligned_cols=199 Identities=30% Similarity=0.406 Sum_probs=172.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3678899999999999999875 79999999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999887532 2235889999999999999999999986 999999999999999999999999999765332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 21 2345689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=318.39 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=171.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999875 68999999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 335788999999999999999999986 999999999999999999999999987532100
Q ss_pred C----------------------------------------------ceeeecccCccccccchhcccCCCCCchhHHHH
Q 040398 671 K----------------------------------------------THISTRVAGTIGYMAPEYALWGYLTYKADVYSF 704 (732)
Q Consensus 671 ~----------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSl 704 (732)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 001123579999999999998889999999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 040398 705 GVVALEIVSGKNNMSY 720 (732)
Q Consensus 705 Gvll~elltG~~P~~~ 720 (732)
||++|||+||+.||..
T Consensus 235 G~il~elltG~~Pf~~ 250 (381)
T cd05626 235 GVILFEMLVGQPPFLA 250 (381)
T ss_pred hhHHHHHHhCCCCCcC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.16 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=174.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccc-hHHHHHHHHHHhcCC-CCceeeeeeeEEeCC-EEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQ-HPNLVKLYGCCIEGD-QLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~l 587 (732)
..++|..+++||.|+||.||+|+.. +|..||||+++...... ...=.||++.|+++. ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4567888999999999999999865 78999999998764432 233478999999998 999999999999988 9999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|||||+ .+|.+.+++. +..+++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+-.
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999995 5999998654 567999999999999999999999997 999999999999998889999999999865
Q ss_pred CccCceeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ..+.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++-|-..
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 5433 235678899999999876 458999999999999999999999877543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=318.25 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=171.7
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999875 78999999886432 233466888999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999998843 346788999999999999999999986 99999999999999999999999999853211
Q ss_pred cCc----------------------------------------------eeeecccCccccccchhcccCCCCCchhHHH
Q 040398 670 EKT----------------------------------------------HISTRVAGTIGYMAPEYALWGYLTYKADVYS 703 (732)
Q Consensus 670 ~~~----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwS 703 (732)
... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0001246999999999999889999999999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 040398 704 FGVVALEIVSGKNNMSY 720 (732)
Q Consensus 704 lGvll~elltG~~P~~~ 720 (732)
|||++|||++|+.||..
T Consensus 234 lGvil~elltG~~Pf~~ 250 (377)
T cd05629 234 LGAIMFECLIGWPPFCS 250 (377)
T ss_pred cchhhhhhhcCCCCCCC
Confidence 99999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.55 Aligned_cols=197 Identities=24% Similarity=0.363 Sum_probs=174.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467889999999999999999986 68999999986532 23346788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998843 346788999999999999999999986 9999999999999999999999999997654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 322 235689999999999998899999999999999999999999964
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.97 Aligned_cols=207 Identities=24% Similarity=0.380 Sum_probs=177.6
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 581 (732)
.+++....++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+++++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999986 6899999998642 22334567889999999999999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998843 24788889999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccC----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWG----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 99976544332223346799999999998754 378899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=318.62 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=171.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 68999999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998853 235788999999999999999999986 999999999999999999999999997422100
Q ss_pred ----------------------------------------------CceeeecccCccccccchhcccCCCCCchhHHHH
Q 040398 671 ----------------------------------------------KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSF 704 (732)
Q Consensus 671 ----------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSl 704 (732)
........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0001123469999999999999899999999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 040398 705 GVVALEIVSGKNNMSY 720 (732)
Q Consensus 705 Gvll~elltG~~P~~~ 720 (732)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.38 Aligned_cols=205 Identities=27% Similarity=0.405 Sum_probs=173.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCc-eeeeeeeEEeCC-----
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPN-LVKLYGCCIEGD----- 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~----- 583 (732)
...|+.+++||+|+||+||+|+.+ +|+.||+|++..... .......+|+.+++.++|+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 445677788999999999999875 799999999887644 24456789999999999999 999999999877
Q ss_pred -EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 584 -QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 584 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
..++|+||++. +|..++.........++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999965 898888554332245667889999999999999999996 9999999999999999999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+|+...-... ..++.++|..|.|||++.+. .|+...||||+|||++||++++.-|....
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 9985542222 23456789999999999987 79999999999999999999998886543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.54 Aligned_cols=196 Identities=27% Similarity=0.381 Sum_probs=174.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999986 68999999987542 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999843 346789999999999999999999986 99999999999999999999999999875433
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 22345699999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=318.15 Aligned_cols=201 Identities=26% Similarity=0.356 Sum_probs=172.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.+|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999875 68999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999843 345788899999999999999999986 99999999999999999999999999742210
Q ss_pred c------------------------------------------CceeeecccCccccccchhcccCCCCCchhHHHHHHH
Q 040398 670 E------------------------------------------KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVV 707 (732)
Q Consensus 670 ~------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvl 707 (732)
. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000113469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 040398 708 ALEIVSGKNNMSYV 721 (732)
Q Consensus 708 l~elltG~~P~~~~ 721 (732)
+|||++|+.||...
T Consensus 234 lyell~G~~Pf~~~ 247 (376)
T cd05598 234 LYEMLVGQPPFLAD 247 (376)
T ss_pred eeehhhCCCCCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.90 Aligned_cols=188 Identities=32% Similarity=0.503 Sum_probs=167.1
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
.++-||+|+.|.||.|+.+ ++.||||+++.-. ..+++-|++|+||||+.+.|+|...-.++||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3467999999999999998 5889999875321 3478899999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.++|+ ...++.......|..+||.|+.|||.+ +|||||||+-||||..+..+||+|||.++...+... .-.
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMS 270 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMS 270 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhh
Confidence 99994 445678889999999999999999988 599999999999999999999999999986655422 335
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
++||..|||||++.+.+.++|.|||||||+|||||||.-||..+.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 789999999999999999999999999999999999999998644
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.59 Aligned_cols=196 Identities=30% Similarity=0.424 Sum_probs=166.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----EEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-----QLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv 588 (732)
.|...+++|+|+||.||+|... +++.||||+.-...+. --+|+++|++++|||||++..+|.... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999865 6799999987544332 246899999999999999998887532 34589
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeeecceeC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLD 667 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfGla~~~ 667 (732)
|||||. +|.+.++.....+..++...++-++.||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 899998765556677888889999999999999999986 9999999999999987 88999999999987
Q ss_pred CccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|..
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 6654443 35678899999999876 799999999999999999999988875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.78 Aligned_cols=201 Identities=30% Similarity=0.458 Sum_probs=177.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..|..++.||+|.||.||+|.+. +++.||+|++.... ....++.++|+.++.+++++||.++|+.|..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666788999999999999875 78999999998764 34567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|.||++.+.+. ....+.+..+.-|+++++.|+.|||.++ .+|||||+.|||+..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999983 3344577778889999999999999995 9999999999999999999999999987665544
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
... ..++||+.|||||++....|+.|+|||||||+.+||.+|.+|+....
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 433 56889999999999998899999999999999999999999997543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.00 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=173.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-C-CeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-D-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~-g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+++ + +..||+|++... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457889999999999999999864 3 468999988643 22334678899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999843 346889999999999999999999986 999999999999999999999999999765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 4321 235699999999999988899999999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.05 Aligned_cols=193 Identities=27% Similarity=0.360 Sum_probs=168.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999987532 233456788999999999999999999999999999999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 99998843 346889999999999999999999986 99999999999999999999999999874322211 12
Q ss_pred ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 235699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.27 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=173.8
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
...++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999876 6899999998643 2233455788999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998843 24778889999999999999999986 99999999999999999999999999876
Q ss_pred CCccCceeeecccCccccccchhcccC----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWG----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 543322222345799999999988653 478899999999999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.99 Aligned_cols=193 Identities=27% Similarity=0.362 Sum_probs=167.6
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999987542 233456788999999999999999999999999999999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99988843 346889999999999999999999986 99999999999999999999999999864322211 12
Q ss_pred ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 235699999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.31 Aligned_cols=200 Identities=26% Similarity=0.360 Sum_probs=172.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 68899999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++++.+..+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765542 2346889999999999999999999986 999999999999999999999999999765433
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 22222345689999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.98 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=173.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|+..+.||+|+||.||+|+.+ +++.||+|++... .......+.+|++++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999876 6899999998643 2233467788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999843 346889999999999999999999986 99999999999999999999999999864321
Q ss_pred cCc----------------------------------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC
Q 040398 670 EKT----------------------------------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 670 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~ 715 (732)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0112356999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 040398 716 NNMSYV 721 (732)
Q Consensus 716 ~P~~~~ 721 (732)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=291.77 Aligned_cols=205 Identities=25% Similarity=0.330 Sum_probs=176.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.+.|+.++.||+|.-|+||.|+.. ++..+|+|++.+.. +....+.+.|-+||+.++||.++.+|+.++.+...++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 345667789999999999999987 56899999998653 34456788899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||||+||+|+...+. +....+++..++-+|..|+-||+|||-.| ||+|||||+||||.++|++-|+||.++....
T Consensus 156 meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999988753 45667999999999999999999999997 9999999999999999999999999873210
Q ss_pred c---------------------------------cCc----------------------eeeecccCccccccchhcccC
Q 040398 669 E---------------------------------EKT----------------------HISTRVAGTIGYMAPEYALWG 693 (732)
Q Consensus 669 ~---------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~ 693 (732)
. ... .....++||-+|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 011125799999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 694 YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 694 ~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
..+.+.|+|+|||++|||+.|+.||....
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999999998644
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.56 Aligned_cols=201 Identities=25% Similarity=0.338 Sum_probs=172.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999876 6899999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999843 2345889999999999999999999986 99999999999999999999999999875543
Q ss_pred cCceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33222233468999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.22 Aligned_cols=201 Identities=25% Similarity=0.321 Sum_probs=173.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999876 6889999998642 2223455788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999542 236788999999999999999999986 99999999999999999999999999876544
Q ss_pred cCceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33322233569999999998875 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.87 Aligned_cols=205 Identities=27% Similarity=0.429 Sum_probs=169.9
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC-C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG-D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 583 (732)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999974 235789999987543 23346789999999999 899999999988764 4
Q ss_pred EEEEEEEecCCCchhHHhhcCCC---------------------------------------------------------
Q 040398 584 QLMLVYEYLENNSLAHALFGGEN--------------------------------------------------------- 606 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (732)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999998864321
Q ss_pred -CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee-eecccCcccc
Q 040398 607 -SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI-STRVAGTIGY 684 (732)
Q Consensus 607 -~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y 684 (732)
...++++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235788899999999999999999986 9999999999999999999999999997543322211 1223456789
Q ss_pred ccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 685 MAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 685 ~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998899999999999999999997 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.71 Aligned_cols=191 Identities=27% Similarity=0.379 Sum_probs=167.2
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 6889999998643 233446778999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 998843 346889999999999999999999986 99999999999999999999999999875332221 2234
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 5799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.53 Aligned_cols=193 Identities=28% Similarity=0.372 Sum_probs=168.2
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999987532 234467889999999999999999999999999999999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99988843 346889999999999999999999986 99999999999999999999999999874322211 22
Q ss_pred ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 345799999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.96 Aligned_cols=199 Identities=25% Similarity=0.453 Sum_probs=175.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+++.. +|..+|+|++.... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999986 68899999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999843 335789999999999999999999864 4999999999999999999999999998754332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12335689999999999988999999999999999999999999963
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.42 Aligned_cols=203 Identities=20% Similarity=0.280 Sum_probs=176.9
Q ss_pred CCcccceecccCceEEEEEEEc-C-CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-D-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999764 4 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.++++.......++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654444557899999999999999999999986 99999999999999999999999999986543221
Q ss_pred -eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 -HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 -~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......+||++|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 223346799999999999998999999999999999999999999964
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.12 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=170.2
Q ss_pred CCcccceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999975 258899999986431 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998843 345889999999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..............||..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 5433322223345799999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.70 Aligned_cols=200 Identities=28% Similarity=0.435 Sum_probs=171.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccc--ccccchHHHHHHHHHHhcCCCCceeeeeeeEEe-----CCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSS--KSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-----GDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~ 584 (732)
...|..++.||+|+||.|++|.++ +|+.||+|++.. ......++..+|+++|+.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999876 799999999874 345567889999999999999999999998765 257
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
+|+|+|+| +.+|+..++ .+..++...+..++.||++||+|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 89999999 569999884 3445899999999999999999999985 999999999999999999999999999
Q ss_pred eeCCcc-CceeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEE-KTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~-~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+..... .....+..+.|.+|.|||++. ...|+...||||+|||+.||++|++-|..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 977542 122234577899999999876 45899999999999999999999988865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.70 Aligned_cols=198 Identities=27% Similarity=0.401 Sum_probs=169.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCC-ceeeeeeeEEeCCEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHP-NLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~ 589 (732)
+|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999876 67899999987532 23446678899999999765 5888999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998843 345788999999999999999999986 99999999999999999999999999864322
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 111 12235699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.49 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=175.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 78999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998532 46889999999999999999999986 99999999999999999999999999875443
Q ss_pred cC----------------------------ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EK----------------------------THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 32 1112235689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.19 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=172.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.++||+|+||.||+++.+ +++.+|+|++... .......+.+|+.++..++|++|+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999876 5789999998642 2223345788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999542 235889999999999999999999986 99999999999999999999999999875433
Q ss_pred cCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 3332233457999999999986 34678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.32 Aligned_cols=200 Identities=24% Similarity=0.410 Sum_probs=170.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357889999999999999999876 78999999987543 2334567899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 888887432 235788999999999999999999986 999999999999999999999999998754322
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 1223467899999998865 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.48 Aligned_cols=201 Identities=29% Similarity=0.364 Sum_probs=174.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999876 78999999987542 234466889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998543 246899999999999999999999986 99999999999999999999999999986654
Q ss_pred cCceeeecccCccccccchhcc------cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYAL------WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 3333333457899999999986 45678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.27 Aligned_cols=199 Identities=27% Similarity=0.406 Sum_probs=169.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999876 67899999987542 22334567788887777 5899999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998843 345789999999999999999999986 99999999999999999999999999874332
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 211 223457999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.15 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=169.3
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||+||+++.+ +++.||+|++..... ...+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 789999999865322 2335678899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+.+.........+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9888654444567899999999999999999999986 99999999999999999999999999875443222 1223
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 5689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.78 Aligned_cols=201 Identities=24% Similarity=0.431 Sum_probs=170.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 789999999875432 334567889999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 577777643 2345788999999999999999999986 999999999999999999999999998754322
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 2223568899999998865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.69 Aligned_cols=193 Identities=28% Similarity=0.437 Sum_probs=164.3
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhc-CCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISC-LQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999987532 2233455667666664 4899999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998843 346889999999999999999999986 9999999999999999999999999987543222 22
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 2345799999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=280.34 Aligned_cols=200 Identities=27% Similarity=0.374 Sum_probs=175.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+.|++.+.||+|.|+.||++.+. +|+.+|+|++... ...+.+++.+|+++-+.++|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999999764 7999999988653 334678889999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfGla~ 665 (732)
+|+|.|++|..-+- .+..+++..+...++||++||+|+|.++ |||||+||+|+++... .-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999976552 3356789999999999999999999996 9999999999999543 459999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... +.......+||++|||||++...+++..+|||+-||+||-|+.|.+||-.
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 766 34455678899999999999999999999999999999999999999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.04 Aligned_cols=202 Identities=28% Similarity=0.446 Sum_probs=180.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE-EEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ-LMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv 588 (732)
.++|+.++.+|+|+||.++.++++ +++.|++|.+.... ....+...+|+.++++++|||||.+.+.|++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999999876 78899999887653 3334567899999999999999999999999887 9999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|+|++||++.+.+...+ ..-++++.+.+++.||+.|+.|||++ +|+|||||+.|||++.+..++|+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999986543 45689999999999999999999977 49999999999999999999999999999877
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+... ....++||+.||+||.+.+.+|+.|+|||||||++|||++-+++|..
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 6543 34457899999999999999999999999999999999999999975
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.85 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=167.1
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHH---hcCCCCceeeeeeeEEeCCEEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTI---SCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999876 78999999987532 22334566665554 567899999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|...++. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988742 35899999999999999999999986 9999999999999999999999999986432
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 2211 22346799999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=294.42 Aligned_cols=201 Identities=31% Similarity=0.440 Sum_probs=179.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.+.|..-++||+|+||.||-++.+ +|+.||+|.+... .+........|-++|.++..+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456788899999999999999876 7999999988653 344556788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
+..|.||+|.-+|..... ..+++..++-+|.+|+.||++||+.. ||+||+||+|||+|+.|+++|+|+|+|.-..
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999988865433 57899999999999999999999985 9999999999999999999999999998776
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+..... ..+||.+|||||++.++.|+...|+|||||++|||+.|+-||..
T Consensus 339 ~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 339 EGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 655443 23799999999999999999999999999999999999999964
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=303.56 Aligned_cols=193 Identities=27% Similarity=0.365 Sum_probs=166.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.||+|+||.||+|+.. +|+.||+|++.... .....++.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999987542 233456788999999999999999999999999999999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 99988843 3468999999999999999999997 54 999999999999999999999999998743222221
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 2235699999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.19 Aligned_cols=194 Identities=28% Similarity=0.447 Sum_probs=166.6
Q ss_pred cceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999975 257899999987531 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998843 345788889999999999999999986 999999999999999999999999998743322
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 22 12235699999999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.28 Aligned_cols=193 Identities=21% Similarity=0.291 Sum_probs=168.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+|++.+.||+|+||.||+|... +++.||+|... .+.+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999875 78999999653 23567899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 688887743 345789999999999999999999986 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 222334679999999999998899999999999999999999998864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.40 Aligned_cols=193 Identities=27% Similarity=0.409 Sum_probs=167.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 68999999987532 23345678899999888 799999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence 999988843 346899999999999999999999986 99999999999999999999999999864222111 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2345799999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.57 Aligned_cols=194 Identities=26% Similarity=0.400 Sum_probs=166.7
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 68899999987542 23345677888888866 799999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988843 345789999999999999999999986 99999999999999999999999999875322221 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 23456899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.68 Aligned_cols=194 Identities=28% Similarity=0.443 Sum_probs=166.6
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ +++.||+|++... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 6899999998753 223345677888888776 699999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999998843 345889999999999999999999986 99999999999999999999999999875322211 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 23456999999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.90 Aligned_cols=193 Identities=27% Similarity=0.407 Sum_probs=166.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 68899999987542 23345677888888776 899999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999988743 346889999999999999999999986 99999999999999999999999999874322211 1
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.15 Aligned_cols=199 Identities=24% Similarity=0.453 Sum_probs=174.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +++.+|+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999886 68899999887543 2344678999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999843 335788999999999999999999753 4999999999999999999999999998654322
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234689999999999988899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=298.21 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=169.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~ 589 (732)
+|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999876 68999999987532 233456778888888885 577888999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998843 346889999999999999999999986 99999999999999999999999999874322
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 211 122356899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.48 Aligned_cols=193 Identities=28% Similarity=0.410 Sum_probs=166.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 67899999987542 23345678899998888 699999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 999988742 346899999999999999999999986 99999999999999999999999999874322111 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2346799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.07 Aligned_cols=208 Identities=35% Similarity=0.557 Sum_probs=176.7
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
+.+-+..+.||+|+||+||+|+.. +...||||.++..... ..++|++|++++..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556688999999999999742 4578999999987555 788999999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCC----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 586 MLVYEYLENNSLAHALFGGEN----------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
++|+|||..|+|.++|+.... ...+++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999854211 134589999999999999999999988 4999999999999999999
Q ss_pred eEEEeeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVPD 723 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~~ 723 (732)
|||+|||+++..-..+ .+...+..-.++|||||.+..++++.++|||||||+|||+++ |+.|+.....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 9999999998543322 222223345679999999999999999999999999999998 8889876543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.90 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=178.4
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc---chHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ---GNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 586 (732)
....|++.+.||+|.||.||+|+.+ +|+.+|+|++...... ......+|+++|+++. |||||.+.+.|++.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3557888899999999999999977 5999999998765432 3468899999999998 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC----CCeEEEeee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD----LNPKISDFG 662 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DfG 662 (732)
+|||++.||.|.+.+... .+++..+..++.||+.|++|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999988543 2899999999999999999999986 9999999999999643 479999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
++..... .......+||++|+|||++....++..+||||+||++|.|++|..||....
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9988766 334456789999999999999999999999999999999999999997644
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=293.84 Aligned_cols=204 Identities=31% Similarity=0.518 Sum_probs=170.0
Q ss_pred CCCcccceecccCceEEEEEEEcC-----------------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeee
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD-----------------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKL 575 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 575 (732)
++|++.++||+|+||.||+|++++ +..||+|++.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 3479999987643 3345679999999999999999999
Q ss_pred eeeEEeCCEEEEEEEecCCCchhHHhhcCCC---------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 040398 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGEN---------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640 (732)
Q Consensus 576 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH 640 (732)
++++.+.+..++||||+++++|.+++..... ....+++..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854211 1234788899999999999999999986 999
Q ss_pred CCCCCCCeEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc--CCCC
Q 040398 641 RDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS--GKNN 717 (732)
Q Consensus 641 ~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt--G~~P 717 (732)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999875433222 22223446789999999988899999999999999999986 5667
Q ss_pred CCC
Q 040398 718 MSY 720 (732)
Q Consensus 718 ~~~ 720 (732)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.79 Aligned_cols=195 Identities=27% Similarity=0.396 Sum_probs=169.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-C-----CceeeeeeeEEeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-H-----PNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 587 (732)
+|++++.||+|+||.|-+|.+. +++.||||+++... ....+.+.|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8899999999999999999865 79999999998653 33556688999999996 4 489999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC--CCeEEEeeecce
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD--LNPKISDFGLAK 665 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DfGla~ 665 (732)
|+|.++ .+|.++++..... .++...++.++.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|.
T Consensus 266 VfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999984 5999999776544 4888999999999999999999886 9999999999999765 469999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....-. ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 6544221 46788899999999999999999999999999999999876654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=295.07 Aligned_cols=193 Identities=31% Similarity=0.455 Sum_probs=165.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhc-CCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISC-LQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987542 2334556777788776 4899999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998843 346788999999999999999999986 99999999999999999999999999874322111 1
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 2345689999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.76 Aligned_cols=200 Identities=31% Similarity=0.453 Sum_probs=171.4
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------EEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------QLML 587 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 587 (732)
|...+.||+|+||.||+++++ +|+.||||.+.... ....++..+|++++++++|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345578999999999999965 89999999998753 344567789999999999999999998855433 5689
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc--CCCC--eEEEeeec
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDLN--PKISDFGL 663 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~--~kL~DfGl 663 (732)
|||||++|||...+.+. ++...+++.+...+..+++.||.|||+++ |+||||||.||++- ++|. .||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999654 34567999999999999999999999885 99999999999984 3343 79999999
Q ss_pred ceeCCccCceeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|+-.++.. ....++||..|.|||... .++++..+|.|||||++|++.||..||...
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99766543 556688999999999998 489999999999999999999999999753
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=295.88 Aligned_cols=193 Identities=30% Similarity=0.446 Sum_probs=165.3
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 68999999987542 23345567787777654 899999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998843 346788999999999999999999986 9999999999999999999999999986432211 12
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 2346799999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.39 Aligned_cols=193 Identities=28% Similarity=0.407 Sum_probs=164.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHH-HHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIG-TISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +|+.||+|++.... ....+++.+|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 78999999986532 223345555554 56789999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99998884 3346889999999999999999999986 99999999999999999999999999864322111 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 2345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=298.55 Aligned_cols=198 Identities=26% Similarity=0.412 Sum_probs=166.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 586 (732)
+|++.+.||+|+||.||+|+.. +|+.||+|++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999875 7899999988743 223345788999999999999999999988653 2579
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689888842 346899999999999999999999986 99999999999999999999999999875
Q ss_pred CCccC--ceeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEK--THISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~--~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ........||..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 42221 112234578999999998865 6789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.70 Aligned_cols=193 Identities=28% Similarity=0.421 Sum_probs=163.8
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHH-HHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIG-TISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +|+.||+|++.... ....+++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 78999999986532 222344455544 56789999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998843 346889999999999999999999986 9999999999999999999999999986432211 12
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 2345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=297.54 Aligned_cols=193 Identities=27% Similarity=0.410 Sum_probs=163.3
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHH-HHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIG-TISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 68999999986532 222344555544 67889999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999988742 345788899999999999999999986 9999999999999999999999999987432211 12
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 2345789999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.19 Aligned_cols=200 Identities=31% Similarity=0.412 Sum_probs=172.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|++.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 78999999986532 2223557889999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888542 2346899999999999999999999986 999999999999999999999999998765332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.. .....|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 21 12346899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=286.86 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=170.6
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ....+.+.+|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999753 35789999987653 3334678999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 246889999999999999999999986 999999999999999999999999987543
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 2211111112235678999999999999999999999999999775 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=284.34 Aligned_cols=202 Identities=30% Similarity=0.449 Sum_probs=178.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
-|+++++||+|+||+||+|.++ +|+++|+|..... .+.+++..|+.++++++.|++|++||.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3677889999999999999775 7999999987654 456889999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
.||..|+++ ..+.++++.++..+.++.++||+|||.. +-||||||..|||++.+|++||+|||.|.........
T Consensus 112 AGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 112 AGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999984 3456799999999999999999999976 4899999999999999999999999998755432222
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~~~~ 725 (732)
...++||+.|||||++..-.|+.++||||||++..||.-|++|+..+..-+
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 234789999999999999899999999999999999999999998755433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=296.96 Aligned_cols=193 Identities=28% Similarity=0.390 Sum_probs=162.4
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHH-HHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEI-GTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 67899999987532 12223444444 456888999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999998843 345778888999999999999999986 99999999999999999999999999864322111 2
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 2345799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=311.57 Aligned_cols=207 Identities=22% Similarity=0.311 Sum_probs=177.0
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD---- 583 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 583 (732)
...++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+..+..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999865 7899999998654 2334567889999999999999999988775432
Q ss_pred ----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 584 ----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 584 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
.+++||||+++|+|.++++........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999765445567899999999999999999999986 9999999999999999999999
Q ss_pred eeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 660 DFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999997654321 1222346799999999999999999999999999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=319.88 Aligned_cols=207 Identities=28% Similarity=0.346 Sum_probs=183.7
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 581 (732)
+.+++...++|++++.||+|+||.|..++.+ ++++||+|++... .+....-|.+|-.+|.-.+.+-|++++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566667899999999999999999999986 7899999999862 34455678899999999999999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
+.++|+|||||+||+|-..+.. ..++++..++-++..|+-||+-+|+.| +|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999832 226899999999999999999999987 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcc----c-CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYAL----W-GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|.+-.+..++.-.....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||=
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 988766655555556678999999999986 3 578999999999999999999999994
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=300.42 Aligned_cols=195 Identities=30% Similarity=0.494 Sum_probs=164.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|+..+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667788999999999999876 78999999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 3456778899999999999999986 9999999999999999999999999987654322
Q ss_pred ceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223568999999998742 3456789999999999999999999973
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=317.89 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=174.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.++||+|+||.||+|++. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999876 68999999987532 223567899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCC-------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 590 EYLENNSLAHALFGGE-------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
||+++++|.+++.... ......++..+.+++.||++||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 11234677888999999999999999986 9999999999999999999999999
Q ss_pred cceeCCccCc-----------------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKT-----------------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9975521100 011124699999999999999999999999999999999999999964
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=270.07 Aligned_cols=211 Identities=26% Similarity=0.319 Sum_probs=180.4
Q ss_pred HhCCCcccceecccCceEEEEEEE-cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----EE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-----QL 585 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~ 585 (732)
..++|++.+.||+|||+-||.++. .+++.||+|++.-...++.+..++|++..++++|||+++++++...+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 456889999999999999999984 588999999998877777888999999999999999999999876543 48
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
|++++|...|||.+.+......+..+++.++.+|+.+|++||++||+.. +++.||||||.|||+.+++.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999777667778999999999999999999999985 469999999999999999999999999986
Q ss_pred eCCccCcee--------eecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 040398 666 LDEEEKTHI--------STRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSYVPD 723 (732)
Q Consensus 666 ~~~~~~~~~--------~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~~~~ 723 (732)
...-.-... ...-..|..|.|||.+. +...++++|||||||++|+|+.|..||++.-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 432211100 11124788999999876 45688999999999999999999999997554
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=283.39 Aligned_cols=200 Identities=29% Similarity=0.507 Sum_probs=172.2
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.+.||+|+||.||+++++++..+|+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999988888999987643 2335678899999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999885432 35889999999999999999999986 999999999999999999999999998754332222
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 2222335668999999988889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.33 Aligned_cols=193 Identities=28% Similarity=0.402 Sum_probs=167.6
Q ss_pred ceecccCceEEEEEEE----cCCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 520 NKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3689999999875422 234567789999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998843 346899999999999999999999986 99999999999999999999999999875433211
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 22345799999999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.73 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=169.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----EEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-----QLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 586 (732)
+|++.+.||+|+||.||+|... +|+.||+|++... .....+++.+|+++++.++|+||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999875 7899999998653 2234567889999999999999999999998876 789
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+. ++|.+.+. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57887773 2346899999999999999999999986 99999999999999999999999999976
Q ss_pred CCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.............++..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 544333333344678899999998864 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=286.63 Aligned_cols=192 Identities=22% Similarity=0.308 Sum_probs=164.7
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccc---hHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEEEEEe
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG---NREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLMLVYEY 591 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~ 591 (732)
...+|+|++|.||+|.. +|+.||||+++...... .+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999988 58999999987643332 4678899999999999999999999877 3578999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++|+|.+++.. ...+++....+++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999953 346889999999999999999999752 37899999999999999999999999987543321
Q ss_pred ceeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 12457889999999876 68899999999999999999999999754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=287.84 Aligned_cols=199 Identities=28% Similarity=0.464 Sum_probs=164.7
Q ss_pred CCCcccceecccCceEEEEEEEc--CCeEEEEEEccccc--ccchHHHHHHHHHHhcC---CCCceeeeeeeEEe-----
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLLSSKS--RQGNREFLNEIGTISCL---QHPNLVKLYGCCIE----- 581 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----- 581 (732)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 47889999886542 22234566677666655 69999999998863
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5898888542 2235789999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 999765432 222345689999999999888999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.20 Aligned_cols=193 Identities=28% Similarity=0.447 Sum_probs=166.2
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999987532 23345677888888877 799999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999988843 346899999999999999999999986 99999999999999999999999999864322211 1
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 2235689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=283.52 Aligned_cols=192 Identities=31% Similarity=0.430 Sum_probs=165.3
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||.||+++.+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 68999999886431 12234556799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9887542 2335788999999999999999999986 9999999999999999999999999987654322 2233
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 5689999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.51 Aligned_cols=206 Identities=29% Similarity=0.457 Sum_probs=171.1
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999999742 34579999997543 33346688999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC-----------------------------------------------------------
Q 040398 585 LMLVYEYLENNSLAHALFGGE----------------------------------------------------------- 605 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 605 (732)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred -------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce-eeec
Q 040398 606 -------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH-ISTR 677 (732)
Q Consensus 606 -------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~-~~~~ 677 (732)
....++++..+++++.||++||+|||+.+ |+||||||+||++++++.++|+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235788999999999999999999986 999999999999999999999999998754332221 1112
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 335668999999998899999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.77 Aligned_cols=206 Identities=27% Similarity=0.461 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44688889999999999999963 246789999987543 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC----------------------------------------------------------
Q 040398 585 LMLVYEYLENNSLAHALFGGEN---------------------------------------------------------- 606 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 606 (732)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864221
Q ss_pred -------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 607 -------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 607 -------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125789999999999999999999986 999999999999999999999999999755432221
Q ss_pred -eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 674 -ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 674 -~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1112335668999999999999999999999999999998 88898653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.47 Aligned_cols=199 Identities=27% Similarity=0.419 Sum_probs=171.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------cchHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------QGNREFLNEIGTISCL-QHPNLVKLYGCCIE 581 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 581 (732)
.-..|+..+.+|+|..++|-++..+ +|+.+|+|++..... ...+.-.+|+.+|+++ .||+|+++.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778889999999999998765 789999999864321 1124456899999998 69999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
+...++|+|.|+.|.|.|++ ...-.+++...++|++|+.+|++|||... ||||||||+|||+|++.+++|+||
T Consensus 95 ~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 99999999999999999999 45567899999999999999999999984 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcc------cCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYAL------WGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|.|....+.. .....+||++|+|||.+. ...|+...|+||.|||||.|+.|.+||=
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9998766533 234589999999999985 2357889999999999999999999983
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=282.38 Aligned_cols=202 Identities=32% Similarity=0.513 Sum_probs=174.6
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788999999999999999998888899999876533 23578899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.++++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999988543 2345788899999999999999999986 99999999999999999999999999986544322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||+..+..++.++|||||||++|+|+| |+.||..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 22223345678999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=277.24 Aligned_cols=200 Identities=29% Similarity=0.381 Sum_probs=175.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccc---hHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG---NREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
..++|+.+++||+|.||.|-.++-+ +++.||+|++++..-.. ...-..|-++|+..+||.+..+-..|...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578999999999999999999866 79999999998764333 3345678899999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||..||.|.-++. ....+++...+-+-..|..||.|||+++ ||+||||.+|.|+|.+|++||.|||+++--
T Consensus 246 VMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999998883 3456788888888999999999999985 999999999999999999999999999732
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
-... .....++||+.|+|||++....|....|+|.+||+||||++|+.||-
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 2222 23456899999999999999999999999999999999999999995
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.23 Aligned_cols=198 Identities=25% Similarity=0.324 Sum_probs=164.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--------C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--------D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 583 (732)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999875 68999999875432 2345799999999999999999887542 2
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeee
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFG 662 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfG 662 (732)
..++||||+++ ++.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 777776544444567899999999999999999999986 99999999999999765 69999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9975543222 2235689999999988764 689999999999999999999999964
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=280.20 Aligned_cols=201 Identities=29% Similarity=0.499 Sum_probs=172.4
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999988877789999887443 234678999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999988542 226899999999999999999999986 999999999999999999999999998755433222
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
......++..|+|||...+..++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 2222345678999999988889999999999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=307.71 Aligned_cols=206 Identities=24% Similarity=0.290 Sum_probs=171.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCC-eEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEE-e------CC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDG-TIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCI-E------GD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~-~------~~ 583 (732)
..++++.+.|.+|||+.||.|+...+ ..||+|++-.......+...+|+++|++|+ |+|||.+++... . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34556788999999999999998765 999999988777778888999999999997 999999999322 2 13
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
+++|.||||.+|+|.|++...... .|++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 678999999999999999654333 399999999999999999999987 57899999999999999999999999999
Q ss_pred ceeCCccCceeee--------cccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 664 AKLDEEEKTHIST--------RVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 664 a~~~~~~~~~~~~--------~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|.-.......... ...-|+.|+|||.+. +.++++|+|||+|||+||.|+..+.||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 8532111111000 123588999999874 678999999999999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=273.04 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=171.8
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEE-EcCCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCC
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGD 583 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 583 (732)
+.++-+.++ +.||+|+|++|--+. ..+|..||||++.+.......+..+|++++.+.+ |+||++++++|++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555544 569999999998886 4689999999999887777889999999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEe
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISD 660 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~D 660 (732)
.+|+|||.|.||+|..+++ .+.-+++.++.++.++|+.||++||.+| |.|||+||+|||-.+... +||||
T Consensus 150 ~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999884 3456899999999999999999999997 999999999999876554 89999
Q ss_pred eecceeCCc--cCce----eeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 661 FGLAKLDEE--EKTH----ISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 661 fGla~~~~~--~~~~----~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|.++.-... +-.. .....+|+..|||||++. ...|+.++|.|||||++|-|++|.+||...
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 988753211 1111 112357999999999874 236889999999999999999999999753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=279.75 Aligned_cols=202 Identities=32% Similarity=0.540 Sum_probs=173.6
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998878889999987543 33567899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999985432 346899999999999999999999986 99999999999999999999999999976543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........+..|+|||+..+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 11112223458999999998899999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=286.28 Aligned_cols=205 Identities=26% Similarity=0.399 Sum_probs=175.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.-|+..+.||+|-|++|..|++- +|.+||||++.+..- .....+.+|++.|+.++|||||++|++..+...+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45677788999999999999865 899999999987633 234568899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCeEEEeeecceeCCc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DfGla~~~~~ 669 (732)
+=++|+|+|++..+ ...+.+..+++++.||+.|+.|+|+.. +|||||||+||.+- +-|-+||.|||.+..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999543 346889999999999999999999884 99999999999874 558899999999865554
Q ss_pred cCceeeecccCccccccchhcccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLT-YKADVYSFGVVALEIVSGKNNMSYVPDSNC 726 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvll~elltG~~P~~~~~~~~~ 726 (732)
.. ..+..+|+..|-|||++.+..|+ ++.||||||||||.|++|++||+...+.+.
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 32 23457899999999999987654 678999999999999999999997665543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=299.01 Aligned_cols=200 Identities=35% Similarity=0.572 Sum_probs=169.3
Q ss_pred CCcccceecccCceEEEEEEEc--CC--eE-EEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT--DG--TI-IAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~--~g--~~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
+-...++||+|+||.||+|+.+ ++ .. ||||..+.. .....++|.+|.+++++++|||||+++|++..+..++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3444589999999999999865 23 23 899988852 3566789999999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+|||+|+||+|.++|... ...++..++.+++.+.|+||+|||+++ +|||||-.+|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999543 236899999999999999999999995 99999999999999999999999999875
Q ss_pred CCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
........ ....-+..|+|||.+....+++++|||||||++||+++ |..||...
T Consensus 312 ~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 312 GSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred Ccceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 43111111 01124569999999999999999999999999999999 88888754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=283.17 Aligned_cols=199 Identities=30% Similarity=0.416 Sum_probs=171.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999876 789999998865322 223457789999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999885422 235889999999999999999999986 999999999999999999999999998754332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....|+..|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 21 1234689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=279.64 Aligned_cols=201 Identities=29% Similarity=0.503 Sum_probs=170.9
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
.+|++.+.||+|+||.||+++++++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998877889999986432 234578899999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998543 236889999999999999999999986 999999999999999999999999998755432221
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 1112224457999999998899999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=282.09 Aligned_cols=199 Identities=30% Similarity=0.388 Sum_probs=171.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 78999999986532 22234578899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888542 2336899999999999999999999986 9999999999999999999999999987543321
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1 12346899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=283.00 Aligned_cols=205 Identities=33% Similarity=0.545 Sum_probs=174.4
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
..+|.+.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346788899999999999999763 3478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCC----------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 586 MLVYEYLENNSLAHALFGGE----------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
++||||+++++|.+++.... .....+++..+..++.||+.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986532 22345789999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999875432221 11223346778999999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=280.30 Aligned_cols=193 Identities=25% Similarity=0.433 Sum_probs=169.2
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 7899999988654 233456788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999987543 4678889999999999999999986 999999999999999999999999998754322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 12235689999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=286.18 Aligned_cols=199 Identities=25% Similarity=0.418 Sum_probs=168.7
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999876 68899999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 788777432 335788999999999999999999986 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 223457889999998865 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=293.19 Aligned_cols=197 Identities=26% Similarity=0.393 Sum_probs=167.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----- 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 583 (732)
..++|++.+.||+|+||.||+|+.. +|+.||+|++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 6899999998653 2334567889999999999999999999986543
Q ss_pred -EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 584 -QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 584 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
..++||||+++ +|.+.++ ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999975 5665552 24788889999999999999999986 9999999999999999999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 98754322 122345689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=278.65 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=172.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 347889999999999999999875 7899999998765544556788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998853 346789999999999999999999986 9999999999999999999999999987543221
Q ss_pred ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......|+..|+|||.+. ...++.++||||+||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 112345888999999874 34577899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.33 Aligned_cols=205 Identities=28% Similarity=0.411 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccc-cchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567888999999999999999752 235799999975433 33467899999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC----------------------------------------------------------
Q 040398 585 LMLVYEYLENNSLAHALFGGEN---------------------------------------------------------- 606 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 606 (732)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864311
Q ss_pred ----------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC
Q 040398 607 ----------------------------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 652 (732)
Q Consensus 607 ----------------------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 652 (732)
....+++..+.+++.||++||+|||+.+ |+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788889999999999999999986 999999999999999
Q ss_pred CCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 653 DLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 653 ~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999998754332221 1222346778999999998899999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=276.75 Aligned_cols=200 Identities=31% Similarity=0.425 Sum_probs=172.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-----cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-----QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|++.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999875 689999998764321 123568889999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|+||+++++|.+++.. ...+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998843 345788999999999999999999986 999999999999999999999999998754
Q ss_pred CccCceee--ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHIS--TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~--~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 33221111 234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=281.91 Aligned_cols=205 Identities=33% Similarity=0.548 Sum_probs=174.0
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356788899999999999999742 35679999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCC---------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeE
Q 040398 587 LVYEYLENNSLAHALFGGE---------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 657 (732)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 12335899999999999999999999986 99999999999999999999
Q ss_pred EEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 658 ISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 658 L~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999875433221 11222345778999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=278.37 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=175.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999875 7899999987542 2233457889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.........+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988544444456889999999999999999999986 99999999999999999999999999876543
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....|+..|+|||.+.+..++.++|+||+|+++|||++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 2221 1234588899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=286.77 Aligned_cols=202 Identities=30% Similarity=0.531 Sum_probs=169.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe----EEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.+|+..+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 343 48999987543 34457789999999999999999999998765 5679
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998543 335788999999999999999999986 999999999999999999999999999865
Q ss_pred CccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 668 EEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 4332221 122234668999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=283.47 Aligned_cols=197 Identities=26% Similarity=0.449 Sum_probs=171.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999876 68899999887542 33346688999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ...+++..+..++.|+++||+|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999853 245789999999999999999999742 49999999999999999999999999986543221
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.....|+..|+|||...+..++.++|+|||||++|+|++|+.||.
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 223568899999999988889999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=313.60 Aligned_cols=208 Identities=24% Similarity=0.392 Sum_probs=172.7
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQL 585 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 585 (732)
...++|++++.||+|+||.||+|+.. +++.+|+|++... .......+.+|+.++++++|||||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 45678999999999999999999876 6789999988653 23345678999999999999999999998865 3578
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCC----CceEeCCCCCCCeEEcCC--------
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR----FKIVHRDIKATNVLLDRD-------- 653 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~----~~iiH~Dlkp~NILl~~~-------- 653 (732)
++||||+++++|.+++.........+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986544444578999999999999999999998531 249999999999999643
Q ss_pred ---------CCeEEEeeecceeCCccCceeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 654 ---------LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 654 ---------~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999997553321 2234569999999999864 4588999999999999999999999964
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.97 Aligned_cols=201 Identities=27% Similarity=0.475 Sum_probs=171.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.+|++.+.||+|+||.||+|..+ +++.+|+|++... ....+++.+|++++++++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999875 5889999998754 233567899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999885432 345789999999999999999999986 99999999999999999999999999876543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 21112234568999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.08 Aligned_cols=201 Identities=32% Similarity=0.473 Sum_probs=175.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|++|.||+|..+ +++.||+|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999876 6899999988643 334567789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ....+++..+++++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998643 2346889999999999999999999986 9999999999999999999999999987654332
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. ......|+..|+|||+..+..++.++|+|||||++++|++|+.||...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2 223346888999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=278.77 Aligned_cols=204 Identities=30% Similarity=0.509 Sum_probs=177.7
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
...+|++.+.||+|+||.||+|..++++.+|+|++..........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578889999999999999999988999999999876655567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999996532 345789999999999999999999986 9999999999999999999999999987553322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.. .....++..|+|||...+..++.++||||||+++|+|++ |+.||...
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 11 112345678999999988899999999999999999998 89999653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.20 Aligned_cols=204 Identities=31% Similarity=0.507 Sum_probs=171.3
Q ss_pred CCCcccceecccCceEEEEEEE-----cCCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999974 246789999987543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 588 VYEYLENNSLAHALFGGEN-------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
||||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 1235789999999999999999999986 99999999999999999
Q ss_pred CeEEEeeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.+||+|||++....... ........++..|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999987543222 122223446678999999988889999999999999999998 9989854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.03 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=171.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
..++|++.+.||+|+||.||+|... ++..||+|++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4667999999999999999998753 35679999886432 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCC------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 585 LMLVYEYLENNSLAHALFGGENS------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
.++||||+++++|.+++...... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 234678899999999999999999986 999999999999999999999
Q ss_pred EeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 659 SDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 659 ~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999998654332211 1112345778999999998899999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.65 Aligned_cols=204 Identities=35% Similarity=0.560 Sum_probs=172.1
Q ss_pred CCCcccceecccCceEEEEEEEcC------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....++.+|++.+.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 2679999887543 334567899999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 587 LVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
++|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 1145889999999999999999999986 99999999999999999
Q ss_pred CeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999875433221 22233456788999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.97 Aligned_cols=198 Identities=34% Similarity=0.517 Sum_probs=173.0
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccch--HHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
|++.+.||+|+||.||+++.. +++.||+|++........ ....+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999986 678999999987644332 23456999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++. ....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-c
Confidence 9999999994 4556899999999999999999999986 999999999999999999999999998754221 2
Q ss_pred eeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.......++..|+|||++. +...+.++||||+|+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2333567899999999998 889999999999999999999999999854
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=287.33 Aligned_cols=208 Identities=34% Similarity=0.543 Sum_probs=178.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.+...+.++||+|-||.|..|+...+.+||||.++... .....+|.+|+++|.+++||||++++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44556779999999999999999888999999998764 44568999999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee-CCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~-~~~~ 670 (732)
|++|+|..++..++... ..-....+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++- +..+
T Consensus 617 mEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999996654333 34455667999999999999987 599999999999999999999999999984 3444
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHH--cCCCCCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIV--SGKNNMSYVPDSN 725 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ell--tG~~P~~~~~~~~ 725 (732)
..+...+.+-++.|||||.+..++++.++|||+||+++||++ +.+.||+...+++
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 445555667788999999999999999999999999999965 4788997655443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=278.09 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=172.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999875 68999999987665455567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998843 346889999999999999999999986 99999999999999999999999999865433211
Q ss_pred eeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||++. ...++.++|||||||++|+|++|+.||..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 122356899999999874 45688899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=292.76 Aligned_cols=191 Identities=28% Similarity=0.381 Sum_probs=159.9
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcC---CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCL---QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
||+|+||.||+|+.+ +++.||+|++..... .....+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 689999999864321 2223445566666655 699999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.++|+|||++........ .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999988843 346889999999999999999999986 99999999999999999999999999864322221 2
Q ss_pred eecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 2345699999999998754 478999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.43 Aligned_cols=197 Identities=24% Similarity=0.358 Sum_probs=167.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------ 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 582 (732)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999875 68899999987542 33456788999999999999999999987643
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 6776662 24778899999999999999999986 9999999999999999999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 997543321 22345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=275.96 Aligned_cols=201 Identities=32% Similarity=0.508 Sum_probs=170.1
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.++||+|+||.||+|++.+...||+|++..... ..+++.+|++++++++||||+++++.+. ++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356889999999999999999887667799999875332 3467899999999999999999998874 45689999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999543 2335789999999999999999999986 99999999999999999999999999976543332
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 22223346678999999988899999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=281.42 Aligned_cols=199 Identities=28% Similarity=0.486 Sum_probs=174.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888999999999999999865 7899999998766555567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||.+.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998843 24788999999999999999999986 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....|++.|+|||...+..++.++|||||||++|+|++|+.||..
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 11 1234688899999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=279.71 Aligned_cols=204 Identities=31% Similarity=0.531 Sum_probs=173.9
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.+|.+.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 356799999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 588 VYEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
||||+++++|.+++.... .....+++..+++++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 12345899999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999875433221 12223456788999999998899999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.40 Aligned_cols=201 Identities=32% Similarity=0.532 Sum_probs=170.9
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346888999999999999999988888899999875433 3467899999999999999999999875 45688999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999998643 2345789999999999999999999986 99999999999999999999999999976543322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 22222345668999999988889999999999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.17 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=168.1
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG----- 582 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 582 (732)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34678999999999999999999875 68999999987542 23346778999999999999999999988653
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 583 -DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
...++||||+++ ++.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 6666652 24788899999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999754332 122345689999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=279.16 Aligned_cols=198 Identities=29% Similarity=0.462 Sum_probs=163.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcC---CCCceeeeeeeEEe-----CC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCL---QHPNLVKLYGCCIE-----GD 583 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 583 (732)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 689999998875422 2234556677766655 79999999998865 34
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..+++|||+++ +|.+++... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 888877532 2235899999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+........ .....|+..|+|||++.+..++.++||||+||++|||++|++||..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 876543221 2235688999999999988999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=276.75 Aligned_cols=203 Identities=26% Similarity=0.421 Sum_probs=175.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+.. +++.+|||.+... ......++.+|+++++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 7899999987643 2233467889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.........+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988654444557899999999999999999999986 99999999999999999999999999875533
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......|+..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 222 12234688899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=274.92 Aligned_cols=201 Identities=32% Similarity=0.492 Sum_probs=171.5
Q ss_pred CCCcccceecccCceEEEEEEEcC----CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|++.+.||+|+||.||+|+++. ...||+|+++... .....++.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998752 4579999887543 33456789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... ...+++..+++++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 236899999999999999999999986 9999999999999999999999999998664
Q ss_pred ccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 669 EEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 669 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
..... ......++..|+|||...+..++.++||||||+++|||++ |..||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 22221 1222335678999999998899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.72 Aligned_cols=196 Identities=26% Similarity=0.392 Sum_probs=159.8
Q ss_pred cceecccCceEEEEEEEc---CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEEEEEEecC
Q 040398 519 MNKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLMLVYEYLE 593 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 593 (732)
.++||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 46789999886542 23557889999999999999999998865 456899999986
Q ss_pred CCchhHHhhcCC-----CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE----cCCCCeEEEeeecc
Q 040398 594 NNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA 664 (732)
Q Consensus 594 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DfGla 664 (732)
+ +|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7877764321 12235899999999999999999999986 9999999999999 45578999999999
Q ss_pred eeCCccCc--eeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKT--HISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 76543221 11234568999999999876 4689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.70 Aligned_cols=196 Identities=31% Similarity=0.451 Sum_probs=173.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999876 68999999986532 233467889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999843 246889999999999999999999986 99999999999999999999999999876543
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3 2234688999999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=273.60 Aligned_cols=201 Identities=34% Similarity=0.550 Sum_probs=172.3
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|++++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 457888999999999999999988899999999875433 346789999999999999999999886 456789999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999988543 2346889999999999999999999886 99999999999999999999999999876543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 22223346678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=292.21 Aligned_cols=196 Identities=20% Similarity=0.255 Sum_probs=168.7
Q ss_pred hCCCcccceecccCceEEEEEEEc---CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..+|++.+.||+|+||.||+|... .++.||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 4678999987643 23468999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|++. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 58888772 3356899999999999999999999986 99999999999999999999999999875443
Q ss_pred cCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 222 1223457999999999999989999999999999999999999999643
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=272.95 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=176.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+++.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999886 8999999987642 2233567899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.........+++..+..++.++++||+|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988654444556899999999999999999999986 99999999999999999999999999875433
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 2221 1234588899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=271.00 Aligned_cols=195 Identities=30% Similarity=0.468 Sum_probs=166.3
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchh
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 598 (732)
++||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876533 33456889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecc
Q 040398 599 HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678 (732)
Q Consensus 599 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~ 678 (732)
+++... ...+++..+..++.|++.||.|+|+.+ ++||||||+||++++++.++|+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988532 235789999999999999999999986 99999999999999999999999999865433221111122
Q ss_pred cCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 679 ~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 34568999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=276.12 Aligned_cols=199 Identities=39% Similarity=0.622 Sum_probs=165.9
Q ss_pred ccceecccCceEEEEEEEc-----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 518 PMNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+.+.||.|.||.||+|.++ .+..|+||.++... ....+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 35789999996543 33468899999999999999999999999988889999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++|+|.+++... ....+++..+.+|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2356899999999999999999999985 9999999999999999999999999998663222
Q ss_pred -ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 672 -THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 672 -~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 222223446779999999999889999999999999999999 78888653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=286.42 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=169.3
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC-C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG-D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 583 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 347889999999999999999632 35789999987543 23345678899999999 899999999988754 5
Q ss_pred EEEEEEEecCCCchhHHhhcCCC---------------------------------------------------------
Q 040398 584 QLMLVYEYLENNSLAHALFGGEN--------------------------------------------------------- 606 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (732)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999998854211
Q ss_pred CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee-eecccCccccc
Q 040398 607 SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI-STRVAGTIGYM 685 (732)
Q Consensus 607 ~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~ 685 (732)
...++++..+.+++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++.......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0236899999999999999999999986 9999999999999999999999999997653322211 12234567899
Q ss_pred cchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 686 APEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 686 APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=286.68 Aligned_cols=198 Identities=27% Similarity=0.400 Sum_probs=168.3
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeC----
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEG---- 582 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---- 582 (732)
....++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999875 788999999875422 2345678899999999999999999887643
Q ss_pred --CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 583 --DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 583 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
...++++|++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3578999988 779988773 235889999999999999999999986 99999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999765432 123568999999999876 5788999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=277.37 Aligned_cols=200 Identities=29% Similarity=0.473 Sum_probs=172.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+.|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+++++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999876 58999999998766666778899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999998877432 235889999999999999999999986 99999999999999999999999998865322211
Q ss_pred eeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 112345788999999884 34578899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=278.53 Aligned_cols=199 Identities=29% Similarity=0.485 Sum_probs=175.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 467889999999999999999874 7899999998765555567788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998842 34788899999999999999999986 9999999999999999999999999987554332
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....+++.|+|||...+..++.++|+|||||++|+|++|+.||..
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 1234688899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=278.56 Aligned_cols=213 Identities=28% Similarity=0.437 Sum_probs=176.6
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEE-
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCI- 580 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 580 (732)
+.++.+..+.++|++.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666678899999999999999999999875 68899999876432 2245678899999999 6999999999874
Q ss_pred ----eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 581 ----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 581 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
.++..++||||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988643334456889999999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+|+|||++........ ......|+..|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999875543221 1223458899999998753 45788999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=275.39 Aligned_cols=198 Identities=28% Similarity=0.498 Sum_probs=170.6
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
|++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999876 5888999998765555567889999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999988753 2346899999999999999999999986 9999999999999999999999999986543221 11
Q ss_pred eecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++..|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 22356889999999874 44578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=299.26 Aligned_cols=200 Identities=22% Similarity=0.305 Sum_probs=162.3
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCC------CceeeeeeeEEe
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH------PNLVKLYGCCIE 581 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~~ 581 (732)
+....++|++.+.||+|+||.||+|.+. +++.||||+++... ...+.+..|+++++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345688999999999999999999875 68899999986432 223445566666666654 458899998876
Q ss_pred C-CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC------
Q 040398 582 G-DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL------ 654 (732)
Q Consensus 582 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~------ 654 (732)
+ .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 5 5788999988 6788888743 346899999999999999999999741 399999999999998765
Q ss_pred ----------CeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 655 ----------NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 655 ----------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998753222 22346799999999999999999999999999999999999999964
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=274.52 Aligned_cols=198 Identities=31% Similarity=0.485 Sum_probs=174.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999876 68999999987553 33456788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998432 7899999999999999999999986 9999999999999999999999999987654332
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......++..|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 22235688899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=253.27 Aligned_cols=203 Identities=27% Similarity=0.395 Sum_probs=169.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++..-...||+|++|.|-+.++. +|+..|+|.+... +.+..++...|+.+..+. .+|.+|.++|.+..+...|+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344445577999999999999875 8999999998765 344566778888776554 7999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|.|+ .||..+-...-.....+++..+-+||..+.+||.|||++- .+||||+||+|||++.+|++|+||||.+.+..+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 4887766555556778999999999999999999999974 799999999999999999999999999976654
Q ss_pred cCceeeecccCccccccchhccc----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.- ..+-..|...|||||.+.. ..|+-|+||||||+++.||.++++|++-
T Consensus 202 Si--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 22 2222457789999998863 3688999999999999999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=290.65 Aligned_cols=192 Identities=32% Similarity=0.497 Sum_probs=168.1
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
|.-++.||.|+||.||-|++. +.++||||++.-..+ ....++..|++.|++++|||++.+-++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555678999999999999875 789999999875433 3456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|- ||-.|++-. ...++-+.++..|+.+.++||+|||+.+ .||||||..|||+++.|.|||+|||.|.+..+..
T Consensus 108 Cl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 95 577777732 3456788899999999999999999985 9999999999999999999999999998776633
Q ss_pred ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.++|||+|||||++. .+.|+-|+|||||||+..||.-.++|..
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 478999999999986 5689999999999999999999999964
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=271.68 Aligned_cols=195 Identities=28% Similarity=0.463 Sum_probs=164.5
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 78999999876543 33456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee-ee
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI-ST 676 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-~~ 676 (732)
.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998532 345789999999999999999999986 9999999999999999999999999986443211110 01
Q ss_pred cccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 677 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 1123457999999998889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=277.68 Aligned_cols=198 Identities=30% Similarity=0.502 Sum_probs=174.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46889999999999999999864 78999999987655555678899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 35789999999999999999999986 99999999999999999999999999875443322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 2234688899999999888899999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=307.93 Aligned_cols=204 Identities=33% Similarity=0.523 Sum_probs=172.9
Q ss_pred CCcccceecccCceEEEEEEEc--CCe----EEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT--DGT----IIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~--~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
..+..+.||+|.||.||+|... +|. .||+|.++.. ..+...+|.+|..+|++++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4455678999999999999865 343 4899988765 45567889999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 588 VYEYLENNSLAHALFGGEN---SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
++|||.+|+|..+|+..+. ....++......++.|||+|+.||+++. +|||||..+|+||++...+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 9999999999999976522 3556889999999999999999999984 999999999999999999999999999
Q ss_pred eeC-CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 665 KLD-EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 665 ~~~-~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+.. ..+......+..-...|||||.+..+.++.|+|||||||++||++| |..||...
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence 943 3322222222223468999999999999999999999999999999 88898753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.17 Aligned_cols=200 Identities=29% Similarity=0.493 Sum_probs=173.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++|++.+.||+|+||.||++... +++.+|+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888999999999999999875 68999999987665556678999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999988432 246899999999999999999999986 99999999999999999999999998764432221
Q ss_pred eeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 122345888999999875 34577899999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=293.03 Aligned_cols=194 Identities=23% Similarity=0.268 Sum_probs=166.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
...|.+.+.||+|+||.||+|++. +++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 557999999999999999999876 58899999632 23457899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+. ++|.+++... ...+++..+..|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6888877432 236899999999999999999999986 9999999999999999999999999997654322
Q ss_pred c-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 T-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
. .......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2 12234569999999999999999999999999999999999887653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=272.75 Aligned_cols=200 Identities=30% Similarity=0.380 Sum_probs=168.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-----ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-----RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQL 585 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 585 (732)
.+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999875 68999999875321 12245788899999999999999999988764 467
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
+++|||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999998843 235788889999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......|+..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 5432111 111234588899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.15 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=170.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 68999999886432 2334668899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|..+.. ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998888763 2335899999999999999999999986 999999999999999999999999999765443
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 22 1123457889999999875 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=271.71 Aligned_cols=200 Identities=29% Similarity=0.467 Sum_probs=175.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999875 67889999988765556678999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999988432 246889999999999999999999986 99999999999999999999999999875433221
Q ss_pred eeeecccCccccccchhcccC---CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG---YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 12235688899999998776 788999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=274.80 Aligned_cols=201 Identities=30% Similarity=0.480 Sum_probs=166.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe----EEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|++.+.||+|+||.||+|.+. +++ .+|+|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999874 444 47788775432 2234577888889999999999999998754 55778
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999542 346889999999999999999999986 999999999999999999999999999765
Q ss_pred CccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 668 EEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
...... ......++..|+|||...+..++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 433221 2223457779999999998899999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=282.87 Aligned_cols=196 Identities=29% Similarity=0.415 Sum_probs=170.6
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
.+.||+|-||.||-|.++ +|+.||||++.+. .......+.+|+.+|++++||.||.+---|++.+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999865 8999999998764 3344577889999999999999999999999999999999999776
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeeecceeCCccCc
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfGla~~~~~~~~ 672 (732)
-|+-++. ....++++....-++.||+.||+|||.++ |+|+||||+|||+... -.+||||||.|++..+..-
T Consensus 649 MLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 6666663 23457888888889999999999999985 9999999999999654 3599999999999877433
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...++||+.|+|||++..+.|+..-|+||+|||+|--++|..||....
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 345789999999999999999999999999999999999999998644
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.71 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=177.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
....|.+.+.||+|.|+.|..|++. +|..||+|++++.. ....+.+.+|+++++.++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567889999999999999999876 79999999998753 23334588999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+.+|.+++++. ...+..+..+..++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999994 3445566888899999999999999996 9999999999999999999999999998776
Q ss_pred ccCceeeecccCccccccchhcccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGY-LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .......+|++.|.|||+..+.. .++.+|+||+|+++|.|+.|..||+.
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 3 44455689999999999998764 56899999999999999999999984
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=275.64 Aligned_cols=204 Identities=31% Similarity=0.526 Sum_probs=172.8
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.+|+..++||+|+||.||+++.. ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999632 467899999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 588 VYEYLENNSLAHALFGGEN-----------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
+|||+++++|.++++.... ....+++..++.++.||+.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865421 1135789999999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 657 KISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+|+|||++........ .......+++.|+|||...+..++.++|||||||++|||++ |+.||..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999875433221 11122335678999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.79 Aligned_cols=202 Identities=35% Similarity=0.556 Sum_probs=173.8
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|..++++.+|+|.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 56788999999999999999998878889999987543 33567899999999999999999999999989999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++|+|||.+........
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999985432 246899999999999999999999986 99999999999999999999999999876543211
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||.+.+..++.++||||+||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 11112234568999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=278.44 Aligned_cols=200 Identities=25% Similarity=0.419 Sum_probs=169.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999876 68899999887543 2334567889999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++ ++|.+++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 5888887432 335788999999999999999999986 999999999999999999999999998654322
Q ss_pred CceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......+++.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 11234568899999988654 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.98 Aligned_cols=200 Identities=30% Similarity=0.555 Sum_probs=171.3
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
.+|++.+.||+|+||.||+|.+.+++.+|+|++..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999887788999998864432 34678999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++... ...+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999988532 235789999999999999999999986 999999999999999999999999998754332221
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......++.+|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 1222335678999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=280.13 Aligned_cols=203 Identities=31% Similarity=0.480 Sum_probs=168.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCe--EEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGT--IIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+++ ++. .+|+|.+... .....+.+.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999875 454 4677776643 233456788999999999 89999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 588 VYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
||||+++++|.++++.... ....+++..++.++.||++||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999864321 2246889999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 99999999863221111 111224567999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=276.16 Aligned_cols=214 Identities=30% Similarity=0.466 Sum_probs=177.7
Q ss_pred cccHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEE
Q 040398 503 SFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCI 580 (732)
Q Consensus 503 ~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 580 (732)
-+++.++..+.++|++.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556666777899999999999999999999875 68999999986432 2345677899999998 8999999999987
Q ss_pred eC-----CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 581 EG-----DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 581 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
.. +..++||||+++++|.++++........+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3589999999999999988654334456899999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCceeeecccCccccccchhcccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-----YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999875433221 11234588899999987643 3688999999999999999999999653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=270.66 Aligned_cols=200 Identities=23% Similarity=0.334 Sum_probs=173.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|++++++++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999876 7899999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988532 2335788999999999999999999986 99999999999999999999999999875543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||+..+..++.++|+||||+++|+|++|+.||..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 22235688899999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.39 Aligned_cols=200 Identities=32% Similarity=0.508 Sum_probs=169.2
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.+.||+|++|.||+|..+.+..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998877789999876433 33467889999999999999999998875 466889999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.++++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999996432 335789999999999999999999986 999999999999999999999999999765432222
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......++..|+|||...+..++.++|||||||++|||+| |+.||..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2222345678999999998899999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.61 Aligned_cols=200 Identities=30% Similarity=0.441 Sum_probs=169.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999876 68999999886542 22346788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
++ ++|.+++.... ....+++..++.++.||++||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58888774432 2356899999999999999999999986 9999999999999999999999999987543221
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.......+++.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122234578899999988654 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.66 Aligned_cols=199 Identities=31% Similarity=0.500 Sum_probs=174.7
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++|+..+.||+|+||.||+|... +++.+|+|.+..... .+++.+|++++++++|+||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888999999999999999987 478999999875433 678999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999998843 2346899999999999999999999986 99999999999999999999999999875543221
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122345788999999999889999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=271.62 Aligned_cols=199 Identities=28% Similarity=0.447 Sum_probs=170.9
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEEcccccc------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998764321 1235688899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999843 235789999999999999999999986 9999999999999999999999999986432
Q ss_pred cc-----CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EE-----KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~-----~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .........|+..|+|||+..+..++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11 11112234688899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=278.49 Aligned_cols=206 Identities=29% Similarity=0.436 Sum_probs=170.7
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|.+.+.||+|+||.||+|+.. +...+|+|.+.... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 457889999999999999999752 23579999987542 23446788899999999 799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..++||||+++++|.+++..... ....+++..+.+++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965322 1235899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
++++.++|+|||.+......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999998754322111 1111224568999999998889999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.54 Aligned_cols=200 Identities=27% Similarity=0.469 Sum_probs=174.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+..+.||+|+||.||.++.. +++.+|+|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788999999999999999865 6899999987654 234456788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999885432 346789999999999999999999986 9999999999999999999999999987654433
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......++..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 2 22345688999999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=273.42 Aligned_cols=202 Identities=30% Similarity=0.509 Sum_probs=170.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC------C
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG------D 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~ 583 (732)
+.+.|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4667888899999999999999875 68899999986543 3346788999999998 799999999998753 4
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 6899999999999999885422 345889999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+........ ......|+..|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 875433221 223456889999999886 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=290.22 Aligned_cols=200 Identities=27% Similarity=0.470 Sum_probs=173.7
Q ss_pred CCCcccceecccCceEEEEEEEcC-CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+.|+++..||.|+||.||+|+.++ +-..|.|++........++|.-|+++|..++||+||++++.|..++.+|+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456677889999999999998874 5556788888777788899999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+||-.+.++. .-...+.+.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred CCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 9999988774 3445789999999999999999999998 499999999999999999999999998753221 12
Q ss_pred eeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++||++|||||++. ..+|++++|||||||+|.||..+.+|-..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 2334588999999999975 45899999999999999999999998754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=289.21 Aligned_cols=192 Identities=28% Similarity=0.489 Sum_probs=163.9
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEcc---c-ccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE--EEEEEEe
Q 040398 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLS---S-KSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ--LMLVYEY 591 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~---~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lv~e~ 591 (732)
..+||+|+|-+||||-+. +|-.||=-.++ . ......++|..|+.+|+.|+||||++++++|.+... +.+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999875 57666533222 1 234456899999999999999999999999998654 7899999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfGla~~~~~~ 670 (732)
|..|+|..+++. ....+...++.|++||++||.|||++ .++|||||||.+|||++.+ |.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999954 34567789999999999999999998 4789999999999999866 89999999999876542
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
. ...++|||.|||||... ..|++..||||||..|+||.|+.+||.
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2 23478999999999776 789999999999999999999999996
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=276.64 Aligned_cols=202 Identities=32% Similarity=0.495 Sum_probs=167.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe--EEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT--IIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|++.+.||+|+||.||+|+.+ ++. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 343 4788887743 333456789999999999 799999999999999999999
Q ss_pred EEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 589 YEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
|||+++++|.++++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999864321 1235889999999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |+.||..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999863221111 111123457999999988889999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.97 Aligned_cols=199 Identities=32% Similarity=0.495 Sum_probs=169.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc---------chHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ---------GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999875 6889999988654221 12567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999843 345788999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCc-----eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKT-----HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 75542111 111224578899999999888899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=268.50 Aligned_cols=194 Identities=28% Similarity=0.465 Sum_probs=161.7
Q ss_pred eecccCceEEEEEEEc---CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCc
Q 040398 521 KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 596 (732)
.||+|+||.||+|.+. ++..||+|++..... ...+++.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 456799999876532 33467899999999999999999999875 457899999999999
Q ss_pred hhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee-
Q 040398 597 LAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS- 675 (732)
Q Consensus 597 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~- 675 (732)
|.+++... ...+++..+.+++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 346899999999999999999999986 99999999999999999999999999875433222111
Q ss_pred -ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 676 -TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 676 -~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11223568999999988889999999999999999996 99999653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=287.25 Aligned_cols=207 Identities=29% Similarity=0.442 Sum_probs=171.6
Q ss_pred HhCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccc-cchHHHHHHHHHHhcCC-CCceeeeeeeEEeCC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGD 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 583 (732)
..++|.+.+.||+|+||.||+|++. .++.||+|++..... ...+.+.+|++++.++. ||||+++++++..++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999853 346899999975432 33457889999999997 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCC---------------------------------------------------------
Q 040398 584 QLMLVYEYLENNSLAHALFGGEN--------------------------------------------------------- 606 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (732)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965321
Q ss_pred -------------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeE
Q 040398 607 -------------------------------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649 (732)
Q Consensus 607 -------------------------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 649 (732)
....+++..+.+++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124678888999999999999999885 999999999999
Q ss_pred EcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 650 LDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 650 l~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999875432211 11122356788999999998889999999999999999998 88998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=273.19 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=168.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCe----EEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|+..+.||+|+||.||+|++. +++ .||+|++... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888999999999999999854 454 4899988754 33345678899999999999999999999875 4567
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+++||+++|+|.++++.. ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999998542 346889999999999999999999986 99999999999999999999999999976
Q ss_pred CCccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........ .....++..|+|||...+..++.++|||||||++|||++ |+.||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 54332221 112234678999999988889999999999999999998 9999875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=277.56 Aligned_cols=195 Identities=26% Similarity=0.405 Sum_probs=158.9
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~ 594 (732)
.+||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 45789999886542 23567889999999999999999998864 5678999999865
Q ss_pred CchhHHhhcCC-----CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE----cCCCCeEEEeeecce
Q 040398 595 NSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAK 665 (732)
Q Consensus 595 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DfGla~ 665 (732)
+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+||++ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777664221 12345889999999999999999999986 9999999999999 456789999999997
Q ss_pred eCCccCce--eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTH--ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 65432221 1223568899999999876 4588999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.83 Aligned_cols=205 Identities=31% Similarity=0.407 Sum_probs=170.6
Q ss_pred hCCCcccceecccCceEEEEEEEcC------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999998753 5789999886543 33346789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEEE
Q 040398 586 MLVYEYLENNSLAHALFGGEN---SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKIS 659 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 659 (732)
++||||+++++|.+++..... ....+++..+.+++.||++||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865421 2246899999999999999999999986 99999999999998765 58999
Q ss_pred eeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 660 DFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99998765322111 1112234568999999998899999999999999999997 9999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.33 Aligned_cols=204 Identities=31% Similarity=0.509 Sum_probs=170.2
Q ss_pred CCCcccceecccCceEEEEEEEc-----------------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeee
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-----------------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKL 575 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-----------------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 575 (732)
++|++.+.||+|+||.||+++.+ ++..+|+|++.... ....+.+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998543 24579999987543 3345678999999999999999999
Q ss_pred eeeEEeCCEEEEEEEecCCCchhHHhhcCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCe
Q 040398 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENS-------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNV 648 (732)
Q Consensus 576 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NI 648 (732)
++++..++..++||||+++++|.+++...... ...+++..+..++.||+.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998654221 234788899999999999999999986 99999999999
Q ss_pred EEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc--CCCCCCC
Q 040398 649 LLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS--GKNNMSY 720 (732)
Q Consensus 649 Ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt--G~~P~~~ 720 (732)
++++++.++|+|||++........ .......++..|+|||...++.++.++|||||||++|||++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999875433221 11222344678999999888899999999999999999998 7788864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.60 Aligned_cols=196 Identities=34% Similarity=0.485 Sum_probs=165.5
Q ss_pred cccceecccCceEEEEEEE-----cCCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEE
Q 040398 517 DPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLV 588 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 588 (732)
+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7889999999999988652 3678999999876432 3456788999999999999999999988763 468999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999843 35899999999999999999999986 9999999999999999999999999987654
Q ss_pred ccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ......++..|+|||...+..++.++||||||+++|||+||..|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 32221 11122356679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.62 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=170.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999876 67899999887543 233457889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999843 345889999999999999999999986 99999999999999999999999998863211
Q ss_pred cC--------------ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EK--------------THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~--------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 00 0011124578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.89 Aligned_cols=200 Identities=31% Similarity=0.466 Sum_probs=168.5
Q ss_pred CCCcccceecccCceEEEEEEE-----cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 586 (732)
.+|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 2578999999877665566788999999999999999999998754 34689
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998532 235889999999999999999999986 99999999999999999999999999986
Q ss_pred CCccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 667 DEEEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 667 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
........ .....++..|+|||+..+..++.++|||||||++|||++|..|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 54332211 111223456999999998889999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.99 Aligned_cols=202 Identities=27% Similarity=0.454 Sum_probs=167.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHH-HhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGT-ISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999876 79999999987543 2233455666664 666789999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++ ++|.+++.........+++..++.++.||+.||+|||++. +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888877554334467899999999999999999999862 4999999999999999999999999998754332
Q ss_pred CceeeecccCccccccchhccc----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1223468889999998764 4568899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.50 Aligned_cols=198 Identities=29% Similarity=0.409 Sum_probs=162.8
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 520 NKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999864 346799998875432 33457889999999999999999999999999999999999999
Q ss_pred chhHHhhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce-
Q 040398 596 SLAHALFGGEN-SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH- 673 (732)
Q Consensus 596 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~- 673 (732)
+|.++++.... .....++..+..++.|+++|++|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965432 2335677888899999999999999986 999999999999999999999999998654332221
Q ss_pred eeecccCccccccchhcccC-------CCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWG-------YLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~-------~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......++..|+|||++.+. .++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 12234577889999988642 35789999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.53 Aligned_cols=206 Identities=26% Similarity=0.436 Sum_probs=172.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIE 581 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 581 (732)
..++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+++++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999741 34579999987542 33456789999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeE
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 649 (732)
....+++|||+++++|.+++..... ....+++..+..++.||++||+|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865322 2245788999999999999999999986 999999999999
Q ss_pred EcCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 650 LDRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 650 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+++++.+||+|||.++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999765432221 1122345678999999988889999999999999999998 7888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=269.94 Aligned_cols=200 Identities=31% Similarity=0.407 Sum_probs=168.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-----ccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-----RQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQL 585 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 585 (732)
.+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999875 68999999876432 1233568889999999999999999998876 3678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999843 235788999999999999999999885 9999999999999999999999999987
Q ss_pred eCCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 5432111 111234578899999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.21 Aligned_cols=199 Identities=19% Similarity=0.269 Sum_probs=164.1
Q ss_pred ccceeccc--CceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 518 PMNKIGEG--GFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 518 ~~~~LG~G--~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++++||+| +|+.||+++.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999875 78999999987542 233456778999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999885322 234789999999999999999999986 99999999999999999999999986532211111
Q ss_pred e------eeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 673 H------ISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 673 ~------~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0111346778999999876 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.05 Aligned_cols=198 Identities=28% Similarity=0.411 Sum_probs=160.8
Q ss_pred eecccCceEEEEEEEcC---CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCc
Q 040398 521 KIGEGGFGPVYKGQLTD---GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 596 (732)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|++.++.++|+||+++++.+.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578888876443 2334578899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCC-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc-ee
Q 040398 597 LAHALFGGENS-QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HI 674 (732)
Q Consensus 597 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~-~~ 674 (732)
|.+++...... ....++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999654322 234567888999999999999999986 99999999999999999999999999864332221 11
Q ss_pred eecccCccccccchhccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALW-------GYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.....++..|+|||+... ..++.++|||||||++|||++ |..||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122345678999998742 456889999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.05 Aligned_cols=201 Identities=32% Similarity=0.490 Sum_probs=170.0
Q ss_pred CCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.+|++.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999864 23479999887543 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998543 245789999999999999999999986 9999999999999999999999999987654
Q ss_pred ccCceeee--cccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 669 EEKTHIST--RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~--~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........ ...++..|+|||.+.+..++.++|+|||||++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 33222211 1223568999999998889999999999999999886 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=285.09 Aligned_cols=192 Identities=22% Similarity=0.313 Sum_probs=164.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4567999999999999999999876 5788999975432 23568999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
++. ++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 588887743 2346899999999999999999999986 999999999999999999999999998753322
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~ 718 (732)
. ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123456899999999999989999999999999999999865554
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=276.71 Aligned_cols=208 Identities=28% Similarity=0.445 Sum_probs=173.4
Q ss_pred HHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
...++|+..+.||+|+||.||++... ....+|+|.+.... .....++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888999999999999999764 23689999887542 23345688999999999 899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..+++|||+++|+|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999986432 23456899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
++++.+||+|||.++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999765432221 1112235668999999988889999999999999999997 98898643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=274.72 Aligned_cols=203 Identities=32% Similarity=0.463 Sum_probs=169.3
Q ss_pred CCcccceecccCceEEEEEEEc------CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999753 3578999998754332 34668899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 588 VYEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
++||+++++|.+++.... .....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999884321 11245788999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999875433221 12223346779999999988889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=273.62 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=168.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 68999999986543 233456788999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||++ +++.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777666322 235678889999999999999999986 99999999999999999999999999875432
Q ss_pred cCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2211 1223578899999988754 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.80 Aligned_cols=199 Identities=29% Similarity=0.447 Sum_probs=171.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999875 78999999987643 33456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999885432 46899999999999999999999986 9999999999999999999999999987654433
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........|+..|+|||.+.+. .++.++||||+||++|||++|++||..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 2222345688899999988654 468999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=270.42 Aligned_cols=204 Identities=29% Similarity=0.354 Sum_probs=171.9
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+.+++++.....||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345666666788999999999999865 6788999998766655667899999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKL--NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~ 665 (732)
+||+++++|.+++.... ..+ ++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||.+.
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999985421 233 77888899999999999999986 999999999999986 6789999999987
Q ss_pred eCCccCceeeecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... ......|+..|+|||+..+. .++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 5433222 12234578899999998654 378899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.15 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=172.2
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999764 24789999986542 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCC------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 586 MLVYEYLENNSLAHALFGGEN------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
++||||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865332 1234788999999999999999999986 9999999999999999999999
Q ss_pred eeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 660 DFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 9999875433221 11222346789999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=276.66 Aligned_cols=202 Identities=27% Similarity=0.378 Sum_probs=173.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999876 589999999875432 24467889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988532 2346899999999999999999999986 99999999999999999999999999864322
Q ss_pred cCce----------------------------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTH----------------------------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~----------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 1110 11124688899999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=277.62 Aligned_cols=196 Identities=28% Similarity=0.488 Sum_probs=169.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344557999999999999875 7899999998765445567788999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 999987732 35789999999999999999999986 999999999999999999999999998644332211
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1235688999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=266.72 Aligned_cols=200 Identities=29% Similarity=0.404 Sum_probs=171.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e 590 (732)
+|++.+.||+|++|.||++..+ +++.||+|.+... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999876 6789999998653 23345678899999999999999999988764 446899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++... ....+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999988542 2345899999999999999999999986 999999999999999999999999998765332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......+++.|+|||+..+..++.++|||||||++++|++|+.||..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 22 22335688899999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.36 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=167.3
Q ss_pred CcccceecccCceEEEEEEEc-C---CeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE-----
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-D---GTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ----- 584 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 584 (732)
|.+.+.||+|+||.||+|... + +..||+|+++... ......+.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 3789999987542 2334678999999999999999999998876554
Q ss_pred -EEEEEEecCCCchhHHhhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 585 -LMLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 585 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
.+++|||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 23346899999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 662 GLAKLDEEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9997654332211 112235678999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.51 Aligned_cols=201 Identities=28% Similarity=0.480 Sum_probs=170.7
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++++.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 7899999988754 233346788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.... ....+++..+..++.||+.||.|||++. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998885432 2346899999999999999999999742 49999999999999999999999999986543221
Q ss_pred ceeeecccCccccccchhcccC------CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG------YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 1234578899999988544 357899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=274.07 Aligned_cols=203 Identities=33% Similarity=0.481 Sum_probs=169.5
Q ss_pred CCcccceecccCceEEEEEEEc------CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ...+++.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999753 235789998875432 334678899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCC--------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 588 VYEYLENNSLAHALFGGE--------------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
++||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 12245889999999999999999999986 9999999999
Q ss_pred eEEcCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 648 VLLDRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 648 ILl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999998754332221 1122345678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.49 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=171.6
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
++|+..+.||+|+||.||+|+.+ +.+.+|+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 3467999988654333 4577999999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 587 LVYEYLENNSLAHALFGGENS-----QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 226899999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|.+...............++..|+|||.+.+...+.++||||||+++|+|++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9986433222222223346778999999988888999999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.61 Aligned_cols=198 Identities=27% Similarity=0.419 Sum_probs=169.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 589999998765322 234678899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887632 234889999999999999999999986 999999999999999999999999998765433
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.. ......++..|+|||+..+ ..++.++|||||||++|||++|+.||.
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 22 2223457889999998875 457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.63 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=170.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999653 24589999876443 2234568889999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 585 LMLVYEYLENNSLAHALFGGEN------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
.++||||+++|+|.+++..... .....++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 1244577888999999999999999986 999999999999999999999
Q ss_pred EeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 659 SDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 659 ~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999875433221 11112235678999999998889999999999999999998 7888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=277.01 Aligned_cols=196 Identities=30% Similarity=0.510 Sum_probs=169.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334467999999999999875 6899999998765555567789999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~- 174 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK- 174 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence 999998832 35788999999999999999999986 999999999999999999999999998644322211
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1234588899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.26 Aligned_cols=201 Identities=31% Similarity=0.484 Sum_probs=171.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998778889999886532 234678899999999999999999999877 7789999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999998543 2345788999999999999999999986 99999999999999999999999999875543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||++....++.++|+|||||++|+++| |+.||..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 22222345678999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=267.61 Aligned_cols=192 Identities=31% Similarity=0.468 Sum_probs=161.7
Q ss_pred eecccCceEEEEEEEc---CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 521 KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57899999987543 234567899999999999999999999875 45678999999999
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee-
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI- 674 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~- 674 (732)
+|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999843 235889999999999999999999986 9999999999999999999999999987654332211
Q ss_pred -eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 675 -STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 675 -~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 112234578999999988889999999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.94 Aligned_cols=206 Identities=25% Similarity=0.394 Sum_probs=173.7
Q ss_pred HhCCCcccceecccCceEEEEEEEcC-----CeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTD-----GTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 584 (732)
..++|++.+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999998765 688999988754 23345678899999999999999999998876 467
Q ss_pred EEEEEEecCCCchhHHhhcCCCC----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 585 LMLVYEYLENNSLAHALFGGENS----QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
.++++||+++++|.+++...... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 256899999999999999999999985 99999999999999999999999
Q ss_pred eecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 661 FGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
||+++...+.... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 9999755333222 1222345678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.70 Aligned_cols=200 Identities=26% Similarity=0.391 Sum_probs=172.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|+||.||+|..+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 6889999988753 23345778999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766552 2345789999999999999999999986 999999999999999999999999998765544
Q ss_pred CceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 33233345678899999999888 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.83 Aligned_cols=202 Identities=31% Similarity=0.496 Sum_probs=169.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CC---eEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DG---TIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|+..+.||+|+||.||+|+.+ ++ ..+|+|.+.... ....+.+.+|++++++++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999875 33 379999887542 3345678999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998532 346899999999999999999999986 999999999999999999999999998755
Q ss_pred CccCceeee--cccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 668 EEEKTHIST--RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~--~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 432221111 1223457999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=259.57 Aligned_cols=198 Identities=27% Similarity=0.468 Sum_probs=166.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+.+.+..||+|+.|.|++++.+ +|...|||.+... +.+..++++..+.++.+- ++|.||+.+|||..+...++-||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3345567999999999999976 6999999998765 455667788888776665 499999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|.. .++..++. ...++++..+-++...+.+||.||-++. .|||||+||+|||+|+.|++|+||||.+..+-+..
T Consensus 173 Ms~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 853 56666643 3446899999999999999999998765 69999999999999999999999999987655433
Q ss_pred ceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..++..|.+.|||||.+.- ..|+-++|||||||.++||.||++||..
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 3455679999999998863 4688899999999999999999999974
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=273.34 Aligned_cols=205 Identities=30% Similarity=0.491 Sum_probs=172.5
Q ss_pred hCCCcccceecccCceEEEEEEEcC-----------------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD-----------------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVK 574 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 574 (732)
..+|++.+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987542 2468999987543 334567889999999999999999
Q ss_pred eeeeEEeCCEEEEEEEecCCCchhHHhhcCCC-------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGEN-------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 575 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999865431 2236899999999999999999999986 9999999999
Q ss_pred eEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc--CCCCCCC
Q 040398 648 VLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS--GKNNMSY 720 (732)
Q Consensus 648 ILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt--G~~P~~~ 720 (732)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999875433221 22233456779999999988889999999999999999998 6778764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=270.11 Aligned_cols=197 Identities=31% Similarity=0.491 Sum_probs=171.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999876 68999999887543 344567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998842 35788899999999999999999985 99999999999999999999999999875543222
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||++.+..++.++|+|||||++|||+||+.||..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.71 Aligned_cols=203 Identities=29% Similarity=0.452 Sum_probs=170.9
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 346888999999999999999741 35689999987543 23346789999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.++++... ...+++..+..++.||+.||+|||+++ ++|+||||+||++++++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999985432 223799999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 665 KLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 754332221 1122345678999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=267.91 Aligned_cols=195 Identities=31% Similarity=0.478 Sum_probs=167.3
Q ss_pred ceecccCceEEEEEEEcC--C--eEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLTD--G--TIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~--g--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|++|.||+|++.+ + ..||+|.+..... ...+++.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce-
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH- 673 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~- 673 (732)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865332 46899999999999999999999986 999999999999999999999999998765432221
Q ss_pred -eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 -ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 -~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1122456789999999998889999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.88 Aligned_cols=201 Identities=28% Similarity=0.449 Sum_probs=164.7
Q ss_pred cccceecccCceEEEEEEEcC-Ce--EEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------CEE
Q 040398 517 DPMNKIGEGGFGPVYKGQLTD-GT--IIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------DQL 585 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~~-g~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 585 (732)
.+.+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998763 33 6899988754 234456788999999999999999999987542 246
Q ss_pred EEEEEecCCCchhHHhhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 586 MLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
+++|||+++|+|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874321 23345899999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 664 AKLDEEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 87654322211 122346678999999998899999999999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=273.58 Aligned_cols=197 Identities=32% Similarity=0.514 Sum_probs=170.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999875 68899999887543 334567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998832 35789999999999999999999986 99999999999999999999999999875443221
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 11224578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=266.68 Aligned_cols=198 Identities=34% Similarity=0.553 Sum_probs=172.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457788899999999999999876 78899999976644 5678999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999985432 235899999999999999999999986 99999999999999999999999999875532211
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
....+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 2234568999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.49 Aligned_cols=200 Identities=26% Similarity=0.455 Sum_probs=172.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999876 68999999876543 3345788999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998843 235889999999999999999999742 4999999999999999999999999988643221
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 1 12346899999999998888999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=274.48 Aligned_cols=204 Identities=30% Similarity=0.491 Sum_probs=168.9
Q ss_pred CCCcccceecccCceEEEEEEEcC---------------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeee
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD---------------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYG 577 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~---------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~ 577 (732)
.+|++.+.||+|+||.||+|+... ...||+|.+.... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999987542 2358999987542 334467899999999999999999999
Q ss_pred eEEeCCEEEEEEEecCCCchhHHhhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeE
Q 040398 578 CCIEGDQLMLVYEYLENNSLAHALFGGEN--------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649 (732)
Q Consensus 578 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 649 (732)
++...+..++||||+++++|.+++..... ....+++..+..++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854321 1124788999999999999999999986 999999999999
Q ss_pred EcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc--CCCCCCC
Q 040398 650 LDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS--GKNNMSY 720 (732)
Q Consensus 650 l~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt--G~~P~~~ 720 (732)
+++++.+||+|||++........ .......++..|+|||+..+..++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999875433221 11222345678999999988889999999999999999998 6667764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=266.71 Aligned_cols=197 Identities=34% Similarity=0.472 Sum_probs=170.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-----ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-----RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999876 78999999876532 22456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999843 235789999999999999999999986 9999999999999999999999999987543
Q ss_pred ccCceeeecccCccccccchhcccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGY-LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||..
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 322 223356888999999987766 89999999999999999999999964
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.55 Aligned_cols=199 Identities=38% Similarity=0.580 Sum_probs=171.4
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|.... +..||+|++...... ..+.+.+|++.++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998763 788999998765433 367889999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 595 NSLAHALFGGENS-----QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 595 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
++|.+++...... ...+++..++.++.|+++||+|||+++ ++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654221 367899999999999999999999986 99999999999999999999999999976544
Q ss_pred cCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 670 EKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 670 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
... .......++..|+|||......++.++||||+||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 12223457889999999988889999999999999999999 69999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.43 Aligned_cols=201 Identities=30% Similarity=0.417 Sum_probs=168.2
Q ss_pred CCCcccceecccCceEEEEEEEcC----CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999887654 4455689999999999999999999998875 557899
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998542 235899999999999999999999986 9999999999999999999999999987654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
...........++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 432222222334568999999988889999999999999999986 99999643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.89 Aligned_cols=200 Identities=25% Similarity=0.420 Sum_probs=168.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999876 789999999865432 233557789999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++ +|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 899888543 236789999999999999999999986 999999999999999999999999998643221
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......++..|+|||+..+ ..++.++||||+||++|+|++|+.||..
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1122346789999998875 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=267.39 Aligned_cols=200 Identities=30% Similarity=0.396 Sum_probs=169.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-----cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-----SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQL 585 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 585 (732)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999875 6899999987532 123345788999999999999999999998764 468
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++++||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998843 235788899999999999999999986 9999999999999999999999999987
Q ss_pred eCCccC--ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEK--THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 543211 1111235688899999999888889999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.31 Aligned_cols=201 Identities=31% Similarity=0.534 Sum_probs=168.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CC---eEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DG---TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.+|++.+.||+|+||.||+|+.+ ++ ..||+|.+... .....++|..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35778899999999999999875 33 36999998754 333456899999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999988543 345889999999999999999999986 9999999999999999999999999987543
Q ss_pred ccCcee--eeccc--CccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 669 EEKTHI--STRVA--GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 669 ~~~~~~--~~~~~--gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
...... ..... .+..|+|||+..+..++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 322111 11111 2357999999998899999999999999999886 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.58 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=173.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 589 (732)
++|+..+.||.|++|.||+|..+ +++.+|+|.+.... .....++.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999985 68999999887543 23456789999999999999999999998654 4689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.........+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887544344556889999999999999999999986 99999999999999999999999999864432
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 12345788999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=267.02 Aligned_cols=200 Identities=36% Similarity=0.538 Sum_probs=173.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 789999999876543 3567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ...+++..++.++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 234788999999999999999999986 9999999999999999999999999987654332
Q ss_pred ceee---ecccCccccccchhcccCC---CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THIS---TRVAGTIGYMAPEYALWGY---LTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~---~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ....++..|+|||++.+.. .+.++||||||+++++|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 2211 1345788999999988766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=266.21 Aligned_cols=204 Identities=30% Similarity=0.475 Sum_probs=175.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999865 68899999986542 33567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999854322 246889999999999999999999986 9999999999999999999999999986544322
Q ss_pred ce---eeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 TH---ISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~---~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.. ......|+..|+|||++... ..+.++|+|||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 21 22334688999999998876 7899999999999999999999999643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.27 Aligned_cols=197 Identities=26% Similarity=0.420 Sum_probs=159.5
Q ss_pred eecccCceEEEEEEEcCC---eEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCc
Q 040398 521 KIGEGGFGPVYKGQLTDG---TIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 596 (732)
+||+|+||.||+++..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 346677665432 3345789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC-ceee
Q 040398 597 LAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK-THIS 675 (732)
Q Consensus 597 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~-~~~~ 675 (732)
|.++++.........++..+..++.||++||+|||+.+ ++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999765444445677788899999999999999986 9999999999999999999999999875322111 1122
Q ss_pred ecccCccccccchhccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALW-------GYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....++..|+|||+... ..++.++|||||||++|||++ |..||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 23567889999998742 245789999999999999997 5668754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=274.38 Aligned_cols=206 Identities=26% Similarity=0.438 Sum_probs=170.0
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 24579999887542 23456788999999999 699999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..+++|||+++|+|.+++..... ....+++..+.+++.||+.||+|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999865321 2345899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
++++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999997544322111 111224457999999998899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.06 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=174.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367889999999999999999865 6889999998765555567789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998843 24688899999999999999999986 9999999999999999999999999886544332
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 2234688899999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.24 Aligned_cols=198 Identities=31% Similarity=0.483 Sum_probs=167.0
Q ss_pred CCcccceecccCceEEEEEEE-----cCCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 586 (732)
.|++++.||+|+||.||.|+. .+++.||+|.++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 357899999987543 33456789999999999999999999998875 5689
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998432 235799999999999999999999986 99999999999999999999999999875
Q ss_pred CCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 040398 667 DEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 667 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~ 718 (732)
...... .......++..|+|||+..+..++.++|||||||++|||+|++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 433221 1122345677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.69 Aligned_cols=197 Identities=25% Similarity=0.431 Sum_probs=166.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999876 78999999886532 22345678899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
++ ++|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4787776432 345899999999999999999999986 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.. .....++..|+|||.+.+. .++.++|||||||++|||+||+.|+.
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 21 2234578899999988764 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=284.78 Aligned_cols=194 Identities=33% Similarity=0.439 Sum_probs=168.3
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhH
Q 040398 521 KIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAH 599 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 599 (732)
+||+|.||+||.|++. +...+|||-+........+.+.+|+...++++|.|||+++|.+.+++++-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999986 456799999887766777888999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCcccC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCCccCceeee
Q 040398 600 ALFGGENSQLKL--NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEEEKTHIST 676 (732)
Q Consensus 600 ~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~ 676 (732)
.++.. =+++ .+.++--+.+||++||.|||++ +|||||||-.|||++. .|.+||+|||.++....- .....
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccc
Confidence 99542 2233 6777888999999999999998 4999999999999965 688999999998755432 23445
Q ss_pred cccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 677 RVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 677 ~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.+.||..|||||++-.+ .|+.++|||||||++.||.||++||-..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 67899999999999865 5888999999999999999999999643
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.83 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=174.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999876 68999999987542 2345788999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999998843 246889999999999999999999986 999999999999999999999999998755432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 1223458889999999988889999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=270.88 Aligned_cols=204 Identities=27% Similarity=0.405 Sum_probs=172.3
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
....+|..+.+||+|+||.|-.|+.+ +.+.||||+++...- ++.+--..|-++|... +-|.+++++..|.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34568999999999999999999876 578899999987532 2233345566777666 578899999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
|+||||+.||+|--.+. +-..+-+..+.-+|..||-||-+||++| ||+||||..||++|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999988884 3445677788889999999999999997 9999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
----. ......++||+.|+|||++...+|+..+|+||+||+||||+.|++||+...
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 223446899999999999999999999999999999999999999998644
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=267.68 Aligned_cols=202 Identities=29% Similarity=0.486 Sum_probs=171.0
Q ss_pred CCcccceecccCceEEEEEEEcC--CeEEEEEEccccc----------ccchHHHHHHHHHHhc-CCCCceeeeeeeEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLTD--GTIIAVKLLSSKS----------RQGNREFLNEIGTISC-LQHPNLVKLYGCCIE 581 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 581 (732)
+|++.+.||+|+||.||+|..+. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 6889999875321 1223457788888765 799999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
++..+++|||+++++|.+++.........+++..+++++.|++.||.|||+.. +++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988554444557899999999999999999999632 4999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 9987654432 22345688899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=267.15 Aligned_cols=190 Identities=25% Similarity=0.387 Sum_probs=159.7
Q ss_pred ceecccCceEEEEEEEcC-------------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 520 NKIGEGGFGPVYKGQLTD-------------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~-------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
+.||+|+||.||+|...+ ...+|+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997531 2358999887665555668889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-------eEEE
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-------PKIS 659 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kL~ 659 (732)
+||||+++++|..+++.. ...+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999887432 345889999999999999999999986 999999999999987654 8999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHH-cCCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIV-SGKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~ell-tG~~P~~~ 720 (732)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||..
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99988644321 1235788999999886 467899999999999999997 68888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=267.65 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=170.0
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEEcccccc------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSR------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+|+..+.||+|++|.||++.. .+++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 4789999998864321 134678899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeeccee
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKL 666 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~ 666 (732)
||||+++++|.+++.. ..++++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 336789999999999999999999986 99999999999998776 599999999865
Q ss_pred CCccCc---eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKT---HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .......++..|+|||...+..++.++||||+|+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 443211 111234678899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=271.43 Aligned_cols=205 Identities=31% Similarity=0.514 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999863 46889999987543 33456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCC------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 586 MLVYEYLENNSLAHALFGGE------------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
+++|||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986431 11235788999999999999999999986 9999999999
Q ss_pred eEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 648 VLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 648 ILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|++++++.++|+|||.+........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999875432211 11122335668999999998899999999999999999997 8888853
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=270.29 Aligned_cols=199 Identities=28% Similarity=0.410 Sum_probs=168.9
Q ss_pred CCcccceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
+|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368999999987532 22346678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999998843 345788999999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..............|+..|+|||.+... .++.++||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6543322222345688999999988753 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.06 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=173.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~ 589 (732)
+|++.+.||+|+||.||+|... +++.+|+|.+... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999865 7889999988643 23345678899999999999999999998764 45689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||+++++|.+++.........+++..++.++.||++||+|||..| ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998665444567899999999999999999999332 235999999999999999999999999998765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 44322 122346889999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=269.74 Aligned_cols=190 Identities=25% Similarity=0.389 Sum_probs=157.9
Q ss_pred eecccCceEEEEEEEcC-------------------------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeee
Q 040398 521 KIGEGGFGPVYKGQLTD-------------------------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKL 575 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 575 (732)
.||+|+||.||+|.... ...||+|++.........++.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999986421 23589998876555555678899999999999999999
Q ss_pred eeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-
Q 040398 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL- 654 (732)
Q Consensus 576 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~- 654 (732)
++++.++...++||||+++|+|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998843 2346789999999999999999999986 99999999999998653
Q ss_pred ------CeEEEeeecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHH-HcCCCCCCCC
Q 040398 655 ------NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEI-VSGKNNMSYV 721 (732)
Q Consensus 655 ------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~el-ltG~~P~~~~ 721 (732)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3799999987543221 11246778999998865 5689999999999999998 5799999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=265.63 Aligned_cols=200 Identities=32% Similarity=0.502 Sum_probs=176.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++.+.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999887 599999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
+++++|.+++... ..+++..+.+++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998532 568999999999999999999999 75 999999999999999999999999998765433
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ....++..|+|||...+..++.++|+||||+++|+|+||+.||...
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 2221 2345788999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=267.03 Aligned_cols=196 Identities=32% Similarity=0.503 Sum_probs=162.2
Q ss_pred ceecccCceEEEEEEEc-CCe--EEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGT--IIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|+.+ ++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999875 443 4688888753 234456788999999999 799999999999999999999999999
Q ss_pred CchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 595 NSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 595 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 1235789999999999999999999986 9999999999999999999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++........ ......+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9853221111 111223567999999988889999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=262.97 Aligned_cols=195 Identities=33% Similarity=0.510 Sum_probs=166.1
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchh
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 598 (732)
++||+|+||.||+|...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988765433 4567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee-ec
Q 040398 599 HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS-TR 677 (732)
Q Consensus 599 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~-~~ 677 (732)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.++|+|||.+........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998542 235788999999999999999999986 99999999999999999999999999875432111111 11
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
...+..|+|||.+.+..++.++|+|||||++|||+| |..||..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 223567999999988899999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=293.54 Aligned_cols=203 Identities=19% Similarity=0.279 Sum_probs=161.5
Q ss_pred HHhCCCcccceecccCceEEEEEEEc--CCeEEEEEEc--------------cc---ccccchHHHHHHHHHHhcCCCCc
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLL--------------SS---KSRQGNREFLNEIGTISCLQHPN 571 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~n 571 (732)
...++|++++.||+|+||.||+|..+ ++..+++|.+ .. ........+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35678999999999999999998754 2222222211 10 11123456789999999999999
Q ss_pred eeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGEN-SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 572 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
|+++++++.+++..++|+|++. ++|.+++..... .........+..++.||+.||+|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 577776644321 1223345667889999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNN 717 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P 717 (732)
+.++.+||+|||++...............||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999986654333333346799999999999999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=266.03 Aligned_cols=198 Identities=29% Similarity=0.428 Sum_probs=164.8
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 518 PMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
.+..||.|+||+|+|..++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..|+-||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3466999999999999876 799999999987654 5567888888765554 79999999999999999999999995
Q ss_pred CchhHHhhc-CCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 595 NSLAHALFG-GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 595 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
.||+.+... .......+++....+|+....+||+||-+.- +|||||+||+|||+|..|.+||||||.+..... +-
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 466653321 2334567899999999999999999998764 799999999999999999999999999865443 33
Q ss_pred eeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..+..+|...|||||.+.. ..++-++|||||||+|||+.||+.|+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 3445678899999999863 3488899999999999999999999864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=267.48 Aligned_cols=202 Identities=31% Similarity=0.563 Sum_probs=169.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe----EEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.+|++.+.||+|+||.||+|..+ +|+ .+|+|.+.... .....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999864 333 58999887553 3345678899999999999999999999987 78899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998542 335899999999999999999999985 999999999999999999999999999765
Q ss_pred CccCceee-ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 668 EEEKTHIS-TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
........ ....++..|+|||......++.++|+|||||++||+++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 43322211 11223568999999988889999999999999999998 999997533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=264.14 Aligned_cols=199 Identities=26% Similarity=0.356 Sum_probs=166.0
Q ss_pred HHHHHHHhCCCccccee--cccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 040398 506 LKQIRAATSNFDPMNKI--GEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIE 581 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~L--G~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 581 (732)
..+.....++|++.+.+ |+|+||.||+++.+ +++.+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 44555667788887776 99999999999875 788999999865422211 22222222 79999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEe
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISD 660 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~D 660 (732)
++..++||||+++++|.+++... ..+++..+..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999998532 37899999999999999999999986 99999999999999998 999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
||++....... ...++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99987543321 245888999999999888999999999999999999999999743
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=264.30 Aligned_cols=195 Identities=32% Similarity=0.493 Sum_probs=166.3
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEE-eCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI-EGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~~ 592 (732)
++|++.+.||+|+||.||++... |+.+|+|.+.... ..+.+.+|+.++++++|+|++++++++. +++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999765 7889999886432 3467899999999999999999999765 456789999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.... ...+++..+.+++.||+.||+|||+++ ++||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999985432 235789999999999999999999986 9999999999999999999999999987543221
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....++..|+|||+..+..++.++|||||||++|||++ |+.||..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12335568999999998889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=263.48 Aligned_cols=193 Identities=33% Similarity=0.509 Sum_probs=161.9
Q ss_pred ceecccCceEEEEEEEc--C--CeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT--D--GTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~--~--g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
++||+|+||.||+|.+. + +..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 26899999876543 34567899999999999999999999876 4567999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999543 26789999999999999999999986 9999999999999999999999999987554332221
Q ss_pred ee--cccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 675 ST--RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 675 ~~--~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.. ...++..|+|||...+..++.++|||||||++|||++ |+.||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 11 1123467999999998899999999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=266.27 Aligned_cols=197 Identities=32% Similarity=0.492 Sum_probs=170.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
-|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999875 68999999876442 233467889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998842 35789999999999999999999986 99999999999999999999999999875543221
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .....++..|+|||...+..++.++|+|||||++|+|++|+.||..
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 1 2234578899999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=298.52 Aligned_cols=198 Identities=31% Similarity=0.471 Sum_probs=163.3
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG----- 582 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 582 (732)
.+...+|+.++.||+||||.|||++++ ||+.||||++.... ........+|+..+.+++|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 467789999999999999999999998 99999999988663 33446688999999999999999998553300
Q ss_pred --------------------------------------------------------------------------------
Q 040398 583 -------------------------------------------------------------------------------- 582 (732)
Q Consensus 583 -------------------------------------------------------------------------------- 582 (732)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHH
Q 040398 583 ----------------------------------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628 (732)
Q Consensus 583 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~ 628 (732)
..+||-||||+..++.++++++.... .....++++++|++||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence 12578999999988888885543221 45778999999999999
Q ss_pred HHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC-----------------ccCceeeecccCccccccchhcc
Q 040398 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-----------------EEKTHISTRVAGTIGYMAPEYAL 691 (732)
Q Consensus 629 yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~APE~~~ 691 (732)
|+|++| +|||||||.||++|++..+||+|||+|.... .......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999997 9999999999999999999999999997511 00111334578999999999987
Q ss_pred cC---CCCCchhHHHHHHHHHHHHc
Q 040398 692 WG---YLTYKADVYSFGVVALEIVS 713 (732)
Q Consensus 692 ~~---~~~~k~DvwSlGvll~ellt 713 (732)
+. +|+.|+|+|||||+++||+.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc
Confidence 54 59999999999999999984
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=268.27 Aligned_cols=199 Identities=26% Similarity=0.454 Sum_probs=173.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|+..+.||+|++|.||+|..+ +++.+|+|++.... ....+++.+|++++++++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999886 68999999887653 34456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999985432 568899999999999999999999 65 999999999999999999999999988644322
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ...++..|+|||...+..++.++||||||+++|+|++|+.||...
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 156888999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=266.75 Aligned_cols=198 Identities=29% Similarity=0.527 Sum_probs=170.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCC---CCceeeeeeeEEeCCEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQ---HPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999874 7899999998754 3334567888999999986 999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998843 26889999999999999999999986 99999999999999999999999999876544
Q ss_pred cCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... .....|+..|+|||...+ ..++.++|+|||||++|+|++|+.||...
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 3322 223468889999998865 45788999999999999999999999653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=277.41 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=167.7
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC-C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG-D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 583 (732)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 357899999987543 23346788999999999 689999999988654 4
Q ss_pred EEEEEEEecCCCchhHHhhcCCC---------------------------------------------------------
Q 040398 584 QLMLVYEYLENNSLAHALFGGEN--------------------------------------------------------- 606 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (732)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998864211
Q ss_pred ------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce-eeeccc
Q 040398 607 ------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH-ISTRVA 679 (732)
Q Consensus 607 ------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~ 679 (732)
....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124688889999999999999999986 999999999999999999999999998754322111 111233
Q ss_pred CccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 680 gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5678999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=270.11 Aligned_cols=198 Identities=28% Similarity=0.400 Sum_probs=168.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc-----chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-----GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999875 6899999998754322 345677899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999985422 36899999999999999999999986 9999999999999999999999999987654
Q ss_pred ccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 43221 122346778999998864 4678999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.83 Aligned_cols=204 Identities=31% Similarity=0.507 Sum_probs=172.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCC------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------ 583 (732)
.+++|++.+.||+|++|.||+|..+ +++.+|+|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 678999999875543 346789999999999 6999999999997644
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988654434567899999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+......... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 8754332221 223458889999998753 3467899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=259.85 Aligned_cols=206 Identities=28% Similarity=0.395 Sum_probs=172.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc---C--CeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEe-CC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT---D--GTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIE-GD 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~---~--g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 583 (732)
....|+....||+|+||.||+|..+ + .+.+|+|.++.+.. .......+|+..++.++|||++.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4567889999999999999999543 2 23799999987633 334677899999999999999999999887 77
Q ss_pred EEEEEEEecCCCchhHHhhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC----CCeEE
Q 040398 584 QLMLVYEYLENNSLAHALFGGE-NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD----LNPKI 658 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL 658 (732)
.+++++||.+. +|..+++-++ .....++...+..|+.||+.|+.|||++= |+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999976 8888886542 23357899999999999999999999984 8899999999999877 88999
Q ss_pred EeeecceeCCccCcee--eecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 659 SDFGLAKLDEEEKTHI--STRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+|||+++++...-... ..+++-|++|.|||.+.+. .|+++.||||.|||+.||+|-++-|...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999765543322 2346679999999999986 6899999999999999999999888653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.85 Aligned_cols=202 Identities=26% Similarity=0.374 Sum_probs=170.2
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 588 (732)
....|+++++||+||.+.||++...+.+.||+|++... ..+....|.+|+..|.+++ |.+|+++++|-..++++|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 35578999999999999999999988899999976543 4456688999999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||| ...+|..+|..... ..+...++.+..||+.|+.++|++| |||.||||.|+|+-+. .+||+|||.|....
T Consensus 439 mE~-Gd~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MEC-GDIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQ 510 (677)
T ss_pred eec-ccccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccC
Confidence 995 46799999965432 2232378889999999999999997 9999999999998754 89999999998766
Q ss_pred ccCce-eeecccCccccccchhcccC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTH-ISTRVAGTIGYMAPEYALWG-----------YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~-~~~~~~gt~~y~APE~~~~~-----------~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
++... .....+||+.||+||.+... ++++++||||||||||+|+.|+.||...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 65443 34457899999999998521 3678999999999999999999999753
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=276.02 Aligned_cols=206 Identities=27% Similarity=0.435 Sum_probs=170.5
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
..+|++.+.||+|+||.||+|+.. .+..||+|.+.... ....+++.+|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 456888999999999999999742 12468999887543 33456789999999999 899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..+++|||+++|+|.+++.... .....+++..+..++.||++||+|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986432 12345889999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999998755432211 1112234567999999998899999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=265.91 Aligned_cols=199 Identities=30% Similarity=0.435 Sum_probs=168.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc----------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR----------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
+|...+.||+|+||.||+|... +|+.+|+|.+..... ...+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 689999998754211 11246788999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998543 46889999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCce-eeecccCccccccchhcccCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTH-ISTRVAGTIGYMAPEYALWGY--LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+......... ......|+..|+|||...... ++.++|+||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 8754322111 122345788999999987654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=262.82 Aligned_cols=200 Identities=38% Similarity=0.561 Sum_probs=170.1
Q ss_pred CcccceecccCceEEEEEEEcC-----CeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLTD-----GTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
+++.+.||+|+||.||+++..+ +..+|+|++...... ..+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998763 388999998765433 5678899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999854321 12899999999999999999999986 99999999999999999999999999976544
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
..........++..|+|||...+..++.++||||+|+++++|++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 32222112336789999999988889999999999999999998 7888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=263.21 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=172.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|+||.||+++.. +|+.||+|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999875 6899999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+.+... ....+++..+.+++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988532 2235788999999999999999999986 9999999999999999999999999987554322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....|+..|+|||+..+...+.++|+|||||++++|++|+.||..
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 21 2234588899999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=272.35 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=169.3
Q ss_pred CCcccceecccCceEEEEEEEc---CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 586 (732)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999875 47899999988633 34456778899999999999999999999988 8899
Q ss_pred EEEEecCCCchhHHhhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC----CCCeEEEee
Q 040398 587 LVYEYLENNSLAHALFGGEN-SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR----DLNPKISDF 661 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~Df 661 (732)
+||||+++ ++.+.+..... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643322 2347899999999999999999999986 999999999999999 899999999
Q ss_pred ecceeCCccCc--eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 662 GLAKLDEEEKT--HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 662 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
|++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99875433222 112234678899999988764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=266.41 Aligned_cols=190 Identities=30% Similarity=0.394 Sum_probs=157.4
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHH---hcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 521 KIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTI---SCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 68999999886432 12223344554433 34479999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999998843 346899999999999999999999986 99999999999999999999999999864432211
Q ss_pred eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....|+..|+|||...+ ..++.++||||+||++|||++|+.||..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 23468999999998864 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=264.49 Aligned_cols=189 Identities=31% Similarity=0.487 Sum_probs=159.4
Q ss_pred ceecccCceEEEEEEEcC-C----------eEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 520 NKIGEGGFGPVYKGQLTD-G----------TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~-g----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998763 3 25788877654333 6788999999999999999999999988 778999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-------CeEEEee
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-------NPKISDF 661 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kL~Df 661 (732)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999985432 26789999999999999999999986 99999999999999887 7999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
|++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 99875433 1123466789999998876 78999999999999999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=262.52 Aligned_cols=199 Identities=27% Similarity=0.434 Sum_probs=171.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+..+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 6889999988654 233456788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~~~~ 670 (732)
+++++|.+++.... ...+++..+.+++.++++||+|||+++ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999985422 345789999999999999999999986 99999999999998654 5899999998765432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 2 12234688899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.29 Aligned_cols=196 Identities=32% Similarity=0.521 Sum_probs=170.4
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...++.++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445578999999999999864 7899999988765555566788999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999998843 35788999999999999999999986 99999999999999999999999998764433221 1
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....|+..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 2234688999999999888899999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=266.83 Aligned_cols=192 Identities=31% Similarity=0.415 Sum_probs=165.1
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||.||+|..+ +|+.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68999999886432 22345677899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 998854322 36899999999999999999999986 9999999999999999999999999886543311 1123
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..++..|+|||...+..++.++||||+||++|+|++|+.||..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 4577899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=268.11 Aligned_cols=209 Identities=31% Similarity=0.509 Sum_probs=172.3
Q ss_pred cHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEe-
Q 040398 505 TLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIE- 581 (732)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 581 (732)
++.+.....+.|++.+.||+|+||.||+|+.. +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34444556778999999999999999999875 68999999986543 2345678899999998 69999999999853
Q ss_pred -----CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 582 -----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 582 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
.+..+++|||+++|+|.+++.... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 467899999999999999885432 235778889999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 9999999865432211 122356888999999875 34678899999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=265.14 Aligned_cols=200 Identities=28% Similarity=0.471 Sum_probs=169.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+|+..+.||+|++|.||+|+.. +|+.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999986 689999999876533 33466788999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++ +|.+++.... ....+++..+.+++.||++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888775432 2346899999999999999999999986 99999999999999999999999999865432211
Q ss_pred eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11234568899999988654 568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=258.22 Aligned_cols=199 Identities=37% Similarity=0.611 Sum_probs=175.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 789999999987655556789999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999885422 46899999999999999999999985 99999999999999999999999999876544321
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23356888999999998888999999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=268.92 Aligned_cols=191 Identities=37% Similarity=0.537 Sum_probs=157.9
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHh--cCCCCceeeeeeeEEeCC----EEEEEEE
Q 040398 517 DPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTIS--CLQHPNLVKLYGCCIEGD----QLMLVYE 590 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~~~~~~~~----~~~lv~e 590 (732)
+.++.+|+|.||.||||+.. ++.||||+|... ..+.|+.|-++.. .++|+||++++++-...+ +++||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45678999999999999987 489999999754 3456777766554 568999999999877655 8999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES------RFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
|.+.|||.++|. ...++|....+|+..|++||+|||+.- .+.|+|||||+.|||+..|+++.|+|||+|
T Consensus 289 fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999994 457899999999999999999999763 356999999999999999999999999999
Q ss_pred eeCCccCce-eeecccCccccccchhcccCC-CC-----CchhHHHHHHHHHHHHcCCC
Q 040398 665 KLDEEEKTH-ISTRVAGTIGYMAPEYALWGY-LT-----YKADVYSFGVVALEIVSGKN 716 (732)
Q Consensus 665 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~~-----~k~DvwSlGvll~elltG~~ 716 (732)
..+.+.... ..-..+||.+|||||++.+.. +. .+.||||+|.+||||++.-.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 766543322 122367999999999998652 22 36899999999999998643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=265.78 Aligned_cols=201 Identities=31% Similarity=0.539 Sum_probs=175.6
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++.|+..+.||+|++|.||+|..+ +++.+|+|++..... ..+.+.+|++++++++|+|++++++.+..++..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4667888899999999999999886 789999999876544 46778899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999995432 37899999999999999999999986 999999999999999999999999987644332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 21 11234578899999999888899999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=269.90 Aligned_cols=201 Identities=30% Similarity=0.550 Sum_probs=166.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCe----EEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|+..+.||+|+||.||+|++. +|. .+|+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999864 444 578898765432 3344788999999999999999999998764 467
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 899999999999988532 335788999999999999999999986 99999999999999999999999999976
Q ss_pred CCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5432221 1122345678999999998899999999999999999997 8999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=267.19 Aligned_cols=199 Identities=30% Similarity=0.477 Sum_probs=168.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+..+.||+|++|.||+|+.+ +|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999876 78999999886542 22346788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
++ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5888887543 2346889999999999999999999986 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......++..|+|||...+. .++.++|||||||++|||+||+.||..
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12233467899999988764 468899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=267.11 Aligned_cols=199 Identities=30% Similarity=0.430 Sum_probs=168.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 588 (732)
++|++.+.||+|+||.||+|..+ +++.+|+|.++... ......+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999986 68999999987542 22234577899999999999999999999887 889999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 898887542 236899999999999999999999986 9999999999999999999999999987554
Q ss_pred ccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||..
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 33211 1234578899999988754 468899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=266.49 Aligned_cols=202 Identities=26% Similarity=0.365 Sum_probs=167.1
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCE-----
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQ----- 584 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 584 (732)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999876 789999998765432 23467888999999995 6999999999887665
Q ss_pred EEEEEEecCCCchhHHhhcCCC-CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeee
Q 040398 585 LMLVYEYLENNSLAHALFGGEN-SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFG 662 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfG 662 (732)
.++||||+++ +|.+++..... ....+++..++.++.||++||+|||+.+ ++||||||+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78887754322 2456899999999999999999999986 999999999999998 8899999999
Q ss_pred cceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 98754322111 122356788999998865 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=267.05 Aligned_cols=193 Identities=31% Similarity=0.510 Sum_probs=168.1
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
..+||+|+||.||++... +++.||+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 356999999999999875 7899999998655555567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........ ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 998732 35788999999999999999999986 99999999999999999999999998864432211 1223
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..|+..|+|||...+..++.++|+||+|+++|+|++|+.||..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4688899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=265.25 Aligned_cols=198 Identities=34% Similarity=0.529 Sum_probs=164.8
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 520 NKIGEGGFGPVYKGQLTD-------GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~-------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+.||+|+||.||+|+.++ ++.+|+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 3679999876543 23456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-----CeEEEeeec
Q 040398 592 LENNSLAHALFGGEN---SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-----NPKISDFGL 663 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kL~DfGl 663 (732)
+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865322 2345789999999999999999999886 99999999999999887 899999999
Q ss_pred ceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 664 AKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 864432211 11112345678999999999999999999999999999998 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=262.03 Aligned_cols=191 Identities=25% Similarity=0.372 Sum_probs=166.9
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 58999999986532 23456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9998432 34789999999999999999999986 9999999999999999999999999987654432 1223
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 46888999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=258.66 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=177.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999876 689999999876533 4567789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998654434567899999999999999999999986 9999999999999999999999999987654432
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.......|++.|+|||...+..++.++|+||+|+++++|++|+.||...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346888999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=265.25 Aligned_cols=189 Identities=30% Similarity=0.447 Sum_probs=158.7
Q ss_pred ceecccCceEEEEEEEc-C-------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 520 NKIGEGGFGPVYKGQLT-D-------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~-------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+.||+|+||.||+|... . ...+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999764 2 234888887665555567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC--------eEEEeeec
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--------PKISDFGL 663 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kL~DfGl 663 (732)
+++|+|.++++.. ...+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998543 236789999999999999999999986 999999999999987765 59999998
Q ss_pred ceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCC-CCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGK-NNMS 719 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~-~P~~ 719 (732)
+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+.
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 7644321 224578899999998864 5789999999999999999995 5554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=261.00 Aligned_cols=194 Identities=29% Similarity=0.442 Sum_probs=157.8
Q ss_pred ceecccCceEEEEEEEc----CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEEEEEEecC
Q 040398 520 NKIGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLMLVYEYLE 593 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~ 593 (732)
+.||+|+||.||+|.+. ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2467999988643 23345678899999999999999999998764 556889999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc-
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT- 672 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~- 672 (732)
+++|.+++... ....++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998532 234577788899999999999999985 99999999999999999999999999875432211
Q ss_pred --eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcC-CCCCC
Q 040398 673 --HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG-KNNMS 719 (732)
Q Consensus 673 --~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG-~~P~~ 719 (732)
.......++..|+|||...+..++.++|||||||++|||++| ..||.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 111123456789999999888999999999999999999995 55554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=261.53 Aligned_cols=200 Identities=29% Similarity=0.483 Sum_probs=175.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|+||.||+++.+ +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 78899999987542 33456778999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998664444567899999999999999999999986 999999999999999999999999998765443
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||...+..++.++|+||||+++|||++|+.||..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12224578899999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=265.49 Aligned_cols=201 Identities=22% Similarity=0.240 Sum_probs=154.4
Q ss_pred hCCCcccceecccCceEEEEEEEcC----CeEEEEEEcccccccch-----------HHHHHHHHHHhcCCCCceeeeee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKSRQGN-----------REFLNEIGTISCLQHPNLVKLYG 577 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~ 577 (732)
.++|.+.+.||+|+||.||+|+..+ +..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4578899999999999999998753 45677776443322111 12233445566779999999998
Q ss_pred eEEeCC----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC
Q 040398 578 CCIEGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653 (732)
Q Consensus 578 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 653 (732)
.+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 776543 44678887643 56665522 223567888999999999999999986 9999999999999999
Q ss_pred CCeEEEeeecceeCCccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 654 LNPKISDFGLAKLDEEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 654 ~~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+.++|+|||+|+........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999754322111 112246999999999999999999999999999999999999999765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=264.13 Aligned_cols=198 Identities=29% Similarity=0.454 Sum_probs=168.7
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLVYE 590 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 590 (732)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999876 58999999988653 33446788999999999999999999999988 89999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888887432 246899999999999999999999986 999999999999999999999999998765543
Q ss_pred CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3222233456788999997765 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=262.94 Aligned_cols=191 Identities=30% Similarity=0.404 Sum_probs=157.9
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHH---HHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 521 KIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEI---GTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
.||+|+||.||+|+.. +++.||+|.+..... .....+..|. +.++...||+|+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 689999998865421 1122233443 34455689999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++. ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999884 2346899999999999999999999986 99999999999999999999999999864432211
Q ss_pred eeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 234689999999998754 6889999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.95 Aligned_cols=201 Identities=31% Similarity=0.460 Sum_probs=170.2
Q ss_pred CCCcccceecccCceEEEEEEEc-----CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQL 585 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 585 (732)
..|+..+.||+|+||.||+|+.. +++.+|+|++...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677889999999999999853 3789999998765443 46789999999999999999999999887 5678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999998543 235899999999999999999999986 9999999999999999999999999997
Q ss_pred eCCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......++..|+|||...+..++.++||||||+++|||+||+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 65432221 11122345679999999888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.96 Aligned_cols=197 Identities=25% Similarity=0.346 Sum_probs=167.9
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------ 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 582 (732)
..++|+..+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4678999999999999999999875 7899999998643 223345678899999999999999999988643
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 88887732 2788899999999999999999986 9999999999999999999999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9976543221 2234578899999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.92 Aligned_cols=198 Identities=29% Similarity=0.458 Sum_probs=167.2
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
|++.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999875 79999999887543 223467889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+ ++|.+++.... ...+++..+.+++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68998885432 136899999999999999999999985 99999999999999999999999999875432221
Q ss_pred eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223467899999987654 578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.30 Aligned_cols=199 Identities=28% Similarity=0.429 Sum_probs=166.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 585 (732)
+++|++.+.||+|+||.||+|+.. +|+.||+|++.... .....++.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 568999999999999999999865 78999999986432 23456688899999999999999999987654 357
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++|+||+++ +|.+.+. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 999999965 7877763 236899999999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCce--eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTH--ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 54332211 1223568899999998754 4688999999999999999999999953
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=265.47 Aligned_cols=195 Identities=32% Similarity=0.498 Sum_probs=166.2
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++.+++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999876 68999999886432 223457889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||++ |++.+.+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5777766322 235899999999999999999999986 99999999999999999999999999875543
Q ss_pred cCceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ...++..|+|||++. ...++.++||||||+++|||+||+.||..
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 21 245788999999874 35688899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.11 Aligned_cols=189 Identities=29% Similarity=0.388 Sum_probs=159.5
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHH-HhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGT-ISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999875 689999999865322 222334455444 4455899999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999843 235789999999999999999999986 99999999999999999999999998875432
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 1234578899999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=262.90 Aligned_cols=200 Identities=30% Similarity=0.429 Sum_probs=166.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|++|.||+|+.+ +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999876 78999999886542 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCCc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEE 669 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~~ 669 (732)
|++ ++|.+.+... ....+++..+..++.||+.||+|||+++ ++|+||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 4787776432 2234678888999999999999999986 999999999999985 45799999999875432
Q ss_pred cCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......++..|+|||++.+ ..++.++||||+||++|+|+||+.||..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 211 1223457889999998866 4578999999999999999999999964
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=259.85 Aligned_cols=194 Identities=30% Similarity=0.488 Sum_probs=165.0
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999875 57889999886532 346788999999999999999999998654 4789999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999998543 2335789999999999999999999986 9999999999999999999999999987543221
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 12234568999999988899999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-31 Score=302.45 Aligned_cols=199 Identities=34% Similarity=0.443 Sum_probs=168.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|.....||.|.||.||-|... +|...|+|-+... .....+...+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 4556678999999999999864 7999999977654 234456788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|++|+|.+.+.. ..-.++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999998832 233566667778899999999999997 9999999999999999999999999997654432
Q ss_pred c---eeeecccCccccccchhcccC---CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 T---HISTRVAGTIGYMAPEYALWG---YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~---~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .......||+.|||||++.+. ....++|||||||+++||.||+.||..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 1 112246799999999999864 355689999999999999999999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=260.86 Aligned_cols=192 Identities=31% Similarity=0.449 Sum_probs=166.1
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||.||+++.. +|+.+|+|++..... ...+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 589999999875432 3456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc-----
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT----- 672 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~----- 672 (732)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998532 36899999999999999999999986 99999999999999999999999999865432211
Q ss_pred --eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 --HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 --~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.......++..|+|||.......+.++||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 112234578899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=267.00 Aligned_cols=200 Identities=34% Similarity=0.465 Sum_probs=166.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 587 (732)
.++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999875 689999999865432 2234567899999999999999999998765 56899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.++|+|||.+...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 788877432 246899999999999999999999986 999999999999999999999999998765
Q ss_pred CccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 432211 122345778999998865 4678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=265.66 Aligned_cols=203 Identities=29% Similarity=0.437 Sum_probs=169.0
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD---- 583 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 583 (732)
.+.++|++.+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45778999999999999999999986 68999999987542 233456788999999999999999999987655
Q ss_pred ------EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeE
Q 040398 584 ------QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657 (732)
Q Consensus 584 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 657 (732)
..++|+||+++ ++.+.+... ...+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999986 676666332 346899999999999999999999986 99999999999999999999
Q ss_pred EEeeecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 658 ISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 658 L~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+|||.+...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987654333222223346778999998765 3578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=259.94 Aligned_cols=200 Identities=25% Similarity=0.438 Sum_probs=171.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+..+.||+|+||.||++..+ +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999876 68899999886532 23446788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-eEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-PKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kL~DfGla~~~~~~ 670 (732)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988542 2235789999999999999999999986 999999999999998864 699999998755432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......|++.|+|||+..+..++.++|+|||||+++||++|+.||..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 22234588899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=255.77 Aligned_cols=198 Identities=32% Similarity=0.502 Sum_probs=173.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++.+++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 678999999876543 4456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988432 56899999999999999999999986 9999999999999999999999999997654433
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2234678899999998887889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=255.10 Aligned_cols=200 Identities=35% Similarity=0.468 Sum_probs=174.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLVY 589 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 589 (732)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 789999999876542 4467889999999999999999999999988 8999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998432 27899999999999999999999986 99999999999999999999999999876554
Q ss_pred cCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ......++..|+|||...+...+.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3321 122356888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=259.52 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=165.0
Q ss_pred CcccceecccCceEEEEEEEc----CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 583 (732)
|.+.+.||+|+||.||+|.+. +++.+|+|++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999753 46889999987542 334567889999999999999999999887542
Q ss_pred EEEEEEEecCCCchhHHhhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 584 QLMLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
..++++||+++|+|.+++.... .....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875322 22345789999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 662 GLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|.++........ ......++..|++||......++.++|||||||++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 998754332211 1122345678999999998889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=253.79 Aligned_cols=196 Identities=23% Similarity=0.279 Sum_probs=164.8
Q ss_pred HhCCCccc-ceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEe----CCE
Q 040398 512 ATSNFDPM-NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIE----GDQ 584 (732)
Q Consensus 512 ~~~~f~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~ 584 (732)
.+++|.+. ++||-|-.|.|-.+..+ +|+++|+|++... ....+|++..-.. .|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46677663 68999999999999876 7999999998654 3346788876665 69999999999875 356
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEee
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDF 661 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~Df 661 (732)
+.+|||.|+||.|.+.+.+. ....+++.++..|+.||+.|++|||+.. |.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 78999999999999999553 3346899999999999999999999984 999999999999964 456999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|.|+..... ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||=
T Consensus 209 GFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 209 GFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999865542 22334678999999999999999999999999999999999999994
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=270.08 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=169.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
-|..++.||-|+||.|.+++.. +...||+|.+.+.. +......+.|-.||...+.+-||++|..|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4667788999999999999754 57889999887542 2334456789999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee----
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---- 666 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~---- 666 (732)
|++||++-.+|.+ ...|.+..++-++..+..|+++.|+.| +|||||||+|||||.+|++||.|||++.-
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999998743 346788889999999999999999987 99999999999999999999999999841
Q ss_pred -----CCccCc-----------------e---------------eeecccCccccccchhcccCCCCCchhHHHHHHHHH
Q 040398 667 -----DEEEKT-----------------H---------------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVAL 709 (732)
Q Consensus 667 -----~~~~~~-----------------~---------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ 709 (732)
+...+- . ..-..+||+.|+|||++....++.-+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 110000 0 001146999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 040398 710 EIVSGKNNMSYVP 722 (732)
Q Consensus 710 elltG~~P~~~~~ 722 (732)
||+.|+.||-...
T Consensus 863 em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT 875 (1034)
T ss_pred HHhhCCCCccCCC
Confidence 9999999997543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=282.75 Aligned_cols=200 Identities=32% Similarity=0.539 Sum_probs=172.4
Q ss_pred CcccceecccCceEEEEEEEc-C---CeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-D---GTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..+.++||.|.||.||+|+++ . ...||+|.++.. ......+|+.|..||.+++||||+++.|+........+|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 345689999999999999876 2 356999999875 34456789999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||++|+|+.+|+.. ...+++.+..-+.++||.|++||-+.+ +|||||..+|||++.+..+|++|||+++..+++
T Consensus 711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999643 456899999999999999999999875 999999999999999999999999999977655
Q ss_pred CceeeecccC--ccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 671 KTHISTRVAG--TIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.....+..-| +.+|.|||.+...+++.++||||+||+|||.++ |..|+=.+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 4332222222 468999999999999999999999999999665 99997543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=264.28 Aligned_cols=193 Identities=31% Similarity=0.495 Sum_probs=164.8
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
|+..+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 677889999999999999875 68999999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++ ++.+.+... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 777766432 345899999999999999999999986 999999999999999999999999988654332
Q ss_pred ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2245788999999874 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.72 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=173.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 588 (732)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++ ||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999876 7899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999843 236899999999999999999999986 9999999999999999999999999987543
Q ss_pred ccCc-------------------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKT-------------------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .......++..|+|||......++.++|+||||++++++++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 112234578899999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=268.96 Aligned_cols=204 Identities=27% Similarity=0.393 Sum_probs=171.4
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEE
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCI 580 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 580 (732)
...+++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345667778899999999999999999999864 78999999987532 223466788999999999999999999886
Q ss_pred eC------CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 581 EG------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 581 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
.. ...+++++++ +++|.+++.. ..+++..++.++.||++||+|||+.+ ++||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 43 3467888877 7799887732 35889999999999999999999986 99999999999999999
Q ss_pred CeEEEeeecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.++|+|||++...... .....++..|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998754321 123457889999998766 4688899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=262.94 Aligned_cols=199 Identities=28% Similarity=0.417 Sum_probs=168.1
Q ss_pred CCcccceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
+|++.+.||+|++|.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 257889999886432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998843 345789999999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhcccCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGY--LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..............|+..|+|||...+.. .+.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 54433222223346888999999987654 78899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=259.67 Aligned_cols=195 Identities=29% Similarity=0.398 Sum_probs=162.1
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCC-CCceeeeeeeEEeC--CEEEEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEG--DQLMLVYE 590 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e 590 (732)
|++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999875 68999999987542 222334557888888885 99999999999987 88999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|++ +++.+.+... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 4787777432 246899999999999999999999986 999999999999999 99999999998755332
Q ss_pred CceeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....++..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 22 12345788999999765 45678899999999999999999999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=263.65 Aligned_cols=201 Identities=31% Similarity=0.451 Sum_probs=164.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+..+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999876 68999999887543 334567889999999996 99999999999999999999999
Q ss_pred cCCCchhHHhhc-CCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFG-GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
++. ++.++... .......+++..+.+++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55543311 1122356899999999999999999999752 4999999999999999999999999998644322
Q ss_pred CceeeecccCccccccchhcccC---CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWG---YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....|+..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 11 1234588899999998766 688999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=264.52 Aligned_cols=203 Identities=30% Similarity=0.444 Sum_probs=169.8
Q ss_pred hCCCcccceecccCceEEEEEEE-cCCeEEEEEEccccccc-------chHHHHHHHHHHhcCCCCceeeeeeeEEe-CC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQ-------GNREFLNEIGTISCLQHPNLVKLYGCCIE-GD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 583 (732)
.++|-.+..||+|||+.||+|-+ ...+.||||+-...... ..+...+|.++.+.++||-||++|+|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34577789999999999999965 46789999985443221 12446789999999999999999999864 56
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEe
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISD 660 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~D 660 (732)
.++-|+|||+|.+|+-+|+. ..-+++.+++.|+.||+.||.||.+. .++|||-||||.|||+-.. |.+||.|
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 78999999999999999943 44689999999999999999999987 4789999999999999544 7899999
Q ss_pred eecceeCCccCce------eeecccCccccccchhcccC----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTH------ISTRVAGTIGYMAPEYALWG----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||++++++.+... ...-..||.+|++||.+.-+ +++.|.||||+|||+|+++.|+.||..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 9999987654332 33446799999999987643 578899999999999999999999975
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=269.31 Aligned_cols=209 Identities=32% Similarity=0.502 Sum_probs=178.4
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEcC---C--eEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEE
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTD---G--TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~---g--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 580 (732)
+++....+..+..++||+|-||.||+|.+.+ | -.||||.-+.. ..+..+.|.+|..++++++||||++++|.|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3444455555566889999999999998643 3 35888987764 4455788999999999999999999999997
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
+ ...|+|||.++-|.|..++.. ....++......++.||+.||.|||+. ++|||||..+|||+....-+||+|
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred c-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 6 568999999999999999954 345688889999999999999999998 599999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
||+++..+.+.....++..-++.|||||.+....++.++|||-|||.+||++. |..||....
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 99999887766655555556789999999999999999999999999999776 899998644
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=264.36 Aligned_cols=202 Identities=30% Similarity=0.425 Sum_probs=165.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----- 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 583 (732)
..++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457899999999999999999876 68999999886432 223345678999999999999999999987654
Q ss_pred ---EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 584 ---QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 584 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
..++||||+.+ +|.+.+.. ....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 45999999965 78877743 2236899999999999999999999986 99999999999999999999999
Q ss_pred eecceeCCccCc---eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKT---HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||.+........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999875433221 112234578899999988664 478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=270.52 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=174.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCC-eEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDG-TIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g-~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+++.+..||-|+||.|-.++.+.. ..+|+|++++. .....+....|-.+|...+.|.||++|..|.++.++|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34555667799999999999987643 34899988764 333455677899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||-|-||.++..++ .+..++....+-++..+++|++|||.++ ||+|||||+|.++|.+|-+||.|||.|+...
T Consensus 499 mEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999994 4556788888899999999999999996 9999999999999999999999999998776
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
...... .++||+.|.|||++.++..+..+|.|||||++|||++|.+||...
T Consensus 572 ~g~KTw--TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 572 SGRKTW--TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred cCCcee--eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 544433 489999999999999999999999999999999999999999853
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.35 Aligned_cols=197 Identities=30% Similarity=0.457 Sum_probs=169.2
Q ss_pred ccceecccCceEEEEEEEc--CCe--EEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 518 PMNKIGEGGFGPVYKGQLT--DGT--IIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~--~g~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
..++||+|.||+|++|.|. +|+ .||||.+...... ...+|.+|+.+|.+++|||++++||+..+ ....+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3478999999999999886 454 4899999876443 67899999999999999999999999887 7788999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+.|||.+.|+. .....+.......++.|||.||.||..++ .|||||..+|+|+-..-.+||+|||+.+-+.....
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999976 34556778888999999999999999985 99999999999999998999999999987654433
Q ss_pred e--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 H--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
. +.....-.+.|+|||.+....++.++|||+|||++||||| |+.||-.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 2 2222334668999999999999999999999999999998 6778864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=258.73 Aligned_cols=193 Identities=33% Similarity=0.470 Sum_probs=157.9
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhc--CCCCceeeeeeeEEeC----CEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISC--LQHPNLVKLYGCCIEG----DQL 585 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~ 585 (732)
...+....+.||+|.||.||+|+++ |+.||||+|.... ++.+.+|.++.+. ++|+||+.+++.-..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4456678899999999999999998 8999999997543 3556777777766 4999999999875543 368
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-----ESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
|||.+|.+.|||+|+|. ...++.....+++..+|.||+|||. +|.+.|.|||||+.|||+..++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 99999999999999993 4578889999999999999999995 4667899999999999999999999999
Q ss_pred eecceeCCccCce---eeecccCccccccchhcccCC------CCCchhHHHHHHHHHHHHc
Q 040398 661 FGLAKLDEEEKTH---ISTRVAGTIGYMAPEYALWGY------LTYKADVYSFGVVALEIVS 713 (732)
Q Consensus 661 fGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~~~k~DvwSlGvll~ellt 713 (732)
+|+|-........ .....+||.+|||||++...- .-..+||||||.++||+..
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999654443222 123457999999999885321 1136899999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=268.34 Aligned_cols=200 Identities=25% Similarity=0.396 Sum_probs=167.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 585 (732)
..+|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468899999999999999999875 68999999987542 2345677889999999999999999998763 3568
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 589888843 345899999999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCc---eeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT---HISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 5432211 11223468889999998765 4688999999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=267.32 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=166.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC--CEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG--DQL 585 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~ 585 (732)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567889999999999999999876 6899999987542 223345677899999999 999999999998754 368
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 589888843 16788899999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCc----eeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT----HISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 5433221 12234568899999998764 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=266.73 Aligned_cols=194 Identities=26% Similarity=0.416 Sum_probs=163.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 583 (732)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999875 78999999886532 22345688999999999999999999998754 2
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++|+||+.. +|.++. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 676655 125788999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 87543221 23457889999998876 4688999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.98 Aligned_cols=197 Identities=30% Similarity=0.443 Sum_probs=168.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
|++.+.||+|++|.||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567788999999999999875 789999998875433 24567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++ ++.+.+... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 888877432 247899999999999999999999986 9999999999999999999999999987655433
Q ss_pred eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 112234578899999998776 789999999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=266.66 Aligned_cols=199 Identities=28% Similarity=0.441 Sum_probs=167.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 584 (732)
..+|.+.+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999875 7899999988753 233345678899999999999999999988654 35
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68888874 2346899999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 7654322 12223457889999998764 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.77 Aligned_cols=197 Identities=25% Similarity=0.389 Sum_probs=167.2
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD---- 583 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 583 (732)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35778999999999999999999865 78999999886432 223456889999999999999999999987643
Q ss_pred --EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 584 --QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 584 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
..++||||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 468999999 6799888732 35889999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9987543321 23457889999998875 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=265.85 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=170.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----EEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-----QLM 586 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 586 (732)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999976 58999999987643 344577899999999999999999999988775 789
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
++|||++ ++|.+++.. ...+++..++.++.||++||+|||+.+ ++||||||+||++++++.++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 488888843 237899999999999999999999986 99999999999999999999999999976
Q ss_pred CCccCc--eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKT--HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 544321 112234578899999999887 889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.50 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=164.5
Q ss_pred hCCCcc-cceecccCceEEEEEEEc-CCeEEEEEEcccccccc--------------hHHHHHHHHHHhcCCCCceeeee
Q 040398 513 TSNFDP-MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG--------------NREFLNEIGTISCLQHPNLVKLY 576 (732)
Q Consensus 513 ~~~f~~-~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~ 576 (732)
.++|.. .+.||+|+||.||+|+.. +++.||+|++....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345554 467999999999999876 78999999886532211 12577899999999999999999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
+++..++..++||||++ ++|.+++. ....+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999997 58988883 2345889999999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccC-------------ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 657 KISDFGLAKLDEEEK-------------THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999987544110 0111123467889999988764 468899999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=248.07 Aligned_cols=202 Identities=27% Similarity=0.419 Sum_probs=175.7
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
..+|+.+.+||+|+|+.|..++++ +.+.||+|+++++ ..++.+-.+.|-.+..+. +||.+|-++..|.++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 568999999999999999999875 7899999998864 233445566777777766 79999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|.||++||+|--++ ..+..++++.++-+...|+-||.|||+.| ||+||||..|+|+|.+|++||.|||+++--
T Consensus 329 vieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999987655 34557899999999999999999999997 999999999999999999999999998743
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
-.+. .....++||+.|+|||++.+..|....|+|+|||+|+||+.|+.||+-..
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 3222 23456899999999999999999999999999999999999999998543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=304.56 Aligned_cols=222 Identities=34% Similarity=0.542 Sum_probs=142.5
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+.+.+|..++++++|++|+|++|.+.+.+|..+..+ +|++|+|++|++.+.+|..++++++|++|+|++|++++.+|..
T Consensus 152 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 231 (968)
T PLN00113 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231 (968)
T ss_pred ccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChh
Confidence 345566666666666666666666666666666555 5666666666666666666666666666666666666666666
Q ss_pred ccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCC
Q 040398 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 163 (732)
++++++|++|+|++|++++.+|..+.++++|+.|++++|.+++.+|..+.++++|+.|+|++|.+++.+|..+.++++|+
T Consensus 232 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 311 (968)
T PLN00113 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311 (968)
T ss_pred HhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCc
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred eeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 164 QLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 164 ~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
.|++++|.+.+..+..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|+
T Consensus 312 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred EEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 666666666666566666666666666666666666666666666666666666666666554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=263.54 Aligned_cols=198 Identities=27% Similarity=0.419 Sum_probs=167.6
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQL 585 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 585 (732)
...+++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999866 7899999987643 22335678899999999999999999999876 5678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++++||+ +++|.+++.. .++++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5689888742 35788888999999999999999986 9999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 543211 22457789999998765 5789999999999999999999999954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=262.50 Aligned_cols=201 Identities=31% Similarity=0.459 Sum_probs=164.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeC-------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEG------- 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 582 (732)
.++|++.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999876 689999998865422 2235678899999999999999999987543
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 583 -DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
...++||||+.+ ++...+.. ....+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 67666643 2346899999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCce----------eeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTH----------ISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++......... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 998754322111 11223567889999987654 578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=259.80 Aligned_cols=200 Identities=29% Similarity=0.492 Sum_probs=164.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|.++ +++.||||+++... .....++.+|++++.+. .||||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 467888999999999999999987 48999999987543 23345667777766666 4999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++ ++.+.+.. ....+++..+..++.||++||+|||+.. +++||||+|+||++++++.++|+|||++.....
T Consensus 94 e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 67766532 1236899999999999999999999742 499999999999999999999999999865433
Q ss_pred cCceeeecccCccccccchhcccCC----CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGY----LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 221 12335778999999987543 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=255.70 Aligned_cols=197 Identities=32% Similarity=0.469 Sum_probs=164.1
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcC---CCCceeeeeeeEEeCCE-----
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCL---QHPNLVKLYGCCIEGDQ----- 584 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 584 (732)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 589999999875422 2234566777766655 69999999999998776
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.+++|||+++ +|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 8888875432 235899999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ .....++..|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 76543221 1223478899999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=257.78 Aligned_cols=193 Identities=32% Similarity=0.496 Sum_probs=163.6
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999875 689999999864322 2335678899999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+. +++.+.+.. ....+++..+..++.||+.|++|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 577776643 2345889999999999999999999986 999999999999999999999999988643221
Q ss_pred ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2346888999999874 45688899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=262.70 Aligned_cols=196 Identities=22% Similarity=0.355 Sum_probs=160.5
Q ss_pred ceeccc--CceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEG--GFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G--~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
..||+| +||.||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 89999999875 79999999987542 23346788999999999999999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
+++.+++.... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999885532 235789999999999999999999986 9999999999999999999999998653221111100
Q ss_pred ------eecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 ------STRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ------~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0112345679999998764 478999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.64 Aligned_cols=199 Identities=29% Similarity=0.410 Sum_probs=165.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC---------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--------- 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------- 582 (732)
..+|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999875 6899999998766555667789999999999999999999776543
Q ss_pred -----CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCe
Q 040398 583 -----DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNP 656 (732)
Q Consensus 583 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~ 656 (732)
...++||||++ ++|.+.+.. ..+++..++.++.||+.||+|||+.+ ++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 588887732 35789999999999999999999986 999999999999985 4578
Q ss_pred EEEeeecceeCCccCce--eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTH--ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+++|||.+......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998765332211 1122357889999997654 5688899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=227.93 Aligned_cols=197 Identities=27% Similarity=0.437 Sum_probs=165.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+|+-.++||+|.||+||+|+.. +++.||+|+.+.. .........+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999875 6899999987654 333456789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|.. +|..+. ..-+..++.+.++.++.|+++||.++|++. +.|||+||.|.|++.+|++|++|||+++...-.-
T Consensus 83 cdq-dlkkyf---dslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 954 676665 234567889999999999999999999984 9999999999999999999999999998654432
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.. ...-+-|.+|.+|.++.+. -|+...|+||-||++.|+.....|..
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 22 2234568899999999887 47888999999999999987555543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=255.69 Aligned_cols=197 Identities=29% Similarity=0.441 Sum_probs=166.2
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEec
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
|++.+.||+|++|.||+|... +++.||+|++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 578999998865432 22334567999999999 999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+++|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789998885432 246799999999999999999999986 99999999999999999999999999875543222
Q ss_pred eeeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++..|+|||++. ...++.++|+||||++++||++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 12345788999999875 44678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=264.49 Aligned_cols=208 Identities=26% Similarity=0.447 Sum_probs=177.6
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
++++....+....++||.|-||.||.|.|+ -.-.||||.++.... ..++|+.|..+|+.++|||+|+++++|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 334444445556789999999999999987 357799999986543 368899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
|||.|||..|+|.++|++. ++..++....+.+|.||+.|++||..+. +|||||..+|.|+.++..+||+|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999654 3445777888999999999999999884 9999999999999999999999999999
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
++..+.........-.+.|.|||-+....++-|+|||+|||+|||+.| |-.|+-.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 887755544333344678999999999999999999999999999988 6667754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=249.04 Aligned_cols=192 Identities=31% Similarity=0.413 Sum_probs=166.8
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
||+|+||.||++... +++.+|+|++..... .....+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 589999999875432 2456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeec
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~ 677 (732)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 999843 235889999999999999999999985 99999999999999999999999999876543221 1234
Q ss_pred ccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 678 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..++..|+|||...+...+.++|+||||+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 56788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=261.01 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=162.9
Q ss_pred CCcccceecccCceEEEEEEEc-C--CeEEEEEEccccc--ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC----CE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-D--GTIIAVKLLSSKS--RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG----DQ 584 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~--g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 584 (732)
+|++.+.||+|+||.||+++.. + ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999875 4 7899999886532 22356788899999999 599999999875432 45
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++++||++ ++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 689888843 346889999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCce---eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTH---ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......... ......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 754332111 1223568899999998765 4688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=267.53 Aligned_cols=196 Identities=27% Similarity=0.398 Sum_probs=165.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.+++|+....+|.|+|++|-.+... +++..|||++..... .-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4778888899999999999999865 689999999986622 234466555555 7999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE-cCCCCeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kL~DfGla~~~~ 668 (732)
|++.++-+.+.+... ..+. .++..|+.+|+.|++|||.+| ||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888777322 2223 677789999999999999997 9999999999999 588999999999998665
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPD 723 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~~ 723 (732)
.. ....+-|..|.|||+.....+++.+|+||||++||+||+|+.||...|.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 54 1223457799999999988999999999999999999999999987654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=258.90 Aligned_cols=195 Identities=21% Similarity=0.243 Sum_probs=158.2
Q ss_pred eecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchh
Q 040398 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 598 (732)
.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+++..+++|||+++++|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444444444433 6899999998754 3345578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc------
Q 040398 599 HALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT------ 672 (732)
Q Consensus 599 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~------ 672 (732)
+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9985432 235788999999999999999999986 99999999999999999999999998864322111
Q ss_pred eeeecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.......++..|+|||++... .++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 111223467789999998753 5788999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=252.99 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=167.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-----cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-----SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+|.+.+.||+|+||.||+++.. .+..+++|+.+.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999875 3455666665432 122334577899999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988654445567899999999999999999999986 999999999999976 469999999987653
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......|+..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3222 22234578899999999888889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=257.57 Aligned_cols=194 Identities=31% Similarity=0.484 Sum_probs=164.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++..++..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667788999999999999876 6889999987642 22334568889999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+. |++.+.+... ...+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 5787766432 235789999999999999999999986 999999999999999999999999998754432
Q ss_pred CceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2345788999999874 35678899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=253.89 Aligned_cols=197 Identities=32% Similarity=0.473 Sum_probs=168.5
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999876 58999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999885422 46899999999999999999999986 99999999999999999999999999875543222
Q ss_pred eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 11223457789999998766 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=279.97 Aligned_cols=146 Identities=27% Similarity=0.433 Sum_probs=130.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|.+.++||+|+||.||+|++. +++.||+|++.... ......+.+|+.++..++||||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999986 78999999987532 22346788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998532 35788899999999999999999986 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=263.50 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=167.8
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE---
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ--- 584 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--- 584 (732)
...++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35778999999999999999999986 6889999998653 22334567789999999999999999998876654
Q ss_pred ---EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 585 ---LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 585 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699998842 46899999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 998754332 123457889999998865 3678999999999999999999999963
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=246.51 Aligned_cols=181 Identities=25% Similarity=0.230 Sum_probs=153.6
Q ss_pred cCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhc
Q 040398 525 GGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG 603 (732)
Q Consensus 525 G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 603 (732)
|.+|.||++++. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 78999999987543 233455555566799999999999999999999999999999998843
Q ss_pred CCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccc
Q 040398 604 GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683 (732)
Q Consensus 604 ~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~ 683 (732)
...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 235889999999999999999999986 9999999999999999999999999876443321 22345678
Q ss_pred cccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 684 YMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 684 y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|+|||...+..++.++||||+|+++|||++|+.|+...
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 99999998888899999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=266.66 Aligned_cols=203 Identities=32% Similarity=0.526 Sum_probs=174.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEe-----CCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIE-----GDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~ 584 (732)
-++.|++.+.+|.|.+|.||+++.. +++..|+|+...... ..+++..|.++++.. .|||++.++++|.- ++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3667889999999999999999865 789999999875543 346677888999888 69999999999874 578
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
+|||||||.+||.-|+++... ...+.|..+..|++.++.|+.+||.. .++|||||=.|||++.++.+||+|||.+
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeee
Confidence 999999999999999997654 67899999999999999999999987 5999999999999999999999999998
Q ss_pred eeCCccCceeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
...+.... .....+||+.|||||++.- ..|+.++|+|||||+..||--|.+|+..+
T Consensus 171 aQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 171 AQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 75543222 2334689999999999863 34777899999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=265.51 Aligned_cols=205 Identities=22% Similarity=0.266 Sum_probs=154.6
Q ss_pred HhCCCcccceecccCceEEEEEEE-----------------cCCeEEEEEEcccccccchHH--------------HHHH
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQL-----------------TDGTIIAVKLLSSKSRQGNRE--------------FLNE 560 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~E 560 (732)
..++|++.++||+|+||.||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 477899999999999999999963 235689999986543322222 3446
Q ss_pred HHHHhcCCCCce-----eeeeeeEEe--------CCEEEEEEEecCCCchhHHhhcCCC--------------------C
Q 040398 561 IGTISCLQHPNL-----VKLYGCCIE--------GDQLMLVYEYLENNSLAHALFGGEN--------------------S 607 (732)
Q Consensus 561 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 607 (732)
+.++.+++|.++ ++++++|.. ++..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 3568999999999999999864211 1
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccc
Q 040398 608 QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687 (732)
Q Consensus 608 ~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~AP 687 (732)
...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123577889999999999999999986 99999999999999999999999999865433221111122347899999
Q ss_pred hhcccCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCC
Q 040398 688 EYALWGYL----------------------TYKADVYSFGVVALEIVSGKN-NMS 719 (732)
Q Consensus 688 E~~~~~~~----------------------~~k~DvwSlGvll~elltG~~-P~~ 719 (732)
|.+..... ..+.||||+||++|||++|.. |+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 98754321 124699999999999999986 664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=259.50 Aligned_cols=197 Identities=24% Similarity=0.341 Sum_probs=166.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc----cc----hHHHHHHHHHHhcCC---CCceeeeeeeE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR----QG----NREFLNEIGTISCLQ---HPNLVKLYGCC 579 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~----~~----~~~~~~E~~~l~~l~---H~nIv~l~~~~ 579 (732)
...+|..++.+|+|+||.|+.|.++ +...|++|.+.++.- .. .-..--|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457899999999999999999887 567889997765321 11 112345899999887 99999999999
Q ss_pred EeCCEEEEEEEecC-CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 580 IEGDQLMLVYEYLE-NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 580 ~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
++++++|++||-.. +-+|.+++ .-...+++.++.-|++||+.|+++||++| |||||||-+|+.++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 99999999999764 34888888 45667899999999999999999999997 999999999999999999999
Q ss_pred EeeecceeCCccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCC
Q 040398 659 SDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~ 718 (732)
+|||.|.+.... ....++||.+|.|||++.+.+| ...-|||++||+||.++....||
T Consensus 712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999998765442 2345789999999999998765 55679999999999999999887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=233.26 Aligned_cols=199 Identities=36% Similarity=0.514 Sum_probs=171.2
Q ss_pred CcccceecccCceEEEEEEEcC-CeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 516 FDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999874 899999999866544 56788999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+++|.+++..... .+++..+..++.++++++.+||+.+ ++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999854321 1788999999999999999999985 999999999999999999999999998766543211
Q ss_pred eeecccCccccccchhc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYA-LWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12234577899999988 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=242.45 Aligned_cols=196 Identities=28% Similarity=0.385 Sum_probs=165.2
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CEEEEE
Q 040398 517 DPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQLMLV 588 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv 588 (732)
+..+.||-|+||+||.+.+. +|+.||.|++... +-...+++.+|+++|.-++|.|++..++...-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999999875 8999999998653 223467899999999999999999988876543 246788
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
.|.|.. +|+.++ -....++...+.-+..||++||+|||+.+ |.||||||.|.|++.+..+||||||+|+..+
T Consensus 136 TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 898854 788776 45567888899999999999999999985 9999999999999999999999999999776
Q ss_pred ccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+.....+.-+-|-+|.|||++.+. .|+...||||+|||+.|++..+--|+.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 6555444444567899999999976 789999999999999999988877764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=263.80 Aligned_cols=199 Identities=33% Similarity=0.509 Sum_probs=170.4
Q ss_pred ccceecccCceEEEEEEE-cCC----eEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 518 PMNKIGEGGFGPVYKGQL-TDG----TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~-~~g----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..++||+|+||.||+|.+ ..| -.||+|++... ..+..+++.+|+-+|.+++|||++|++++|.... ..||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 457899999999999975 334 36899987654 4556789999999999999999999999998876 7899999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|+.|+|.|+++.+ +..+-....+.|..|||+||.|||++. ++||||..+|||+.+..++|+.|||+++....+.
T Consensus 779 mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999654 445677888999999999999999884 9999999999999999999999999999877665
Q ss_pred ceeeec-ccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 040398 672 THISTR-VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVPD 723 (732)
Q Consensus 672 ~~~~~~-~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~~ 723 (732)
...... ..-.+.|||=|.+....++.++|||||||++||++| |..|++.++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 543322 233568999999999999999999999999999888 8999987663
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-29 Score=236.57 Aligned_cols=201 Identities=31% Similarity=0.459 Sum_probs=163.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------- 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 582 (732)
.+.|+-+.++|+|.||.||+|+.+ +|+.||+|+.--+ .........+|+++|..++|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345666778999999999999875 6888999865332 233446678999999999999999999887642
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 583 -DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
..+|+|+++|+. +|.-.+. ....+++..++.+++.++..||.|+|.. +|+|||+|+.|+|++.++.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 358999999965 7877773 2335789999999999999999999987 5999999999999999999999999
Q ss_pred ecceeCCccCce---eeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTH---ISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+++........ ..+..+-|..|.+||.+.+. .++++.|||..||++.||+|+.+-|+.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 999654332221 12334568899999998875 789999999999999999999977764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-28 Score=243.68 Aligned_cols=198 Identities=24% Similarity=0.351 Sum_probs=167.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCC--C----ceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH--P----NLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~~~~~~~~~ 584 (732)
.+++|.++..+|+|.||.|-++.+. .+..||+|+++... ...+...-|+++++++.+ | -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999765 57899999987543 334556779999999942 2 26788899999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC------------
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR------------ 652 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~------------ 652 (732)
.++|+|.+ |-|+.+.+..+ ...+++...++.|+.|+++++++||+.. ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 66999999543 3456888999999999999999999985 999999999999831
Q ss_pred --------CCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 653 --------DLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 653 --------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+..++|+|||.|.+..+... ..+.|..|.|||++.+-.++.++||||+||||+|+.||..-|.-
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHHS----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCcc----eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 23489999999987766443 35678899999999999999999999999999999999988864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=264.51 Aligned_cols=201 Identities=25% Similarity=0.292 Sum_probs=144.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-C----CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeee------EE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-D----GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC------CI 580 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~----g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 580 (732)
..++|++.+.||+|+||.||+|++. + +..||+|++...... +....| .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999876 5 789999987643211 111111 1222222333322221 24
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCC----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENS----------------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
.+...++||||+++++|.+++...... ........+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999988543210 111223456789999999999999986 9999999
Q ss_pred CCCeEEcC-CCCeEEEeeecceeCCccCceeeecccCccccccchhcccC----------------------CCCCchhH
Q 040398 645 ATNVLLDR-DLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG----------------------YLTYKADV 701 (732)
Q Consensus 645 p~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~k~Dv 701 (732)
|+|||+++ ++.+||+|||+|+..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57899999999976544333334456789999999965422 23456799
Q ss_pred HHHHHHHHHHHcCCCCCC
Q 040398 702 YSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 702 wSlGvll~elltG~~P~~ 719 (732)
|||||++|||+++..|++
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999876654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=223.99 Aligned_cols=198 Identities=22% Similarity=0.406 Sum_probs=166.9
Q ss_pred hCCCcccceecccCceEEEEEEE-cCCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCC--EEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGD--QLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv 588 (732)
.++|++.+++|+|.++.||.|.. .+.++++||+++... .+.+.+|+.+|..+. ||||+++++...++. ...++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 56889999999999999999974 578899999998543 456789999999997 999999999988754 46799
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLD 667 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~ 667 (732)
+||+.+.++.... ..++...++.++.++++||+|+|+.| |+|||+||.|+++|... .++|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877654 35777888999999999999999997 99999999999999874 5999999999988
Q ss_pred CccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~~~~~ 725 (732)
.+.... .. .+.+..|.-||.+.. ..++..-|+|||||++..|+..+.||....+..
T Consensus 184 Hp~~eY-nV-RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~ 240 (338)
T KOG0668|consen 184 HPGKEY-NV-RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 240 (338)
T ss_pred CCCcee-ee-eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence 775432 12 235668899998764 468889999999999999999999998765543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.50 Aligned_cols=186 Identities=34% Similarity=0.533 Sum_probs=163.9
Q ss_pred CceEEEEEEEc-CCeEEEEEEcccccccc-hHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhc
Q 040398 526 GFGPVYKGQLT-DGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG 603 (732)
Q Consensus 526 ~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 603 (732)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 58999999988665444 68899999999999999999999999999999999999999999998843
Q ss_pred CCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccc
Q 040398 604 GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683 (732)
Q Consensus 604 ~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~ 683 (732)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 22 2789999999999999999999985 9999999999999999999999999987654432 2234568889
Q ss_pred cccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 684 YMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 684 y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+|||...+..++.++||||||+++++|++|..||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888889999999999999999999999965
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=260.01 Aligned_cols=204 Identities=32% Similarity=0.496 Sum_probs=169.7
Q ss_pred CCcccceecccCceEEEEEEEc----C----CeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT----D----GTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~----~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
+..+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++++.+ +|+||+.++++|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3345568999999999999742 1 457999998865 334667899999999999 69999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC---C-------Cc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC
Q 040398 585 LMLVYEYLENNSLAHALFGGE---N-------SQ--LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 652 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 652 (732)
.++|+||+..|+|.++++..+ . .. ..++......++.|||.|++||++.. +|||||..+|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 999999999999999997655 0 11 23889999999999999999999984 999999999999999
Q ss_pred CCCeEEEeeecceeCCccCceeeecccC--ccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 653 DLNPKISDFGLAKLDEEEKTHISTRVAG--TIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 653 ~~~~kL~DfGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+..+||+|||+|+............-.| ...|||||.+....++.|+|||||||+|||++| |..|+...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999998654443333222222 446999999999999999999999999999999 77788653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=226.39 Aligned_cols=193 Identities=25% Similarity=0.416 Sum_probs=163.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------CE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------DQ 584 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 584 (732)
.+|.-++.+|.|+. .|..|-+. .++.||+|+.... .....++..+|...+..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45667788999998 56666544 6889999987654 334457889999999999999999999988643 35
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.|+|||+|. .+|...++ .+++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 799999995 48888774 45677889999999999999999986 999999999999999999999999999
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
+.-... -..+.++.|..|.|||++.+-.+.+.+||||+||++.||++|+.-|.
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 754432 34566788999999999998889999999999999999999998776
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-27 Score=249.75 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=202.8
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCcc-ccCCCCCCEEecccccCCccCCccccC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSH-LGNITSLTYLDLEENQFSGTIPRELGN 86 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 86 (732)
||+.|.+|+.|++||||.|+++ ..|..+... ++-+|+||+|+|. .||.. +-+|+.|-.||||+|++. .+|..+..
T Consensus 95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR 171 (1255)
T KOG0444|consen 95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR 171 (1255)
T ss_pred CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHH
Confidence 7777888888888888888887 677766655 6778888888887 56644 457778888888888887 77777778
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccc-ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCee
Q 040398 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN-GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 165 (732)
|..|++|+|++|.+...--..+..+++|++|.+++.+-+ ..+|..+..+.+|..++||.|.+. .+|+++.++.+|..|
T Consensus 172 L~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrL 250 (1255)
T KOG0444|consen 172 LSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRL 250 (1255)
T ss_pred HhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhhee
Confidence 888888888888776433334555677777788777653 467888888999999999999998 889999999999999
Q ss_pred eccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc-CCCCCccCcchhhHHHHHHhc
Q 040398 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE-LPDVAVPADLKFTQILMFIRG 244 (732)
Q Consensus 166 ~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~~~l~~~~~~~~~~~ 244 (732)
+||+|.|+.... ......+|+.|+||.|+++ .+|+.++++++|+.|.+.+|+|+-+ ||.. +++
T Consensus 251 NLS~N~iteL~~-~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSG--------------IGK 314 (1255)
T KOG0444|consen 251 NLSGNKITELNM-TEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSG--------------IGK 314 (1255)
T ss_pred ccCcCceeeeec-cHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccc--------------hhh
Confidence 999999887643 2345568899999999999 8999999999999999999998744 4543 888
Q ss_pred cCCCCeEEccCCcCcCCCCCCccccCCCCcccccccccCCC
Q 040398 245 VYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVE 285 (732)
Q Consensus 245 l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~~~~~~~~~ 285 (732)
|.+|+.+..++|+|.-.|...+.|.++..|+++.++...++
T Consensus 315 L~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLP 355 (1255)
T KOG0444|consen 315 LIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLP 355 (1255)
T ss_pred hhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeech
Confidence 88999999999999888888899998888887766544433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=246.61 Aligned_cols=197 Identities=31% Similarity=0.389 Sum_probs=158.4
Q ss_pred CcccceecccCce-EEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 516 FDPMNKIGEGGFG-PVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 516 f~~~~~LG~G~fg-~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
|...+.+|.|+.| .||+|... |+.||||++-... ....++|+..|+.- +||||||+++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3344678899987 78999987 7899999886432 34567899999888 5999999999988899999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---C--CCeEEEeeecceeCC
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---D--LNPKISDFGLAKLDE 668 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kL~DfGla~~~~ 668 (732)
..+|.+++...............+.+..|+++||++||+. +||||||||.||||+. + ..++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999955311111111144567889999999999997 4999999999999976 3 458999999998776
Q ss_pred ccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 040398 669 EEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG-KNNMSY 720 (732)
Q Consensus 669 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG-~~P~~~ 720 (732)
...... .....||.||+|||++....-+..+||||+||++|+.++| ..||..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 554432 3346799999999999988888899999999999998887 899985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=217.11 Aligned_cols=196 Identities=22% Similarity=0.379 Sum_probs=156.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeee-eEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYG-CCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~-~~~~~~~~~lv 588 (732)
..+.|.+.+.+|+|.||.+-.|+++ +.+.+++|.+.... ...++|.+|..----+ .|.||+.-|+ .|++.+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4567889999999999999999987 67889999886543 3357889987654444 5999997765 57788899999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE-cCC-CCeEEEeeeccee
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRD-LNPKISDFGLAKL 666 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~-~~~kL~DfGla~~ 666 (732)
+||++.|+|.+-+- ...+-+....+++.|++.|++|||++. +||||||.+|||+ +.+ .++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998772 245677888899999999999999995 9999999999998 333 5799999999864
Q ss_pred CCccCceeeecccCccccccchhcccC-----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWG-----YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....-+-.|.|||..... ...+.+|+|.|||++|.++||+.||+.
T Consensus 173 ~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 173 VGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 3321 1112234478999976532 356788999999999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-26 Score=244.00 Aligned_cols=200 Identities=27% Similarity=0.457 Sum_probs=175.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|+.+..+|+|+||.||||++. +++..|+|+++........-.++|+-+++..+|||||.+++.|...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 568899999999999999999976 7899999999988777788889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|.+|+|++.-+ ...++++.++..+++..++|++|||++| -+|||||-.||++++.+.+|+.|||.+..+...-
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999764 3457888999999999999999999997 7999999999999999999999999876443221
Q ss_pred ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....++||+.|||||+.. .+.|..++|||++|+...|+---+.|..+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 1223478999999999864 45788999999999999999888877653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=222.01 Aligned_cols=132 Identities=27% Similarity=0.424 Sum_probs=111.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-----C---CceeeeeeeEEe---
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----H---PNLVKLYGCCIE--- 581 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~--- 581 (732)
.+|.+.++||-|-|++||.|.+. +.+.||+|+.+... ...+....|+++|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999875 67899999987542 33456788999999884 3 369999999985
Q ss_pred -CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc
Q 040398 582 -GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD 651 (732)
Q Consensus 582 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~ 651 (732)
+.++++|+|++ |.+|..+|.... ...++...+++|++||+.||+|||.+| +|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 46899999999 668888885433 345788899999999999999999998 899999999999984
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=236.85 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=183.3
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCc-cccCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR-ELGNLVNL 90 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L 90 (732)
|.++++|++++|..|.++ .+|...... +|+.|+|.+|.|+..-..++..++.|+.||||.|.|+ .+|. .|..-.+|
T Consensus 98 f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni 175 (873)
T KOG4194|consen 98 FYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNI 175 (873)
T ss_pred HhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCc
Confidence 467777777777777777 677666555 5777777777777555566777777777777777777 4443 55555678
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 170 (732)
++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.--..|..|++|+.|.|..|
T Consensus 176 ~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN 255 (873)
T KOG4194|consen 176 KKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRN 255 (873)
T ss_pred eEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhc
Confidence 88888888887666667777778888888888887666677777888888888888876333455777777788888888
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCe
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQS 250 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~ 250 (732)
.+....-..|..+.++++|+|+.|++...--.++.++..|+.|+||+|.|.-.-++. ..-.++|+.
T Consensus 256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~--------------WsftqkL~~ 321 (873)
T KOG4194|consen 256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS--------------WSFTQKLKE 321 (873)
T ss_pred CcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch--------------hhhccccee
Confidence 887777777888888888888888888666677888888888888888887655543 223367888
Q ss_pred EEccCCcCcCCCCCCccccCC-CCcccccc
Q 040398 251 LDLSYNNFTWQSPEQPACREK-PNLNLNLF 279 (732)
Q Consensus 251 LdLs~N~l~~~~p~~~~~~~~-~~l~~~~~ 279 (732)
||||+|+|+...++...|.+. ..|++.++
T Consensus 322 LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N 351 (873)
T KOG4194|consen 322 LDLSSNRITRLDEGSFRVLSQLEELNLSHN 351 (873)
T ss_pred EeccccccccCChhHHHHHHHhhhhccccc
Confidence 999999988888877777543 33555444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=204.69 Aligned_cols=183 Identities=41% Similarity=0.662 Sum_probs=157.7
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhH
Q 040398 522 IGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAH 599 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 599 (732)
||+|++|.||+++.. +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 4899999998765432 35678999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCCccCceeeecc
Q 040398 600 ALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEEEKTHISTRV 678 (732)
Q Consensus 600 ~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~~~ 678 (732)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 984321 46789999999999999999999986 999999999999999 89999999999876544321 12234
Q ss_pred cCccccccchhcccC-CCCCchhHHHHHHHHHHH
Q 040398 679 AGTIGYMAPEYALWG-YLTYKADVYSFGVVALEI 711 (732)
Q Consensus 679 ~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~el 711 (732)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 577899999998877 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=229.63 Aligned_cols=257 Identities=21% Similarity=0.233 Sum_probs=223.2
Q ss_pred CCCcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCC
Q 040398 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP 81 (732)
Q Consensus 3 ~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 81 (732)
+.++|-+| ++-++|||++|.|...-+..|.++ +|++++|.+|.|+ .+|.......+|+.|+|.+|.|+..-.
T Consensus 70 ~~l~g~lp------~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~s 142 (873)
T KOG4194|consen 70 SRLKGFLP------SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTS 142 (873)
T ss_pred cccCCcCc------cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccH
Confidence 45677777 457789999999998888888888 8999999999999 899877778889999999999996666
Q ss_pred ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 82 RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
..+..++.|+.||||.|.|+...-..|..-.+|+.|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+|++
T Consensus 143 e~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 143 EELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPK 222 (873)
T ss_pred HHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcch
Confidence 78999999999999999999544456767789999999999999888889999999999999999999666778899999
Q ss_pred CCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHH
Q 040398 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 241 (732)
|+.|+|..|+|.....-.|.++++|+.|.|..|.|...--..|..+.++++|+|+.|+++..--.+
T Consensus 223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~-------------- 288 (873)
T KOG4194|consen 223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW-------------- 288 (873)
T ss_pred hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc--------------
Confidence 999999999999998889999999999999999999766778889999999999999998433322
Q ss_pred HhccCCCCeEEccCCcCcCCCC-CCccccCCCCccccccc
Q 040398 242 IRGVYEHQSLDLSYNNFTWQSP-EQPACREKPNLNLNLFR 280 (732)
Q Consensus 242 ~~~l~~L~~LdLs~N~l~~~~p-~~~~~~~~~~l~~~~~~ 280 (732)
+-+|..|+.||||+|.|...-+ ....|.++..|.+..+.
T Consensus 289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~ 328 (873)
T KOG4194|consen 289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR 328 (873)
T ss_pred ccccchhhhhccchhhhheeecchhhhcccceeEeccccc
Confidence 4567889999999999987754 35678888888765543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-24 Score=218.93 Aligned_cols=202 Identities=31% Similarity=0.446 Sum_probs=166.8
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc----CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
....+.|...++||+|+|++||++... .++.||+|.+...+. ..+..+|+++|..+ .+.||+++.+.+..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345667889999999999999999643 468899998876533 36688999999999 59999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeeec
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGL 663 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfGl 663 (732)
..+|+||++.....++.. .++..++..+++.+..||+++|++| ||||||||+|+|.+.. +.-.|+|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999988773 4667889999999999999999997 9999999999999876 6689999999
Q ss_pred ceeCCcc---------------C-------------------c---------eeeecccCccccccchhcccC-CCCCch
Q 040398 664 AKLDEEE---------------K-------------------T---------HISTRVAGTIGYMAPEYALWG-YLTYKA 699 (732)
Q Consensus 664 a~~~~~~---------------~-------------------~---------~~~~~~~gt~~y~APE~~~~~-~~~~k~ 699 (732)
|...... . . .......||+||.|||++..- ..+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9611000 0 0 001124699999999998754 568899
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCC
Q 040398 700 DVYSFGVVALEIVSGKNNMSYVPD 723 (732)
Q Consensus 700 DvwSlGvll~elltG~~P~~~~~~ 723 (732)
||||.|||++.++++++||-..++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred ceeeccceeehhhccccccccCcc
Confidence 999999999999999999976543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=227.25 Aligned_cols=208 Identities=23% Similarity=0.303 Sum_probs=169.9
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC------CCceeeee
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ------HPNLVKLY 576 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~ 576 (732)
|.+.-.+..-..|.+....|+|-|+.|.+|.+. -|..||||++... ....+.=+.|+++|++|+ --++++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333333445678999999999999999999875 5789999999753 333455578999999995 35799999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CC
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LN 655 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~ 655 (732)
..|...+++|||+|-+ .-+|.++|..... ...+....+..++.|+.-||..|-..+ |+|+||||.|||+++. ..
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 9999999999999987 4589998865432 334677888999999999999998765 9999999999999987 55
Q ss_pred eEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+||||||.|....+... +++.-+..|.|||++.|-+|+...|+||+||.||||.||+.-|..
T Consensus 576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 89999999876554322 234456689999999999999999999999999999999988754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=219.33 Aligned_cols=167 Identities=22% Similarity=0.204 Sum_probs=129.9
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEc--CCeEEEEEEcccc-----cccchHHHHHHHHHHhcCCCCceee-eeeeEE
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLLSSK-----SRQGNREFLNEIGTISCLQHPNLVK-LYGCCI 580 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~ 580 (732)
.....++|++.+.||+|+||+||+|++. +++.+|||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3456778999999999999999999875 5788899986533 1223456899999999999999985 4432
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC-CCCCeEEcCCCCeEEE
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI-KATNVLLDRDLNPKIS 659 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~ 659 (732)
+..++||||+++++|.... .. . ...++.++++||+|||+.| |+|||| ||+|||++.++.++|+
T Consensus 91 --~~~~LVmE~~~G~~L~~~~-----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR-----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC-----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 4579999999999997321 10 0 1467889999999999986 999999 9999999999999999
Q ss_pred eeecceeCCccCcee-------eecccCccccccchhcccC
Q 040398 660 DFGLAKLDEEEKTHI-------STRVAGTIGYMAPEYALWG 693 (732)
Q Consensus 660 DfGla~~~~~~~~~~-------~~~~~gt~~y~APE~~~~~ 693 (732)
|||+|+......... .....+++.|+|||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998654432111 1245688889999988643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=211.99 Aligned_cols=214 Identities=22% Similarity=0.303 Sum_probs=175.1
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeee
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGC 578 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 578 (732)
.+++.....+++....+-+|.||.||+|.+. +.+.|-||.++.. +.-....+.+|--.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4555666677888888999999999999543 3456777877654 33455778999999999999999999999
Q ss_pred EEeC-CEEEEEEEecCCCchhHHhhcC----CCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC
Q 040398 579 CIEG-DQLMLVYEYLENNSLAHALFGG----ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653 (732)
Q Consensus 579 ~~~~-~~~~lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 653 (732)
+.++ +..++.|.++.-|+|..++... ......++..+...+|.|++.|++|||+++ |||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 4567889999999999998621 233445777888899999999999999996 9999999999999999
Q ss_pred CCeEEEeeecceeCCccCcee-eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 654 LNPKISDFGLAKLDEEEKTHI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 654 ~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
..+||+|=.+++...+.+.+. ...--.+..||+||.+.+..++..+|||||||+||||+| |+.|+..+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 999999999998766655443 222335668999999999999999999999999999988 888987644
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-25 Score=231.91 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=177.9
Q ss_pred ccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCc-cCCccc
Q 040398 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG-TIPREL 84 (732)
Q Consensus 7 g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~l 84 (732)
+..|..+..|++++.|.|...++. .+|..++.+ +|+.|.+++|+|. .+-.+++.|+.|+.+++.+|++.. -+|..+
T Consensus 22 ~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~di 99 (1255)
T KOG0444|consen 22 DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDI 99 (1255)
T ss_pred CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchh
Confidence 456777777777777777777777 677777777 5777777777777 666677777777777777777752 367777
Q ss_pred cCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCe
Q 040398 85 GNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQ 164 (732)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 164 (732)
..+..|+.||||+|+++ +.|..+..-+++-+|+|++|+|..+....|.+++.|-.|+||+|++. .+|..+..|..|+.
T Consensus 100 F~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt 177 (1255)
T KOG0444|consen 100 FRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT 177 (1255)
T ss_pred cccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence 77777777777777777 77777777777777777777777443444667777777777777776 66666777777777
Q ss_pred eeccCcCCCCC-------------------------CcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCc
Q 040398 165 LRISDLQGPNQ-------------------------TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219 (732)
Q Consensus 165 L~ls~N~l~~~-------------------------~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 219 (732)
|+|++|.+.-. .+..+..+.+|..+|||.|.+. .+|+++-++++|+.|+||+|.
T Consensus 178 L~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 178 LKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK 256 (1255)
T ss_pred hhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence 77777764221 2345666778888888888888 888888889999999999998
Q ss_pred CcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCc
Q 040398 220 LTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNL 274 (732)
Q Consensus 220 l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l 274 (732)
|+..-. ..+...+|++|+||.|+|+..|...+...++..|
T Consensus 257 iteL~~---------------~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kL 296 (1255)
T KOG0444|consen 257 ITELNM---------------TEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKL 296 (1255)
T ss_pred eeeeec---------------cHHHHhhhhhhccccchhccchHHHhhhHHHHHH
Confidence 883211 1344467899999999998776544333344444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=209.84 Aligned_cols=202 Identities=23% Similarity=0.244 Sum_probs=165.9
Q ss_pred CCcccceecccCceEEEEEEEcC--CeEEEEEEcccccccchHHHHHHHHHHhcCCC----CceeeeeeeE-EeCCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLTD--GTIIAVKLLSSKSRQGNREFLNEIGTISCLQH----PNLVKLYGCC-IEGDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 587 (732)
.|.+.+.||+|+||.||.+.... ...+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998764 35899998776544333367788888888863 6888899888 57788999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-----CCeEEEeee
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-----LNPKISDFG 662 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kL~DfG 662 (732)
||+.+ |.+|.++..... ...++..+..+|+.|++.+|++||+.| ++||||||.|+.+... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 779999774433 567999999999999999999999997 9999999999999765 358999999
Q ss_pred cce--eCCccCc----ee---eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 663 LAK--LDEEEKT----HI---STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 663 la~--~~~~~~~----~~---~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+++ ....... .. ...+.||..|+++....+...+++.|+||++.++.|++.|..||....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 998 3211111 11 123569999999999999999999999999999999999999996533
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-24 Score=221.28 Aligned_cols=236 Identities=26% Similarity=0.410 Sum_probs=213.2
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+-+.+.++..|.+|++++|++. ..|.+++.+ .++.|+.++|+++ .+|..++++.+|..|+.+.|.+. .+|+.++.+
T Consensus 60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~ 136 (565)
T KOG0472|consen 60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRL 136 (565)
T ss_pred ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHH
Confidence 4566788999999999999999 788888888 8999999999999 99999999999999999999999 889999999
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeec
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 167 (732)
-.|+.|+..+|+++ ..|+++.++.+|..|++.+|++....|+.+. ++.|+.|+...|.++ .+|+.++.+.+|+.|++
T Consensus 137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL 213 (565)
T KOG0472|consen 137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYL 213 (565)
T ss_pred hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHh
Confidence 99999999999999 8999999999999999999999966666555 999999999999998 89999999999999999
Q ss_pred cCcCCCCCCcccccCCCCccEEEcccccccCCcchhhc-CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccC
Q 040398 168 SDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVY 246 (732)
Q Consensus 168 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~ 246 (732)
..|++...+ .|.++..|++|+++.|.|. .+|.... ++++|..|||..|+++ +.|+. +..+.
T Consensus 214 ~~Nki~~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde--------------~clLr 275 (565)
T KOG0472|consen 214 RRNKIRFLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE--------------ICLLR 275 (565)
T ss_pred hhcccccCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH--------------HHHhh
Confidence 999998877 8999999999999999999 6776555 8999999999999999 55654 66678
Q ss_pred CCCeEEccCCcCcCCCCCCccc
Q 040398 247 EHQSLDLSYNNFTWQSPEQPAC 268 (732)
Q Consensus 247 ~L~~LdLs~N~l~~~~p~~~~~ 268 (732)
+|+.||+|+|.|++.|++.+..
T Consensus 276 sL~rLDlSNN~is~Lp~sLgnl 297 (565)
T KOG0472|consen 276 SLERLDLSNNDISSLPYSLGNL 297 (565)
T ss_pred hhhhhcccCCccccCCcccccc
Confidence 8999999999999999876543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-25 Score=223.11 Aligned_cols=228 Identities=25% Similarity=0.388 Sum_probs=212.6
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 86 (732)
++|++++++..++.|+.+.|++. .+|...... +|+.|+++.|++. ++|+.++.+..|+.|+..+|+++ +.|..+++
T Consensus 82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~ 158 (565)
T KOG0472|consen 82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN 158 (565)
T ss_pred hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH
Confidence 58999999999999999999999 788887777 8999999999999 99999999999999999999999 89999999
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeee
Q 040398 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLR 166 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 166 (732)
+.+|..|++.+|+++ ..|+..-+++.|+.|++..|.+. .+|..++.+.+|..|+|.+|++. .+| .|..++.|++|.
T Consensus 159 ~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh 234 (565)
T KOG0472|consen 159 LSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELH 234 (565)
T ss_pred HHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHH
Confidence 999999999999999 66666666999999999999987 88999999999999999999998 777 899999999999
Q ss_pred ccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccC
Q 040398 167 ISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVY 246 (732)
Q Consensus 167 ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~ 246 (732)
++.|++.-++.....++++|..|||.+|+++ +.|+.+.-+.+|..||||+|.|++.++. ++++
T Consensus 235 ~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~s---------------Lgnl- 297 (565)
T KOG0472|consen 235 VGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYS---------------LGNL- 297 (565)
T ss_pred hcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcc---------------cccc-
Confidence 9999999999999999999999999999999 8999999999999999999999976664 5677
Q ss_pred CCCeEEccCCcCc
Q 040398 247 EHQSLDLSYNNFT 259 (732)
Q Consensus 247 ~L~~LdLs~N~l~ 259 (732)
.|++|-+.+|++-
T Consensus 298 hL~~L~leGNPlr 310 (565)
T KOG0472|consen 298 HLKFLALEGNPLR 310 (565)
T ss_pred eeeehhhcCCchH
Confidence 8999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=187.31 Aligned_cols=203 Identities=26% Similarity=0.331 Sum_probs=167.7
Q ss_pred HhCCCcccceecccCceEEEEEE-EcCCeEEEEEEcccccccchHHHHHHHHHHhcCCC-CceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~ 589 (732)
...+|..+++||+|+||.+|.|. ..+|..||+|+-..... ...+..|.++.+.++| ..|..+..+..+.++-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999997 46899999999765433 3556778888888875 67888888888899999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeeeccee
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKL 666 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfGla~~ 666 (732)
|.+ |.||++...- ....++..++..+|-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 988 7799998732 3446788899999999999999999997 9999999999998533 4589999999975
Q ss_pred CCccCc--e----eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 040398 667 DEEEKT--H----ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPD 723 (732)
Q Consensus 667 ~~~~~~--~----~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~~ 723 (732)
+.+... + ......||..|.+-....+...+.+.|+-|+|.+|.++--|..||+....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 433222 1 12235799999998888888889999999999999999999999987543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=189.69 Aligned_cols=200 Identities=26% Similarity=0.347 Sum_probs=167.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.-.|.+.++||+|+||+.+.|+.- +++.||+|.....++ ..++..|.+..+.| ..++|..++.+..++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 457889999999999999999854 789999998765433 34566788888777 47899999988888888899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-----CeEEEeeecce
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-----NPKISDFGLAK 665 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kL~DfGla~ 665 (732)
.+ |.||+|+.- .....|+..++..+|.|++.-++|+|++. .|.|||||+|+||...+ .+.++|||+|+
T Consensus 105 LL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 779999772 34557899999999999999999999985 99999999999996543 48999999998
Q ss_pred eCCccCce--e----eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 666 LDEEEKTH--I----STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 666 ~~~~~~~~--~----~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.+.+.... . .....||..||+-....+...+.+.|+-|||-++.+.|-|..||+..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 65443322 1 22357999999999999999999999999999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-20 Score=195.57 Aligned_cols=200 Identities=37% Similarity=0.567 Sum_probs=169.3
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEEccccccc---chHHHHHHHHHHhcCCCC-ceeeeeeeEEeCCEEEEEEEe
Q 040398 516 FDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ---GNREFLNEIGTISCLQHP-NLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~ 591 (732)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999877 78899988765332 367899999999999988 799999999887888999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~~~~ 670 (732)
+.++++.+.+...... ..++......++.|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766332211 36888999999999999999999996 99999999999999998 7999999999755443
Q ss_pred Cce-----eeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTH-----ISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~-----~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 2345679999999999987 68889999999999999999999996643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-21 Score=190.97 Aligned_cols=170 Identities=16% Similarity=0.174 Sum_probs=132.9
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHH---------HHHHHHHHhcCCCCceeeeeeeEEeC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE---------FLNEIGTISCLQHPNLVKLYGCCIEG 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~~~~~~~ 582 (732)
..++|...+.+|+|+||.||.+.. ++..+|+|++........+. +.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 477899999999999999999766 57789999997653332222 68899999999999999998886643
Q ss_pred --------CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 583 --------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 583 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
...+++|||++|.+|.++. .++. ....+++.++..+|+.| ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3578999999999998864 1222 24568999999999996 99999999999999988
Q ss_pred CeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHH
Q 040398 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEI 711 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~el 711 (732)
++|+|||........... ..++....+..++|+||||+++..+
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 999999987654321111 1134444566799999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=233.28 Aligned_cols=147 Identities=17% Similarity=0.185 Sum_probs=112.2
Q ss_pred cCCC-CceeeeeeeE-------EeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 040398 566 CLQH-PNLVKLYGCC-------IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637 (732)
Q Consensus 566 ~l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ 637 (732)
.++| +||++++++| .+.+.++.++||+ +++|.+++.. ....+++.+++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5777888877 2334577888987 5699999953 2345899999999999999999999986
Q ss_pred eEeCCCCCCCeEEcCCC-------------------CeEEEeeecceeCCccC---------------ceeeecccCccc
Q 040398 638 IVHRDIKATNVLLDRDL-------------------NPKISDFGLAKLDEEEK---------------THISTRVAGTIG 683 (732)
Q Consensus 638 iiH~Dlkp~NILl~~~~-------------------~~kL~DfGla~~~~~~~---------------~~~~~~~~gt~~ 683 (732)
|+||||||+|||++..+ .+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 45555666554211000 000112357889
Q ss_pred cccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 684 YMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 684 y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 999999999999999999999999999999998875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=182.78 Aligned_cols=140 Identities=17% Similarity=0.198 Sum_probs=107.7
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEccccccc--c-------hHH-----------------HHHHHHHHhcCCCCce
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ--G-------NRE-----------------FLNEIGTISCLQHPNL 572 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nI 572 (732)
...||+|+||.||+|...+|+.||||+++..... . ..+ ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998754211 1 112 2349999999988877
Q ss_pred eeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeCCCCCCCeEEc
Q 040398 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL-HEESRFKIVHRDIKATNVLLD 651 (732)
Q Consensus 573 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL-H~~~~~~iiH~Dlkp~NILl~ 651 (732)
.....+.. ...++||||++++++..... ....+++..+.+++.|++.+|+|+ |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333322 22389999999887765431 224678899999999999999999 5765 99999999999998
Q ss_pred CCCCeEEEeeecceeCC
Q 040398 652 RDLNPKISDFGLAKLDE 668 (732)
Q Consensus 652 ~~~~~kL~DfGla~~~~ 668 (732)
+ +.++|+|||+|....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=176.35 Aligned_cols=140 Identities=19% Similarity=0.202 Sum_probs=110.5
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccc--------------------------hHHHHHHHHHHhcCCCCce
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG--------------------------NREFLNEIGTISCLQHPNL 572 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~nI 572 (732)
...||+|++|.||+|+..+|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999987542110 1224578999999999988
Q ss_pred eeeeeeEEeCCEEEEEEEecCCCchhHH-hhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEE
Q 040398 573 VKLYGCCIEGDQLMLVYEYLENNSLAHA-LFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 573 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl 650 (732)
.....+.... .++||||++++++... +. ...++.....+++.|++.++.++|+ .| |+||||||+||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 5544443332 4899999998865433 31 2356778899999999999999999 76 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCc
Q 040398 651 DRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~ 669 (732)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=212.00 Aligned_cols=219 Identities=24% Similarity=0.383 Sum_probs=148.3
Q ss_pred CCCCcccCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCC
Q 040398 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP 81 (732)
Q Consensus 2 l~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 81 (732)
|++++..|| +.|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|
T Consensus 190 LtsLP~~Ip------~~L~~L~Ls~N~Lt-sLP~~l~-~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP 257 (754)
T PRK15370 190 LTTIPACIP------EQITTLILDNNELK-SLPENLQ-GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELP 257 (754)
T ss_pred cCcCCcccc------cCCcEEEecCCCCC-cCChhhc-cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCC
Confidence 344555554 35788888888888 5565443 26888888888887 6676553 46888888888887 677
Q ss_pred ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 82 RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|++ +|..+. ++|+.|+|++|+++ .+|..+. ++
T Consensus 258 ~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~s 326 (754)
T PRK15370 258 ERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-ALPETLP--PG 326 (754)
T ss_pred hhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-cCCcccc--cc
Confidence 6664 47888888888887 5676554 478888888888873 454432 46778888888887 3554432 57
Q ss_pred CCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHH
Q 040398 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 241 (732)
|+.|++++|.++.++.. + .++|+.|+|++|+|+ .+|..+ .++|+.|+|++|+|+. +|+..
T Consensus 327 L~~L~Ls~N~Lt~LP~~-l--~~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP~~l------------- 386 (754)
T PRK15370 327 LKTLEAGENALTSLPAS-L--PPELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LPENL------------- 386 (754)
T ss_pred ceeccccCCccccCChh-h--cCcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CCHhH-------------
Confidence 88888888887765432 2 257888888888887 566655 3578888888888874 34321
Q ss_pred HhccCCCCeEEccCCcCcCCCCCCc
Q 040398 242 IRGVYEHQSLDLSYNNFTWQSPEQP 266 (732)
Q Consensus 242 ~~~l~~L~~LdLs~N~l~~~~p~~~ 266 (732)
. ..|+.|++++|+|+..|...+
T Consensus 387 -~--~sL~~LdLs~N~L~~LP~sl~ 408 (754)
T PRK15370 387 -P--AALQIMQASRNNLVRLPESLP 408 (754)
T ss_pred -H--HHHHHHhhccCCcccCchhHH
Confidence 0 246677777777775543333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-19 Score=170.65 Aligned_cols=183 Identities=16% Similarity=0.105 Sum_probs=137.9
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEccccccc----chHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEec
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ----GNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+...|++|+||.||.+.. .+.+++.+.+...... ....+.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999997765 5778887777654331 1235889999999995 5889999886 4468999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC-CCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI-KATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
.|.+|...+. . . ...++.|++++|+++|++| |+|||| ||+|||+++++.++|+|||+|....+..
T Consensus 81 ~G~~L~~~~~-----~-----~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP-----R-----G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh-----h-----h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999875441 0 1 1347789999999999997 999999 7999999999999999999998654432
Q ss_pred ce---ee---------ecccCccccccchhcccC-CCC-CchhHHHHHHHHHHHHcCCCCCC
Q 040398 672 TH---IS---------TRVAGTIGYMAPEYALWG-YLT-YKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 672 ~~---~~---------~~~~gt~~y~APE~~~~~-~~~-~k~DvwSlGvll~elltG~~P~~ 719 (732)
.- .. .....++.|++|+...-- ..+ ...+.++.|..+|.++|+..|.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 00 012257788888854322 223 56799999999999999998754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=203.57 Aligned_cols=222 Identities=23% Similarity=0.320 Sum_probs=129.6
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+||+.+. ++|+.|++++|+|+ .+|... .+|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+
T Consensus 215 sLP~~l~--~~L~~L~L~~N~Lt-~LP~lp--~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp--- 281 (788)
T PRK15387 215 TLPDCLP--AHITTLVIPDNNLT-SLPALP--PELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP--- 281 (788)
T ss_pred cCCcchh--cCCCEEEccCCcCC-CCCCCC--CCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---
Confidence 3565554 36888888888888 466421 26888888888888 56643 245666666666665 444322
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccc-------------------cCCccccCCCCCCEEEcccCCC
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG-------------------SAPDFIQSWTQLNRLEIQGSGL 148 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-------------------~~p~~~~~l~~L~~L~Ls~N~l 148 (732)
++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ .+|.. ..+|+.|+|++|+|
T Consensus 282 ~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~l---p~~Lq~LdLS~N~L 354 (788)
T PRK15387 282 SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTL---PSGLQELSVSDNQL 354 (788)
T ss_pred hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCCcccccccccccCcccccccc---ccccceEecCCCcc
Confidence 33445555555554 33321 2345555555555442 12221 13577777777777
Q ss_pred cCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCC
Q 040398 149 EGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVA 228 (732)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 228 (732)
+ .+|.. .++|+.|++++|++..++. .+.+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+. +|..
T Consensus 355 s-~LP~l---p~~L~~L~Ls~N~L~~LP~----l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l- 420 (788)
T PRK15387 355 A-SLPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML- 420 (788)
T ss_pred C-CCCCC---CcccceehhhccccccCcc----cccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc-
Confidence 6 34442 2356666777777665432 1346888888888888 45543 3578888888888885 4532
Q ss_pred ccCcc--------hhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 229 VPADL--------KFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 229 ~~~~l--------~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
+..+ .+..++..+.++.+|+.|+|++|+|++.+|.
T Consensus 421 -~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 421 -PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHH
Confidence 1111 1123344456666777777777777665543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-19 Score=171.77 Aligned_cols=106 Identities=30% Similarity=0.262 Sum_probs=92.8
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|+|.+++... ...+++..++.|+.||++||+|||+++ ||+|||++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 6889988532 346899999999999999999999874 999999999999999 99987654322
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2588999999999999999999999999999999999999964
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=203.65 Aligned_cols=198 Identities=21% Similarity=0.234 Sum_probs=160.7
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCC---CCceeeeeeeEEeCCEE
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~ 585 (732)
.......|.+.+.+|+|+||+||+|...+|+.||+|+-+.......-- -.+++.+|+ -+.|..+...+.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 334566788899999999999999998889999999988776653211 112233333 35566777777778888
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-------CCCeEE
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-------DLNPKI 658 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL 658 (732)
++|+||.+.|+|.+++. ....++|...+.++.||++.+++||..+ |||+||||+|.+|.. ..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999994 5567899999999999999999999986 999999999999943 234899
Q ss_pred EeeecceeCCcc-CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCC
Q 040398 659 SDFGLAKLDEEE-KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716 (732)
Q Consensus 659 ~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~ 716 (732)
+|||.+..+..- +.......++|-.+-++|...|.++++.+|.|.+.-+++.||.|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999998643221 1234556788999999999999999999999999999999999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=201.41 Aligned_cols=216 Identities=25% Similarity=0.375 Sum_probs=174.7
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
.||..+. ++|++|+|++|+++ .+|..+.. +|+.|+|++|++. .+|..+. ++|++|+|++|+|+ .+|..+.
T Consensus 213 sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~-~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 213 SLPENLQ--GNIKTLYANSNQLT-SIPATLPD-TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred cCChhhc--cCCCEEECCCCccc-cCChhhhc-cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 3666554 58999999999999 67765432 6999999999999 8888775 58999999999999 7888765
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeec
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 167 (732)
++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++
T Consensus 283 ~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~L 353 (754)
T PRK15370 283 EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDV 353 (754)
T ss_pred CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEEC
Confidence 58999999999999 5676553 579999999999984 56544 3689999999999984 777664 79999999
Q ss_pred cCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCC
Q 040398 168 SDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYE 247 (732)
Q Consensus 168 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~ 247 (732)
++|++..++. .+ .++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|+. ++.....+++
T Consensus 354 s~N~L~~LP~-~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~s----------l~~~~~~~~~ 416 (754)
T PRK15370 354 SKNQITVLPE-TL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPES----------LPHFRGEGPQ 416 (754)
T ss_pred CCCCCCcCCh-hh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchh----------HHHHhhcCCC
Confidence 9999986553 22 368999999999999 6777654 37999999999998 55542 2334556688
Q ss_pred CCeEEccCCcCc
Q 040398 248 HQSLDLSYNNFT 259 (732)
Q Consensus 248 L~~LdLs~N~l~ 259 (732)
+..|+|.+|+|+
T Consensus 417 l~~L~L~~Npls 428 (754)
T PRK15370 417 PTRIIVEYNPFS 428 (754)
T ss_pred ccEEEeeCCCcc
Confidence 999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=167.28 Aligned_cols=136 Identities=17% Similarity=0.293 Sum_probs=105.8
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-----CCCceeeeeeeEEeCC---EE-EE
Q 040398 518 PMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-----QHPNLVKLYGCCIEGD---QL-ML 587 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~-~l 587 (732)
..+.||+|+||.||. +. ++.. +||++........+.+.+|+++++.+ .||||++++++++++. .. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 457899999999996 44 4444 79988765444567899999999999 5799999999999873 43 37
Q ss_pred EEEe--cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeCCCCCCCeEEcCC----CCeEEEe
Q 040398 588 VYEY--LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL-AFLHEESRFKIVHRDIKATNVLLDRD----LNPKISD 660 (732)
Q Consensus 588 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL-~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~D 660 (732)
|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999432 24444 35677888777 9999996 9999999999999743 3799999
Q ss_pred -eeccee
Q 040398 661 -FGLAKL 666 (732)
Q Consensus 661 -fGla~~ 666 (732)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=196.30 Aligned_cols=185 Identities=29% Similarity=0.375 Sum_probs=154.0
Q ss_pred ecccCceEEEEEE----EcCCeEEEEEEccccccc--chHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 522 IGEGGFGPVYKGQ----LTDGTIIAVKLLSSKSRQ--GNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 522 LG~G~fg~Vy~a~----~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+|+|+||.|+.++ ...|+.||+|+.+..... .......|..++...+ ||.+|++...+..+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999874 235788999988764221 1225566788888887 99999999999999999999999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
|.+...+. ....+.+.........++-|++++|+.+ ++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 82 g~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99988773 3345666777777788999999999986 999999999999999999999999998754432222
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999988 456689999999999999999999975
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-20 Score=188.28 Aligned_cols=139 Identities=22% Similarity=0.350 Sum_probs=120.1
Q ss_pred CCCCcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEeccc-ccCCcc
Q 040398 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEE-NQFSGT 79 (732)
Q Consensus 2 l~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~ 79 (732)
|+.||.+||++ -++|+|..|+|+...|.+|..+ +|++|||++|+|+.+-|+.|..+.+|.+|.+-+ |+|+ .
T Consensus 58 L~eVP~~LP~~------tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~ 130 (498)
T KOG4237|consen 58 LTEVPANLPPE------TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-D 130 (498)
T ss_pred cccCcccCCCc------ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-h
Confidence 67889999965 7889999999997777889998 799999999999977799999999999887776 9999 5
Q ss_pred CCc-cccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCC
Q 040398 80 IPR-ELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG 147 (732)
Q Consensus 80 ~p~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 147 (732)
+|. .|.+|..|+.|.+.-|++.-.....|..|++|..|.+-+|.+...--..|..+..++.+.+..|.
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 564 78899999999999999987777889999999999999999884444478888888888888877
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=204.42 Aligned_cols=264 Identities=20% Similarity=0.216 Sum_probs=174.7
Q ss_pred cccCCccCCCCC-CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccc
Q 040398 6 PGTLPPQIVNLP-YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL 84 (732)
Q Consensus 6 ~g~lP~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 84 (732)
...+|+.+..++ .|+.|++.+|.++ .+|..+...+|++|+|.+|++. .+|..+..+++|+.|+|++|.....+| .+
T Consensus 577 ~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~l 653 (1153)
T PLN03210 577 RWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DL 653 (1153)
T ss_pred eeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-cc
Confidence 345677776664 4788888877776 6777775557888888888887 677777788888888888765444666 47
Q ss_pred cCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCe
Q 040398 85 GNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQ 164 (732)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 164 (732)
+.+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|.....+|.. .++|+.
T Consensus 654 s~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~ 729 (1153)
T PLN03210 654 SMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISW 729 (1153)
T ss_pred ccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence 777888888888876555778888888888888888875545666655 6777777777777654444432 345666
Q ss_pred eeccCcCCCCCCcc-----------------------------cccCCCCccEEEcccccccCCcchhhcCCCCCcEEeC
Q 040398 165 LRISDLQGPNQTFP-----------------------------MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDL 215 (732)
Q Consensus 165 L~ls~N~l~~~~~~-----------------------------~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 215 (732)
|++++|.+...+.. ....+++|+.|+|++|...+.+|..++++++|+.|+|
T Consensus 730 L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 730 LDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred eecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 66666665443321 0112357888888888877788888888888999999
Q ss_pred CCCcCcccCCCCCccCcchhhHHH------HHHhccCCCCeEEccCCcCcCCCCCCccccCCCCccc
Q 040398 216 SFNQLTGELPDVAVPADLKFTQIL------MFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNL 276 (732)
Q Consensus 216 s~N~l~g~~p~~~~~~~l~~~~~~------~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~ 276 (732)
++|...+.+|......++....+. .+.....+|+.|+|++|.++..|.+...+..+..|++
T Consensus 810 s~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L 876 (1153)
T PLN03210 810 ENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDM 876 (1153)
T ss_pred CCCCCcCeeCCCCCccccCEEECCCCCccccccccccccCEeECCCCCCccChHHHhcCCCCCEEEC
Confidence 887655566654322222111110 1111235678888888888866655544554544443
|
syringae 6; Provisional |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-19 Score=201.29 Aligned_cols=197 Identities=26% Similarity=0.329 Sum_probs=156.6
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEEcc----cc-c-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 518 PMNKIGEGGFGPVYKGQLT-DGTIIAVKLLS----SK-S-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~----~~-~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..+.+|.|++|.|+.+... ..+.++.|.+. .. . ......+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988887643 34445555433 11 1 1111226678888899999999988887777666666699
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||++ +|...+.. ...+...++..++.|+++|++|+|+.| +.|||+|++|+++..++.+||+|||.+....-.
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99998833 246778889999999999999999997 999999999999999999999999998654332
Q ss_pred C---ceeeecccCccccccchhcccCCCCC-chhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 671 K---THISTRVAGTIGYMAPEYALWGYLTY-KADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 671 ~---~~~~~~~~gt~~y~APE~~~~~~~~~-k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
. .......+|+..|+|||++.+..|.+ ..||||.||++..|.+|+.||....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 2 25566788999999999999887776 5799999999999999999998543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-19 Score=170.23 Aligned_cols=197 Identities=25% Similarity=0.450 Sum_probs=155.3
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCc
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 596 (732)
.-+|.+...|..|+|++. |..+++|++... .....++|.+|.-.|+.+.||||.++++.|..+....++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345788889999999998 455677776543 33445789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceE-eCCCCCCCeEEcCCCCeEEEeeecceeCCccCceee
Q 040398 597 LAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV-HRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 597 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ii-H~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
|+..+|+. .....+..++.++|.+||+|++|||+.. +++ ---|.+..+++|++.+++|. .+-+++.....
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~---- 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV---- 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeecc----
Confidence 99999764 3456678889999999999999999985 344 44688999999999887764 22222221111
Q ss_pred ecccCccccccchhcccCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLT---YKADVYSFGVVALEIVSGKNNMSYVPDSNC 726 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~---~k~DvwSlGvll~elltG~~P~~~~~~~~~ 726 (732)
...-.+.||+||.++.++-+ +.+|+|||.|++||+.|...||...+.-++
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 12235689999999876543 478999999999999999999987665443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=191.68 Aligned_cols=175 Identities=22% Similarity=0.257 Sum_probs=126.0
Q ss_pred CCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
..-..|+|+.|.|+ .+|..+.. +|+.|++.+|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~~-~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchhc-CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 34678999999999 78886653 7999999999999 67753 589999999999999 67753 4689999999
Q ss_pred CCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCC
Q 040398 97 SNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 97 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
+|.|+ .+|..+ ++|+.|+|++|+++ .+|.. +++|+.|+|++|++++ +|... .+|+.|++++|.++.++
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~LP 338 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTSLP 338 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccccc
Confidence 99998 666533 67899999999998 45543 4789999999999985 44422 24556666666665543
Q ss_pred cccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 177 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
. ...+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+
T Consensus 339 ~----lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~ 375 (788)
T PRK15387 339 T----LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT 375 (788)
T ss_pred c----cccccceEecCCCccC-CCCCC---Ccccceehhhccccc
Confidence 2 1135666666666666 34432 234445555555555
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-20 Score=169.17 Aligned_cols=156 Identities=24% Similarity=0.456 Sum_probs=114.4
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+.+++++++|.||.|+++ .+|..++.+ +|+.|++++|+++ .+|.+++.++.|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456667777788888887 666666666 7888888888877 77777888888888888888877 7777888888888
Q ss_pred EEeCCCCcccc-cCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCc
Q 040398 92 TLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170 (732)
Q Consensus 92 ~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 170 (732)
.|||.+|++.. .+|..|..++.|+.|+|++|.|. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 88888777764 56777777777777888888776 66777777777777777777776 56666666665555555544
Q ss_pred CCC
Q 040398 171 QGP 173 (732)
Q Consensus 171 ~l~ 173 (732)
++.
T Consensus 184 rl~ 186 (264)
T KOG0617|consen 184 RLT 186 (264)
T ss_pred eee
Confidence 443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.6e-20 Score=202.82 Aligned_cols=223 Identities=24% Similarity=0.349 Sum_probs=134.9
Q ss_pred CCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
++|+.|+.+.|.++ ..-..+...+|++++++.|+++ .+|+.++.+.+|+.|++.+|+|+ .+|..+...++|+.|++.
T Consensus 219 ~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 219 PSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred cchheeeeccCcce-eeccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 45666666666666 3333333446888888888888 77788888888888888888886 777777777888888888
Q ss_pred CCcccccCCccccCCCCCCEEEccCccccccCCcc-ccC-------------------------CCCCCEEEcccCCCcC
Q 040398 97 SNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF-IQS-------------------------WTQLNRLEIQGSGLEG 150 (732)
Q Consensus 97 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~-------------------------l~~L~~L~Ls~N~l~~ 150 (732)
.|.++ -+|.....++.|+.|+|..|+|. ..|+. +.- ++.|+.|.+.+|.++.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 88877 66767777788888888888776 33322 211 2234444444555544
Q ss_pred cCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCcc
Q 040398 151 PIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVP 230 (732)
Q Consensus 151 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 230 (732)
..-..+.+..+|+.|+|++|++...+...+.+++.|++|+||+|+++ .+|+.+.+++.|++|...+|+|. ..|
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP----- 446 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP----- 446 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-----
Confidence 44444444555555555555555555555555555555555555554 44444444444444444444443 122
Q ss_pred CcchhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 231 ADLKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 231 ~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
.+..++.|+.+|||.|+|+-.
T Consensus 447 ----------e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 447 ----------ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ----------hhhhcCcceEEecccchhhhh
Confidence 244556666666666666543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.8e-19 Score=199.44 Aligned_cols=197 Identities=21% Similarity=0.290 Sum_probs=152.9
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEEccccc-ccchHHHHHHHHH--HhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS-RQGNREFLNEIGT--ISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++...+.||++.|=+|.+|++.+|. |+||+|.... .-..+.|.++++. ...++|||.+++...-+.+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667788999999999999998887 8999887654 3344555554443 4555899999999887778888999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce--eCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~--~~~~ 669 (732)
+.. +|+|.+ ..+.-+...+.+.||.|++.||..+|+.| |+|||||.+|||++.-+.+.|+||..-+ +.++
T Consensus 103 vkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 855 899988 34445677788899999999999999996 9999999999999999999999997654 2233
Q ss_pred cCcee----eecccCccccccchhcccC----------C-CCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 670 EKTHI----STRVAGTIGYMAPEYALWG----------Y-LTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 670 ~~~~~----~~~~~gt~~y~APE~~~~~----------~-~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+.... ...-..-.+|+|||.+... . .+++.||||+||+++||++ |++||+.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 22211 1111233489999987531 2 6788999999999999988 6888863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-19 Score=201.92 Aligned_cols=218 Identities=26% Similarity=0.360 Sum_probs=168.6
Q ss_pred CCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
+|++++++.|+++ .+|..++.+ +|+.|+..+|+|. .+|..+...++|+.|++.+|.++ .+|..+..++.|++|+|.
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 5777777777777 555555555 6777777777775 67777777777777777777776 666666667777777777
Q ss_pred CCcccccCCccc--------------------------cCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcC
Q 040398 97 SNRLIGNLPMEL--------------------------VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG 150 (732)
Q Consensus 97 ~N~l~~~~p~~l--------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 150 (732)
.|+|. .+|+.+ ..++.|+.|++.+|.++...-..+.++.+|+.|+|++|++.
T Consensus 319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~- 396 (1081)
T KOG0618|consen 319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN- 396 (1081)
T ss_pred hcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-
Confidence 77775 343322 12346789999999998777778899999999999999998
Q ss_pred cCCc-cccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCc
Q 040398 151 PIPP-SISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAV 229 (732)
Q Consensus 151 ~~p~-~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 229 (732)
.+|. .+.+++.|++|+||+|.++.++ ..+..+..|+.|...+|+|. ..| .+..++.|+.+|||.|+|+...-....
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 5554 5899999999999999999988 77888999999999999998 788 788999999999999999854222111
Q ss_pred cCcchhhHHHHHHhccCCCCeEEccCCc
Q 040398 230 PADLKFTQILMFIRGVYEHQSLDLSYNN 257 (732)
Q Consensus 230 ~~~l~~~~~~~~~~~l~~L~~LdLs~N~ 257 (732)
+ -++|++|||++|.
T Consensus 474 p--------------~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 474 P--------------SPNLKYLDLSGNT 487 (1081)
T ss_pred C--------------CcccceeeccCCc
Confidence 1 1689999999996
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=165.82 Aligned_cols=197 Identities=20% Similarity=0.264 Sum_probs=129.9
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCC----------CceeeeeeeEE---
Q 040398 518 PMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQH----------PNLVKLYGCCI--- 580 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~--- 580 (732)
..+.||.|+++.||.+++. +|+.+|||++.... ....+.+.+|.-....+.+ -.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3467999999999999986 69999999876543 2234666777655555433 11222222211
Q ss_pred ------eC---CE-----EEEEEEecCCCchhHHhh---cCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 581 ------EG---DQ-----LMLVYEYLENNSLAHALF---GGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 581 ------~~---~~-----~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
.. .. .+++|+-+ .++|.+.+. ........+....+..+..|+.+.+++||+.| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 11 25677777 458877642 22222344566677788899999999999997 999999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhccc--------CCCCCchhHHHHHHHHHHHHcCC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW--------GYLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DvwSlGvll~elltG~ 715 (732)
+|+|++++++|.++|+||+.......... . ...+..|.+||.... ..++.+.|.|+||+++|.|.+|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999987764433111 1 234568999997643 25788999999999999999999
Q ss_pred CCCCCCC
Q 040398 716 NNMSYVP 722 (732)
Q Consensus 716 ~P~~~~~ 722 (732)
.||+...
T Consensus 248 lPf~~~~ 254 (288)
T PF14531_consen 248 LPFGLSS 254 (288)
T ss_dssp -STCCCG
T ss_pred CCCCCCC
Confidence 9998643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=164.88 Aligned_cols=146 Identities=18% Similarity=0.139 Sum_probs=111.7
Q ss_pred hCCCcccceecccCceEEEEEE--EcCCeEEEEEEccccccc------------------------chHHHHHHHHHHhc
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQ------------------------GNREFLNEIGTISC 566 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~ 566 (732)
.-.|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+|++.+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3358889999999999999998 458999999998743210 01235689999999
Q ss_pred CCCCc--eeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 567 LQHPN--LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 567 l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
+.+.. +.+++++ ...++||||+++.+|..... ....+.......++.||+.++++||+.+ .++|||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 97643 3344432 23589999999988876541 2234556667899999999999999984 39999999
Q ss_pred CCCeEEcCCCCeEEEeeecceeCCc
Q 040398 645 ATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 645 p~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 88999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.1e-17 Score=160.90 Aligned_cols=135 Identities=21% Similarity=0.312 Sum_probs=113.2
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEccccccc--------chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ--------GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
+.||+|++|.||+|+. +|..+++|+....... ...++.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5778999976543211 124578899999999999998877777778888999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988421 12 77899999999999999986 99999999999999 788999999998753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-16 Score=194.41 Aligned_cols=122 Identities=23% Similarity=0.269 Sum_probs=92.4
Q ss_pred CCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeC
Q 040398 136 TQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDL 215 (732)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 215 (732)
++|+.|+|++|...+.+|..+.++++|+.|+|++|......+..+ .+++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 578888999998877899999999999999999975433333333 6889999999998766566653 468999999
Q ss_pred CCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccC-CcCcCCCCCCccccCCCCccc
Q 040398 216 SFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY-NNFTWQSPEQPACREKPNLNL 276 (732)
Q Consensus 216 s~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~-N~l~~~~p~~~~~~~~~~l~~ 276 (732)
++|.++ .+|.. +..+++|+.|+|++ |+|+..++....+..+..+.+
T Consensus 854 s~n~i~-~iP~s--------------i~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l 900 (1153)
T PLN03210 854 SRTGIE-EVPWW--------------IEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDF 900 (1153)
T ss_pred CCCCCc-cChHH--------------HhcCCCCCEEECCCCCCcCccCcccccccCCCeeec
Confidence 999998 45543 67788999999998 677776665555554444443
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-18 Score=184.04 Aligned_cols=243 Identities=19% Similarity=0.215 Sum_probs=177.6
Q ss_pred CCccCCCCCCCCEEEcccCcCccc----cCcccccc-ccceEecccccccc------cCCccccCCCCCCEEecccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGS----IPREWASM-QLKYISVFANRLSG------NIPSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~~-~L~~L~L~~n~l~~------~~p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
.+..+..+++|++|++++|.++.. ++..+... +|++|+++.+.+.+ .++..+..+++|++|+|++|.+.
T Consensus 15 ~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~ 94 (319)
T cd00116 15 ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALG 94 (319)
T ss_pred hHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCC
Confidence 444556677799999999998643 33333333 48999999988772 34456777889999999999998
Q ss_pred ccCCccccCCCC---CCEEeCCCCcccc----cCCccccCC-CCCCEEEccCcccccc----CCccccCCCCCCEEEccc
Q 040398 78 GTIPRELGNLVN---LETLRLSSNRLIG----NLPMELVKL-KNLTDFRINDNNFNGS----APDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 78 ~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~ 145 (732)
+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|+.|+|++
T Consensus 95 ~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~ 174 (319)
T cd00116 95 PDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN 174 (319)
T ss_pred hhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcC
Confidence 666666655555 9999999999873 334456667 8999999999998843 344567778999999999
Q ss_pred CCCcCc----CCccccCccCCCeeeccCcCCCCCCcc----cccCCCCccEEEcccccccCCcchhhcC-----CCCCcE
Q 040398 146 SGLEGP----IPPSISALDKLNQLRISDLQGPNQTFP----MLRNMTGLTRIILRNCNIAGEIPEYIWG-----IKNLRF 212 (732)
Q Consensus 146 N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~ 212 (732)
|.+++. ++..+..+++|+.|++++|.+.+.... .+..+++|++|++++|.+++.....+.. .+.|+.
T Consensus 175 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~ 254 (319)
T cd00116 175 NGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLT 254 (319)
T ss_pred CCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceE
Confidence 999843 334456667999999999988765433 3567788999999999998644443332 379999
Q ss_pred EeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 213 LDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 213 L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
|++++|.++.. ....+...+..+++|+.||+++|+++..
T Consensus 255 L~l~~n~i~~~----------~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 255 LSLSCNDITDD----------GAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred EEccCCCCCcH----------HHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 99999988722 1123344566668899999999998744
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-19 Score=160.93 Aligned_cols=163 Identities=27% Similarity=0.397 Sum_probs=116.8
Q ss_pred cccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCC
Q 040398 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQL 138 (732)
Q Consensus 59 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 138 (732)
.+.++++++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3556677777778888877 67777777778888888888877 77777777788888888777776 677777777777
Q ss_pred CEEEcccCCCcC-cCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCC
Q 040398 139 NRLEIQGSGLEG-PIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217 (732)
Q Consensus 139 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 217 (732)
+.|||..|++.. .+|..|..++.|..|.|++|.+..++ +..+.+++|+.|.+..|.+- .+|..++.+..|+.|.+.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp-~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILP-PDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCC-hhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 777777777753 56777777777777777777665433 34566666677777777666 6777777777777777777
Q ss_pred CcCcccCCC
Q 040398 218 NQLTGELPD 226 (732)
Q Consensus 218 N~l~g~~p~ 226 (732)
|+++-.+|+
T Consensus 183 nrl~vlppe 191 (264)
T KOG0617|consen 183 NRLTVLPPE 191 (264)
T ss_pred ceeeecChh
Confidence 777755544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=156.94 Aligned_cols=132 Identities=25% Similarity=0.342 Sum_probs=107.2
Q ss_pred eecccCceEEEEEEEcCCeEEEEEEcccccc--------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR--------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.||+|+||.||+|++ +|..+++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 478899998654221 11356778999999999988766666666777789999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
+|++|.+.+.... . .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~~----------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998873211 0 78999999999999986 99999999999999 7899999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-18 Score=182.56 Aligned_cols=240 Identities=21% Similarity=0.256 Sum_probs=182.0
Q ss_pred CCccCCCCCCCCEEEcccCcCcc------ccCcccccc-ccceEecccccccccCCccccCCCC---CCEEecccccCCc
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHG------SIPREWASM-QLKYISVFANRLSGNIPSHLGNITS---LTYLDLEENQFSG 78 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~------~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~ 78 (732)
+++.+...+.|++|+++++.+.+ .++..+..+ +|++|+|++|.+.+..+..+..+.+ |++|++++|++++
T Consensus 43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~ 122 (319)
T cd00116 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD 122 (319)
T ss_pred HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence 66678888899999999998872 233445545 7999999999998766666666655 9999999999983
Q ss_pred ----cCCccccCC-CCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCcccccc----CCccccCCCCCCEEEccc
Q 040398 79 ----TIPRELGNL-VNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFNGS----APDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 79 ----~~p~~l~~l-~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~ 145 (732)
.+...+..+ ++|+.|+|++|.+++ .++..+..+++|+.|++++|.+++. ++..+..+++|+.|+|++
T Consensus 123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 202 (319)
T cd00116 123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202 (319)
T ss_pred HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence 234456677 899999999999984 3445567788999999999999842 334456678999999999
Q ss_pred CCCcCc----CCccccCccCCCeeeccCcCCCCCCccccc-----CCCCccEEEcccccccC----CcchhhcCCCCCcE
Q 040398 146 SGLEGP----IPPSISALDKLNQLRISDLQGPNQTFPMLR-----NMTGLTRIILRNCNIAG----EIPEYIWGIKNLRF 212 (732)
Q Consensus 146 N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~ 212 (732)
|.+++. +...+..+++|+.|++++|.+++.....+. ..+.|++|++++|.+++ .+...+..+++|+.
T Consensus 203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 999743 344567789999999999998874443332 23799999999999973 34456677899999
Q ss_pred EeCCCCcCcccCCCCCccCcchhhHHHHHHhcc-CCCCeEEccCCcC
Q 040398 213 LDLSFNQLTGELPDVAVPADLKFTQILMFIRGV-YEHQSLDLSYNNF 258 (732)
Q Consensus 213 L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l-~~L~~LdLs~N~l 258 (732)
|++++|.++..... .+...+... ..|+.||+.+|++
T Consensus 283 l~l~~N~l~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 283 LDLRGNKFGEEGAQ----------LLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EECCCCCCcHHHHH----------HHHHHHhhcCCchhhcccCCCCC
Confidence 99999999944221 122223333 6789999988864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=155.55 Aligned_cols=143 Identities=19% Similarity=0.185 Sum_probs=110.3
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEccccccc----------------------chHHHHHHHHHHh
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ----------------------GNREFLNEIGTIS 565 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~ 565 (732)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333444447788999999999999999888999999986543210 1123577888899
Q ss_pred cCCCCc--eeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 566 CLQHPN--LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 566 ~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
.+.|++ +++.++ ....++||||+++++|.+... ......++.++++++.++|+.+ ++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 888874 334433 245689999999999876541 0234578899999999999986 999999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||+||++++++.++|+|||++...
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=161.63 Aligned_cols=144 Identities=28% Similarity=0.398 Sum_probs=107.4
Q ss_pred CCCceeeeeeeEEe---------------------------CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHH
Q 040398 568 QHPNLVKLYGCCIE---------------------------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620 (732)
Q Consensus 568 ~H~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 620 (732)
+|||||++.++|.+ +...|+||.-.+ .+|+.++.. ...+...+.-|.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887653 224688988664 489988843 234566777889
Q ss_pred HHHHHHHHHHHhCCCCceEeCCCCCCCeEE--cCCCC--eEEEeeecceeCCccC-----ceeeecccCccccccchhcc
Q 040398 621 LGIARGLAFLHEESRFKIVHRDIKATNVLL--DRDLN--PKISDFGLAKLDEEEK-----THISTRVAGTIGYMAPEYAL 691 (732)
Q Consensus 621 ~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~--~kL~DfGla~~~~~~~-----~~~~~~~~gt~~y~APE~~~ 691 (732)
.|+++|+.|||++| |.|||+|++|||+ |+|.. +.|+|||++--.+... .......-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999997 9999999999998 44433 7899999874322211 11122234777899999876
Q ss_pred cCCC------CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 692 WGYL------TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 692 ~~~~------~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..+- -.|+|.|+.|.+.||+++...||=.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 4321 2489999999999999999999953
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=177.89 Aligned_cols=140 Identities=21% Similarity=0.280 Sum_probs=112.6
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEE-cccc-c------ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKL-LSSK-S------RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
...|...+.||+|+||.||++.+.... +++|+ .... . ....+++.+|+++++.++|++++....++.++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999876443 33333 2211 1 1123568899999999999999988888877778
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999883 35679999999999999986 9999999999999 5778999999999
Q ss_pred eeCCc
Q 040398 665 KLDEE 669 (732)
Q Consensus 665 ~~~~~ 669 (732)
+....
T Consensus 475 ~~~~~ 479 (535)
T PRK09605 475 KYSDL 479 (535)
T ss_pred ccCCc
Confidence 86543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.8e-18 Score=171.17 Aligned_cols=237 Identities=18% Similarity=0.224 Sum_probs=189.6
Q ss_pred cCC-ccCCCCCCCCEEEcccCcCccccCcccccc-ccceE-ecccccccccCCccccCCCCCCEEecccccCCccCCccc
Q 040398 8 TLP-PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYI-SVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL 84 (732)
Q Consensus 8 ~lP-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L-~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 84 (732)
.|| .+|+.+++|++|||+.|+|+.+-|.+|..+ +|.+| ++++|+|+..-...|+.|..|+.|.+.-|++.-...+.|
T Consensus 81 ~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al 160 (498)
T KOG4237|consen 81 SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDAL 160 (498)
T ss_pred cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHH
Confidence 355 589999999999999999999999999999 55555 555599994444789999999999999999996666789
Q ss_pred cCCCCCCEEeCCCCcccccCCc-cccCCCCCCEEEccCcccc------------ccCCccccCCCCCCEEEccc------
Q 040398 85 GNLVNLETLRLSSNRLIGNLPM-ELVKLKNLTDFRINDNNFN------------GSAPDFIQSWTQLNRLEIQG------ 145 (732)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L~~L~Ls~------ 145 (732)
..+++|..|.+.+|.+. .++. .|..+.+++.+.+..|.+- ...|..++.+....-..+..
T Consensus 161 ~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~ 239 (498)
T KOG4237|consen 161 RDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQE 239 (498)
T ss_pred HHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhccc
Confidence 99999999999999998 6665 8899999999999999832 12222333222222222221
Q ss_pred -------------------CCCcCcCC-ccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhc
Q 040398 146 -------------------SGLEGPIP-PSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW 205 (732)
Q Consensus 146 -------------------N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 205 (732)
+...+.-| ..|..|++|+.|+|++|+++.+...+|..+.+|++|.|..|+|...-...|.
T Consensus 240 ~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~ 319 (498)
T KOG4237|consen 240 DARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQ 319 (498)
T ss_pred chhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhh
Confidence 11222333 3478899999999999999999999999999999999999999866667888
Q ss_pred CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 206 GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 206 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
++..|+.|+|.+|+|+...|.. |..+..|.+|+|-.|++.
T Consensus 320 ~ls~L~tL~L~~N~it~~~~~a--------------F~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 320 GLSGLKTLSLYDNQITTVAPGA--------------FQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccccceeeeecCCeeEEEeccc--------------ccccceeeeeehccCccc
Confidence 9999999999999999777754 666788999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.8e-16 Score=173.70 Aligned_cols=165 Identities=26% Similarity=0.366 Sum_probs=119.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+|+.++.+..|+||.||.++++ +.+.+|+|+=+.. - +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhhc--cccccCCccee------------------
Confidence 467889999999999999999987 5677888543211 1 0110 23333333333
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
|+-.+.++ ...+++-. ++.+++|+|+.+ |+|||+||+|.+++.-|++|+.|||+++......
T Consensus 136 ---gDc~tllk----~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLK----NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcc----cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33333331 22233322 267899999997 9999999999999999999999999987421110
Q ss_pred c--------e------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 T--------H------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~--------~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
. . ....++||+.|+|||++....|...+|+|++|+|+||.+.|..||...
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0 0 122368999999999999999999999999999999999999999754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.9e-15 Score=137.09 Aligned_cols=136 Identities=20% Similarity=0.232 Sum_probs=113.9
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCC--CceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH--PNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
+.+.+|+|.++.||++...+ +.+++|....... ...+.+|+..++.++| ..+++++.+...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45779999999999999764 7899999865443 5678899999999976 58889988888888899999999987
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
.+... +......++.+++++++++|......++|+|++|+||++++.+.++++|||.+...
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 66532 45667788999999999999864345999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=141.78 Aligned_cols=135 Identities=22% Similarity=0.232 Sum_probs=95.9
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEccccccc--chHH----------------------HHHHHHHHhcCCCCc--e
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ--GNRE----------------------FLNEIGTISCLQHPN--L 572 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--I 572 (732)
.+.||+|+||.||+|...+|+.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988653221 1111 134555565554433 3
Q ss_pred eeeeeeEEeCCEEEEEEEecCCCchhH-HhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEE
Q 040398 573 VKLYGCCIEGDQLMLVYEYLENNSLAH-ALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 573 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl 650 (732)
.+.++. ...++||||++++.+.. .+... ... .....++.+++.++.++|. .+ |+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 333332 24589999999954322 11100 001 5677899999999999998 65 9999999999999
Q ss_pred cCCCCeEEEeeecceeC
Q 040398 651 DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~ 667 (732)
+ ++.++++|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-15 Score=162.91 Aligned_cols=124 Identities=26% Similarity=0.411 Sum_probs=105.9
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
.+.++.|++|...+|.+|+.+.+ .....++.....++.|++.|++| ++ .+|+|+||.||+...+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996443 34466888999999999999999 54 8999999999999999999999999
Q ss_pred cceeCCccC-----ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc
Q 040398 663 LAKLDEEEK-----THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713 (732)
Q Consensus 663 la~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt 713 (732)
+........ ....+...||..||+||.+.+..|+.|+||||||++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 986544333 122344679999999999999999999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.7e-14 Score=142.83 Aligned_cols=136 Identities=20% Similarity=0.232 Sum_probs=104.8
Q ss_pred ceec-ccCceEEEEEEEcCCeEEEEEEccccc-------------ccchHHHHHHHHHHhcCCCCce--eeeeeeEEeCC
Q 040398 520 NKIG-EGGFGPVYKGQLTDGTIIAVKLLSSKS-------------RQGNREFLNEIGTISCLQHPNL--VKLYGCCIEGD 583 (732)
Q Consensus 520 ~~LG-~G~fg~Vy~a~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~ 583 (732)
..|| .|+.|+||+++.. +..++||++.... .....++.+|++++..++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999999875 6778999875311 1223568899999999998885 56676644332
Q ss_pred ----EEEEEEEecCC-CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 584 ----QLMLVYEYLEN-NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 584 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
..++|||++++ .+|.+++.. .+++.. .+.+|+.++.+||+.| |+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22599999997 689888743 234433 3578999999999997 999999999999999999999
Q ss_pred EeeecceeCC
Q 040398 659 SDFGLAKLDE 668 (732)
Q Consensus 659 ~DfGla~~~~ 668 (732)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999987644
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-15 Score=162.63 Aligned_cols=172 Identities=26% Similarity=0.356 Sum_probs=125.4
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
-...||+.|++. ++|..++.+..|+.|.|..|.+. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 445677777777 67777777777777777777776 66777777777777777777776 6666666654 67777777
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP 201 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 201 (732)
|+++ .+|+.++.++.|..|+.+.|.+. .+|..+..+.+|+.|.+..|++...+.... .-.|..||+|+|+++ .+|
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~--~LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC--SLPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh--CCceeeeecccCcee-ecc
Confidence 7766 66666666677777777777776 666667777777777777777666654433 235889999999998 899
Q ss_pred hhhcCCCCCcEEeCCCCcCcc
Q 040398 202 EYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 202 ~~l~~l~~L~~L~Ls~N~l~g 222 (732)
..|.+|+.|++|-|.+|.|..
T Consensus 228 v~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhhheeeeeccCCCCC
Confidence 999999999999999999983
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.8e-14 Score=152.09 Aligned_cols=154 Identities=30% Similarity=0.489 Sum_probs=126.8
Q ss_pred HhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 564 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
|+.+.|.|+.++++.+.++...+.|.+||+.|+|.|.+.. ....++|.....++++|++||+|+|+.. -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4678999999999999999999999999999999999954 4567899999999999999999999873 2289999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeCCccC-ceeeecccCccccccchhcccC-------CCCCchhHHHHHHHHHHHHcCC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWG-------YLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-------~~~~k~DvwSlGvll~elltG~ 715 (732)
+++|.++|....+|+.|||+..+..... ........-..-|.|||.+... ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987654210 0111111233478999998763 1467899999999999999999
Q ss_pred CCCCCCC
Q 040398 716 NNMSYVP 722 (732)
Q Consensus 716 ~P~~~~~ 722 (732)
.||....
T Consensus 156 ~~~~~~~ 162 (484)
T KOG1023|consen 156 GPFDLRN 162 (484)
T ss_pred Ccccccc
Confidence 9998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.8e-15 Score=166.08 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=161.2
Q ss_pred CCCcccceecccCceEEEEEEEc--CCeEEEEEEccccc--ccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 588 (732)
..|...+.||+|+|+.|-.+... ....+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35666777999999999888754 34567777665543 222344455777777776 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCceEeCCCCCCCeEEcCCC-CeEEEeeeccee
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH-EESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKL 666 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~ 666 (732)
.+|..++++.+-+. .......+......+..|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.|||+|..
T Consensus 100 ~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999988772 111113455566789999999999999 775 99999999999999999 999999999976
Q ss_pred CCc--cCceeeecccC-ccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 667 DEE--EKTHISTRVAG-TIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 667 ~~~--~~~~~~~~~~g-t~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
... .........+| ++.|+|||...+ +...+..|+||.|+++..+++|..|++...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 544 22333444678 999999999887 466788999999999999999999998643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=152.65 Aligned_cols=202 Identities=31% Similarity=0.466 Sum_probs=114.5
Q ss_pred eEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCC-CCCEEeCCCCcccccCCccccCCCCCCEEEccCc
Q 040398 44 YISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLV-NLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122 (732)
Q Consensus 44 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 122 (732)
.|.+..|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 3555555553 22333444456666666666665 5555555553 6666666666665 55455566666666666666
Q ss_pred cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcch
Q 040398 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPE 202 (732)
Q Consensus 123 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 202 (732)
+++ .+|...+..++|+.|++++|+++ .+|.....+..|++|++++|.+.. .+..+..+.++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~-~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCccee-cchhhhhcccccccccCCceee-eccc
Confidence 665 44444445566666666666665 555554455556666666664221 1223445555666666666665 3455
Q ss_pred hhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccc
Q 040398 203 YIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPAC 268 (732)
Q Consensus 203 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~ 268 (732)
.+..+++|+.|++++|.++...+ ++.+.+++.||+++|.++..+|....+
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~----------------~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS----------------LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred hhccccccceecccccccccccc----------------ccccCccCEEeccCccccccchhhhcc
Confidence 66666667777777777663322 334456667777777776666665444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=150.59 Aligned_cols=199 Identities=30% Similarity=0.448 Sum_probs=170.0
Q ss_pred EEEcccCcCccccCccccccccceEecccccccccCCccccCCC-CCCEEecccccCCccCCccccCCCCCCEEeCCCCc
Q 040398 21 TVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT-SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNR 99 (732)
Q Consensus 21 ~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 99 (732)
.|+++.|.+...+........+..|++.+|+++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 588888888633333333337999999999999 8998888885 9999999999999 888889999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCccc
Q 040398 100 LIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPM 179 (732)
Q Consensus 100 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 179 (732)
++ .+|.....+++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+.++.++..|.+.+|++... +..
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~ 250 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PES 250 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cch
Confidence 99 77877768899999999999998 77877777788999999999755 6778889999999999999988765 456
Q ss_pred ccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCC
Q 040398 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDV 227 (732)
Q Consensus 180 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 227 (732)
++.++.|++|++++|.++ .++. +..+.+|+.|++++|.+...+|..
T Consensus 251 ~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 251 IGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 778888999999999999 5555 889999999999999999887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.2e-13 Score=146.89 Aligned_cols=141 Identities=21% Similarity=0.238 Sum_probs=99.6
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEcccccccch----------------------------------------HHHHH
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN----------------------------------------REFLN 559 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 559 (732)
+.||+|++|.||+|+.++|+.||||+......... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999764321100 02445
Q ss_pred HHHHHhcCC----CCceeeeeeeE-EeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHH-HHHHHHhC
Q 040398 560 EIGTISCLQ----HPNLVKLYGCC-IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR-GLAFLHEE 633 (732)
Q Consensus 560 E~~~l~~l~----H~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-aL~yLH~~ 633 (732)
|.+.+.+++ |.+-+.+-..+ ...+..++||||++|++|.+....... .. .+.+++.++++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555542 32223322222 224557999999999999887632111 11 23457777766 47888988
Q ss_pred CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 634 ~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
| ++|+|+||.||++++++.++++|||++....+
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 99999999999999999999999999976654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.5e-13 Score=128.86 Aligned_cols=169 Identities=37% Similarity=0.592 Sum_probs=106.1
Q ss_pred eEEEecCCCee-eecCceecCCCCCCCCcceeeecCCCCceeccccCCCCCCccccccccccCCCCCchhhhcccccCcc
Q 040398 305 SLHINCGGGNV-KVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDDDEQNTNYIANSQSSGISELYNDARISPL 383 (732)
Q Consensus 305 s~~i~c~~~~~-~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (732)
++.|||||+.. ...+..|+.|....|+...|...... ..........-..+....+|++.|..|.
T Consensus 2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~--------------~~~~~~~~~~i~~t~d~~Lyqt~R~g~~ 67 (174)
T PF11721_consen 2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDN--------------NGSTSSTNSSIPGTTDDPLYQTERYGPS 67 (174)
T ss_dssp EEEEEETSSSEEETTTEEE-SSSSSTTSS-------------------------SSTTS--TTS-HHHHHTTT-----SS
T ss_pred EEEEECCCCcccCCCCCEEcCCCCCCCCCccccccccc--------------ccccccccccccCCCchhhhHhhcCCCC
Confidence 57899999998 44456999999887765443321000 0000001111224456789999999999
Q ss_pred ceeEEEEeecCcceeEEEEeeEEEeeccccccccCceeeEEEecceecccccchhhhccCCCCceeeee-eeeeccceEE
Q 040398 384 SLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPF-TANVSNHILE 462 (732)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~ 462 (732)
+++|..-|+.+|.|.|.|||||+.+.....+...|+|+|+|++.++.+.++++|.+++++..++..+.+ ...+.+....
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~ 147 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLN 147 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEE
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEE
Confidence 999999899999999999999999998888889999999999999999999999999999887777776 7888898999
Q ss_pred EEEEEcCCCcccccCCCccC-CCccc
Q 040398 463 IRFQWAGKGTTAIPIGGVYG-PLISA 487 (732)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~-p~~~~ 487 (732)
+.|.|.+++...++..+.++ |++++
T Consensus 148 i~f~~~~~~~~~i~~~~~~~~p~Isa 173 (174)
T PF11721_consen 148 IQFVWAGKGTLCIPFIGSYGNPLISA 173 (174)
T ss_dssp TTEEEE--SEEEEEEESSSSSSSEEE
T ss_pred EEEEecCCCcEEeeccccCCCcEEee
Confidence 99999999988887645444 66654
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.8e-14 Score=151.94 Aligned_cols=196 Identities=26% Similarity=0.386 Sum_probs=169.7
Q ss_pred eEecccccccccCCccc--cCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 44 YISVFANRLSGNIPSHL--GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 44 ~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
+|.|++-+++ +.|..- -.+..-...||+.|++. .+|..+..+..|+.|.|..|.|. .+|..++++..|++|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 5667777776 555322 34667778999999999 99999999999999999999999 9999999999999999999
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP 201 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 201 (732)
|+++ .+|..++.|+ |+.|.+++|+++ .+|+.++.+.+|..||.+.|.+..++ ..++++.+|+.|.+..|++. .+|
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slp-sql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLP-SQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhch-HHhhhHHHHHHHHHhhhhhh-hCC
Confidence 9998 7888888876 999999999999 89999999999999999999988765 46788999999999999999 788
Q ss_pred hhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 202 EYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 202 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+.+..+ .|..||+|+|+++ .+|-. |.+|..|++|-|.+|+|...|.
T Consensus 206 ~El~~L-pLi~lDfScNkis-~iPv~--------------fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKIS-YLPVD--------------FRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred HHHhCC-ceeeeecccCcee-ecchh--------------hhhhhhheeeeeccCCCCCChH
Confidence 888855 5889999999999 55543 8899999999999999985444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-12 Score=120.52 Aligned_cols=132 Identities=20% Similarity=0.184 Sum_probs=97.6
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCcee-eeeeeEEeCCEEEEEEEecCCCch
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV-KLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
.+.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.+++ +++.+. .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999876 77899998765432 223467889999888765554 444433 3345799999999877
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
.+.- .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.+...
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5420 111345678999999999875 22369999999999999 668999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-12 Score=143.14 Aligned_cols=147 Identities=16% Similarity=0.211 Sum_probs=94.7
Q ss_pred hCCCcccceecccCceEEEEEEEcC-CeEEEEEEccccccc----------------------------------chH--
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQ----------------------------------GNR-- 555 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~----------------------------------~~~-- 555 (732)
...|+. +.||+|++|.||+|+.++ |+.||||+....... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999987 999999998743110 001
Q ss_pred ----HHHHHHHHHhcCC----CCceeeeeeeEEe-CCEEEEEEEecCCCchhHHh--hcCCCCcccCCHHHHHHHHHHHH
Q 040398 556 ----EFLNEIGTISCLQ----HPNLVKLYGCCIE-GDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIA 624 (732)
Q Consensus 556 ----~~~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~ 624 (732)
+|.+|+..+.+++ +...+.+=..+.+ ....++||||++|+.+.+.- .........+....+..++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~--- 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT--- 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH---
Confidence 1344444444442 3333333333332 45678999999999998742 11111111222222333333
Q ss_pred HHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEeeecceeCCcc
Q 040398 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDFGLAKLDEEE 670 (732)
Q Consensus 625 ~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DfGla~~~~~~ 670 (732)
.++..| ++|+|+||.||+++.++ .++++|||++...++.
T Consensus 275 ----Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 ----QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334454 99999999999999988 8999999999766543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-13 Score=136.01 Aligned_cols=241 Identities=20% Similarity=0.233 Sum_probs=177.6
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccc----cc-ccceEecccc---cccccCCcc-------ccCCCCCCEEeccc
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWA----SM-QLKYISVFAN---RLSGNIPSH-------LGNITSLTYLDLEE 73 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----~~-~L~~L~L~~n---~l~~~~p~~-------l~~l~~L~~L~Ls~ 73 (732)
+-+.+..+..++.|+|++|.+...--..++ .. +|++.++++- ++...+|+. +-.+++|++||||+
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 335567788999999999999865444443 33 6888888762 334455644 34557999999999
Q ss_pred ccCCccCCcc----ccCCCCCCEEeCCCCcccccC-------------CccccCCCCCCEEEccCcccccc----CCccc
Q 040398 74 NQFSGTIPRE----LGNLVNLETLRLSSNRLIGNL-------------PMELVKLKNLTDFRINDNNFNGS----APDFI 132 (732)
Q Consensus 74 N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~-------------p~~l~~l~~L~~L~L~~N~l~~~----~p~~~ 132 (732)
|-|.-.-+.. +.++..|++|.|.||.+...- ..-..+-++|+++...+|++... +...|
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~ 181 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAF 181 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHH
Confidence 9998444433 457899999999999986211 11223457899999999998632 23457
Q ss_pred cCCCCCCEEEcccCCCcCc----CCccccCccCCCeeeccCcCCCCCC----cccccCCCCccEEEcccccccCCcchhh
Q 040398 133 QSWTQLNRLEIQGSGLEGP----IPPSISALDKLNQLRISDLQGPNQT----FPMLRNMTGLTRIILRNCNIAGEIPEYI 204 (732)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~~p~~l 204 (732)
...+.|+.+.++.|.|... +...+..+++|+.|||.+|-++... ...+..+++|+.|++++|.+...-...+
T Consensus 182 ~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~ 261 (382)
T KOG1909|consen 182 QSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAF 261 (382)
T ss_pred HhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHH
Confidence 7789999999999998632 3456789999999999999987654 3457788899999999999987655444
Q ss_pred c-----CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 205 W-----GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 205 ~-----~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
. ..|+|+.|.|.+|.++-.- ...+...+...+.|..|+|++|.+.
T Consensus 262 ~~al~~~~p~L~vl~l~gNeIt~da----------~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 262 VDALKESAPSLEVLELAGNEITRDA----------ALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHhccCCCCceeccCcchhHHHH----------HHHHHHHHhcchhhHHhcCCccccc
Confidence 3 3789999999999998321 1122233455788999999999984
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-12 Score=128.43 Aligned_cols=133 Identities=17% Similarity=0.165 Sum_probs=59.4
Q ss_pred CCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEc
Q 040398 112 KNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIIL 191 (732)
Q Consensus 112 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L 191 (732)
..|+.|+|++|.|+ .+.+...-+|+++.|++|+|.++. + ..+..+++|+.||||+|.++...- +-..+-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAECVG-WHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHhhhh-hHhhhcCEeeeeh
Confidence 33444444444443 333333334444444444444431 1 124444444444444444433221 1112334555555
Q ss_pred ccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 192 RNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 192 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+.|.|. --..+.++=+|..||+++|+|... +-...+++++-|+.|.|.+|++.+.+.
T Consensus 360 a~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~l-------------deV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIE--TLSGLRKLYSLVNLDLSSNQIEEL-------------DEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHh--hhhhhHhhhhheeccccccchhhH-------------HHhcccccccHHHHHhhcCCCccccch
Confidence 555554 112234444555666666665511 111235566666666666666665543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=128.35 Aligned_cols=167 Identities=18% Similarity=0.226 Sum_probs=126.4
Q ss_pred EEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCH
Q 040398 534 QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613 (732)
Q Consensus 534 ~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 613 (732)
+..++..|.|...+...........+-++.++.++||||+++++.++.++..|+|.|-+. -|..++.. +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 344788888888877655444556777899999999999999999999999999999875 45555522 235
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccC
Q 040398 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693 (732)
Q Consensus 614 ~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 693 (732)
......+.||+.||.+||+.| +++|++|.-.-|+++..|+.||++|.++........ ......--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 566678899999999999887 799999999999999999999999988754332221 00111112256677754332
Q ss_pred CCCCchhHHHHHHHHHHHHcC
Q 040398 694 YLTYKADVYSFGVVALEIVSG 714 (732)
Q Consensus 694 ~~~~k~DvwSlGvll~elltG 714 (732)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 246999999999999999
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-11 Score=140.14 Aligned_cols=109 Identities=28% Similarity=0.504 Sum_probs=97.8
Q ss_pred CCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcc
Q 040398 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQ 144 (732)
Q Consensus 65 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 144 (732)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCcCCccccCc-cCCCeeeccCcCCC
Q 040398 145 GSGLEGPIPPSISAL-DKLNQLRISDLQGP 173 (732)
Q Consensus 145 ~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~ 173 (732)
+|+++|.+|..+..+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999888764 46778888888643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-12 Score=133.40 Aligned_cols=205 Identities=20% Similarity=0.254 Sum_probs=143.9
Q ss_pred ccceEecccccccccCC--ccccCCCCCCEEecccccCCcc--CCccccCCCCCCEEeCCCCcccccCCc-cccCCCCCC
Q 040398 41 QLKYISVFANRLSGNIP--SHLGNITSLTYLDLEENQFSGT--IPRELGNLVNLETLRLSSNRLIGNLPM-ELVKLKNLT 115 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~ 115 (732)
+|+++.|.++... ..+ .....|++++.|||+.|-|..- +-.....|++|+.|+|+.|++.-.... .-..++.|+
T Consensus 122 kL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 122 KLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred hhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 5888888888877 444 3677889999999999988732 223456789999999999988622211 112467899
Q ss_pred EEEccCcccccc-CCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCC-cccccCCCCccEEEccc
Q 040398 116 DFRINDNNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQT-FPMLRNMTGLTRIILRN 193 (732)
Q Consensus 116 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-~~~l~~l~~L~~L~Ls~ 193 (732)
.|.|+.|.|+.. +-.....+|+|+.|+|..|............+..|+.|||++|++.+.+ ....+.++.|+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 999999998722 3334567899999999998643344455566778899999998887755 44577888888899988
Q ss_pred ccccCC-cchh-----hcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 194 CNIAGE-IPEY-----IWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 194 N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
|.|... +|+. ...+++|++|+++.|++. ..+.. ..+..+.+|+.|.+..|.|+
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl------------~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSL------------NHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccc-ccccc------------chhhccchhhhhhccccccc
Confidence 888743 2322 345788999999999886 22211 11344566777777777765
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-12 Score=133.52 Aligned_cols=208 Identities=19% Similarity=0.205 Sum_probs=156.8
Q ss_pred CCCCCCCCEEEcccCcCccccCc--ccccc-ccceEecccccccc--cCCccccCCCCCCEEecccccCCccCCcc-ccC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPR--EWASM-QLKYISVFANRLSG--NIPSHLGNITSLTYLDLEENQFSGTIPRE-LGN 86 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~--~~~~~-~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~ 86 (732)
=+++++|+.+.|.+.... ..+. ....+ +++.|||+.|-+.. .+-.-...|++|+.|+|+.|++.-..... -..
T Consensus 117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 357888999999998887 3332 33334 89999999998873 22344567899999999999987332221 235
Q ss_pred CCCCCEEeCCCCcccc-cCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCC--ccccCccCCC
Q 040398 87 LVNLETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIP--PSISALDKLN 163 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~ 163 (732)
++.|+.|.|+.|.|+- .+-..+..+|+|+.|+|..|..-.........+..|+.|+|++|++- ..+ .....++.|+
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh
Confidence 7889999999999983 22333556899999999999643344455566789999999999986 333 4578899999
Q ss_pred eeeccCcCCCCCCcccc------cCCCCccEEEcccccccCCcc--hhhcCCCCCcEEeCCCCcCccc
Q 040398 164 QLRISDLQGPNQTFPML------RNMTGLTRIILRNCNIAGEIP--EYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 164 ~L~ls~N~l~~~~~~~l------~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
.|+++.+.+.++..+.- ..+++|++|+++.|+|. ..+ ..+..+++|+.|....|.|+-+
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccccccc
Confidence 99999999988765543 67799999999999997 333 3566788999999999999844
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=116.60 Aligned_cols=120 Identities=27% Similarity=0.429 Sum_probs=34.5
Q ss_pred cccCcCccccCccccccccceEecccccccccCCcccc-CCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccc
Q 040398 24 FAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLG-NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIG 102 (732)
Q Consensus 24 Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 102 (732)
|+.+.|. .+|......++++|+|.+|.|+ .+. .++ .+.+|+.|||++|.|+ .+. .+..++.|+.|++++|+|+
T Consensus 4 lt~~~i~-~~~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~- 77 (175)
T PF14580_consen 4 LTANMIE-QIAQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS- 77 (175)
T ss_dssp -----------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----
T ss_pred ccccccc-cccccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-
Confidence 3344444 4444444446777888888777 343 454 4677888888888877 443 4667777888888888877
Q ss_pred cCCccc-cCCCCCCEEEccCccccccC-CccccCCCCCCEEEcccCCCc
Q 040398 103 NLPMEL-VKLKNLTDFRINDNNFNGSA-PDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 103 ~~p~~l-~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
.+...+ ..+++|+.|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 78 ~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 78 SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 454444 35777888888888775321 134556677777777777665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-11 Score=114.88 Aligned_cols=128 Identities=23% Similarity=0.287 Sum_probs=39.9
Q ss_pred CCCCCCEEeCCCCcccccCCcccc-CCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCe
Q 040398 86 NLVNLETLRLSSNRLIGNLPMELV-KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQ 164 (732)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 164 (732)
+..++++|+|.+|+|+ .+. .++ .+.+|+.|+|++|.|+.. +.+..+++|+.
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--------------------------~~l~~L~~L~~ 68 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--------------------------EGLPGLPRLKT 68 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----------------------------TT----TT--E
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--------------------------cCccChhhhhh
Confidence 3445566666666665 232 333 345556666666655521 12334444444
Q ss_pred eeccCcCCCCCCcccccCCCCccEEEcccccccCC-cchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHh
Q 040398 165 LRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE-IPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243 (732)
Q Consensus 165 L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~ 243 (732)
|++++|.++.+.......+++|+.|+|++|+|... .-..+..+++|+.|+|.+|+++.. + ......+.
T Consensus 69 L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~----------~YR~~vi~ 137 (175)
T PF14580_consen 69 LDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-K----------NYRLFVIY 137 (175)
T ss_dssp EE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-T----------THHHHHHH
T ss_pred cccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-h----------hHHHHHHH
Confidence 55555554444322223455666666666666532 123566778888888888887732 2 12345567
Q ss_pred ccCCCCeEE
Q 040398 244 GVYEHQSLD 252 (732)
Q Consensus 244 ~l~~L~~Ld 252 (732)
.+++|+.||
T Consensus 138 ~lP~Lk~LD 146 (175)
T PF14580_consen 138 KLPSLKVLD 146 (175)
T ss_dssp H-TT-SEET
T ss_pred HcChhheeC
Confidence 778888887
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.9e-11 Score=136.16 Aligned_cols=117 Identities=29% Similarity=0.455 Sum_probs=93.4
Q ss_pred CCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCC
Q 040398 138 LNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217 (732)
Q Consensus 138 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 217 (732)
++.|+|++|.++|.+|..+..+++|+.|+|++|.+.+..+..+..+++|+.|+|++|+++|.+|+.++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67788888888888888888888888888888888888777888888899999999999888898888899999999999
Q ss_pred CcCcccCCCCCccCcchhhHHHHHHhc-cCCCCeEEccCCcCcCCCCCCccc
Q 040398 218 NQLTGELPDVAVPADLKFTQILMFIRG-VYEHQSLDLSYNNFTWQSPEQPAC 268 (732)
Q Consensus 218 N~l~g~~p~~~~~~~l~~~~~~~~~~~-l~~L~~LdLs~N~l~~~~p~~~~~ 268 (732)
|+++|.+|.. ++. +.++..+++++|+..+..|....|
T Consensus 500 N~l~g~iP~~--------------l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 500 NSLSGRVPAA--------------LGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CcccccCChH--------------HhhccccCceEEecCCccccCCCCCCCC
Confidence 9999888864 222 235667888888765544443333
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=122.43 Aligned_cols=196 Identities=22% Similarity=0.252 Sum_probs=141.6
Q ss_pred ccceEeccc--------ccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCC
Q 040398 41 QLKYISVFA--------NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLK 112 (732)
Q Consensus 41 ~L~~L~L~~--------n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 112 (732)
+|++|.++. |-+...+|-.+.-+.+|..+.+|.+.-. .|-+....-+.|+++.+.+.-++ ..| .+-..+
T Consensus 183 ~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~-~l~pe~ 259 (490)
T KOG1259|consen 183 QLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVP-SLLPET 259 (490)
T ss_pred heeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-ccc-cccchh
Confidence 577776663 2222334555566677888887776543 33333334466888877766554 222 222233
Q ss_pred CCCEEEccCcc-ccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEc
Q 040398 113 NLTDFRINDNN-FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIIL 191 (732)
Q Consensus 113 ~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L 191 (732)
.+..+..+.-. .+|..-..+..++.|+.||||+|.|+ .+.+++.-+++++.|++|+|.+..+.. +..+++|+.|||
T Consensus 260 ~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDL 336 (490)
T KOG1259|consen 260 ILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDL 336 (490)
T ss_pred hhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeec
Confidence 44433333222 24555566677889999999999998 788889999999999999999987765 888999999999
Q ss_pred ccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 192 RNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 192 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
|+|.++ .+-.+-.++-|++.|.|+.|.|... ..++++.+|..||+++|+|.
T Consensus 337 S~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L----------------SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 337 SGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL----------------SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred ccchhH-hhhhhHhhhcCEeeeehhhhhHhhh----------------hhhHhhhhheeccccccchh
Confidence 999999 6777777889999999999998722 23778899999999999985
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-10 Score=108.60 Aligned_cols=135 Identities=16% Similarity=0.143 Sum_probs=95.9
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEEcccccc----------------------cchHHH----HHHHHHHhc
Q 040398 520 NKIGEGGFGPVYKGQLTD-------GTIIAVKLLSSKSR----------------------QGNREF----LNEIGTISC 566 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~-------g~~vAvK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 566 (732)
..||.|--+.||.|...+ +..+|||+++.... ...+.+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47899998753110 001122 378899988
Q ss_pred CCC--CceeeeeeeEEeCCEEEEEEEecCCCchhH-HhhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeCC
Q 040398 567 LQH--PNLVKLYGCCIEGDQLMLVYEYLENNSLAH-ALFGGENSQLKLNWSVRQKICLGIARGLAFL-HEESRFKIVHRD 642 (732)
Q Consensus 567 l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL-H~~~~~~iiH~D 642 (732)
+.. -++.+++++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |+.+ +||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 854 345556654 45689999998754432 221 12344556677889999999999 6664 99999
Q ss_pred CCCCCeEEcCCCCeEEEeeecceeC
Q 040398 643 IKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 643 lkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|++.||++++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.8e-10 Score=112.23 Aligned_cols=143 Identities=20% Similarity=0.262 Sum_probs=109.0
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCc--eeeeeeeEEeC---CEEEEEEEecC
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPN--LVKLYGCCIEG---DQLMLVYEYLE 593 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~---~~~~lv~e~~~ 593 (732)
+.++.|..+.||+++..+|+.+++|+...... .....+.+|+++++.+++.+ +.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999998764322 23457889999999997644 46677766553 25689999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES--------------------------------------- 634 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--------------------------------------- 634 (732)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 24667777788888888888888531
Q ss_pred --------------CCceEeCCCCCCCeEEcC--CCCeEEEeeecceeC
Q 040398 635 --------------RFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLD 667 (732)
Q Consensus 635 --------------~~~iiH~Dlkp~NILl~~--~~~~kL~DfGla~~~ 667 (732)
+..++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 234789999999999998 566899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-11 Score=128.31 Aligned_cols=197 Identities=25% Similarity=0.293 Sum_probs=152.8
Q ss_pred CCcccceecc--cCceEEEEEEE--c-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEE
Q 040398 515 NFDPMNKIGE--GGFGPVYKGQL--T-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 515 ~f~~~~~LG~--G~fg~Vy~a~~--~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 586 (732)
.|.+.+.+|+ |.+|.||++.. . ++..+|+|+-+.. ......+=.+|+....+++ |+|.++.+..+++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3456678999 99999999976 3 7899999984433 2233344467777777774 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHH----HHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR----GLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDF 661 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~Df 661 (732)
+-.|++. .+|.++-+. ...-++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999885 677776643 2233666777888888888 999999985 9999999999999999 88999999
Q ss_pred ecceeCCccCc----eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 662 GLAKLDEEEKT----HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 662 Gla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|+........- ....+..|..-|++||... +-++..+|+||+|.+..+..+|..+..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 99876544331 1223335777899999665 466889999999999999888766543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-11 Score=136.66 Aligned_cols=128 Identities=27% Similarity=0.328 Sum_probs=67.4
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
.++.++++.|.+. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+. +. .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~-~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LE-GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-cc-chhhccchhhheec
Confidence 4555555555555 33344555566666666666665 333335555666666666666652 21 34445556666666
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCC-ccccCccCCCeeeccCcCCCCC
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIP-PSISALDKLNQLRISDLQGPNQ 175 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~ 175 (732)
+|.|+.. ..+..++.|+.+++++|.+...-+ . ...+.+|+.+++.+|.+..+
T Consensus 149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI 201 (414)
T ss_pred cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc
Confidence 6665421 223335566666666666652222 1 35555566666666655443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.4e-12 Score=126.48 Aligned_cols=210 Identities=17% Similarity=0.211 Sum_probs=160.1
Q ss_pred ccCCCCCCCCEEEcccC---cCccccCcccccc--------ccceEecccccccccCCc----cccCCCCCCEEeccccc
Q 040398 11 PQIVNLPYLETVDFAYN---YLHGSIPREWASM--------QLKYISVFANRLSGNIPS----HLGNITSLTYLDLEENQ 75 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N---~l~~~~p~~~~~~--------~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~ 75 (732)
+.|.+.++|++.++++= ++...+|..+..+ +|++|+||+|-+...-+. -+.++.+|++|.|.+|.
T Consensus 52 ~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~G 131 (382)
T KOG1909|consen 52 KVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCG 131 (382)
T ss_pred HHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCC
Confidence 45677788999998863 4445666654322 799999999999744443 34668999999999998
Q ss_pred CCccC--------------CccccCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCccccc----cCCcccc
Q 040398 76 FSGTI--------------PRELGNLVNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFNG----SAPDFIQ 133 (732)
Q Consensus 76 l~~~~--------------p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~ 133 (732)
+. .. .....+-+.|+.+...+|++.. .+...|...+.|+.+.+..|.|.. .+...+.
T Consensus 132 lg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~ 210 (382)
T KOG1909|consen 132 LG-PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALE 210 (382)
T ss_pred CC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHH
Confidence 86 21 1224556789999999999973 233457778999999999999852 1235578
Q ss_pred CCCCCCEEEcccCCCcCc----CCccccCccCCCeeeccCcCCCCCCcccc-----cCCCCccEEEcccccccCC----c
Q 040398 134 SWTQLNRLEIQGSGLEGP----IPPSISALDKLNQLRISDLQGPNQTFPML-----RNMTGLTRIILRNCNIAGE----I 200 (732)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~----~ 200 (732)
.+++|+.|+|.+|-++.. +...+..+++|+.|++++|.+.......| ...|+|+.|.|.+|.|+.. +
T Consensus 211 ~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~l 290 (382)
T KOG1909|consen 211 HCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALAL 290 (382)
T ss_pred hCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHH
Confidence 899999999999999742 35567888999999999999988765443 3468999999999999843 3
Q ss_pred chhhcCCCCCcEEeCCCCcCc
Q 040398 201 PEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
...+...+.|..|+|++|++.
T Consensus 291 a~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 291 AACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHhcchhhHHhcCCccccc
Confidence 345567899999999999995
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.4e-09 Score=100.62 Aligned_cols=134 Identities=23% Similarity=0.303 Sum_probs=102.3
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEccccc---c-----cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS---R-----QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~---~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+++|+-+.+|.+.+. |..+.+|.-.... + -...+..+|.+++.+++--.|....=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 3446666433221 1 1234567899999999877776666666778888899999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
++|..|.+.+... ...++..+-+.+.-||..| |+|+||.++||++..+. +.++|||++.+...
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888432 2456777778888999986 99999999999998875 99999999986443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-09 Score=99.12 Aligned_cols=144 Identities=18% Similarity=0.284 Sum_probs=105.6
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEE-cccc-------cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKL-LSSK-------SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~-~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.+..+-+|+-+.|+++.+. |+.+.||. +.+. ..-..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999886 77777774 3321 1123467889999999987666665555566666667899
Q ss_pred EecCC-CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEeeecce
Q 040398 590 EYLEN-NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAK 665 (732)
Q Consensus 590 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DfGla~ 665 (732)
||++| .++.+++...... +.........+.+|-+.+.-||..+ +||+||..+||++..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 4677776543221 1222233678889999999999985 999999999999976654 5899999986
Q ss_pred eC
Q 040398 666 LD 667 (732)
Q Consensus 666 ~~ 667 (732)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.9e-10 Score=124.00 Aligned_cols=203 Identities=23% Similarity=0.216 Sum_probs=151.9
Q ss_pred cccHHH-HHHHhCCCcccceecccCceEEEEEEEc--CCeEEEEEEccccccc--chHHHHHHHHHHhcC-CCCceeeee
Q 040398 503 SFTLKQ-IRAATSNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLLSSKSRQ--GNREFLNEIGTISCL-QHPNLVKLY 576 (732)
Q Consensus 503 ~~~~~~-~~~~~~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~ 576 (732)
.+.-++ ......+|..+..||.|.|+.|++...+ ++..||+|-....... ....-..|+.+...+ .|.++++..
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 4456778999999999999999998644 6789999977654322 222335566666666 599999999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CC
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LN 655 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~ 655 (732)
..|...+..++-.||+.++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhh
Confidence 9998888888999999999887655 22334667778899999999999999885 9999999999999886 78
Q ss_pred eEEEeeecceeCCccCceeeecccCccccc--cchhcccCCCCCchhHHHHHHHHHHHHcCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYM--APEYALWGYLTYKADVYSFGVVALEIVSGKN 716 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~~~k~DvwSlGvll~elltG~~ 716 (732)
.+++|||++.-..-. .....+..+++ +|+......+..++|++|||.-+.+..+|..
T Consensus 406 ~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred hhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 899999987531110 01112222444 5555566678889999999999999998874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.6e-10 Score=111.36 Aligned_cols=153 Identities=23% Similarity=0.304 Sum_probs=119.5
Q ss_pred HHhcCCCCceeeeeeeEEeCC-----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 040398 563 TISCLQHPNLVKLYGCCIEGD-----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637 (732)
Q Consensus 563 ~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ 637 (732)
-+-.+.|.|||+++.||.+.. +..++.|||..|++..+|++.+.....+......+|+-||..||.|||+. .+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 345567999999999987643 47889999999999999988888888888899999999999999999986 578
Q ss_pred eEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce----eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc
Q 040398 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH----ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713 (732)
Q Consensus 638 iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt 713 (732)
|+|+++..+-|++..++-+|++- +.-......... -...-.+-++|.|||+-..-..+..+|||+||...+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999988888642 111111110000 0112235679999998877777889999999999999988
Q ss_pred CCCC
Q 040398 714 GKNN 717 (732)
Q Consensus 714 G~~P 717 (732)
|...
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.4e-10 Score=128.28 Aligned_cols=195 Identities=24% Similarity=0.326 Sum_probs=85.8
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
..++.+.+..|.+.. +-..+..+ +|..|++.+|+|. .+...+..+++|++|+|++|+|+. +. .+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~-~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LE-GLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-cc-chhhccchhhhee
Confidence 344444455555542 22223333 4555555555555 333334455555555555555552 21 3444444555555
Q ss_pred CCCcccccCCccccCCCCCCEEEccCccccccCC-ccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCC
Q 040398 96 SSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174 (732)
Q Consensus 96 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 174 (732)
++|.|+ .+. .+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++.+|.+..
T Consensus 148 ~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 148 SGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred ccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhccccccee
Confidence 555554 222 33335555555555555542222 1 344555555555555553 11223333333334444444443
Q ss_pred CCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 175 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
+.......+..|+.+++++|.+. .++..+..+.++..|+++.|++.
T Consensus 223 ~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 223 LEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 32211110012445555555554 23233444444455555554444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=107.58 Aligned_cols=168 Identities=20% Similarity=0.295 Sum_probs=128.3
Q ss_pred eEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEEEEEecCC-CchhHHh
Q 040398 528 GPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLMLVYEYLEN-NSLAHAL 601 (732)
Q Consensus 528 g~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l 601 (732)
...||+..+ ||..|++|++..........-..-+++++++.|+|+|++.+++.. +..+++||+|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999765 899999999954433322223456889999999999999998873 4568999999886 5787755
Q ss_pred hcCC-----------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 602 FGGE-----------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 602 ~~~~-----------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
.... ..+...++..+|.++.|+..||.++|+.| ...+-|.+.+|+++.+.+++|...|......++
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3321 23345788999999999999999999997 888999999999999999999887776554432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~ 716 (732)
.. |-+.. -.+-|.=.||.+++.|.||..
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 20 11111 125789999999999999954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=99.24 Aligned_cols=126 Identities=24% Similarity=0.292 Sum_probs=81.7
Q ss_pred EEEEEEEcCCeEEEEEEcccccc---------------------c-----chHHHHHHHHHHhcCCCCc--eeeeeeeEE
Q 040398 529 PVYKGQLTDGTIIAVKLLSSKSR---------------------Q-----GNREFLNEIGTISCLQHPN--LVKLYGCCI 580 (732)
Q Consensus 529 ~Vy~a~~~~g~~vAvK~~~~~~~---------------------~-----~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~ 580 (732)
-||.|...+|..+|||+.+.... . ......+|.+.|.++...+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999998999999998653110 0 0134678999999998764 5566544
Q ss_pred eCCEEEEEEEecC--CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeCCCCCCCeEEcCCCCeE
Q 040398 581 EGDQLMLVYEYLE--NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL-HEESRFKIVHRDIKATNVLLDRDLNPK 657 (732)
Q Consensus 581 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL-H~~~~~~iiH~Dlkp~NILl~~~~~~k 657 (732)
. ..++||||++ |..+..+. .. .++......++.+++..+..+ |..| ++|+|+.+.||+++++ .+.
T Consensus 79 ~--~~~ivME~I~~~G~~~~~l~-~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPRLK-DV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp E--TTEEEEE--EETTEEGGCHH-HC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred e--CCEEEEEecCCCccchhhHH-hc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 2 3479999998 55554433 11 111234556777888866654 6665 9999999999999988 999
Q ss_pred EEeeecceeCC
Q 040398 658 ISDFGLAKLDE 668 (732)
Q Consensus 658 L~DfGla~~~~ 668 (732)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.4e-10 Score=127.82 Aligned_cols=206 Identities=21% Similarity=0.247 Sum_probs=149.0
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
+...+.+.+.+.+-+|.++.++.+.-. .|...+.|+..... ....+...++-.++-.-+||-+++....+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345677888888999999999988644 46556666544321 11222233333444444567777666555556778
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
+++++|..+++|...+|... ..+.+..+.....+..+++|||.. .+.|+|++|.|++...+++.++.|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999886432 344444556666788899999986 38999999999999999999999998432
Q ss_pred eCCc------c------------------------CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC
Q 040398 666 LDEE------E------------------------KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 666 ~~~~------~------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~ 715 (732)
.... . .........||+.|.|||...+......+|+|++|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 1100 0 001122356899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 040398 716 NNMSYVP 722 (732)
Q Consensus 716 ~P~~~~~ 722 (732)
.||+...
T Consensus 1033 pp~na~t 1039 (1205)
T KOG0606|consen 1033 PPFNAET 1039 (1205)
T ss_pred CCCCCcc
Confidence 9998644
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.9e-08 Score=98.99 Aligned_cols=139 Identities=17% Similarity=0.059 Sum_probs=99.0
Q ss_pred ecccCceEEEEEEEcCCeEEEEEEccccccc-----------chHHHHHHHHHHhcCCCCcee--eeeeeEEe-----CC
Q 040398 522 IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ-----------GNREFLNEIGTISCLQHPNLV--KLYGCCIE-----GD 583 (732)
Q Consensus 522 LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv--~l~~~~~~-----~~ 583 (732)
+-+-....|++++. +|+.|.||........ ....+.+|.+.+.++...+|. +++++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667665 4788999977543211 112478899988888655543 44555543 23
Q ss_pred EEEEEEEecCCC-chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-------CCC
Q 040398 584 QLMLVYEYLENN-SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-------DLN 655 (732)
Q Consensus 584 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~ 655 (732)
..++|+|++++. +|.+++.... ..+.+......++.+++..+.-||..| |+|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 568999999886 8988874221 123456677899999999999999997 999999999999985 467
Q ss_pred eEEEeeeccee
Q 040398 656 PKISDFGLAKL 666 (732)
Q Consensus 656 ~kL~DfGla~~ 666 (732)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-09 Score=105.81 Aligned_cols=240 Identities=18% Similarity=0.161 Sum_probs=167.5
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-----ccceEeccccc---ccccC-------CccccCCCCCCEEecccccCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-----QLKYISVFANR---LSGNI-------PSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-----~L~~L~L~~n~---l~~~~-------p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
+.-+..++.++||+|.|...-...+++. +|+..+++.-- ....+ .+.+-.|++|+..+||+|.|.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 4447889999999999987665555544 68888887632 22222 345678899999999999998
Q ss_pred ccCCcc----ccCCCCCCEEeCCCCccccc----CCcc---------ccCCCCCCEEEccCccccccCC----ccccCCC
Q 040398 78 GTIPRE----LGNLVNLETLRLSSNRLIGN----LPME---------LVKLKNLTDFRINDNNFNGSAP----DFIQSWT 136 (732)
Q Consensus 78 ~~~p~~----l~~l~~L~~L~L~~N~l~~~----~p~~---------l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~ 136 (732)
...|.. +++-+.|++|.|++|.+... +... ..+-|.|++..+..|++..-.. ..+..-.
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~ 185 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHE 185 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhc
Confidence 766654 45678999999999988621 1111 2345789999999999862211 1233446
Q ss_pred CCCEEEcccCCCcCc-----CCccccCccCCCeeeccCcCCCCCCc----ccccCCCCccEEEcccccccCCcchhhc--
Q 040398 137 QLNRLEIQGSGLEGP-----IPPSISALDKLNQLRISDLQGPNQTF----PMLRNMTGLTRIILRNCNIAGEIPEYIW-- 205 (732)
Q Consensus 137 ~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-- 205 (732)
.|+.+.+..|.|.-. +-..+..+.+|+.|||.+|-++.... ..+..++.|++|.+..|-++..-...+-
T Consensus 186 ~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~ 265 (388)
T COG5238 186 NLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRR 265 (388)
T ss_pred CceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHH
Confidence 899999999998622 11234567899999999998876543 3456778899999999999865544332
Q ss_pred ----CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 206 ----GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 206 ----~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
..|+|..|.+.+|...+.+-....... ..-.+++-|..|-+.+|+|.
T Consensus 266 f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~-------~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 266 FNEKFVPNLMPLPGDYNERRGGIILDISLNE-------FEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred hhhhcCCCccccccchhhhcCceeeeechhh-------hhhcccHHHHHHHHccCcch
Confidence 368999999999998876543211111 12345566777777888774
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.7e-09 Score=80.56 Aligned_cols=59 Identities=29% Similarity=0.375 Sum_probs=29.6
Q ss_pred CCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCc
Q 040398 161 KLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219 (732)
Q Consensus 161 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 219 (732)
+|+.|++++|++..++...|..+++|++|+|++|+|+...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444555555555555555554444455555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-08 Score=79.38 Aligned_cols=57 Identities=39% Similarity=0.527 Sum_probs=21.8
Q ss_pred CCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCc
Q 040398 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122 (732)
Q Consensus 66 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 122 (732)
|++|+|++|+|+...+..|.++++|++|++++|+|+...|..|..+++|+.|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 344444444443222223333444444444444443333333334444444444433
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.1e-09 Score=122.24 Aligned_cols=126 Identities=25% Similarity=0.377 Sum_probs=84.9
Q ss_pred CCCEEEcccCc--CccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEe
Q 040398 18 YLETVDFAYNY--LHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLR 94 (732)
Q Consensus 18 ~L~~L~Ls~N~--l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 94 (732)
.|++|-+..|. +.......|..+ .|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 67777777775 443333345556 5888888877666678888888888888888888887 7788888888888888
Q ss_pred CCCCcccccCCccccCCCCCCEEEccCccc--cccCCccccCCCCCCEEEcc
Q 040398 95 LSSNRLIGNLPMELVKLKNLTDFRINDNNF--NGSAPDFIQSWTQLNRLEIQ 144 (732)
Q Consensus 95 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l--~~~~p~~~~~l~~L~~L~Ls 144 (732)
+..+.-...+|.....|++|++|.+..-.. ....-..+.++.+|+.|...
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 887765545566666688888887765542 22222334555555555553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-07 Score=95.99 Aligned_cols=192 Identities=16% Similarity=0.243 Sum_probs=129.2
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceee--------eeeeEEeCCEEEEEEE
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVK--------LYGCCIEGDQLMLVYE 590 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~--------l~~~~~~~~~~~lv~e 590 (732)
..||+|+-+.+|-.-.- ...+.|++.......... .+..|... .||-+-. ++|-- ....+.+.|.
T Consensus 17 r~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflmP 90 (637)
T COG4248 17 RPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLMP 90 (637)
T ss_pred ccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEecc
Confidence 56999999999964221 123556665443332222 22333333 4654332 11110 1223678888
Q ss_pred ecCCCc-hhHHhhc--CCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 591 YLENNS-LAHALFG--GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
.+++.. .+++..- .+.......|....+.++.++.+.+-||..| .+-+|+.++|+|+.+++.+.|.|=..-.+.
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 887752 2332211 2334456799999999999999999999997 888999999999999999999986544333
Q ss_pred CccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcC-CCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSG-KNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG-~~P~~~~~ 722 (732)
.. .......+|...|.+||... +..-+...|-|.|||++++++.| +.||..++
T Consensus 168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 22 22233457899999999765 33456788999999999998887 99998755
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-08 Score=101.95 Aligned_cols=243 Identities=20% Similarity=0.165 Sum_probs=154.8
Q ss_pred CCCcccCCccCCCCCCCCEEEcccCcCccccC-cccccc--ccceEecccccccc--cCCccccCCCCCCEEecccccCC
Q 040398 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIP-REWASM--QLKYISVFANRLSG--NIPSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 3 ~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~--~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
+..+|-.|-.+..+..++-|.+.++.|...-. ..|+.. +++.|||.+|.|+. ++-.-+.+++.|++|+|+.|.++
T Consensus 31 t~~~g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~ 110 (418)
T KOG2982|consen 31 TTSAGLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLS 110 (418)
T ss_pred ecccccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCC
Confidence 34556667677777788888888888764322 234433 69999999999972 45555678899999999999998
Q ss_pred ccCCccc-cCCCCCCEEeCCCCcccc-cCCccccCCCCCCEEEccCccccccC--CccccCC-CCCCEEEcccCCCcC--
Q 040398 78 GTIPREL-GNLVNLETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFNGSA--PDFIQSW-TQLNRLEIQGSGLEG-- 150 (732)
Q Consensus 78 ~~~p~~l-~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l-~~L~~L~Ls~N~l~~-- 150 (732)
..| +.+ ..+.+|+.|.|.+..+.= .....+..+|.++.|.++.|.+.... .+..... +.+++|++-.|...-
T Consensus 111 s~I-~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~ 189 (418)
T KOG2982|consen 111 SDI-KSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWL 189 (418)
T ss_pred Ccc-ccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHH
Confidence 433 333 467789999998887751 23345667888889999988554221 1122222 244444444433210
Q ss_pred cCCccccCccCCCeeeccCcCCCCCCc-ccccCCCCccEEEcccccccCC-cchhhcCCCCCcEEeCCCCcCcccCCCCC
Q 040398 151 PIPPSISALDKLNQLRISDLQGPNQTF-PMLRNMTGLTRIILRNCNIAGE-IPEYIWGIKNLRFLDLSFNQLTGELPDVA 228 (732)
Q Consensus 151 ~~p~~~~~l~~L~~L~ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 228 (732)
.+..--.-++++..+.+.+|.+..... ..+..++.+.-|+|+.|+|..- --+.+..++.|..|.+++|.|...+-..
T Consensus 190 ~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~- 268 (418)
T KOG2982|consen 190 NKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGG- 268 (418)
T ss_pred HHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCC-
Confidence 011111234667777788887776543 3466677777888888888643 2246778888999999999888654432
Q ss_pred ccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 229 VPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 229 ~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
.+.. ..++.+++++.|+=|
T Consensus 269 err~-------llIaRL~~v~vLNGs 287 (418)
T KOG2982|consen 269 ERRF-------LLIARLTKVQVLNGS 287 (418)
T ss_pred cceE-------EEEeeccceEEecCc
Confidence 1111 125666777777643
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.5e-08 Score=118.09 Aligned_cols=203 Identities=21% Similarity=0.272 Sum_probs=144.4
Q ss_pred CCCCCCCEEEcccCcCccccCccccccccceEeccccc--ccccCC-ccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 14 VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANR--LSGNIP-SHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~--l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
.+....+++.+-+|.+. .++.......|++|-+..|. +. .++ ..|..++.|..|||++|.=-+.+|..+++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34467888999999887 66666666689999999997 55 454 457789999999999887666999999999999
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCC--cCcCCccccCccCCCeeecc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL--EGPIPPSISALDKLNQLRIS 168 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~L~ls 168 (732)
++|+|++..++ .+|..+.+|++|.+|++..+.....+|.....+++|++|.+..-.. +...-..+.++.+|+.|...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 99999999999 9999999999999999999987667788888899999999976542 22334445566666666553
Q ss_pred CcCCCCCCcccccCCCCcc----EEEcccccccCCcchhhcCCCCCcEEeCCCCcCcc
Q 040398 169 DLQGPNQTFPMLRNMTGLT----RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 169 ~N~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 222 (732)
.... .....+..++.|. .+.+..+... ..+..+..+.+|+.|.+.++.++.
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 3222 1111222233322 2332232322 344456667777777777776653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.4e-10 Score=121.97 Aligned_cols=177 Identities=20% Similarity=0.276 Sum_probs=107.8
Q ss_pred CccCCCCCCCCEEEcccCcCccccCcccccc--ccceEeccccccc----------ccCCccccCCCCCCEEecccccCC
Q 040398 10 PPQIVNLPYLETVDFAYNYLHGSIPREWASM--QLKYISVFANRLS----------GNIPSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 10 P~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~L~~n~l~----------~~~p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
|-.|..++.|++|.|.++.|.. . ..+..+ +|++|.-.+ .+. |.+.+++. --.|.+.+.+.|.|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 5578889999999999998873 2 122222 466654432 221 11211111 124666677777776
Q ss_pred ccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCcc-ccCCCCCCEEEcccCCCcCcCCccc
Q 040398 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF-IQSWTQLNRLEIQGSGLEGPIPPSI 156 (732)
Q Consensus 78 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~ 156 (732)
.+..++.-++.|+.|+|++|+++ ... .+..|+.|+.|||+.|.++ .+|.. ...+ +|+.|.|++|.++.. ..+
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhH
Confidence 56666666777777777777776 222 6666777777777777776 33432 2223 377777777777522 345
Q ss_pred cCccCCCeeeccCcCCCCCC-cccccCCCCccEEEccccccc
Q 040398 157 SALDKLNQLRISDLQGPNQT-FPMLRNMTGLTRIILRNCNIA 197 (732)
Q Consensus 157 ~~l~~L~~L~ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~ 197 (732)
.+|.+|+.||+++|-+.+.. ...+..+..|+.|+|.+|.+-
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 66777777777777666532 333555666777777777765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.2e-07 Score=91.58 Aligned_cols=133 Identities=23% Similarity=0.200 Sum_probs=94.3
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEcccccc----------------------cchHHHHHHHHHHhcCCCC--ce
Q 040398 517 DPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR----------------------QGNREFLNEIGTISCLQHP--NL 572 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--nI 572 (732)
.+..+||.|--+.||.|...+|.++|||.=+.... ......++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996321100 0123467899999998755 66
Q ss_pred eeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC
Q 040398 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 652 (732)
Q Consensus 573 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 652 (732)
.+.+++ +...+||||++|-.|...- ++.+....++..|++-+.-+-..| +||+|+++-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 666665 6778999999986665422 112223334444444444444454 999999999999999
Q ss_pred CCCeEEEeeecce
Q 040398 653 DLNPKISDFGLAK 665 (732)
Q Consensus 653 ~~~~kL~DfGla~ 665 (732)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-09 Score=119.59 Aligned_cols=181 Identities=23% Similarity=0.193 Sum_probs=118.5
Q ss_pred CccccCCCCCCEEecccccCCccCCccccCC-CCCCEEeCCCCccc----------ccCCccccCCCCCCEEEccCcccc
Q 040398 57 PSHLGNITSLTYLDLEENQFSGTIPRELGNL-VNLETLRLSSNRLI----------GNLPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 57 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~----------~~~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
|-.|..+.+|++|.|.++.|+ . ...+..+ ..|+.|...+ .+. |.+-..+ ....|...+++.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~-~-~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLS-T-AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchh-h-hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence 556777788888888888776 2 1222222 2344444332 221 1111111 1235777778888876
Q ss_pred ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhc
Q 040398 126 GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW 205 (732)
Q Consensus 126 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 205 (732)
.+...+.-++.|+.|+|++|+++... .+..+++|+.|||+.|.+..++--....+. |..|.|++|.++ .+ ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT-TL-RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH-hh-hhHH
Confidence 56667777888888888888887432 777888888888888888777665555555 888888888887 22 2367
Q ss_pred CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcC
Q 040398 206 GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 206 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~ 260 (732)
++++|+.|||++|-|.+.-- +..++.|..|+.|.|.+|++-.
T Consensus 252 ~LksL~~LDlsyNll~~hse-------------L~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSE-------------LEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhhccchhHhhhhcchh-------------hhHHHHHHHHHHHhhcCCcccc
Confidence 88888889999888875321 1225556677888888887743
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-07 Score=89.37 Aligned_cols=125 Identities=22% Similarity=0.204 Sum_probs=91.9
Q ss_pred CCeEEEEEEcccc-c------ccchHHHHHHHHHHhcCCCCce--eeeeeeEEeC----CEEEEEEEecCCC-chhHHhh
Q 040398 537 DGTIIAVKLLSSK-S------RQGNREFLNEIGTISCLQHPNL--VKLYGCCIEG----DQLMLVYEYLENN-SLAHALF 602 (732)
Q Consensus 537 ~g~~vAvK~~~~~-~------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~ 602 (732)
.++.+-+|..... . .-...+..+|.+.+..+....| .+.+++.+.. ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 3566666653321 1 1234567889888888865544 4566666553 2458999999884 7998884
Q ss_pred cCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEEEeeecceeCC
Q 040398 603 GGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLDE 668 (732)
Q Consensus 603 ~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DfGla~~~~ 668 (732)
... ..+......++.++++.++-||..| |+|+|++++|||++.+. .+.++||+-++...
T Consensus 111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWE----QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhc----ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 321 2556677899999999999999997 99999999999999887 79999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.7e-09 Score=93.56 Aligned_cols=104 Identities=22% Similarity=0.388 Sum_probs=63.0
Q ss_pred cceEecccccccccCCccc---cCCCCCCEEecccccCCccCCccccC-CCCCCEEeCCCCcccccCCccccCCCCCCEE
Q 040398 42 LKYISVFANRLSGNIPSHL---GNITSLTYLDLEENQFSGTIPRELGN-LVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 117 (732)
+..++|++|+|- .+++.. .....|+..+|++|.|. .+|..|.. .+.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 556666666665 444433 33455555677777776 55555543 345667777777776 666666666667777
Q ss_pred EccCccccccCCccccCCCCCCEEEcccCCCc
Q 040398 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 118 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+++.|.|. ..|..+..+.+|..|+..+|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 77666665 45555555666666666666554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.4e-07 Score=102.06 Aligned_cols=141 Identities=17% Similarity=0.236 Sum_probs=93.5
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEcccccccch------------------------------H----------HHHH
Q 040398 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN------------------------------R----------EFLN 559 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~------------------------------~----------~~~~ 559 (732)
+.++.++-|.||+|+.++|+.||||+....-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999764321110 0 1334
Q ss_pred HHHHHhcCC-----CCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHH-HHHHHhC
Q 040398 560 EIGTISCLQ-----HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARG-LAFLHEE 633 (732)
Q Consensus 560 E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~a-L~yLH~~ 633 (732)
|...+.+++ .+++.-..=|++-....+++|||++|-.+.+...-.. ...+ +..++..++++ ++.+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHhc
Confidence 444444442 3444322223333566789999999988887641111 1223 33455545444 3334334
Q ss_pred CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 634 ~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
| ++|+|.+|.||+++.++++.+.|||+....++
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4 99999999999999999999999999875544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 732 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-17 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-149
Identities = 102/236 (43%), Positives = 150/236 (63%), Gaps = 3/236 (1%)
Query: 500 QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN-REFL 558
Q F+L++++ A+ NF N +G GGFG VYKG+L DGT++AVK L + QG +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
E+ IS H NL++L G C+ + +LVY Y+ N S+A L SQ L+W RQ+
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
I LG ARGLA+LH+ KI+HRD+KA N+LLD + + DFGLAKL + + TH++T V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNN--MSYVPDSNCTCPLDW 732
GTIG++APEY G + K DV+ +GV+ LE+++G+ ++ + + + LDW
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-137
Identities = 101/248 (40%), Positives = 152/248 (61%), Gaps = 4/248 (1%)
Query: 486 SAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKL 545
S + + F++ L + AT+NFD IG G FG VYKG L DG +A+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 546 LSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE 605
+ +S QG EF EI T+S +HP+LV L G C E ++++L+Y+Y+EN +L L+G +
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 606 NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
+ ++W R +IC+G ARGL +LH + I+HRD+K+ N+LLD + PKI+DFG++K
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 666 L-DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDS 724
E ++TH+ST V GT+GY+ PEY + G LT K+DVYSFGVV E++ ++ +
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 725 NCTCPLDW 732
+W
Sbjct: 248 EMVNLAEW 255
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-132
Identities = 99/239 (41%), Positives = 145/239 (60%), Gaps = 17/239 (7%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDP------MNKIGEGGFGPVYKGQLTDGTIIAVK 544
+ +LE + + SF+ +++ T+NFD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 545 LLSS----KSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHA 600
L++ + + ++F EI ++ QH NLV+L G +GD L LVY Y+ N SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 601 LFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660
L + + L+W +R KI G A G+ FLHE +HRDIK+ N+LLD KISD
Sbjct: 121 LSCLDGTP-PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 661 FGLAKL-DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718
FGLA+ ++ +T +++R+ GT YMAPE L G +T K+D+YSFGVV LEI++G +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 5e-75
Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 24/248 (9%)
Query: 502 SSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEI 561
+ + + + G FG V+K QL +AVK+ + +Q + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEV 69
Query: 562 GTISCLQHPNLVKLYGCCIEGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
++ ++H N+++ G G L L+ + E SL+ L ++W+
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELC 124
Query: 618 KICLGIARGLAFLHEE-------SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
I +ARGLA+LHE+ + I HRDIK+ NVLL +L I+DFGLA E
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 671 KTHI-STRVAGTIGYMAPEYA-----LWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDS 724
K+ + GT YMAPE + D+Y+ G+V E+ S D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 725 NCTCPLDW 732
+
Sbjct: 245 YMLPFEEE 252
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 1e-65
Identities = 72/249 (28%), Positives = 107/249 (42%), Gaps = 41/249 (16%)
Query: 497 LEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE 556
+E AS +L N + IG G +G VYKG L D +AVK+ S +RQ
Sbjct: 1 MEAAASEPSL-----DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---N 51
Query: 557 FLNE--IGTISCLQHPNLVKLYGCCIEGD-----QLMLVYEYLENNSLAHALFGGENSQL 609
F+NE I + ++H N+ + + +LV EY N SL L S
Sbjct: 52 FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLH 106
Query: 610 KLNWSVRQKICLGIARGLAFLHEE------SRFKIVHRDIKATNVLLDRDLNPKISDFGL 663
+W ++ + RGLA+LH E + I HRD+ + NVL+ D ISDFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 664 AKL-------DEEEKTHISTRVAGTIGYMAPEYA-------LWGYLTYKADVYSFGVVAL 709
+ E+ + + GTI YMAPE + D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 710 EIVSGKNNM 718
EI ++
Sbjct: 227 EIFMRCTDL 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYG 577
KIG G FG V++ + G+ +AVK+L + EFL E+ + L+HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ L +V EYL SL L ++ +L+ R + +A+G+ +LH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE------YAL 691
IVHR++K+ N+L+D+ K+ DFGL++L + S AGT +MAPE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS-- 216
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
K+DVYSFGV+ E+ + +
Sbjct: 217 ----NEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 68/221 (30%), Positives = 115/221 (52%), Gaps = 28/221 (12%)
Query: 520 NKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN-------REFLNEIGTISCLQHPN 571
+IG+GGFG V+KG+ + D +++A+K L +G +EF E+ +S L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+VKLYG +V E++ L H L + + WSV+ ++ L IA G+ ++
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 632 EESRFKIVHRDIKATNVLLD-----RDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
++ IVHRD+++ N+ L + K++DFGL++ + H + + G +MA
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 687 PEYALWGYLTY--KADVYSFGVVALEIVSGK---NNMSYVP 722
PE +Y KAD YSF ++ I++G+ + SY
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 6e-57
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 9/228 (3%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFA-YNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHL 60
P +P + NLPYL + N L G IP A + L Y+ + +SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNL-TDFRI 119
I +L LD N SGT+P + +L NL + NR+ G +P L T I
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPNQTF 177
+ N G P + L +++ + LEG + ++ ++ L
Sbjct: 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD---L 237
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225
+ L + LRN I G +P+ + +K L L++SFN L GE+P
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 35/292 (11%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGS--IPREWASMQ-LKYISVF-ANRLSGNIPSH 59
+ G L + +D + L IP A++ L ++ + N L G IP
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 60 LGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119
+ +T L YL + SG IP L + L TL S N L G LP + L NL
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 120 NDNNFNGSAPDFIQSWTQLNR-LEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPNQT 176
+ N +G+ PD S+++L + I + L G IPP+ + L L + +S L+G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGD--- 212
Query: 177 FPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKF 235
+ + +I L ++A ++ + + KNL LDL N++ G LP +
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP--------QG 263
Query: 236 TQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENN 287
L F+ SL++S+NN + P+ NL F S+ NN
Sbjct: 264 LTQLKFL------HSLNVSFNNLCGEIPQ--------GGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 57/231 (24%), Positives = 85/231 (36%), Gaps = 30/231 (12%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGT--IPRELGNLVNLETLRLSS-NRLIGNLPM 106
G + + LDL IP L NL L L + N L+G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 107 ELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLR 166
+ KL L I N +G+ PDF+ L L+ + L G +PPSIS+L L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 167 ISD--LQGPNQTFPM-LRNMTGLTRII-LRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
+ G P + + L + + + G+IP + NL F+DLS N L G
Sbjct: 156 FDGNRISGA---IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG 211
Query: 223 ELPDVAVPADLKFTQIL--------------MFIRGVYEHQSLDLSYNNFT 259
+ + K TQ + + + LDL N
Sbjct: 212 DASVLF--GSDKNTQKIHLAKNSLAFDLGKVGLSKNL---NGLDLRNNRIY 257
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 56/215 (26%), Positives = 78/215 (36%), Gaps = 29/215 (13%)
Query: 56 IPSHLGNITSL----TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIG--NLPMELV 109
I LGN T+L D + G + + L LS L +P L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 110 KLKNLTDFRI-NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
L L I NN G P I TQL+ L I + + G IP +S + L L S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 169 D--LQGPNQTFPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNL-RFLDLSFNQLTGEL 224
L G P + ++ L I I+G IP+ L + +S N+LTG++
Sbjct: 134 YNALSGT---LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 225 PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
P A+L +DLS N
Sbjct: 191 PPTF--ANLNLAF-------------VDLSRNMLE 210
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANR-LSGN 55
GTLP + L +L +++ ++N L G IP+ + + N+ L G+
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-57
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
+G G FG V K + +A+K + S+S + + F+ E+ +S + HPN+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639
+ + + LV EY E SL + L G E + CL ++G+A+LH ++
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 640 HRDIKATNVLLDRDLN-PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-YALWGYLTY 697
HRD+K N+LL KI DFG A + T G+ +MAPE + Y +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNY-SE 182
Query: 698 KADVYSFGVVALEIVSGK 715
K DV+S+G++ E+++ +
Sbjct: 183 KCDVFSWGIILWEVITRR 200
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 520 NKIGEGGFGPVYKGQL-TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+G+G FG K G ++ +K L + R FL E+ + CL+HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
+ +L + EY++ +L + ++ + WS R IA G+A+LH I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH-------------ISTRVAGTIGYM 685
+HRD+ + N L+ + N ++DFGLA+L +EKT V G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725
APE K DV+SFG+V EI+ N
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLL----SSKSRQGNREFLNEIGTISCLQHPNLVKL 575
IG GGFG VY+ G +AVK Q E + L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
G C++ L LV E+ L L S ++ + + IARG+ +LH+E+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 636 FKIVHRDIKATNVLLDRDLNP--------KISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
I+HRD+K++N+L+ + + KI+DFGLA+ E +T + AG +MAP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMAP 183
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSGK 715
E + +DV+S+GV+ E+++G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYG 577
K+ E G ++KG+ G I VK+L + R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 578 CCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
C L+ ++ SL + L E + ++ S K L +ARG+AFLH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-- 693
I + + +V++D D+ +IS + + S ++APE AL
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKP 184
Query: 694 YLTY--KADVYSFGVVALEIVSGK 715
T AD++SF V+ E+V+ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 29/224 (12%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNE--IGTISCLQHPNLVKLYG 577
+G+G +G V++G G +AVK+ SS + + + E + L+H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 578 CCIEGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ QL L+ Y E SL L L+ +I L IA GLA LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 634 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI---STRVAGTIGYM 685
I HRD+K+ N+L+ ++ I+D GLA + + + + GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 686 APE------YALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPD 723
APE + D+++FG+V E+ + V D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNE--IGTISCLQHPNLVKLYG 577
+IG+G +G V+ G+ G +AVK+ + + E I ++H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 578 CCIEGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
I+G QL L+ +Y EN SL L L+ K+ GL LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 634 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI---STRVAGTIGYM 685
I HRD+K+ N+L+ ++ I+D GLA + + GT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 686 APEYALWGYLTY-------KADVYSFGVVALEIVSGKNNMSYVPD 723
PE L L AD+YSFG++ E+ + V +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-53
Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYG 577
+IG G FG VYKG+ G + AVK+L+ + + F NE+G + +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
QL +V ++ E +SL H L E K I ARG+ +LH +
Sbjct: 88 YSTA-PQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---S 140
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKL-DEEEKTHISTRVAGTIGYMAPE---YALWG 693
I+HRD+K+ N+ L D KI DFGLA +H +++G+I +MAPE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
++++DVY+FG+V E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-52
Identities = 70/265 (26%), Positives = 112/265 (42%), Gaps = 28/265 (10%)
Query: 4 SLPGTLPPQIV---NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHL 60
S+ G V L+ + + N + G + + L+++ V +N S IP L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPF-L 219
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
G+ ++L +LD+ N+ SG R + L+ L +SSN+ +G +P LK+L +
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277
Query: 121 DNNFNGSAPDFIQ-SWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPNQTF 177
+N F G PDF+ + L L++ G+ G +PP + L L +S G
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE---L 334
Query: 178 P--MLRNMTGLTRIILRNCNIAGEIPEYIWGIK-NLRFLDLSFNQLTGELPDVAVPADLK 234
P L M GL + L +GE+PE + + +L LDLS N +G +
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 235 FTQILMFIRGVYEHQSLDLSYNNFT 259
Q L L N FT
Sbjct: 395 TL------------QELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-49
Identities = 69/270 (25%), Positives = 109/270 (40%), Gaps = 34/270 (12%)
Query: 4 SLPGTLPPQIVNL-PYLETVDFAYNYLHGSIPREWASMQ---LKYISVFANRLSGNIPSH 59
G LP + NL L T+D + N G I L+ + + N +G IP
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 60 LGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119
L N + L L L N SGTIP LG+L L L+L N L G +P EL+ +K L +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPM 179
+ N+ G P + + T LN + + + L G IP I
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG---------------------- 511
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD------VAVPADL 233
+ L + L N + +G IP + ++L +LDL+ N G +P + A+
Sbjct: 512 --RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569
Query: 234 KFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263
+ ++I+ + + N +Q
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-49
Identities = 71/259 (27%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGN 62
L G +P +++ + LET+ +N L G IP ++ L +IS+ NRL+G IP +G
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
+ +L L L N FSG IP ELG+ +L L L++N G +P + K I N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLE--GPIPPSISALDKLNQLRISDLQGPNQTFPML 180
G +I++ G+ LE G ++ L N I+ T P
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240
N + + + ++G IP+ I + L L+L N ++G +PD + L
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD-------EVGD-LR 680
Query: 241 FIRGVYEHQSLDLSYNNFT 259
+ LDLS N
Sbjct: 681 GL------NILDLSSNKLD 693
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-44
Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 32/268 (11%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPS--H 59
L + +++L LE++ + ++++GS+ S L + + N LSG + +
Sbjct: 62 LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 60 LGNITSLTYLDLEENQFSGTIPRELG-NLVNLETLRLSSNRLIGNLPMELV---KLKNLT 115
LG+ + L +L++ N G L +LE L LS+N + G + V L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGP 173
I+ N +G + L L++ + I P + L L IS L G
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGD 238
Query: 174 NQTFPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPAD 232
F + T L + + + G IP +K+L++L L+ N+ TGE+PD
Sbjct: 239 ---FSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPD------ 287
Query: 233 LKFTQILMFIRGVYEH-QSLDLSYNNFT 259
F+ G + LDLS N+F
Sbjct: 288 --------FLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 43/246 (17%), Positives = 78/246 (31%), Gaps = 71/246 (28%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPRE-----------------------WASM 40
S G +P ++ + L +D N +G+IP
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ + + G L +++ ++ + G N ++ L +S N L
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
G +P E+ + L + N+ +GS IP + L
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGS------------------------IPDEVGDLR 680
Query: 161 KLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQL 220
LN L +S N + G IP+ + + L +DLS N L
Sbjct: 681 GLNILDLS------------SN------------KLDGRIPQAMSALTMLTEIDLSNNNL 716
Query: 221 TGELPD 226
+G +P+
Sbjct: 717 SGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-29
Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 1/130 (0%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHL 60
L G Q+ L + G + + + ++ + N LSG IP +
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
G++ L L+L N SG+IP E+G+L L L LSSN+L G +P + L LT+ ++
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712
Query: 121 DNNFNGSAPD 130
+NN +G P+
Sbjct: 713 NNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 24/207 (11%)
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFR 118
+TS+ N + L +L LE+L LS++ + G++ +LT
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 119 INDNNFNGSAPDF--IQSWTQLNRLEIQGSGLEGPIP-PSISALDKLNQLRIS--DLQGP 173
++ N+ +G + S + L L + + L+ P L+ L L +S + G
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 174 N-QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPAD 232
N + + L + + I+G++ + NL FLD+S N + +P +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG---- 220
Query: 233 LKFTQILMFIRGVYEHQSLDLSYNNFT 259
+ + Q LD+S N +
Sbjct: 221 -DCSAL----------QHLDISGNKLS 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNE--IGTISCLQHPNLVKLYG 577
IG+G FG V++G+ G +AVK+ SS + R + E I L+H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 578 CCIEGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ + QL LV +Y E+ SL L ++ + K+ L A GLA LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 634 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI---STRVAGTIGYM 685
I HRD+K+ N+L+ ++ I+D GLA + I GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 686 APEYALWGYLTY-------KADVYSFGVVALEIVSGKNNMSYVPD 723
APE L + +AD+Y+ G+V EI + D
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-51
Identities = 47/243 (19%), Positives = 94/243 (38%), Gaps = 39/243 (16%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVKLYG 577
IG+G FG VY G+ G + A++L+ + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
C+ L ++ + +L + + L+ + ++I I +G+ +LH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHISTRVAGTIGYMAPEYALWG 693
I+H+D+K+ NV D + I+DFGL + + G + ++APE
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 694 YL---------TYKADVYSFGVVALEIVSGK---NNMSYV------------PDSNCTCP 729
+ +DV++ G + E+ + + S
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 730 LDW 732
+
Sbjct: 270 KEI 272
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTI-IAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+IG G FG V+ G+L +AVK + +FL E + HPN+V+L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G C + + +V E ++ L +L ++ A G+ +L +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEYALW 692
+HRD+ A N L+ KISDFG+++ + + + G + + APE +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNY 289
Query: 693 GYLTYKADVYSFGVVALEIVS 713
G + ++DV+SFG++ E S
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 28/242 (11%)
Query: 482 GPLISAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT----- 536
G ++S ++ F+ + +GEG FG V +
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIR------------DLGEGHFGKVELCRYDPEGDN 48
Query: 537 DGTIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLMLVYEYLE 593
G +AVK L + EI + L H N+VK G C E G+ + L+ E+L
Sbjct: 49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653
+ SL L +N ++ L + K + I +G+ +L SR + VHRD+ A NVL++ +
Sbjct: 109 SGSLKEYLPKNKN-KINLKQQL--KYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESE 162
Query: 654 LNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWGYLTYKADVYSFGVVALEI 711
KI DFGL K E +K + + + + + APE + +DV+SFGV E+
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 712 VS 713
++
Sbjct: 223 LT 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-43
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 36/242 (14%)
Query: 482 GPLISAISVDPNLEGL-----EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT 536
GPL S P+ GL E T + ++G G FG V G+
Sbjct: 1 GPLGS--KNAPSTAGLGYGSWEIDPKDLTFLK------------ELGTGQFGVVKYGKWR 46
Query: 537 DGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594
+A+K++ S S EF+ E + L H LV+LYG C + + ++ EY+ N
Sbjct: 47 GQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103
Query: 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654
L + L + + + ++C + + +L E +F +HRD+ A N L++
Sbjct: 104 GCLLNYLREMR-HRFQTQQLL--EMCKDVCEAMEYL-ESKQF--LHRDLAARNCLVNDQG 157
Query: 655 NPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALWGYLTYKADVYSFGVVALEI 711
K+SDFGL++ ++ T G+ + + PE ++ + K+D+++FGV+ EI
Sbjct: 158 VVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 712 VS 713
S
Sbjct: 215 YS 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 31/233 (13%)
Query: 491 DPNLEGLEF-QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG-----TIIAVK 544
PN L + + F + +G G FG VYKG +A+K
Sbjct: 3 APNQALLRILKETEFKKIK------------VLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 545 LL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG 603
L + S + N+E L+E ++ + +P++ +L G C+ + L+ + + L +
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-- 107
Query: 604 GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663
+ + C+ IA+G+ +L E+ R VHRD+ A NVL+ + KI+DFGL
Sbjct: 108 -REHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGL 163
Query: 664 AKL---DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
AKL +E+E +V I +MA E L T+++DV+S+GV E+++
Sbjct: 164 AKLLGAEEKEYHAEGGKVP--IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 70/270 (25%), Positives = 111/270 (41%), Gaps = 43/270 (15%)
Query: 469 GKGTTAIPIGGVYGPLISAISVDPNLEGL----EFQASSFTLKQIRAATSNFDPMNKIGE 524
G G++ P G L I +P + L ++GE
Sbjct: 4 GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVL------------KWELGE 51
Query: 525 GGFGPVYKGQLTDG------TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
G FG V+ + + ++AVK L S ++F E ++ LQH ++V+ +G
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111
Query: 579 CIEGDQLMLVYEYLENNSL---------AHALFGGENSQLKLNWSVRQ--KICLGIARGL 627
C EG L++V+EY+ + L L G + Q + +A G+
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IG 683
+L VHRD+ N L+ + L KI DFG+++ RV G I
Sbjct: 172 VYL--AGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIR 225
Query: 684 YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+M PE L+ T ++DV+SFGVV EI +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKSRQ 552
+F+ Q ++G+G FG V + G ++AVK L + +
Sbjct: 6 QFEERHLKFLQ------------QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 53
Query: 553 GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLK 610
R+F EI + LQH N+VK G C + L L+ EYL SL L + + +
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER 110
Query: 611 LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
++ + I +G+ +L ++ + +HRD+ N+L++ + KI DFGL K+ ++
Sbjct: 111 IDHIKLLQYTSQICKGMEYL--GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
Query: 671 KTHISTRVAGT--IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
K + G I + APE + +DV+SFGVV E+ +
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 29/221 (13%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLL--SSKSRQGNR 555
E + TL + ++G G FG V G+ +AVK++ S S
Sbjct: 4 ELKREEITLLK------------ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED--- 48
Query: 556 EFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSV 615
EF E T+ L HP LVK YG C + + +V EY+ N L + L L+ + +
Sbjct: 49 EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLL 107
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675
++C + G+AFL E +F +HRD+ A N L+DRDL K+SDFG+ + +++
Sbjct: 108 --EMCYDVCEGMAFL-ESHQF--IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--- 159
Query: 676 TRVAGT---IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
GT + + APE + + K+DV++FG++ E+ S
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+ +IG G FG V+ G + +A+K + + S + +F+ E + L HP LV+LY
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G C+E + LV E++E+ L+ L + +CL + G+A+L EE+
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLL--GMCLDVCEGMAYL-EEACV 125
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALWG 693
+HRD+ A N L+ + K+SDFG+ + ++ T GT + + +PE +
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFS 180
Query: 694 YLTYKADVYSFGVVALEIVS 713
+ K+DV+SFGV+ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKSRQ 552
+F+ Q ++G+G FG V + G ++AVK L + +
Sbjct: 37 QFEERHLKFLQ------------QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84
Query: 553 GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLK 610
R+F EI + LQH N+VK G C + L L+ EYL SL L + + +
Sbjct: 85 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER 141
Query: 611 LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
++ + I +G+ +L ++ + +HRD+ N+L++ + KI DFGL K+ ++
Sbjct: 142 IDHIKLLQYTSQICKGMEYL--GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
Query: 671 KTHISTRVAGT--IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
K + + G I + APE + +DV+SFGVV E+ +
Sbjct: 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 72/200 (36%), Positives = 108/200 (54%), Gaps = 17/200 (8%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+ ++G G FG V+ G T +AVK L S S FL E + LQH LV+LY
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+ + + ++ EY+EN SL L +L +N + + IA G+AF+ EE +
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFI-EERNY 130
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALWG 693
+HRD++A N+L+ L+ KI+DFGLA+L E+ T G I + APE +G
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 185
Query: 694 YLTYKADVYSFGVVALEIVS 713
T K+DV+SFG++ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
+G+G +G VY G L++ IA+K + + + ++ EI L+H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVH 640
E + + E + SL AL + LK N I GL +LH+ +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 641 RDIKATNVLLD-RDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE---YALWGYLT 696
RDIK NVL++ KISDFG +K T GT+ YMAPE GY
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY-G 203
Query: 697 YKADVYSFGVVALEIVSGK 715
AD++S G +E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 66/196 (33%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ IG+G FG V G G +AVK + K+ + FL E ++ L+H NLV+L G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 579 CIEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+E L +V EY+ SL L S L + + K L + + +L E
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYL--EGN-N 137
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
VHRD+ A NVL+ D K+SDFGL K E T + ++ + + APE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFST 193
Query: 698 KADVYSFGVVALEIVS 713
K+DV+SFG++ EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 492 PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTI-IAVKLL--SS 548
PN + E + + T+K K+G G +G VY+G ++ +AVK L +
Sbjct: 3 PNYDKWEMERTDITMKH------------KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 50
Query: 549 KSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQ 608
+ EFL E + ++HPNLV+L G C ++ E++ +L L +
Sbjct: 51 MEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 609 LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-- 666
+ + + I+ + +L E + +HRD+ A N L+ + K++DFGL++L
Sbjct: 108 VSAVVLL--YMATQISSAMEYL--EKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162
Query: 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ H + I + APE + + K+DV++FGV+ EI +
Sbjct: 163 GDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 28/217 (12%)
Query: 519 MNKIGEGGFGPVYKGQLTDG------TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL 572
++GEG FG V+ + + ++AVK L + ++F E ++ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSL----------AHALFGGENSQLKLNWSVRQ--KIC 620
VK YG C +GD L++V+EY+++ L A L G+ Q K + Q I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAG 680
IA G+ +L S+ VHRD+ N L+ +L KI DFG+++ + RV G
Sbjct: 140 SQIASGMVYL--ASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGG 193
Query: 681 T----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
I +M PE ++ T ++DV+SFGV+ EI +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 521 KIGEGGFGPVYKGQLTDG---TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
++G G FG V +G +A+K+L + E + E + L +P +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G C + + LMLV E L L + ++ S ++ ++ G+ +L EE F
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL-EEKNF 131
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWGY 694
VHRD+ A NVLL KISDFGL+K + ++ + R AG + + APE +
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 695 LTYKADVYSFGVVALEIVS 713
+ ++DV+S+GV E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 521 KIGEGGFGPVYKGQLTDG---TIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKL 575
++G G FG V KG +AVK+L + E L E + L +P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
G C E + MLV E E L L +N +K + ++ ++ G+ +L EES
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNII--ELVHQVSMGMKYL-EESN 137
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWG 693
F VHRD+ A NVLL KISDFGL+K ++ + + G + + APE +
Sbjct: 138 F--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 694 YLTYKADVYSFGVVALEIVS 713
+ K+DV+SFGV+ E S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 70/235 (29%), Positives = 116/235 (49%), Gaps = 30/235 (12%)
Query: 491 DPNLEGLEFQ----ASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTI-----I 541
DPN L+F S T ++ IG G FG VYKG L + +
Sbjct: 29 DPNQAVLKFTTEIHPSCVTRQK------------VIGAGEFGEVYKGMLKTSSGKKEVPV 76
Query: 542 AVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHA 600
A+K L + + + +FL E G + H N+++L G + +M++ EY+EN +L
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 601 LFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660
L + + + V + GIA G+ +L + VHRD+ A N+L++ +L K+SD
Sbjct: 137 LREKDG-EFSVLQLVG--MLRGIAAGMKYL-ANMNY--VHRDLAARNILVNSNLVCKVSD 190
Query: 661 FGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
FGL+++ E++ T G I + APE + T +DV+SFG+V E+++
Sbjct: 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 519 MNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
++++G+G FG V + G ++AVK L R+F EI + L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 574 KLYGCCIEGDQ--LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
K G + L LV EYL + L L ++L + + I +G+ +L
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLL--LYSSQICKGMEYL- 143
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEY 689
R VHRD+ A N+L++ + + KI+DFGLAKL +K + R G I + APE
Sbjct: 144 GSRRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 690 ALWGYLTYKADVYSFGVVALEIVS 713
+ ++DV+SFGVV E+ +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 490 VDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG----TIIAVKL 545
+P+ +A ++I A S IG G G V G+L +A+K
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA 84
Query: 546 L-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGG 604
L + + + R+FL+E + HPN+++L G G M+V EY+EN SL L
Sbjct: 85 LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 605 ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
+ Q + V + G+ G+ +L + + VHRD+ A NVL+D +L K+SDFGL+
Sbjct: 145 DG-QFTIMQLVG--MLRGVGAGMRYL-SDLGY--VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 665 KL--DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
++ D+ + + +T I + APE + + +DV+SFGVV E+++
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 490 VDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKL 545
VDP+ Q K++ A +N +G G FG V G+L +A+K
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 546 L-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGG 604
L + + R+FL E + HPN+++L G + +M+V EY+EN SL L
Sbjct: 81 LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
Query: 605 ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
+ Q + V + GIA G+ +L + + VHRD+ A N+L++ +L K+SDFGL
Sbjct: 141 DA-QFTVIQLVG--MLRGIASGMKYL-SDMGY--VHRDLAARNILINSNLVCKVSDFGLG 194
Query: 665 KL--DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
++ D+ E + + I + +PE + T +DV+S+G+V E++S
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG-----TIIAVKLL-SSKSR 551
F+ + + +G G FG V+KG + +K++ R
Sbjct: 9 IFKETELRKLK------------VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 56
Query: 552 QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKL 611
Q + + + I L H ++V+L G C L LV +YL SL + + L
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV---RQHRGAL 112
Query: 612 NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DE 668
+ + IA+G+ +L EE VHR++ A NVLL +++DFG+A L D+
Sbjct: 113 GPQLLLNWGVQIAKGMYYL-EEHGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
++ + + I +MA E +G T+++DV+S+GV E+++
Sbjct: 170 KQLLYSEAKTP--IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-41
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTI-IAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKL 575
+K+G G +G VY+G ++ +AVK L + + EFL E + ++HPNLV+L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 281
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
G C ++ E++ +L L ++ + + I+ + +L E +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYL--EKK 337
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL 695
+HR++ A N L+ + K++DFGL++L + I + APE +
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 696 TYKADVYSFGVVALEIVS 713
+ K+DV++FGV+ EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK---LLSSKSRQGNREFLNEIGTISCLQH 569
+NF KIG G F VY+ L DG +A+K + + + + EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLK----LNWSVRQKICLGI 623
PN++K Y IE ++L +V E + L+ + F + + + Q +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-FVQ-----L 145
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
L +H +++HRDIK NV + K+ D GL + + T + V GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 684 YMAPEYALW---GYLTYKADVYSFGVVALEIVSGK 715
YM+PE GY +K+D++S G + E+ + +
Sbjct: 202 YMSPE--RIHENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 491 DPNLEGLEF-QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG-----TIIAVK 544
PN L + + F + +G G FG VYKG +A+K
Sbjct: 3 APNQALLRILKETEFKKIK------------VLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 545 LL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG 603
L + S + N+E L+E ++ + +P++ +L G C+ + L+ + + L +
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-- 107
Query: 604 GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663
+ + C+ IA+G+ +L E+ R VHRD+ A NVL+ + KI+DFGL
Sbjct: 108 -REHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGL 163
Query: 664 AK-LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
AK L EEK + + I +MA E L T+++DV+S+GV E+++
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 519 MNKIGEGGFGPVYKGQLTD-----GTIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNL 572
+ +GEG FG V G ++AVK L + Q + EI + L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 573 VKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+K GCC + L LV EY+ SL L + L + I G+A+L
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLL--LFAQQICEGMAYL 150
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPE 688
++ +HRD+ A NVLLD D KI DFGLAK E + R G + + APE
Sbjct: 151 --HAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 689 YALWGYLTYKADVYSFGVVALEIVS 713
Y +DV+SFGV E+++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 66/196 (33%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
+ IG+G FG V G G +AVK + K+ + FL E ++ L+H NLV+L G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 579 CI-EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFK 637
+ E L +V EY+ SL L S L + + K L + + +L E
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYL--EGN-N 309
Query: 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTY 697
VHRD+ A NVL+ D K+SDFGL K E T + ++ + + APE +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFST 365
Query: 698 KADVYSFGVVALEIVS 713
K+DV+SFG++ EI S
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
K+G+G FG V+ G T +A+K L + FL E + L+H LV+LY
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
E + + +V EY+ SL L G L+L V + IA G+A++ E +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIASGMAYV-ERMNY-- 301
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
VHRD++A N+L+ +L K++DFGLA+L E+ + I + APE AL+G T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 699 ADVYSFGVVALEIVS 713
+DV+SFG++ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-40
Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
K+G G FG V+ T +AVK + S FL E + LQH LVKL+
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
+ + + ++ E++ SL L E S+ L + IA G+AF+ E R
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFI--EQR-NY 305
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALWGYL 695
+HRD++A N+L+ L KI+DFGLA++ E+ + T G I + APE +G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSF 362
Query: 696 TYKADVYSFGVVALEIVS 713
T K+DV+SFG++ +EIV+
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVK--LLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
+IG G F VYKG +A ++ + F E + LQHPN+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 578 CCI----EGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLH 631
++LV E + + +L L F + V + C I +GL FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 146
Query: 632 EESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
+ I+HRD+K N+ + + KI D GLA L V GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 202
Query: 691 LWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNCTCP 729
Y DVY+FG+ LE+ + + P S C
Sbjct: 203 EEKY-DESVDVYAFGMCMLEMATSE-----YPYSECQNA 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 24/206 (11%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
++G G FG V++ + G AVK + + + + E+ + L P +V LYG
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117
Query: 578 CCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
EG + + E LE SL + G L GL +LH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR-- 169
Query: 636 FKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEEEKTHISTR----VAGTIGYMAPE-Y 689
+I+H D+KA NVLL D + + DFG A + + S + GT +MAPE
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
K D++S + L +++G
Sbjct: 229 MGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGC 578
K+G+G FG V+ G T +A+K L + FL E + L+H LV+LY
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 330
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
E + + +V EY+ SL L G L+L V + IA G+A++ E +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIASGMAYV-ERMNY-- 384
Query: 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYK 698
VHRD++A N+L+ +L K++DFGLA+L E+ + I + APE AL+G T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 699 ADVYSFGVVALEIVS 713
+DV+SFG++ E+ +
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 519 MNKIGEGGFGPVYKGQLTDG------TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPN 571
M ++GE FG VYKG L +A+K L K EF +E + LQHPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQ-------KI 619
+V L G + L +++ Y + L + S +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
IA G+ +L S +VH+D+ NVL+ LN KISD GL + ++
Sbjct: 134 VAQIAAGMEYL--SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---YKLL 187
Query: 680 GT----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
G I +MAPE ++G + +D++S+GVV E+ S
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 520 NKIGEGGFGPVYKGQLTDG---TIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPNLVK 574
+ IGEG FG V K ++ A+K + S+ +R+F E+ + L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 575 LYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQ-------KICLG 622
L G C L L EY + +L + + + N +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ARG+ +L + + +HRD+ A N+L+ + KI+DFGL++ E R+ +
Sbjct: 151 VARGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MA E + T +DV+S+GV+ EIVS
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 521 KIGEGGFGPVYKGQLTDG----TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKL 575
+GEG FG VY+G T+ +AVK + +F++E + L HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
G E + ++ E L H L +N LK+ V L I + +A+L E
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVL--YSLQICKAMAYL-ESIN 133
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---IGYMAPEYALW 692
VHRDI N+L+ K+ DFGL++ E+E + + T I +M+PE +
Sbjct: 134 C--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 693 GYLTYKADVYSFGVVALEIVS 713
T +DV+ F V EI+S
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 27/283 (9%)
Query: 443 GVLKPVTRPFTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPNLEGLEFQAS 502
G+L P P + + + G+ + G I +++P L QA
Sbjct: 24 GILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPEL----VQAV 79
Query: 503 SFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG----TIIAVKLL-SSKSRQGNREF 557
+ + +F+ IG G FG VY G L D AVK L +F
Sbjct: 80 QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 137
Query: 558 LNEIGTISCLQHPNLVKLYGCCIEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
L E + HPN++ L G C+ + ++V Y+++ L + + N +V+
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVK 192
Query: 617 Q--KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674
L +A+G+ FL +F VHRD+ A N +LD K++DFGLA+ D +K
Sbjct: 193 DLIGFGLQVAKGMKFL-ASKKF--VHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFD 248
Query: 675 STRVAGT----IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
S + +MA E T K+DV+SFGV+ E+++
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 71/238 (29%), Positives = 119/238 (50%), Gaps = 20/238 (8%)
Query: 489 SVDPNLEGLEFQASSFTLKQIRAA----TSNFDP------MNKIGEGGFGPVYKGQ-LTD 537
VD E L FQ+ T +Q +AA DP KIGEG G V +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 538 GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597
G +AVK++ + +Q NE+ + QH N+V++Y + G++L ++ E+L+ +L
Sbjct: 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657
+ SQ++LN +C + + LA+LH + ++HRDIK+ ++LL D K
Sbjct: 130 TDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 658 ISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+SDFG ++ + V GT +MAPE + D++S G++ +E+V G+
Sbjct: 182 LSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 68/244 (27%), Positives = 99/244 (40%), Gaps = 29/244 (11%)
Query: 489 SVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG------TIIA 542
+PN +S LK++ N + +G G FG VY+GQ++ +A
Sbjct: 7 HHNPNYCFAGKTSSISDLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 64
Query: 543 VKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL---- 597
VK L S Q +FL E IS H N+V+ G ++ ++ E + L
Sbjct: 65 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124
Query: 598 -AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---D 653
+ S L + + + IA G +L E +HRDI A N LL
Sbjct: 125 RETRPRPSQPSSLAMLDLL--HVARDIACGCQYL--EEN-HFIHRDIAARNCLLTCPGPG 179
Query: 654 LNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEYALWGYLTYKADVYSFGVVAL 709
KI DFG+A+ R G + +M PE + G T K D +SFGV+
Sbjct: 180 RVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236
Query: 710 EIVS 713
EI S
Sbjct: 237 EIFS 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPN 571
+ + KIGEG FG + DG +K +S S + E E+ ++ ++HPN
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK----LNWSVRQKICLGIARGL 627
+V+ E L +V +Y E L + + + L+W V Q I L
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV-Q-----ICLAL 138
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
+H+ KI+HRDIK+ N+ L +D ++ DFG+A++ + GT Y++P
Sbjct: 139 KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSP 194
Query: 688 EYALW---GYLTYKADVYSFGVVALEIVSGK 715
E + Y K+D+++ G V E+ + K
Sbjct: 195 E--ICENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 519 MNKIGEGGFGPVYKGQLTDG----TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLV 573
IGEG FG V++G +A+K + S +FL E T+ HP++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
KL G E + + ++ E L L + L L + ++ LA+L E
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLI--LYAYQLSTALAYL-ES 134
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
RF VHRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE +
Sbjct: 135 KRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 694 YLTYKADVYSFGVVALEIVS 713
T +DV+ FGV EI+
Sbjct: 193 RFTSASDVWMFGVCMWEILM 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 521 KIGEGGFGPVYKGQLT----DGTIIAVKLL---SSKSRQGNREFLNEIGTISCLQHPNLV 573
K+G+G FG V +G+ +AVK L + +F+ E+ + L H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LYG + + +V E SL L + L + + +A G+ +L E
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLS--RYAVQVAEGMGYL-ES 139
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYAL 691
RF +HRD+ A N+LL KI DFGL + + H + + APE
Sbjct: 140 KRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 692 WGYLTYKADVYSFGVVALEIVS 713
++ +D + FGV E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 521 KIGEGGFGPVYKGQLT--DGTI-IAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLY 576
++G G FG V +G I +A+K+L + E + E + L +P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G C + + LMLV E L L + ++ S ++ ++ G+ +L EE F
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL-EEKNF 457
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT--IGYMAPEYALWGY 694
VHR++ A NVLL KISDFGL+K + ++ + R AG + + APE +
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 695 LTYKADVYSFGVVALEIVS 713
+ ++DV+S+GV E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 40/252 (15%)
Query: 484 LISAISVDPNL----EGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG- 538
++ ++ + L E + FTL + +G+G FG V + QL
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGR------------MLGKGEFGSVREAQLKQED 48
Query: 539 ---TIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------QLML 587
+AVK+L + EFL E + HP++ KL G + M+
Sbjct: 49 GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108
Query: 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKA 645
+ ++++ L L + N ++ + + IA G+ +L SR +HRD+ A
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSR-NFIHRDLAA 165
Query: 646 TNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEYALWGYLTYKADV 701
N +L D+ ++DFGL++ + R + ++A E T +DV
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDV 222
Query: 702 YSFGVVALEIVS 713
++FGV EI++
Sbjct: 223 WAFGVTMWEIMT 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL 558
L+++R+ S DP KIG+G G VY + G +A++ ++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
NEI + ++PN+V + GD+L +V EYL SL + ++ ++
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 120
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+C + L FLH +++HRDIK+ N+LL D + K++DFG E++ ST V
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE K D++S G++A+E++ G+
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 44/233 (18%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK-----LLSSKSRQGNREFLNEIGTISC 566
T+ F + KIG G FG V+K DG I A+K L S Q L E+ +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ---NALREVYAHAV 66
Query: 567 L-QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625
L QH ++V+ + E D +++ EY SLA A+ + + + L + R
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNP-------------------KISDFGLAKL 666
GL ++H +VH DIK +N+ + R P KI D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 667 DEEEKTHISTRVAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSGK 715
+ G ++A E + +L KAD+++ + + +
Sbjct: 184 ISSPQVEE-----GDSRFLANE--VLQENYTHL-PKADIFALALTVVCAAGAE 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 519 MNKIGEGGFGPVYKGQLTDG------TIIAVKLLSSKSRQGNR-EFLNEIGTISCLQHPN 571
++G+G FG VY+G T +A+K ++ + R EFLNE + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHAL----FGGENSQLKLNWSVRQ--KICLGIAR 625
+V+L G +G +++ E + L L N+ + S+ + ++ IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT---- 681
G+A+L + K VHRD+ A N ++ D KI DFG+ + E R G
Sbjct: 150 GMAYL--NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLP 203
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +M+PE G T +DV+SFGVV EI +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 519 MNKIGEGGFGPVYKGQLTD--------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHP 570
+G+G F ++KG + T + +K+L R + F +S L H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+LV YG C+ GD+ +LV E+++ SL L +N + + W + ++ +A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKL--EVAKQLAAAMHFL 129
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNP--------KISDFGLAKLDEEEKTHISTRVAGTI 682
EE+ +H ++ A N+LL R+ + K+SD G++ + + I
Sbjct: 130 -EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--I 181
Query: 683 GYMAPEYALWG-YLTYKADVYSFGVVALEIVS 713
++ PE L D +SFG EI S
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 66/240 (27%), Positives = 111/240 (46%), Gaps = 25/240 (10%)
Query: 485 ISAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG----TI 540
I +++P L QA + + +F+ IG G FG VY G L D
Sbjct: 2 IDLSALNPEL----VQAVQHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIH 55
Query: 541 IAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-QLMLVYEYLENNSLA 598
AVK L +FL E + HPN++ L G C+ + ++V Y+++ L
Sbjct: 56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 599 HALFGGENSQLKLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656
+ + N +V+ L +A+G+ +L +F VHRD+ A N +LD
Sbjct: 116 NFI---RNETHNP--TVKDLIGFGLQVAKGMKYL-ASKKF--VHRDLAARNCMLDEKFTV 167
Query: 657 KISDFGLAK-LDEEEKTHISTRVAGT--IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
K++DFGLA+ + ++E + + + +MA E T K+DV+SFGV+ E+++
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 483 PLISAISVD--PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG-- 538
L+ S + LE + + L + +GEG FG V +G L
Sbjct: 13 GLVPRGSEELQNKLEDVVIDRNLLILGK------------ILGEGEFGSVMEGNLKQEDG 60
Query: 539 --TIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-----QLMLVY 589
+AVK + + S++ EFL+E + HPN+++L G CIE + M++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 590 EYLENNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATN 647
+++ L L + ++ K + IA G+ +L +R +HRD+ A N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNR-NFLHRDLAARN 177
Query: 648 VLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG-----YMAPEYALWGYLTYKADVY 702
+L D+ ++DFGL+K + G I ++A E T K+DV+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 703 SFGVVALEIVS 713
+FGV EI +
Sbjct: 234 AFGVTMWEIAT 244
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
S+F+ + +G+G FG V K + D A+K + + + L+E+ ++ L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 572 LVKLYGCCIEGDQ-------------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
+V+ Y +E L + EY EN +L + + L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS--- 675
+ I L+++H + I+HRD+K N+ +D N KI DFGLAK +
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 676 ----------TRVAGTIGYMAPE-YALWGYLTYKADVYSFGVVALEIVSG 714
T GT Y+A E G+ K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 520 NKIGEGGFGPVYKGQLTDG----TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVK 574
IG+G FG VY G+ D A+K L Q FL E + L HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 575 LYGCCIEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L G + + ++ Y+ + L + + + L +ARG+ +L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLI--SFGLQVARGMEYL--A 141
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGT----IGYMAPEY 689
+ K VHRD+ A N +LD K++DFGLA+ D ++ + S + + + A E
Sbjct: 142 EQ-KFVHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLPVKWTALES 199
Query: 690 ALWGYLTYKADVYSFGVVALEIVS 713
T K+DV+SFGV+ E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 519 MNKIGEGGFGPVYKGQLTDG------TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPN 571
+ +G G FG VY+GQ++ +AVK L S Q +FL E IS H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQKICLGIARG 626
+V+ G ++ ++ E + L + S L + + + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL--HVARDIACG 193
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLDEEEKTHISTRVAGT-- 681
+L E +HRDI A N LL KI DFG+A+ R G
Sbjct: 194 CQYL--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAM 247
Query: 682 --IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ +M PE + G T K D +SFGV+ EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCL-Q 568
+F ++++G G +G V+K + DG + AVK S +G ++ L E+G+ + Q
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP V+L EG L L E SL E L + LA
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGP-SLQQHC---EAWGASLPEAQVWGYLRDTLLALA 171
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAP 687
LH + +VH D+K N+ L K+ DFGL L + G YMAP
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAP 225
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSGK 715
E Y ADV+S G+ LE+
Sbjct: 226 ELLQGSY-GTAADVFSLGLTILEVACNM 252
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL 558
LK++ + P + K+GEG +G VYK G I+A+K + +S +E +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
EI + P++VK YG + L +V EY S++ + L
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIAT 129
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
I +GL +LH + +HRDIKA N+LL+ + + K++DFG+A + +T +
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE AD++S G+ A+E+ GK
Sbjct: 187 -GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 5e-38
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG----TIIAVKLL 546
P+ E Q L + IGEG FG V++G +A+K
Sbjct: 379 MPSTRDYEIQRERIELGR------------CIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 547 -SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE 605
+ S +FL E T+ HP++VKL G E + + ++ E L L +
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK 485
Query: 606 NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
L L + ++ LA+L E RF VHRDI A NVL+ + K+ DFGL++
Sbjct: 486 F-SLDLASLI--LYAYQLSTALAYL-ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
E+ + +++ I +MAPE + T +DV+ FGV EI+
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 506 LKQIRAATSNFDP------MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL 558
++ + DP + ++G+G FG VYK + G + A K++ +KS + +++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 559 NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
EI ++ HP +VKL G +L ++ E+ ++ + L Q
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQV 121
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTR 677
+C + L FLH + +I+HRD+KA NVL+ + + +++DFG+ AK + + S
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176
Query: 678 VAGTIGYMAPEYALW------GYLTYKADVYSFGVVALEIVSGK 715
GT +MAPE + Y YKAD++S G+ +E+ +
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIE 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL 572
+F + IG GGFG V+K + DG +K + + N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNI 66
Query: 573 VKLYGCCIEGD----------------QLMLVYEYLENNSLAHALFGGENSQLK----LN 612
V GC D L + E+ + +L + +L L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
Q I +G+ ++H + K+++RD+K +N+ L KI DFGL + +
Sbjct: 127 L-FEQ-----ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 673 HISTRVAGTIGYMAPE-YALWGYLTYKADVYSFGVVALEIVSG 714
TR GT+ YM+PE + Y + D+Y+ G++ E++
Sbjct: 178 R--TRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHV 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 51/255 (20%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG------TIIAVK 544
+P L LE+ ++ + IGEG FG V++ + T++AVK
Sbjct: 36 NPKLLSLEYPRNNIEYVR------------DIGEGAFGRVFQARAPGLLPYEPFTMVAVK 83
Query: 545 LLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL------ 597
+L + S +F E ++ +PN+VKL G C G + L++EY+ L
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 598 --AHALFGGENSQLKLNWSVRQ------------KICLGIARGLAFLHEESRFKIVHRDI 643
H + +S L V I +A G+A+L R K VHRD+
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SER-KFVHRDL 200
Query: 644 KATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY-----MAPEYALWGYLTYK 698
N L+ ++ KI+DFGL++ + A M PE + T +
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTE 256
Query: 699 ADVYSFGVVALEIVS 713
+DV+++GVV EI S
Sbjct: 257 SDVWAYGVVLWEIFS 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHP 570
F + KIG+G FG V+KG ++A+K++ + + E EI +S P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+ K YG ++ +L ++ EYL S L G L+ + I I +GL +L
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYL 135
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
H E K +HRDIKA NVLL K++DFG+A + + +T V GT +MAPE
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
KAD++S G+ A+E+ G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-37
Identities = 37/266 (13%), Positives = 79/266 (29%), Gaps = 30/266 (11%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+ ++ L L + E + + + N+ LT
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICE----AWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLI--------GNLPMELVKLKNLTDFRI 119
+++ +P L L ++ + ++ NR I + + + I
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 120 NDNNF-NGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PNQ 175
NN +Q +L LE + LEG P+ + KL L ++ + P
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPAN 371
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEY--IWGIKNLRFLDLSFNQLTGELPDVAVPADL 233
+ + + + IP + + +D S+N++
Sbjct: 372 FCGFTEQ---VENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK------- 420
Query: 234 KFTQILMFIRGVYEHQSLDLSYNNFT 259
F + S++LS N +
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQIS 446
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 38/283 (13%), Positives = 85/283 (30%), Gaps = 53/283 (18%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITS 65
+ + + L ++ YN L G +P + S L +++ N+++ + G
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 66 LTYLDLEENQFSGTIPR--ELGNLVNLETLRLSSNRL-------IGNLPMELVKLKNLTD 116
+ L N+ IP + ++ + + S N + L K N++
Sbjct: 379 VENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 117 FRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG-------PIPPSISALDKLNQLRISD 169
+++N + + + + L+ + + G+ L + L + +
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 170 LQGPNQ--TFP---MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFL------DLSFN 218
N+ + L I L + + P L+ D N
Sbjct: 498 ----NKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 219 QLTGELPDVAVPADLKFTQI--LMFIRGVYEHQSLDLSYNNFT 259
+ E P+ T L L + N+
Sbjct: 553 RTLREWPEG-------ITLCPSL---------TQLQIGSNDIR 579
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 33/244 (13%), Positives = 78/244 (31%), Gaps = 32/244 (13%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG----TIPRELGNLVNLETLRLS 96
++ +S+ SG +P +G +T L L L + P+ + ++ E +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 97 SNRLIGNLPMELVKLK--NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPP 154
+ +L IN + S + + ++ + + +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200
Query: 155 SISALDKLNQLRISD--LQGPNQTF-----------------PMLRNMTGLTRIILRNCN 195
++ L KL Q + + N N+ LT + + NC
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260
Query: 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255
++P ++ + ++ ++++ N+ Q L + Q + + Y
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGIS------GEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 256 NNFT 259
NN
Sbjct: 315 NNLK 318
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 40/291 (13%), Positives = 76/291 (26%), Gaps = 60/291 (20%)
Query: 8 TLPPQIV-NLPYLETVDFAYNYLHGSIPREWASMQ---LKYISVFANRLSG-------NI 56
+P +E + FA+N L IP + + + I N + +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 57 PSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL-------IGNLPMELV 109
+++ ++L NQ S L ++ L N L + +
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 110 KLKNLTDFRINDNNFNGSAPDF-IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
LT + N + DF + L +++ + P L I
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 169 DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVA 228
+ + + E PE I +L L + N +
Sbjct: 545 NQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK------ 580
Query: 229 VPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLF 279
V + I LD+ N P + ++
Sbjct: 581 VNEKI-TPNI----------SVLDIKDNPNISIDLSYVC----PYIEAGMY 616
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 33/227 (14%), Positives = 73/227 (32%), Gaps = 37/227 (16%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSG-------NIPS 58
L P + +++ + N + +++ L I++ N L+ +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 59 HLGNITSLTYLDLEENQFSGTIPREL--GNLVNLETLRLSSNRLIGNLPMELVKLKNLTD 116
+ N LT +DL N+ + + + L L + LS N P + + L
Sbjct: 483 NFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 117 FRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPN 174
F I + + QG+ P I+ L QL+I ++ N
Sbjct: 541 FGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVN 582
Query: 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
+ ++ + +++ Y+ L +++
Sbjct: 583 EKI-----TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-18
Identities = 27/220 (12%), Positives = 59/220 (26%), Gaps = 16/220 (7%)
Query: 51 RLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVK 110
G N LD+ Q + L + + L L G +P + +
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGAQPGVS----LNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 111 LKNLTDFRINDNNFNG----SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD--KLNQ 164
L L + + P I + + + + D L +
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 165 LRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGEL 224
I+ R T+I + NI + + + + LR + + E
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 225 PDVAV-PADLKFTQILMFIRGVYEH----QSLDLSYNNFT 259
A + ++ Q +++ +++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 12/104 (11%), Positives = 27/104 (25%), Gaps = 10/104 (9%)
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239
L + +T + L +G +P+ I + L L L +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER----------LFGP 126
Query: 240 MFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSS 283
I + ++ + + +L + S
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP 170
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 53/266 (19%)
Query: 482 GPLISAISVD--PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDG- 538
GPL ++ EF + L + +GEG FG V K
Sbjct: 1 GPLSLSVDAFKILEDPKWEFPRKNLVLGK------------TLGEGEFGKVVKATAFHLK 48
Query: 539 -----TIIAVKLL-SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592
T +AVK+L + S R+ L+E + + HP+++KLYG C + L+L+ EY
Sbjct: 49 GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108
Query: 593 ENNSL------------AHALFGGENSQLKLNWSVRQKICLG--------IARGLAFLHE 632
+ SL + GG + L+ + + +G I++G+ +L
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-- 166
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG-----YMAP 687
K+VHRD+ A N+L+ KISDFGL++ EE ++ V + G +MA
Sbjct: 167 AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY----VKRSQGRIPVKWMAI 221
Query: 688 EYALWGYLTYKADVYSFGVVALEIVS 713
E T ++DV+SFGV+ EIV+
Sbjct: 222 ESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLL-SSKSRQGNREFLNEIGTI-SCLQHP 570
+ +P+ ++G G +G V K + G I+AVK + ++ + Q + L ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
V YG + + E + + SL + + + KI + I + L L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-- 688
H + ++HRD+K +NVL++ K+ DFG++ AG YMAPE
Sbjct: 126 HSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181
Query: 689 ---YALWGYLTYKADVYSFGVVALEIVSGK 715
GY + K+D++S G+ +E+ +
Sbjct: 182 NPELNQKGY-SVKSDIWSLGITMIELAILR 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPN 571
+++ IG G V +A+K ++ + Q + + L EI +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAH----ALFGGENSQLKLNWSVRQKICLGIARGL 627
+V Y + D+L LV + L S+ + GE+ L+ S I + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKL-DEEEKTHISTR--VAGTIG 683
+LH+ +HRD+KA N+LL D + +I+DFG+ A L + T R GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 684 YMAPE--YALWGYLTYKADVYSFGVVALEIVSGK 715
+MAPE + GY +KAD++SFG+ A+E+ +G
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 520 NKIGEGGFGPVYKGQLTD--------GTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QH 569
+GEG FG V + +AVK+L + + + ++E+ + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQ------- 617
N++ L G C + L ++ EY +L A G E S Q
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+ARG+ +L S+ K +HRD+ A NVL+ + KI+DFGLA+ +
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 678 VAGTIG-----YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
T G +MAPE T+++DV+SFGV+ EI +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLL-SSKSRQGNREFLNEIGTI 564
+ + + +IG G +G V K G I+AVK + S+ + ++ L ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 565 -SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL-FGGENSQLKLNWSVRQKICLG 622
P +V+ YG + E + + S + + + KI L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRVAGT 681
+ L L E KI+HRDIK +N+LLDR N K+ DFG+ +L + TR AG
Sbjct: 134 TVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGC 188
Query: 682 IGYMAPE-----YALWGYLTYKADVYSFGVVALEIVSGK 715
YMAPE + GY ++DV+S G+ E+ +G+
Sbjct: 189 RPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 65/249 (26%), Positives = 102/249 (40%), Gaps = 46/249 (18%)
Query: 492 PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD--------GTIIAV 543
P EF TL + +GEG FG V + +AV
Sbjct: 71 PEDPKWEFPRDKLTLGK------------PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118
Query: 544 KLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLENNSL---- 597
K+L + + + ++E+ + + +H N++ L G C + L ++ EY +L
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 598 -AHALFGGENSQLKLNWSVRQ-------KICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
A G E S Q +ARG+ +L S+ K +HRD+ A NVL
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQ-KCIHRDLAARNVL 235
Query: 650 LDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG-----YMAPEYALWGYLTYKADVYSF 704
+ + KI+DFGLA+ T G +MAPE T+++DV+SF
Sbjct: 236 VTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 705 GVVALEIVS 713
GV+ EI +
Sbjct: 292 GVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 520 NKIGEGGFGPVYKGQLTD------GTIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPN 571
+G G FG V + +AVK+L S+ ++E+ +S L QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHAL------------FGGENSQLKLNWSVRQKI 619
+V L G C G ++++ EY L + L F NS +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL--HF 169
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHIST 676
+A+G+AFL S+ +HRD+ A NVLL KI DFGLA+ D +
Sbjct: 170 SSQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
R+ + +MAPE T ++DV+S+G++ EI S
Sbjct: 227 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 36/187 (19%), Positives = 60/187 (32%), Gaps = 32/187 (17%)
Query: 308 INCGGG-NVKVNDSTFEGDAGVGGGAATYHLLDGTNWGISSTGDFTDDDDEQNTNYIANS 366
+N GG +V V+ + D G G +S N
Sbjct: 10 VNAGGESHVDVHGIHYRKDPLEGR------------VGRASDYGMKLPILRSNPED---- 53
Query: 367 QSSGISELYNDARISPLSLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYI 426
LY R + S Y E G Y + L FAE+ F +++FD+ +
Sbjct: 54 -----QVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFAQS------QQKVFDVRV 102
Query: 427 QDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHILEIRFQ---WAGKGTTAIPIGGVYGP 483
V KD +I G ++ L ++ + + GK + G P
Sbjct: 103 NGHTVVKDLDIFDRV-GHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP 161
Query: 484 LISAISV 490
+ A+ +
Sbjct: 162 KVCALFI 168
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPN 571
++F+P+ +G GGFG V++ + D A+K + +R+ RE + E+ ++ L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 572 LVKLYGCCIEGDQ------------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
+V+ + +E + L + + +L + G + + SV I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
L IA + FLH + ++HRD+K +N+ D K+ DFGL ++++ +
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 680 -----------GTIGYMAPE-YALWGYLTYKADVYSFGVVALEI 711
GT YM+PE Y ++K D++S G++ E+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPN 571
+++ + IG G +G K + +DG I+ K S + + ++E+ + L+HPN
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 572 LVKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+V+ Y I+ L +V EY E LA + G + L+ ++ + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 630 LHE--ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
H + ++HRD+K NV LD N K+ DFGLA++ + + T V GT YM+P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 688 EYALWGYLTY--KADVYSFGVVALEIVSGK 715
E ++Y K+D++S G + E+ +
Sbjct: 186 E--QMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 23/234 (9%)
Query: 500 QASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL 558
+ F + ++ + K+GEGGF V + L DG A+K + +Q E
Sbjct: 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74
Query: 559 NEIGTISCLQHPNLVKLYGCCIE----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWS 614
E HPN+++L C+ + L+ + + +L + + +
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLT 132
Query: 615 VRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
Q + LGI RGL +H + HRD+K TN+LL + P + D G
Sbjct: 133 EDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 673 HISTRVA--------GTIGYMAPE-YALWGY--LTYKADVYSFGVVALEIVSGK 715
+ TI Y APE +++ + + + DV+S G V ++ G+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 25/236 (10%)
Query: 496 GLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKL--LSSKSRQG 553
G++ + + + + + +IG GG V++ I A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 554 NREFLNEIGTISCLQHPNL--VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKL 611
+ NEI ++ LQ + ++LY I + +V E N L L + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSI 124
Query: 612 NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEE 670
+ R+ + + +H+ IVH D+K N L+ K+ DFG+A + +
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 671 KTHISTRVAGTIGYMAPE-----------YALWGYLTYKADVYSFGVVALEIVSGK 715
+ + GT+ YM PE ++ K+DV+S G + + GK
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 520 NKIGEGGFGPVYKGQLTD------GTIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPN 571
+G G FG V + +AVK+L + +R ++E+ + + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 572 LVKLYGCCIEGDQ-LMLVYEYLENNSLAHAL----------FGGENSQLKLNWSVRQ--K 618
+V L G C + LM++ E+ + +L+ L K ++
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRV 678
+A+G+ FL SR K +HRD+ A N+LL KI DFGLA+ ++ V
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYV 205
Query: 679 AGTIG-----YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+MAPE T ++DV+SFGV+ EI S
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 500 QASSFTLKQIRAATSNFDP------MNKIGEGGFGPVYKGQ-LTDGTIIAVK---LLSSK 549
+A S + DP + +IG G FG VY + + + ++A+K +
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 550 SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL 609
S + ++ + E+ + L+HPN ++ GC + LV EY S + L E +
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKK 149
Query: 610 KLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669
L + G +GLA+LH ++HRD+KA N+LL K+ DFG A
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 670 EKTHISTR--VAGTIGYMAPEYALW----GYLTYKADVYSFGVVALEIVSGK 715
+ ++ GT +MAPE L Y K DV+S G+ +E+ K
Sbjct: 202 --SIMAPANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 520 NKIGEGGFGPVYKGQLTD--------GTIIAVKLL-SSKSRQGNREFLNEIGTISCL-QH 569
+GEG FG V + T +AVK+L S + + + ++E+ + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSL--------AHALFGGENSQLKLNWSVRQK--- 618
N++ L G C + L ++ EY +L L N + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 619 -ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+ARG+ +L S+ K +HRD+ A NVL+ D KI+DFGLA+
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DYY 247
Query: 678 VAGTIG-----YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
T G +MAPE T+++DV+SFGV+ EI +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 48/204 (23%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 516 FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG-NREFLNEIGTISCLQHPNLV 573
F+ ++++G G G V+K G ++A KL+ + + + + E+ + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
YG ++ + E+++ SL L ++ + K+ + + +GL +L E+
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEEEKTHISTRVAGTIGYMAPEYAL 691
KI+HRD+K +N+L++ K+ DFG++ +D + + GT YM+PE
Sbjct: 151 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQ 203
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
+ + ++D++S G+ +E+ G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCLQHPNL--VKL 575
+IG GG V++ I A+K L Q + NEI ++ LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
Y I + +V E N L L + ++ R+ + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPE------ 688
IVH D+K N L+ K+ DFG+A + + + + GT+ YM PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 689 -----YALWGYLTYKADVYSFGVVALEIVSGK 715
++ K+DV+S G + + GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 20/217 (9%)
Query: 513 TSNFDPMNKIGEG--GFGPVYKGQ-LTDGTIIAVKL--LSSKSRQGNREFLNEIGTISCL 567
++ + IG+G V + G + V+ L + S + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
HPN+V I ++L +V ++ S + + I G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKAL 141
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG-LAKLDEEEK-----THISTRVAGT 681
++H VHR +KA+++L+ D +S + +
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 682 IGYMAPE---YALWGYLTYKADVYSFGVVALEIVSGK 715
+ +++PE L GY K+D+YS G+ A E+ +G
Sbjct: 199 LPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 520 NKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQGNR-EFLNEIGTISCL-QHPN 571
+G G FG V + +AVK+L + R ++E+ +S L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSL-----AHALFGGENSQLKLNWSVRQK-------- 618
+V L G C G +++ EY L + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 619 -ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+A+G+AFL S+ +HRD+ A N+LL KI DFGLA+ + + ++
Sbjct: 149 SFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 678 VAGT-IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
A + +MAPE T+++DV+S+G+ E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 59/226 (26%), Positives = 88/226 (38%), Gaps = 39/226 (17%)
Query: 520 NKIGEGGFGPVYKGQLTDG------TIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPN 571
+G G FG V +AVK+L ++E+ ++ L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSL-----------AHALFGGENSQLKLNWSVRQKIC 620
+V L G C + L++EY L + EN + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 621 LG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
+A+G+ FL E + VHRD+ A NVL+ KI DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-- 225
Query: 673 HISTRVAGTIG-----YMAPEYALWGYLTYKADVYSFGVVALEIVS 713
S V +MAPE G T K+DV+S+G++ EI S
Sbjct: 226 --SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKL--LSSKSRQGNR 555
+ +ASS + I + + +IG GG V++ I A+K L Q
Sbjct: 40 DDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 99
Query: 556 EFLNEIGTISCLQHPNL--VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613
+ NEI ++ LQ + ++LY I + +V E N L L + ++
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDP 154
Query: 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKT 672
R+ + + +H+ IVH D+K N L+ K+ DFG+A + + +
Sbjct: 155 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 210
Query: 673 HISTRVAGTIGYMAPE-----------YALWGYLTYKADVYSFGVVALEIVSGK 715
+ G + YM PE ++ K+DV+S G + + GK
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-34
Identities = 41/268 (15%), Positives = 87/268 (32%), Gaps = 34/268 (12%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSL 66
+ I L L+ + FA + ++ + + + N N+ L
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNLKDL 493
Query: 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIG---------NLPMELVKLKNLTDF 117
T ++L +P L +L L++L ++ NR I L + + F
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 118 RINDNNFNG-SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-P 173
+ NN A +Q +L L+ + + + KL L++ ++ P
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIP 611
Query: 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEY--IWGIKNLRFLDLSFNQLTGELPDVAVPA 231
+ + + + IP + + +D S+N++ E +++
Sbjct: 612 EDFCAFTDQ---VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 232 DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
D ++ LSYN
Sbjct: 668 DDYKGINA---------STVTLSYNEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-30
Identities = 49/309 (15%), Positives = 92/309 (29%), Gaps = 33/309 (10%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSG------ 54
NL L V+ +P + +L+ +++ NR
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535
Query: 55 ---NIPSHLGNITSLTYLDLEENQFSG-TIPRELGNLVNLETLRLSSNRLIGNLPMELVK 110
+ + + N L +V L L N++ +L
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV-RHLE-AFGT 593
Query: 111 LKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQL---- 165
LTD +++ N DF Q+ L + L+ P + ++ + +
Sbjct: 594 NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 166 -RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGEL 224
+I + + L I E + + LS N +T +
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI 712
Query: 225 PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNL-NLNLFRSSS 283
P+ + + Y ++DL +N T S + A P L N+++ S
Sbjct: 713 PENS------LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL-PYLSNMDV--SY- 762
Query: 284 VENNFGVFP 292
N F FP
Sbjct: 763 --NCFSSFP 769
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 36/269 (13%), Positives = 73/269 (27%), Gaps = 54/269 (20%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASMQ---LKYISVFANRLSG---NIPSHL 60
+P +E + F++N L IP + + + + N++ NI +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 61 G--NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL-------IGNLPMELVKL 111
+ + + L N+ + T+ LS+N + +
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 112 KNLTDFRINDNNFNG-SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170
LT + N S + L+ +++ + P +L I
Sbjct: 728 YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786
Query: 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVP 230
+ I + P I +L L + N + V
Sbjct: 787 R------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK------VD 822
Query: 231 ADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
L Q+ LD++ N
Sbjct: 823 EKL-TPQL----------YILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 37/298 (12%), Positives = 78/298 (26%), Gaps = 63/298 (21%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHG--------SIPREWASMQLKYISVFANRLSG 54
F G +P I L L+ + F + + + + + I + ++
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 55 NIPSHL----------------GNITSLTYLDLEENQFSG------TIPRELGNLVNLET 92
+ L I + + L++ Q I + + L L+
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 93 LRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPI 152
+ +++ + + N + + + L +E+ +
Sbjct: 453 IYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 153 PPSISALDKLNQLRISD--LQGPNQTF-------PMLRNMTGLTRIILRNCNIAGEIPE- 202
P + L +L L I+ Q + + N+ E P
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPAS 566
Query: 203 -YIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+ + L LD N++ L L L L YN
Sbjct: 567 ASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL---------------TDLKLDYNQIE 608
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 34/244 (13%), Positives = 82/244 (33%), Gaps = 31/244 (12%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
++ +S+ G +P +G +T L L + + + + + +R+
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 101 IGNLP------MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPP 154
+ + + L +L IN N + + ++ + + I
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISK 442
Query: 155 SISALDKLNQLRISD-------------------LQGPNQTFPMLRNMTGLTRIILRNCN 195
+I L KL + ++ + N+ LT + L NC
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255
++P++++ + L+ L+++ N+ A +T++ + Q + Y
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGIS-----AAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 256 NNFT 259
NN
Sbjct: 558 NNLE 561
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 33/259 (12%), Positives = 68/259 (26%), Gaps = 50/259 (19%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLP---- 105
+ L N +T L L G +P +G L L+ L ++ +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 106 --------------------------MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN 139
+ + L +L IN N + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 140 RLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE 199
++ + + I +I L KL + ++ + F
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFAN----SP-FTYDNIAVDWEDANSDYAKQYEN 482
Query: 200 IPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+K+L ++L +LPD + + E QSL+++ N
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDF--------------LYDLPELQSLNIACNRGI 528
Query: 260 WQSPEQPACREKPNLNLNL 278
+ + +
Sbjct: 529 SAAQLKADWTRLADDEDTG 547
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 17/146 (11%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGN----IPSHLGN 62
N L T+D +N L S+ ++ + L Y+S +S N P+ N
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM--DVSYNCFSSFPTQPLN 774
Query: 63 ITSLTYLDLEE------NQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTD 116
+ L + N+ P + +L L++ SN + + +L L
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYI 831
Query: 117 FRINDN-NFNGSAPDFIQSWTQLNRL 141
I DN N + +
Sbjct: 832 LDIADNPNISIDVTSVCPYIEAGMYV 857
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 17/109 (15%), Positives = 33/109 (30%), Gaps = 12/109 (11%)
Query: 8 TLPPQIVNLPYLET------VDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHL 60
+ P Q +N L+ D N + P + L + + +N + + L
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825
Query: 61 GNITSLTYLDLEENQF-SGTIPRELGNLV-NLETLRLSSNRLIGNLPME 107
L LD+ +N S + + + L + I
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 37/272 (13%), Positives = 81/272 (29%), Gaps = 31/272 (11%)
Query: 27 NYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86
E S++ + +V N+L T + ++ + + I
Sbjct: 226 QSGIKRSELETQSVRGESFTVIDNKL-----------TKDANVPIQLKETAEYIKDYKAL 274
Query: 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146
E L + R + N +F + + + + ++ L + G
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 147 GLEGPIPPSISALDKLNQLRISD--LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI 204
G +G +P +I L +L L + F +T ++ ++
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG-DEELTPDMSEERKHRIRMHYKKMFL 392
Query: 205 WGIKNLRFLDLSFNQLTGELPDVAVP----ADLKFTQILMF----------IRGVYEHQS 250
+ L DL + + + LK TQI I+ + + Q
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 251 LDLSYNNFTWQSPEQPACREKPNLNLNLFRSS 282
+ + + FT+ + E N + +
Sbjct: 453 IYFANSPFTYDNIAV--DWEDANSDYAKQYEN 482
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-34
Identities = 55/268 (20%), Positives = 96/268 (35%), Gaps = 22/268 (8%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGN 62
L L ++D +N + P + LK +++ N LS
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
T+LT L L N NL TL LS N L V+L+NL + +++N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 123 NFNGSAPDFIQSW--TQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ---GPNQTF 177
+ + + + L +LE+ + ++ P A+ +L L ++++Q +
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIK--NLRFLDLSFNQLTGELPDVAVPADLKF 235
+ T + + L N ++ G+K NL LDLS+N L D
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND--------- 266
Query: 236 TQILMFIRGVYEHQSLDLSYNNFTWQSP 263
+ + + L YNN
Sbjct: 267 -----SFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-33
Identities = 53/281 (18%), Positives = 88/281 (31%), Gaps = 32/281 (11%)
Query: 10 PPQIVNLPYLETVDFAYNYLHGSIPR----EWASMQLKYISVFANRLSGNIPSHLGN--I 63
P + L + L S+ E A+ ++ +S+ ++LS +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLK---------NL 114
T+LT LDL N + L LE L N + L L +
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL-----RISD 169
T I+ + Q L L ++ + + G + L L L S
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAV 229
N+TF L + + L + L I+ + + +L LDL N++ EL
Sbjct: 368 RTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 230 PA-------DLKFTQILMFIRGVYEH----QSLDLSYNNFT 259
L + + L R + Q L L
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 50/249 (20%), Positives = 91/249 (36%), Gaps = 15/249 (6%)
Query: 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFS 77
E D ++ L +P + + + +++ N+L ++ + LT LD+ N S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT-NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQ 137
P L L+ L L N L NLT+ + N+ +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 138 LNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPNQTFPMLRNMTGLTRIILRNCN 195
L L++ +GL + L+ L +L +S+ +Q + + L ++ L +
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255
I P I L L L+ QL L + + +L T I ++L LS
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE-KLCLELANTSI----------RNLSLSN 231
Query: 256 NNFTWQSPE 264
+ + S
Sbjct: 232 SQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 42/261 (16%), Positives = 88/261 (33%), Gaps = 33/261 (12%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSH-LGNITSLTYLDLE 72
L ++ N + ++ + L+ + + N + + + ++ + L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRL--IGNLPMELVKLKNLTDFRINDNNFNGSAPD 130
N++ + +L+ L L L + + P L+NLT +++NN D
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL-RISDLQGPNQTFPMLRNMTGLTRI 189
++ +L L++Q N L R+ P L+ ++ L +
Sbjct: 499 MLEGLEKLEILDLQH-----------------NNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 190 ILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA------DLKFTQILMFIR 243
L + E + L+ +DL N L V +L+ I +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 244 GVYEH-----QSLDLSYNNFT 259
V+ LD+ +N F
Sbjct: 602 KVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-30
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLS-----GNIP 57
SLP L LE ++ N + G + + LKY+S+ + S
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 58 SHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLP-MELVKLKNLTD 116
L + + L L+L +N+ S L +LE L L N + L E L+N+ +
Sbjct: 376 VSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 117 FRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ- 175
++ N + + L RL ++ L+ + S S L L I DL N
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILDLSN-NNI 492
Query: 176 -TFP--MLRNMTGLTRIILRNCNI--------AGEIPEYIWGIKNLRFLDLSFNQLTGEL 224
ML + L + L++ N+ G ++ G+ +L L+L N
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 225 PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNL-NLNL 278
+V + ++E + +DL NN + +L +LNL
Sbjct: 553 VEV--------------FKDLFELKIIDLGLNNLNTLPAS--VFNNQVSLKSLNL 591
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-28
Identities = 51/314 (16%), Positives = 99/314 (31%), Gaps = 44/314 (14%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ----------LKYISVFANRLS 53
+L LP LE YN + + S+ L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 54 GNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL----IGNLPMELV 109
+ L +L++E+N G L+NL+ L LS++ + N +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 110 KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPS-ISALDKLNQLRIS 168
L + N + D L L++ + + + L+ + ++ +S
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 169 D--LQG-PNQTFPMLRNMTGLTRIILRNCNIAG--EIPEYIWGIKNLRFLDLSFNQLTGE 223
+F ++ + L R++LR + P ++NL LDLS N +
Sbjct: 439 YNKYLQLTRNSFALVPS---LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 224 LPDV------------------AVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQ 265
D+ + + F++G+ L+L N F E
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE- 554
Query: 266 PACREKPNL-NLNL 278
++ L ++L
Sbjct: 555 -VFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-21
Identities = 43/230 (18%), Positives = 77/230 (33%), Gaps = 24/230 (10%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
S D + + +P +L N+ L L+ N+L + LT + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PNQTFPML 180
+ P+ Q L L +Q + L + + L +L + +Q N F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF--- 117
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA--------- 231
L + L + ++ ++NL+ L LS N++ L +
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKL 176
Query: 232 DLKFTQILMFIRGVYEH----QSLDLSYNNFTWQSPEQPACREKPNLNLN 277
+L QI F G + L L+ E+ C E N ++
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL-CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 29/208 (13%), Positives = 63/208 (30%), Gaps = 15/208 (7%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLS-------- 53
+ P L L +D + N + + +L+ + + N L+
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 54 GNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKN 113
G L ++ L L+LE N F +L L+ + L N L +
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 114 LTDFRINDNNFNGSAPD-FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172
L + N F ++ L L+++ + + ++ +N+ + +
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 173 PNQTF----PMLRNMTGLTRIILRNCNI 196
+ P + +C
Sbjct: 646 SSHYLCNTPPHYHGFP-VRLFDTSSCKD 672
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLL-SSKSRQGNREFLNEIGTI 564
++ +A ++ + + ++G G G V+K + G +IAVK + S +++ N+ L ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 565 -SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
P +V+ +G I + + E + + + + K+ + I
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAI 133
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
+ L +L E+ ++HRD+K +N+LLD K+ DFG++ R AG
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAA 189
Query: 684 YMAPE------YALWGYLTYKADVYSFGVVALEIVSGK 715
YMAPE Y +ADV+S G+ +E+ +G+
Sbjct: 190 YMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQ 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL----NEIGTISCLQHPNLVKL 575
K+G GG VY + +A+K + + E L E+ S L H N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
E D LV EY+E +L+ + + L ++ ++ I G+ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAIN--FTNQILDGIKHAH---D 129
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYALWGY 694
+IVHRDIK N+L+D + KI DFG+AK L E T + V GT+ Y +PE A
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188
Query: 695 LTYKADVYSFGVVALEIVSGK 715
D+YS G+V E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTIS-CLQHP 570
F+ + +G G +G VYKG+ + G + A+K++ E EI + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 571 NLVKLYGC------CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
N+ YG DQL LV E+ S+ + + + LK W IC I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
RGL+ LH+ K++HRDIK NVLL + K+ DFG++ + +T GT +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYW 195
Query: 685 MAPE------YALWGYLTYKADVYSFGVVALEIVSGK 715
MAPE Y +K+D++S G+ A+E+ G
Sbjct: 196 MAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGA 231
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL----NEIGTISCLQHPNLVKL 575
+G GG G VY+ + I+A+KL+S + + F E T LQ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 576 YGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
+ QL + + LA L L +V I I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDAAHAA-- 153
Query: 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYALWGY 694
HRD+K N+L+ D + DFG+A +E+ T + GT+ YMAPE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 695 LTYKADVYSFGVVALEIVSGK 715
TY+AD+Y+ V E ++G
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL----NEIGTISCLQHPNLVKL 575
+G GG V+ + L D +AVK+L + + F E + L HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 576 Y--GCCIEGDQLMLVY---EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
Y G E L Y EY++ +L + + ++ + + L F
Sbjct: 78 YDTGE-AETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIE--VIADACQALNFS 132
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHIST-RVAGTIGYMAPE 688
H + I+HRD+K N+++ K+ DFG+A+ + + + T V GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
A + ++DVYS G V E+++G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 21/211 (9%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGT-ISCLQHPNLV 573
+F P + +G G G + + D +AVK + + E+ +HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+ + + + E +L + E + GLA LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 634 SRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEEEKTHISTR--VAGTIGYMA 686
IVHRD+K N+L+ + ISDFGL K + S R V GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 687 PEY---ALWGYLTYKADVYSFGVVALEIVSG 714
PE TY D++S G V ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 48/294 (16%), Positives = 86/294 (29%), Gaps = 40/294 (13%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREW---------ASMQLKYISVFA--- 49
L + L + + + + + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 50 ------NRLSGNIPSHLGNITSLTYLDLEENQ--FSGTIPRELGNLVNLETLRLSSNRLI 101
G ++ SL +LDL N F G + +L+ L LS N +I
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 102 GNLPMELVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
+ + L+ L +N + S L L+I + + L
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 161 KLNQLRISD--LQG--PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLS 216
L L+++ Q F LRN LT + L C + P + +L+ L++S
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRN---LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 217 FNQLTGELPDVAVPA------DLKFTQILMFIRGVYEH-----QSLDLSYNNFT 259
N D I+ + +H L+L+ N+F
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 46/287 (16%), Positives = 87/287 (30%), Gaps = 39/287 (13%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHL 60
+ +P LP NL D ++N L + S +L+ + + +
Sbjct: 19 FYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+++ L+ L L N L +L+ L L + LK L + +
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 121 DNNFNG-SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS-DLQG------ 172
N P++ + T L L++ + ++ + L ++ L +S DL
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 173 PNQTFPMLRNMTGLTRIILRNCNIAGEIPEY-IWGIKNLRFLDLSFNQLTGELPDVAVPA 231
F +R L ++ LRN + + + I G+ L L + E
Sbjct: 193 QPGAFKEIR----LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 232 -------------------DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
D I+ + S L
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 44/298 (14%), Positives = 91/298 (30%), Gaps = 39/298 (13%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGN 62
+ +L +L T+ N + ++ + L+ + L+ +G+
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 63 ITSLTYLDLEENQF-SGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN- 120
+ +L L++ N S +P NL NLE L LSSN++ +L L + ++
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 121 ---DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG----- 172
N N P + +L++L ++ + + + + L L + L
Sbjct: 183 DLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTC--IQGLAGLEVHRLVLGEFRN 239
Query: 173 -------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225
L N+T + +I + + N+ L +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--- 296
Query: 226 DVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSS 283
D + Q L+L F + L + +
Sbjct: 297 ----VKDFSYNFGW---------QHLELVNCKFGQFPTL--KLKSLKRLTFTSNKGGN 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS----SKSRQGNREFLNEIGTISCLQ 568
+F+ +G+G FG VY + I+A+K+L K+ ++ E+ S L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HPN+++LYG + ++ L+ EY ++ L K + +A L+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALS 123
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+ H +++HRDIK N+LL KI+DFG + + + GT+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
K D++S GV+ E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 45/225 (20%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFL---------------- 558
++ + + +G F + + A+K + R+F
Sbjct: 32 DYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 559 -NEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN----NSLAHALFGGENSQLKLNW 613
NE+ I+ +++ + G D++ ++YEY+EN + +N +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673
V + I + +++H + I HRD+K +N+L+D++ K+SDFG ++ ++K
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 674 ISTRVAGTIGYMAPEYALWGYLTY---KADVYSFGVVALEIVSGK 715
S GT +M PE +Y K D++S G+ +
Sbjct: 209 GS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPNLVKLYGC 578
+G+G V++G+ G + A+K+ ++ S + E + L H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 579 --CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+L+ E+ SL L N+ L S + + G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 637 KIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE---- 688
IVHR+IK N++ D K++DFG A+ E+ + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 689 --YALWGYLTY--KADVYSFGVVALEIVSGK 715
Y D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 51/220 (23%), Positives = 81/220 (36%), Gaps = 29/220 (13%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGC 578
+ EGGF VY+ Q + G A+K L S + NR + E+ + L HPN+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 579 CI-------EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGLAF 629
G L+ L L L + + + S KI R +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA---------- 679
+H + I+HRD+K N+LL K+ DFG A + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 680 -GTIGYMAPE-YALWGYLTY--KADVYSFGVVALEIVSGK 715
T Y PE L+ K D+++ G + + +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 66/209 (31%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPNLVKLYGC 578
++G GGFG V + G +A+K + NRE EI + L HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 579 CIE-------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+ D +L EY E L L EN L + + I+ L +LH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSALRYLH 138
Query: 632 EESRFKIVHRDIKATNVLLDRDLNP---KISDFGLAK-LDEEEKTHISTRVAGTIGYMAP 687
E +I+HRD+K N++L KI D G AK LD+ E V GT+ Y+AP
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTLQYLAP 192
Query: 688 E-YALWGYLTYKADVYSFGVVALEIVSGK 715
E Y T D +SFG +A E ++G
Sbjct: 193 ELLEQKKY-TVTVDYWSFGTLAFECITGF 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS-SKSRQGNRE--FLNEIGTISCLQH 569
+FD +G+G FG VY + + I+A+K+L S+ + E EI S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIA 624
PN++++Y + ++ L+ E+ GE + + +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAP---------RGELYKELQKHGRFDEQRSATFMEELA 124
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
L + H K++HRDIK N+L+ KI+DFG + + T + GT+ Y
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDY 178
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ PE K D++ GV+ E + G
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 42/203 (20%), Positives = 79/203 (38%), Gaps = 24/203 (11%)
Query: 521 KIGEGGFGPVYKG--QLTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLYG 577
I GG G +Y + +G + +K L + + E ++ + HP++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 578 CCIEGDQLM-----LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
D+ +V EY+ SL + +L + ++ L I L++LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIA--YLLEILPALSYLHS 200
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
+V+ D+K N++L + K+ D G + GT G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIVR- 250
Query: 693 GYLTYKADVYSFGVVALEIVSGK 715
T D+Y+ G +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 35/228 (15%), Positives = 72/228 (31%), Gaps = 22/228 (9%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQGNREFLNE 560
+ + + + +GEG F VY+ D +K+ +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 561 IGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL-FGGENSQLKLNWSVRQKI 619
+ + +K Y + + +LV E +L +A+ + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLL-----------DRDLNPKISDFGLAK-LD 667
+ + + +H+ +I+H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
K I T T G+ E Y+ D + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 53/234 (22%), Positives = 87/234 (37%), Gaps = 23/234 (9%)
Query: 8 TLPPQIVNL--PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNIT 64
+ + P ++ L P + + L+++++ A L +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL---------VKLKNLT 115
L L L N +P + +L L L + + + LP L L NL
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175
R+ S P I + L L+I+ S L + P+I L KL +L DL+G
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL---DLRGCTA 241
Query: 176 --TFPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
+P L R+IL++C+ +P I + L LDL LP
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 26/241 (10%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITSL 66
P Q L +L+ + L +P L+ +++ N L +P+ + ++ L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152
Query: 67 TYLDLEENQFSGTIPRELGN---------LVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
L + +P L + LVNL++LRL + +LP + L+NL
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQG-SGLEGPIPPSISALDKLNQLRISDLQGPNQ- 175
+I ++ + + I +L L+++G + L PP L +L L+ +
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRL---ILKDCSNL 266
Query: 176 -TFPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN---QLTGELPDVAVP 230
T P+ + +T L ++ LR C +P I + + + + QL P VA P
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP-VARP 325
Query: 231 A 231
A
Sbjct: 326 A 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 34/201 (16%), Positives = 60/201 (29%), Gaps = 35/201 (17%)
Query: 56 IPSHLGNITSLTYLDLEENQFSG-------------------TIPRELGNL--VNLETLR 94
L D + L + L
Sbjct: 28 YHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALE 87
Query: 95 LSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPP 154
L S L P + +L +L I+ PD +Q + L L + + L +P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 155 SISALDKLNQLRISDLQ---------GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW 205
SI++L++L +L I + + L + L I +P I
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 206 GIKNLRFLDLSFNQLTGELPD 226
++NL+ L + + L+ L
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGP 223
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 33/207 (15%), Positives = 57/207 (27%), Gaps = 23/207 (11%)
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFR 118
H + + L + + L + + T
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQIET--- 62
Query: 119 INDNNFNGSAPDFIQSWTQLN--RLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ- 175
+ D ++ TQ LE++ L P L L + I
Sbjct: 63 -RTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDA----AGL 116
Query: 176 -TFPM-LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLS-FNQLTGELPDVAVPAD 232
P ++ GL + L + +P I + LR L + +LT +P
Sbjct: 117 MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT------ELPEP 169
Query: 233 LKFTQILMFIRGVYEHQSLDLSYNNFT 259
L T +G+ QSL L +
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR 196
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 28/156 (17%), Positives = 56/156 (35%), Gaps = 6/156 (3%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITSL 66
+ L L+++ + + S+P A++Q LK + + + LS + + ++ L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG 126
LDL P G L+ L L + LP+++ +L L +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 127 SAPDFIQSWTQLNRLEI---QGSGLEGPIPPSISAL 159
P I + + + L+ P + A
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 34/234 (14%)
Query: 497 LEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNR 555
L+ F + + + + K+G G +G V A+K++ K+
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTS 78
Query: 556 E---FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL--- 609
L E+ + L HPN++KLY + LV E + GGE L
Sbjct: 79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK---------GGE---LFDE 126
Query: 610 ---KLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDF 661
++ ++ I + G+ +LH+ IVHRD+K N+LL ++D KI DF
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GL+ + E +K GT Y+APE L K DV+S GV+ +++G
Sbjct: 184 GLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFL-NEIGTISCLQHPNLVKLYGC 578
+G+G V++G+ G + A+K+ ++ S + E + L H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 579 --CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+L+ E+ SL L N+ L S + + G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 637 KIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE---- 688
IVHR+IK N++ D K++DFG A+ E+ + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 689 --YALWGYLTY--KADVYSFGVVALEIVSGK 715
Y D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLS----SKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+G+GGF ++ D + A K++ K Q + EI L H ++V +
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G + D + +V E SL + L + I G +LH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
+++HRD+K N+ L+ DL KI DFGLA E + + GT Y+APE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 697 YKADVYSFGVVALEIVSGK 715
++ DV+S G + ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 29/232 (12%), Positives = 65/232 (28%), Gaps = 41/232 (17%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREF----------------------- 557
+G+ + G V + R +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 558 --LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL-------ENNSLAHALFGGENSQ 608
L I ++ P K+ ++ + ++ + + L ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 609 LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668
L R ++ L + R LA LH + +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 669 EEKTHISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGK 715
R A + +T+ D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 522 IGEGGFGPVYKGQLTD-GTIIAVKLLS----SKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+G+GGF ++ D + A K++ K Q + EI L H ++V +
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
G + D + +V E SL + L + I G +LH R
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
+++HRD+K N+ L+ DL KI DFGLA E + + GT Y+APE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 697 YKADVYSFGVVALEIVSGK 715
++ DV+S G + ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNLVKLYGC 578
K+G G FG V+ + + G +K ++ Q E EI + L HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGE-------NSQLKLNWSVRQ--KICLGIARGLAF 629
+ + +V E E GGE S ++ + LA+
Sbjct: 89 FEDYHNMYIVMETCE---------GGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 630 LHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
H + +VH+D+K N+L KI DFGLA+L + ++ T AGT YMA
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMA 194
Query: 687 PEYALWGYLTYKADVYSFGVV 707
PE +T+K D++S GVV
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVV 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLS----SKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+G+G F VY+ + + G +A+K++ K+ R NE+ L+HP++++LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRF 636
+ + + LV E N + L +N + + + I G+ +LH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLT 696
I+HRD+ +N+LL R++N KI+DFGLA + T + GT Y++PE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190
Query: 697 YKADVYSFGVVALEIVSGK 715
++DV+S G + ++ G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-28
Identities = 50/269 (18%), Positives = 96/269 (35%), Gaps = 17/269 (6%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSH-LGNITS 65
LP +V L L+ + + N ++ L ++S+ N + + L N+ +
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 66 LTYLDLEENQ--FSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
L LDL + S +L NL +L++L LS N + + L +
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 124 FNGSAPD-FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD---LQGPNQTFPM 179
Q+ L L + S L+ L L L + +G Q
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA-----DLK 234
L+ + L ++L C+++ +K + +DLS N+LT + +L
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLA 531
Query: 235 FTQILMFIRGVYEH----QSLDLSYNNFT 259
I + + + ++++L N
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 51/291 (17%), Positives = 92/291 (31%), Gaps = 33/291 (11%)
Query: 2 LFSLPGTLPPQIV------------------NLPYLETVDFAYNYLHGSIPREWASM-QL 42
L +PGTLP L L +D ++ + S +L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 43 KYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIG 102
+ + AN L + L +L +L + S L N LE+L L SN +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 103 NLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE-GPIPPSISALDK 161
+ + L +N + + + + S Q L + +G + I P
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 162 LNQLRISDLQGPNQTFPMLRN--MTGLTRIILRNCNIAGEIPEYIWGIK--NLRFLDLSF 217
L Q F L+N + L + + P G+ ++ ++L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 218 NQLTGELPDVAVPA------DL---KFTQILMFIRGVYEHQSLDLSYNNFT 259
+ + DL +++ + G+ + L LS N F
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 51/298 (17%), Positives = 105/298 (35%), Gaps = 28/298 (9%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHL 60
+ + + + +E+++ +Y + L+ + + A LS +PS L
Sbjct: 240 DEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRI 119
+++L L L N+F N +L L + N L L L+NL + +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 120 NDNNFNGS--APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PN 174
+ ++ S +++ + L L + + + +L L ++ L+
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA--- 231
Q+ +N+ L + L + + + G+ L+ L+L N +
Sbjct: 418 QSP--FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK-GNIQKTNSLQT 474
Query: 232 -------DLKFTQILMFIRGVYEH----QSLDLSYNNFTWQSPEQPACREKPNLNLNL 278
L F + + + +DLS+N T S E A + LNL
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE--ALSHLKGIYLNL 530
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 45/274 (16%), Positives = 89/274 (32%), Gaps = 27/274 (9%)
Query: 1 MLFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHL 60
+L G I +L D + ++ M ++ I++ + +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+ L LDL S +P L L L+ L LS+N+ + +LT I
Sbjct: 275 HCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333
Query: 121 DNNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG------P 173
N +++ L L++ +E L L+ L+ +L
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVAVPAD 232
+ F + L + L + + + + + L+ L+LS + L +
Sbjct: 393 TEAF---KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL----- 444
Query: 233 LKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQP 266
L Q L+L N+F + ++
Sbjct: 445 FDGLPAL---------QHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 41/257 (15%), Positives = 79/257 (30%), Gaps = 21/257 (8%)
Query: 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT 79
+T + L+ IP + + N L + + +LT+LDL Q
Sbjct: 15 KTYNCENLGLN-EIPGT-LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN 139
+ L+TL L++N LI L K L + + + L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 140 RLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PNQTFPMLRNMTGLTRIILRNCNI 196
L + + + P +KL L + + + L+ T L+ + L +I
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-LNLNGNDI 191
Query: 197 AGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA--------DLKFTQILMFIRGVYEH 248
I + + L+ Q + + + V+E
Sbjct: 192 -AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 249 ------QSLDLSYNNFT 259
+S++L + F
Sbjct: 251 LCEMSVESINLQKHYFF 267
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 39/282 (13%), Positives = 90/282 (31%), Gaps = 28/282 (9%)
Query: 8 TLPPQ-IVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITS 65
++ + N LE++ N++ + + LK + N + + ++
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 66 LT--YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV--KLKNLTDFRIND 121
T L+L N + I + ++L + + + L +++L D
Sbjct: 179 ATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 122 NNFNGSAPDFIQSWTQLN--RLEIQGSGLEGPIPPSISALDKLNQLRISD--LQGPNQTF 177
+ +P + +++ + +Q + L +L ++ L
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGL 297
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQ 237
++ L +++L +L L + N EL L+ +
Sbjct: 298 ---VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC----LENLE 350
Query: 238 ILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN-LNL 278
L + LDLS+++ R +L LNL
Sbjct: 351 NL---------RELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-17
Identities = 39/235 (16%), Positives = 66/235 (28%), Gaps = 39/235 (16%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV 109
L+ IP L N S L+ N L+NL L L+ ++
Sbjct: 22 LGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 110 KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD 169
L + N A + L L +G+ I
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFI-------------- 123
Query: 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAV 229
L N L + L + +I+ + + L+ LD N + +
Sbjct: 124 ---------PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED-- 172
Query: 230 PADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSV 284
+ L+ L SL+L+ N+ P +LN ++ V
Sbjct: 173 MSSLQQATNL----------SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 27/137 (19%), Positives = 57/137 (41%), Gaps = 8/137 (5%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQ----LKYISVFANRLSGNIPSHLGNITSLTYLD 70
LP L+ ++ N+ ++ S+Q L+ + + LS ++ + ++D
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 71 LEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG--SA 128
L N+ + + L +L + L L+SN + LP L L + N + S
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565
Query: 129 PDFIQSWTQLNRLEIQG 145
F++ W + N +++
Sbjct: 566 IYFLE-WYKENMQKLED 581
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 22/111 (19%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
+L + VD ++N L S + ++ Y+++ +N +S +PS L ++ ++L +N
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQN 557
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
T N+ LE + + +L L R++D +
Sbjct: 558 PLDCTC----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 68/234 (29%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 497 LEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNR 555
L F + + +G+G FG V G AVK++S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 556 E----FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL-- 609
L E+ + L HPN++KLY + LV E GGE L
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT---------GGE---LFD 115
Query: 610 ----KLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISD 660
+ +S +I + G+ ++H+ KIVHRD+K N+LL +D N +I D
Sbjct: 116 EIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIID 172
Query: 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
FGL+ E K GT Y+APE L G K DV+S GV+ ++SG
Sbjct: 173 FGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQ 568
++ + +G+G FG V K AVK+++ K+ N++ L E+ + L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KIC 620
HPN++KL+ + +V E GGE L + +S +I
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYT---------GGE---LFDEIIKRKRFSEHDAARII 127
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTR 677
+ G+ ++H+ IVHRD+K N+LL ++D + KI DFGL+ ++
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KD 182
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
GT Y+APE L G K DV+S GV+ ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 31/238 (13%), Positives = 68/238 (28%), Gaps = 52/238 (21%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------------------------ 556
+G+ + G V + R +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 557 ----FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL----ENNSLAHALFGGENSQ 608
F+ + Q ++++ + L + Y + L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 609 LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668
L R ++ L + R LA LH + +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 669 EEKTHISTRVAGTIGYMAPEYALW-----------GYLTYKADVYSFGVVALEIVSGK 715
+ + G+ PE +T+ D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQ 568
++ + +G+G FG V K AVK+++ K+ N++ L E+ + L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGI 623
HPN++KL+ + +V E GGE + + + +I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAG 680
G+ ++H+ IVHRD+K N+LL ++D + KI DFGL+ ++ G
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185
Query: 681 TIGYMAPEYALWGYLTYKADVYSFGVV 707
T Y+APE Y K DV+S GV+
Sbjct: 186 TAYYIAPEVLRGTY-DEKCDVWSAGVI 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 21/228 (9%), Positives = 52/228 (22%), Gaps = 41/228 (17%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQHPNLVKLYG 577
+ G V+ + A+K+ + + E + L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 578 CC----------IEGD----------------QLMLVYEYLENN--SLAHALFGGENSQL 609
++ +L+ + L L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 610 KLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669
+ + R A L + +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 670 EKTHISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
+ + Y E+ T+ + + G+ +
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCL 567
+ + K+GEG +G VYK + + G I+A+K + R + + EI + L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISLLKEL 76
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
HPN+V L L LV+E++E + L L + ++ L S + + RG+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGV 132
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
A H+ +I+HRD+K N+L++ D K++DFGLA+ + V T+ Y AP
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSGK 715
+ L G Y D++S G + E+++GK
Sbjct: 189 D-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 50/196 (25%), Positives = 75/196 (38%), Gaps = 24/196 (12%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
IG G +G V Q A K + + F EI + L HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLHEES 634
+ + LV E GGE + S +I + +A+ H+
Sbjct: 76 EDNTDIYLVMELCT---------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL- 125
Query: 635 RFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
+ HRD+K N L D K+ DFGLA + K GT Y++P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLE 181
Query: 692 WGYLTYKADVYSFGVV 707
Y + D +S GV+
Sbjct: 182 GLY-GPECDEWSAGVM 196
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 34/209 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHP 570
F M +G G F V+ Q G + A+K + KS NEI + ++H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHE 66
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ---------KICL 621
N+V L LV + + GGE L + + + +
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVS---------GGE---L-FDRILERGVYTEKDASLVIQ 113
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRV 678
+ + +LHE IVHRD+K N+L + + I+DFGL+K+++ +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STA 167
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVV 707
GT GY+APE + D +S GV+
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 43/249 (17%)
Query: 491 DPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLS-- 547
+ +G+ + K+ ++ + K+G G +G V + + A+K++
Sbjct: 13 NLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKS 72
Query: 548 -----------SKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNS 596
+ + E NEI + L HPN++KL+ + LV E+ E
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE--- 129
Query: 597 LAHALFGGENSQL------KLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNV 648
GGE L + + I I G+ +LH+ IVHRDIK N+
Sbjct: 130 ------GGE---LFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENI 177
Query: 649 LL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFG 705
LL + LN KI DFGL+ ++ GT Y+APE L K DV+S G
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 706 VVALEIVSG 714
V+ ++ G
Sbjct: 235 VIMYILLCG 243
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 56/232 (24%), Positives = 81/232 (34%), Gaps = 42/232 (18%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGT-ISCLQHPNL 572
+ +G G G V G +AVK + L EI HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALF-----GGENSQLKLNWSVRQ--KICLGIAR 625
++ Y L + E N L + + + IA
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGLAKLDEEEKT 672
G+A LH KI+HRD+K N+L+ +L ISDFGL K + ++
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 673 HISTR---VAGTIGYMAPE-------YALWGYLTYKADVYSFGVVALEIVSG 714
T +GT G+ APE LT D++S G V I+S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 33/208 (15%)
Query: 515 NFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+G G FG V+K + G +A K++ ++ + E NEI ++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGE--NSQLKLNWS---------VRQKICLG 622
+LY + ++LV EY++ GGE + + +++ ++Q
Sbjct: 150 QLYDAFESKNDIVLVMEYVD---------GGELFDRIIDESYNLTELDTILFMKQ----- 195
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLAKLDEEEKTHISTRVAG 680
I G+ +H+ I+H D+K N+L +RD KI DFGLA+ + + + G
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-G 250
Query: 681 TIGYMAPEYALWGYLTYKADVYSFGVVA 708
T ++APE + ++++ D++S GV+A
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 53/251 (21%), Positives = 101/251 (40%), Gaps = 32/251 (12%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLD 70
+ NL + +++ N+ + L Y++V +++ P + N+T L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 71 LEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPD 130
L NQ P L +L +L N+ I ++ + + L +I +N +P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQ-ITDIT-PVANMTRLNSLKIGNNKITDLSP- 238
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTR 188
+ + +QL LEI + + I+A+ L +L++ ++ NQ +L N++ L
Sbjct: 239 -LANLSQLTWLEIGTNQIS-----DINAVKDLTKLKMLNVGS-NQISDISVLNNLSQLNS 291
Query: 189 IILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEH 248
+ L N + E E I G+ NL L LS N +T + + + +
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD----------------IRPLASLSKM 335
Query: 249 QSLDLSYNNFT 259
S D +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 34/251 (13%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLD 70
I L LE ++ N + P +L + + N+++ S L N+T+L L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISPLSNLV-KLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 71 LEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPD 130
L E+ S P L NL + +L L +N + +L L + L + ++ P
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP- 172
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTR 188
I + T L L + + +E P +++L L+ NQ + NMT L
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV----NQITDITPVANMTRLNS 225
Query: 189 IILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEH 248
+ + N I P + + L +L++ NQ++ + A T++
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISD------INAVKDLTKL---------- 267
Query: 249 QSLDLSYNNFT 259
+ L++ N +
Sbjct: 268 KMLNVGSNQIS 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 40/184 (21%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ + ++ + S+T L + + + +I + L NLE L L+ N+
Sbjct: 23 EGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQ- 77
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
I ++ L L LT+ I N + +Q+ T L L + + IS L
Sbjct: 78 ITDIS-PLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNIS-----DISPLA 129
Query: 161 KLNQLRISDLQGPNQT--FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218
L ++ +L + L NMTGL + + + P I + +L L L++N
Sbjct: 130 NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 219 QLTG 222
Q+
Sbjct: 188 QIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 28/204 (13%), Positives = 75/204 (36%), Gaps = 31/204 (15%)
Query: 58 SHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
++ L++ + + L ++ L ++ + + ++ + L NL
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK-VASIQ-GIEYLTNLEYL 71
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ-- 175
+N N +P + + +L L I + + ++ L L +L +++ +
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNE----DNIS 123
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKF 235
L N+T + + L + ++ + + L +L ++ +++ + +A
Sbjct: 124 DISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD-VTPIA-----NL 176
Query: 236 TQILMFIRGVYEHQSLDLSYNNFT 259
T + SL L+YN
Sbjct: 177 TDL----------YSLSLNYNQIE 190
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCLQ 568
+ + KIGEG +G VYK Q G A+K K R + + EI + L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKELK 58
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
H N+VKLY +L+LV+E+L+ + L L + + L + L + G+A
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+ H+ +++HRD+K N+L++R+ KI+DFGLA+ + + T+ Y AP+
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 689 YALWGYLTYKA--DVYSFGVVALEIVSGK 715
L G Y D++S G + E+V+G
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCL 567
++ + KIGEG +G V+K + G I+A+K K + + L EI + L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQL 59
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
+HPNLV L +L LV+EY ++ + H L + Q + + + I + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQAV 115
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
F H+ +HRD+K N+L+ + K+ DFG A+L + VA T Y +P
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSP 171
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSGK 715
E L G Y DV++ G V E++SG
Sbjct: 172 E-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREF---------LNEIGT 563
++ ++ +GEG F VYK + I+A+K K + G+R L EI
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIK----KIKLGHRSEAKDGINRTALREIKL 65
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
+ L HPN++ L + LV++++E + L + +++ L L S + L
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMT 121
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
+GL +LH + I+HRD+K N+LLD + K++DFGLAK + +V T
Sbjct: 122 LQGLEYLH--QHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRW 177
Query: 684 YMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
Y APE L+G Y D+++ G + E++
Sbjct: 178 YRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCL 567
++ + +GEG +G V K + G I+A+K K + + + + EI + L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
+H NLV L C + + LV+E++++ + L E L++ V QK I G+
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIINGI 137
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
F H I+HRDIK N+L+ + K+ DFG A+ VA T Y AP
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAP 193
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVSGK 715
E L G + Y DV++ G + E+ G+
Sbjct: 194 E-LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 13/204 (6%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK-----LLSSKSRQGNREFLNEIGTISC 566
++ IG+G F V + G AVK +S + E
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARG 626
L+HP++V+L L +V+E+++ L + ++ + +V I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 627 LAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
L + H+ I+HRD+K VLL + K+ FG+A E RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 684 YMAPEYALWGYLTYKADVYSFGVV 707
+MAPE DV+ GV+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 20/215 (9%)
Query: 511 AATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-----FLNEIGTI 564
+++S F + K+G G + VYKG T G +A+K + + + E + EI +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHAL--FGGENSQLKLNWSVRQKICLG 622
L+H N+V+LY ++L LV+E+++N+ L + N+ L ++ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ +GLAF HE KI+HRD+K N+L+++ K+ DFGLA+ S+ V T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 683 GYMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
Y AP+ L G TY D++S G + E+++GK
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE-----FLNEIGTISCLQ 568
+ ++K+GEG + VYKG ++A+K + R + E + E+ + L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
H N+V L+ L LV+EYL+ + L L ++ +N + + RGLA
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+ H + K++HRD+K N+L++ K++DFGLA+ V T+ Y P+
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
Query: 689 YALWGYLTYKA--DVYSFGVVALEIVSGK 715
L G Y D++ G + E+ +G+
Sbjct: 171 -ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 53/224 (23%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN--------------------- 559
IG+G +G V D T A+K+LS K + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 560 ------EIGTISCLQHPNLVKLYGCCIEG---DQLMLVYEYLENNSLAHALFGGE----N 606
EI + L HPN+VKL ++ D L +V+E + G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVN---------QGPVMEVP 129
Query: 607 SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666
+ L+ + + +G+ +LH KI+HRDIK +N+L+ D + KI+DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 667 DEEEKTHISTRVAGTIGYMAPE---YALWGYLTYKADVYSFGVV 707
+ +S GT +MAPE + DV++ GV
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
+D + ++G G FG V++ + G + K +++ NEI ++ L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE------NSQLKLN-----WSVRQKIC 620
L+ L+ + +++L+ E+L GGE K++ +RQ
Sbjct: 110 LINLHDAFEDKYEMVLILEFLS---------GGELFDRIAAEDYKMSEAEVINYMRQ--- 157
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLA-KLDEEEKTHISTR 677
GL +HE IVH DIK N++ + + KI DFGLA KL+ +E
Sbjct: 158 --ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KV 209
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
T + APE + + D+++ GV+
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 70/329 (21%), Positives = 126/329 (38%), Gaps = 32/329 (9%)
Query: 394 NGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEK---DFNIEAE-AHGVLKPVT 449
+G V + E + ++ + + + L +F I AE HG KP
Sbjct: 36 DGGSLVTNYTIEKREAMGGSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCE 95
Query: 450 RPFTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPNLEGLEFQASSFTLKQI 509
+ + R + I G V + Q +
Sbjct: 96 PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155
Query: 510 RAATSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
++D ++G G FG V++ + G A K + + EI T+S L+
Sbjct: 156 L---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE------NSQLKLNWSVRQKICLG 622
HP LV L+ + ++++++YE++ GGE + K++ +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMS---------GGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLA-KLDEEEKTHISTRVA 679
+ +GL +HE VH D+K N++ + N K+ DFGL LD ++ +
Sbjct: 264 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TT 317
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVA 708
GT + APE A + Y D++S GV++
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCL 567
++ + KIGEG +G V+K + I+A+K + R + + L EI + L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKEL 58
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
+H N+V+L+ +L LV+E+ + + L ++ L+ + + + +GL
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGL 114
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
F H ++HRD+K N+L++R+ K+++FGLA+ S V T+ Y P
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170
Query: 688 EYALWGYLTYKA--DVYSFGVVALEIVS 713
+ L+G Y D++S G + E+ +
Sbjct: 171 D-VLFGAKLYSTSIDMWSAGCIFAELAN 197
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNE-- 560
I ++F IG GGFG VY + D G + A+K L K +QG LNE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 561 -IGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
+ +S P +V + D+L + + + GG+ L++ + Q
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGD-----LHYHLSQHG 287
Query: 620 CLGIAR----------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669
A GL +H +V+RD+K N+LLD + +ISD GLA +
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 670 EKTHISTRVAGTIGYMAPEYAL--WGYLTYKADVYSFGVVALEIVSGK 715
+K H V GT GYMAPE Y AD +S G + +++ G
Sbjct: 345 KKPH--ASV-GTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGH 388
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 54/254 (21%), Positives = 85/254 (33%), Gaps = 56/254 (22%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK-----LLSSKSRQGNREFLNEIGTISC 566
+ IG+G +G V + I A+K + + + E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLE--------------------------------- 593
L HPN+ +LY + + LV E
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 594 -NNSLAHALFGGENSQLKLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650
N + G L + I I L +LH I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 651 --DRDLNPKISDFGLAKL----DEEEKTHISTRVAGTIGYMAPE---YALWGYLTYKADV 701
++ K+ DFGL+K + E ++T+ GT ++APE Y K D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESY-GPKCDA 259
Query: 702 YSFGVVALEIVSGK 715
+S GV+ ++ G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE--F----LNEIGTISC 566
S ++ + KIG+G FG V+K + G +A+K K N + F L EI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72
Query: 567 LQHPNLVKLYGCCIE--------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQK 618
L+H N+V L C + LV+++ E++ LA L N +K S ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKR 128
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEEEKTHI 674
+ + GL ++H KI+HRD+KA NVL+ RD K++DFGLA+ +
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 675 STRVAGTIGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
+ RV T+ Y PE L G Y D++ G + E+ +
Sbjct: 186 TNRVV-TLWYRPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 39/223 (17%), Positives = 82/223 (36%), Gaps = 12/223 (5%)
Query: 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM---QLKYISVFANRLSGNIPSHLGNI 63
G++ + V LP L +D + N L S ++ + L+++ + N + ++ +
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398
Query: 64 TSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
L +LD + + +L L L +S + + L +L ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 123 NFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PNQTFP 178
+F + + + T L L++ LE L +L L +S L + +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
+ L+ + I K+L F +L+ N +
Sbjct: 519 ---QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 49/284 (17%), Positives = 84/284 (29%), Gaps = 30/284 (10%)
Query: 6 PGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITS 65
PG+L P I +P + T L +P + K I + N L N +
Sbjct: 1 PGSLNPCIEVVPNI-TYQCMDQKLS-KVPDD-IPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L +LDL + + L +L L L+ N + P L +L + +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 126 GSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISD--LQG-PNQTFPMLR 181
I L +L + + + +P S L L + +S +Q LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 182 NMT-GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240
+ + I I + + L L L N + + +L +
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTC-LQNLAGLHVHR 235
Query: 241 FIRGVYEH--------------------QSLDLSYNNFTWQSPE 264
I G ++ L+Y N
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 46/248 (18%), Positives = 77/248 (31%), Gaps = 42/248 (16%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLS--GNIPSHLGNITSLTYLDLE 72
+LP+L+++ N ++ A L Y+ + N LS G SL +LDL
Sbjct: 326 DLPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSAPDF 131
N + L L+ L + L + L+ L I+ N
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIIL 191
T LN L++ G+ + ++ N T LT + L
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNV-----------------------FANTTNLTFLDL 480
Query: 192 RNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSL 251
C + + L+ L++S N L +Y +L
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS--------------HYNQLYSLSTL 526
Query: 252 DLSYNNFT 259
D S+N
Sbjct: 527 DCSFNRIE 534
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 39/281 (13%), Positives = 79/281 (28%), Gaps = 33/281 (11%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNI------PSH 59
+ Q L + N+ +I + L + PS
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 60 LGNITSLTY--LDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
+ + +T L + L N+ + L+ + ++ K
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSL 312
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PN 174
I L L + + +G I AL L+ L +S L
Sbjct: 313 SIIRCQLKQFPT---LDLPFLKSLTL--TMNKGSISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA--- 231
++ L L + L + G++ L+ LD + L A +
Sbjct: 368 CSYSDL-GTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 232 ----DLKFTQILMFIRGVYEH----QSLDLSYNNFTWQSPE 264
D+ +T + G++ +L ++ N+F +
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 6/143 (4%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM--QLKYISVFANRLSGNIPSHLGNIT 64
I + L L T+ A N + + L ++ + +L +
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
L L++ N L +L TL S NR+ + + K+L F + +N+
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 125 --NGSAPDFIQSWTQLNRLEIQG 145
F+Q W + + +
Sbjct: 558 ACICEHQKFLQ-WVKEQKQFLVN 579
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/99 (18%), Positives = 37/99 (37%), Gaps = 2/99 (2%)
Query: 4 SLPGTLPPQIV-NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLG 61
S + N L +D + L + ++ +L+ +++ N L SH
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ SL+ LD N+ + +L L++N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREF------LNEIGTISC 566
+ + K+GEG +G VYK +A+K + R + E + E+ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARG 626
LQH N+++L +L L++EY E + L + ++ V + + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEEEKTHISTRVAGT 681
+ F H + +HRD+K N+LL KI DFGLA+ + + T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 682 IGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
+ Y PE L G Y D++S + E++
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 33/201 (16%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNLVKLYGCC 579
+GEG +G V +AVK++ K E + EI L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGE-------NSQLKLNWSVR---QKICLGIARGLAF 629
EG+ L EY GGE + + + R Q + G+ +
Sbjct: 75 REGNIQYLFLEYCS---------GGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVY 120
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAP 687
LH I HRDIK N+LLD N KISDFGLA + + ++ GT+ Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 688 E-YALWGYLTYKADVYSFGVV 707
E + DV+S G+V
Sbjct: 177 ELLKRREFHAEPVDVWSCGIV 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHP 570
T ++ IG G + + AVK++ KS++ E EI + QHP
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHP 76
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KICLG 622
N++ L +G + +V E ++ GGE L + +S R+ +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMK---------GGE---LLDKILRQKFFSEREASAVLFT 124
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KISDFGLAKLDEEEKTHISTRV 678
I + + +LH + +VHRD+K +N+L D NP +I DFG AK E + T
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 679 AGTIGYMAPE-YALWGYLTYKADVYSFGVV 707
T ++APE GY D++S GV+
Sbjct: 182 -YTANFVAPEVLERQGY-DAACDIWSLGVL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 33/201 (16%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN-EIGTISCLQHPNLVKLYGCC 579
+GEG +G V +AVK++ K E + EI L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGE-------NSQLKLNWSVR---QKICLGIARGLAF 629
EG+ L EY GGE + + + R Q + G+ +
Sbjct: 75 REGNIQYLFLEYCS---------GGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVY 120
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYMAP 687
LH I HRDIK N+LLD N KISDFGLA + + ++ GT+ Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 688 E-YALWGYLTYKADVYSFGVV 707
E + DV+S G+V
Sbjct: 177 ELLKRREFHAEPVDVWSCGIV 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 27/244 (11%)
Query: 485 ISAISVDPNLEGLEFQASSFTLKQI-RAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAV 543
++ + ++P + + + + + IG G FG V++ +L + +A+
Sbjct: 10 LNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAI 69
Query: 544 KLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ------LMLVYEYLENNSL 597
K K Q R E+ + ++HPN+V L L LV EY+ +
Sbjct: 70 K----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-V 124
Query: 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP- 656
A + + + + + R LA++H I HRDIK N+LLD
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVL 181
Query: 657 KISDFGLAK-LDEEEK-TH-ISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEI 711
K+ DFG AK L E I +R Y APE ++G Y D++S G V E+
Sbjct: 182 KLIDFGSAKILIAGEPNVSYICSRY-----YRAPE-LIFGATNYTTNIDIWSTGCVMAEL 235
Query: 712 VSGK 715
+ G+
Sbjct: 236 MQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 36/215 (16%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTI-----------SCLQH 569
+G+GGFG V+ G LTD +A+K++ ++R L++ T + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIA 624
P +++L + MLV E + + L + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP--------AQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEEEKTHISTRVAGTIG 683
+ H +VHRDIK N+L+D K+ DFG L +E GT
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRV 203
Query: 684 YMAPEYALWG--YLTYKADVYSFGVVALEIVSGKN 716
Y PE+ + Y A V+S G++ ++V G
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDI 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 40/210 (19%), Positives = 78/210 (37%), Gaps = 34/210 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
+ +G G FG V++ + + K + EI ++ +H N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE------NSQLKLN-----WSVRQKIC 620
++ L+ ++L++++E++ G + S +LN V Q
Sbjct: 63 ILHLHESFESMEELVMIFEFIS---------GLDIFERINTSAFELNEREIVSYVHQ--- 110
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEKTHISTRV 678
+ L FLH + I H DI+ N++ + KI +FG A+ + +
Sbjct: 111 --VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLL 163
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
Y APE ++ D++S G +
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
R F G+G FG V G+ G +A+K + R NRE L + ++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 569 HPNLVKLYGCCIEGDQ-------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
HPN+V+L + L +V EY+ + L Q+ + +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLDEEEKTHIS--- 675
+ R + LH S + HRDIK NVL++ L K+ DFG AK + +++
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 676 TRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
+R Y APE + T D++S G + E++ G+
Sbjct: 194 SRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK--------LLSSKSRQGNRE-FLNEIG 562
N++P +G G V + AVK S++ Q RE L E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 563 TISCL-QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVR 616
+ + HPN+++L LV++ ++ GE ++ L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK---------KGELFDYLTEKVTLSEKET 126
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
+KI + + LH+ IVHRD+K N+LLD D+N K++DFG + + + +
Sbjct: 127 RKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LRE 182
Query: 677 RVAGTIGYMAPE-------YALWGYLTYKADVYSFGVV 707
GT Y+APE GY + D++S GV+
Sbjct: 183 VC-GTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 33/210 (15%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE---FLNEIGTISCLQ 568
+ N+D ++G+G F V + T G A K+++ + R+ E LQ
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KIC 620
HPN+V+L+ E LV++ + GGE L + +S
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVT---------GGE---LFEDIVAREFYSEADASHCI 111
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTR 677
I +A+ H IVHR++K N+LL + K++DFGLA + +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HG 166
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVV 707
AGT GY++PE + D+++ GV+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 43/285 (15%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITS 65
+ + ++ +D + N L + A +L+ +++ +N L L ++++
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L LDL N EL ++ETL ++N I + + + + +N
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-ISRVSCSR--GQGKKNIYLANNKIT 133
Query: 126 GSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISDLQGPNQ--TFPMLRN 182
+++ L+++ + ++ ++ D L L + N
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY----NFIYDVKGQVV 189
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
L + L + +A + + ++ L N+L + L+F+Q L
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV------LIEKALRFSQNL--- 239
Query: 243 RGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENN 287
+ DL N F C + R +V
Sbjct: 240 ------EHFDLRGNGFH--------CGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 42/230 (18%), Positives = 75/230 (32%), Gaps = 37/230 (16%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ K V + L + S + ++ LDL N S +L LE L LSSN
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV- 69
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
+ +L L L +N+N + + L + + + S
Sbjct: 70 LYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSR--GQ 120
Query: 161 KLNQL-----RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAG-EIPEYIWGIKNLRFLD 214
+ +I+ L + + + + L+ I E L L+
Sbjct: 121 GKKNIYLANNKITML--RDLDE---GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 215 LSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264
L +N + V + F ++ ++LDLS N + PE
Sbjct: 176 LQYNFIY------DVKGQVVFAKL----------KTLDLSSNKLAFMGPE 209
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 26/157 (16%), Positives = 51/157 (32%), Gaps = 6/157 (3%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
+ LE ++ YN+++ + + +LK + + +N+L+ + + +T++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRL-IGNLPMELVKLKNLTDFRINDNNFNGSAPDF 131
N+ I + L NLE L N G L K + + +
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQN 279
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
+ T E P L L
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLS--------SKSRQGNREFLNEIGTISCLQHPN 571
+G G G V + +A++++S ++ EI + L HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARG 626
++K+ + + +V E +E GGE +L + + +
Sbjct: 202 IIKIKNF-FDAEDYYIVLELME---------GGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 627 LAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
+ +LHE I+HRD+K NVLL + D KI+DFG +K+ E + + T GT
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPT 306
Query: 684 YMAPE----YALWGYLTYKADVYSFGVV 707
Y+APE GY D +S GV+
Sbjct: 307 YLAPEVLVSVGTAGY-NRAVDCWSLGVI 333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
F +G GGFG V+ Q+ G + A K L+ K R+G + + E ++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-NSQLKLNWSVRQKICLGIAR--- 625
+V L L LV + GG+ + A
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMN---------GGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 626 -----GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAG 680
GL LH+ I++RD+K NVLLD D N +ISD GLA + +T G
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-G 351
Query: 681 TIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
T G+MAPE L Y + D ++ GV E+++ +
Sbjct: 352 TPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 30/218 (13%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN---------EIGTI 564
+ M+ +G G FG V+ + VK + K + ++ EI +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKI 619
S ++H N++K+ LV E + G + + +L+ + I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGS--------GLDLFAFIDRHPRLDEPLASYI 135
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ + +L I+HRDIK N+++ D K+ DFG A E K T
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FC 190
Query: 680 GTIGYMAPE-YALWGYLTYKADVYSFGVVALEIVSGKN 716
GTI Y APE Y + +++S GV +V +N
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLS--------SKSRQGNREFLNEIGT 563
+ +G G G V + +A+K++S ++ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQK 618
+ L HP ++K+ + + +V E +E GGE +L + +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELME---------GGELFDKVVGNKRLKEATCKL 118
Query: 619 ICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHIS 675
+ + +LHE I+HRD+K NVLL + D KI+DFG +K+ E +
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MR 174
Query: 676 TRVAGTIGYMAPE----YALWGYLTYKADVYSFGVV 707
T GT Y+APE GY D +S GV+
Sbjct: 175 TLC-GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 521 KIGEGGFGPVYKGQ---LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG 577
K+G G +G VYK + D A+K + + EI + L+HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 578 CCIE--GDQLMLVYEYLENNSLA-----HALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+ ++ L+++Y E++ L H ++L + + + I G+ +L
Sbjct: 86 VFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKL---DEEEKTHISTRVAGTIG 683
H ++HRD+K N+L+ + KI+D G A+L + + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 684 YMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
Y APE L G Y D+++ G + E+++ +
Sbjct: 201 YRAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNR------EFLNEIGTIS 565
+D ++G G F V K + + G A K + + + +R E E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE----------NSQLKLNWSV 615
+ HPN++ L+ ++L+ E + GGE S+ + +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVS---------GGELFDFLAQKESLSEEEATSFI 121
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KISDFGLAKLDEEEK 671
+Q I G+ +LH + KI H D+K N++L D+++ K+ DFGLA E+
Sbjct: 122 KQ-----ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
+ GT ++APE + L +AD++S GV+
Sbjct: 174 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
R ++ IG G FG VY+ +L D G ++A+K K Q R E+ + L
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLD 105
Query: 569 HPNLVKLYGCCIEGDQ------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
H N+V+L + L LV +Y+ + ++ L +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKL---DEEEKTHISTRV 678
+ R LA++H F I HRDIK N+LLD D K+ DFG AK E ++I +R
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 679 AGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
Y APE ++G Y DV+S G V E++ G+
Sbjct: 222 -----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE--------FLNEIGT 563
+DP + IG G V + G AVK++ + + + E E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 564 ISCL-QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQ 617
+ + HP+++ L + LV++ + GE ++ L+ +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMR---------KGELFDYLTEKVALSEKETR 203
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
I + ++FLH IVHRD+K N+LLD ++ ++SDFG + E + +
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LREL 259
Query: 678 VAGTIGYMAPE-------YALWGYLTYKADVYSFGVV 707
GT GY+APE GY + D+++ GV+
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVI 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 38/175 (21%), Positives = 60/175 (34%), Gaps = 15/175 (8%)
Query: 547 SSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGEN 606
S +I + N V L + + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-C 156
Query: 607 SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 665
S V I + IA + FLH + ++HRD+K +N+ D K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 666 ----------LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALE 710
L T GT YM+PE ++K D++S G++ E
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 37/241 (15%)
Query: 482 GPLISAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKG-QLTDGTI 540
GP +++++ + + S F + + N+D ++G+G F V + T G
Sbjct: 1 GPHMASMTGGQQM----GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLE 56
Query: 541 IAVKLLSSKSRQGNRE---FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597
A K+++ + R+ E LQHPN+V+L+ E LV++ +
Sbjct: 57 FAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT---- 111
Query: 598 AHALFGGENSQL------KLNWSVRQ--KICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
GGE L + +S I +A+ H IVHR++K N+L
Sbjct: 112 -----GGE---LFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLL 160
Query: 650 L---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGV 706
L + K++DFGLA + + AGT GY++PE + D+++ GV
Sbjct: 161 LASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 707 V 707
+
Sbjct: 219 I 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 32/200 (16%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHPNLVKLYGC 578
+GEG F K AVK++S + + EI + C HPN+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KICLGIARGLAFL 630
+ LV E L GGE L K ++S + I + ++ +
Sbjct: 75 FHDQLHTFLVMELLN---------GGE---LFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 631 HEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
H+ +VHRD+K N+L + +L KI DFG A+L + + T T+ Y AP
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAP 178
Query: 688 EYALWGYLTYKADVYSFGVV 707
E D++S GV+
Sbjct: 179 ELLNQNGYDESCDLWSLGVI 198
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 46/245 (18%), Positives = 88/245 (35%), Gaps = 32/245 (13%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
L + ++ + Q+ + + + + +LT ++ N
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQTDLD-QVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 78
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
Q + P L NL L + +++N++ P L L NLT + +N P +++
Sbjct: 79 QLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNC 194
T LNRLE+ + + ISAL L L+ L N+T L R+ + +
Sbjct: 133 LTNLNRLELSSNTIS-----DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 187
Query: 195 NIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254
++ + + NL L + NQ++ + T + L L+
Sbjct: 188 KVSD--ISVLAKLTNLESLIATNNQISD------ITPLGILTNL----------DELSLN 229
Query: 255 YNNFT 259
N
Sbjct: 230 GNQLK 234
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 19/222 (8%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+ + L LE++ N + P + L +S+ N+L L ++T+LT
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLT 246
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
LDL NQ S P L L L L+L +N++ P L L LT+ +N+N
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTG 185
+P I + L L + + + P +S+L KL +L + N+ L N+T
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN----NKVSDVSSLANLTN 354
Query: 186 LTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDV 227
+ + + I+ P + + + L L+ T +
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-22
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 36/252 (14%)
Query: 10 PPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYL 69
+ L L ++F+ N L P + + +L I + N+++ P L N+T+LT L
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITPLKNLT-KLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 70 DLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP 129
L NQ + P L NL NL L LSSN I ++ L L +L N P
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNT-ISDIS-ALSGLTSLQQLSFG-NQVTDLKP 172
Query: 130 DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLT 187
+ + T L RL+I + + ++ L L L ++ NQ L +T L
Sbjct: 173 --LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATN----NQISDITPLGILTNLD 224
Query: 188 RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYE 247
+ L + + + NL LDL+ NQ++ + T++
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN------LAPLSGLTKL--------- 267
Query: 248 HQSLDLSYNNFT 259
L L N +
Sbjct: 268 -TELKLGANQIS 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 63/280 (22%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDL 71
+ NL LE +D + N + S A + L+ + N++S P LG +T+L L L
Sbjct: 173 LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 72 EENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF 131
NQ L +L NL L L++N++ P L L LT+ ++ N + +P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRI 189
+ T L LE+ + LE IS + L L L N + ++T L R+
Sbjct: 283 LAGLTALTNLELNENQLE-----DISPISNLKNLTYLTLYF-NNISDISPVSSLTKLQRL 336
Query: 190 ILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQ 249
N + + + N+ +L NQ++ + T+I
Sbjct: 337 FFYNNKV--SDVSSLANLTNINWLSAGHNQISD------LTPLANLTRI----------T 378
Query: 250 SLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFG 289
L L+ +T A PN N+ +
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 13/214 (6%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+ +L L +D A N + P + +L + + AN++S P L +T+LT
Sbjct: 234 KDIGTLASLTNLTDLDLANNQISNLAPLSGLT-KLTELKLGANQISNISP--LAGLTALT 290
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
L+L ENQ P + NL NL L L N + P + L L +N +
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD- 345
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLT 187
+ + T +N L + + P ++ L ++ QL ++D N N++
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP- 401
Query: 188 RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
++N A P I + D+++N +
Sbjct: 402 -NTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 31/164 (18%), Positives = 56/164 (34%), Gaps = 18/164 (10%)
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
G + S T + + L L + + L +T + +
Sbjct: 1 GPLGSATITQ--DTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFP 178
D ++ L ++ + L P + L KL + +++ NQ
Sbjct: 55 RLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN----NQIADIT 106
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
L N+T LT + L N I P + + NL L+LS N ++
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 27/147 (18%), Positives = 60/147 (40%), Gaps = 8/147 (5%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDL 71
+ +L L+ + F N + S A++ + ++S N++S P L N+T +T L L
Sbjct: 327 VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382
Query: 72 EENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF 131
+ ++ N+ T++ + LI P + + T+ I N + +
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEV 439
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISA 158
+++Q + + G + + A
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 42/218 (19%)
Query: 513 TSNFDPMNKIGEGGFGPVYK------GQLTDGTIIAVKLLSSKSRQGNRE-FLNEIGTIS 565
+D ++G G F V K G I + + R +RE E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE----------NSQLKLNWSV 615
+ H N++ L+ ++L+ E + GGE S+ + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVS---------GGELFDFLAQKESLSEEEATSFI 121
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KISDFGLA-KLDEEE 670
+Q I G+ +LH + KI H D+K N++L D+++ K+ DFGLA ++++
Sbjct: 122 KQ-----ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
+ + GT ++APE + L +AD++S GV+
Sbjct: 174 EF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 46/220 (20%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKL-----LSSKSRQGNRE-FLNEIGTIS 565
+++ ++G G F V K Q G A K LSS R +RE E+ +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWS----- 614
++HPN++ L+ ++L+ E + GGE L K + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVS---------GGE---LFDFLAEKESLTEDEAT 111
Query: 615 --VRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDE 668
++Q I G+ +LH + +I H D+K N++L P K+ DFG+A E
Sbjct: 112 QFLKQ-----ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
+ GT ++APE + L +AD++S GV+
Sbjct: 164 AGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 42/215 (19%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNRE--FLNEIGTISCLQH 569
T + ++G+G F V + ++ G A ++++K E L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KICL 621
PN+V+L+ E L+++ + GGE L + +S
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVT---------GGE---LFEDIVAREYYSEADASHCIQ 117
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRV 678
I + H+ +VHR++K N+LL + K++DFGLA E E+
Sbjct: 118 QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 679 AGTIGYMAPE------YALWGYLTYKADVYSFGVV 707
GT GY++PE Y D+++ GV+
Sbjct: 175 -GTPGYLSPEVLRKDPY------GKPVDLWACGVI 202
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 522 IGEGGFGPVYKG--QLTDGTIIAVKLLS-SKSRQGNREFLN-EIGTISCLQHPNLVKLYG 577
IG+G F V LT G +A+K++ ++ + + L E+ + L HPN+VKL+
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 578 CCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLHE 632
L L+ EY GGE + ++ + I + + H
Sbjct: 82 VIETEKTLYLIMEYAS---------GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH- 131
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLA---KLDEEEKTHISTRVAGTIGYMAPEY 689
+ +IVHRD+KA N+LLD D+N KI+DFG + + + G Y APE
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-----CGAPPYAAPEL 184
Query: 690 ALW-GYLTYKADVYSFGVVALEIVSGK 715
Y + DV+S GV+ +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 34/213 (15%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN-------EIGTISCLQH--PN 571
+G GGFG VY G ++D +A+K + K R + L E+ + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARG 626
+++L D +L+ E E + + L + + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP--------VQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEEKTHISTRVAGTIGYM 685
+ H ++HRDIK N+L+D + K+ DFG L ++ GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYS 215
Query: 686 APEYALWG--YLTYKADVYSFGVVALEIVSGKN 716
PE+ + Y A V+S G++ ++V G
Sbjct: 216 PPEW-IRYHRYHGRSAAVWSLGILLYDMVCGDI 247
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 83/338 (24%), Positives = 132/338 (39%), Gaps = 37/338 (10%)
Query: 390 YCLENGNYSVALHF----AEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVL 445
+C S + F AE + T D K GR + ++ V
Sbjct: 70 FCATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGP-------DLIPEVP 122
Query: 446 KPVTRPFTANVSNHILEIRFQWAGKGTTAIPIGGVYGPLISAISVDPNLEGLEFQASSFT 505
+ + T + + FQ + T + + +I + L+ + T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEI 561
+ F +G+GGFG V Q+ G + A K L K R+G LNE
Sbjct: 183 K-------NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 562 GTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSV--RQKI 619
+ + +V L D L LV + L ++ + +V +I
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRV 678
C G L LH E +IV+RD+K N+LLD + +ISD GLA + E + RV
Sbjct: 296 CCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV 346
Query: 679 AGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
GT+GYMAPE Y T+ D ++ G + E+++G+
Sbjct: 347 -GTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQ 382
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 40/217 (18%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVK-----LLSSKSRQGNREFL-NEIGTIS 565
+D ++G G F V K + + G A K S R +RE + E+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE----------NSQLKLNWSV 615
+QHPN++ L+ ++L+ E + GGE ++ + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVA---------GGELFDFLAEKESLTEEEATEFL 120
Query: 616 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEEEK 671
+Q I G+ +LH +I H D+K N++L KI DFGLA +
Sbjct: 121 KQ-----ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
+ GT ++APE + L +AD++S GV+
Sbjct: 173 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 496 GLEFQASSFTLKQIRAATSNFDPMNK-IGEGGFGPVYKG-QLTDGTIIAVKLLS-SKSRQ 552
G++ + + + + + +K +G G F V + + G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 553 GNRE-FLNEIGTISCLQH-PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE----- 605
R L+EI + + P ++ L+ +++L+ EY GGE
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA---------GGEIFSLC 120
Query: 606 NSQLKLNWS-------VRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLN 655
+L S ++Q I G+ +LH+ IVH D+K N+LL +
Sbjct: 121 LPELAEMVSENDVIRLIKQ-----ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172
Query: 656 PKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVA 708
KI DFG+++ + + + GT Y+APE + +T D+++ G++A
Sbjct: 173 IKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 55/219 (25%), Positives = 79/219 (36%), Gaps = 46/219 (21%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLS----SKSRQGNREFLNEIGTISCLQHPNLVKLY 576
+GEG +G V + AVK+L + G EI + L+H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 577 G--CCIEGDQLMLVYEYLENNSL---------------AHALFGGENSQLKLNWSVRQKI 619
E ++ +V EY AH F Q I
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-------------CQLI 119
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEEEKTHISTRV 678
GL +LH IVH+DIK N+LL KIS G+ L
Sbjct: 120 D-----GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 679 AGTIGYMAPEYA--LWGYLTYKADVYSFGVVALEIVSGK 715
G+ + PE A L + +K D++S GV I +G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
+F+ + IG+G FG V Q D + A+K ++ + R R E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG------- 622
P LV L+ + + + +V + L GG+ L + ++Q +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLL---------GGD-----LRYHLQQNVHFKEETVKLF 120
Query: 623 ---IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ L +L +I+HRD+K N+LLD + I+DF +A + E + +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 680 GTIGYMAPE----YALWGYLTYKADVYSFGVVALEIVSGK 715
GT YMAPE GY ++ D +S GV A E++ G+
Sbjct: 176 GTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 513 TSNFDPMNKIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
+ F+ +++G G VY+ Q A+K+L + + EIG + L HPN
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KICLGI 623
++KL ++ LV E + GGE L K +S R I
Sbjct: 110 IIKLKEIFETPTEISLVLELVT---------GGE---LFDRIVEKGYYSERDAADAVKQI 157
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAG 680
+A+LHE IVHRD+K N+L D KI+DFGL+K+ E + V G
Sbjct: 158 LEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCG 212
Query: 681 TIGYMAPE-YALWGYLTYKADVYSFGVV 707
T GY APE Y + D++S G++
Sbjct: 213 TPGYCAPEILRGCAY-GPEVDMWSVGII 239
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 48/210 (22%), Positives = 79/210 (37%), Gaps = 39/210 (18%)
Query: 522 IGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHPNLVKLYGCC 579
+GEG V L AVK++ + E+ + C H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 580 IEGDQLMLVYEYLENNSLAHALFGGENSQL------KLNWSVRQ--KICLGIARGLAFLH 631
E D+ LV+E + GG + + +++ + + +A L FLH
Sbjct: 81 EEEDRFYLVFEKMR---------GGS---ILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 632 EESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTR------VAGTI 682
+ I HRD+K N+L ++ KI DF L + G+
Sbjct: 129 NK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 683 GYMAPE---YALWGYLTY--KADVYSFGVV 707
YMAPE Y + D++S GV+
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 43/285 (15%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITS 65
+ + ++ +D + N L + A +L+ +++ +N L L ++++
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L LDL N EL ++ETL ++N I + + + + +N
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-ISRVSCSR--GQGKKNIYLANNKIT 133
Query: 126 GSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISDLQGPNQ--TFPMLRN 182
+++ L+++ + ++ ++ D L L + N
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY----NFIYDVKGQVV 189
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
L + L + +A + + ++ L N+L + L+F+Q L
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV------LIEKALRFSQNL--- 239
Query: 243 RGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENN 287
+ DL N F C + R +V
Sbjct: 240 ------EHFDLRGNGFH--------CGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 9e-21
Identities = 38/281 (13%), Positives = 83/281 (29%), Gaps = 30/281 (10%)
Query: 8 TLPPQ-IVNLPYLETVDFAYNYLHG-SIPREWASMQ-LKYISVFANRLSGNIPSHLGNIT 64
L ++ +D N + + AS L+++++ N + ++ +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124
L LDL N+ + + E + + + L +N+L+ + L +NL F + N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 125 N-GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+ G+ DF ++ + ++ + + P +
Sbjct: 250 HCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 184 TGLTRIILRNCNIAG----EIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239
L R + G + R +D Q + V + K
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAK----- 362
Query: 240 MFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFR 280
+L+ R L+ L +
Sbjct: 363 ---------ITLEQKKKALD--EQVSNGRRAHAELDGTLQQ 392
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-19
Identities = 43/230 (18%), Positives = 75/230 (32%), Gaps = 37/230 (16%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ K V + L + S + ++ LDL N S +L LE L LSSN L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
+L L L +N+N + + L + + + S
Sbjct: 71 Y-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSCSR--GQ 120
Query: 161 KLNQL-----RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAG-EIPEYIWGIKNLRFLD 214
+ +I+ L + + + + L+ I E L L+
Sbjct: 121 GKKNIYLANNKITML--RDLDE---GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 215 LSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264
L +N + V + F ++ ++LDLS N + PE
Sbjct: 176 LQYNFIY------DVKGQVVFAKL----------KTLDLSSNKLAFMGPE 209
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 22/218 (10%), Positives = 48/218 (22%), Gaps = 4/218 (1%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+ + LE D N H R++ S + +V + + T T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRL----IGNLPMELVKLKNLTDFRINDNN 123
L+ L+ + L E +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
+ LE + L+ + A +L+ +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
+ + + +R D+ ++ T
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 512 ATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVK-LLSSKSRQGNREF----LNEIGT-- 563
ATS ++P+ +IG G +G VYK + G +A+K + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 564 -ISCLQHPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
+ +HPN+V+L C ++ LV+E+++ + L L + L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIK 123
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+ RGL FLH IVHRD+K N+L+ K++DFGLA++ + ++
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPV 179
Query: 678 VAGTIGYMAPEYALWGYLTYKA--DVYSFGVVALEIVSGK 715
V T+ Y APE L TY D++S G + E+ K
Sbjct: 180 VV-TLWYRAPE-VLLQ-STYATPVDMWSVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 36/203 (17%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHPNLVKLYGC 578
+G G G V + G A+KLL + E+ P++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 579 C----IEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQ--KICLGIARGL 627
L+++ E +E GGE + ++ R+ +I I +
Sbjct: 91 YENMHHGKRCLLIIMECME---------GGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 628 AFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
FLH I HRD+K N+L ++D K++DFG AK + + T T Y
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYY 195
Query: 685 MAPEYALWGYLTYKADVYSFGVV 707
+APE D++S GV+
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVI 218
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 56/284 (19%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLD 70
P++ N +L+ +D N L +P S L++I+ N+L +P L N+ LT +
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNNQLE-ELPE-LQNLPFLTAIY 201
Query: 71 LEENQFSG------------------TIPRELGNLVNLETLRLSSNRLIGNLPMELVKLK 112
+ N EL NL L T+ +N L LP L+
Sbjct: 202 ADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE 260
Query: 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172
L + DN P+ QS T L+ E SGL +PP++ L+ + I L
Sbjct: 261 ALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLN-ASSNEIRSLCD 314
Query: 173 P-----------NQ--TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219
N+ P L R+I ++A E+PE +NL+ L + +N
Sbjct: 315 LPPSLEELNVSNNKLIELP--ALPPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNP 368
Query: 220 LTGELPDVAVPADLKFTQILMFIRGVYEH----QSLDLSYNNFT 259
L E PD +P ++ ++ + V E + L + N
Sbjct: 369 LR-EFPD--IPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 45/244 (18%), Positives = 85/244 (34%), Gaps = 38/244 (15%)
Query: 34 PREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLV----- 88
PR ++ L+ ++ L+ +P N+ S T +++ P G
Sbjct: 5 PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 89 --------NLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNR 140
L L++ L +LP L++L + N+ P+ QS L
Sbjct: 64 RLRDCLDRQAHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLV 118
Query: 141 LEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200
L +PP + L ++ ++ L P L+N + L I + N ++ ++
Sbjct: 119 DNNNLKALSD-LPPLLEYLG-VSNNQLEKL-------PELQNSSFLKIIDVDNNSLK-KL 168
Query: 201 PEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKF-----TQILMFIRGVYEHQSLDLSY 255
P+ +L F+ NQL ELP++ L + +S+
Sbjct: 169 PD---LPPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGN 224
Query: 256 NNFT 259
N
Sbjct: 225 NILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 52/254 (20%), Positives = 92/254 (36%), Gaps = 30/254 (11%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
LP +L L + L P L+Y+ V N+L +P L N + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLPE-LQNSSFLK 156
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
+D++ N +P +LE + +N+L LP EL L LT ++N+
Sbjct: 157 IIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL--- 207
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTG 185
L + + LE P + L L + + N T P L
Sbjct: 208 -KKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADN----NLLKTLPDL--PPS 258
Query: 186 LTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245
L + +R+ + ++PE + L + F+ L+ P++ + +I
Sbjct: 259 LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYY-LNASSNEIRSLCDLP 316
Query: 246 YEHQSLDLSYNNFT 259
+ L++S N
Sbjct: 317 PSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
P++ NLP+L T+ N L ++P S L+ ++V N L+ ++P + LT
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPS--LEALNVRDNYLT-DLPELPQS---LT 280
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
+LD+ EN FS + NL L SSN I +L +L + +++N
Sbjct: 281 FLDVSENIFS-GLSELPPNL---YYLNASSNE-IRSLCDLP---PSLEELNVSNNKLI-E 331
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLT 187
P +L RL + L +P L QL + + FP + +
Sbjct: 332 LPALP---PRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNP--LREFPDI--PESVE 380
Query: 188 RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
LR + E+PE +NL+ L + N L E PD
Sbjct: 381 D--LRMNSHLAEVPE---LPQNLKQLHVETNPLR-EFPD 413
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 25/134 (18%), Positives = 43/134 (32%), Gaps = 27/134 (20%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGN----- 62
LP L L ++N+L +P + LK + V N L P +
Sbjct: 331 ELPALPPRLERL---IASFNHLA-EVPELPQN--LKQLHVEYNPLR-EFPDIPESVEDLR 383
Query: 63 -----------ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKL 111
+L L +E N P ++ E LR++S R++
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESV---EDLRMNSERVVDPYEFAHETT 439
Query: 112 KNLTDFRINDNNFN 125
L D ++ +
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 26/197 (13%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN----EIGTISCLQHPNLVKLY 576
+G G FG V G+ G +AVK+L+ + + + + + EI + +HP+++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLH 631
+V EY+ GGE ++ +++ I + + H
Sbjct: 78 QVISTPTDFFMVMEYVS---------GGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-YA 690
R +VHRD+K NVLLD +N KI+DFGL+ + + + T G+ Y APE +
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRT-SCGSPNYAAPEVIS 183
Query: 691 LWGYLTYKADVYSFGVV 707
Y + D++S GV+
Sbjct: 184 GRLYAGPEVDIWSCGVI 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 48/228 (21%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQGN----------REFLNEI 561
++ + +IGEG +G V+K + G +A+K + R RE
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE----- 61
Query: 562 GTISCLQ------HPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGEN-SQL 609
++ L+ HPN+V+L+ C +L LV+E+++ + L L + +
Sbjct: 62 --VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEP 115
Query: 610 KLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669
+ + + + RGL FLH ++VHRD+K N+L+ K++DFGLA++
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 670 EKTHISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGK 715
+ +++ V T+ Y APE L Y T D++S G + E+ K
Sbjct: 173 QMA-LTSVVV-TLWYRAPE-VLLQSSYAT-PVDLWSVGCIFAEMFRRK 216
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-21
Identities = 55/315 (17%), Positives = 97/315 (30%), Gaps = 62/315 (19%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+LP L L +L L + +F N+L+ ++P L
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLT-SLPVLPPG---LQ 144
Query: 68 YLDLEENQFSGTIPRELGNLV-----------------NLETLRLSSNRLIGNLPMELVK 110
L + +NQ + ++P L L+ L +S N+L +LP +
Sbjct: 145 ELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSE 202
Query: 111 LKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKL----NQLR 166
L L +N S P + L L + G+ L +P S L +L N+L
Sbjct: 203 LYKLW---AYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPSELKELMVSGNRLT 254
Query: 167 ISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
+ P +GL + + + +PE + + + ++L N L+
Sbjct: 255 ---------SLP--MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302
Query: 227 VAVPADLKFTQILMFIRGVYEHQSL-----DLSYNNFTWQSPEQPACREKPNLNLNLFRS 281
IR S L W P + + +
Sbjct: 303 ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE----PAPADRWHM 358
Query: 282 SSVENNFGVFPCTNN 296
E+N F +
Sbjct: 359 FGQEDNADAFSLFLD 373
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 50/261 (19%), Positives = 93/261 (35%), Gaps = 68/261 (26%)
Query: 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG 78
++ + L ++P + + + + N L+ ++P+ L L++ NQ +
Sbjct: 42 NAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT- 94
Query: 79 TIPRELGNLVNLETLRLSSNRL----------------IGNLPMELVKLKNLTDFRINDN 122
++P L+ L L + +LP+ L+ L+ ++DN
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELS---VSDN 151
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKL----NQLRISDLQGPNQTFP 178
S P +L Q + L P S L +L NQL + P
Sbjct: 152 QLA-SLPALPSELCKLWAYNNQLTSL----PMLPSGLQELSVSDNQL---------ASLP 197
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQI 238
L + L ++ N + +P L+ L +S N+LT LP +P++L
Sbjct: 198 TL--PSELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLT-SLP--VLPSEL----- 243
Query: 239 LMFIRGVYEHQSLDLSYNNFT 259
+ L +S N T
Sbjct: 244 ----------KELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 38/196 (19%), Positives = 68/196 (34%), Gaps = 41/196 (20%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
L++ E+ + T+P L ++ TL + N L +LP +L+ L ++ N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
S P +L+ + L +P + L + +++ L P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW-IFGNQLTSL--PVL-------P 140
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243
GL + + + +A +P L L NQLT LP + +
Sbjct: 141 PGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPM-------LPSGL----- 183
Query: 244 GVYEHQSLDLSYNNFT 259
Q L +S N
Sbjct: 184 -----QELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 32/195 (16%), Positives = 64/195 (32%), Gaps = 16/195 (8%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+LP L L + N L S+P + +LK + V NRL+ ++P L
Sbjct: 215 SLPALPSGLKEL---IVSGNRL-TSLPVLPS--ELKELMVSGNRLT-SLPMLPSG---LL 264
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
L + NQ + +P L +L + T+ L N L ++ ++
Sbjct: 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPII---R 319
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLT 187
S + R + +P ++ + + F + + T
Sbjct: 320 FDMAGASAPRETRALHLAAAD-WLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
Query: 188 RIILRNCNIAGEIPE 202
+++ +I
Sbjct: 379 ENFIKDAGFKAQISS 393
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 32/246 (13%)
Query: 485 ISAISVDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAV 543
+ + +P Q + + + +F +GEG F V + A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 544 KLLSSKSRQGNREF---LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHA 600
K+L + + E +S L HP VKLY + ++L Y +
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK------- 113
Query: 601 LFGGENSQLKLNWSVRQKICLG----------IARGLAFLHEESRFKIVHRDIKATNVLL 650
GE L +R+ I L +LH I+HRD+K N+LL
Sbjct: 114 --NGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILL 163
Query: 651 DRDLNPKISDFGLAKLDEEEKTHISTR-VAGTIGYMAPEYALWGYLTYKADVYSFGVVAL 709
+ D++ +I+DFG AK+ E GT Y++PE +D+++ G +
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 710 EIVSGK 715
++V+G
Sbjct: 224 QLVAGL 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 54/204 (26%), Positives = 77/204 (37%), Gaps = 42/204 (20%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
IG G FG + ++AVK + + + EI L+HPN+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 581 EGDQLMLVYEYLENNSL--------------AHALFGGENSQLKLNWSVRQKICLGIARG 626
L ++ EY L A F +Q + G
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-------------QQLLS-----G 128
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEKTHISTRVAGTIGY 684
+++ H +I HRD+K N LLD P KI DFG +K + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAY 183
Query: 685 MAPE-YALWGYLTYKADVYSFGVV 707
+APE Y ADV+S GV
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVT 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 21/201 (10%), Positives = 48/201 (23%), Gaps = 45/201 (22%)
Query: 521 KIGEGGFGPVYKGQLTD---GTIIAVKLL---SSKSRQGNREFLNEIGTISCLQHPNLVK 574
G ++ D +A+ + +E L+ +S + P + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
+ ++V E++ SL ++R +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIR--AMQSLAAAADAAHRAG 149
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY 694
+ + V + D G L M
Sbjct: 150 ---VALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 695 LTYKADVYSFGVVALEIVSGK 715
+ D+ G ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 35/235 (14%)
Query: 499 FQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS--RQGNR 555
+ + +KQ+R +F+ + IG G FG V +L + + A+K+L+ ++
Sbjct: 59 AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET 118
Query: 556 E-FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-NSQLKLNW 613
F E + + L+ + + L LV +Y GG+ + L
Sbjct: 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV---------GGDLLTLLS--- 166
Query: 614 SVRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
++ +AR + +H+ VHRDIK N+L+D + + +++DFG
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 666 LDEEEKTHISTRVAGTIGYMAPE------YALWGYLTYKADVYSFGVVALEIVSG 714
E+ T S+ GT Y++PE Y + D +S GV E++ G
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYG 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN----EIGTISCLQHPNLVKLY 576
+GEG FG V +A+K +S + + EI + L+HP+++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQKICLGIARGLAFLH 631
+++V EY GGE + ++ ++ I + + H
Sbjct: 76 DVITTPTDIVMVIEYA----------GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-YA 690
R KIVHRD+K N+LLD +LN KI+DFGL+ + + + T G+ Y APE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPEVIN 180
Query: 691 LWGYLTYKADVYSFGVV 707
Y + DV+S G+V
Sbjct: 181 GKLYAGPEVDVWSCGIV 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 36/202 (17%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN----EIGTISCLQHPNLVKLY 576
+G G FG V G+ G +AVK+L+ + + + + + EI + +HP+++KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 577 GCCIEGDQLMLVYEYLENNSLAHALFGGE-------NSQLKLNWSVR---QKICLGIARG 626
+ +V EY+ GGE N +L S R Q + G
Sbjct: 83 QVISTPSDIFMVMEYVS---------GGELFDYICKNGRLDEKESRRLFQQILS-----G 128
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMA 686
+ + H R +VHRD+K NVLLD +N KI+DFGL+ + + + + T G+ Y A
Sbjct: 129 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAA 183
Query: 687 PE-YALWGYLTYKADVYSFGVV 707
PE + Y + D++S GV+
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVI 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-20
Identities = 45/225 (20%), Positives = 81/225 (36%), Gaps = 18/225 (8%)
Query: 14 VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLS--GNIPSHLGNITSLTYLDL 71
+ L L+ + F N + E L+++ + N LS G TSL YLDL
Sbjct: 322 LKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 72 EENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSAPD 130
N T+ L LE L + L + L+NL I+ + +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG------PNQTFPMLRNMT 184
+ L L++ G+ + P I +L L DL F +++
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDI--FTELRNLTFLDLSQCQLEQLSPTAF---NSLS 494
Query: 185 GLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVA 228
L + + + + +P+ I+ + +L+ + L N P +
Sbjct: 495 SLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 51/253 (20%), Positives = 94/253 (37%), Gaps = 36/253 (14%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
+LE V+ + + LK ++ +N+ N S ++ SL +LDL N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKS-----LKRLTFTSNKGG-NAFS-EVDLPSLEFLDLSRN 357
Query: 75 Q--FSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG-SAPDF 131
F G + +L+ L LS N +I + + L+ L +N S
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ---TFP--MLRNMTGL 186
S L L+I + I + L+ L + + G N F + + L
Sbjct: 417 FLSLRNLIYLDISHTHTRV-AFNGI--FNGLSSLEVLKMAG-NSFQENFLPDIFTELRNL 472
Query: 187 TRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245
T + L C + ++ + + +L+ L+++ NQL +PD + T +
Sbjct: 473 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFD---RLTSL------- 520
Query: 246 YEHQSLDLSYNNF 258
Q + L N +
Sbjct: 521 ---QKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 52/293 (17%), Positives = 99/293 (33%), Gaps = 24/293 (8%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRL-SGNIPSHLGNIT 64
+L L L+ + L + LK ++V N + S +P + N+T
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLE----TLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+L +LDL N+ +L L + +L LS N + + K L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLHKLTLR 208
Query: 121 DNNFNGSAPD-FIQSWTQLNRLEIQGSGLEGP---IPPSISALDKLNQLRISDLQG---- 172
+N + + IQ L + SAL+ L L I + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 173 --PNQTFPMLRNMTGLTRIILRNCNIAGEIPE--YIWGIKNLRFLDLSFNQLTGELPDVA 228
+ + +T ++ L + I + + Y +G ++L ++ F Q
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 229 VPADLKFTQILMFIRGVYEH--QSLDLSYNNFTWQSPEQPACREKPNLN-LNL 278
+ V + LDLS N +++ + +L L+L
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 41/229 (17%), Positives = 80/229 (34%), Gaps = 20/229 (8%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHL 60
+ +P LP NL D ++N L + S +L+ + + +
Sbjct: 19 FYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+++ L+ L L N L +L+ L L + LK L + +
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 121 DNNFN-GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS-DLQG------ 172
N P++ + T L L++ + ++ + L ++ L +S DL
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 173 PNQTFPMLRNMTGLTRIILRNCNIAGEIPE-YIWGIKNLRFLDLSFNQL 220
F +R L ++ LRN + + + I G+ L L +
Sbjct: 193 QPGAFKEIR----LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 33/173 (19%), Positives = 67/173 (38%), Gaps = 7/173 (4%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIP-SHL 60
S G L+ +D ++N + ++ + + QL+++ + L S
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRI 119
++ +L YLD+ L +LE L+++ N N + +L+NLT +
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172
+ +P S + L L + + L+ +P D+L L+ L
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPD--GIFDRLTSLQKIWLHT 527
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 49/275 (17%), Positives = 82/275 (29%), Gaps = 28/275 (10%)
Query: 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGN----IPSHLGNIT 64
LP NL LE +D + N + + + + + LS N I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 65 SLTYLDLEENQFSGTIPRE-LGNLVNLETLRL------SSNRLIGNLPMELVKLKNLTDF 117
L L L N S + + + L LE RL + L L L NLT
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQG-SGLEGPIPPSISALDKLNQLRISDLQGPNQT 176
+ D I + L + + S L + + +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT 236
L++ L R+ + E + +L FLDLS N L+ +
Sbjct: 321 TLKLKS---LKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 237 QILMF----IRGVYEH-------QSLDLSYNNFTW 260
+ L + + + + LD ++N
Sbjct: 376 KYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 410
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 42/256 (16%), Positives = 81/256 (31%), Gaps = 36/256 (14%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGN----IP--SHLGNITSLTY 68
L L +F YL + + +V + L + S+ L
Sbjct: 253 GLCNLTIEEFRLAYLDYY-LDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 69 LDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN--G 126
++ + QF L +L+ L +SN+ GN V L +L ++ N + G
Sbjct: 312 VNCKFGQFPT------LKLKSLKRLTFTSNK-GGNAF-SEVDLPSLEFLDLSRNGLSFKG 363
Query: 127 SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD--LQG-PNQTFPMLRNM 183
T L L++ +G+ + + L++L L L+ + ++
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV--FLSL 420
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243
L + + + + G+ +L L ++ N P + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL----PDIFTELRNL---- 472
Query: 244 GVYEHQSLDLSYNNFT 259
LDLS
Sbjct: 473 -----TFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 20/103 (19%), Positives = 41/103 (39%), Gaps = 5/103 (4%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM--QLKYISVFANRLSGNIPSHLGNIT 64
I L LE + A N + + + L ++ + +L P+ +++
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 65 SLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPM 106
SL L++ NQ ++P L +L+ + L +N + P
Sbjct: 495 SLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 37/204 (18%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHPNLVKLYG- 577
+G G G V + A+K+L + E+ Q P++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 578 ---CCIEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQ--KICLGIARGL 627
L++V E L+ GGE + ++ R+ +I I +
Sbjct: 124 YENLYAGRKCLLIVMECLD---------GGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 628 AFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGY 684
+LH I HRD+K N+L + K++DFG AK + ++T T Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 685 MAPE-YALWGYLTYKADVYSFGVV 707
+APE Y D++S GV+
Sbjct: 230 VAPEVLGPEKY-DKSCDMWSLGVI 252
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-19
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 44/311 (14%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHL 60
+FSL L L+ ++ AYN ++ + + L+ +++ N L S+
Sbjct: 278 VFSLN---SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL--IGNLP------MELVKLK 112
+ + Y+DL++N + + L L+TL L N L I +P + KL
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV 394
Query: 113 NLTDFRINDNNFNGS--------APDFIQSWTQLNRLEIQGSGLEG-------PIPPSIS 157
L + N + S F+ L L + + PS+
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454
Query: 158 ALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217
L L + + + + ++ L + L + + P + LR L L+
Sbjct: 455 QLF-LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
Query: 218 NQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277
N+LT L +PA+L+ LD+S N +P+ ++ N
Sbjct: 514 NRLT-VLSHNDLPANLE---------------ILDISRNQLLAPNPDVFVSLSVLDITHN 557
Query: 278 LFRSSSVENNF 288
F + F
Sbjct: 558 KFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 42/283 (14%), Positives = 88/283 (31%), Gaps = 33/283 (11%)
Query: 4 SLPGTLPPQIVNLPYLETVDFAYN---YLHGSIPREWASMQLKYISVFANRLSGNIPSH- 59
++ + ++ ++ F ++ + A ++++ + + ++ S
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV 285
Query: 60 LGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFR 118
+ L L+L N+ + L NL+ L LS N +G L L +
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL-LGELYSSNFYGLPKVAYID 344
Query: 119 INDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALD--------------KLN 163
+ N+ + +L L+++ + L PSI + N
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTAN 404
Query: 164 QLRISDLQGPN-QTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLT 221
+ +S+ + N L + L +IL + + +L L L N L
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 222 GELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264
+ L Q L L++N P
Sbjct: 465 LAWETELCWDVFEGLSHL---------QVLYLNHNYLNSLPPG 498
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 48/274 (17%), Positives = 96/274 (35%), Gaps = 22/274 (8%)
Query: 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT 79
+ + L +P+ + + + + N + S + L L+L T
Sbjct: 7 RIAFYRFCNLT-QVPQVLNT--TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 80 IPRE-LGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSA--PDFIQSW 135
I +E NL NL L L S++ I L + L +L + R+ + + + ++
Sbjct: 64 IDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 136 TQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISDLQ---GPNQTFPMLRNMTGLTRIIL 191
L RL++ + + + PS L+ L + S Q L+ T L+ L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LSFFSL 181
Query: 192 RNCNIAGEIPEYIWGIKN------LRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245
++ + N L LD+S N T ++ + +Q I
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG-NFSNAISKSQAFSLILAH 240
Query: 246 YEHQSLDLSYNNFTWQSPEQPACREKPNL-NLNL 278
+ ++N A + ++ +L+L
Sbjct: 241 HI-MGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 54/269 (20%), Positives = 98/269 (36%), Gaps = 38/269 (14%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASM---QLKYISVFANRLSGNIPSHLGNIT--SLTYL 69
NL L +D + N + S+ + LK I +N++ L + +L++
Sbjct: 121 NLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 70 DLEENQFSGTIPRELGNLVN------LETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
L N + + G +N LE L +S N ++ + +
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 124 FNGSAPDFIQSWTQLNRLE-IQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
+ F + ++ + G S+ LD L+ + L ++ F
Sbjct: 240 HHIMGAGF-----GFHNIKDPDQNTFAGLARSSVRHLD-LSHGFVFSL--NSRVF---ET 288
Query: 183 MTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLT-------GELPDVAVPADLK 234
+ L + L I +I + +G+ NL+ L+LS+N L LP VA DL+
Sbjct: 289 LKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY-IDLQ 346
Query: 235 FTQILMFIRGVYEH----QSLDLSYNNFT 259
I + ++ Q+LDL N T
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 50/313 (15%), Positives = 96/313 (30%), Gaps = 30/313 (9%)
Query: 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ---LKYISVFANRLSGNIPSHLGNI-- 63
L P L L+++DF+ N + E +Q L + S+ AN L + G
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 64 ----TSLTYLDLEENQFS------------GTIPRELGNLVNLETLRLSSNRL--IGNLP 105
L LD+ N ++ + L ++ + +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 106 MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165
+ ++ ++ ++ L L + + + + LD L L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVL 319
Query: 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225
+S + + I L+ +IA + ++ L+ LDL N LT +
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIH 378
Query: 226 DVAVPA--DLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACR----EKPNLNLNLF 279
+ L +++ + + LS N R + LN N F
Sbjct: 379 FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 280 RSSSVENNFGVFP 292
S S + P
Sbjct: 439 SSCSGDQTPSENP 451
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 50/224 (22%), Positives = 79/224 (35%), Gaps = 29/224 (12%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL--IGNLPMELVKLKN 113
+P+ + +S T L+LE N+ L L L LSSN L G +
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG- 172
L ++ N + +F+ QL L+ Q S L+ S L L D+
Sbjct: 80 LKYLDLSFNGVITMSSNFLGL-EQLEHLDFQHSNLK--QMSEFSVFLSLRNLIYLDISHT 136
Query: 173 -----PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPD 226
N F ++ L + + + I+ ++NL FLDLS QL +L
Sbjct: 137 HTRVAFNGIF---NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192
Query: 227 VAVPA-------DLKFTQILMFIRGVYEH----QSLDLSYNNFT 259
A + ++ Y+ Q LD S N+
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 52/268 (19%), Positives = 90/268 (33%), Gaps = 37/268 (13%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLS--GNIPS 58
L S+P +P L + N L + + QL +S+ +N LS G
Sbjct: 19 LTSVPTGIPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDF 117
TSL YLDL N T+ L LE L + L + + L+NL
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG----- 172
I+ + + + L L++ G+ + P +L L DL
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD--IFTELRNLTFLDLSQCQLEQ 189
Query: 173 -PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVP 230
F +++ L + + + N + + + +L+ LD S N +
Sbjct: 190 LSPTAF---NSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM------TSK 239
Query: 231 ADLKFTQILMFIRGVYEHQSLDLSYNNF 258
+ L+L+ N+F
Sbjct: 240 KQE-LQHFPSSL------AFLNLTQNDF 260
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 49/278 (17%), Positives = 85/278 (30%), Gaps = 44/278 (15%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+L + + + L S+P Q+ + + N L ++P + L
Sbjct: 51 SLLKEC-LINQFSELQLNRLNLS-SLPDNLPP-QITVLEITQNALI-SLPELPAS---LE 103
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
YLD +N+ S T+P +L + L + +N+L LP L+ + ++N
Sbjct: 104 YLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPALLEYI---NADNNQLT-M 154
Query: 128 APDFIQSWTQL----NRLEIQGSGLEGPIPPSISALDKL----NQLRISDLQGPNQTFPM 179
P+ S L N+L +P +L+ L N L P
Sbjct: 155 LPELPTSLEVLSVRNNQLTF--------LPELPESLEALDVSTNLLE----SLPAVPVRN 202
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD------VAVPADL 233
+ R I IPE I + + L N L+ A P
Sbjct: 203 HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYH 260
Query: 234 KFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREK 271
G L+ W + + +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 41/268 (15%), Positives = 82/268 (30%), Gaps = 35/268 (13%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
LP +L L N L +P S L+ + V N L ++P+
Sbjct: 154 MLPELPTSLEVL---SVRNNQL-TFLPELPES--LEALDVSTNLLE-SLPAVPVRNHHSE 206
Query: 68 ----YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
+ EN+ + IP + +L T+ L N L + L + D+
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL--------------DKLNQLRIS- 168
F+ D Q+ + + +S + L++L +
Sbjct: 266 FS--MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTV 323
Query: 169 ----DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGEL 224
Q L ++ + ++ +A + E L + +L L +
Sbjct: 324 SARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
Query: 225 PDVAVPADLKFTQILMFIRGVYEHQSLD 252
+ D +L R ++ + L+
Sbjct: 384 SEGLFDNDTG--ALLSLGREMFRLEILE 409
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 36/206 (17%), Positives = 64/206 (31%), Gaps = 56/206 (27%)
Query: 79 TIPRELGNLVNLETLRLSSNRL---IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSW 135
+I + N +L N + + K + N N + +
Sbjct: 2 SIMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 136 TQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCN 195
Q + L++ L +P ++ P +T + +
Sbjct: 59 NQFSELQLNRLNLSS-LPDNL---------------PPQ-----------ITVLEITQNA 91
Query: 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255
+ +PE +L +LD N+L+ LP+ +PA L + LD+
Sbjct: 92 L-ISLPE---LPASLEYLDACDNRLS-TLPE--LPASL---------------KHLDVDN 129
Query: 256 NNFTWQSPEQPACREKPNLNLNLFRS 281
N T PE PA E N + N
Sbjct: 130 NQLTM-LPELPALLEYINADNNQLTM 154
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 64/236 (27%), Positives = 98/236 (41%), Gaps = 33/236 (13%)
Query: 495 EGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQG 553
G E S + R + F+ + +G+G FG V + G A+K+L +
Sbjct: 129 SGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA 188
Query: 554 NREF---LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK 610
E L E + +HP L L D+L V EY GGE
Sbjct: 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN---------GGE----- 234
Query: 611 LNWSVRQKICLGIAR----------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660
L + + ++ R L +LH S +V+RD+K N++LD+D + KI+D
Sbjct: 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITD 292
Query: 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
FGL K ++ + T GT Y+APE Y D + GVV E++ G+
Sbjct: 293 FGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 36/234 (15%)
Query: 499 FQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNRE- 556
++ + ++ +R +++ + IG G FG V + + A+KLLS K R
Sbjct: 54 YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSD 112
Query: 557 ---FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGE-NSQLKLN 612
F E ++ P +V+L+ + L +V EY+ GG+ + +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMS-- 161
Query: 613 WSVRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
+ AR L +H +HRD+K N+LLD+ + K++DFG
Sbjct: 162 ---NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 665 KLDEEEKTHISTRVAGTIGYMAPE--YALWGYLTYKADV--YSFGVVALEIVSG 714
+E GT Y++PE + G Y + +S GV E++ G
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 39/252 (15%)
Query: 486 SAISVDPNLEGLEFQASSFT--LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIA 542
S ++ D + A LK++R +F+ + IG G F V ++ G + A
Sbjct: 31 SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 543 VKLLSSKSRQGNRE----FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLA 598
+K++ +K R F E + + +L+ + + L LV EY
Sbjct: 91 MKIM-NKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV----- 144
Query: 599 HALFGGE-NSQLKLNWSVRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVL 649
GG+ + L ++I +AR + +H VHRDIK N+L
Sbjct: 145 ----GGDLLTLLS---KFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNIL 194
Query: 650 LDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE-----YALWGYLTY--KADVY 702
LDR + +++DFG + T S GT Y++PE G +Y + D +
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 703 SFGVVALEIVSG 714
+ GV A E+ G
Sbjct: 255 ALGVFAYEMFYG 266
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 57/263 (21%), Positives = 92/263 (34%), Gaps = 49/263 (18%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSH-LGNI 63
LPP + N+P L + N L S+PR + +L +S+ N L I
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
TSL L L N+ + + L + +L +S N L L + + + N+
Sbjct: 165 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG------PNQTF 177
N L L++Q + L + L L DL F
Sbjct: 217 INVVRGPVNVE---LTILKLQHNNLT-----DTAWLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADL-KFT 236
M L R+ + N + + Y I L+ LDLS N L V + +F
Sbjct: 269 ---VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL------HVERNQPQFD 318
Query: 237 QILMFIRGVYEHQSLDLSYNNFT 259
++ ++L L +N+
Sbjct: 319 RL----------ENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 45/260 (17%), Positives = 94/260 (36%), Gaps = 42/260 (16%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSHL-GNI 63
+ ++ + +N + +P L + + N LS ++P + N
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140
Query: 64 TSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
LT L + N I + +L+ L+LSSNR + ++ + L + +L ++ N
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR-LTHVDLSL--IPSLFHANVSYN 196
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPML 180
+ + + L+ + + + +L L++ N L
Sbjct: 197 LLS-----TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQH----NNLTDTAWL 244
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239
N GL + L + +I + + ++ L L +S N+L A+ + L
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV------ALNLYGQPIPTL 297
Query: 240 MFIRGVYEHQSLDLSYNNFT 259
+ LDLS+N+
Sbjct: 298 ---------KVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 36/257 (14%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSH-LGNIT 64
+ + L + V F + + +P + Q++ +++ ++ I ++
Sbjct: 36 YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAH 93
Query: 65 SLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRINDN 122
++ L + N +P N+ L L L N + +LP + LT +++N
Sbjct: 94 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNN 151
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182
N D Q+ T L L++ + L + S + L +S N L
Sbjct: 152 NLERIEDDTFQATTSLQNLQLSSNRLTH-VDLS--LIPSLFHANVSY----NL-LSTLAI 203
Query: 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
+ + + +I + + L L L N LT L + +
Sbjct: 204 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT------DTAWLLNYPGL---- 250
Query: 243 RGVYEHQSLDLSYNNFT 259
+DLSYN
Sbjct: 251 ------VEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 39/244 (15%), Positives = 76/244 (31%), Gaps = 40/244 (16%)
Query: 41 QLKYISVFANRLSGNIPSH-LGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSN 98
K ++ + + +P+ L + + L+L + Q I ++ L + N
Sbjct: 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 103
Query: 99 RLIGNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS 157
I LP + LT + N+ + + +L L + + LE I
Sbjct: 104 A-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IED--D 159
Query: 158 ALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDL 215
L+ L N+ L + L + ++ + I + LD
Sbjct: 160 TFQATTSLQNLQLSS-NRLTHVD-LSLIPSLFHANVSYNLLS-TLAIPI----AVEELDA 212
Query: 216 SFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275
S N + V + ++ L L +NN T + P L
Sbjct: 213 SHNSIN------VVRGPV-NVEL----------TILKLQHNNLT----DTAWLLNYPGLV 251
Query: 276 -LNL 278
++L
Sbjct: 252 EVDL 255
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 34/215 (15%), Positives = 74/215 (34%), Gaps = 20/215 (9%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT 115
I S+L + ++ E L N + + ++ + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG--- 172
+ND + +L + + + +PP + L + L+
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPP--HVFQNVPLLTVLVLERNDL 129
Query: 173 ---PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVA 228
P F N LT + + N N+ I + + +L+ L LS N+LT +
Sbjct: 130 SSLPRGIF---HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 229 VPA----DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+P+ ++ + + + + LD S+N+
Sbjct: 185 IPSLFHANVSYNLLST-LAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/161 (17%), Positives = 61/161 (37%), Gaps = 11/161 (6%)
Query: 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDL 71
+ +E +D ++N ++ + +++L + + N L+ + L N L +DL
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGP-VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDL 255
Query: 72 EENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPD 130
N+ I + LE L +S+NR + L + + L ++ N+
Sbjct: 256 SYNELE-KIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171
+ +L L + + + + S L L +S
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 9/130 (6%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLGNITS 65
+ V + LE + + N L ++ + LK + + N L ++ +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L L L+ N T+ L L+ L LS N N L +N+ ++D + +
Sbjct: 320 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374
Query: 126 GSAPDFIQSW 135
++
Sbjct: 375 CKIDYQLEHG 384
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 498 EFQASSFTLKQIRAAT-SNFDPMNKIGEGGFGPVY----KGQLTDGTIIAVKLLSSKSRQ 552
E + + A S F+ + +G+G FG V+ + A+K+L K+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATL 65
Query: 553 GNREFLNEIGTIS------CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGEN 606
R + + T + HP +VKL+ +L L+ ++L GG+
Sbjct: 66 KVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR---------GGD- 112
Query: 607 SQLKLNWSVRQKICLG----------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656
L + +++ +A L LH I++RD+K N+LLD + +
Sbjct: 113 ----LFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHI 165
Query: 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
K++DFGL+K + + + GT+ YMAPE G+ T AD +SFGV+ E+++G
Sbjct: 166 KLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 63/245 (25%), Positives = 104/245 (42%), Gaps = 50/245 (20%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVY---KGQLTD-GTIIAVKLLS-----S 548
E + ++ T + NF+ + +G G +G V+ K D G + A+K+L
Sbjct: 38 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 549 KSRQ-----GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG 603
K++ R+ L I Q P LV L+ +L L+ +Y+ G
Sbjct: 98 KAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQTETKLHLILDYIN---------G 143
Query: 604 GENSQLKLNWSVRQKICLGIAR----------GLAFLHEESRFKIVHRDIKATNVLLDRD 653
GE L + Q+ L LH+ I++RDIK N+LLD +
Sbjct: 144 GE-----LFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSN 195
Query: 654 LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE---YALWGYLTYKADVYSFGVVALE 710
+ ++DFGL+K ++T + GTI YMAP+ G+ D +S GV+ E
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYE 254
Query: 711 IVSGK 715
+++G
Sbjct: 255 LLTGA 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSS-KSRQGNREFLNEIGTISCLQ-- 568
++ + K+G G + V++ +T+ + VK+L K ++ RE I L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 569 --HPNLVKLYGCCIEGDQ---LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
PN++ L ++ LV+E++ N L+ L + I
Sbjct: 88 RGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDF-KQLYQ------TLTDYDIRFYMYEI 139
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEEEKTHISTRVAG 680
+ L + H S I+HRD+K NV++D R L ++ D+GLA+ + + + RVA
Sbjct: 140 LKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NVRVA- 192
Query: 681 TIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
+ + PE + + Y D++S G + ++ K
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 49/225 (21%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---- 568
+FD + IG G + V +L I A+K++ +E +N+ I +Q
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKH 61
Query: 569 -------HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
HP LV L+ C +L V EY+ GG+ L + ++++ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVN---------GGD-----LMFHMQRQRKL 107
Query: 622 G----------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671
I+ L +LHE I++RD+K NVLLD + + K++D+G+ K
Sbjct: 108 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164
Query: 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
ST GT Y+APE Y + D ++ GV+ E+++G+
Sbjct: 165 DTTST-FCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 2e-17
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 43/222 (19%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISC------ 566
++F+ + +G+G FG V + + AVK+L K +++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQD---DDVECTMVEKRVLA 396
Query: 567 --LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG-- 622
+ P L +L+ C D+L V EY+ GG+ L + ++Q
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVN---------GGD-----LMYHIQQVGRFKEP 442
Query: 623 --------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674
IA GL FL I++RD+K NV+LD + + KI+DFG+ K + +
Sbjct: 443 HAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
Query: 675 STRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
T GT Y+APE + Y D ++FGV+ E+++G+
Sbjct: 500 KT-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 2e-17
Identities = 47/270 (17%), Positives = 82/270 (30%), Gaps = 62/270 (22%)
Query: 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLL--------SSKSRQGNREFLNEI-- 561
T KIGEG FG V++ D T +A+K++ + ++ E L EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 562 -------GTISCLQHPNLVKLYGCCI----EGDQLMLVYEYL--ENNSLAHALFGGENSQ 608
C + + L L+ +++ S ++ Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 609 L-------------------KLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649
L + + + I + LA + HRD+ NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 650 LDRDLNPKISDFGLAK--------LDEEEKTHISTRVA--GTIGYM---APEYALWGYLT 696
L + K+ K L + +R+ G + + E G
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254
Query: 697 YKADVYSFGVVALEIVSGKNNMSYVPDSNC 726
Y+ D+Y ++ + Y P SN
Sbjct: 255 YQFDIYRL----MKKENNNRWGEYHPYSNV 280
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 31/169 (18%), Positives = 58/169 (34%), Gaps = 19/169 (11%)
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+ SLTY+ L + + N++ L +++ N + L NL RI
Sbjct: 41 AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH-ATNYN-PISGLSNLERLRIM 96
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL------RISDLQGPN 174
+ + T L L+I S + I I+ L K+N + I+D+
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-- 154
Query: 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223
L+ + L + ++ + I L L + G+
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 22/105 (20%), Positives = 46/105 (43%), Gaps = 3/105 (2%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
L+ + + ++ + +L +TSLT LD+ + +I ++ L + ++ LS N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145
I ++ L L L I + + I+ + +LN+L
Sbjct: 149 ITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 27/171 (15%), Positives = 56/171 (32%), Gaps = 19/171 (11%)
Query: 89 NLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL 148
+ + ++ +LT + + N I+ + L I
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA 78
Query: 149 EGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIK 208
P IS L L +LRI + P L +T LT + + + I I +
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 209 NLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+ +DLS+N ++ + ++ +SL++ ++
Sbjct: 137 KVNSIDLSYNGAITDIMPLK-----TLPEL----------KSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 10 PPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTY 68
P + L L +D +++ SI + ++ ++ I + N +I L + L
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163
Query: 69 LDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
L+++ + + + L L S +
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 50/239 (20%)
Query: 502 SSFTLKQIRAATSNFDPMNKIGEGGFGPVY---KGQLTD-GTIIAVKLLS-----SKSRQ 552
+S + F+ + +G+GG+G V+ K + G I A+K+L ++
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 553 -----GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENS 607
R L E+ +HP +V L G +L L+ EYL GGE
Sbjct: 65 TAHTKAERNILEEV------KHPFIVDLIYAFQTGGKLYLILEYLS---------GGE-- 107
Query: 608 QLKLNWSVRQKICLGIAR----------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657
L + ++ L LH+ I++RD+K N++L+ + K
Sbjct: 108 ---LFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVK 161
Query: 658 ISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
++DFGL K + T T GTI YMAPE + G+ D +S G + ++++G
Sbjct: 162 LTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+A+G+ FL SR K +HRD+ A N+LL KI DFGLA+ ++ ++
Sbjct: 197 CYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 678 VAGT-IGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
A + +MAPE T ++DV+SFGV+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 34/216 (15%), Positives = 70/216 (32%), Gaps = 38/216 (17%)
Query: 520 NKIGEGGFGPVYKGQLTD------GTIIAVKLL-SSKSRQGNREFLNEIGTISCL-QHPN 571
+G G FG V + +AVK+L + +R ++E+ + + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 572 LVKLYGCCI-EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+V L G C G LM++ E+ + +L+ L S R + +G F
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGARFR 136
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
+ + D+K + + S + + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSG------------FVEEKSLSDVEEEEAPED 184
Query: 691 LWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNC 726
L+ + + + ++ G M ++ C
Sbjct: 185 LYKDFLTLEHLICY---SFQVAKG---MEFLASRKC 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 34/217 (15%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREF---LNEIGTISCLQH 569
++FD + +G+G FG V + G A+K+L + E + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR---- 625
P L L D+L V EY GGE L + + ++ R
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYAN---------GGE-----LFFHLSRERVFTEERARFY 110
Query: 626 ------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
L +LH +V+RDIK N++LD+D + KI+DFGL K + + T
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FC 166
Query: 680 GTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
GT Y+APE Y D + GVV E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 3e-17
Identities = 57/262 (21%), Positives = 89/262 (33%), Gaps = 47/262 (17%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSH-LGNI 63
LPP + N+P L + N L S+PR + +L +S+ N L I
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
TSL L L N+ + + L + +L +S N L L + + + N+
Sbjct: 171 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 222
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG------PNQTF 177
N L L++Q + L + L L DL F
Sbjct: 223 INVVRGPVNVE---LTILKLQHNNLT-----DTAWLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQ 237
M L R+ + N + + Y I L+ LDLS N L V +
Sbjct: 275 ---VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL------HVERNQPQFD 324
Query: 238 ILMFIRGVYEHQSLDLSYNNFT 259
L ++L L +N+
Sbjct: 325 RL---------ENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-17
Identities = 60/290 (20%), Positives = 107/290 (36%), Gaps = 42/290 (14%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSHLGNIT 64
LP + + +E ++ + I + ++ + + N + P N+
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 65 SLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDN 122
LT L LE N S ++PR + N L TL +S+N + + + +L + +++ N
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSN 181
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP--------- 173
I S N S L IP ++ LD + I+ ++GP
Sbjct: 182 RLTHVDLSLIPSLFHANVSYNLLSTL--AIPIAVEELD-ASHNSINVVRGPVNVELTILK 238
Query: 174 ---NQ--TFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDV 227
N L N GL + L + +I + + ++ L L +S N+L
Sbjct: 239 LQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV------ 291
Query: 228 AVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277
A+ + L + LDLS+N+ QP NL L+
Sbjct: 292 ALNLYGQPIPTL---------KVLDLSHNHLLHVERNQPQFDRLENLYLD 332
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 9e-14
Identities = 40/242 (16%), Positives = 82/242 (33%), Gaps = 28/242 (11%)
Query: 50 NRLSGNIPSHLGNIT--SLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPM 106
+ + ++ +IT + + + + +P L + +E L L+ + I +
Sbjct: 35 DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ-IEEIDT 92
Query: 107 E-LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165
+ + N P Q+ L L ++ + L +P I +L
Sbjct: 93 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGI--FHNTPKL 149
Query: 166 RISDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219
+ + TF + T L + L + + + + I +L ++S+N
Sbjct: 150 TTLSMSNNNLERIEDDTF---QATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 203
Query: 220 LTGELPDVAVPA-DLKFTQILMFIRGVYEH-QSLDLSYNNFTWQSPEQPACREKPNLN-L 276
L+ +AV D I + V L L +NN T + P L +
Sbjct: 204 LSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT----DTAWLLNYPGLVEV 259
Query: 277 NL 278
+L
Sbjct: 260 DL 261
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 37/222 (16%), Positives = 68/222 (30%), Gaps = 32/222 (14%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFAN----RLSGNIPSHLGN 62
+ L+ + + N L + +S+ + +S N+ S L
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVD----------LSLIPSLFHANVSYNLLSTLAI 209
Query: 63 ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
++ LD N + + + V L L+L N L + L+ L + ++ N
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYN 264
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPM- 179
+L RL I + L + + L L +S N
Sbjct: 265 ELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH----NHLLHVERN 319
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
L + L + +I + L+ L LS N
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 37/216 (17%), Positives = 75/216 (34%), Gaps = 22/216 (10%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNL 114
I S+L + ++ E L N + + ++ + LP L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQV 77
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG-- 172
+ND + +L + + + +PP + L + L+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPP--HVFQNVPLLTVLVLERND 134
Query: 173 ----PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDV 227
P F N LT + + N N+ I + +L+ L LS N+LT +
Sbjct: 135 LSSLPRGIF---HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS 189
Query: 228 AVPA----DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+P+ ++ + L + + LD S+N+
Sbjct: 190 LIPSLFHANVSYNL-LSTLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 9/130 (6%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITS 65
+ V + LE + + N L ++ + LK + + N L ++ +
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
Query: 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125
L L L+ N T+ L L+ L LS N N L +N+ ++D + +
Sbjct: 326 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 380
Query: 126 GSAPDFIQSW 135
++
Sbjct: 381 CKIDYQLEHG 390
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 49/225 (21%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---- 568
+FD + IG G + V +L I A++++ +E +N+ I +Q
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKH 104
Query: 569 -------HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
HP LV L+ C +L V EY+ GG+ L + ++++ L
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVN---------GGD-----LMFHMQRQRKL 150
Query: 622 G----------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671
I+ L +LHE I++RD+K NVLLD + + K++D+G+ K
Sbjct: 151 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207
Query: 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
ST GT Y+APE Y + D ++ GV+ E+++G+
Sbjct: 208 DTTST-FCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNRE 556
+F T Q A FD + +G G FG V + + G A+K+L + ++
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 557 F---LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613
LNE + + P LVKL + L +V EY+ GGE +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA---------GGE-----MFS 130
Query: 614 SVRQKICLG----------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663
+R+ I +LH +++RD+K N+L+D+ +++DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSG 714
AK + +T T + GT +APE L GY D ++ GV+ E+ +G
Sbjct: 188 AKRV-KGRTW--T-LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAG 234
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 26/237 (10%)
Query: 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLI 101
+ + + NR+ + L L+L EN S P NL NL TL L SNR +
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR-L 92
Query: 102 GNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
+P+ L NLT I++N Q L LE+ + L I A
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-ISH--RAFS 149
Query: 161 KLNQLRISDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFL 213
LN L L+ P + ++ GL + LR+ NI I +Y + + L+ L
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEAL---SHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVL 205
Query: 214 DLSFNQLTGELPDVAVPA------DLKFTQILMFIRGVYEH----QSLDLSYNNFTW 260
++S + + + + H + L+LSYN +
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 55/324 (16%), Positives = 99/324 (30%), Gaps = 61/324 (18%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPREW-ASM-QLKYISVFANRLSGNIPSH-LGNI 63
L + +L L++++ N L I + + L+ +++ L+ +IP+ L ++
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHL 175
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
L L L + L L+ L +S + + + NLT I N
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
++ L L L+ IS + +
Sbjct: 236 LTAVPYLAVRHLVYLRFLN-------------------LSYNPISTI--EGSML---HEL 271
Query: 184 TGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
L I L +A + Y G+ LR L++S NQLT + +
Sbjct: 272 LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT------TLEESV--------F 316
Query: 243 RGVYEHQSLDLSYNNFT------W---------QSPEQPACREKPNLNLNLFRSSSVENN 287
V ++L L N W + +QP C + F+
Sbjct: 317 HSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLL 376
Query: 288 FGVFPCTNNFTCHRYWHSLHINCG 311
F C R + ++ G
Sbjct: 377 PNYFTCRRARIRDRKAQQVFVDEG 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 45/276 (16%), Positives = 93/276 (33%), Gaps = 36/276 (13%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ---------LKYISVFANRLSGNIPS 58
L I+ L +E D N L P E + ++ + + L ++ +
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL---IGNLPMELVKLKNLT 115
+ + + +E ++ +L +LE L LS N + +L
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 116 DFRINDNNFN--GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173
++ N+ + + + L L+I + P+P S +K+ L +S
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS---- 419
Query: 174 NQ--TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA 231
L + + N N+ + L+ L +S N+L LPD ++
Sbjct: 420 TGIRVVKT-CIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFP 473
Query: 232 -----DLKFTQILMFIRGVYEH----QSLDLSYNNF 258
+ Q+ G+++ Q + L N +
Sbjct: 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-17
Identities = 39/295 (13%), Positives = 101/295 (34%), Gaps = 38/295 (12%)
Query: 8 TLPPQ-IVNLPYLETVDFAYNYLHG-SIPREWASM-QLKYISVFANRLSGNIPSH-LGNI 63
+L L L+ ++ N + + ++ L+ + + I +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
TSL L+++ + L ++ ++ L L + L + L ++ + D N
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 124 ---FNGSAPDFIQSWTQLNRLEIQGSGLE----GPIPPSISALDKLNQLRISDLQG---- 172
F S + + + +L +GS L + + + +L+++ D
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 173 --PNQTFPMLRNMTGLTRIILRNCNIAG----EIPEYIW-GIKNLRFLDLSFNQLTGELP 225
++ + + + +R +I ++ ++ ++ + + +++ +P
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVP 326
Query: 226 DVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREK-PNLN-LNL 278
+ + LDLS N + + AC+ P+L L L
Sbjct: 327 CSF------SQHLKSL-------EFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 38/215 (17%), Positives = 78/215 (36%), Gaps = 12/215 (5%)
Query: 14 VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEE 73
++ D SIP + +K + + N+++ L +L L L+
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 74 NQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNG-SAPD 130
++ + TI + +L +LE L LS N L +L L +L + N +
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 131 FIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN-QTFP--MLRNMTGLT 187
+ T L L I I L L +++ + + + L+++ +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRR--IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175
Query: 188 RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
+ L A + + + ++R+L+L L
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 41/274 (14%), Positives = 90/274 (32%), Gaps = 32/274 (11%)
Query: 15 NLPYLETVDFAYNYL----HGSIPREWASMQLKYISVFANRLS----GNIPSHLGNITSL 66
L + ++ L +P + S +K ++ + L+ + L I L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 67 TYLDLEENQFSG---------TIPRELGNL--VNLETLRLSSNRLIGNLPMELVKLKNLT 115
+ ++ ++ +G + ELG + V + L + L +L L+ +
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175
+ ++ F Q L L++ + + + + L+ L N
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ-NH 372
Query: 176 ------TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAV 229
T +L + LT + + +P+ + +RFL+LS + +
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP 430
Query: 230 PA----DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
D+ + F + Q L +S N
Sbjct: 431 QTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 37/297 (12%), Positives = 84/297 (28%), Gaps = 43/297 (14%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEE 73
++ + + + + + ++Y+ + L+ S L + +
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 74 NQFS-------GTIPRELGNLVNLETLRLSSNRL--IGNLPMEL---------VKLKNLT 115
+ S + + L ++ L + L +G+ V+ +
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL-----RISDL 170
I ++ R+ ++ S + L L L + +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 171 QGPNQTFPMLRNMTGLTRIILRNCNIA--GEIPEYIWGIKNLRFLDLSFNQLTGELPDVA 228
N L ++L ++ + E + +KNL LD+S N
Sbjct: 350 YLKNSAC--KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQ 407
Query: 229 VPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVE 285
P ++F L+LS P E +++ N S S+
Sbjct: 408 WPEKMRF---------------LNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF 449
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 21/159 (13%), Positives = 44/159 (27%), Gaps = 46/159 (28%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNIT--- 64
+P + ++ + + + L+ + V N L + L +
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ-TLEVLDVSNNNLD-SFSLFLPRLQELY 457
Query: 65 ----------------SLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPME 107
L + + NQ ++P L +L+ + L +N + P
Sbjct: 458 ISRNKLKTLPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516
Query: 108 LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146
D++ W N + QGS
Sbjct: 517 ----------------------DYLSRWLNKNSQKEQGS 533
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 45/258 (17%), Positives = 87/258 (33%), Gaps = 42/258 (16%)
Query: 15 NLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
NL L T+ N + I ++L+ + + N+L +P + +L L +
Sbjct: 74 NLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH 129
Query: 73 ENQFSGTIPRE-LGNLVNLETLRLSSNRL-IGNLPME-LVKLKNLTDFRINDNNFNGSAP 129
EN+ + + + L + + L +N L + +K L+ RI D N
Sbjct: 130 ENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 188
Query: 130 DFIQSWTQL----NRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG------PNQTFPM 179
S T+L N++ + + +L LN L L N +
Sbjct: 189 GLPPSLTELHLDGNKITK--------VDAA--SLKGLNNLAKLGLSFNSISAVDNGSL-- 236
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239
N L + L N + ++P + K ++ + L N ++ + T
Sbjct: 237 -ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT--- 290
Query: 240 MFIRGVYEHQSLDLSYNN 257
+ + L N
Sbjct: 291 ----KKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 36/250 (14%)
Query: 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFS 77
+L V + L +P++ + + N+++ N+ +L L L N+ S
Sbjct: 32 HLRVVQCSDLGLE-KVPKD-LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQ 137
P LV LE L LS N+L LP ++ K L + R+++N Q
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 138 LNRLEIQGSGL-EGPIPPSISALDKLNQLRISDLQG------PNQTFPMLRNMTGLTRII 190
+ +E+ + L I A + +L + P P LT +
Sbjct: 147 MIVVELGTNPLKSSGIENG--AFQGMKKLSYIRIADTNITTIPQGLPP------SLTELH 198
Query: 191 LRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQ 249
L I ++ G+ NL L LSFN ++ + + + + +
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGS-------------LANTPHLR 243
Query: 250 SLDLSYNNFT 259
L L+ N
Sbjct: 244 ELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 43/254 (16%), Positives = 83/254 (32%), Gaps = 34/254 (13%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSH-LGNITSLTYLDLEE 73
L LE + + N L +P + L+ + V N ++ + + + ++L
Sbjct: 98 PLVKLERLYLSKNQLK-ELPEK-MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGT 154
Query: 74 NQF-SGTIPRE-LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF 131
N S I + L +R++ I +P L +LT+ ++ N
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGL--PPSLTELHLDGNKITKVDAAS 211
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFP-MLRNMTGLTR 188
++ L +L + + + + +L LR L N+ P L + +
Sbjct: 212 LKGLNNLAKLGLSFNSISA-VDNG--SLANTPHLRELHLNN-NKLVKVPGGLADHKYIQV 267
Query: 189 IILRNCNI------AGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI 242
+ L N NI P Y + + L N + + F
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ----YWEIQPS-------TF- 315
Query: 243 RGVYEHQSLDLSYN 256
R VY ++ L
Sbjct: 316 RCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 12/95 (12%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPS-------HLGNITSL 66
N P+L + N L +P A ++ + + N +S I S + S
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 67 TYLDLEENQFSGT-IPREL-GNLVNLETLRLSSNR 99
+ + L N I + ++L + +
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 9e-17
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 37/216 (17%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREF---LNEIGTISCLQH 569
+F + +G G FG V+ + G A+K+L + ++ +E +S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG------- 622
P +++++G + Q+ ++ +Y+E GGE L +R+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIE---------GGE-----LFSLLRKSQRFPNPVAKFY 111
Query: 623 ---IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ L +LH I++RD+K N+LLD++ + KI+DFG AK + T+ T +
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY--T-LC 164
Query: 680 GTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSG 714
GT Y+APE Y D +SFG++ E+++G
Sbjct: 165 GTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAG 199
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTIS------- 565
S+F + IG+G FG V + AVK+L K+ +E + +S
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH---IMSERNVLLK 94
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG--- 622
++HP LV L+ D+L V +Y+ GGE L + ++++ C
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYIN---------GGE-----LFYHLQRERCFLEPR 140
Query: 623 -------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS 675
IA L +LH IV+RD+K N+LLD + ++DFGL K + E + S
Sbjct: 141 ARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 676 TRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
T GT Y+APE Y D + G V E++ G
Sbjct: 198 T-FCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 45/223 (20%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---------SRQGNREFLNEIGT 563
NF+ + +G+G FG V ++ + G + AVK+L + L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 81
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
HP L +L+ C D+L V E++ GG+ L + +++
Sbjct: 82 ----NHPFLTQLFCCFQTPDRLFFVMEFVN---------GGD-----LMFHIQKSRRFDE 123
Query: 624 AR----------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673
AR L FLH+ I++RD+K NVLLD + + K++DFG+ K
Sbjct: 124 ARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 674 ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
+T GT Y+APE Y D ++ GV+ E++ G
Sbjct: 181 TAT-FCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 55/247 (22%), Positives = 88/247 (35%), Gaps = 57/247 (23%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
+ + +G G FG V + + G A+K + R NRE + + L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 572 LVKLYGCCIEGDQ--------------------------------------LMLVYEYLE 593
++KL L ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653
+ L L S + ++ + R + F+H I HRDIK N+L++
Sbjct: 122 DT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 654 LNP-KISDFGLAKLDEEEKTHIS---TRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVA 708
N K+ DFG AK + ++ +R Y APE L T D++S G V
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 709 LEIVSGK 715
E++ GK
Sbjct: 233 GELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 45/223 (20%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLS---------SKSRQGNREFLNEIGT 563
++F+ + +G+G FG V + + AVK+L + + L G
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 564 ISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG- 622
+ P L +L+ C D+L V EY+ GG+ L + ++Q
Sbjct: 79 ----KPPFLTQLHSCFQTMDRLYFVMEYVN---------GGD-----LMYHIQQVGRFKE 120
Query: 623 ---------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673
IA GL FL I++RD+K NV+LD + + KI+DFG+ K + +
Sbjct: 121 PHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 674 ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGK 715
T GT Y+APE + Y D ++FGV+ E+++G+
Sbjct: 178 TKT-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/265 (23%), Positives = 94/265 (35%), Gaps = 44/265 (16%)
Query: 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFS 77
+L V + L ++P+E S + + N +S + L L L N+ S
Sbjct: 34 HLRVVQCSDLGLK-AVPKE-ISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQ 137
+ L L+ L +S N L+ +P L +L + RI+DN
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 138 LNRLEIQGSGL-EGPIPPSISALDKLNQLRISDLQG---PNQTFPMLR------------ 181
+N +E+ G+ L P KLN LRIS+ + P L
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAI 208
Query: 182 ------NMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVPADLK 234
+ L R+ L + I I + LR L L N+L+ VPA L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS------RVPAGLP 261
Query: 235 FTQILMFIRGVYEHQSLDLSYNNFT 259
++L Q + L NN T
Sbjct: 262 DLKLL---------QVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 38/219 (17%), Positives = 81/219 (36%), Gaps = 23/219 (10%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSH-LGNITSLTYLDLEE 73
L L+ + + N+L IP L + + NR+ +P + ++ +++
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPN-LPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGG 156
Query: 74 NQF-SGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFI 132
N + + + L LR+S +L +P +L + L + ++ N + +
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDL 213
Query: 133 QSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFP-MLRNMTGLTRI 189
+++L RL + + + I +L L LR L N+ P L ++ L +
Sbjct: 214 LRYSKLYRLGLGHNQIRM-IENG--SLSFLPTLRELHLDN-NKLSRVPAGLPDLKLLQVV 269
Query: 190 ILRNCNIAGEIPE-------YIWGIKNLRFLDLSFNQLT 221
L NI ++ + + L N +
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 35/218 (16%), Positives = 68/218 (31%), Gaps = 44/218 (20%)
Query: 15 NLPYLETVDFAYNYLHGSI--PREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
L + ++ N L S P + ++L Y+ + +L+ IP L +L L L+
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLD 201
Query: 73 ENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDF 131
N+ I E L L L L N++ I + + +
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR----------------MIENGSLSF----- 239
Query: 132 IQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL-----RISDLQGPNQTFPMLR---NM 183
L L + + L +P + L L + I+ + F +
Sbjct: 240 ---LPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKV--GVNDFCPVGFGVKR 293
Query: 184 TGLTRIILRNCNIA-GEIPEYIW-GIKNLRFLDLSFNQ 219
I L N + E+ + + + + +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 42/211 (19%), Positives = 86/211 (40%), Gaps = 19/211 (9%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
+L + T+ + +I L + + N+++ ++ L N+T +T L+L
Sbjct: 37 QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELS 93
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFI 132
N + + L +++TL L+S + I ++ L L NL ++ N +P +
Sbjct: 94 GNPLK-NVS-AIAGLQSIKTLDLTSTQ-ITDVT-PLAGLSNLQVLYLDLNQITNISP--L 147
Query: 133 QSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRII 190
T L L I + + ++ L L++L N+ L ++ L +
Sbjct: 148 AGLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADD-NKISDISPLASLPNLIEVH 201
Query: 191 LRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
L+N I+ P + NL + L+ +T
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 45/258 (17%), Positives = 91/258 (35%), Gaps = 35/258 (13%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
I+ + ++ + ++ +T L + TI + L NL L L N+
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ- 74
Query: 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160
I +L L L +T+ ++ N I + L++ + + ++ L
Sbjct: 75 ITDLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-----DVTPLA 126
Query: 161 KLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218
L+ L++ L NQ L +T L + + N ++ P + + L L N
Sbjct: 127 GLSNLQVLYLDL-NQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183
Query: 219 QLTGELPDVAVPA-----DLKFTQI--LMFIRGVYEHQSLDLSYNNFTWQSPEQPACREK 271
+++ ++ +A LK QI + + + L+ T +
Sbjct: 184 KIS-DISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT---------NQP 233
Query: 272 PNLNLNLFRSSSVENNFG 289
N NL + V+ G
Sbjct: 234 VFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 24/140 (17%), Positives = 48/140 (34%), Gaps = 14/140 (10%)
Query: 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEI 143
L N + + + + L +T +Q L LE+
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 144 QGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILRNCNIAGEIP 201
+ + + ++ L L ++ +L G N + + + + L + I P
Sbjct: 71 KDNQIT-----DLAPLKNLTKITELELSG-NPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 202 EYIWGIKNLRFLDLSFNQLT 221
+ G+ NL+ L L NQ+T
Sbjct: 125 --LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 5/111 (4%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
+ L L+ + + P S +L + N++S +I L ++ +L + L+
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTPLANLS-KLTTLKADDNKIS-DISP-LASLPNLIEVHLK 203
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123
NQ S P L N NL + L++ + L +
Sbjct: 204 NNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGA 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISC------ 566
+F +G+G FG V+ + A+K L K +++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMD---DDVECTMVEKRVLS 72
Query: 567 --LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
+HP L ++ + L V EYL GG+ L + ++ ++
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGD-----LMYHIQSCHKFDLS 118
Query: 625 R----------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674
R GL FLH IV+RD+K N+LLD+D + KI+DFG+ K +
Sbjct: 119 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 675 STRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSG 714
+T GT Y+APE L Y + D +SFGV+ E++ G
Sbjct: 176 NT-FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIG 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 26/220 (11%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVK--LLSSKSRQGNREFLN---------EI 561
S + I G +G V G ++G +A+K + + + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 562 GTISCLQHPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
++ HPN++ L + +L LV E + + LA + + ++ ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQRIVISPQHI 136
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
Q I GL LHE +VHRD+ N+LL + + I DF LA+ D + + +
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTH 192
Query: 677 RVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
V Y APE + + T D++S G V E+ + K
Sbjct: 193 YVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 42/262 (16%), Positives = 94/262 (35%), Gaps = 38/262 (14%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWAS--MQLKYISVFANRLSGNIPSHL-GNITSLTYLDL 71
L+ + N ++ +I + S L+++ + N LS N+ S ++SLT+L+L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 72 EENQFSGTIPRE--LGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSA 128
N + T+ +L L+ LR+ + + + L L + I+ ++
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 129 PDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG-----------PNQTF 177
P ++S ++ L + + +D + + +L+
Sbjct: 191 PKSLKSIQNVSHLILHMKQHIL-LLEI--FVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQ 237
L + + + ++ ++ + + I L L+ S NQL +PD
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIF-------- 297
Query: 238 ILMFIRGVYEHQSLDLSYNNFT 259
+ Q + L N +
Sbjct: 298 -----DRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 41/243 (16%), Positives = 85/243 (34%), Gaps = 33/243 (13%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKN 113
+IPS L ++ LDL N+ + +L VNL+ L L+SN I + + L +
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGS 101
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG- 172
L ++ N + + + + + L L + G+ + + + S L +L+I +
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGET-SLFSHLTKLQILRVGNM 159
Query: 173 ------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLTGELP 225
+ F +T L + + ++ I+N+ L L Q L
Sbjct: 160 DTFTKIQRKDF---AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 226 DVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW-QSPEQPACREKPNLNLNLFRSSSV 284
++ + + L+L + E + FR+ +
Sbjct: 215 EIF-------------VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 285 ENN 287
+
Sbjct: 262 TDE 264
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 33/175 (18%), Positives = 59/175 (33%), Gaps = 15/175 (8%)
Query: 8 TLPPQIV--NLPYLETVDFAYNYLHGSIPREW-ASM-QLKYISVFANRLSGNIPSHLGNI 63
TL + +L L+ + I R+ A + L+ + + A+ L P L +I
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197
Query: 64 TSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMELV-----KLKNLTDF 117
++++L L Q + ++E L L L EL L F
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
Query: 118 RINDNNFNG--SAPDFIQSWTQLNRLEIQGSGLEGPIPPSI-SALDKLNQLRISD 169
R + + L LE + L+ +P I L L ++ +
Sbjct: 257 RNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHT 310
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLN---------EIG 562
+ + IG G G V +A+K LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 563 TISCLQHPNLVKLY------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
+ C+ H N++ L E + +V E ++ N L + Q++L+
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERM 129
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
+ + G+ LH I+HRD+K +N+++ D KI DFGLA+ + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMT 184
Query: 677 RVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
T Y APE L GY D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGG 223
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 44/245 (17%), Positives = 83/245 (33%), Gaps = 25/245 (10%)
Query: 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG 78
V L +P + +Y+++ N + ++ L L L N
Sbjct: 56 FSKVVCTRRGLS-EVP-QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR- 112
Query: 79 TIPRE-LGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSWT 136
I L +L TL L N + +P L L + + +N
Sbjct: 113 QIEVGAFNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171
Query: 137 QLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN-QTFPMLRNMTGLTRIILRNCN 195
L RL++ I A + L L+ +L N + P L + GL + + +
Sbjct: 172 SLMRLDLGELKKLEYISE--GAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNH 229
Query: 196 IAGEIPEY-IWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254
EI G+ +L+ L + +Q++ + + G+ L+L+
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQVS------LIERNA--------FDGLASLVELNLA 274
Query: 255 YNNFT 259
+NN +
Sbjct: 275 HNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 20/107 (18%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNR 99
LKY+++ + ++P +L + L L++ N F I L +L+ L + +++
Sbjct: 197 NLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQ 253
Query: 100 LIGNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145
+ + L +L + + NN + D L L +
Sbjct: 254 -VSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 7/92 (7%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREW-ASM-QLKYISVFANRLSGNIPSH-LGNITSLT 67
P + L LE ++ + N+ I + LK + V +++S I + + SL
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLV 269
Query: 68 YLDLEENQFSGTIPRE-LGNLVNLETLRLSSN 98
L+L N S ++P + L L L L N
Sbjct: 270 ELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 41/198 (20%), Positives = 68/198 (34%), Gaps = 16/198 (8%)
Query: 32 SIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91
++P + I + NR+S + +LT L L N + L LE
Sbjct: 25 AVPVG-IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 92 TLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG 150
L LS N + ++ L L ++ P + L L +Q + L+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 151 PIPPSISALDKLNQLRISDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI 204
+P L L L G P + F R + L R++L +A + +
Sbjct: 144 -LPD--DTFRDLGNLTHLFLHGNRISSVPERAF---RGLHSLDRLLLHQNRVA-HVHPHA 196
Query: 205 -WGIKNLRFLDLSFNQLT 221
+ L L L N L+
Sbjct: 197 FRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/207 (15%), Positives = 55/207 (26%), Gaps = 67/207 (32%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNL 114
+P + + + L N+ S NL L L SN + + L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALL 82
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174
++DN ++ +
Sbjct: 83 EQLDLSDNA------------------------------------------QLRSV--DP 98
Query: 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVPADL 233
TF + L + L C + E+ + G+ L++L L N L LPD
Sbjct: 99 ATF---HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT----F 149
Query: 234 KFTQILMFIRGVYEHQSLDLSYNNFTW 260
+ L L L N +
Sbjct: 150 RDLGNL---------THLFLHGNRISS 167
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 38/263 (14%), Positives = 77/263 (29%), Gaps = 58/263 (22%)
Query: 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVF--ANRLSGNIPSHLGNI-----T 64
+++ + L+ + + G+ P +++ N + L +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME----LVKLKNLTDFRIN 120
L L + + ++ L TL LS N +G + +K L +
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS--DLQG--PNQT 176
+ G +A +L L +S L+ +
Sbjct: 210 NAGME---------------------TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT 236
L + L + ++P+ + L LDLS+N+L P+ +
Sbjct: 249 CDWPSQ---LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR------NPSPDELP 296
Query: 237 QILMFIRGVYEHQSLDLSYNNFT 259
Q+ +L L N F
Sbjct: 297 QV----------GNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 47/243 (19%), Positives = 81/243 (33%), Gaps = 45/243 (18%)
Query: 60 LGNITSLTYLDLEENQFSGTIP-RELGNLVNLETLRLSSNRLIGNLPMELVKLKN---LT 115
G SL YL + + ++ ++L+ L + + R+ + +++ L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175
+ + + G+AP + T + L+ LN +S +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPD-------------------LNILNLRNVS-WATRDA 138
Query: 176 TFPMLRN--MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE--LPDVAVPA 231
L+ GL + + + E + L LDLS N GE L P
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 232 DLKFTQILMF-------IRGVYEH--------QSLDLSYNNFTWQSPEQPACREKPNL-N 275
Q+L GV Q LDLS+N+ + P+C L +
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR-DAAGAPSCDWPSQLNS 257
Query: 276 LNL 278
LNL
Sbjct: 258 LNL 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 28/159 (17%), Positives = 48/159 (30%), Gaps = 17/159 (10%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-----QLKYISVFANR---LS 53
+ Q+ P L T+D + N G A L+ +++ S
Sbjct: 161 SLNFS---CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 54 GNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMELVKLK 112
G + L LDL N L +L LS L +P L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PA 274
Query: 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP 151
L+ ++ N + + Q+ L ++G+
Sbjct: 275 KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLN---------EIG 562
+ +G G +G V G +A+K LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 563 TISCLQHPNLVKLY------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
+ +QH N++ L LV +++ + L + LK +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKI 128
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH-IS 675
Q + + +GL ++H +VHRD+K N+ ++ D KI DFGLA+ + E T +
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 676 TRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
TR Y APE L W + D++S G + E+++GK
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 38/222 (17%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR---QGNRE--FLNEIGTISCLQHP-- 570
+ K+G G F V+ + + + T +A+K++ E L + +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 571 ---NLVKLYGC----CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
+++KL G +++V+E L N LA + + ++I +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHRGIPLIYVKQISKQL 140
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP------KISDFGLAKLDEEEKT-HIST 676
GL ++H I+H DIK NVL++ +P KI+D G A +E T I T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 677 RVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGK 715
R Y +PE L WG AD++S + E+++G
Sbjct: 199 RE-----YRSPEVLLGAPWG---CGADIWSTACLIFELITGD 232
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 41/232 (17%), Positives = 83/232 (35%), Gaps = 30/232 (12%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSH- 59
L +P + L + N + + + L+ + + N + I
Sbjct: 55 LREVPDGISTNTRLL------NLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGA 107
Query: 60 LGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDF 117
+ +L L+L +N+ + TIP L L+ L L +N I ++P ++ +L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRL 165
Query: 118 RINDNNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG---- 172
+ + + + + L L + L I L L +L DL G
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-----EIPNLTPLIKLDELDLSGNHLS 220
Query: 173 --PNQTFPMLRNMTGLTRIILRNCNIAGEIPEY-IWGIKNLRFLDLSFNQLT 221
+F + + L ++ + I I +++L ++L+ N LT
Sbjct: 221 AIRPGSF---QGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 45/213 (21%), Positives = 70/213 (32%), Gaps = 46/213 (21%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-L 108
L +P + T+ L+L ENQ +L +LE L+LS N I + +
Sbjct: 53 KNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH-IRTIEIGAF 108
Query: 109 VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
L NL + DN ++L L L I
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYLSKLKEL-------------------WLRNNPIE 149
Query: 169 DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDV 227
+ P+ F + L R+ L I E G+ NLR+L+L+ L
Sbjct: 150 SI--PSYAF---NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR------ 198
Query: 228 AVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260
+P ++ LDLS N+ +
Sbjct: 199 EIPNLTPLIKL----------DELDLSGNHLSA 221
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 4/106 (3%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNR 99
L+Y+++ L IP +L + L LDL N S I L++L+ L + ++
Sbjct: 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ 242
Query: 100 LIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145
+ L++L + + NN D L R+ +
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 20/92 (21%), Positives = 42/92 (45%), Gaps = 7/92 (7%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREW-ASM-QLKYISVFANRLSGNIPSH-LGNITSLT 67
P + L L+ +D + N+L +I + L+ + + +++ I + N+ SL
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLV 258
Query: 68 YLDLEENQFSGTIPRE-LGNLVNLETLRLSSN 98
++L N + +P + L +LE + L N
Sbjct: 259 EINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLN---------EIG 562
+ + IG G G V +A+K LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 563 TISCLQHPNLVKLY------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR 616
+ C+ H N++ L E + LV E ++ N + Q++L+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV-----IQMELDHERM 166
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
+ + G+ LH S I+HRD+K +N+++ D KI DFGLA+ + T
Sbjct: 167 SYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMT 221
Query: 677 RVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
T Y APE L GY D++S G + E+V K
Sbjct: 222 PYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSS--KSRQGNREFLNEIGTISCLQH 569
+ + + +G G +G V G +A+K L +S + E+ + ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 570 PNLVKLY------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
N++ L + LV ++ + L + + KL Q + +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM----KHE-KLGEDRIQFLVYQM 137
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTI 682
+GL ++H I+HRD+K N+ ++ D KI DFGLA+ + E T ++ TR
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 683 GYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L W T D++S G + E+++GK
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 39/244 (15%), Positives = 81/244 (33%), Gaps = 23/244 (9%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPME- 107
N ++ + + L +L +E+ I L +L L+L N+ L
Sbjct: 40 NSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGA 98
Query: 108 LVKLKNLTDFRINDNNFNGSA--PDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165
L NL + N +G+ +F + T L L ++ + ++ I P+ S + +
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPA-SFFLNMRRF 156
Query: 166 RISDLQG------PNQTFPMLR-------NMTGLTRIILRNCNIAGEIPEYIWGIKNLRF 212
+ DL + + ++ +T + + E + ++
Sbjct: 157 HVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITT 216
Query: 213 LDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKP 272
LDLS N E + T+I I + + NF + P+ +
Sbjct: 217 LDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF--KDPDNFTFKGLE 273
Query: 273 NLNL 276
+
Sbjct: 274 ASGV 277
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 44/253 (17%), Positives = 78/253 (30%), Gaps = 26/253 (10%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRINDN 122
+ Y+DL N + L +L+ L++ + L +L +++ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG-------PNQ 175
F L L + L+G + + L L + L+ P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG-NFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIW---GIKNLRFLDLSFNQLTGELPDVAVPAD 232
F NM + L + I E K+ L LS L ++
Sbjct: 149 FF---LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ-DMN----EYW 199
Query: 233 LKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQ----PACREKPNLNLNLFRSSSVENNF 288
L + + + +LDLS N F ++ A + +L L+ +
Sbjct: 200 LGWEKCGNPFKNT-SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 289 GVFPCTNNFTCHR 301
F +NFT
Sbjct: 259 TNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/256 (14%), Positives = 79/256 (30%), Gaps = 43/256 (16%)
Query: 8 TLPPQIV--NLPYLETVDFAYNYLHGSIPREWASMQ-----------LKYISVFANRLSG 54
+ P N+ +D +N + + + Q + + L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV----- 109
+ TS+T LDL N F ++ + + + ++ N+
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 110 ----------KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159
+ + ++ + +T L +L + + + I + A
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDN--AF 319
Query: 160 DKLNQLRISDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WGIKNLRF 212
L L +L ++ F N+ L + L +I + + G+ NL+
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMF---ENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKE 375
Query: 213 LDLSFNQLTGELPDVA 228
L L NQL +PD
Sbjct: 376 LALDTNQLK-SVPDGI 390
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSH 59
+F+L ++ + LE + A N ++ I W L +++ N L +I S
Sbjct: 287 IFALLKSVF---SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSR 341
Query: 60 L-GNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPME-LVKLKNLTD 116
+ N+ L LDL N + + L NL+ L L +N+L ++P +L +L
Sbjct: 342 MFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK 399
Query: 117 FRINDNNFNGSAPD--FIQSWTQLNRLEIQGS 146
++ N ++ S P ++ W N + QGS
Sbjct: 400 IWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGS 431
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 56/188 (29%), Positives = 77/188 (40%), Gaps = 30/188 (15%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNL 572
NF KIG G FG + G+ L +A+KL KSR E L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA----RGLA 628
++Y G +V E L SL LF + L K L IA +
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSL------KTVLMIAIQLISRME 119
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPK-----ISDFGLAK--LDEEEKTHISTR---- 677
++H ++ +++RD+K N L+ R N I DF LAK +D E K HI R
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 678 VAGTIGYM 685
+ GT YM
Sbjct: 177 LTGTARYM 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSS--KSRQGNREFLNEIGTISCLQH 569
+ ++ +G G +G V T G +AVK LS +S + E+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 570 PNLVKLY------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
N++ L E + + LV + + L + + + + + + + Q I
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQ-----I 141
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTI 682
RGL ++H I+HRD+K +N+ ++ D KI DFGLA+ +E T +++TR
Sbjct: 142 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW---- 194
Query: 683 GYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L W + D++S G + E+++G+
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 31/160 (19%)
Query: 521 KIGEGGFGPVYKG-QLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC 579
+G G G V + A+K+L + RE E+ Q P++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 80
Query: 580 ----IEGDQLMLVYEYLENNSLAHALFGGE-----NSQLKLNWSVRQ--KICLGIARGLA 628
L++V E L+ GGE + ++ R+ +I I +
Sbjct: 81 ENLYAGRKCLLIVMECLD---------GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 629 FLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAK 665
+LH I HRD+K N+L + K++DFG AK
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN 571
S + + +G GG G V+ D +A+K + Q + L EI I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 572 LVKLY--------------GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
+VK++ G E + + +V EY+E + LA+ L G + + Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARLFMYQ 128
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL---DEEEKTH 673
+ RGL ++H + ++HRD+K N+ ++ DL KI DFGLA++ K H
Sbjct: 129 -----LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 674 ISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
+S + T Y +P L T D+++ G + E+++GK
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLS--SKSRQGNREFLNEIGTISCLQH 569
+ ++ IGEG +G V +A+K +S R L EI + +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 570 PNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
N++ + + + +V + +E + L L +Q L+ I
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLL----KTQ-HLSNDHICYFLYQIL 138
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHISTRVAGT 681
RGL ++H + ++HRD+K +N+LL+ + KI DFGLA++ D + ++ VA T
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-T 194
Query: 682 IGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L T D++S G + E++S +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 44/267 (16%), Positives = 90/267 (33%), Gaps = 38/267 (14%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
+ L ++ N + + ++QL ++ +N+L+ I + +T LTY D
Sbjct: 187 VSQNKLLNRLNCDTNNIT-KLDLN-QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCS 241
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFI 132
N + + + L L TL L+ + L L F+ +
Sbjct: 242 VNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--V 293
Query: 133 QSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRII 190
TQL L+ Q +G+ + +S KL L +++ + + + T L +
Sbjct: 294 THNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN----TELTELD-VSHNTKLKSLS 345
Query: 191 LRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI-------- 242
N +I + + I L + Q + L +
Sbjct: 346 CVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
Query: 243 -----RGVYEHQSLDLSYNNFTWQSPE 264
GVY+ + +++ N + +P
Sbjct: 404 IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 43/288 (14%), Positives = 82/288 (28%), Gaps = 55/288 (19%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
+ L T+D ++N + + L ++ N ++ + L LT
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELDVSQNK-LLNRLNCDTNNIT-KLD--LNQNIQLT 215
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
+LD N+ + I + L L S N L L + L LT
Sbjct: 216 FLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQT----- 264
Query: 128 APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLT 187
L + ++ +L + + + + T L
Sbjct: 265 ---------DLLEI-------------DLTHNTQLIYFQAEGCR--KIKELDVTHNTQLY 300
Query: 188 RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA----DLKFTQILMF-- 241
+ + I E+ + L +L L+ +LT EL I F
Sbjct: 301 LLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTKLKSLSCVNAHIQDFSS 356
Query: 242 IRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFG 289
+ + + + E N +L + S + + FG
Sbjct: 357 VGKIPALNNNFEAEGQTITMPKE-----TLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 46/251 (18%), Positives = 87/251 (34%), Gaps = 43/251 (17%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYL 69
I L L + N + ++ + L Y++ +N+L+ N+ + +T LTYL
Sbjct: 58 TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 70 DLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP 129
+ + N+ + + + L L + N L + + LT+ + N
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 130 DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ-TFPMLRNMTGLTR 188
+ TQL L+ + + +S LN+L N T L LT
Sbjct: 166 --VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDT----NNITKLDLNQNIQLTF 216
Query: 189 IILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEH 248
+ + + EI + + L + D S N LT EL +++
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS------TLSKL---------- 256
Query: 249 QSLDLSYNNFT 259
+L +
Sbjct: 257 TTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 34/180 (18%), Positives = 58/180 (32%), Gaps = 16/180 (8%)
Query: 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLI 101
A + + +LT LD + + + + L L L +SN I
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN-I 76
Query: 102 GNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161
L L + NLT + N + T+L L + L + S +
Sbjct: 77 TTLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLT-KLDVS-----Q 125
Query: 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
L + T + + T LT + ++ + L LD SFN++T
Sbjct: 126 NPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 28/178 (15%), Positives = 63/178 (35%), Gaps = 20/178 (11%)
Query: 89 NLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL 148
N + ++ + + +L LT ++++ + I+ T L +L + +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI 76
Query: 149 EGPIPPSISALDKLNQLRISDLQGPNQ-TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGI 207
+ +S L L N+ T + +T LT + + ++ +
Sbjct: 77 TT-LD--LSQNTNLTYLACDS----NKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 208 KNLRFLDLSFNQLTGELPDVAVPA----DLKFTQILMF--IRGVYEHQSLDLSYNNFT 259
L +L+ + N LT E+ D + + + + +LD S+N T
Sbjct: 127 PLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 49/334 (14%), Positives = 105/334 (31%), Gaps = 34/334 (10%)
Query: 58 SHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
+L++ + + L +++ + +++ I ++ + L N+T
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKL 70
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ-- 175
+N N P + + L L + + ++ +S+L L +L+ L+ N
Sbjct: 71 FLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEH-NGIS 122
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA---- 231
L ++ L + L N I + + L L L NQ++ ++ +A
Sbjct: 123 DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQN 179
Query: 232 -DLKFTQI--LMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNF 288
L I L + G+ L+L + N NL ++V+N
Sbjct: 180 LYLSKNHISDLRALAGLKNLDVLELFSQECLN---------KPINHQSNLVVPNTVKNTD 230
Query: 289 GVFPCTNNFTCHRYWHSLHINCGGGNVKVNDS-TFEGDAGVGGGAATYHLLDGTNWGISS 347
G + + ++ S F +G A +H
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVY 290
Query: 348 TGDFTDDDDEQNTNYIANSQSSGISELYNDARIS 381
T + D T A ++ + +
Sbjct: 291 TVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVF 324
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 40/287 (13%), Positives = 95/287 (33%), Gaps = 33/287 (11%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
L ++ + + + S+ + + + N+L+ +I L N+ +L +L L+EN
Sbjct: 41 ELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN 97
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
+ L +L L++L L N I ++ LV L L + +N + +
Sbjct: 98 KIKDLSS--LKDLKKLKSLSLEHNG-ISDIN-GLVHLPQLESLYLGNNKI--TDITVLSR 151
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILR 192
T+L+ L ++ + + I L L +L+ L N L + L + L
Sbjct: 152 LTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSK-NHISDLRALAGLKNLDVLELF 205
Query: 193 NCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLD 252
+ + + + + + L I +++ +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSL----------------VTPEIISDDGDYEKPN 249
Query: 253 LSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNNFTC 299
+ ++ + + + + R T ++
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDV 296
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 7/131 (5%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
+V+LP LE++ N + + +L +S+ N++S +I L +T L L L
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLT-KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 183
Query: 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFI 132
+N + R L L NL+ L L S + L + D + P+ I
Sbjct: 184 KNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEII 239
Query: 133 QSWTQLNRLEI 143
+ +
Sbjct: 240 SDDGDYEKPNV 250
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 30/230 (13%), Positives = 65/230 (28%), Gaps = 17/230 (7%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM------QLKYISVFANRLSGNIPSHLG 61
Q+V + + L G + L V ++
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
+++ + + + L S+N L + L L +
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 122 NNFN--GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG---PNQT 176
N + L +L+I + + L ++ +
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD--CSWTKSLLSLNMSSNILTDTI 415
Query: 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
F L + + L + I IP+ + ++ L+ L+++ NQL +PD
Sbjct: 416 FRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 34/264 (12%), Positives = 76/264 (28%), Gaps = 43/264 (16%)
Query: 1 MLFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHL 60
L L ++ L ++ +N + W + + Y S+ +L G +
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT-TVWYFSISNVKLQGQLDFRD 267
Query: 61 G-----NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT 115
++ +L+ + + F N+ + + + K+
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175
++N + + T+L L +Q + L+ + ++ L+ D+
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS---- 382
Query: 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKF 235
+N E K+L L++S N LT +
Sbjct: 383 ----------------QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-------CL 419
Query: 236 TQILMFIRGVYEHQSLDLSYNNFT 259
+ + LDL N
Sbjct: 420 PPRI---------KVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 41/271 (15%), Positives = 79/271 (29%), Gaps = 26/271 (9%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL--------- 100
N +S S + +++ L L + N+ LE L LS N+L
Sbjct: 31 NYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTV 90
Query: 101 -----------IGNLPM--ELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG 147
LP+ E + L ++ + S+ I L + G
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 148 LEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGI 207
P L N + + N+ F + +++ T L NI + +
Sbjct: 151 YGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 208 KNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPA 267
L N L + + + + ++ V+ S +N Q
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNI--ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 268 CREKPNLNLNLFRSSSVENNFGVFPCTNNFT 298
+ +L V ++ FP + +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 48/299 (16%), Positives = 98/299 (32%), Gaps = 32/299 (10%)
Query: 13 IVNLPYLETVDFAYNYLHGSIP----REWASMQLKYISVFANRLSGNIPSHLGNITSLTY 68
I +L + + +++ + L + + + + +L
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 69 LDLEENQFSGTIPRELGNLVNLET------LRLSSNRLIGNLPMELVKL---KNLTDFRI 119
+++ L L L+T L L++ N + +++L + F I
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 120 NDNNFNGSAP--DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG-PNQT 176
++ G DF S T L L I + P + + + I + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 177 FPML--RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLK 234
ML ++ + N + + E + L L L NQL EL +A +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTT-Q 372
Query: 235 FTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNL-NLNLFRSSSVENNFGVFP 292
+ Q LD+S N+ ++ + C +L +LN+ + + F P
Sbjct: 373 MKSL----------QQLDISQNSVSYDEKKG-DCSWTKSLLSLNMSSNILTDTIFRCLP 420
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 32/239 (13%), Positives = 69/239 (28%), Gaps = 22/239 (9%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNL 114
+P L T L++ +N S ++ +L L L +S NR I L + + L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQEL 71
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174
++ N + + L+ L P ++QL+ L
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDAL-----PICKEFGNMSQLKFLGLST-T 125
Query: 175 Q----TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVP 230
+ + ++ +++ + G+++ L T +
Sbjct: 126 HLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHF--- 180
Query: 231 ADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQP-ACREKPNLNLNLFRSSSVENNF 288
+ + + L N ++ NL L + N+F
Sbjct: 181 --ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQH----- 569
+ IG+G FG V K +A+K++ ++ R Q EI + L+
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 570 -PNLVKLYGC-------CIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKIC 620
N++ + C+ + L M +YE ++ N F G + + +K
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNK-----FQG------FSLPLVRKFA 206
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEK-THISTR 677
I + L LH + +I+H D+K N+LL + K+ DFG + + + T+I +R
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
Y APE L D++S G + E+++G
Sbjct: 264 F-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 28/180 (15%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNLVKLYGC 578
KIG G FG +Y G + G +A+KL K++ E +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA----RGLAFLHEES 634
EGD ++V E L SL LF + + L K L +A + ++H ++
Sbjct: 74 GAEGDYNVMVMELL-GPSLED-LFNFCSRKFSL------KTVLLLADQMISRIEYIHSKN 125
Query: 635 RFKIVHRDIKATNVLLDRDLNPK---ISDFGLAK--LDEEEKTHISTR----VAGTIGYM 685
+HRD+K N L+ I DFGLAK D HI R + GT Y
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 37/180 (20%), Positives = 56/180 (31%), Gaps = 12/180 (6%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMEL 108
N L + L LDL + TI +L +L TL L+ N + +L +
Sbjct: 38 NPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGA 95
Query: 109 -VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167
L +L + N I L L + + ++ P L L
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP--EYFSNLTNLEH 153
Query: 168 SDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
DL +L M L + + N I + L+ L L NQL
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 39/219 (17%), Positives = 68/219 (31%), Gaps = 44/219 (20%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKN 113
N+P S LDL N + L+ L LS I + L +
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSH 77
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173
L+ + N A + L +L + L + + L L+ ++
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LEN--FPIGHLKTLKELNVAH- 133
Query: 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT----------GE 223
N + ++PEY + NL LDLS N++ +
Sbjct: 134 NL----------IQSF---------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 224 LPDVAVPADLKFTQILMFIRGVYEH---QSLDLSYNNFT 259
+P + + DL + G ++ + L L N
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK 213
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNLVKLYGC 578
+IGEG FG +++G L + +A+K +S + +E T L + +Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA----RGLAFLHEES 634
EG +LV + L SL L + + K A + +HE+S
Sbjct: 75 GQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSV------KTVAMAAKQMLARVQSIHEKS 126
Query: 635 RFKIVHRDIKATNVLLDRDLNPK-----ISDFGLAK--LDEEEKTHISTR----VAGTIG 683
+V+RDIK N L+ R + + DFG+ K D K HI R ++GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 684 YM 685
YM
Sbjct: 184 YM 185
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/167 (23%), Positives = 76/167 (45%), Gaps = 30/167 (17%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLN---------EIG 562
++ + IG G +G V + + ++A+K + R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 563 TISCLQHPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
++ L H ++VK+ I + D+L +V E +++ LF + + L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-F-KKLF---RTPVYLTELHIK 159
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664
+ + G+ ++H I+HRD+K N L+++D + K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 14/208 (6%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
+ V+ L ++P + + + N L + L T LT L+L+
Sbjct: 8 KVASHLEVNCDKRNL-TALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
+ + + G L L TL LS N+L +LP+ L LT ++ N ++
Sbjct: 66 ELT-KLQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFP--MLRNMTGLTRII 190
+L L ++G+ L+ +PP L +L L N P +L + L ++
Sbjct: 123 LGELQELYLKGNELKT-LPPG--LLTPTPKLEKLSLAN-NNLTELPAGLLNGLENLDTLL 178
Query: 191 LRNCNIAGEIPEYIWGIKNLRFLDLSFN 218
L+ ++ IP+ +G L F L N
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 45/172 (26%), Positives = 66/172 (38%), Gaps = 19/172 (11%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNL 114
++P T L L EN L L L L L L L L
Sbjct: 28 DLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVL 79
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174
++ N S P Q+ L L++ + L +P AL L +L+ L+G N
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPL--GALRGLGELQELYLKG-N 134
Query: 175 Q--TFP--MLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLT 221
+ T P +L L ++ L N N+ E+P + G++NL L L N L
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR---QGNRE--FLNEIGTISCLQHPNL 572
+ IG+G FG V K + +A+K++ +K Q E L + +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 573 VKLYGC-------CIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
V L C+ + L +Y+ L N + F G ++ ++ +K +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN-----FRG------VSLNLTRKFAQQMC 167
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEK-THISTRVAGT 681
L FL I+H D+K N+LL KI DFG + + +I +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 682 IGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y +PE L Y D++S G + +E+ +G+
Sbjct: 224 --YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLN---------EIG 562
N+ + IG G +G VY + +A+K ++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 563 TISCLQHPNLVKLYGCCI-----EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
++ L+ +++LY I + D+L +V E +++ L LF + + L +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-L-KKLF---KTPIFLTEEHIK 132
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEEEKTHIST 676
I + G F+HE I+HRD+K N LL++D + K+ DFGLA ++ E+ T+I
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 677 RVAGTIGYMAPEYALWGYLT 696
+ L LT
Sbjct: 190 DLEENEEPGPHNKNLKKQLT 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLS--SKSRQGNREFLNEIGTISCLQH 569
+S+F + +GEG +G V G I+A+K + K R L EI + +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 570 PNLVKLY-----GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
N++ ++ +++ ++ E ++ + L + S + + + Q
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQYFIYQ-----TL 122
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG- 683
R + LH + ++HRD+K +N+L++ + + K+ DFGLA++ +E S G
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 684 --------YMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
Y APE L + DV+S G + E+ +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 37/209 (17%), Positives = 79/209 (37%), Gaps = 17/209 (8%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
L ++ + + + S+ + + + N+L+ +I L N+ +L +L L+EN
Sbjct: 44 ELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN 100
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
+ L +L L++L L N I ++ LV L L + +N + +
Sbjct: 101 KVKDLSS--LKDLKKLKSLSLEHNG-ISDIN-GLVHLPQLESLYLGNNKI--TDITVLSR 154
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILR 192
T+L+ L ++ + + I L L +L+ L N L + L + L
Sbjct: 155 LTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSK-NHISDLRALAGLKNLDVLELF 208
Query: 193 NCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
+ + + + + + L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 36/203 (17%), Positives = 73/203 (35%), Gaps = 36/203 (17%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+ ++ ++ + + S+ + + ++ + L N+ L L+ N+L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKL 80
Query: 101 -----IGNLPM---------------ELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNR 140
+ NL L LK L + N S + + QL
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLES 138
Query: 141 LEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILRNCNIAG 198
L + + + I+ L +L +L L+ NQ L +T L + L +I+
Sbjct: 139 LYLGNNKIT-----DITVLSRLTKLDTLSLED-NQISDIVPLAGLTKLQNLYLSKNHIS- 191
Query: 199 EIPEYIWGIKNLRFLDLSFNQLT 221
++ + G+KNL L+L +
Sbjct: 192 DL-RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 24/140 (17%), Positives = 49/140 (35%), Gaps = 14/140 (10%)
Query: 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEI 143
L + + +L ++ N+++ + IQ + +L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFL 75
Query: 144 QGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILRNCNIAGEIP 201
G+ L I L L L L N+ L+++ L + L + I+ +I
Sbjct: 76 NGNKLT-----DIKPLANLKNLGWLFLDE-NKVKDLSSLKDLKKLKSLSLEHNGIS-DI- 127
Query: 202 EYIWGIKNLRFLDLSFNQLT 221
+ + L L L N++T
Sbjct: 128 NGLVHLPQLESLYLGNNKIT 147
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGC 578
KIG G FG +Y G + +A+KL + K++ + + L E LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG---IARGLAFLHEESR 635
+EGD +LV + L SL LF + +L S++ + L I R + F+H +S
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL----SLKTVLMLADQMINR-VEFVHSKS- 123
Query: 636 FKIVHRDIKATNVLLDRDLNPK---ISDFGLAKL--DEEEKTHISTR----VAGTIGYM 685
+HRDIK N L+ I DFGLAK D HI R + GT Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 37/198 (18%), Positives = 69/198 (34%), Gaps = 44/198 (22%)
Query: 521 KIGEGGFGPVYKGQLTDGTII------AVKLLSSKSRQ-----------GNREFLNEIGT 563
IG+GGFG +Y + + VK+ S + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 564 ISCLQHPNLVKLYGCCIEGDQL----MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
L++ + K +G + ++ + + L ++ + K
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSR------KT 153
Query: 620 CLGIA----RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAK--LDEEEK 671
L ++ L ++HE VH DIKA+N+LL+ ++ D+GLA E
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 672 THISTR----VAGTIGYM 685
+ GTI +
Sbjct: 211 KAYAADPKRCHDGTIEFT 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 43/207 (20%), Positives = 70/207 (33%), Gaps = 30/207 (14%)
Query: 64 TSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRIND 121
S L L E TIP NL N+ + +S + + L L +T I +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 122 NNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG-------P 173
PD ++ L L I +GL+ + P ++ + + I ++ P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK--MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADL 233
F L N + L N + Y + L + L+ N+ + A
Sbjct: 148 VNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA----- 199
Query: 234 KFTQILMFIRGVYEH-QSLDLSYNNFT 259
F GVY LD+S + T
Sbjct: 200 -F-------GGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 37/199 (18%), Positives = 61/199 (30%), Gaps = 41/199 (20%)
Query: 41 QLKYISVFANRLSGNIPSHL-GNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSN 98
+ I V + + SH N++ +T++++ + I + L L L+ L + +
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISA 158
LK D + S LEI + IP +A
Sbjct: 116 G-----------LKMFPDLT------------KVYSTDIFFILEITDNPYMTSIPV--NA 150
Query: 159 LDKL-NQLRISDLQG------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWG--IKN 209
L N+ L F N T L + L I + +G
Sbjct: 151 FQGLCNETLTLKLYNNGFTSVQGYAF----NGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 210 LRFLDLSFNQLTGELPDVA 228
LD+S +T LP
Sbjct: 207 PSLLDVSQTSVT-ALPSKG 224
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 6e-11
Identities = 28/135 (20%), Positives = 55/135 (40%), Gaps = 6/135 (4%)
Query: 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDL 71
+ + D +L + + ++ + + L+ + HL + +T+LDL
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDL 470
Query: 72 EENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG-SAPD 130
N+ +P L L LE L+ S N + N+ + L L + + +N +A
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNA-LENVD-GVANLPRLQELLLCNNRLQQSAAIQ 527
Query: 131 FIQSWTQLNRLEIQG 145
+ S +L L +QG
Sbjct: 528 PLVSCPRLVLLNLQG 542
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 40/265 (15%), Positives = 70/265 (26%), Gaps = 31/265 (11%)
Query: 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFS 77
L + W + V L +L + S
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-S 361
Query: 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT---DFRINDNNFNGSAPDFIQS 134
+ EL + L+ L + + + + + L L + + P
Sbjct: 362 TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNC 194
L + + + + L L ++ L L + +T + L +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLH-LAHKDLTVL-------CHLEQLLLVTHLDLSHN 473
Query: 195 NIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254
+ +P + ++ L L S N L + VA L Q L L
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRL---------------QELLLC 516
Query: 255 YNNFTWQSPEQPACREKPNL-NLNL 278
N QS P L LNL
Sbjct: 517 NNRLQ-QSAAIQPLVSCPRLVLLNL 540
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 6e-04
Identities = 20/108 (18%), Positives = 32/108 (29%), Gaps = 27/108 (25%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
LPP + L LE + + N L+ + + N+ L
Sbjct: 477 ALPPALAALRCLEVLQASDN-------------ALENV------------DGVANLPRLQ 511
Query: 68 YLDLEENQFSG-TIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNL 114
L L N+ + L + L L L N L +L +
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 29/203 (14%), Positives = 61/203 (30%), Gaps = 52/203 (25%)
Query: 520 NKIGEGGFGPVYKGQ---------LTDGTIIAVKLLSSKS----------RQGNREFLNE 560
+ G +Y+ ++KL + R +N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 561 IGTISCLQHPNLVKLYGCCIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQK- 618
+ + G + D+ LV L G + Q L+ S +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-----------GRSLQSALDVSPKHVL 156
Query: 619 -----ICLG---IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAKLDE 668
+ + + L FLHE VH ++ A N+ +D + ++ + +G A
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 669 EEKTHISTR------VAGTIGYM 685
H++ G + ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 48/237 (20%), Positives = 82/237 (34%), Gaps = 64/237 (27%)
Query: 519 MNKIGEGGFGPVYKG--QLTDGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHP--- 570
+ +GEG FG V + + +A+K++ + + EI + ++
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKE 79
Query: 571 ---NLVKLYGC-------CIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
V + CI + L +E+L+ N+ F + +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN-----FQP------YPLPHVRHM 128
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-------------------KISD 660
+ L FLHE ++ H D+K N+L +++D
Sbjct: 129 AYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 661 FGLAKLDEEEK-THISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
FG A D E T ++TR Y PE L G+ DV+S G + E G
Sbjct: 186 FGSATFDHEHHTTIVATRH-----YRPPEVILELGW-AQPCDVWSIGCILFEYYRGF 236
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 30/172 (17%), Positives = 57/172 (33%), Gaps = 16/172 (9%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRE--LGNLVNLETLRLSSNRLIGNLPME-LVKLK 112
+P L + LDL N S + E L NL +L LS N + + E V +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVP 88
Query: 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172
NL ++ N+ + L L + + + + +A + + QL+ L
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDR--NAFEDMAQLQKLYLSQ 145
Query: 173 ------PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218
P + + L + L + + + + L +
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 29/128 (22%), Positives = 52/128 (40%), Gaps = 13/128 (10%)
Query: 8 TLPPQI-VNLPYLETVDFAYNYLHGSIPRE--WASMQLKYISVFANRLSGNIPSH-LGNI 63
+ + V +P L +D + N+LH ++ L+ + ++ N + + + ++
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135
Query: 64 TSLTYLDLEENQFSGTIPRE----LGNLVNLETLRLSSNRLIGNLPMELVKLKNLT--DF 117
L L L +NQ S P E L L L LSSN+L +L KL
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 118 RINDNNFN 125
+++N
Sbjct: 195 YLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 19/121 (15%)
Query: 152 IPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNL 210
+P + LD L+ +S L+ T +T L ++L + ++ I + + NL
Sbjct: 37 LPSYTALLD-LSHNNLSRLR-AEWTP---TRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 211 RFLDLSFNQLTGELPDVA---VPA----DLKFTQILMFIRGVYEH----QSLDLSYNNFT 259
R+LDLS N L L + + A L I++ R +E Q L LS N +
Sbjct: 91 RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 260 W 260
Sbjct: 150 R 150
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 40/205 (19%), Positives = 79/205 (38%), Gaps = 21/205 (10%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
L + + + ++ S ++ + + + ++ + + T+L L L N
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
Q S P L +L LE L ++ NRL + + L+ +++N D +
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL--RDTDSLIH 126
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ--TFPMLRNMTGLTRIILR 192
L L I+ + L+ SI L L++L + DL G N+ L + + I L
Sbjct: 127 LKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHG-NEITNTGGLTRLKKVNWIDLT 180
Query: 193 NCNIAGEIPEY---IWGIKNLRFLD 214
E +Y ++ ++ D
Sbjct: 181 GQKCVNEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 22/164 (13%), Positives = 55/164 (33%), Gaps = 35/164 (21%)
Query: 58 SHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
+ + +L + + + L ++ ++ I +L + NL +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSN-IQSLA-GMQFFTNLKEL 68
Query: 118 RINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF 177
++ N S ++ T+L L + + L+ +++ +
Sbjct: 69 HLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSAC-------------- 107
Query: 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
L+R+ L N + + + +KNL L + N+L
Sbjct: 108 --------LSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK 141
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 64/237 (27%)
Query: 519 MNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHP--- 570
++ +GEG FG V + G +AVK++ + R +EI + L
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPN 74
Query: 571 ---NLVKLYGC-------CIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
V++ CI + L + Y++++ N F +K+
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENG-----FLP------FRLDHIRKM 123
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-------------------KISD 660
I + + FLH K+ H D+K N+L + K+ D
Sbjct: 124 AYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 661 FGLA-KLDEEEKTHISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
FG A DE T +STR Y APE L G+ + DV+S G + +E G
Sbjct: 181 FGSATYDDEHHSTLVSTRH-----YRAPEVILALGW-SQPCDVWSIGCILIEYYLGF 231
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 37/210 (17%), Positives = 63/210 (30%), Gaps = 37/210 (17%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWAS--MQLKYISVF-ANRLSGNIPSH-LGNITSLTYLD 70
LE ++ + N + I + S +L I + AN L I N+ +L YL
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLL 110
Query: 71 LEENQFSGTIPREL-GNLVNLETLRLSSNRLI--------GNLPMELVKL---------- 111
+ +P + + L + N I L E V L
Sbjct: 111 ISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169
Query: 112 --------KNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163
+ ++NN D + L+I + + +P L+ L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS--YGLENLK 226
Query: 164 QLRISDLQGPNQTFPMLRNMTGLTRIILRN 193
+LR + P L + L L
Sbjct: 227 KLRARSTYN-LKKLPTLEKLVALMEASLTY 255
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 52/315 (16%), Positives = 94/315 (29%), Gaps = 68/315 (21%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME-LVKLKNL 114
IPS L + L + +LE + +S N ++ + + L L
Sbjct: 24 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 115 TDFRI-NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG- 172
+ RI NN P+ Q+ L L I +G++ +P Q + D+Q
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPD--VHKIHSLQKVLLDIQDN 138
Query: 173 ------PNQTFPMLR---------------------NMTGLTRIILRNCNIAGEIPEYI- 204
+F L N T L + L + N E+P +
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 205 WGIKNLRFLDLSFNQLTGELPDVAVPADLK---------FTQILMFIRGVYEHQSLDLSY 255
G LD+S ++ LP +LK ++ + L+Y
Sbjct: 199 HGASGPVILDISRTRIH-SLPS-YGLENLKKLRARSTYNLKKLPTL-EKLVALMEASLTY 255
Query: 256 N-------------NFTWQSPEQPACREKPNL--NLNLFRSSSVENNFGVFPCTNNFTCH 300
+ + R++ + RSS E+N + + T
Sbjct: 256 PSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYT 315
Query: 301 RY-----WHSLHINC 310
+ + + C
Sbjct: 316 EFDYDLCNEVVDVTC 330
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 68/241 (28%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQH----- 569
+ K+G+G FG V Q + + AVK++ + + E + +Q+
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINN 95
Query: 570 PNLVKLYGC-------CIEGDQL-MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
N+VK +G C+ + L +YE + N+ + G + + C+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNN-----YNG------FHIEDIKLYCI 144
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP------------------------- 656
I + L +L + + H D+K N+LLD
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 657 KISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSG 714
K+ DFG A + + I+TR Y APE L G+ +D++SFG V E+ +G
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255
Query: 715 K 715
Sbjct: 256 S 256
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 51/237 (21%), Positives = 93/237 (39%), Gaps = 50/237 (21%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGT------IS 565
++ + K+G+G +G V+K G ++AVK + F N I
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 566 CLQ----HPNLVKLYGCCI--EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
L H N+V L + LV++Y+E + L + + + V Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQYVVYQ-- 117
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVA 679
+ + + +LH S ++HRD+K +N+LL+ + + K++DFGL++ + +
Sbjct: 118 ---LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 680 GTIGYMAPEYALWGYLT-------YKA--------------DVYSFGVVALEIVSGK 715
LT Y+A D++S G + EI+ GK
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 54/260 (20%), Positives = 93/260 (35%), Gaps = 74/260 (28%)
Query: 519 MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----HPN- 571
+ K+G G F V+ + +A+K++ S L+EI + ++ PN
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNR 100
Query: 572 --LVKLYGC-CIEGDQLM---LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625
+V+L I G +V+E L ++ L + +++ L +KI + +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 626 GLAFLHEESRFKIVHRDIKATNVLL----------------------------------- 650
GL +LH + +I+H DIK N+LL
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 651 --------------DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYL 695
L KI+D G A + T I TR Y + E +
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGY 270
Query: 696 TYKADVYSFGVVALEIVSGK 715
AD++S +A E+ +G
Sbjct: 271 NTPADIWSTACMAFELATGD 290
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 46/175 (26%), Positives = 65/175 (37%), Gaps = 22/175 (12%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKN 113
NIP LDL+ N+ S + L L L L+ N+L LP + +LKN
Sbjct: 34 NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKN 86
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG- 172
L + DN L L + + L+ +PP D L +L L
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPP--RVFDSLTKLTYLSLGYN 143
Query: 173 -----PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW-GIKNLRFLDLSFNQLT 221
P F +T L + L N N +PE + + L+ L L NQL
Sbjct: 144 ELQSLPKGVF---DKLTSLKELRLYN-NQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 24/161 (14%)
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+ +S T+L+ +N F+ ++ + L L+TL L N L N + KN++
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETL 408
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180
D LN L + + + + L +S F L
Sbjct: 409 DV--------------SLNSLN------SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
+ + L N I IP+ + ++ L+ L+++ NQL
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 30/225 (13%), Positives = 62/225 (27%), Gaps = 42/225 (18%)
Query: 40 MQLKYISVFANRLSGNIPSHLGNIT-----SLTYLDLEENQFSGTIPRELGNLVNLETLR 94
++Y++++ ++ I + SL ++ F + +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 95 LSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPP 154
LS + + + T N F S + +L L +Q +GL+
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFK 394
Query: 155 SISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLD 214
++ L D+ N + +++ L+
Sbjct: 395 VALMTKNMSSLETLDVS--------------------LNSLNSHAYDRTCAWAESILVLN 434
Query: 215 LSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259
LS N LTG + + + LDL N
Sbjct: 435 LSSNMLTGSVFR-------CLPPKV---------KVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 33/262 (12%), Positives = 75/262 (28%), Gaps = 30/262 (11%)
Query: 27 NYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86
++ G + + + S ++ +L +L L + + + L
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 87 LV-----NLETLRLSSNRLIGNLP-----MELVKLKNLTDFRINDNNFNGSAP--DFIQS 134
+ L ++ + + + + I + +F S
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN-QTFPML--RNMTGLTRIIL 191
T L L I+ + + + ++ I L + M+ + + T +
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360
Query: 192 RNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVA-VPADLKFTQIL-----MFIRGV 245
+ + +K L+ L L N L VA + ++ + L
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 246 YEH--------QSLDLSYNNFT 259
Y+ L+LS N T
Sbjct: 420 YDRTCAWAESILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 38/251 (15%), Positives = 71/251 (28%), Gaps = 23/251 (9%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRINDN 122
L L +N S ++ L L LRLS NR+ +L + + ++L ++ N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHN 110
Query: 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ----TFP 178
+ L L++ + + +P L +L L +
Sbjct: 111 RL-QNISC--CPMASLRHLDLSFNDFDV-LPVC-KEFGNLTKLTFLGLSA-AKFRQLDLL 164
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQI 238
+ ++ ++ I N L L F+ + L V V +
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS--LFSVQVNMSVNALGH 222
Query: 239 LMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNNFT 298
L ++ N+ Q L +E + F
Sbjct: 223 LQLS---------NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 299 CHRYWHSLHIN 309
R L+I
Sbjct: 274 WPRPVEYLNIY 284
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 27/136 (19%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 15 NLPYLETVDFAYNYLHGSIPR---EWASMQ-LKYISVFANRLSGNIPSHL-GNITSLTYL 69
L L+T+ N L + + +M L+ + V N L+ + S+ L
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 70 DLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP 129
+L N +G++ R L ++ L L +NR+ ++P ++ L+ L + + N
Sbjct: 434 NLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPD 490
Query: 130 DFIQSWTQLNRLEIQG 145
T L + +
Sbjct: 491 GVFDRLTSLQYIWLHD 506
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 36/195 (18%), Positives = 61/195 (31%), Gaps = 41/195 (21%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQ--------------GNREFLNEIGTIS 565
KIG GGFG +Y A ++ + ++ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 566 CLQHPNLVKLYGC----CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
L + + YG +V E L L + + L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-IS---GQNGTF--KKSTVLQL 156
Query: 622 G---IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAK--LDEEEKTHI 674
G + L ++HE VH DIKA N+LL ++ +D+GL+
Sbjct: 157 GIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 675 STRVA----GTIGYM 685
GTI +
Sbjct: 213 QENPRKGHNGTIEFT 227
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSNRLIGNLPME- 107
+ + HL +LT L +E Q + L L L L + + + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDA 75
Query: 108 LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL 148
L+ ++ N + +Q + L L + G+ L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 14/87 (16%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 41 QLKYISVFANRLSGNIPSH-LGNITSLTYLDLEENQFSGTIPRE-LGNLVNLETLRLSSN 98
L + + + ++ L + L L + ++ + + L L LS N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90
Query: 99 RLIGNLPMELVKLKNLTDFRINDNNFN 125
L +L + V+ +L + ++ N +
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 13/75 (17%), Positives = 24/75 (32%), Gaps = 9/75 (12%)
Query: 152 IPPSISALDKLNQLRISDLQG----PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYI-WG 206
+ + L +L I + Q + R + L + + + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDL---RGLGELRNLTIVKSGLR-FVAPDAFHF 78
Query: 207 IKNLRFLDLSFNQLT 221
L L+LSFN L
Sbjct: 79 TPRLSRLNLSFNALE 93
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 85/564 (15%), Positives = 162/564 (28%), Gaps = 193/564 (34%)
Query: 11 PQIVNLPYLETVDFAYN----YLHGSIPREWASMQLK----------YI----------S 46
P ++ Y+E D YN + ++ R ++L+ + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 47 VFAN----------RLSGNI----------PSHLGNITSLTYLDLEENQFSGTIPRELGN 86
A ++ I P + + ++ N S N
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR--SDHSSN 222
Query: 87 L-VNLETLRLSSNRLIGN--LPMELVKLKNLTDFRINDNNFNGSAP-----------DFI 132
+ + + +++ RL+ + L+ L N+ + + + FN S DF+
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA-FNLSCKILLTTRFKQVTDFL 281
Query: 133 QSWTQLN-RLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ---TFPMLRNMTGLTR 188
+ T + L+ L S L K R DL P + T P ++
Sbjct: 282 SAATTTHISLDHHSMTLTPD--EVKSLLLKYLDCRPQDL--PREVLTTNPRRLSI----- 332
Query: 189 IILRNCNIAGEIPEYI--W------GIKNL-RFLDLSFNQLTGELPDVAVPADLK--FTQ 237
IA I + + W L ++ S N L PA+ + F +
Sbjct: 333 -------IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE--------PAEYRKMFDR 377
Query: 238 ILMFIRGVY-EHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNN 296
+ +F + L L + + + L + S VE
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK--------LHKYSLVEKQP------KE 423
Query: 297 FTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGGAATYH--LLDGTNWGISSTGDFTDD 354
T S+++ + + + H ++D ++ I T D D
Sbjct: 424 STI--SIPSIYL----------ELKVKLE-----NEYALHRSIVD--HYNIPKTFDSDDL 464
Query: 355 DDEQNTNYIANSQSSGISELYNDARISPLSLTYIGYCLENGNYS----------VALHFA 404
Y Y+ +IG+ L+N + + F
Sbjct: 465 IPPYLDQYF-----------YS----------HIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 405 EIQFTNDKT--------YKTLGR-RIFDIYIQDK------LVE--KDFNIEAEAHGVLKP 447
E + +D T TL + + + YI D LV DF + E + +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 448 VTRPFTANVSNHILEIRFQWAGKG 471
T +L I +
Sbjct: 564 YTD---------LLRIALMAEDEA 578
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 70/468 (14%), Positives = 122/468 (26%), Gaps = 134/468 (28%)
Query: 350 DFTDDDDEQNTNYIANSQSSGIS-ELYNDARISP---LSLTYIGYCLENGNYSVALHFAE 405
F D+ D + + S +S E + +S + + L + + F E
Sbjct: 28 AFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 406 IQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTA-NVS--NHILE 462
+ YK L I Q ++ + + E L + F NVS L+
Sbjct: 85 EVLRIN--YKFLMSPIKTEQRQPSMMTRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 463 IRFQWAGKGTTAIPIGGV--YGPL--------ISAISVDPNLEGLEFQASSFTLKQIRAA 512
+R Q + P V G L + ++F+ LK +
Sbjct: 140 LR-QALLE---LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL----- 567
+ + + K+ P + +D + +KL + R L +CL
Sbjct: 196 ETVLEMLQKLLYQ-IDPNWT-SRSDHSS-NIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252
Query: 568 -QHPNLVKLY--GCCI---------------------------------EGDQLMLVY-- 589
Q+ + C I E L+L Y
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 590 --------EYLENNSLAHALFGGENSQLKLNWS-VRQ----KICLGIARGLAFLH-EESR 635
E L N ++ W + K+ I L L E R
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 636 -----FKIVHRDIK-ATNVL------------------------LDRDLNP-KISDFGL- 663
+ T +L +++ IS +
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 664 ----AKLDEEEKTH--ISTRVAGTIGYMAPE-YALWGYLTYKADVYSF 704
KL+ E H I Y P+ + + D Y +
Sbjct: 433 LELKVKLENEYALHRSIVDH------YNIPKTFDSDDLIPPYLDQYFY 474
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 4/122 (3%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMEL 108
N + P L +DL NQ S + + L +L +L L N++ LP L
Sbjct: 42 NTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSL 99
Query: 109 -VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167
L +L +N N N D Q LN L + + L+ + S L + + +
Sbjct: 100 FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL 159
Query: 168 SD 169
+
Sbjct: 160 AQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 29/151 (19%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 1 MLFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPS- 58
L +P LP I + N + P ++ +L+ I + N++S +
Sbjct: 22 GLTEIPTNLPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 59 ---HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL-VKLKNL 114
L SL L L N+ + L +L+ L L++N++ L ++ L NL
Sbjct: 75 AFQGL---RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNL 130
Query: 115 TDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145
+ DN A + + +
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 30/203 (14%), Positives = 59/203 (29%), Gaps = 37/203 (18%)
Query: 66 LTYLDLEENQFS----GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
+D EE + S + L + L L++ NL + NL I
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIIS 202
Query: 122 NNFNGSAPDFIQS--WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPM 179
S + I L +L + + ++ L FP
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS---------KDRFPN 253
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWG---IKNLRFLDLSFNQLTGELPDVAVPADLKFT 236
L+ + + + + E + L +D+S LT E + + K
Sbjct: 254 LK------WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307
Query: 237 QILMFIRGVYEHQSLDLSYNNFT 259
+ + +++ YN +
Sbjct: 308 HL----------KFINMKYNYLS 320
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 39/250 (15%), Positives = 80/250 (32%), Gaps = 40/250 (16%)
Query: 41 QLKYISVFANRLS----GNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLV-----NLE 91
Q + + + L+ +I S L +L L+L N+ + + ++
Sbjct: 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88
Query: 92 TLRLSSNRL----IGNLPMELVKLKNLTDFRINDNNFNGS-----APDFIQSWTQLNRLE 142
L L + L G L L L L + ++DN + + +L +L+
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 148
Query: 143 IQGSGLEGPIPPSI-SALDKLNQLRISDLQGPNQTFPMLR--------NMTGLTRIILRN 193
++ L + S L + + + +R + L + L +
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208
Query: 194 CNI----AGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQ 249
C + ++ + +LR L L N+L P L + L +
Sbjct: 209 CGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL---------R 259
Query: 250 SLDLSYNNFT 259
+L + T
Sbjct: 260 TLWIWECGIT 269
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 35/224 (15%), Positives = 67/224 (29%), Gaps = 42/224 (18%)
Query: 64 TSLTYLDLEENQFSGTIPRELGNLV-NLETLRLSSNRL----IGNLPMELVKLKNLTDFR 118
+ LD++ + S EL L+ + +RL L ++ L L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 119 INDNNFNGS-----APDFIQSWTQLNRLEIQGSGL--EGPIPPSISALDKLNQLRISDLQ 171
+ N ++ +L +Q L G S L L L+ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG-CGVLSSTLRTLPTLQELHLS 121
Query: 172 GPNQ---------TFPMLRNMTGLTRIILRNCNI----AGEIPEYIWGIKNLRFLDLSFN 218
N +L L ++ L C++ + + + + L +S N
Sbjct: 122 D-NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 219 QLTGELPDVAVPA---DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
+ + V LK + + ++L L T
Sbjct: 181 DIN----EAGVRVLCQGLKDSPCQL--------EALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 36/231 (15%), Positives = 69/231 (29%), Gaps = 44/231 (19%)
Query: 60 LGNITSLTYLDLEENQFSGTIPRELG-----NLVNLETLRLSSNRL----IGNLPMELVK 110
L L + N + R L + LE L+L S + +L +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 111 LKNLTDFRINDNNFNGS-----APDFIQSWTQLNRLEIQGSGLEGPIPPSIS-ALDKLNQ 164
+L + + N P + ++L L I G+ + L
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 165 LRISDLQGPNQ---------TFPMLRNMTGLTRIILRNCNI----AGEIPEYIWGIKNLR 211
L+ L G N+ +L L + +++C+ + + L
Sbjct: 286 LKELSLAG-NELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 212 FLDLSFNQLTGELPDVAVPA---DLKFTQILMFIRGVYEHQSLDLSYNNFT 259
L +S N+L D V L ++ + L L+ + +
Sbjct: 345 ELQISNNRLE----DAGVRELCQGLGQPGSVL--------RVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 37/210 (17%), Positives = 70/210 (33%), Gaps = 38/210 (18%)
Query: 51 RLSGN---------IPSHLGNITSLTYLDLEENQFSGTIPRELGNLV-----NLETLRLS 96
L + S L + +L L L +N + L + LE L+L
Sbjct: 91 SLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLE 150
Query: 97 SNRL----IGNLPMELVKLKNLTDFRINDNNFNGS-----APDFIQSWTQLNRLEIQGSG 147
L L L + + +++N+ N + S QL L+++ G
Sbjct: 151 YCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210
Query: 148 LEGPIPPSI-SALDKLNQLRISDLQGPNQTFP---------MLRNMTGLTRIILRNCNI- 196
+ + + LR L N+ +L + L + + C I
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGS-NKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269
Query: 197 ---AGEIPEYIWGIKNLRFLDLSFNQLTGE 223
G++ + ++L+ L L+ N+L E
Sbjct: 270 AKGCGDLCRVLRAKESLKELSLAGNELGDE 299
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 34/160 (21%), Positives = 56/160 (35%), Gaps = 35/160 (21%)
Query: 62 NITSLTYLDLEENQFS-GTIPRELGNLVNLETLRLSSNRL--IGNLPMELVKLKNLTDFR 118
+ + L L+ ++ + G + LE L + L I NLP KL L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 119 INDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178
++DN +G + L L + G N +I DL T
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSG-----------------N--KIKDL----STIE 107
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEY----IWGIKNLRFLD 214
L+ + L + L NC + + +Y + L +LD
Sbjct: 108 PLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
LE + L SI +LK + + NR+SG + +LT+L+L N
Sbjct: 40 EFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 75 QFSG-TIPRELGNLVNLETLRLSSN 98
+ + L L NL++L L +
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 19/168 (11%)
Query: 33 IPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLE 91
IP + + L+ L+ + +T LT+L+L+ NQ T+ + +L L
Sbjct: 33 IPADTEKLDLQS-----TGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELG 86
Query: 92 TLRLSSNRLIGNLPMELV--KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE 149
TL L++N+L +LP V L L + N T+L L + + L+
Sbjct: 87 TLGLANNQL-ASLP-LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 150 GPIPPSISALDKLNQLRISDLQGPNQTFPMLR----NMTGLTRIILRN 193
IP A DKL L+ L NQ + + L I L
Sbjct: 145 S-IPA--GAFDKLTNLQTLSLST-NQLQSVPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/140 (22%), Positives = 48/140 (34%), Gaps = 17/140 (12%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV-KLKN 113
IP LDL+ + L L L L N+L L + L
Sbjct: 32 GIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTE 84
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG- 172
L + +N TQL++L + G+ L+ +P D+L +L+ L
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPS--GVFDRLTKLKELRLNTN 141
Query: 173 -----PNQTFPMLRNMTGLT 187
P F L N+ L+
Sbjct: 142 QLQSIPAGAFDKLTNLQTLS 161
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/206 (17%), Positives = 60/206 (29%), Gaps = 44/206 (21%)
Query: 60 LGNITSLTYLDLEENQFSGT----IPRELGNLVNLETLRLSSNRLIGNLPME-------- 107
L S+ + L N + + + +LE S G + E
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF-TGRVKDEIPEALRLL 86
Query: 108 ---LVKLKNLTDFRINDNNF--NGSAP--DFIQSWTQLNRLEIQGSGL--EG-------- 150
L+K L R++DN F P DF+ T L L + +GL +
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 151 PIPPSISALDKLNQLRISDLQGPNQTFP--------MLRNMTGLTRIILRNCNIAGE--- 199
LR N+ ++ L + + I E
Sbjct: 147 QELAVNKKAKNAPPLRSIICGR-NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE 205
Query: 200 --IPEYIWGIKNLRFLDLSFNQLTGE 223
+ E + + L+ LDL N T
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHL 231
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/202 (20%), Positives = 73/202 (36%), Gaps = 40/202 (19%)
Query: 60 LGNITSLTYLDLEENQFSGTIPRELGNL----VNLETLRLSSNRL-------------IG 102
L L + L +N F T L + LE L L +N L
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 103 NLPMELVKLKNLTDFRINDNNF-NGSAPDF---IQSWTQLNRLEIQGSGL--EGPIPPSI 156
+ + L N NGS ++ QS L+ +++ +G+ EG +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 157 SALDKLNQLRISDLQGPNQTF---------PMLRNMTGLTRIILRNCNI----AGEIPEY 203
L +L++ DLQ N F L++ L + L +C + A + +
Sbjct: 210 EGLAYCQELKVLDLQD-NT-FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 204 IWGIKN--LRFLDLSFNQLTGE 223
++N L+ L L +N++ +
Sbjct: 268 FSKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 27/190 (14%), Positives = 56/190 (29%), Gaps = 42/190 (22%)
Query: 60 LGNITSLTYLDLEENQFSG----TIPRELGNLVNLETLRLSSNRLIGN-----LPMELVK 110
+ S+ L+ + + ++ L +++ + LS N IG L +
Sbjct: 1 MAR-FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNT-IGTEAARWLSENIAS 58
Query: 111 LKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD- 169
K+L +D R++ + + ++ KL+ +R+SD
Sbjct: 59 KKDLEIAEFSDI--------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104
Query: 170 ---LQGPNQTFPMLRNMTGLTRIILRNCNI-------------AGEIPEYIWGIKNLRFL 213
L T L + L N + + + LR +
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 214 DLSFNQLTGE 223
N+L
Sbjct: 165 ICGRNRLENG 174
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/191 (16%), Positives = 57/191 (29%), Gaps = 60/191 (31%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL--IGNLPMELVKLK 112
+ + L + + +L L N I L + NL L L N + I NL L+
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLE 96
Query: 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172
L I+ N +I+ L G
Sbjct: 97 ELW---ISYN-------------------------------------------QIASLSG 110
Query: 173 PNQTFPMLRNMTGLTRIILRNCNIA--GEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVP 230
+ + L + + N I GEI + + + L L L+ N L + +
Sbjct: 111 -------IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNAT 162
Query: 231 ADLKFTQILMF 241
++ + +
Sbjct: 163 SEYRIEVVKRL 173
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 8/91 (8%)
Query: 33 IPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLET 92
IPR+ + L N+ + +P L N LT +DL N+ S + N+ L T
Sbjct: 29 IPRDVTELYLDG-----NQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82
Query: 93 LRLSSNRLIGNLPMELV-KLKNLTDFRINDN 122
L LS NRL +P LK+L ++ N
Sbjct: 83 LILSYNRL-RCIPPRTFDGLKSLRLLSLHGN 112
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 33 IPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLE 91
IP + L N+++ P ++ +L L L NQ +P + +L L
Sbjct: 38 IPTNAQILYLHD-----NQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLT 91
Query: 92 TLRLSSNRLIGNLPMELV-KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG 150
L L +N+L LP + +L +L + + N P I+ T L L + + L+
Sbjct: 92 VLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149
Query: 151 PIPPSISALDKLNQL 165
IP A D+L+ L
Sbjct: 150 -IPH--GAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 15/143 (10%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV-KLKN 113
IP T+ L L +NQ + P +L+NL+ L L SN+L G LP+ + L
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQ 89
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ-- 171
LT + N L L + + L +P I L L L + Q
Sbjct: 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
Query: 172 -GPNQTFPMLRNMTGLTRIILRN 193
P+ F ++ LT L
Sbjct: 149 SIPHGAFD---RLSSLTHAYLFG 168
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 25/147 (17%), Positives = 50/147 (34%), Gaps = 29/147 (19%)
Query: 83 ELGNLVNLETLRLSSNRL--IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNR 140
+ N V L L ++ I NL L + + +DN + + L R
Sbjct: 14 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIRK-----LDGFPLLRR 65
Query: 141 LEI------QGSGLEGPIPPSISALDKLNQL---RISDLQGPNQTFPMLRNMTGLTRIIL 191
L+ + + + ++ L +L L + +L L ++ LT + +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELI-LTNNSLVEL----GDLDPLASLKSLTYLCI 120
Query: 192 RNCNIAGEIPEY----IWGIKNLRFLD 214
+ Y I+ + +R LD
Sbjct: 121 LRNPVT-NKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 8/101 (7%)
Query: 4 SLPGTLPPQIVNL----PYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSH 59
L G P I NL + +DF+ N + + +LK + V NR+
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGL 83
Query: 60 LGNITSLTYLDLEENQFS--GTIPRELGNLVNLETLRLSSN 98
+ LT L L N G + L +L +L L + N
Sbjct: 84 DQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 32/165 (19%), Positives = 51/165 (30%), Gaps = 54/165 (32%)
Query: 54 GNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKN 113
G I +L +L L ++ L L L+ L LS NR+ G L M KL N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 114 LTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173
LT ++ N ++ + L
Sbjct: 97 LTHLNLSGNK--------LKDISTLEP--------------------------------- 115
Query: 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEY----IWGIKNLRFLD 214
L+ + L + L NC + + +Y + L +LD
Sbjct: 116 ------LKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 25/122 (20%), Positives = 44/122 (36%), Gaps = 18/122 (14%)
Query: 13 IVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLE 72
LE + L S+ +LK + + NR+ G + + +LT+L+L
Sbjct: 45 TAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 73 ENQFS--GTIPRELGNLVNLETLRLSSN----------RLIGNLPMELVKLKNLTDFRIN 120
N+ T+ L L L++L L + + LP +L L +
Sbjct: 104 GNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP----QLTYLDGYDRE 158
Query: 121 DN 122
D
Sbjct: 159 DQ 160
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 43/211 (20%), Positives = 70/211 (33%), Gaps = 49/211 (23%)
Query: 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLS--GNIPSHLGNITSLTYLDLEENQFS 77
+ + + + I + + I + ++ YL L N+
Sbjct: 22 IKANLKKKSV-TDAVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH 76
Query: 78 GTIPRELG---NLVNLETLRLSSNRLIGNLPMELV-KLKNLTDFRINDNNFNGSAPDFIQ 133
++ L NL L L+ N+L +LP + KL NL + + +N
Sbjct: 77 -----DISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD 130
Query: 134 SWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRN 193
T L L + + L+ +P + DKL L DL NQ L +
Sbjct: 131 KLTNLTYLNLAHNQLQS-LPKGV--FDKLTNLTELDLSY-NQ----------LQSL---- 172
Query: 194 CNIAGEIPEYIWGI----KNLRFLDLSFNQL 220
PE G+ L+ L L NQL
Sbjct: 173 -------PE---GVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 45/162 (27%), Positives = 62/162 (38%), Gaps = 30/162 (18%)
Query: 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100
+L IS L T+LTYL L NQ L NL+ L L N+L
Sbjct: 74 KLHDISAL-KEL-----------TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121
Query: 101 IGNLPMELV-KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159
+LP + KL NLT + N T L L++ + L+ +P +
Sbjct: 122 -QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGV--F 177
Query: 160 DKLNQLRISDLQGPNQTFPMLR--------NMTGLTRIILRN 193
DKL QL+ L NQ L+ +T L I L +
Sbjct: 178 DKLTQLKDLRLYQ-NQ----LKSVPDGVFDRLTSLQYIWLHD 214
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 24/166 (14%), Positives = 49/166 (29%), Gaps = 50/166 (30%)
Query: 51 RLSGNIPSHL------GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNL 104
RL+ N + L + L ++ N+ + + + L+SNRL N+
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NV 96
Query: 105 PMEL-VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163
++ L++L + N I + + L+
Sbjct: 97 QHKMFKGLESLKTLMLRSNR--------ITC-----------------VGN--DSFIGLS 129
Query: 164 QLRISDLQG------PNQTFPMLRNMTGLTRIILRN------CNIA 197
+R+ L F + L+ + L C +A
Sbjct: 130 SVRLLSLYDNQITTVAPGAF---DTLHSLSTLNLLANPFNCNCYLA 172
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 42/168 (25%), Positives = 58/168 (34%), Gaps = 43/168 (25%)
Query: 33 IPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLET 92
IP + + L+ N L +TSLT L L N+ L +L
Sbjct: 26 IPAQTTYLDLET-----NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 93 LRLSSNRLIGNLPMELV-KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP 151
L LS+N+L +LP + KL L + +N N QL L
Sbjct: 81 LNLSTNQL-QSLPNGVFDKLTQLKELALNTN--------------QLQSL---------- 115
Query: 152 IPPSISALDKLNQLRISDLQG------PNQTFPMLRNMTGLTRIILRN 193
P DKL QL+ L P+ F +T L I L +
Sbjct: 116 -PD--GVFDKLTQLKDLRLYQNQLKSVPDGVFD---RLTSLQYIWLHD 157
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 732 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.93 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.91 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.4 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.76 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.55 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.4 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.54 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.27 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.15 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.68 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=396.64 Aligned_cols=198 Identities=31% Similarity=0.506 Sum_probs=180.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
..|+..++||+|+||.||+|+++ +|+.||||++........+.+.+|++++++++|||||+++++|.+++.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999986 79999999997665556677899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+.......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999998843 35899999999999999999999996 99999999999999999999999999987654333
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23457899999999999999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=390.93 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=180.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 7999999998753 2344578999999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|||+||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999994 3456899999999999999999999996 99999999999999999999999999987654
Q ss_pred cCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 332 334457899999999999999999999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=394.94 Aligned_cols=202 Identities=25% Similarity=0.410 Sum_probs=174.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++++.||+|+||.||+|++. +|+.||||++... .....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 7999999998754 2334578999999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|||+||+|.+++... ....+++..++.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999999543 2345789999999999999999999996 99999999999999999999999999986654
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 178 ~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 178 TVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp HHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ccc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 222 23346799999999999999999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=390.05 Aligned_cols=205 Identities=33% Similarity=0.547 Sum_probs=179.1
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 478999999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCC---------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 588 VYEYLENNSLAHALFGGE---------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
|||||++|+|.++++... .....++|.++.+|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 23457999999999999999999999986 999999999999999999999
Q ss_pred EeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 659 SDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 659 ~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999865443322 2233568999999999999999999999999999999999 99999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=398.41 Aligned_cols=198 Identities=31% Similarity=0.506 Sum_probs=180.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+.|+.+++||+|+||.||+|+++ +|+.||||++........+.+.+|++++++++|||||+++++|.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 79999999998766666677899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
+||+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999843 35899999999999999999999996 99999999999999999999999999987654332
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23457899999999999999999999999999999999999999964
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=389.01 Aligned_cols=205 Identities=30% Similarity=0.511 Sum_probs=173.4
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|.+.++||+|+||.||+|+++ +++.||||+++.......++|.+|++++++++|||||+++++|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46677889999999999999864 478999999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 588 VYEYLENNSLAHALFGGEN-----------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
|||||++|+|.++++.... ...+++|.++.+|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 2356999999999999999999999985 9999999999999999999
Q ss_pred EEEeeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 657 KISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 657 kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
||+|||+|+...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 999999998654432 223345679999999999999999999999999999999999 89999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=385.22 Aligned_cols=197 Identities=27% Similarity=0.314 Sum_probs=171.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.+.|++.++||+|+||.||+|+++ +|+.||||+++.... ..+|++++++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788899999999999999986 799999999875432 24699999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeCCcc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEEE 670 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~~~~ 670 (732)
|+||+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999953 346899999999999999999999986 99999999999999987 6999999999876543
Q ss_pred Cce----eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KTH----ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~~----~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ....++||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 221 122367999999999999999999999999999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=373.97 Aligned_cols=198 Identities=29% Similarity=0.474 Sum_probs=162.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+++.+|++++++++|||||++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999975 79999999987542 33456799999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+ +|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 6799998843 356999999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 422 2334689999999999998765 6899999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=383.44 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=169.7
Q ss_pred CCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|++.+.||+|+||+||+|+.. +++.||+|+++... .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 47899999987542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999943 346899999999999999999999996 999999999999999999999999999864
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 33222 23356899999999999999999999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=382.49 Aligned_cols=205 Identities=31% Similarity=0.449 Sum_probs=176.8
Q ss_pred CCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
+++++.++||+|+||.||+|++. +++.||||+++... ....++|.+|++++++++|||||+++++|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567789999999999999862 57899999997643 344678999999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 587 LVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
+|||||++|+|.++|+.... ....++|..+.+|+.|||+||+|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 2356899999999999999999999986 99999999999999999
Q ss_pred CeEEEeeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.+||+|||+|+...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999998654332 223345679999999999999999999999999999999998 89999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=380.40 Aligned_cols=199 Identities=31% Similarity=0.522 Sum_probs=167.5
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.+++++.++||+|+||.||+|++++ .||||+++.. .....++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4567788999999999999998763 5899998754 33446789999999999999999999998754 56899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||++|+|.++++.. ...++|..+.+|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999643 346899999999999999999999986 999999999999999999999999999865432
Q ss_pred C-ceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 K-THISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~-~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .......+||+.|||||++.+ ++++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 2 223345689999999999864 4689999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=372.48 Aligned_cols=195 Identities=31% Similarity=0.459 Sum_probs=168.8
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEEEE
Q 040398 517 DPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLMLVY 589 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 589 (732)
++.++||+|+||.||+|++. +++.||+|++... .....++|.+|++++++++|||||+++++|.+ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999986 6899999998654 33345779999999999999999999999875 35689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~ 668 (732)
|||++|+|.+++.. ...+++..+..++.||++||+|||+++ .+||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999953 356899999999999999999999884 35999999999999984 7899999999998644
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....+||+.|||||++.+ .++.++|||||||++|||+||+.||..
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32 2335689999999998865 689999999999999999999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=366.90 Aligned_cols=200 Identities=27% Similarity=0.481 Sum_probs=162.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------- 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 583 (732)
.++|++++.||+|+||+||+|+++ +|+.||||+++... ....+++.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356899999999999999999986 79999999987543 334567899999999999999999999987644
Q ss_pred -----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 584 -----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 584 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
++|+|||||++|+|.+++.... .....++..++.++.||++||+|||+++ ||||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 3799999999999999996532 2234577788999999999999999996 999999999999999999999
Q ss_pred EeeecceeCCccCce-----------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 659 SDFGLAKLDEEEKTH-----------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 659 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
+|||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 999999865432211 1234579999999999999999999999999999999996 775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.40 Aligned_cols=200 Identities=32% Similarity=0.398 Sum_probs=163.4
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----EEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----QLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~ 589 (732)
.+|.+.++||+|+||.||+|+++ |+.||||++..... ....+..|+..+.+++|||||+++++|.+++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35677889999999999999884 89999999865422 1223345677778899999999999998754 689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
|||++|+|.++++. ..++|..+.+++.|+++||+|||+++ ..+||||||||+|||+++++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999953 35899999999999999999999862 235999999999999999999999999999
Q ss_pred eeCCccCcee---eecccCccccccchhcccC------CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHI---STRVAGTIGYMAPEYALWG------YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+......... ....+||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 8654433221 2245799999999998754 467899999999999999999887753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=373.12 Aligned_cols=214 Identities=27% Similarity=0.396 Sum_probs=182.1
Q ss_pred cHHHHHHHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCC-Cceeeee
Q 040398 505 TLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQH-PNLVKLY 576 (732)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~ 576 (732)
..++++...++|++.+.||+|+||.||+|++. +++.||||++.... ....++|.+|++++.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34455566788999999999999999999864 24689999987653 3445779999999999965 8999999
Q ss_pred eeEEeC-CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 577 GCCIEG-DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 577 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
++|.++ +.+++|||||++|+|.++|+.... ....+++..+..++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 568999999999999999975422 2345899999999999999999999996 999999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986644333 23344679999999999999999999999999999999998 99999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=366.08 Aligned_cols=200 Identities=23% Similarity=0.368 Sum_probs=171.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEe------CC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIE------GD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 583 (732)
.++|++++.||+|+||.||+|++. +|+.||||+++... ....+++.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999986 79999999987542 3345678899999999999999999998764 35
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
.+|+|||||+ |+|.+++. ....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999884 3457999999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccC---ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEK---THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 98653321 2233457899999999998875 579999999999999999999999964
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=360.35 Aligned_cols=199 Identities=29% Similarity=0.409 Sum_probs=171.2
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc----CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
....+.|++.+.||+|+||+||+|+.+ +++.||+|++.... ...++.+|+++++.+ +|||||++++++.++++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999763 47899999886543 346788999999998 69999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeeec
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGL 663 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfGl 663 (732)
.++||||+++|+|.+++. .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999882 4889999999999999999999996 9999999999999887 7899999999
Q ss_pred ceeCCccCc---------------------------eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCC
Q 040398 664 AKLDEEEKT---------------------------HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGK 715 (732)
Q Consensus 664 a~~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~ 715 (732)
|+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 976543211 112235799999999999875 5899999999999999999999
Q ss_pred CCCCC
Q 040398 716 NNMSY 720 (732)
Q Consensus 716 ~P~~~ 720 (732)
.||..
T Consensus 245 ~Pf~~ 249 (361)
T 4f9c_A 245 YPFYK 249 (361)
T ss_dssp SSSSC
T ss_pred CCCCC
Confidence 99953
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=378.43 Aligned_cols=198 Identities=28% Similarity=0.371 Sum_probs=172.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHH---HHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREF---LNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....... .+++++++.++|||||+++++|.+++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 568999999999999999999986 79999999986431 1222223 3446777888999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999943 456899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ....+||+.|||||++.. ..++.++|||||||++|||++|+.||..
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765432 234689999999999974 5799999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=373.97 Aligned_cols=200 Identities=25% Similarity=0.432 Sum_probs=180.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 7999999999876666677889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC--CCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD--LNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DfGla~~~~~ 669 (732)
|+||+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999998843 2346899999999999999999999996 9999999999999864 7899999999987765
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ....+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus 310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 332 2346799999999999999999999999999999999999999964
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.83 Aligned_cols=215 Identities=46% Similarity=0.813 Sum_probs=189.5
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
+++.++..++++|+..+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556788999999999999999999998889999999988766666788999999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++|+|.+++.........+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999765555567999999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 664 AKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 664 a~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 97644322 22233456899999999999999999999999999999999999999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.95 Aligned_cols=219 Identities=44% Similarity=0.775 Sum_probs=195.1
Q ss_pred cccccHHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeE
Q 040398 501 ASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCC 579 (732)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 579 (732)
...++.+++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356788999999999999999999999999999988899999999876532 2344789999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 580 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
.+++..++||||+++|+|.+++.........+++..+..++.||+.||+|||+.+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998776666779999999999999999999999822339999999999999999999999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|||++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776555555555679999999999998899999999999999999999999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=346.72 Aligned_cols=210 Identities=25% Similarity=0.331 Sum_probs=183.5
Q ss_pred cHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEE
Q 040398 505 TLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCI 580 (732)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 580 (732)
.++++....++|++.++||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555667889999999999999999999987 58999999987532 222344889999999999999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
+++..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999542 346899999999999999999999986 99999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+|+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 9999876555444445578999999999987 56789999999999999999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.15 Aligned_cols=218 Identities=30% Similarity=0.492 Sum_probs=186.7
Q ss_pred ccCcccccccccHHHHHHHhCC----------CcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHH
Q 040398 494 LEGLEFQASSFTLKQIRAATSN----------FDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIG 562 (732)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~----------f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~ 562 (732)
...+.++...++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~ 94 (321)
T 2c30_A 15 TENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94 (321)
T ss_dssp ----------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred ccceeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHH
Confidence 3334455667888888887764 777789999999999999987 79999999998766666788999999
Q ss_pred HHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCC
Q 040398 563 TISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRD 642 (732)
Q Consensus 563 ~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~D 642 (732)
++++++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||+.+ |+|||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 166 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRD 166 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 99999999999999999999999999999999999998842 36899999999999999999999986 99999
Q ss_pred CCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 643 IKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 643 lkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865543222 2346799999999999999999999999999999999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.33 Aligned_cols=199 Identities=28% Similarity=0.486 Sum_probs=179.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999875 7899999998776666677899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999843 25889999999999999999999996 9999999999999999999999999988665433
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 2346799999999999999999999999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=343.17 Aligned_cols=207 Identities=24% Similarity=0.361 Sum_probs=181.3
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 581 (732)
++++....++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556789999999999999999999986 6899999998652 12234557899999999999999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
++..++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999853 35889999999999999999999996 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCC----CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY----LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 999876654444444678999999999998655 78999999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.12 Aligned_cols=210 Identities=25% Similarity=0.319 Sum_probs=182.6
Q ss_pred cHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEE
Q 040398 505 TLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCI 580 (732)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 580 (732)
.+++.....++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555566789999999999999999999986 79999999986531 223345788999999999999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
+++..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999532 236899999999999999999999986 99999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-------WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 9999876554443344568999999999987 35789999999999999999999999964
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.05 Aligned_cols=200 Identities=28% Similarity=0.376 Sum_probs=177.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999986 7999999998754 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998843 346899999999999999999999996 9999999999999999999999999997543
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 3222 22346799999999999999999999999999999999999999964
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.92 Aligned_cols=200 Identities=28% Similarity=0.430 Sum_probs=176.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+++++.++||||+++++++.+++..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568999999999999999999984 8999999998754 333456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999843 346899999999999999999999996 9999999999999999999999999997554
Q ss_pred ccCceeeecccCccccccchhcccCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLT-YKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 322 23456799999999999887765 799999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.82 Aligned_cols=201 Identities=30% Similarity=0.425 Sum_probs=172.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+++.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999976 78999999885432 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999843 346899999999999999999999996 9999999999999999999999999997654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...........||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 4333333446799999999999999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.51 Aligned_cols=202 Identities=32% Similarity=0.518 Sum_probs=178.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999986 6899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999542 346899999999999999999999996 9999999999999999999999999998654332
Q ss_pred cee-------------eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THI-------------STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~-------------~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 211 1145799999999999999999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.43 Aligned_cols=201 Identities=27% Similarity=0.437 Sum_probs=172.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 586 (732)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|.+++..+ +||||+++++++.+++..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999986 6899999998753 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999843 346899999999999999999999996 99999999999999999999999999975
Q ss_pred CCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 33222 223346799999999999988999999999999999999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.07 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=177.4
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc------chHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ------GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
..+.|++.+.||+|+||.||+|+.+ +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999986 7999999998754321 34778999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEe
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISD 660 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~D 660 (732)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999943 346899999999999999999999996 99999999999998876 799999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99998765432 22346799999999999998999999999999999999999999964
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=333.37 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=175.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999986 68999999987542 23345678899999887 89999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999998843 346899999999999999999999996 999999999999999999999999999753
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2222 223456899999999999999999999999999999999999999964
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=360.28 Aligned_cols=294 Identities=26% Similarity=0.359 Sum_probs=245.3
Q ss_pred CcccCCccCCC--CCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCC
Q 040398 5 LPGTLPPQIVN--LPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP 81 (732)
Q Consensus 5 ~~g~lP~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 81 (732)
++|.+|+.+.. +++|++|+|++|++++.+|..+..+ +|++|+|++|++++.+|..++++++|++|+|++|.+++.+|
T Consensus 380 l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 459 (768)
T 3rgz_A 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459 (768)
T ss_dssp EEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCC
Confidence 56778888877 8889999999999888888888887 79999999999888888888888999999999999888888
Q ss_pred ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 82 RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
..+..+++|++|+|++|++++.+|..+.++++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++
T Consensus 460 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 539 (768)
T 3rgz_A 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT
T ss_pred HHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence 88888889999999999988888888888899999999999988888888888899999999999998888888888899
Q ss_pred CCeeeccCcCCCCCCcc---------------------------------------------------------------
Q 040398 162 LNQLRISDLQGPNQTFP--------------------------------------------------------------- 178 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~--------------------------------------------------------------- 178 (732)
|+.|++++|.+.+..+.
T Consensus 540 L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 619 (768)
T 3rgz_A 540 LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619 (768)
T ss_dssp CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred CCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence 99999988877643222
Q ss_pred -------cccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeE
Q 040398 179 -------MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSL 251 (732)
Q Consensus 179 -------~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~L 251 (732)
.+..+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|+. ++++++|+.|
T Consensus 620 ~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~--------------l~~L~~L~~L 685 (768)
T 3rgz_A 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE--------------VGDLRGLNIL 685 (768)
T ss_dssp EEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG--------------GGGCTTCCEE
T ss_pred ecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH--------------HhCCCCCCEE
Confidence 3445678999999999999999999999999999999999999999976 7888999999
Q ss_pred EccCCcCcCCCCCCccccCCCCcccccccccCCCCCCcccccccCCCCCCcceeEEEecCCCeeeecCceecCCCCCCCC
Q 040398 252 DLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCTNNFTCHRYWHSLHINCGGGNVKVNDSTFEGDAGVGGG 331 (732)
Q Consensus 252 dLs~N~l~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~p~~~~~~c~~~~~s~~i~c~~~~~~~~~~~~~~~~~~~g~ 331 (732)
|||+|+++|.+|.... .+..| .....+.++..|.+|...++ .++....|.||+++||.
T Consensus 686 dLs~N~l~g~ip~~l~--~l~~L---~~L~ls~N~l~g~iP~~~~~-----------------~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 686 DLSSNKLDGRIPQAMS--ALTML---TEIDLSNNNLSGPIPEMGQF-----------------ETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp ECCSSCCEECCCGGGG--GCCCC---SEEECCSSEEEEECCSSSSG-----------------GGSCGGGGCSCTEEEST
T ss_pred ECCCCcccCcCChHHh--CCCCC---CEEECcCCcccccCCCchhh-----------------ccCCHHHhcCCchhcCC
Confidence 9999999999986432 12222 12234566677777765443 57778899999999997
Q ss_pred cce
Q 040398 332 AAT 334 (732)
Q Consensus 332 ~~~ 334 (732)
+..
T Consensus 744 ~l~ 746 (768)
T 3rgz_A 744 PLP 746 (768)
T ss_dssp TSC
T ss_pred CCc
Confidence 643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.43 Aligned_cols=197 Identities=26% Similarity=0.440 Sum_probs=176.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 457899999999999999999986 79999999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999953 346899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 32 2345799999999999999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.70 Aligned_cols=199 Identities=28% Similarity=0.449 Sum_probs=176.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999976 6899999998653 233457789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999853 346899999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 432 2345679999999999874 4589999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.57 Aligned_cols=203 Identities=29% Similarity=0.431 Sum_probs=176.9
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
....++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|.+++..+ +||||+++++++.+++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345789999999999999999999986 78999999987542 33456678899999877 99999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999843 346899999999999999999999996 999999999999999999999999999
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 75432222 23456799999999999999999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.86 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=176.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|.+++.++ +||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457889999999999999999986 68999999987542 23345688899999988 89999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998843 346899999999999999999999996 999999999999999999999999999753
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 32222 23356799999999999999999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.72 Aligned_cols=199 Identities=21% Similarity=0.312 Sum_probs=176.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999986 68999999987543 3356788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC--CCCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DfGla~~~~~ 669 (732)
+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999843 2346899999999999999999999996 999999999999987 78999999999987654
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 332 2345699999999999988899999999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.95 Aligned_cols=204 Identities=24% Similarity=0.363 Sum_probs=177.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-----ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-----RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.+.|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999876 78999999986421 224577899999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEeeec
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGL 663 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DfGl 663 (732)
+||||+++++|.+.+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999887544334456899999999999999999999996 999999999999987654 99999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 987654322 22345799999999999999999999999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.86 Aligned_cols=203 Identities=18% Similarity=0.205 Sum_probs=173.7
Q ss_pred HhCCCcccceecccCceEEEEEE------EcCCeEEEEEEcccccccchHHHHHHHHHHhcCC---CCceeeeeeeEEeC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQ------LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLYGCCIEG 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 582 (732)
..++|.+.+.||+|+||.||+|. ..+++.||+|++.... ..++.+|+++++.++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678999999999999999994 3468999999987543 456677777777776 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCC-CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---------
Q 040398 583 DQLMLVYEYLENNSLAHALFGGE-NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--------- 652 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------- 652 (732)
+..++||||+++|+|.+++.... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996432 23456999999999999999999999986 999999999999998
Q ss_pred --CCCeEEEeeecceeCCc-cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 653 --DLNPKISDFGLAKLDEE-EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 653 --~~~~kL~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++.+||+|||+|+.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999975432 223334456799999999999999999999999999999999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.80 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=176.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 586 (732)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|.+++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4678999999999999999999987 5889999998754 223456788999999988 8999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999843 346899999999999999999999996 99999999999999999999999999975
Q ss_pred CCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 332222 23346799999999999999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=320.28 Aligned_cols=203 Identities=30% Similarity=0.441 Sum_probs=174.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 789999999865432 334668899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999883 3446899999999999999999999986 999999999999999999999999999765432
Q ss_pred Cc-eeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 671 KT-HISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 671 ~~-~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22 22335679999999999987765 779999999999999999999997543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=322.95 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=176.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999986 79999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999853 346899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 32 2245799999999999999999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.28 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=176.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999986 689999999875422 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF 661 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~Df 661 (732)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999843 346899999999999999999999986 99999999999999887 7999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 99987643322 2345799999999999989999999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.57 Aligned_cols=200 Identities=25% Similarity=0.371 Sum_probs=176.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999886 78999999987542 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DfGla~ 665 (732)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998843 346899999999999999999999996 99999999999998654 59999999997
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 654322 22346799999999999998999999999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.17 Aligned_cols=200 Identities=25% Similarity=0.399 Sum_probs=178.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999886 7899999999876555567889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC--CCCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DfGla~~~~~ 669 (732)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998843 2346899999999999999999999996 999999999999974 46799999999987654
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 332 2234699999999999999999999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.46 Aligned_cols=202 Identities=29% Similarity=0.440 Sum_probs=173.2
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|++.+.||+|+||.||+|++.+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3578999999999999999999998899999999875432 23467889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++ +|.+.+.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 88887743 2345899999999999999999999996 99999999999999999999999999986643
Q ss_pred cCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 3222 234568999999999876 56899999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.54 Aligned_cols=205 Identities=28% Similarity=0.408 Sum_probs=182.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999986 79999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999765544567999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 43322 23457999999999999999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=323.64 Aligned_cols=206 Identities=26% Similarity=0.445 Sum_probs=177.2
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+++.+|+++++++ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 45689999997653 33456799999999999 899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..++||||+++|+|.+++..... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965432 2345899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999986544322 12223457889999999999999999999999999999999 99999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.40 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=174.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|.+.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999974 7899999998653 223346789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+ +|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6789888743 346899999999999999999999996 9999999999999999999999999997654
Q ss_pred ccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... .....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||...
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 432 2234579999999999988765 78999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.86 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=166.9
Q ss_pred hCCCcccceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 478999999987542 2334567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999843 346889999999999999999999996 999999999999999999999999998
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 75432222 22346799999999999999999999999999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=308.04 Aligned_cols=201 Identities=32% Similarity=0.523 Sum_probs=178.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467889999999999999999999888999999875433 3567899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 86 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999853 2345899999999999999999999996 99999999999999999999999999987655444
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 43444557778999999998899999999999999999999 9999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.32 Aligned_cols=201 Identities=30% Similarity=0.528 Sum_probs=177.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|++.+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 457889999999999999999998899999999875433 3567999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999998542 346899999999999999999999996 99999999999999999999999999976554333
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 33334557788999999999999999999999999999999 9999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=325.06 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=166.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHH-HhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGT-ISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999986 68999999987543 2234456677776 577899999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999998843 346889999999999999999999996 999999999999999999999999998753
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 2221 223456799999999999999999999999999999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.27 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=175.3
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999875 79999999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc---CCCCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DfGla~ 665 (732)
|||+++|+|.+.+.. ...+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999998853 346899999999999999999999996 99999999999998 45789999999997
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 6554332 22346799999999999998999999999999999999999999954
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.82 Aligned_cols=204 Identities=24% Similarity=0.436 Sum_probs=173.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 583 (732)
..++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4567999999999999999999987 79999999987543 334578999999999999999999999986643
Q ss_pred ---------------------------------------------------EEEEEEEecCCCchhHHhhcCCCCcccCC
Q 040398 584 ---------------------------------------------------QLMLVYEYLENNSLAHALFGGENSQLKLN 612 (732)
Q Consensus 584 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~ 612 (732)
..++||||+++++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence 38999999999999999966432 34567
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc-----------eeeecccCc
Q 040398 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-----------HISTRVAGT 681 (732)
Q Consensus 613 ~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~-----------~~~~~~~gt 681 (732)
+..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 8889999999999999999996 99999999999999999999999999986654321 122335699
Q ss_pred cccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 682 ~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999987763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.32 Aligned_cols=202 Identities=31% Similarity=0.417 Sum_probs=179.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 567999999999999999999986 7999999998653 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999886432 335899999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 4322 23457999999999999989999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.28 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=168.7
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------------------------cchHHHHHHHHHHh
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------------------------QGNREFLNEIGTIS 565 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 565 (732)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999875 789999999865421 11356889999999
Q ss_pred cCCCCceeeeeeeEEe--CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 566 CLQHPNLVKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 566 ~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 56899999999999998765 2346899999999999999999999996 999999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGY---LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+||+++.++.+||+|||++......... .....||+.|+|||.+.+.. .+.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999866543322 23467999999999987654 47889999999999999999999964
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=315.67 Aligned_cols=207 Identities=32% Similarity=0.519 Sum_probs=169.8
Q ss_pred HHhCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
...++|++.+.||+|+||.||+|+. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3466889999999999999999987 48899999987543 33446789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999996432 1234899999999999999999999883 239999999999999999999999999997543
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 223456999999999999999999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=308.66 Aligned_cols=197 Identities=24% Similarity=0.412 Sum_probs=170.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999986 68999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++ ++.+.+.. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 55555532 2346899999999999999999999996 999999999999999999999999999865433
Q ss_pred CceeeecccCccccccchhcccCC-CCCchhHHHHHHHHHHHHcCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGY-LTYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvll~elltG~~P~ 718 (732)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 22 223457899999999998765 799999999999999999999886
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.13 Aligned_cols=199 Identities=30% Similarity=0.438 Sum_probs=170.0
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|+||.||+|+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999986543 23357789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++ +|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 899888532 346889999999999999999999996 9999999999999999999999999987543322
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 12234689999999998764 589999999999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=332.65 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=166.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999976 7899999998753 233446678999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998843 3468999999999999999999998 75 999999999999999999999999999754
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 33222 23346799999999999999999999999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=315.21 Aligned_cols=202 Identities=32% Similarity=0.493 Sum_probs=173.2
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457889999999999999999874 3556999998764 33445789999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999998532 346899999999999999999999996 999999999999999999999999999876
Q ss_pred CccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 668 EEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 668 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 543222 2223446778999999998999999999999999999999 9999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=315.76 Aligned_cols=201 Identities=24% Similarity=0.280 Sum_probs=175.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467899999999999999999974 799999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-----eEEEeeecce
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKISDFGLAK 665 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DfGla~ 665 (732)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999998543 347899999999999999999999996 999999999999998887 9999999998
Q ss_pred eCCccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 666 LDEEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 666 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 65332221 1234679999999999999999999999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.25 Aligned_cols=201 Identities=24% Similarity=0.388 Sum_probs=167.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----E
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----Q 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 584 (732)
.++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 568999999999999999999974 789999999876432 33457889999999999999999999987654 3
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999843 346899999999999999999999996 999999999999999999999999999
Q ss_pred eeCCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 765443221 22335689999999999999999999999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.37 Aligned_cols=203 Identities=29% Similarity=0.467 Sum_probs=161.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999876 68999999987543 3345778999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcC--CCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 591 YLENNSLAHALFGG--ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 591 ~~~~gsL~~~l~~~--~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|++ ++|.+++... ......+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988543 122345899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3322 22345689999999998764 689999999999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.54 Aligned_cols=194 Identities=28% Similarity=0.458 Sum_probs=168.0
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
.+.||+|+||.||+|+.. +|+.||+|++........+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999875 7899999999876656677899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE--cCCCCeEEEeeecceeCCccCceee
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL--DRDLNPKISDFGLAKLDEEEKTHIS 675 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kL~DfGla~~~~~~~~~~~ 675 (732)
.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 998853 2346899999999999999999999996 9999999999999 5667899999999987654332 2
Q ss_pred ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 676 TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 676 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 235699999999999999999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.52 Aligned_cols=202 Identities=24% Similarity=0.332 Sum_probs=174.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC--EEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD--QLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457889999999999999999986 68999999987543 344577889999999999999999999998765 78999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE----cCCCCeEEEeeecc
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA 664 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DfGla 664 (732)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999996432 2234899999999999999999999996 9999999999999 77788999999999
Q ss_pred eeCCccCceeeecccCccccccchhcc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYAL--------WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87654332 23456999999999886 57889999999999999999999999963
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.97 Aligned_cols=202 Identities=26% Similarity=0.477 Sum_probs=175.3
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..++|++.+.||+|+||.||+|++.++..||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3567889999999999999999999889999999875433 357789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999998542 346899999999999999999999996 9999999999999999999999999997654433
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 332333457788999999998899999999999999999998 9999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.93 Aligned_cols=199 Identities=32% Similarity=0.453 Sum_probs=169.9
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----EEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----QLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999876 79999999865432 3345667999999999999999999998743 47999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE----------SRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
|||+++|+|.+++.. ..+++..++.++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999953 3489999999999999999999987 5 999999999999999999999
Q ss_pred EeeecceeCCccCc-eeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 659 SDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 659 ~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999976544322 12233579999999999886 35667889999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.38 Aligned_cols=198 Identities=28% Similarity=0.401 Sum_probs=160.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..+.|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4568999999999999999999987 68899999987543 34668899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DfGla~~~ 667 (732)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999843 345899999999999999999999996 999999999999975 789999999999765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 4322 22345799999999999998999999999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=306.78 Aligned_cols=215 Identities=44% Similarity=0.694 Sum_probs=186.3
Q ss_pred cccccHHHHHHHhCCCccc------ceecccCceEEEEEEEcCCeEEEEEEccccc----ccchHHHHHHHHHHhcCCCC
Q 040398 501 ASSFTLKQIRAATSNFDPM------NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQHP 570 (732)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~------~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 570 (732)
...+++.++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678899999999999887 8999999999999987 57899999986532 23457789999999999999
Q ss_pred ceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 571 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
||+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999985432 2346899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
++++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 9999999999999986544322 22334579999999998765 5789999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=318.81 Aligned_cols=204 Identities=19% Similarity=0.276 Sum_probs=176.3
Q ss_pred hCCCcccceeccc--CceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEG--GFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G--~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5678999999999 99999999987 79999999987543 3345678889999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999986432 245899999999999999999999996 999999999999999999999999988643
Q ss_pred CccCc------eeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 668 EEEKT------HISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 668 ~~~~~------~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 22111 11122468999999999987 57899999999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.20 Aligned_cols=199 Identities=25% Similarity=0.329 Sum_probs=176.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..++|++.+.||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567899999999999999999986 578999999887666667889999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~~ 667 (732)
|+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998843 345899999999999999999999996 9999999999999 78889999999999865
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC
Confidence 54322 234569999999998865 489999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=317.39 Aligned_cols=198 Identities=26% Similarity=0.381 Sum_probs=165.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 568999999999999999999987 78999999987543 2346788999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC--eEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--PKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DfGla~~~~~ 669 (732)
+++|+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999998843 346899999999999999999999986 999999999999988765 99999999874322
Q ss_pred cCceeeecccCccccccchhcccCCCCCc-hhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYK-ADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k-~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 21 2234569999999999988777655 8999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=326.05 Aligned_cols=199 Identities=27% Similarity=0.460 Sum_probs=176.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999986 79999999987542 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999984 3456899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 422 2234579999999999988765 6899999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=319.26 Aligned_cols=201 Identities=27% Similarity=0.425 Sum_probs=163.6
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCC--E
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGD--Q 584 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 584 (732)
...++|++.+.||+|+||.||+|.+. +|+.||||++... .....+++.+|+.+++.+. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999875 7899999998643 3344567889999999997 999999999998654 7
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++|||||+ ++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 589998843 36889999999999999999999996 999999999999999999999999999
Q ss_pred eeCCcc--------------------CceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEE--------------------KTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~--------------------~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+..... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 764321 1112234679999999999886 6789999999999999999999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=319.40 Aligned_cols=214 Identities=27% Similarity=0.407 Sum_probs=180.3
Q ss_pred cHHHHHHHhCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeee
Q 040398 505 TLKQIRAATSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLY 576 (732)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~ 576 (732)
...++....++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3455566788999999999999999999973 256899999997643 33456799999999999 799999999
Q ss_pred eeEEeCC-EEEEEEEecCCCchhHHhhcCCCC------------------------------------------------
Q 040398 577 GCCIEGD-QLMLVYEYLENNSLAHALFGGENS------------------------------------------------ 607 (732)
Q Consensus 577 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------ 607 (732)
+++.+.+ ..++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998865 489999999999999999754321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc-
Q 040398 608 --------------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT- 672 (732)
Q Consensus 608 --------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~- 672 (732)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999996 99999999999999999999999999976543322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 23334568899999999999999999999999999999998 99999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.18 Aligned_cols=202 Identities=29% Similarity=0.469 Sum_probs=171.8
Q ss_pred hCCCcccceecccCceEEEEEEE-----cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 585 (732)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 26899999999876666678899999999999999999999998654 458
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999543 335899999999999999999999986 9999999999999999999999999998
Q ss_pred eCCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......++..|+|||.+.+..++.++|||||||++|||+||..|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 6544322 122234577789999999999999999999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=316.16 Aligned_cols=210 Identities=25% Similarity=0.303 Sum_probs=174.1
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-----cccchHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-----SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE 581 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 581 (732)
++....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34567788999999999999999999875 7899999998643 23445789999999999999999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCC------------------------------------CCcccCCHHHHHHHHHHHHH
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGE------------------------------------NSQLKLNWSVRQKICLGIAR 625 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------~~~~~l~~~~~~~i~~~i~~ 625 (732)
.+..++||||+++|+|.+++.... .....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999884210 01223467888899999999
Q ss_pred HHHHHHhCCCCceEeCCCCCCCeEEcCCC--CeEEEeeecceeCCccCc---eeeecccCccccccchhccc--CCCCCc
Q 040398 626 GLAFLHEESRFKIVHRDIKATNVLLDRDL--NPKISDFGLAKLDEEEKT---HISTRVAGTIGYMAPEYALW--GYLTYK 698 (732)
Q Consensus 626 aL~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kL~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~--~~~~~k 698 (732)
||+|||+.+ |+||||||+||+++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999996 99999999999998776 899999999975433211 12234579999999999875 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCC
Q 040398 699 ADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 699 ~DvwSlGvll~elltG~~P~~~ 720 (732)
+|||||||++|||++|+.||..
T Consensus 257 ~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.22 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=176.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc------chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ------GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999986 6899999998754221 357799999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF 661 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~Df 661 (732)
++||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999953 346889999999999999999999996 99999999999999887 7999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 99986654322 2345699999999999999999999999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.19 Aligned_cols=202 Identities=27% Similarity=0.379 Sum_probs=174.1
Q ss_pred hCCCcccceecccCceEEEEEEE----cCCeEEEEEEccccc----ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL----TDGTIIAVKLLSSKS----RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 583 (732)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999987 368999999987532 22345677899999999 6999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999853 346899999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 98665444433445679999999999985 35789999999999999999999999743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.38 Aligned_cols=197 Identities=29% Similarity=0.344 Sum_probs=164.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.++||+|+||.||+|++. +|+.||||++..... ....++..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 457999999999999999999987 799999998765422 2334455666555555 899999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67998887432 346899999999999999999999986 9999999999999999999999999987654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 432 2234569999999998876 78999999999999999999976654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.48 Aligned_cols=202 Identities=30% Similarity=0.506 Sum_probs=163.9
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457889999999999999999865 5678999999764 33445689999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999542 346899999999999999999999986 999999999999999999999999999865
Q ss_pred CccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 668 EEEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 4432211 112235678999999999999999999999999999998 9999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.65 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=175.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------cchHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------QGNREFLNEIGTISCLQHPNLVKLYGCCIEG 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 582 (732)
..++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4668999999999999999999875 789999999875421 1234577899999999999999999999999
Q ss_pred CEEEEEEEecCCC-chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 583 DQLMLVYEYLENN-SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 583 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99998843 346899999999999999999999996 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99987654332 233569999999999988776 7899999999999999999999965
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=311.34 Aligned_cols=190 Identities=26% Similarity=0.374 Sum_probs=151.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 520 NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
+.||+|+||.||+|++. +++.||||++... ....+.+|+++++.+. ||||+++++++.+++..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999986 7899999998643 3466788999999997 99999999999999999999999999999
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEEEeeecceeCCccCcee
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DfGla~~~~~~~~~~ 674 (732)
.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 999954 346899999999999999999999996 99999999999998765 7999999999865543322
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 2345689999999999999999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.35 Aligned_cols=203 Identities=27% Similarity=0.454 Sum_probs=174.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999987 78999999987543 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999853 2346899999999999999999999996 999999999999999999999999999864432
Q ss_pred Cceee-ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 671 KTHIS-TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 671 ~~~~~-~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21111 11235678999999998899999999999999999998 99999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.49 Aligned_cols=208 Identities=30% Similarity=0.486 Sum_probs=177.6
Q ss_pred HHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999874 34899999997653 334577999999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCC--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC
Q 040398 584 QLMLVYEYLENNSLAHALFGGENS--------------------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDI 643 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dl 643 (732)
..++||||+++++|.+++...... ...+++..++.++.||++||+|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999653221 257899999999999999999999996 999999
Q ss_pred CCCCeEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 644 KATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 644 kp~NILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
||+||++++++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999875433221 22233568889999999999999999999999999999999 99999653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=314.38 Aligned_cols=207 Identities=27% Similarity=0.367 Sum_probs=179.6
Q ss_pred cccHHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-----CCceeeee
Q 040398 503 SFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----HPNLVKLY 576 (732)
Q Consensus 503 ~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~ 576 (732)
.+++++.....++|++.+.||+|+||.||+|++. +++.||||++... ....+.+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 4455555567889999999999999999999985 7899999998743 333466788999999886 99999999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC----
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---- 652 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---- 652 (732)
+++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 9999999999999999 899999986432 235889999999999999999999996 999999999999975
Q ss_pred ---------------------CCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHH
Q 040398 653 ---------------------DLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEI 711 (732)
Q Consensus 653 ---------------------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~el 711 (732)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7889999999998654322 245789999999999999999999999999999999
Q ss_pred HcCCCCCCC
Q 040398 712 VSGKNNMSY 720 (732)
Q Consensus 712 ltG~~P~~~ 720 (732)
++|+.||..
T Consensus 253 l~g~~pf~~ 261 (360)
T 3llt_A 253 YTGSLLFRT 261 (360)
T ss_dssp HHSSCSCCC
T ss_pred HHCCCCCCC
Confidence 999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=309.21 Aligned_cols=207 Identities=32% Similarity=0.476 Sum_probs=177.8
Q ss_pred HhCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
..++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788999999999999999986 245889999997543 3445778999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC--------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 585 LMLVYEYLENNSLAHALFGGEN--------------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
.++||||+++++|.+++..... ....+++..++.++.||++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965432 1235899999999999999999999996 9999999
Q ss_pred CCCeEEcCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 645 ATNVLLDRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 645 p~NILl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
|+||++++++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999866443322 2223457889999999999999999999999999999999 99999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.34 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=171.7
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457889999999999999999876 68999999987653 3346789999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~~ 667 (732)
|+++++|.+.+.........+++..++.++.||++||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988654334467899999999999999999999996 9999999999999 44578999999999765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||..
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 4322 223456999999999876 5688999999999999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.96 Aligned_cols=202 Identities=28% Similarity=0.340 Sum_probs=166.3
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999986 789999999875432 234678999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999853 346899999999999999999999996 999999999999999999999999998765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 54333333345689999999999999999999999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.01 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=175.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999876 68999999986542 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DfGla~ 665 (732)
|||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||.+.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988843 346899999999999999999999996 999999999999987655 9999999997
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 6554322 2345799999999999999999999999999999999999999954
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.85 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=169.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999986 689999998865432 23567889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999988743 345899999999999999999999996 99999999999999999999999999986653
Q ss_pred cCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 155 PSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 3222 234568999999999876 5789999999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.40 Aligned_cols=196 Identities=25% Similarity=0.369 Sum_probs=165.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 583 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999876 7899999998754 334457788999999999999999999999754 4
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++ +|.+.+. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999976 4666662 24889999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9865432 223446799999999999999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.36 Aligned_cols=201 Identities=30% Similarity=0.462 Sum_probs=168.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-----ccchHHHHHHHHHHhcC---CCCceeeeeeeEEeC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-----RQGNREFLNEIGTISCL---QHPNLVKLYGCCIEG 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~ 582 (732)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999975 78999999986432 12235667777777666 499999999999876
Q ss_pred C-----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeE
Q 040398 583 D-----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657 (732)
Q Consensus 583 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 657 (732)
. ..++||||++ ++|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5899999997 59999885432 234899999999999999999999996 99999999999999999999
Q ss_pred EEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 658 ISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 658 L~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999997654322 22346799999999999999999999999999999999999999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.75 Aligned_cols=199 Identities=31% Similarity=0.504 Sum_probs=164.0
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccc----cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR----QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457889999999999999999976 89999999875422 2346789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC--------CCCeEEEe
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--------DLNPKISD 660 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kL~D 660 (732)
|||+++++|.+++. ...+++..++.++.|+++||+|||+++..+|+||||||+||++++ ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999883 346899999999999999999999986445899999999999986 67799999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999975543222 234689999999999999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=338.05 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=177.4
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 585 (732)
...++|++.+.||+|+||.||+|+.+ +++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34678999999999999999999976 6899999998753 233456788899999988 799999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999953 346899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 5433222 23456899999999999999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.47 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=170.4
Q ss_pred hCCCccc-ceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPM-NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567775 78999999999999875 7899999999876666678899999999885 7999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEeeeccee
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAKL 666 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DfGla~~ 666 (732)
||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999853 346899999999999999999999996 999999999999998776 99999999875
Q ss_pred CCccCc------eeeecccCccccccchhccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 667 DEEEKT------HISTRVAGTIGYMAPEYALW-----GYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 667 ~~~~~~------~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 432111 11223469999999999875 568899999999999999999999997543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.83 Aligned_cols=199 Identities=28% Similarity=0.460 Sum_probs=172.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4568999999999999999999876 67899999986432 2335678999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998843 346899999999999999999999986 999999999999999999999999988644
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 3322 2345689999999999999999999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.54 Aligned_cols=206 Identities=29% Similarity=0.433 Sum_probs=177.2
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+++.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999852 34689999987653 33457789999999999 999999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999965432 1246899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999976543222 22233457889999999999999999999999999999999 99999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=302.05 Aligned_cols=201 Identities=30% Similarity=0.516 Sum_probs=176.9
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999998889999999876533 3467899999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999998542 346889999999999999999999996 99999999999999999999999999976544322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 22233457789999999998899999999999999999999 8999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.65 Aligned_cols=196 Identities=30% Similarity=0.472 Sum_probs=164.1
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhc--CCCCceeeeeeeEEeC----CEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISC--LQHPNLVKLYGCCIEG----DQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 586 (732)
.++|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56899999999999999999988 5899999998643 33455666666665 7999999999987653 4689
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH--------EESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
+||||+++|+|.+++. ...+++..+.+++.||++||+||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 9999999999999993 236899999999999999999999 66 4999999999999999999999
Q ss_pred EeeecceeCCccCcee---eecccCccccccchhcccC------CCCCchhHHHHHHHHHHHHcC----------CCCCC
Q 040398 659 SDFGLAKLDEEEKTHI---STRVAGTIGYMAPEYALWG------YLTYKADVYSFGVVALEIVSG----------KNNMS 719 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvll~elltG----------~~P~~ 719 (732)
+|||+++......... .....||+.|+|||++.+. .+++++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997644333221 2234799999999999876 455799999999999999999 77775
Q ss_pred C
Q 040398 720 Y 720 (732)
Q Consensus 720 ~ 720 (732)
.
T Consensus 235 ~ 235 (301)
T 3q4u_A 235 D 235 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.74 Aligned_cols=205 Identities=30% Similarity=0.402 Sum_probs=174.0
Q ss_pred hCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457889999999999999999842 5778999998754 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEEE
Q 040398 586 MLVYEYLENNSLAHALFGGE---NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKIS 659 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 659 (732)
++||||+++|+|.+++.... .....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 23346899999999999999999999996 99999999999999554 59999
Q ss_pred eeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 660 DFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999997432211 112223467899999999999999999999999999999998 9999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.22 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=174.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 567999999999999999999974 79999999986442 234578899999999 79999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-----eEEEeeecce
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKISDFGLAK 665 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DfGla~ 665 (732)
|+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999543 335899999999999999999999986 999999999999987776 9999999998
Q ss_pred eCCccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 666 LDEEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 666 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 65443221 2234679999999999999999999999999999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=326.11 Aligned_cols=204 Identities=30% Similarity=0.473 Sum_probs=176.8
Q ss_pred HHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
....++|++.+.||+|+||.||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34467888999999999999999999888999999987643 34678999999999999999999999986 66789999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999532 2235788999999999999999999996 99999999999999999999999999986544
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
..........++..|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 32222233456789999999998999999999999999999999 9999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=304.19 Aligned_cols=202 Identities=29% Similarity=0.397 Sum_probs=162.5
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|++. .+..||+|++... .....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 567889999999999999999874 3567999998764 334456789999999999999999999997 4567889
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999998532 346899999999999999999999986 999999999999999999999999999865
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 5433323333457789999999998899999999999999999997 99999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.45 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=156.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467899999999999999999975 78999999986532 22347789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998532 346899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 32221 22356899999999999888999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.66 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=161.9
Q ss_pred hCCCccc-ceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHh-cCCCCceeeeeeeEEe----CCEE
Q 040398 513 TSNFDPM-NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTIS-CLQHPNLVKLYGCCIE----GDQL 585 (732)
Q Consensus 513 ~~~f~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~ 585 (732)
.++|.+. +.||+|+||.||+|++. +|+.||||++.. ...+.+|++++. ..+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999986 789999999863 245678888874 4589999999999876 5678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEeee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFG 662 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DfG 662 (732)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999643 2346899999999999999999999986 999999999999998 7889999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 998654322 22346789999999999999999999999999999999999999964
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=315.17 Aligned_cols=202 Identities=21% Similarity=0.270 Sum_probs=168.8
Q ss_pred HhCCCcccceecccCceEEEEEEEcC------CeEEEEEEcccccccc-----------hHHHHHHHHHHhcCCCCceee
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQG-----------NREFLNEIGTISCLQHPNLVK 574 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~ 574 (732)
..++|++.+.||+|+||.||+|++.+ ++.||||++....... ...+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998764 4789999987543211 123455667788889999999
Q ss_pred eeeeEEeC----CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 575 LYGCCIEG----DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 575 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998874 5589999999 9999999854 2346899999999999999999999996 9999999999999
Q ss_pred c--CCCCeEEEeeecceeCCccCcee------eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 651 D--RDLNPKISDFGLAKLDEEEKTHI------STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 651 ~--~~~~~kL~DfGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9 88999999999998665432211 1234599999999999999999999999999999999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.02 Aligned_cols=204 Identities=29% Similarity=0.433 Sum_probs=177.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3567899999999999999999986 78999999987543 334577899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++. ....+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999883 3346899999999999999999999986 99999999999999999999999999976543
Q ss_pred cCc-eeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 670 EKT-HISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 670 ~~~-~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 222 22334578999999999987664 779999999999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.44 Aligned_cols=197 Identities=23% Similarity=0.373 Sum_probs=170.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++...... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999986 7899999998755332 34688888887 7999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-C---CeEEEeeecce
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-L---NPKISDFGLAK 665 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~---~~kL~DfGla~ 665 (732)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ + .+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999998853 346899999999999999999999996 9999999999998543 3 49999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 6544322 22346789999999999888889999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.98 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=167.1
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCC--CceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQH--PNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv 588 (732)
.+.|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45788999999999999999998889999999987542 3345778999999999986 9999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 567899999953 346889999999999999999999996 99999999999997 5789999999998654
Q ss_pred ccCce-eeecccCccccccchhccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTH-ISTRVAGTIGYMAPEYALW-----------GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43322 2334679999999999865 6789999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.38 Aligned_cols=199 Identities=28% Similarity=0.388 Sum_probs=168.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 584 (732)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999976 6899999998754 233457889999999999999999999998876 57
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||++ ++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 599999843 346899999999999999999999996 999999999999999999999999999
Q ss_pred eeCCccCc---------------------eeeecccCccccccchhc-ccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 665 KLDEEEKT---------------------HISTRVAGTIGYMAPEYA-LWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 665 ~~~~~~~~---------------------~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
+....... ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86543321 112456799999999986 55679999999999999999999777664
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=298.88 Aligned_cols=199 Identities=24% Similarity=0.377 Sum_probs=173.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356889999999999999999987 789999999875421 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF 661 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~Df 661 (732)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999843 346899999999999999999999986 99999999999998877 7999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|.+........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 99986544222 2345689999999999989999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.28 Aligned_cols=200 Identities=25% Similarity=0.362 Sum_probs=176.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999986 68899999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||.+....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998843 346899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3222 22345689999999999998999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.24 Aligned_cols=204 Identities=26% Similarity=0.466 Sum_probs=178.9
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
...+|++.+.||+|+||.||+|+++ ++..||||+++... ...++|.+|++++++++||||+++++++.+++..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3567888999999999999999987 58999999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999643 2345889999999999999999999996 999999999999999999999999999876543
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.........++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 3333334456789999999999999999999999999999999 99999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.65 Aligned_cols=204 Identities=26% Similarity=0.464 Sum_probs=180.0
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34667889999999999999999987 58999999987543 34577899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999643 2345899999999999999999999996 99999999999999999999999999987655
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
..........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 44444444557889999999999999999999999999999999 9999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.77 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=163.4
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------cchHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------QGNREFLNEIGTISCLQHPNLVKLYGCCIE 581 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 581 (732)
...++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45679999999999999999999876 689999999865321 11235789999999999999999999975
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC---CeEE
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKI 658 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL 658 (732)
.+..++||||+++|+|.+++. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999884 3456899999999999999999999996 99999999999997544 5999
Q ss_pred EeeecceeCCccCceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 659 SDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999865442 22334679999999999853 5678899999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.84 Aligned_cols=209 Identities=24% Similarity=0.432 Sum_probs=161.8
Q ss_pred HHHhCCCcccceecccCceEEEEEEEcC-Ce---EEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLTD-GT---IIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~~-g~---~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
....++|++.+.||+|+||.||+|++.. +. .||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3446789999999999999999998753 32 7999998764 3344678999999999999999999999998876
Q ss_pred EE------EEEEEecCCCchhHHhhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 584 QL------MLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 584 ~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
.. ++||||+++|+|.+++.... .....+++..++.++.||++||+|||+++ |+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 99999999999999885432 23336899999999999999999999996 999999999999999999
Q ss_pred eEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999976543222 12223456789999999999999999999999999999999 99999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.69 Aligned_cols=202 Identities=30% Similarity=0.513 Sum_probs=166.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCe----EEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|++.+.||+|+||.||+|++. +++ +||+|.+... .....+++.+|++++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 457889999999999999999865 444 3688887643 3345678999999999999999999999998765 77
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+|+||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 899999999999998543 346899999999999999999999996 99999999999999999999999999976
Q ss_pred CCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 667 DEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 667 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
...... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 543322 22233457889999999999999999999999999999999 99999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.77 Aligned_cols=210 Identities=21% Similarity=0.341 Sum_probs=177.5
Q ss_pred ccHHHHHHHhCCCccc-ceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCC-CCceeeeeee
Q 040398 504 FTLKQIRAATSNFDPM-NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQ-HPNLVKLYGC 578 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~ 578 (732)
..++......+.|.+. +.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3445556667778887 88999999999999886 68999999987643 334678899999999994 6999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCC
Q 040398 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLN 655 (732)
Q Consensus 579 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~ 655 (732)
+.+.+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999988432 2356899999999999999999999996 999999999999998 789
Q ss_pred eEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999986644322 2345799999999999999999999999999999999999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.89 Aligned_cols=208 Identities=30% Similarity=0.460 Sum_probs=175.1
Q ss_pred HhCCCcccceecccCceEEEEEEE------cCCeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGD 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 583 (732)
..++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357888999999999999999986 24678999998754 334457899999999999 8999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCC-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 584 QLMLVYEYLENNSLAHALFGGENS-------------------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
..++||||+++|+|.+++...... ...+++..++.++.||++||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 134799999999999999999999996 9999999
Q ss_pred CCCeEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 645 ATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 645 p~NILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
|+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999975543322 22233457889999999999999999999999999999998 999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.87 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=176.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+|.+.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999986 6889999998654 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998843 346899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 3322 22345699999999999998999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.14 Aligned_cols=195 Identities=30% Similarity=0.481 Sum_probs=170.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888999999999999999974 79999999987542 223467899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||++ |+|.+.+.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688887742 2346899999999999999999999996 99999999999999999999999999976543
Q ss_pred cCceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2356999999999985 56789999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.47 Aligned_cols=201 Identities=35% Similarity=0.547 Sum_probs=175.0
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788999999999999999999888899999987543 34578999999999999999999999876 45688999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||.+........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999998431 1236899999999999999999999996 99999999999999999999999999987655443
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 33334557889999999998899999999999999999999 9999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.49 Aligned_cols=194 Identities=25% Similarity=0.384 Sum_probs=154.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 584 (732)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999876 7899999998653 233457789999999999999999999998543 57
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+ +++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5689998843 346899999999999999999999996 999999999999999999999999999
Q ss_pred eeCCccCc--------------------------eeeecccCccccccchhc-ccCCCCCchhHHHHHHHHHHHHcC
Q 040398 665 KLDEEEKT--------------------------HISTRVAGTIGYMAPEYA-LWGYLTYKADVYSFGVVALEIVSG 714 (732)
Q Consensus 665 ~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvll~elltG 714 (732)
+....... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 86542211 122345789999999976 466799999999999999999994
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.77 Aligned_cols=201 Identities=27% Similarity=0.337 Sum_probs=167.7
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------ 582 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 582 (732)
....++|++.+.||+|+||.||+|++. +|+.||+|++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999875 7999999988654322 24699999999999999999998543
Q ss_pred --------------------------------CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHH
Q 040398 583 --------------------------------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630 (732)
Q Consensus 583 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL 630 (732)
...++||||++ ++|.+.+.........+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 588887754334456789999999999999999999
Q ss_pred HhCCCCceEeCCCCCCCeEEc-CCCCeEEEeeecceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHH
Q 040398 631 HEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVA 708 (732)
Q Consensus 631 H~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll 708 (732)
|+.+ |+||||||+|||++ +++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9986 99999999999998 678999999999986644332 2345689999999998865 589999999999999
Q ss_pred HHHHcCCCCCCC
Q 040398 709 LEIVSGKNNMSY 720 (732)
Q Consensus 709 ~elltG~~P~~~ 720 (732)
|||++|+.||..
T Consensus 233 ~ell~g~~pf~~ 244 (383)
T 3eb0_A 233 GELILGKPLFSG 244 (383)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.50 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=175.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467899999999999999999986 68899999986432 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999998843 346899999999999999999999986 9999999999999999999999999987554
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 322 2245689999999999999999999999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.86 Aligned_cols=199 Identities=25% Similarity=0.427 Sum_probs=164.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 7899999998754322 223456799999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5898888542 346899999999999999999999996 9999999999999999999999999997554322
Q ss_pred ceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2233568999999999876 5689999999999999999999999965
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=317.63 Aligned_cols=199 Identities=32% Similarity=0.501 Sum_probs=172.6
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC-EEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD-QLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e 590 (732)
..++|++.+.||+|+||.||+|++. |+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888999999999999999886 7899999997543 4578999999999999999999999988765 7999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999642 2234789999999999999999999996 999999999999999999999999999854332
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
. ....++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 343 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred c----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 12357889999999999999999999999999999998 999997644
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.68 Aligned_cols=202 Identities=30% Similarity=0.497 Sum_probs=169.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeE----EEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTI----IAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457889999999999999999875 4543 7888775432 334456788999999999999999999886 46688
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999998542 346888999999999999999999996 99999999999999999999999999986
Q ss_pred CCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 667 DEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 667 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 6443322 2334567889999999999999999999999999999999 99999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.72 Aligned_cols=199 Identities=25% Similarity=0.367 Sum_probs=167.8
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCC--CCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQ--HPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv 588 (732)
...|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3468999999999999999999888999999998654 2334577899999999996 59999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 5688999998543 36788999999999999999999986 99999999999996 5789999999998654
Q ss_pred ccCce-eeecccCccccccchhccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTH-ISTRVAGTIGYMAPEYALW-----------GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 43222 2334679999999999865 4688999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.64 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=177.3
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------cchHHHHHHHHHHhcC-CCCceeeee
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------QGNREFLNEIGTISCL-QHPNLVKLY 576 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~ 576 (732)
.......++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 799999999865431 1235678999999999 799999999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
+++...+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 346899999999999999999999996 9999999999999999999
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhccc------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW------GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999986654322 234679999999999863 3588899999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=323.87 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=172.6
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-------------cchHHHHHHHHHHhcCCCCceeeee
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-------------QGNREFLNEIGTISCLQHPNLVKLY 576 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~ 576 (732)
...++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999986 689999999875421 2356789999999999999999999
Q ss_pred eeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC--
Q 040398 577 GCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-- 654 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 654 (732)
+++.+++..++||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998843 346899999999999999999999996 99999999999998876
Q ss_pred -CeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 655 -NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 655 -~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|+.||..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 699999999987654322 23457999999999877 4689999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.12 Aligned_cols=200 Identities=26% Similarity=0.389 Sum_probs=172.2
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
..++|++.+.||+|+||.||+|+.. +++.||+|++... ......++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4568999999999999999999986 7999999998754 233456788999999999 99999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC--------------
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-------------- 653 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------- 653 (732)
||||+++++|.+++.........+++..++.++.||++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999654333356899999999999999999999996 9999999999999844
Q ss_pred -----CCeEEEeeecceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 654 -----LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 654 -----~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998665432 23589999999998866 66689999999999999999997764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.92 Aligned_cols=206 Identities=26% Similarity=0.445 Sum_probs=175.6
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 568889999999999999999863 46789999997653 33456789999999999 899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965432 1235899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999866543322 2223457889999999998899999999999999999999 99999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.01 Aligned_cols=200 Identities=31% Similarity=0.471 Sum_probs=171.5
Q ss_pred CCCcccceecccCceEEEEEEE-----cCCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQL 585 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 585 (732)
..|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578899999999999999983 368999999987543 34457889999999999999999999999876 668
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999843 2345899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 666 LDEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 666 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
....... .......||..|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 7654433 22334568888999999999999999999999999999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.12 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=173.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC--EEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD--QLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457889999999999999999986 68999999987543 334577889999999999999999999998765 78999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE----cCCCCeEEEeeecc
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA 664 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DfGla 664 (732)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999985432 2234899999999999999999999996 9999999999999 77778999999999
Q ss_pred eeCCccCceeeecccCccccccchhccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALW--------GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 87654332 234579999999999865 5678899999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.24 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=173.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567889999999999999999986 799999999986655555778999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~~ 667 (732)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++ ++++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998843 346899999999999999999999996 9999999999999 77889999999998754
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 3321 2234689999999999999999999999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.01 Aligned_cols=207 Identities=28% Similarity=0.478 Sum_probs=177.8
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEcccccc-cchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKSR-QGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 56788999999999999999985 2578999999875533 3457789999999999 99999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC--------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 585 LMLVYEYLENNSLAHALFGGEN--------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
.++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 1235899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
++++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999865543322 2233457889999999999999999999999999999999 999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.57 Aligned_cols=205 Identities=25% Similarity=0.358 Sum_probs=173.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467899999999999999999974 789999999876666667789999999999999999999999873 347899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.........+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||.+...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998654444567899999999999999999999996 999999999999999999999999998754
Q ss_pred CccCce--------eeecccCccccccchhcccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTH--------ISTRVAGTIGYMAPEYALWGY---LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 321111 011235799999999987543 68899999999999999999999953
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.48 Aligned_cols=198 Identities=23% Similarity=0.454 Sum_probs=174.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457999999999999999999986 7899999998765 33445778999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999843 34688999999999999999999985 5 99999999999999999999999999864322
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 22345799999999999999999999999999999999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.78 Aligned_cols=200 Identities=26% Similarity=0.363 Sum_probs=164.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4668999999999999999999876 789999999975432 2345678999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-----CCCCeEEEeeec
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-----RDLNPKISDFGL 663 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kL~DfGl 663 (732)
|||+++ +|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999974 99998843 335899999999999999999999996 99999999999994 445599999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 975443222 22345689999999999874 589999999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.07 Aligned_cols=199 Identities=32% Similarity=0.484 Sum_probs=176.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.+.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999875 78999999987543 3446789999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999984 246899999999999999999999996 999999999999999999999999999765443
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 22 22345689999999999999999999999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=311.25 Aligned_cols=195 Identities=26% Similarity=0.408 Sum_probs=165.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 583 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 568999999999999999999985 7999999998653 2334567899999999999999999999998753
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899998853 35889999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9865432 234578999999999887 6899999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.71 Aligned_cols=195 Identities=28% Similarity=0.422 Sum_probs=170.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CC-------eEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DG-------TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|+.. ++ +.||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457889999999999999999865 33 5799999987666677889999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC--------e
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--------P 656 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~ 656 (732)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999542 334899999999999999999999996 999999999999998887 9
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~ 718 (732)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999998654332 12357889999999987 67899999999999999999965443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.32 Aligned_cols=202 Identities=30% Similarity=0.434 Sum_probs=176.6
Q ss_pred hCCCcccceecccCceEEEEEEE-----cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 585 (732)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 45788999999999999999984 3689999999987766667789999999999999999999999874 5678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999998532 335899999999999999999999986 9999999999999999999999999998
Q ss_pred eCCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 76543322 22334588889999999998999999999999999999999999853
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.66 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=170.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 567899999999999999999986 689999998865432 33466889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988763 2345899999999999999999999996 99999999999999999999999999976543
Q ss_pred cCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222 22345689999999998875 7899999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.05 Aligned_cols=202 Identities=32% Similarity=0.520 Sum_probs=169.7
Q ss_pred HhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..++|++.+.||+|+||.||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788899999999999999999888889999997643 335789999999999999999999999866 678999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999431 2235889999999999999999999996 9999999999999999999999999998654433
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 222333457789999999999999999999999999999999 9999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=317.85 Aligned_cols=200 Identities=15% Similarity=0.171 Sum_probs=163.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHH---HHHhcCCCCceeeee-------ee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEI---GTISCLQHPNLVKLY-------GC 578 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~ 578 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457888999999999999999974 7999999998743 334457789999 555666899999998 66
Q ss_pred EEeCC-----------------EEEEEEEecCCCchhHHhhcCC---CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 040398 579 CIEGD-----------------QLMLVYEYLENNSLAHALFGGE---NSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638 (732)
Q Consensus 579 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~i 638 (732)
+.+++ ..++||||+ +|+|.+++.... .....+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 679999985421 11234556888999999999999999996 9
Q ss_pred EeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccC-----------CCCCchhHHHHHHH
Q 040398 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-----------YLTYKADVYSFGVV 707 (732)
Q Consensus 639 iH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~k~DvwSlGvl 707 (732)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985433 2234567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 040398 708 ALEIVSGKNNMSYV 721 (732)
Q Consensus 708 l~elltG~~P~~~~ 721 (732)
+|||++|+.||...
T Consensus 303 l~elltg~~Pf~~~ 316 (377)
T 3byv_A 303 IYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHSSCCC---
T ss_pred HHHHHHCCCCCccc
Confidence 99999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=321.68 Aligned_cols=199 Identities=29% Similarity=0.461 Sum_probs=169.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+.|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3557999999999999999999986 78999999987542 33467889999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfGla~ 665 (732)
|||+++|+|.+.+.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.. +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999998843 346899999999999999999999996 9999999999999764 459999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 664432 223457999999999876 5689999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=305.58 Aligned_cols=201 Identities=30% Similarity=0.424 Sum_probs=171.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------- 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 582 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999985 78999999986543 23356788999999999999999999999873
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 583 -DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
+..++||||+++ +|.+.+... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999975 777766432 345899999999999999999999996 999999999999999999999999
Q ss_pred ecceeCCccC---ceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEK---THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9998654322 122234578999999998876 4689999999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=308.66 Aligned_cols=200 Identities=23% Similarity=0.258 Sum_probs=165.5
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccccc-----------chHHHHHHHHHHhcCCCCceeeeee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKSRQ-----------GNREFLNEIGTISCLQHPNLVKLYG 577 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~ 577 (732)
.++|++.+.||+|+||.||+|+.. ++..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467889999999999999999975 5788999998754321 1234678889999999999999999
Q ss_pred eEEe----CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC
Q 040398 578 CCIE----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653 (732)
Q Consensus 578 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 653 (732)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9988 78899999999 9999999843 237899999999999999999999996 9999999999999988
Q ss_pred C--CeEEEeeecceeCCccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 654 L--NPKISDFGLAKLDEEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 654 ~--~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 9999999999866433211 11345799999999999999999999999999999999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.38 Aligned_cols=208 Identities=26% Similarity=0.364 Sum_probs=171.4
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEccccccc-----------chHHHHHHHHHHhcCCCCce
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ-----------GNREFLNEIGTISCLQHPNL 572 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nI 572 (732)
..++++....++|++.+.||+|+||.||+|+..+|+.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3467888889999999999999999999999888999999988643221 13778999999999999999
Q ss_pred eeeeeeEEeC-----CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 573 VKLYGCCIEG-----DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 573 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
+++++++... ...++||||++ |+|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 9999998653 36899999997 588887753 3346899999999999999999999996 9999999999
Q ss_pred eEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 648 VLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 648 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999997543322 2234568999999999876 6789999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.53 Aligned_cols=204 Identities=26% Similarity=0.416 Sum_probs=166.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999875 7899999998753 233456789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.........+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998654334556899999999999999999999996 9999999999999999999999999987654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 3222 22235689999999999999999999999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.53 Aligned_cols=199 Identities=33% Similarity=0.568 Sum_probs=169.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccc-------hHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG-------NREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++....... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999985 78999999986543221 267899999999999999999999987665
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-----eEEE
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKIS 659 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~ 659 (732)
++||||+++++|.+.+.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 689999999999988854 2346899999999999999999999883 23999999999999988776 9999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL--WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999874333 223457999999999983 456789999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.54 Aligned_cols=201 Identities=29% Similarity=0.474 Sum_probs=172.5
Q ss_pred hCCCcccc-eecccCceEEEEEEEc---CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMN-KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|.+.+ .||+|+||.||+|++. +++.||+|++.... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 8999999999999853 57889999997643 34567799999999999999999999999 5567899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999843 3446899999999999999999999996 999999999999999999999999999876
Q ss_pred CccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 668 EEEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 5433322 222346889999999998899999999999999999998 9999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=321.76 Aligned_cols=199 Identities=27% Similarity=0.425 Sum_probs=172.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999986 7899999998643 233467889999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc---CCCCeEEEeeecce
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAK 665 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DfGla~ 665 (732)
|||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998843 346899999999999999999999996 99999999999995 45679999999997
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 554322 2234579999999998875 589999999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.62 Aligned_cols=208 Identities=27% Similarity=0.449 Sum_probs=174.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999986 78999999987542 3445678999999999999999999998865 568999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
||||+++++|.+++.........+++..++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||.+.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999654444456899999999999999999999874 1229999999999999999999999999987
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 6543222 122346899999999999889999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=303.37 Aligned_cols=203 Identities=31% Similarity=0.489 Sum_probs=170.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEE--EEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTII--AVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~v--AvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.. ++..+ |+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 357888999999999999999875 66654 99988753 333456789999999999 89999999999999999999
Q ss_pred EEEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 588 VYEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
||||+++++|.+++.... .....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999996543 23357899999999999999999999996 999999999999999999
Q ss_pred eEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 9999999987433221 1122356889999999998889999999999999999998 9999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=322.46 Aligned_cols=199 Identities=29% Similarity=0.447 Sum_probs=174.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999986 79999999986542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecc
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLA 664 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla 664 (732)
||||+.+|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998853 346899999999999999999999996 9999999999999 46788999999999
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 76544322 233569999999998876 689999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=300.95 Aligned_cols=197 Identities=32% Similarity=0.475 Sum_probs=171.0
Q ss_pred CcccceecccCceEEEEEEEc-----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEE
Q 040398 516 FDPMNKIGEGGFGPVYKGQLT-----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLML 587 (732)
Q Consensus 516 f~~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 587 (732)
|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988642 68999999997653 34456789999999999999999999999984 67899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999843 24899999999999999999999996 999999999999999999999999999876
Q ss_pred CccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ......+|..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 543322 22345688899999999998999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.28 Aligned_cols=196 Identities=24% Similarity=0.365 Sum_probs=162.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 583 (732)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999876 7899999998753 2334567889999999999999999999998765
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888773 24789999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 97654321 22345799999999999999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.88 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=159.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-c-chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-Q-GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... . ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 567899999999999999999975 799999999875422 2 2334455566688899999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||++ |+|.+++.........+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 488887754333456789999999999999999999997 6 9999999999999999999999999997654
Q ss_pred ccCceeeecccCccccccchhc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYA----LWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4322 2234689999999996 566789999999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.01 Aligned_cols=201 Identities=29% Similarity=0.421 Sum_probs=169.1
Q ss_pred hCCCcccceecccCceEEEEEEEcC----CeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|++.+ +..||+|++... .....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 5678899999999999999998642 346999998765 33456789999999999999999999999765 45689
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999853 2345899999999999999999999996 999999999999999999999999999765
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 5433333334557889999999998899999999999999999998 9999964
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.90 Aligned_cols=203 Identities=29% Similarity=0.417 Sum_probs=166.7
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc-----chHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-----GNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
....++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999976 6899999998753221 2346889999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999986 88888843 2346788899999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 976543322 22345789999999998764 588999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.95 Aligned_cols=199 Identities=35% Similarity=0.563 Sum_probs=160.0
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. ..+|+|+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 567889999999999999999865 359999987543 33457799999999999999999999964 5567899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999843 3356899999999999999999999996 999999999999999999999999998754332
Q ss_pred C-ceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 K-THISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~-~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 1 22223456999999999986 56788899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=314.40 Aligned_cols=197 Identities=28% Similarity=0.361 Sum_probs=163.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------CEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------DQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~ 586 (732)
.+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... .+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888999999999999999986 689999998865322 234699999999999999999988642 2367
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEeeecce
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAK 665 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DfGla~ 665 (732)
+||||+++ ++.+.+.........+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 666665433334557899999999999999999999986 9999999999999965 568999999998
Q ss_pred eCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 6544322 2345789999999998765 789999999999999999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.13 Aligned_cols=213 Identities=27% Similarity=0.408 Sum_probs=179.2
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeee
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYG 577 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 577 (732)
..+.....++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445678899999999999999999974 257899999987643 33456789999999999 7999999999
Q ss_pred eEEeCC-EEEEEEEecCCCchhHHhhcCCCC------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 578 CCIEGD-QLMLVYEYLENNSLAHALFGGENS------------QLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 578 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
++...+ ..++||||+++++|.+++...... ...+++..+..++.||++||+|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988754 589999999999999999654322 223789999999999999999999996 9999999
Q ss_pred CCCeEEcCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 645 ATNVLLDRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 645 p~NILl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
|+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999976544322 22234557889999999999999999999999999999998 99999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.09 Aligned_cols=200 Identities=26% Similarity=0.389 Sum_probs=174.6
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---------ccchHHHHHHHHHHhcCC-CCceeeeeeeEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---------RQGNREFLNEIGTISCLQ-HPNLVKLYGCCI 580 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 580 (732)
..++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4678999999999999999999986 78999999986542 122456789999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 581 EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 581 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
+++..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999843 346899999999999999999999996 99999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcc------cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYAL------WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||++........ .....|++.|+|||++. ...++.++||||||+++|+|++|+.||..
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 999986554322 23456899999999885 45688999999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=294.92 Aligned_cols=199 Identities=26% Similarity=0.442 Sum_probs=167.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 568899999999999999999986 79999999986532 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999843 345889999999999999999999996 9999999999999999999999999987654
Q ss_pred ccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 422 1223568999999999987765 6899999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.65 Aligned_cols=201 Identities=30% Similarity=0.398 Sum_probs=170.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
+|.....||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4455568999999999999975 789999999987666666789999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-CCCeEEEeeecceeCCccCc
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DfGla~~~~~~~~ 672 (732)
+++|.+++.... ....+++..+..++.||++||+|||+.+ ++||||||+||+++. ++.+||+|||.+........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999986432 2345678999999999999999999986 999999999999988 89999999999976543222
Q ss_pred eeeecccCccccccchhcccCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGY--LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 223456899999999987653 78999999999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.34 Aligned_cols=192 Identities=21% Similarity=0.366 Sum_probs=169.7
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEe--CCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIE--GDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 467999999999999999999875 7899999998743 3467899999999997 9999999999998 6678999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLD 667 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~ 667 (732)
|||+++++|.+++. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999873 3788999999999999999999996 99999999999999776 8999999999866
Q ss_pred CccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 54332 233568999999999877 678999999999999999999999995
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.77 Aligned_cols=200 Identities=32% Similarity=0.476 Sum_probs=171.6
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
..+.|++.+.||+|+||.||+|+.. +|+.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999986 68999999987543 35778999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++++|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999998842 2346899999999999999999999986 999999999999999999999999999765432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 22 22345689999999999998999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.82 Aligned_cols=211 Identities=27% Similarity=0.391 Sum_probs=178.4
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeE
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCC 579 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 579 (732)
+++....++|++.+.||+|+||.||+|++. +++.||+|++.... .....++.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 444556788999999999999999999754 36889999987543 23456789999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhcCC------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC
Q 040398 580 IEGDQLMLVYEYLENNSLAHALFGGE------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653 (732)
Q Consensus 580 ~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 653 (732)
.+.+..++||||+++|+|.+++.... .....+++..+.+++.||++||+|||+++ |+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999985421 11245789999999999999999999996 9999999999999999
Q ss_pred CCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 654 LNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 654 ~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999998754332221 1223456889999999999999999999999999999999 8999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.08 Aligned_cols=200 Identities=26% Similarity=0.369 Sum_probs=168.1
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc--------cchHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR--------QGNREFLNEIGTISCLQHPNLVKLYGCCIEG 582 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 582 (732)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567999999999999999999876 689999999865321 1234578999999999999999999998765
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKIS 659 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~ 659 (732)
+ .++||||+++++|.+++. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999884 3446899999999999999999999996 999999999999987654 9999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999998664422 122356899999999874 467889999999999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.82 Aligned_cols=200 Identities=29% Similarity=0.438 Sum_probs=162.9
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcC--CCCceeeeeeeEEeC--
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL--QHPNLVKLYGCCIEG-- 582 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~-- 582 (732)
.......++|++.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 333455678999999999999999999886 8999999986432 33445555555554 899999999999987
Q ss_pred --CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCCeEEcCCCC
Q 040398 583 --DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 583 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~ 655 (732)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 789999999999999999943 35899999999999999999999871 113999999999999999999
Q ss_pred eEEEeeecceeCCccCcee---eecccCccccccchhcccCCCCCc------hhHHHHHHHHHHHHcCC
Q 040398 656 PKISDFGLAKLDEEEKTHI---STRVAGTIGYMAPEYALWGYLTYK------ADVYSFGVVALEIVSGK 715 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~k------~DvwSlGvll~elltG~ 715 (732)
+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||+||.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 9999999997654433221 123579999999999987766655 99999999999999993
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=300.69 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=212.5
Q ss_pred CCCCEEEcccCcCcc--ccCcccccc-ccceEeccc-ccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCE
Q 040398 17 PYLETVDFAYNYLHG--SIPREWASM-QLKYISVFA-NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLET 92 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~--~~p~~~~~~-~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 92 (732)
.+++.|+|++|.+++ .+|..+..+ +|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578899999999998 888888888 799999994 8898889999999999999999999998888989999999999
Q ss_pred EeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCC-CCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 93 LRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWT-QLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 93 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
|+|++|+|++.+|..+..+++|+.|++++|++++.+|..+..++ +|+.|+|++|++++.+|..+..++ |+.|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999988899999999999999999999888999998888 899999999999988899988887 9999999999
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeE
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSL 251 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~L 251 (732)
+.+..+..|..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|.. +.++++|+.|
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~--------------l~~l~~L~~L 273 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG--------------LTQLKFLHSL 273 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG--------------GGGCTTCCEE
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH--------------HhcCcCCCEE
Confidence 9888888899999999999999999876666 778899999999999999888865 6677889999
Q ss_pred EccCCcCcCCCCCCccccCCCCcc
Q 040398 252 DLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 252 dLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
+|++|+|+|.+|.......+..+.
T Consensus 274 ~Ls~N~l~~~ip~~~~l~~L~~l~ 297 (313)
T 1ogq_A 274 NVSFNNLCGEIPQGGNLQRFDVSA 297 (313)
T ss_dssp ECCSSEEEEECCCSTTGGGSCGGG
T ss_pred ECcCCcccccCCCCccccccChHH
Confidence 999999998888764444444443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.65 Aligned_cols=195 Identities=28% Similarity=0.419 Sum_probs=154.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------D 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 583 (732)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999875 7999999998754 233456788999999999999999999998754 5
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6899988842 46899999999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9764432 234578999999999887 6789999999999999999999999964
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.34 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=167.9
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeE-EeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC-IEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~ 589 (732)
..++|++.+.||+|+||.||+|++. +++.||||++..... .+.+.+|+++++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4678999999999999999999974 789999998654432 24578899999999988877666555 6678899999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeeccee
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKL 666 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~ 666 (732)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 99999998532 345899999999999999999999996 9999999999999 7889999999999986
Q ss_pred CCccCc------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 667 DEEEKT------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 667 ~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 544322 11234579999999999999999999999999999999999999998644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.51 Aligned_cols=199 Identities=26% Similarity=0.389 Sum_probs=171.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 585 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999876 78999999987543 33447789999999999999999999998765 368
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599998843 35899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCcee--eecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHI--STRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 765433221 234579999999998764 4589999999999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.63 Aligned_cols=202 Identities=22% Similarity=0.352 Sum_probs=174.9
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccc-----------------hHHHHHHHHHHhcCCCCceeee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQG-----------------NREFLNEIGTISCLQHPNLVKL 575 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 575 (732)
.++|++.+.||+|+||.||+|+. +|+.||+|++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999999999 89999999987542211 1789999999999999999999
Q ss_pred eeeEEeCCEEEEEEEecCCCchhHHhhc----CCCCcccCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEE
Q 040398 576 YGCCIEGDQLMLVYEYLENNSLAHALFG----GENSQLKLNWSVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 576 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl 650 (732)
++++.+++..++||||+++++|.+++.. .......+++..++.++.||+.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998321 11224678999999999999999999998 75 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccC-CCCC-chhHHHHHHHHHHHHcCCCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTY-KADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999865432 23346799999999999877 5665 999999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=295.16 Aligned_cols=197 Identities=25% Similarity=0.449 Sum_probs=172.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe---------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--------- 581 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 581 (732)
...+|++.+.||+|+||.||+|++. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999986 79999999987543 346789999999999999999998865
Q ss_pred -------CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC
Q 040398 582 -------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 654 (732)
Q Consensus 582 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 654 (732)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44589999999999999999542 2346899999999999999999999996 99999999999999999
Q ss_pred CeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999986654322 233568999999999999999999999999999999999998874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.38 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=170.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC--CEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG--DQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457889999999999999999986 8899999987643 34456799999999999999999999999887 788999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++... ....+++..++.++.||++||+|||+.+ ..++||||||+||++++++.++|+|||.+....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999643 2235899999999999999999999873 249999999999999999999999998865322
Q ss_pred ccCceeeecccCccccccchhcccCCCCC---chhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTY---KADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~---k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ....||+.|+|||.+.+...+. ++|||||||++|||++|+.||..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 1245899999999998765444 79999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.69 Aligned_cols=202 Identities=30% Similarity=0.513 Sum_probs=165.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeE----EEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTI----IAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~----vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... .....+++.+|++++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999875 4543 577776543 3445678999999999999999999999998765 78
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+|+||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999998543 346899999999999999999999996 99999999999999999999999999976
Q ss_pred CCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 667 DEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 667 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 543322 12223456789999999999999999999999999999999 99999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.77 Aligned_cols=197 Identities=31% Similarity=0.450 Sum_probs=169.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 587 (732)
.|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999876 6889999998754 33445778999999999999999999999876 456899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCeEEEeeeccee
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL 666 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DfGla~~ 666 (732)
||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ .+|+||||||+||+++ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999943 346889999999999999999999873 2499999999999998 788999999999975
Q ss_pred CCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... ....||+.|+|||++. +.++.++|||||||++|+|++|+.||..
T Consensus 182 ~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 182 KRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 443322 2356999999999876 4689999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=293.66 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=171.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeE-EeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCC-IEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .+++.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 578999999999999999999974 799999999865432 34688999999999988877655554 66788899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~~ 667 (732)
|+ +++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||++ ++++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999998532 346899999999999999999999996 9999999999999 48889999999999865
Q ss_pred CccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 668 EEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 443221 1234579999999999999999999999999999999999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=299.91 Aligned_cols=206 Identities=28% Similarity=0.430 Sum_probs=158.3
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++..++..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4678999999999999999999865 78999999987543 334567889999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcC----CCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 590 EYLENNSLAHALFGG----ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 590 e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
||+++++|.+++... ......+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988531 223456899999999999999999999996 9999999999999999999999999987
Q ss_pred eCCccCc----eeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKT----HISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 5443211 11233568999999999876 5689999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=300.11 Aligned_cols=201 Identities=27% Similarity=0.484 Sum_probs=170.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.+.|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 568899999999999999999986 6899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++.. ....+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999998843 2345899999999999999999999996 9999999999999999999999999875321111
Q ss_pred ceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.......||+.|+|||++. +..++.++||||||+++|+|++|+.||..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 1122356899999999883 56789999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.02 Aligned_cols=199 Identities=31% Similarity=0.522 Sum_probs=164.3
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 356888999999999999999886 788999998643 34578899999999999999999999876 3478999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-eEEEeeecceeCCccC
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-PKISDFGLAKLDEEEK 671 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kL~DfGla~~~~~~~ 671 (732)
++++|.+++.... ....+++..++.++.||++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999996542 2235788999999999999999999932225999999999999998887 799999998754332
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 12345899999999999999999999999999999999999999743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.98 Aligned_cols=207 Identities=29% Similarity=0.447 Sum_probs=175.7
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CC-----eEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DG-----TIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGD 583 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 583 (732)
..++|++.+.||+|+||.||+|+.. ++ +.||+|++.... ....+.+.+|+++++++ +||||+++++++.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4578899999999999999999874 23 479999987653 33456789999999999 8999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCC----------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC
Q 040398 584 QLMLVYEYLENNSLAHALFGGEN----------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 653 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 653 (732)
..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999854211 1345799999999999999999999996 9999999999999999
Q ss_pred CCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 654 LNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 654 ~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999975433222 22233457889999999999999999999999999999999 99999753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.87 Aligned_cols=210 Identities=27% Similarity=0.416 Sum_probs=166.4
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG 582 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 582 (732)
+....++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3345678889999999999999999764 35689999987542 33456789999999999999999999999876
Q ss_pred CE-----EEEEEEecCCCchhHHhhcCC--CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC
Q 040398 583 DQ-----LMLVYEYLENNSLAHALFGGE--NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 655 (732)
Q Consensus 583 ~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 655 (732)
+. .++||||+++++|.+++.... .....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 53 599999999999999885432 34456899999999999999999999986 999999999999999999
Q ss_pred eEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 656 PKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 656 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999975543221 12223457889999999999999999999999999999999 88898753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=309.00 Aligned_cols=197 Identities=22% Similarity=0.331 Sum_probs=170.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC------CCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL------QHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 585 (732)
..+|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999876 6899999998754 23345677788877776 577999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC--eEEEeeec
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--PKISDFGL 663 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DfGl 663 (732)
++||||++ ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 68999885432 234899999999999999999999986 999999999999999987 99999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 9765432 2235799999999999999999999999999999999999999965
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=325.33 Aligned_cols=203 Identities=32% Similarity=0.516 Sum_probs=175.2
Q ss_pred HHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
...++|++.+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999987643 335789999999999999999999999866 67899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999431 2235889999999999999999999986 999999999999999999999999999765432
Q ss_pred CceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2222233457789999999999999999999999999999999 9999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=301.99 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=174.5
Q ss_pred hCCCcccceecccCceEEEEEEE-----cCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC--EE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-----TDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD--QL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~ 585 (732)
..+|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368999999998766666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999543 245899999999999999999999986 9999999999999999999999999998
Q ss_pred eCCccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
......... .....++..|+|||.+.+..++.++|||||||++|||+||..|+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 765443321 2234577789999999988899999999999999999999998863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.98 Aligned_cols=206 Identities=30% Similarity=0.511 Sum_probs=170.1
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEe----
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIE---- 581 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~---- 581 (732)
++....++|++.+.||+|+||.||+|++. +|+.||+|++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33446788999999999999999999985 78999999987543 3457789999999999 89999999999987
Q ss_pred --CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 582 --GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 582 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
.+..++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46889999999999999998643 2346899999999999999999999996 9999999999999999999999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999875543221 123356899999999987 56789999999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.64 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=165.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEE-----------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI----------- 580 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 580 (732)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468899999999999999999987 58999999988766666788999999999999999999999873
Q ss_pred ---eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCe
Q 040398 581 ---EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNP 656 (732)
Q Consensus 581 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 656 (732)
+.+..++||||++ |+|.+++.. ..+++..++.++.||++||+|||+++ |+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3468899999997 699998842 46889999999999999999999996 99999999999997 56789
Q ss_pred EEEeeecceeCCccCc--eeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKT--HISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 657 kL~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 9999999986543221 11223457889999998865 67899999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.12 Aligned_cols=198 Identities=27% Similarity=0.362 Sum_probs=163.4
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------EEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------QLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 586 (732)
..+|++.+.||+|+||.||+|+..++..+|+|++...... ..+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3468899999999999999999987777999987643222 236999999999999999999987543 378
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCeEEEeeecce
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAK 665 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DfGla~ 665 (732)
+||||++++.+ +.+.........+++..++.++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999987544 333222223457899999999999999999999996 99999999999999 78999999999998
Q ss_pred eCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7644332 2345789999999998765 589999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.06 Aligned_cols=202 Identities=31% Similarity=0.484 Sum_probs=167.1
Q ss_pred hCCCcccceecccCceEEEEEEEcC-----CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD-----GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
..+|+..+.||+|+||.||+|+... +..||+|++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567788999999999999998652 3469999987543 334567899999999999999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999998542 346899999999999999999999996 99999999999999999999999999976
Q ss_pred CCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 5433221 1122346788999999998999999999999999999999 9999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.97 Aligned_cols=208 Identities=25% Similarity=0.332 Sum_probs=162.9
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
........++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556678899999999999999999999986 78999999886543 233456788889999999999999999976433
Q ss_pred -------EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--hCCCCceEeCCCCCCCeEEcC-CC
Q 040398 585 -------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH--EESRFKIVHRDIKATNVLLDR-DL 654 (732)
Q Consensus 585 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--~~~~~~iiH~Dlkp~NILl~~-~~ 654 (732)
.++||||+++ +|.+.+.........+++..+..++.||+.||+||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999986 555544332234557889999999999999999999 775 999999999999997 89
Q ss_pred CeEEEeeecceeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 999999999986554332 2345789999999998765 489999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.73 Aligned_cols=201 Identities=31% Similarity=0.444 Sum_probs=160.2
Q ss_pred CCcccceecccCceEEEEEEEc--CC--eEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT--DG--TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLMLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv 588 (732)
.|++.+.||+|+||.||+|++. ++ ..||+|.+... .....+++.+|++++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 33 46899998754 33446789999999999999999999998765 4578999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999953 2345788999999999999999999996 9999999999999999999999999997543
Q ss_pred ccCc---eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 669 EEKT---HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 669 ~~~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 3221 11223457889999999999999999999999999999999 67777643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=323.85 Aligned_cols=201 Identities=28% Similarity=0.468 Sum_probs=167.1
Q ss_pred CCCcccc-eecccCceEEEEEEEc---CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMN-KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999764 46789999997653 3456789999999999999999999999876 568999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999853 2446899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceee--ecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 669 EEKTHIS--TRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~--~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 3322211 12335689999999999999999999999999999998 99999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.84 Aligned_cols=198 Identities=19% Similarity=0.218 Sum_probs=169.6
Q ss_pred hCCCcccceecccCceEEEEEEEcC---------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCceee---------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD---------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK--------- 574 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 574 (732)
.++|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678999999999999999998763 789999998643 45788999999999999987
Q ss_pred ------eeeeEEe-CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 575 ------LYGCCIE-GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 575 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6677776 68899999999 99999999543 1356899999999999999999999996 9999999999
Q ss_pred eEEcCCC--CeEEEeeecceeCCccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 648 VLLDRDL--NPKISDFGLAKLDEEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 648 ILl~~~~--~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765443221 1133579999999999999899999999999999999999999997
Q ss_pred CC
Q 040398 720 YV 721 (732)
Q Consensus 720 ~~ 721 (732)
..
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 54
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.91 Aligned_cols=202 Identities=29% Similarity=0.422 Sum_probs=167.7
Q ss_pred hCCCcccceecccCceEEEEEEEcC----CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~ 586 (732)
...|++.+.||+|+||.||+|++.+ +..+|+|.+.... ....+.+.+|++++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467888999999999999998642 3468999887543 3445778999999999999999999998654 56789
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999954 2345789999999999999999999996 99999999999999999999999999976
Q ss_pred CCccCc---eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKT---HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 543321 12233457889999999999999999999999999999999 5556654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=293.28 Aligned_cols=200 Identities=31% Similarity=0.442 Sum_probs=169.1
Q ss_pred hCCCcccc-eecccCceEEEEEEEc---CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 513 TSNFDPMN-KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 513 ~~~f~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
.++|++.+ .||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999642 47899999987643 22357799999999999999999999998 667789
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999954 345899999999999999999999996 99999999999999999999999999987
Q ss_pred CCccCcee--eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKTHI--STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 65433322 122346788999999998889999999999999999999 9999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.05 Aligned_cols=198 Identities=32% Similarity=0.489 Sum_probs=159.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHH--HHHHhcCCCCceeeeeeeEEe-----CCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNE--IGTISCLQHPNLVKLYGCCIE-----GDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~H~nIv~l~~~~~~-----~~~~ 585 (732)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..| +..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 56889999999999999999977 58999999986443 2334444 444556899999999986553 2367
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES------RFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
++||||+++|+|.+++... ..++..+..++.||++||+|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999432 3488999999999999999999881 0139999999999999999999999
Q ss_pred eeecceeCCccC-------ceeeecccCccccccchhccc-------CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 660 DFGLAKLDEEEK-------THISTRVAGTIGYMAPEYALW-------GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 660 DfGla~~~~~~~-------~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
|||++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999997654321 112224569999999999886 456778999999999999999987764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=306.25 Aligned_cols=199 Identities=24% Similarity=0.337 Sum_probs=169.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC--------CCceeeeeeeEE---
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ--------HPNLVKLYGCCI--- 580 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 580 (732)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999875 7899999998743 334567889999999986 788999999988
Q ss_pred -eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcCCC----
Q 040398 581 -EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDL---- 654 (732)
Q Consensus 581 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~---- 654 (732)
.....++||||+ ++++.+.+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 456789999999 55666655432 224689999999999999999999998 6 99999999999999775
Q ss_pred ---------------------------------------------CeEEEeeecceeCCccCceeeecccCccccccchh
Q 040398 655 ---------------------------------------------NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689 (732)
Q Consensus 655 ---------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~ 689 (732)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999866543 223568999999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 690 ALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 690 ~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+.+..++.++|||||||++|||+||+.||....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999997533
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.58 Aligned_cols=196 Identities=10% Similarity=0.067 Sum_probs=151.5
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHH---HHHhcCCCCceeeee-------eeE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEI---GTISCLQHPNLVKLY-------GCC 579 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~ 579 (732)
.+|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+ +.++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35788999999999999999976 799999999986532 3345667774 45555 799988754 444
Q ss_pred EeC-----------------CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 040398 580 IEG-----------------DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVR------QKICLGIARGLAFLHEESRF 636 (732)
Q Consensus 580 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~aL~yLH~~~~~ 636 (732)
..+ ...++||||++ |+|.+++... ...+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 34899999998 8999999543 123344455 678899999999999996
Q ss_pred ceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcC
Q 040398 637 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSG 714 (732)
Q Consensus 637 ~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG 714 (732)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 13457799999999987 6899999999999999999999
Q ss_pred CCCCCCC
Q 040398 715 KNNMSYV 721 (732)
Q Consensus 715 ~~P~~~~ 721 (732)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=295.03 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=226.8
Q ss_pred CCcc--cCCccCCCCCCCCEEEccc-CcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCcc
Q 040398 4 SLPG--TLPPQIVNLPYLETVDFAY-NYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT 79 (732)
Q Consensus 4 ~~~g--~lP~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 79 (732)
.++| .+|+.+.++++|++|+|++ |.+.+.+|..+..+ +|++|+|++|++++.+|..++++++|++|+|++|.+++.
T Consensus 61 ~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 140 (313)
T 1ogq_A 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140 (313)
T ss_dssp CCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESC
T ss_pred CccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCc
Confidence 4667 8999999999999999995 99999999999988 899999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCEEeCCCCcccccCCccccCCC-CCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccC
Q 040398 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLK-NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISA 158 (732)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 158 (732)
+|..+..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++.+|..+..++ |+.|+|++|++++..|..+..
T Consensus 141 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~ 219 (313)
T 1ogq_A 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS 219 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCT
T ss_pred CChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhc
Confidence 999999999999999999999999999999998 999999999999999999999998 999999999999999999999
Q ss_pred ccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHH
Q 040398 159 LDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQI 238 (732)
Q Consensus 159 l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~ 238 (732)
+++|+.|+|++|.+....+. +..+++|++|+|++|+|++.+|..+..+++|+.|+|++|+++|.+|+.
T Consensus 220 l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~----------- 287 (313)
T 1ogq_A 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG----------- 287 (313)
T ss_dssp TSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-----------
T ss_pred CCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-----------
Confidence 99999999999999876555 888999999999999999999999999999999999999999999974
Q ss_pred HHHHhccCCCCeEEccCCc-CcCCC
Q 040398 239 LMFIRGVYEHQSLDLSYNN-FTWQS 262 (732)
Q Consensus 239 ~~~~~~l~~L~~LdLs~N~-l~~~~ 262 (732)
+.+++|+.|++++|+ +.|.|
T Consensus 288 ----~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 288 ----GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp ----TTGGGSCGGGTCSSSEEESTT
T ss_pred ----ccccccChHHhcCCCCccCCC
Confidence 345789999999998 55543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.51 Aligned_cols=205 Identities=30% Similarity=0.403 Sum_probs=170.1
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|++ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999983 25789999999754 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCC---CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEE
Q 040398 586 MLVYEYLENNSLAHALFGGEN---SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKIS 659 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~ 659 (732)
++||||+++++|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 2245899999999999999999999996 999999999999984 4469999
Q ss_pred eeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 660 DFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|||++....... ........|++.|+|||++.+..++.++|||||||++|+|+| |+.||..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999986432211 112223467889999999999999999999999999999998 9999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=291.28 Aligned_cols=203 Identities=25% Similarity=0.323 Sum_probs=169.0
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc----ccchHHHHHHHHHHhcCCCCceeeeeeeEE--eCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQHPNLVKLYGCCI--EGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~ 584 (732)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999975 78999999987542 234577999999999999999999999985 4457
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||++++ |.+++... ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||.+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 66666432 2346899999999999999999999996 999999999999999999999999999
Q ss_pred eeCCccC-ceeeecccCccccccchhcccCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEK-THISTRVAGTIGYMAPEYALWGY--LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8654322 22233456999999999987643 47899999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=299.80 Aligned_cols=199 Identities=24% Similarity=0.375 Sum_probs=169.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 585 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++.... .....++.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 568999999999999999999986 79999999986533 33456788999999999999999999987764 678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599998843 36899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCce---------eeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTH---------ISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65432211 1123568999999998764 6789999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.23 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=155.4
Q ss_pred hCCCcc-cceecccCceEEEEEEEc---CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEE
Q 040398 513 TSNFDP-MNKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLM 586 (732)
Q Consensus 513 ~~~f~~-~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 586 (732)
.+.|++ .++||+|+||.||+|+.+ +++.||+|++.... ....+.+|++++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344665 457999999999999965 57899999987542 24578899999999999999999999965 67899
Q ss_pred EEEEecCCCchhHHhhcC-----CCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE----cCCCCeE
Q 040398 587 LVYEYLENNSLAHALFGG-----ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPK 657 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~-----~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~k 657 (732)
+||||+++ +|.+++... ......+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999964 787776422 112235899999999999999999999996 9999999999999 6778999
Q ss_pred EEeeecceeCCccCc--eeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 658 ISDFGLAKLDEEEKT--HISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 658 L~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999986543221 222346799999999999874 5899999999999999999999999643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.46 Aligned_cols=194 Identities=26% Similarity=0.398 Sum_probs=166.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE----
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL---- 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 585 (732)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+++.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568899999999999999999876 79999999987642 33357788999999999999999999999877654
Q ss_pred --EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 586 --MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 586 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888772 24899999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9754432 234578999999999887 6889999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=296.62 Aligned_cols=203 Identities=31% Similarity=0.430 Sum_probs=171.1
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhc--CCCCceeeeeeeEEeCC
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISC--LQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~ 583 (732)
+.......++|++.+.||+|+||.||+|+.. |+.||||++... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3334456778999999999999999999884 899999998643 34667888888887 78999999999998876
Q ss_pred ----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeCCCCCCCeEEc
Q 040398 584 ----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH--------EESRFKIVHRDIKATNVLLD 651 (732)
Q Consensus 584 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiH~Dlkp~NILl~ 651 (732)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +. +|+||||||+||+++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 79999999999999999953 35899999999999999999999 66 499999999999999
Q ss_pred CCCCeEEEeeecceeCCccCce---eeecccCccccccchhcccC------CCCCchhHHHHHHHHHHHHcC--------
Q 040398 652 RDLNPKISDFGLAKLDEEEKTH---ISTRVAGTIGYMAPEYALWG------YLTYKADVYSFGVVALEIVSG-------- 714 (732)
Q Consensus 652 ~~~~~kL~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvll~elltG-------- 714 (732)
.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999765443322 22345799999999998765 233689999999999999999
Q ss_pred --CCCCCC
Q 040398 715 --KNNMSY 720 (732)
Q Consensus 715 --~~P~~~ 720 (732)
+.||..
T Consensus 262 ~~~~p~~~ 269 (342)
T 1b6c_B 262 DYQLPYYD 269 (342)
T ss_dssp CCCCTTTT
T ss_pred ccccCccc
Confidence 778764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=292.55 Aligned_cols=198 Identities=29% Similarity=0.389 Sum_probs=166.9
Q ss_pred CCcccceecccCceEEEEEEEc-C---CeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE-EEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-D---GTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL-MLV 588 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lv 588 (732)
.|...+.||+|+||.||+|++. + +..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455689999999999999853 2 3479999987543 34457889999999999999999999999876655 999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+.+++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999954 2346789999999999999999999996 9999999999999999999999999997543
Q ss_pred ccCc---eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 040398 669 EEKT---HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718 (732)
Q Consensus 669 ~~~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~ 718 (732)
.... .......+++.|+|||.+.+..++.++|||||||++|+|++|..|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 3221 1223356788999999999999999999999999999999966654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=295.69 Aligned_cols=201 Identities=28% Similarity=0.466 Sum_probs=169.6
Q ss_pred HhCCCcccceecccCceEEEEEEE--cCCeEEEEEEcccccc--cchHHHHHHHHHHhcC---CCCceeeeeeeEE----
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQL--TDGTIIAVKLLSSKSR--QGNREFLNEIGTISCL---QHPNLVKLYGCCI---- 580 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 580 (732)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 467899999999999999999998 3689999999865322 2233566777766665 8999999999987
Q ss_pred -eCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 581 -EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 581 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
.....++||||++ |+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999885432 234899999999999999999999996 9999999999999999999999
Q ss_pred eeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 660 DFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|||++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999997654322 22345689999999999999999999999999999999999999964
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=291.46 Aligned_cols=197 Identities=31% Similarity=0.493 Sum_probs=164.4
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-CEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-DQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 567889999999999999999875 8999999987543 457789999999999999999999997654 478999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999998532 1223789999999999999999999996 9999999999999999999999999987543321
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 12357889999999998999999999999999999998 99999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.66 Aligned_cols=205 Identities=25% Similarity=0.307 Sum_probs=158.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEe--------C
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIE--------G 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--------~ 582 (732)
..+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457889999999999999999975 78999999987666666778899999999996 9999999999853 3
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
...++||||++ |+|.+++.... ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45899999996 69998875421 2346899999999999999999999873 239999999999999999999999999
Q ss_pred cceeCCccCce-----------eeecccCccccccchhc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTH-----------ISTRVAGTIGYMAPEYA---LWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~-----------~~~~~~gt~~y~APE~~---~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99765432221 11134589999999998 566789999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=322.90 Aligned_cols=194 Identities=31% Similarity=0.458 Sum_probs=163.4
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
+.||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46889999987643 2345789999999999999999999999864 558899999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc--
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT-- 672 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~-- 672 (732)
|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999953 346899999999999999999999996 99999999999999999999999999986544322
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12223456789999999999999999999999999999998 99999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.72 Aligned_cols=201 Identities=28% Similarity=0.352 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCC-CceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.++||+|+||.||+|++. +++.||||++..... .+++.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 568999999999999999999975 789999998765433 2457889999999987 556666677778899999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE---cCCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DfGla~~~ 667 (732)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 99999998532 346899999999999999999999996 9999999999999 68899999999999865
Q ss_pred CccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 668 EEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 443221 1224679999999999999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.27 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEE-c-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCc------eeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL-T-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN------LVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~-~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 56899999999999999999987 3 6899999998754 233567888999998887654 9999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC------------
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR------------ 652 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~------------ 652 (732)
.++||||+ +++|.+++.... ...+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 889999885432 236889999999999999999999996 999999999999987
Q ss_pred -------CCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 653 -------DLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 653 -------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6679999999998654322 2457899999999999999999999999999999999999999753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=324.67 Aligned_cols=249 Identities=30% Similarity=0.493 Sum_probs=235.2
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
++|.+|+.+.++++|++|+|++|++++.+|..+..+ +|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..
T Consensus 406 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 485 (768)
T 3rgz_A 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485 (768)
T ss_dssp EEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred cccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHH
Confidence 567899999999999999999999999999999988 7999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccc-------
Q 040398 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSI------- 156 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------- 156 (732)
+.++++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus 486 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~ 565 (768)
T 3rgz_A 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI 565 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCB
T ss_pred HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchh
Confidence 9999999999999999999999999999999999999999999999999999999999999999988877643
Q ss_pred ---------------------------------------------------------------cCccCCCeeeccCcCCC
Q 040398 157 ---------------------------------------------------------------SALDKLNQLRISDLQGP 173 (732)
Q Consensus 157 ---------------------------------------------------------------~~l~~L~~L~ls~N~l~ 173 (732)
..+++|+.|+|++|+++
T Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~ 645 (768)
T 3rgz_A 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645 (768)
T ss_dssp CCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCB
T ss_pred hhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccc
Confidence 33577899999999999
Q ss_pred CCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEc
Q 040398 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDL 253 (732)
Q Consensus 174 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdL 253 (732)
+..+..++.+++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|+. +.++..|++|||
T Consensus 646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~--------------l~~l~~L~~L~l 711 (768)
T 3rgz_A 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA--------------MSALTMLTEIDL 711 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG--------------GGGCCCCSEEEC
T ss_pred ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH--------------HhCCCCCCEEEC
Confidence 999999999999999999999999999999999999999999999999999976 778899999999
Q ss_pred cCCcCcCCCCCCcc
Q 040398 254 SYNNFTWQSPEQPA 267 (732)
Q Consensus 254 s~N~l~~~~p~~~~ 267 (732)
|+|+|+|.+|....
T Consensus 712 s~N~l~g~iP~~~~ 725 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQ 725 (768)
T ss_dssp CSSEEEEECCSSSS
T ss_pred cCCcccccCCCchh
Confidence 99999999997654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.80 Aligned_cols=208 Identities=24% Similarity=0.359 Sum_probs=170.1
Q ss_pred ccHHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCC--CCceeeeeeeE
Q 040398 504 FTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQ--HPNLVKLYGCC 579 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 579 (732)
+.++.+....++|++.+.||+|+||.||+|+..+++.||||++... .....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444557789999999999999999999888999999998654 2334577899999999997 59999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEE
Q 040398 580 IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 659 (732)
Q Consensus 580 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 659 (732)
.+++..++||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||++++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 568899999853 346889999999999999999999996 999999999999975 789999
Q ss_pred eeecceeCCccCce-eeecccCccccccchhccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 660 DFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALW-----------GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 660 DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|||++......... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 99999765433221 2234568999999999875 4788899999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.84 Aligned_cols=195 Identities=29% Similarity=0.466 Sum_probs=161.9
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe---------
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE--------- 581 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 581 (732)
..++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999975 7899999998643 3345678999999999999999999998865
Q ss_pred ----CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeE
Q 040398 582 ----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK 657 (732)
Q Consensus 582 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 657 (732)
.+..++||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 35689999999999999999542 345788999999999999999999996 99999999999999999999
Q ss_pred EEeeecceeCCccC-------------ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHc
Q 040398 658 ISDFGLAKLDEEEK-------------THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVS 713 (732)
Q Consensus 658 L~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~ellt 713 (732)
|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999987554221 1112345689999999998764 78999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=291.26 Aligned_cols=201 Identities=26% Similarity=0.451 Sum_probs=162.8
Q ss_pred hCCCcccceecccCceEEEEEEEc--CC--eEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--DG--TIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|++. ++ ..||+|++... .....+.+.+|++++++++||||+++++++.+++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457889999999999999999853 33 36899988754 2334578899999999999999999999988765 7
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999988532 346899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 666 LDEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
........ ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 76543322 2223457889999999998889999999999999999999 9999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=288.76 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=172.8
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44678999999999999999999986 78999999986542 3346788999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeeecc
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLA 664 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfGla 664 (732)
||||+++++|.+.+.. ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998843 346899999999999999999999996 9999999999999764 46999999998
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 75543221 123458889999998875 489999999999999999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.49 Aligned_cols=194 Identities=26% Similarity=0.400 Sum_probs=165.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE-----
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ----- 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 584 (732)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+++.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999976 79999999987542 2335678899999999999999999999987654
Q ss_pred -EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 585 -LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 585 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
.++||||++ ++|.+++. ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58887762 24899999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8754332 223568999999999886 6789999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=294.08 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=151.7
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHH-HHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIG-TISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999986 79999999987643 233445566665 778889999999999999999999999
Q ss_pred EecCCCchhHHhhcC-CCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 590 EYLENNSLAHALFGG-ENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 590 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||+++ +|.+++... ......+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 887776421 11245689999999999999999999997 6 999999999999999999999999999765
Q ss_pred CccCceeeecccCccccccchhc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYA----LWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||..
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 43222 2234689999999998 456789999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=297.33 Aligned_cols=207 Identities=22% Similarity=0.390 Sum_probs=169.6
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD 583 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 583 (732)
.++.....++|++.+.||+|+||.||+|+... .+|+|++.... ....+.+.+|++++++++||||+++++++.+++
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34444557789999999999999999998763 49999987542 233456788999999999999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..++||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ ++||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999943 2346889999999999999999999996 99999999999998 67999999999
Q ss_pred ceeCCccC----ceeeecccCccccccchhccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 664 AKLDEEEK----THISTRVAGTIGYMAPEYALW---------GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 664 a~~~~~~~----~~~~~~~~gt~~y~APE~~~~---------~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
+....... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 86543211 111223458999999999874 35788999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=299.40 Aligned_cols=202 Identities=23% Similarity=0.306 Sum_probs=170.7
Q ss_pred HHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CC-----ceeeeeeeEEeC
Q 040398 510 RAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HP-----NLVKLYGCCIEG 582 (732)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~ 582 (732)
....++|++.+.||+|+||.||+|+.. +++.||||++... .....++.+|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345689999999999999999999876 7899999998743 233466778888888875 54 499999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc--CCCCeEEEe
Q 040398 583 DQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDLNPKISD 660 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~D 660 (732)
+..++||||++ ++|.+++.... ...+++..++.++.||+.||+|||.+ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 59999886432 23589999999999999999999953 12599999999999995 467899999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999866432 2245789999999999999999999999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-33 Score=294.79 Aligned_cols=203 Identities=23% Similarity=0.349 Sum_probs=172.3
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc------chHHHHHHHHHHhcCC--CCceeeeeee
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ------GNREFLNEIGTISCLQ--HPNLVKLYGC 578 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~ 578 (732)
+.....++|++.+.||+|+||.||+|+.. +++.||||++...... ..+++.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445778999999999999999999875 7899999998754221 2245678999999996 5999999999
Q ss_pred EEeCCEEEEEEEecCC-CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCe
Q 040398 579 CIEGDQLMLVYEYLEN-NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNP 656 (732)
Q Consensus 579 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~ 656 (732)
+.+++..++|||++.+ ++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 899998843 346899999999999999999999986 99999999999999 77899
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 999999998665432 224569999999999887665 6889999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=318.60 Aligned_cols=203 Identities=28% Similarity=0.390 Sum_probs=170.4
Q ss_pred HHhCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
...++|++.+.||+|+||.||+|++. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34567889999999999999999874 25689999987543 334577999999999999999999999984 5668
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999999532 345899999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 665433333334457889999999998999999999999999999997 9999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-33 Score=293.44 Aligned_cols=203 Identities=25% Similarity=0.370 Sum_probs=163.4
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccccc------chHHHHHHHHHHhcC----CCCceeeee
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ------GNREFLNEIGTISCL----QHPNLVKLY 576 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~ 576 (732)
+.....++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456788999999999999999999875 7899999998754321 223456788888888 899999999
Q ss_pred eeEEeCCEEEEEEEe-cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCC
Q 040398 577 GCCIEGDQLMLVYEY-LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDL 654 (732)
Q Consensus 577 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~ 654 (732)
+++.+.+..++|||| +.+++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||+++ +++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999853 346899999999999999999999986 99999999999999 789
Q ss_pred CeEEEeeecceeCCccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 655 NPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 655 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+||+|||++....... .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998765432 234568999999999887665 4589999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=296.52 Aligned_cols=197 Identities=23% Similarity=0.330 Sum_probs=167.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-----------CCceeeeeeeEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----------HPNLVKLYGCCI 580 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 580 (732)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 457899999999999999999975 7899999998743 233567888999988886 899999999998
Q ss_pred eCC----EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcC---
Q 040398 581 EGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDR--- 652 (732)
Q Consensus 581 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~--- 652 (732)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++.
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 754 789999999 889999885432 23588999999999999999999997 6 999999999999953
Q ss_pred ---CCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 653 ---DLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 653 ---~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 3479999999998665422 235689999999999999999999999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=303.02 Aligned_cols=199 Identities=28% Similarity=0.308 Sum_probs=156.2
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
.|...+.||+|+||.||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456889999999998776678999999988643 235678899999876 89999999999999999999999996
Q ss_pred CCchhHHhhcCCCCccc---CCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-------------CCeE
Q 040398 594 NNSLAHALFGGENSQLK---LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-------------LNPK 657 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~k 657 (732)
|+|.+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999654322211 134456789999999999999986 9999999999999754 4799
Q ss_pred EEeeecceeCCccCce---eeecccCccccccchhccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 658 ISDFGLAKLDEEEKTH---ISTRVAGTIGYMAPEYALW-------GYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 658 L~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||..
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 9999999876543322 1224579999999999875 678999999999999999999 9999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=290.74 Aligned_cols=197 Identities=22% Similarity=0.337 Sum_probs=168.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CC-eEEEEEEcccccccchHHHHHHHHHHhcCCCCc------eeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DG-TIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN------LVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|+.. ++ +.||+|++... ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 568999999999999999999875 44 78999998743 234567888999999987766 8999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE--------------
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-------------- 650 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl-------------- 650 (732)
.++||||+ ++++.+.+... ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 56676666432 2236899999999999999999999986 9999999999999
Q ss_pred -----cCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 651 -----DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 651 -----~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 667899999999998654322 235799999999999999999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=290.90 Aligned_cols=197 Identities=22% Similarity=0.275 Sum_probs=146.8
Q ss_pred HhCCCcccc-eecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEE
Q 040398 512 ATSNFDPMN-KIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQL 585 (732)
Q Consensus 512 ~~~~f~~~~-~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 585 (732)
..++|.+.+ .||+|+||.||+|++. +|+.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356888855 6999999999999987 79999999986432 222223344667799999999999876 4568
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC---CCeEEEeee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFG 662 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DfG 662 (732)
++||||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||+++.+ +.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999643 2246899999999999999999999996 9999999999999864 559999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 997654322 2235689999999999888899999999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=318.08 Aligned_cols=192 Identities=23% Similarity=0.326 Sum_probs=166.4
Q ss_pred hCCCcccceecccCceEEEEEEEc--CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE-----
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ----- 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 584 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 68999999986543 3445678999999999999999999999987655
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.+++.. .+++..++.++.||++||+|||+++ |+||||||+|||++++ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987732 6899999999999999999999996 9999999999999986 8999999999
Q ss_pred eeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+..... ....||++|+|||++.+.. +.++|||||||++|+|++|..||..
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 866543 2356999999999987765 8899999999999999999988864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-33 Score=300.15 Aligned_cols=191 Identities=23% Similarity=0.248 Sum_probs=158.9
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--------ccchHHHHHHHHHHhcCC---------CCceeee
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--------RQGNREFLNEIGTISCLQ---------HPNLVKL 575 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 575 (732)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999988 68999999987542 223377889999988886 6666666
Q ss_pred eeeE-----------------Ee-------------CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHH
Q 040398 576 YGCC-----------------IE-------------GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625 (732)
Q Consensus 576 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 625 (732)
.+.+ .+ ++..++||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 5543 32 6789999999999977766622 45799999999999999
Q ss_pred HHHHHH-hCCCCceEeCCCCCCCeEEcCCC--------------------CeEEEeeecceeCCccCceeeecccCcccc
Q 040398 626 GLAFLH-EESRFKIVHRDIKATNVLLDRDL--------------------NPKISDFGLAKLDEEEKTHISTRVAGTIGY 684 (732)
Q Consensus 626 aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y 684 (732)
||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ..+||+.|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 886 99999999999999887 8999999999865431 23699999
Q ss_pred ccchhcccCCCCCchhHHHHHHH-HHHHHcCCCCCC
Q 040398 685 MAPEYALWGYLTYKADVYSFGVV-ALEIVSGKNNMS 719 (732)
Q Consensus 685 ~APE~~~~~~~~~k~DvwSlGvl-l~elltG~~P~~ 719 (732)
+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998766 889999998777 788999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=287.16 Aligned_cols=199 Identities=25% Similarity=0.436 Sum_probs=151.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc-cc-hHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-QG-NREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 567889999999999999999986 789999999875432 22 233445556788889999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||+ ++.+...... ....+++..+..++.||++||+|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 4555554421 234689999999999999999999985 5 9999999999999999999999999987554
Q ss_pred ccCceeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ......|++.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 322 223456899999999984 55788999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=297.78 Aligned_cols=198 Identities=25% Similarity=0.340 Sum_probs=157.4
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
..+|+..+.||+|+||.||.....+|+.||||++...... .+.+|+++++.+ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4468888999999999876555567899999998654332 346799999999 799999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-----CCCeEEEeeeccee
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLNPKISDFGLAKL 666 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DfGla~~ 666 (732)
++ |+|.+++.... ....+..+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 59999986433 23344456789999999999999996 999999999999953 23588999999986
Q ss_pred CCccCc--eeeecccCccccccchhcc---cCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKT--HISTRVAGTIGYMAPEYAL---WGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~--~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 543321 2233467999999999987 4567889999999999999999 9999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=311.43 Aligned_cols=202 Identities=29% Similarity=0.414 Sum_probs=172.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEe------CCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE------GDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 584 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999875 6899999998764 33445778999999999999999999998765 667
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC---eEEEee
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDF 661 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~Df 661 (732)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999996532 2335888999999999999999999986 999999999999997765 899999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9998654432 22346799999999999999999999999999999999999999953
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=273.40 Aligned_cols=173 Identities=10% Similarity=0.056 Sum_probs=151.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|++++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999986 589999999976532 2347789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++++|.+++... .....+.+++.||++||+|||+++ |+||||||+|||+++++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP------- 173 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec-------
Confidence 9999999999998421 245578899999999999999996 999999999999999999998743
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+|++| ++.++|||||||++|||+||+.||....
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34443 6889999999999999999999997543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=286.10 Aligned_cols=246 Identities=15% Similarity=0.177 Sum_probs=166.7
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCcccc-Ccccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSI-PREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR 82 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 82 (732)
+.+..|..|.++++|++|+|++|.+.+.+ |..|..+ +|++|+|++|++++..|..|+++++|++|+|++|++++.+|.
T Consensus 42 i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 121 (455)
T 3v47_A 42 IAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLS 121 (455)
T ss_dssp CCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHH
T ss_pred cCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccC
Confidence 45555777788888888888888776444 4556666 688888888888766777788888888888888887765554
Q ss_pred c--ccCCCCCCEEeCCCCcccccCCcc-ccCCCCCCEEEccCccccccCCccccCC------------------------
Q 040398 83 E--LGNLVNLETLRLSSNRLIGNLPME-LVKLKNLTDFRINDNNFNGSAPDFIQSW------------------------ 135 (732)
Q Consensus 83 ~--l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l------------------------ 135 (732)
. +.++++|++|+|++|++++..|.. +.++++|+.|++++|++++..+..+..+
T Consensus 122 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~ 201 (455)
T 3v47_A 122 GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201 (455)
T ss_dssp SSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT
T ss_pred cccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc
Confidence 4 777778888888888887666655 6777888888888887776665544332
Q ss_pred ----------C---------------------------------------------------------------CCCEEE
Q 040398 136 ----------T---------------------------------------------------------------QLNRLE 142 (732)
Q Consensus 136 ----------~---------------------------------------------------------------~L~~L~ 142 (732)
+ +|+.|+
T Consensus 202 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ 281 (455)
T 3v47_A 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCD 281 (455)
T ss_dssp HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEE
T ss_pred ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEE
Confidence 2 344444
Q ss_pred cccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcc
Q 040398 143 IQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 143 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 222 (732)
+++|.+++..|..+..+++|+.|+|++|.+.+..+..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++
T Consensus 282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 361 (455)
T 3v47_A 282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence 44444444455556666666666666666666666666666666666666666665556666666666666666666666
Q ss_pred cCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 223 ELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 223 ~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
.+|.. +.++++|+.|+|++|+|++.++.
T Consensus 362 ~~~~~--------------~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 362 LGDQS--------------FLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp ECTTT--------------TTTCTTCCEEECCSSCCSCCCTT
T ss_pred cChhh--------------ccccccccEEECCCCccccCCHh
Confidence 55543 55566777777777777766654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=288.13 Aligned_cols=199 Identities=15% Similarity=0.150 Sum_probs=154.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCC-Cceee--------------
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQH-PNLVK-------------- 574 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~-------------- 574 (732)
..|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34667789999999999999965 79999999987432 2336789999999999987 32211
Q ss_pred -e------eeeEEe-----CCEEEEEEEecCCCchhHHhhcC---CCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 040398 575 -L------YGCCIE-----GDQLMLVYEYLENNSLAHALFGG---ENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIV 639 (732)
Q Consensus 575 -l------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ii 639 (732)
+ ..++.. ....+++|+++ +++|.+++... ......+++..+..++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1 111111 12356777765 67999887321 223456889999999999999999999996 99
Q ss_pred eCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhc----------ccCCCCCchhHHHHHHHHH
Q 040398 640 HRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA----------LWGYLTYKADVYSFGVVAL 709 (732)
Q Consensus 640 H~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~k~DvwSlGvll~ 709 (732)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865432 334567 999999999 5556888999999999999
Q ss_pred HHHcCCCCCCCC
Q 040398 710 EIVSGKNNMSYV 721 (732)
Q Consensus 710 elltG~~P~~~~ 721 (732)
||+||+.||...
T Consensus 309 elltg~~Pf~~~ 320 (413)
T 3dzo_A 309 WIWCADLPNTDD 320 (413)
T ss_dssp HHHHSSCCCCTT
T ss_pred HHHHCCCCCCCc
Confidence 999999999753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-31 Score=304.48 Aligned_cols=223 Identities=18% Similarity=0.205 Sum_probs=179.9
Q ss_pred cCccccCcccccc-ccceEeccccccccc-----------------CCcccc--CCCCCCEEecccccCCccCCccccCC
Q 040398 28 YLHGSIPREWASM-QLKYISVFANRLSGN-----------------IPSHLG--NITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 28 ~l~~~~p~~~~~~-~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
++++ +|..++.+ +|++|+|++|++++. +|..++ ++++|++|+|++|++.+.+|..++++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 3444 78888888 799999999999975 899988 99999999999999998999999999
Q ss_pred CCCCEEeCCCCc-ccc-cCCccccCC------CCCCEEEccCccccccCCc--cccCCCCCCEEEcccCCCcCcCCcccc
Q 040398 88 VNLETLRLSSNR-LIG-NLPMELVKL------KNLTDFRINDNNFNGSAPD--FIQSWTQLNRLEIQGSGLEGPIPPSIS 157 (732)
Q Consensus 88 ~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 157 (732)
++|++|+|++|+ ++| .+|..++++ ++|+.|++++|+++ .+|. .++++++|+.|+|++|+++|.+| .+.
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999998 888 888888876 89999999999998 7888 89999999999999999998888 888
Q ss_pred CccCCCeeeccCcCCCCCCcccccCCCC-ccEEEcccccccCCcchhhcCCC--CCcEEeCCCCcCcccCCCCCccCcch
Q 040398 158 ALDKLNQLRISDLQGPNQTFPMLRNMTG-LTRIILRNCNIAGEIPEYIWGIK--NLRFLDLSFNQLTGELPDVAVPADLK 234 (732)
Q Consensus 158 ~l~~L~~L~ls~N~l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~g~~p~~~~~~~l~ 234 (732)
.+++|+.|++++|.+.. .+..+..+++ |++|+|++|+++ .+|..+..++ +|+.|+|++|++++.+|....+....
T Consensus 351 ~l~~L~~L~L~~N~l~~-lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~ 428 (636)
T 4eco_A 351 SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428 (636)
T ss_dssp EEEEESEEECCSSEEEE-CCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred CCCCCCEEECCCCcccc-ccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccc
Confidence 89999999999998884 3445888888 999999999998 7888777654 89999999999998887653210000
Q ss_pred hhHHHHHHhccCCCCeEEccCCcCcCCC
Q 040398 235 FTQILMFIRGVYEHQSLDLSYNNFTWQS 262 (732)
Q Consensus 235 ~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 262 (732)
...+.+|+.|+|++|+++..+
T Consensus 429 -------~~~~~~L~~L~Ls~N~l~~lp 449 (636)
T 4eco_A 429 -------PFKGINVSSINLSNNQISKFP 449 (636)
T ss_dssp -------CCCCCCEEEEECCSSCCCSCC
T ss_pred -------cccCCCCCEEECcCCccCcCC
Confidence 003345566666666666433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=283.67 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=208.2
Q ss_pred cccC-CccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCcc--ccCCCCCCEEecccccCCccCC
Q 040398 6 PGTL-PPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSH--LGNITSLTYLDLEENQFSGTIP 81 (732)
Q Consensus 6 ~g~l-P~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p 81 (732)
.+.+ |..|.++++|++|+|++|++++..|..+..+ +|++|+|++|++++.+|.. ++.+++|++|+|++|++++..|
T Consensus 67 ~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 146 (455)
T 3v47_A 67 GLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146 (455)
T ss_dssp TCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCC
T ss_pred cceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCc
Confidence 3455 4578889999999999999988888888888 7999999999988755554 8888999999999999887667
Q ss_pred cc-ccCCCCCCEEeCCCCcccccCCccccCC-------------------------------------------------
Q 040398 82 RE-LGNLVNLETLRLSSNRLIGNLPMELVKL------------------------------------------------- 111 (732)
Q Consensus 82 ~~-l~~l~~L~~L~L~~N~l~~~~p~~l~~l------------------------------------------------- 111 (732)
.. +.++++|++|+|++|++++..|..+..+
T Consensus 147 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 226 (455)
T 3v47_A 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226 (455)
T ss_dssp CGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH
T ss_pred ccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc
Confidence 65 7888888888888888886666544332
Q ss_pred ------------------------------------------------CCCCEEEccCccccccCCccccCCCCCCEEEc
Q 040398 112 ------------------------------------------------KNLTDFRINDNNFNGSAPDFIQSWTQLNRLEI 143 (732)
Q Consensus 112 ------------------------------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 143 (732)
++|+.|++++|.+++.+|..+..+++|+.|+|
T Consensus 227 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 306 (455)
T 3v47_A 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306 (455)
T ss_dssp HHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEEC
Confidence 35666666666666677888999999999999
Q ss_pred ccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 144 QGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 144 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
++|++++..|..+..+++|+.|+|++|.+....+..|..+++|++|+|++|++++..|..+..+++|+.|+|++|+|++.
T Consensus 307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 99999988899999999999999999999999999999999999999999999988899999999999999999999976
Q ss_pred CCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 224 LPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 224 ~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
++.. +..+++|+.|+|++|++++..|.
T Consensus 387 ~~~~--------------~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 387 PDGI--------------FDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CTTT--------------TTTCTTCCEEECCSSCBCCCTTT
T ss_pred CHhH--------------hccCCcccEEEccCCCcccCCCc
Confidence 5543 56778999999999999977664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.63 Aligned_cols=175 Identities=22% Similarity=0.306 Sum_probs=150.8
Q ss_pred hCCCccc-ceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHH-hcCCCCceeeeeeeEEe----CCEE
Q 040398 513 TSNFDPM-NKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTI-SCLQHPNLVKLYGCCIE----GDQL 585 (732)
Q Consensus 513 ~~~f~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~ 585 (732)
.++|.+. +.||+|+||.||+|+.. +++.||+|++.. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 78999999999999875 789999999863 24567888887 66699999999999987 6778
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEeee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFG 662 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DfG 662 (732)
++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999643 2236899999999999999999999996 999999999999998 7889999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++.... +..++.++|||||||++|||++|+.||..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 986432 13467789999999999999999999964
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=299.04 Aligned_cols=244 Identities=16% Similarity=0.215 Sum_probs=216.5
Q ss_pred CCcccCCccCCCCCCCCEEEcccCcCccc-----------------cCcccc--cc-ccceEecccccccccCCccccCC
Q 040398 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGS-----------------IPREWA--SM-QLKYISVFANRLSGNIPSHLGNI 63 (732)
Q Consensus 4 ~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~~-~L~~L~L~~n~l~~~~p~~l~~l 63 (732)
.++| ||++++++++|++|+|++|.+++. +|..+. .+ +|++|+|++|++.+.+|..++++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 5678 999999999999999999999985 999988 88 89999999999999999999999
Q ss_pred CCCCEEeccccc-CCc-cCCccccCC------CCCCEEeCCCCcccccCCc--cccCCCCCCEEEccCccccccCCcccc
Q 040398 64 TSLTYLDLEENQ-FSG-TIPRELGNL------VNLETLRLSSNRLIGNLPM--ELVKLKNLTDFRINDNNFNGSAPDFIQ 133 (732)
Q Consensus 64 ~~L~~L~Ls~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~ 133 (732)
++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .+.++++|+.|++++|+++|.+| .+.
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999998 998 899988876 99999999999999 8998 89999999999999999999999 899
Q ss_pred CCCCCCEEEcccCCCcCcCCccccCccC-CCeeeccCcCCCCCCcccccCCC--CccEEEcccccccCCcchhhc-----
Q 040398 134 SWTQLNRLEIQGSGLEGPIPPSISALDK-LNQLRISDLQGPNQTFPMLRNMT--GLTRIILRNCNIAGEIPEYIW----- 205 (732)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p~~l~----- 205 (732)
.+++|+.|+|++|+++ .+|..+..+++ |+.|++++|.++.++ ..+..++ +|++|+|++|++++.+|..+.
T Consensus 351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~ 428 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIP-NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428 (636)
T ss_dssp EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCC-SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccc-hhhhhcccCccCEEECcCCcCCCcchhhhcccccc
Confidence 9999999999999999 88999999999 999999999999544 4555544 899999999999999998888
Q ss_pred --CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCc
Q 040398 206 --GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQP 266 (732)
Q Consensus 206 --~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~ 266 (732)
.+++|+.|+|++|+++ .+|.. .+..+++|+.|+|++|+++..++...
T Consensus 429 ~~~~~~L~~L~Ls~N~l~-~lp~~-------------~~~~l~~L~~L~Ls~N~l~~i~~~~~ 477 (636)
T 4eco_A 429 PFKGINVSSINLSNNQIS-KFPKE-------------LFSTGSPLSSINLMGNMLTEIPKNSL 477 (636)
T ss_dssp CCCCCCEEEEECCSSCCC-SCCTH-------------HHHTTCCCSEEECCSSCCSBCCSSSS
T ss_pred cccCCCCCEEECcCCccC-cCCHH-------------HHccCCCCCEEECCCCCCCCcCHHHh
Confidence 7889999999999999 44532 24567888899999999885554433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=280.35 Aligned_cols=216 Identities=20% Similarity=0.265 Sum_probs=108.3
Q ss_pred CccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCC
Q 040398 10 PPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLV 88 (732)
Q Consensus 10 P~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 88 (732)
|..|.++++|++|+|++|.+++..|..|..+ +|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..++
T Consensus 49 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 128 (477)
T 2id5_A 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128 (477)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred HhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccc
Confidence 3445555555555555555554445555554 455555555555533233445555555555555555544444555555
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeecc
Q 040398 89 NLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168 (732)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 168 (732)
+|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+++..+..+..+++|+.|+++
T Consensus 129 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 208 (477)
T 2id5_A 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208 (477)
T ss_dssp TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEE
T ss_pred cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCC
Confidence 55555555555554445555555555555555555554444445555555555555555554444444444444444444
Q ss_pred CcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 169 DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 169 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
+|......+.......+|++|+|++|++++..+..+..+++|+.|+|++|++++..+
T Consensus 209 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 265 (477)
T 2id5_A 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265 (477)
T ss_dssp CCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccCh
Confidence 433222222211222244444445555553333455556666666666666664444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=264.73 Aligned_cols=225 Identities=23% Similarity=0.324 Sum_probs=204.0
Q ss_pred CCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEe
Q 040398 16 LPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLR 94 (732)
Q Consensus 16 l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 94 (732)
.++++.|+|++|+++ .+|..+..+ +|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478999999999999 788877777 7999999999999 89999999999999999999999 8899999999999999
Q ss_pred CCCCcccccCCccccC---------CCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCee
Q 040398 95 LSSNRLIGNLPMELVK---------LKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165 (732)
Q Consensus 95 L~~N~l~~~~p~~l~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 165 (732)
|++|++.+.+|..+.. +++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence 9999888888887765 999999999999998 88888999999999999999999 467789999999999
Q ss_pred eccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhcc
Q 040398 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245 (732)
Q Consensus 166 ~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l 245 (732)
+|++|.+.+..+..+..+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|+. ++++
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~--------------l~~L 300 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL--------------IAQL 300 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGG--------------GGGS
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHH--------------Hhhc
Confidence 99999999888888999999999999999999999999999999999999999999999976 7788
Q ss_pred CCCCeEEccCCcCc
Q 040398 246 YEHQSLDLSYNNFT 259 (732)
Q Consensus 246 ~~L~~LdLs~N~l~ 259 (732)
++|+.++++.|.+.
T Consensus 301 ~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 301 PANCIILVPPHLQA 314 (328)
T ss_dssp CTTCEEECCGGGSC
T ss_pred cCceEEeCCHHHHH
Confidence 89999999888664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=297.49 Aligned_cols=256 Identities=18% Similarity=0.218 Sum_probs=209.8
Q ss_pred CCcccCCccCCCCCCCCEEEc-ccCcCccc--------------------------------------------------
Q 040398 4 SLPGTLPPQIVNLPYLETVDF-AYNYLHGS-------------------------------------------------- 32 (732)
Q Consensus 4 ~~~g~lP~~l~~l~~L~~L~L-s~N~l~~~-------------------------------------------------- 32 (732)
++.|.+|++|++|++|++|+| ++|.+.|.
T Consensus 334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~ 413 (876)
T 4ecn_A 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413 (876)
T ss_dssp CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence 578999999999999999999 77755443
Q ss_pred --------------------------cCcccccc-ccceEecccccccc-----------------cCCcccc--CCCCC
Q 040398 33 --------------------------IPREWASM-QLKYISVFANRLSG-----------------NIPSHLG--NITSL 66 (732)
Q Consensus 33 --------------------------~p~~~~~~-~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L 66 (732)
+|..+..+ +|++|+|++|+|++ .+|..++ ++++|
T Consensus 414 ~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L 493 (876)
T 4ecn_A 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493 (876)
T ss_dssp SCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred ccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCC
Confidence 77888888 79999999999997 3899988 99999
Q ss_pred CEEecccccCCccCCccccCCCCCCEEeCCCCc-ccc-cCCccccCCC-------CCCEEEccCccccccCCc--cccCC
Q 040398 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNR-LIG-NLPMELVKLK-------NLTDFRINDNNFNGSAPD--FIQSW 135 (732)
Q Consensus 67 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l 135 (732)
++|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..+.+++ +|+.|+|++|+++ .+|. .++++
T Consensus 494 ~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L 572 (876)
T 4ecn_A 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM 572 (876)
T ss_dssp CEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC
T ss_pred CEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcC
Confidence 999999999999999999999999999999998 888 7888776665 9999999999999 8888 89999
Q ss_pred CCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCC-ccEEEcccccccCCcchhhcCCCC--CcE
Q 040398 136 TQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTG-LTRIILRNCNIAGEIPEYIWGIKN--LRF 212 (732)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~--L~~ 212 (732)
++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+. ..+..+..+++ |+.|+|++|+|+ .+|..+..++. |+.
T Consensus 573 ~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~ 648 (876)
T 4ecn_A 573 VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648 (876)
T ss_dssp TTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEE
T ss_pred CCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCE
Confidence 99999999999998 888 8999999999999999998 44456888888 999999999998 78888777654 999
Q ss_pred EeCCCCcCcccCCCCCc------cCcch--------hhHHHH-HHhccCCCCeEEccCCcCcCCCCC
Q 040398 213 LDLSFNQLTGELPDVAV------PADLK--------FTQILM-FIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 213 L~Ls~N~l~g~~p~~~~------~~~l~--------~~~~~~-~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
|+|++|+++|.+|.... ..++. +..++. .+..+++|+.|+|++|+|+..++.
T Consensus 649 L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~ 715 (876)
T 4ecn_A 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715 (876)
T ss_dssp EECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTT
T ss_pred EECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChH
Confidence 99999999988774320 00111 112232 234677788888888888744443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=261.77 Aligned_cols=230 Identities=20% Similarity=0.212 Sum_probs=204.4
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccc--cCCccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSG--NIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
++|++|+|++|+++...+..+..+ +|++|+|++|+++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 579999999999995444557777 89999999999983 33677888999999999999998 688889999999999
Q ss_pred eCCCCcccccCC-ccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcC-cCCccccCccCCCeeeccCcC
Q 040398 94 RLSSNRLIGNLP-MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 94 ~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~ 171 (732)
+|++|++++..+ ..+..+++|+.|++++|.+.+..+..+..+++|+.|+|++|.+++ .+|..+..+++|+.|++++|.
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 999999995544 578999999999999999998889999999999999999999987 578999999999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhcc-CCCCe
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV-YEHQS 250 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l-~~L~~ 250 (732)
+....+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++.+|.. +..+ ++|+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~~~~~L~~ 252 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE--------------LQHFPSSLAF 252 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSS--------------CCCCCTTCCE
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHH--------------HHhhhccCCE
Confidence 99998889999999999999999999877778999999999999999999988865 4445 48999
Q ss_pred EEccCCcCcCC
Q 040398 251 LDLSYNNFTWQ 261 (732)
Q Consensus 251 LdLs~N~l~~~ 261 (732)
|+|++|++++.
T Consensus 253 L~L~~N~~~~~ 263 (306)
T 2z66_A 253 LNLTQNDFACT 263 (306)
T ss_dssp EECTTCCEECS
T ss_pred EEccCCCeecc
Confidence 99999998754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-28 Score=256.90 Aligned_cols=228 Identities=18% Similarity=0.264 Sum_probs=193.1
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
+.|++|+|++|++++..+..+..+ +|++|+|++|++++..|..++++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 578899999999997767678877 7999999999999777888999999999999999988 6777665 78999999
Q ss_pred CCCcccccCCccccCCCCCCEEEccCcccc--ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCC
Q 040398 96 SSNRLIGNLPMELVKLKNLTDFRINDNNFN--GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173 (732)
Q Consensus 96 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 173 (732)
++|++++..+..+.++++|+.|++++|.+. +..+..+..+++|+.|++++|.++ .+|..+. ++|+.|++++|.+.
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCC
Confidence 999998766777888999999999999985 367788889999999999999988 4665554 78999999999998
Q ss_pred CCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEc
Q 040398 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDL 253 (732)
Q Consensus 174 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdL 253 (732)
...+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+++ .+|.. +..+++|+.|+|
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~--------------l~~l~~L~~L~l 270 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG--------------LADHKYIQVVYL 270 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT--------------TTTCSSCCEEEC
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh--------------hccCCCcCEEEC
Confidence 888888999999999999999999777778888999999999999998 55554 556788999999
Q ss_pred cCCcCcCCCCCC
Q 040398 254 SYNNFTWQSPEQ 265 (732)
Q Consensus 254 s~N~l~~~~p~~ 265 (732)
++|+|++.++..
T Consensus 271 ~~N~i~~~~~~~ 282 (330)
T 1xku_A 271 HNNNISAIGSND 282 (330)
T ss_dssp CSSCCCCCCTTS
T ss_pred CCCcCCccChhh
Confidence 999998776653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-28 Score=269.81 Aligned_cols=227 Identities=15% Similarity=0.186 Sum_probs=170.9
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
++|++|+|++|++++..|..|..+ +|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 467888888888887777777777 6888888888888666777888888888888888887555556777888888888
Q ss_pred CCCcccccCCccccCCCCCCEEEccCc-cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCC
Q 040398 96 SSNRLIGNLPMELVKLKNLTDFRINDN-NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174 (732)
Q Consensus 96 ~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 174 (732)
++|+|+...+..+.++++|+.|++++| .+....+..|..+++|+.|+|++|++++ +| .+..+++|+.|+|++|.+.+
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcc
Confidence 888887555567777888888888874 4444444567778888888888888874 33 46777788888888888888
Q ss_pred CCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 175 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
+.+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.++.. +..+++|+.|+|+
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~L~L~ 298 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL--------------FTPLRYLVELHLH 298 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS--------------STTCTTCCEEECC
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH--------------hccccCCCEEEcc
Confidence 77777888888888888888888777777778888888888888887555543 4456777888888
Q ss_pred CCcCc
Q 040398 255 YNNFT 259 (732)
Q Consensus 255 ~N~l~ 259 (732)
+|++.
T Consensus 299 ~Np~~ 303 (452)
T 3zyi_A 299 HNPWN 303 (452)
T ss_dssp SSCEE
T ss_pred CCCcC
Confidence 88654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-28 Score=271.00 Aligned_cols=234 Identities=20% Similarity=0.188 Sum_probs=207.8
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
++|++|+|++|++++..|..|..+ +|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 579999999999998888899988 8999999999999888999999999999999999999555557899999999999
Q ss_pred CCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCC
Q 040398 96 SSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQ 175 (732)
Q Consensus 96 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 175 (732)
++|++++..|..+.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+..+
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 99999988899999999999999999999999999999999999999999999977777899999999999999999999
Q ss_pred CcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccC
Q 040398 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255 (732)
Q Consensus 176 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~ 255 (732)
....|..+++|++|+|++|.+.+.+|..+....+|+.|+|++|++++..+. .+.++++|+.|+|++
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--------------~~~~l~~L~~L~Ls~ 257 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL--------------AVRHLVYLRFLNLSY 257 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH--------------HHTTCTTCCEEECCS
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH--------------HhcCccccCeeECCC
Confidence 988999999999999999999889998888888999999999999954321 244556666666666
Q ss_pred CcCcCCCCC
Q 040398 256 NNFTWQSPE 264 (732)
Q Consensus 256 N~l~~~~p~ 264 (732)
|++++.++.
T Consensus 258 n~l~~~~~~ 266 (477)
T 2id5_A 258 NPISTIEGS 266 (477)
T ss_dssp SCCCEECTT
T ss_pred CcCCccChh
Confidence 666655543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-28 Score=267.66 Aligned_cols=227 Identities=15% Similarity=0.179 Sum_probs=175.1
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
++++.|+|++|++++..+..|..+ +|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 567888888888887777777777 6888888888888666677888888888888888888544456788888888888
Q ss_pred CCCcccccCCccccCCCCCCEEEccCc-cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCC
Q 040398 96 SSNRLIGNLPMELVKLKNLTDFRINDN-NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN 174 (732)
Q Consensus 96 ~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 174 (732)
++|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|.++.
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence 888888666667788888888888874 444444456788888888888888887 444 47778888888888888888
Q ss_pred CCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 175 QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 175 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
+.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+.. +..+++|+.|+|+
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~L~L~ 287 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL--------------FTPLHHLERIHLH 287 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTT--------------TSSCTTCCEEECC
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhH--------------hccccCCCEEEcC
Confidence 87778888888888888888888777777888888888888888888655543 4566778888888
Q ss_pred CCcCc
Q 040398 255 YNNFT 259 (732)
Q Consensus 255 ~N~l~ 259 (732)
+|++.
T Consensus 288 ~Np~~ 292 (440)
T 3zyj_A 288 HNPWN 292 (440)
T ss_dssp SSCEE
T ss_pred CCCcc
Confidence 88664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=292.77 Aligned_cols=263 Identities=17% Similarity=0.228 Sum_probs=209.2
Q ss_pred cCCccCC--CCCCCCEEEcccCcCccccCcccccc-ccceEeccccc-ccc-cCCccccCCC-------CCCEEeccccc
Q 040398 8 TLPPQIV--NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANR-LSG-NIPSHLGNIT-------SLTYLDLEENQ 75 (732)
Q Consensus 8 ~lP~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~Ls~N~ 75 (732)
.+|+.++ ++++|++|+|++|++.+.+|..+..+ +|++|+|++|+ +++ .+|..+++++ +|++|+|++|+
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence 5999998 99999999999999999999999988 89999999998 998 8888776665 99999999999
Q ss_pred CCccCCc--cccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCC-CCEEEcccCCCcCcC
Q 040398 76 FSGTIPR--ELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQ-LNRLEIQGSGLEGPI 152 (732)
Q Consensus 76 l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~ 152 (732)
|+ .+|. .++++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+
T Consensus 560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l 634 (876)
T 4ecn_A 560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634 (876)
T ss_dssp CC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred CC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence 99 8998 8999999999999999999 888 8999999999999999999 88989999999 999999999999 88
Q ss_pred CccccCccC--CCeeeccCcCCCCCCccc---cc--CCCCccEEEcccccccCCcchhh-cCCCCCcEEeCCCCcCcccC
Q 040398 153 PPSISALDK--LNQLRISDLQGPNQTFPM---LR--NMTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGEL 224 (732)
Q Consensus 153 p~~~~~l~~--L~~L~ls~N~l~~~~~~~---l~--~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~g~~ 224 (732)
|..+..++. |+.|+|++|.+.+..+.. +. .+++|+.|+|++|+|+ .+|..+ ..+++|+.|+|++|+|+ .+
T Consensus 635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~i 712 (876)
T 4ecn_A 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SI 712 (876)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-cc
Confidence 888877754 999999999998754422 22 3458999999999998 566554 47899999999999998 55
Q ss_pred CCCCccC---------cch--------hhHHHHHHh--ccCCCCeEEccCCcCcCCCCCCccccCCCCcccc
Q 040398 225 PDVAVPA---------DLK--------FTQILMFIR--GVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277 (732)
Q Consensus 225 p~~~~~~---------~l~--------~~~~~~~~~--~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~ 277 (732)
|...... .+. +..++..+. .+++|+.|+|++|+|++.++....+..+..|++.
T Consensus 713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls 784 (876)
T 4ecn_A 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIR 784 (876)
T ss_dssp CTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECC
T ss_pred ChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECC
Confidence 5532210 111 112233343 5666666666666666644444444444444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=253.31 Aligned_cols=232 Identities=22% Similarity=0.280 Sum_probs=176.3
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|..+. ++|++|+|++|.+++..|..+..+ +|++|+|++|++++..|..++++++|++|+|++|+++ .+|..+.
T Consensus 48 ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-- 122 (332)
T 2ft3_A 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-- 122 (332)
T ss_dssp CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--
T ss_pred cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--
Confidence 444442 567778888777776666677766 6788888888777666777777788888888887777 6666555
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccc--ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCee
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN--GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 165 (732)
++|++|++++|++++..+..+..+++|+.|++++|.++ +..+..+..+ +|+.|++++|++++ +|..+. ++|+.|
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L 198 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNEL 198 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCC
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEE
Confidence 67788888888777555556777788888888888774 3566667766 77777888877774 555443 688888
Q ss_pred eccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhcc
Q 040398 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245 (732)
Q Consensus 166 ~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l 245 (732)
++++|.+....+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|.. +..+
T Consensus 199 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~--------------l~~l 263 (332)
T 2ft3_A 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG--------------LPDL 263 (332)
T ss_dssp BCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT--------------GGGC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh--------------hhcC
Confidence 88888888888888888888999999999988777778888889999999999888 55653 5677
Q ss_pred CCCCeEEccCCcCcCCCCC
Q 040398 246 YEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 246 ~~L~~LdLs~N~l~~~~p~ 264 (732)
++|+.|+|++|+|++.++.
T Consensus 264 ~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp TTCCEEECCSSCCCBCCTT
T ss_pred ccCCEEECCCCCCCccChh
Confidence 8889999999999877665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=279.42 Aligned_cols=245 Identities=20% Similarity=0.201 Sum_probs=181.0
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCc-
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR- 82 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~- 82 (732)
+.+..|..+.++++|++|+|++|+++ .+|..+..+ +|++|+|++|++++..|..+.++++|++|+|++|.+.+.+|.
T Consensus 266 l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (606)
T 3t6q_A 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344 (606)
T ss_dssp CSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS
T ss_pred cCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh
Confidence 34444556888888888888888887 677777766 688888888888866677788888888888888887766655
Q ss_pred cccCCCCCCEEeCCCCcccccC--CccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCcc-ccCc
Q 040398 83 ELGNLVNLETLRLSSNRLIGNL--PMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPS-ISAL 159 (732)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 159 (732)
.+..+++|++|++++|++++.. |..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++..+.. +..+
T Consensus 345 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 424 (606)
T 3t6q_A 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424 (606)
T ss_dssp TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTC
T ss_pred hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCc
Confidence 3777888888888888877554 667777888888888888877777777777888888888888877665543 7777
Q ss_pred cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCC---cchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhh
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE---IPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT 236 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~ 236 (732)
++|+.|++++|.+....+..+..+++|++|+|++|++++. .+..+..+++|+.|+|++|++++.+|..
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--------- 495 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA--------- 495 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTT---------
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhh---------
Confidence 7888888888877777777777777888888888877652 2245777777888888888777766654
Q ss_pred HHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 237 QILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 237 ~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
+.++++|+.|||++|++++.+|.
T Consensus 496 -----~~~l~~L~~L~Ls~N~l~~~~~~ 518 (606)
T 3t6q_A 496 -----FTSLKMMNHVDLSHNRLTSSSIE 518 (606)
T ss_dssp -----TTTCTTCCEEECCSSCCCGGGGG
T ss_pred -----hccccCCCEEECCCCccCcCChh
Confidence 45556666666666666666553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=263.99 Aligned_cols=259 Identities=17% Similarity=0.133 Sum_probs=130.9
Q ss_pred CCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 14 VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
..++.....++++|.++ .+|..+.. +|++|+|++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|
T Consensus 28 ~~C~~~~~c~~~~~~l~-~iP~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLN-SIPSGLTE-AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CEECTTSEEECCSTTCS-SCCTTCCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCeEeeCCCCCcc-cccccccc-cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 33444445555555555 34443322 45555555555553333355555555555555555554444455555555555
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccCccccccCC-ccccCCCCCCEEEcccC-CCcCcCCccccCccCCCeeeccCcC
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNRLEIQGS-GLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
+|++|+|++..+..+.++++|+.|++++|++++..+ ..+..+++|+.|++++| .++...+..+..+++|+.|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 555555553222225555555555555555553222 24555555555555555 2443344455555555555555555
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcch-hhcCCCCCcEEeCCCCcCcccCCCCCcc-----------------Ccc
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPE-YIWGIKNLRFLDLSFNQLTGELPDVAVP-----------------ADL 233 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~-----------------~~l 233 (732)
+.+..+..+..+++|++|+|++|+++ .+|. .+..+++|+.|+|++|.+++..+..... ...
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred cCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 55555555555555555555555554 2332 2333555555555555555433221100 001
Q ss_pred hhhHHHHHHhccCCCCeEEccCCcCcCCCCCC-ccccCCCCcc
Q 040398 234 KFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQ-PACREKPNLN 275 (732)
Q Consensus 234 ~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~-~~~~~~~~l~ 275 (732)
....++..+.++++|+.|||++|+|+..++.. ..+..+..|+
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~ 307 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEE
Confidence 12244555677777777777777777555543 3444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=251.38 Aligned_cols=224 Identities=21% Similarity=0.218 Sum_probs=125.4
Q ss_pred CEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCc
Q 040398 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNR 99 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 99 (732)
++++++++.++ .+|..+. .+|++|+|++|++++..+..|.++++|++|+|++|.+++..|..+.++++|++|+|++|.
T Consensus 14 ~~~~c~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred eEEEcCcCCcc-cCCcCCC-CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 45555555555 3443221 145566666666654444555556666666666666554445555556666666666664
Q ss_pred -ccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcc
Q 040398 100 -LIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178 (732)
Q Consensus 100 -l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 178 (732)
++...|..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.++.++..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 5433355555556666666666666555555555566666666666666544444555556666666666655555555
Q ss_pred cccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcC
Q 040398 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNF 258 (732)
Q Consensus 179 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l 258 (732)
.|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+++ .+..+++|+.|+|++|++
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------------~~~~l~~L~~L~l~~N~~ 237 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE--------------ALAPLRALQYLRLNDNPW 237 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH--------------HHTTCTTCCEEECCSSCE
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHH--------------HcccCcccCEEeccCCCc
Confidence 555556666666666666555555555566666666666665543322 144455556666666655
Q ss_pred c
Q 040398 259 T 259 (732)
Q Consensus 259 ~ 259 (732)
+
T Consensus 238 ~ 238 (285)
T 1ozn_A 238 V 238 (285)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=274.21 Aligned_cols=234 Identities=17% Similarity=0.211 Sum_probs=135.3
Q ss_pred CCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
+|++|++++|.+++..+..|..+ +|++|+|++|+++ .+|..++.+++|++|+|++|.+++..|..+.++++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 45666666666665555555555 5666666666665 556566666666666666666664445556666666666666
Q ss_pred CCcccccCCcc-ccCCCCCCEEEccCccccccC--CccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCC
Q 040398 97 SNRLIGNLPME-LVKLKNLTDFRINDNNFNGSA--PDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173 (732)
Q Consensus 97 ~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 173 (732)
+|.+.+.+|.. +..+++|+.|++++|.+++.. +..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+.
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 66655444433 555666666666666665443 455566666666666666666555556666666666666666665
Q ss_pred CCCcc-cccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc-CCCCCccCcchhhHHHHHHhccCCCCeE
Q 040398 174 NQTFP-MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE-LPDVAVPADLKFTQILMFIRGVYEHQSL 251 (732)
Q Consensus 174 ~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~~~l~~~~~~~~~~~l~~L~~L 251 (732)
...+. .+..+++|+.|+|++|.+++..|..+..+++|+.|+|++|++++. +|.. ..+..+++|+.|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------~~~~~l~~L~~L 481 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT------------NSLQTLGRLEIL 481 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSS------------CGGGGCTTCCEE
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccc------------hhhccCCCccEE
Confidence 54433 255566666666666666655555566666666666666666542 1110 014445566666
Q ss_pred EccCCcCcCCCCC
Q 040398 252 DLSYNNFTWQSPE 264 (732)
Q Consensus 252 dLs~N~l~~~~p~ 264 (732)
+|++|++++.+|.
T Consensus 482 ~Ls~n~l~~~~~~ 494 (606)
T 3t6q_A 482 VLSFCDLSSIDQH 494 (606)
T ss_dssp ECTTSCCCEECTT
T ss_pred ECCCCccCccChh
Confidence 6666666655543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-27 Score=250.97 Aligned_cols=241 Identities=19% Similarity=0.231 Sum_probs=210.3
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+++..+..|.++++|++|+|++|.+++..|..+..+ +|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..
T Consensus 64 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~ 140 (330)
T 1xku_A 64 ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSV 140 (330)
T ss_dssp CCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHH
T ss_pred CCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhH
Confidence 455445589999999999999999998889999988 8999999999999 7887765 89999999999999766678
Q ss_pred ccCCCCCCEEeCCCCcccc--cCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 84 LGNLVNLETLRLSSNRLIG--NLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
+.++++|+.|+|++|.++. ..+..+.++++|+.|++++|.++. +|..+. ++|+.|++++|++++..|..+..+++
T Consensus 141 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~ 217 (330)
T 1xku_A 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 217 (330)
T ss_dssp HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTT
T ss_pred hcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCC
Confidence 9999999999999999963 678889999999999999999984 565543 89999999999999888999999999
Q ss_pred CCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHH
Q 040398 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 241 (732)
|+.|++++|.+....+..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+........
T Consensus 218 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~-------- 288 (330)
T 1xku_A 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY-------- 288 (330)
T ss_dssp CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC--------
T ss_pred CCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccc--------
Confidence 999999999999998889999999999999999999 89999999999999999999999766654221110
Q ss_pred HhccCCCCeEEccCCcCcC
Q 040398 242 IRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 242 ~~~l~~L~~LdLs~N~l~~ 260 (732)
......++.|++++|++..
T Consensus 289 ~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 289 NTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CTTSCCCSEEECCSSSSCG
T ss_pred ccccccccceEeecCcccc
Confidence 1123678899999999864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=248.28 Aligned_cols=239 Identities=18% Similarity=0.183 Sum_probs=206.6
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEeccccc-CCccCCccccC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQ-FSGTIPRELGN 86 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~ 86 (732)
+|..+ .++|++|+|++|.+++..+..+..+ +|++|+|++|++++..|..+..+++|++|+|++|. ++...|..+..
T Consensus 26 ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~ 103 (285)
T 1ozn_A 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103 (285)
T ss_dssp CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTT
T ss_pred CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcC
Confidence 45433 3689999999999998777888888 89999999999998879999999999999999997 87555889999
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeee
Q 040398 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLR 166 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 166 (732)
+++|++|+|++|++++..|..+.++++|+.|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 99999999999999987788899999999999999999987778899999999999999999977777899999999999
Q ss_pred ccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccC
Q 040398 167 ISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVY 246 (732)
Q Consensus 167 ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~ 246 (732)
+++|.+....+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+..+.. .+. .
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~---------~~~------~ 248 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR---------PLW------A 248 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH---------HHH------H
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH---------HHH------H
Confidence 9999999998999999999999999999999877788999999999999999998654321 111 1
Q ss_pred CCCeEEccCCcCcCCCCC
Q 040398 247 EHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 247 ~L~~LdLs~N~l~~~~p~ 264 (732)
.++.++.+.|.+.+..|.
T Consensus 249 ~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHCCSEECCCBEEESG
T ss_pred HHHhcccccCccccCCch
Confidence 234455667777655554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=253.41 Aligned_cols=210 Identities=20% Similarity=0.326 Sum_probs=200.0
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 86 (732)
.+|+.+.++++|++|+|++|.++ .+|..+..+ +|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~ 172 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh
Confidence 68999999999999999999999 899999888 8999999999999 89999999999999999999998899988765
Q ss_pred ---------CCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCcccc
Q 040398 87 ---------LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS 157 (732)
Q Consensus 87 ---------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 157 (732)
+++|++|+|++|+|+ .+|..+.++++|+.|+|++|++++ +|..+..+++|+.|+|++|++.+.+|..+.
T Consensus 173 ~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~ 250 (328)
T 4fcg_A 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG 250 (328)
T ss_dssp EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT
T ss_pred ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc
Confidence 999999999999999 899999999999999999999995 677899999999999999999999999999
Q ss_pred CccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 158 ALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 158 ~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
.+++|+.|+|++|.+.+..+..+..+++|++|+|++|++.+.+|+.+.++++|+.+++..|.+.
T Consensus 251 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999988889999999999999999999999999999999999999988776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=287.10 Aligned_cols=185 Identities=18% Similarity=0.137 Sum_probs=129.2
Q ss_pred eecccCceEEEEEEE-cCCeEEEEEEccccc----------ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEE
Q 040398 521 KIGEGGFGPVYKGQL-TDGTIIAVKLLSSKS----------RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 521 ~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 588 (732)
..+.|+.|.+..++. -.|+.||||++.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 466777777776653 358899999986531 12345799999999999 799999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||++|++|.+++... .+++.. +|+.||+.||+|+|++| ||||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999543 345543 58999999999999997 9999999999999999999999999998655
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNN 717 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P 717 (732)
.... .....+||++|||||++.+ .+..++|+||+|+++++|.++..|
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4332 2334679999999998876 456789999999998877665433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=257.99 Aligned_cols=246 Identities=20% Similarity=0.192 Sum_probs=139.9
Q ss_pred CCcc-CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCc-ccc
Q 040398 9 LPPQ-IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR-ELG 85 (732)
Q Consensus 9 lP~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~ 85 (732)
+|+. +.++++|++|+|++|.+++..+..+..+ +|++|+|++|++++..|..++++++|++|+|++|+++ .+|. .+.
T Consensus 60 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~ 138 (390)
T 3o6n_A 60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138 (390)
T ss_dssp ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhc
Confidence 4433 4556666666666666665555556555 5666666666666555555666666666666666666 3443 345
Q ss_pred CCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc-CCccc--------
Q 040398 86 NLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP-IPPSI-------- 156 (732)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~-------- 156 (732)
++++|++|+|++|++++..|..+..+++|+.|++++|++++.. +..+++|+.|++++|.+++. .|..+
T Consensus 139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n 215 (390)
T 3o6n_A 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215 (390)
T ss_dssp TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSS
T ss_pred CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCC
Confidence 6666666666666666555555666666666666666665432 22223333322222222210 00000
Q ss_pred -------cCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCc
Q 040398 157 -------SALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAV 229 (732)
Q Consensus 157 -------~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 229 (732)
...++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..+.
T Consensus 216 ~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--- 290 (390)
T 3o6n_A 216 SINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLY--- 290 (390)
T ss_dssp CCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECS---
T ss_pred eeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcc---
Confidence 1124566777777776654 4677777778888888877777777777777777788877777754221
Q ss_pred cCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 230 PADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 230 ~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
+..+++|+.|+|++|+++..++....+..+..|+
T Consensus 291 ------------~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 291 ------------GQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 324 (390)
T ss_dssp ------------SSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEE
T ss_pred ------------cCCCCCCCEEECCCCcceecCccccccCcCCEEE
Confidence 1233455555555555554444433334444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-27 Score=249.46 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=211.1
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+.+..|..+.++++|++|+|++|++++..|..+..+ +|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..
T Consensus 66 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~ 142 (332)
T 2ft3_A 66 ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGV 142 (332)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGG
T ss_pred CCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhH
Confidence 455556789999999999999999998889999988 8999999999999 7887776 89999999999999655667
Q ss_pred ccCCCCCCEEeCCCCccc--ccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 84 LGNLVNLETLRLSSNRLI--GNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
+.++++|+.|++++|.++ +..|..+..+ +|+.|++++|++++ +|..+. ++|+.|+|++|.+++..+..+..+++
T Consensus 143 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~ 218 (332)
T 2ft3_A 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSK 218 (332)
T ss_dssp GSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTT
T ss_pred hCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCC
Confidence 999999999999999996 3678888888 99999999999985 565554 79999999999999888899999999
Q ss_pred CCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHH
Q 040398 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 241 (732)
|+.|++++|.+....+..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++..+........
T Consensus 219 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------- 289 (332)
T 2ft3_A 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------- 289 (332)
T ss_dssp CSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC--------
T ss_pred CCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc--------
Confidence 999999999999999989999999999999999999 89999999999999999999999776654222110
Q ss_pred HhccCCCCeEEccCCcCc--CCCCC
Q 040398 242 IRGVYEHQSLDLSYNNFT--WQSPE 264 (732)
Q Consensus 242 ~~~l~~L~~LdLs~N~l~--~~~p~ 264 (732)
......|+.|++++|+++ ...|.
T Consensus 290 ~~~~~~l~~L~l~~N~~~~~~~~~~ 314 (332)
T 2ft3_A 290 GVKRAYYNGISLFNNPVPYWEVQPA 314 (332)
T ss_dssp CSSSCCBSEEECCSSSSCGGGSCGG
T ss_pred ccccccccceEeecCcccccccCcc
Confidence 012367899999999987 44443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-27 Score=269.47 Aligned_cols=98 Identities=17% Similarity=0.162 Sum_probs=73.3
Q ss_pred CccccCccCCCeeeccCcCCCCCCc-ccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc-CCCCCcc
Q 040398 153 PPSISALDKLNQLRISDLQGPNQTF-PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE-LPDVAVP 230 (732)
Q Consensus 153 p~~~~~l~~L~~L~ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~ 230 (732)
|..+..+++|+.|++++|.+.+..+ ..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++. +|..
T Consensus 392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--- 468 (606)
T 3vq2_A 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV--- 468 (606)
T ss_dssp CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC---
T ss_pred hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHh---
Confidence 4556677888888888888888766 6788888888888888888888888888888888888888888874 5543
Q ss_pred CcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 231 ADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 231 ~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
++++++|+.|+|++|++++.+|.
T Consensus 469 -----------~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 469 -----------FANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp -----------CTTCTTCCEEECTTSCCCEECTT
T ss_pred -----------hccCCCCCEEECCCCcCCccChh
Confidence 34455566666666666655543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=268.58 Aligned_cols=112 Identities=21% Similarity=0.279 Sum_probs=79.5
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|+.+. ++|++|+|++|.+++..|..|..+ +|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|.. .+
T Consensus 15 ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l 89 (520)
T 2z7x_B 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PT 89 (520)
T ss_dssp CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CC
T ss_pred cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--cc
Confidence 555544 677777777777776666667666 6777777777777666777777777777777777777 56655 67
Q ss_pred CCCCEEeCCCCcccc-cCCccccCCCCCCEEEccCcccc
Q 040398 88 VNLETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
++|++|+|++|+|++ .+|..++++++|+.|++++|.++
T Consensus 90 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp CCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC
T ss_pred CCccEEeccCCccccccchhhhccCCcceEEEecCcccc
Confidence 777777777777775 45677777777777777777664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-27 Score=255.51 Aligned_cols=244 Identities=17% Similarity=0.119 Sum_probs=200.2
Q ss_pred CCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCE
Q 040398 14 VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLET 92 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 92 (732)
..+++|++|++++|.++...+..+..+ +|++|+|++|++++..+..+..+++|++|+|++|.+++..|..+.++++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 356899999999999995555557777 8999999999999777789999999999999999999777888999999999
Q ss_pred EeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeec-----
Q 040398 93 LRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI----- 167 (732)
Q Consensus 93 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l----- 167 (732)
|+|++|+++...+..+.++++|+.|++++|.+++..+..+..+++|+.|++++|++++.. +..+++|+.|++
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccc
Confidence 999999999444444689999999999999999888899999999999999999998643 344455555544
Q ss_pred --------------cCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcc
Q 040398 168 --------------SDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADL 233 (732)
Q Consensus 168 --------------s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l 233 (732)
++|.+...+. ..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++.+|..
T Consensus 199 ~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~------ 267 (390)
T 3o6n_A 199 STLAIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP------ 267 (390)
T ss_dssp SEEECCSSCSEEECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG------
T ss_pred cccCCCCcceEEECCCCeeeeccc---cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH------
Confidence 4444444322 2246899999999999853 57889999999999999999887754
Q ss_pred hhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcccccc
Q 040398 234 KFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLF 279 (732)
Q Consensus 234 ~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~~~ 279 (732)
+.++++|+.|+|++|++++.++....+..+..|++...
T Consensus 268 --------~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n 305 (390)
T 3o6n_A 268 --------FVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHN 305 (390)
T ss_dssp --------GTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSS
T ss_pred --------ccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCC
Confidence 67789999999999999987766555666666655443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-27 Score=267.03 Aligned_cols=255 Identities=20% Similarity=0.203 Sum_probs=187.8
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCc-cCCc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG-TIPR 82 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~ 82 (732)
+.+..|..|.++++|++|+|++|++++..|..|..+ +|++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|.
T Consensus 33 i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~ 109 (520)
T 2z7x_B 33 ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICK 109 (520)
T ss_dssp CCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCG
T ss_pred ccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchh
Confidence 445445678888888888888888887777788777 7888888888887 56655 67888888888888875 4667
Q ss_pred cccCCCCCCEEeCCCCccc-------------------------ccCCccccCCC-------------------------
Q 040398 83 ELGNLVNLETLRLSSNRLI-------------------------GNLPMELVKLK------------------------- 112 (732)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~-------------------------~~~p~~l~~l~------------------------- 112 (732)
.++++++|++|+|++|+|+ +..|..+..+.
T Consensus 110 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l 189 (520)
T 2z7x_B 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189 (520)
T ss_dssp GGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTC
T ss_pred hhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcc
Confidence 7777777777777777664 23344443322
Q ss_pred ----------------------------------------------------------CCCEEEccCccccccCCccc--
Q 040398 113 ----------------------------------------------------------NLTDFRINDNNFNGSAPDFI-- 132 (732)
Q Consensus 113 ----------------------------------------------------------~L~~L~L~~N~l~~~~p~~~-- 132 (732)
+|+.|++++|++++.+|..+
T Consensus 190 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~ 269 (520)
T 2z7x_B 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFD 269 (520)
T ss_dssp SEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCC
T ss_pred cceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhh
Confidence 67778888888877666654
Q ss_pred ---------------------------------------------------cCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 133 ---------------------------------------------------QSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 133 ---------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
..+++|+.|++++|++++.+|..+..+++
T Consensus 270 ~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 349 (520)
T 2z7x_B 270 YSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349 (520)
T ss_dssp CCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSS
T ss_pred cccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCC
Confidence 67889999999999999889999999999
Q ss_pred CCeeeccCcCCCCCC--cccccCCCCccEEEcccccccCCcchh-hcCCCCCcEEeCCCCcCcccCCCCCccCcc-----
Q 040398 162 LNQLRISDLQGPNQT--FPMLRNMTGLTRIILRNCNIAGEIPEY-IWGIKNLRFLDLSFNQLTGELPDVAVPADL----- 233 (732)
Q Consensus 162 L~~L~ls~N~l~~~~--~~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l----- 233 (732)
|+.|++++|.+.+++ +..+..+++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|.... ..+
T Consensus 350 L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~L 428 (520)
T 2z7x_B 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDL 428 (520)
T ss_dssp CCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEEC
T ss_pred CCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEEC
Confidence 999999999998743 356889999999999999999767764 77889999999999999887765421 111
Q ss_pred ---hhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 234 ---KFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 234 ---~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
....++..+.++++|+.|+|++|+|+..++
T Consensus 429 s~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~ 461 (520)
T 2z7x_B 429 HSNKIKSIPKQVVKLEALQELNVASNQLKSVPD 461 (520)
T ss_dssp CSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred CCCcccccchhhhcCCCCCEEECCCCcCCccCH
Confidence 011223334455666666666666664443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=270.73 Aligned_cols=206 Identities=18% Similarity=0.150 Sum_probs=125.4
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+.++++|++|+|++|.+++..|..|..+ +|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|+
T Consensus 71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 150 (597)
T 3oja_B 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150 (597)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCC
Confidence 4566777777777777776666666666 577777777777765566667777777777777777633333456677777
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc-CCccc--------------
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP-IPPSI-------------- 156 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~-------------- 156 (732)
+|+|++|.|++..|..+..+++|+.|+|++|.+++.. +..+++|+.|++++|.+++. .|..+
T Consensus 151 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~ 227 (597)
T 3oja_B 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVR 227 (597)
T ss_dssp EEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEE
T ss_pred EEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccc
Confidence 7777777777666666777777777777777766432 22233333333333322210 00000
Q ss_pred -cCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 157 -SALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 157 -~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
...++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.
T Consensus 228 ~~~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 293 (597)
T 3oja_B 228 GPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 293 (597)
T ss_dssp CSCCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE
T ss_pred cccCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC
Confidence 0013456666666666553 4566677777777777777766666777777777777777777653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-27 Score=267.71 Aligned_cols=113 Identities=19% Similarity=0.231 Sum_probs=83.8
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|..+. ++|++|+|++|.+++..|..|..+ +|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|.. .+
T Consensus 46 ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l 120 (562)
T 3a79_B 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PM 120 (562)
T ss_dssp CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CC
T ss_pred CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--cc
Confidence 454443 678888888888876666777777 6888888888888666777888888888888888877 66665 67
Q ss_pred CCCCEEeCCCCcccc-cCCccccCCCCCCEEEccCccccc
Q 040398 88 VNLETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFNG 126 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~ 126 (732)
++|++|+|++|+|++ .+|..+.++++|+.|++++|++++
T Consensus 121 ~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 121 ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp TTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred ccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 788888888888775 345677777788887777777753
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=269.51 Aligned_cols=239 Identities=19% Similarity=0.233 Sum_probs=142.8
Q ss_pred cCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccc----------------------------cccccCCccccC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFAN----------------------------RLSGNIPSHLGN 62 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n----------------------------~l~~~~p~~l~~ 62 (732)
.+..+++|++|+|++|.+++..|..+..+ +|++|+|++| ++++..|..+..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 66777777777777777776666656555 4555555554 444444555555
Q ss_pred CCCCCEEecccccCCccCC-ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccc--ccCCccccCCCCCC
Q 040398 63 ITSLTYLDLEENQFSGTIP-RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN--GSAPDFIQSWTQLN 139 (732)
Q Consensus 63 l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~ 139 (732)
+++|++|+|++|.+++.+| ..+.++++|++|+|++|++++..+..+..+++|+.|++++|.+. +.+|..+..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 6666666666666554444 35555566666666666655555555555666666666666554 34556666666666
Q ss_pred EEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCC--------cccccCCCCccEEEcccccccCCcchhhcCCCCCc
Q 040398 140 RLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQT--------FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLR 211 (732)
Q Consensus 140 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~--------~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 211 (732)
.|+|++|++++..+..+..+++|+.|++++|.+..+. ...|..+++|+.|+|++|+++...+..|..+++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 6666666666555555666666666666666665432 12355666666666666666633333456666666
Q ss_pred EEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 212 FLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 212 ~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
.|+|++|+|++.++.. +.++++|+.|+|++|+|++.+|.
T Consensus 564 ~L~Ls~N~l~~l~~~~--------------~~~l~~L~~L~L~~N~l~~~~~~ 602 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASV--------------FNNQVSLKSLNLQKNLITSVEKK 602 (680)
T ss_dssp EEECCSSCCCCCCTTT--------------TTTCTTCCEEECTTSCCCBCCHH
T ss_pred eeECCCCCCCcCCHhH--------------hCCCCCCCEEECCCCcCCccChh
Confidence 6666666666443332 44556666677777766666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=255.44 Aligned_cols=230 Identities=17% Similarity=0.185 Sum_probs=206.2
Q ss_pred CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
....++.+++.++ .+|..+. .+|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP-SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCcEEEECCCCcC-ccCCCCC-CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 4678999999998 6776543 3799999999999988899999999999999999999987788999999999999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccC-CCcCcCCccccCccCCCeeeccCcCCCCCC
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS-GLEGPIPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
|+|++..+..+..+++|+.|+|++|+|+...+..|.++++|+.|+|++| .+....+..+..+++|+.|+|++|.++.++
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP 212 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc
Confidence 9999766777999999999999999999888889999999999999995 455444557999999999999999999874
Q ss_pred cccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCC
Q 040398 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYN 256 (732)
Q Consensus 177 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N 256 (732)
.+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|.. +.++++|+.|||++|
T Consensus 213 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------------~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 213 --NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA--------------FDGLASLVELNLAHN 276 (452)
T ss_dssp --CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTT--------------TTTCTTCCEEECCSS
T ss_pred --cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHH--------------hcCCCCCCEEECCCC
Confidence 5889999999999999999888999999999999999999999887765 677899999999999
Q ss_pred cCcCCCCCC
Q 040398 257 NFTWQSPEQ 265 (732)
Q Consensus 257 ~l~~~~p~~ 265 (732)
+|++.++..
T Consensus 277 ~l~~~~~~~ 285 (452)
T 3zyi_A 277 NLSSLPHDL 285 (452)
T ss_dssp CCSCCCTTS
T ss_pred cCCccChHH
Confidence 999887764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=279.25 Aligned_cols=246 Identities=17% Similarity=0.197 Sum_probs=153.1
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCcccc-Ccccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSI-PREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR 82 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 82 (732)
+++..|..|.++++|++|+|++|.+.+.+ |..|..+ +|++|+|++|++++..|..|+++++|++|+|++|.+++.+|.
T Consensus 36 i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 115 (844)
T 3j0a_A 36 IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115 (844)
T ss_dssp CCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCST
T ss_pred CCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccccc
Confidence 45556677777777777777777554444 5667766 677777777777766677777777777777777777765555
Q ss_pred c--ccCCCCCCEEeCCCCcccccCC-ccccCCCCCCEEEccCccccccCCccccCC--CCCCEEEcccCCCcCcCCcccc
Q 040398 83 E--LGNLVNLETLRLSSNRLIGNLP-MELVKLKNLTDFRINDNNFNGSAPDFIQSW--TQLNRLEIQGSGLEGPIPPSIS 157 (732)
Q Consensus 83 ~--l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~ 157 (732)
. +.++++|++|+|++|.+++..+ ..+.++++|+.|+|++|.+++..+..+..+ ++|+.|+|++|.+.+..|..+.
T Consensus 116 ~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~ 195 (844)
T 3j0a_A 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195 (844)
T ss_dssp TCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC
T ss_pred CccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchh
Confidence 4 7777777777777777775443 467777777777777777766666555544 4444444444444433333322
Q ss_pred Cc--------------------------------------------------------------------cCCCeeeccC
Q 040398 158 AL--------------------------------------------------------------------DKLNQLRISD 169 (732)
Q Consensus 158 ~l--------------------------------------------------------------------~~L~~L~ls~ 169 (732)
.+ ++|+.|++++
T Consensus 196 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~ 275 (844)
T 3j0a_A 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275 (844)
T ss_dssp SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTT
T ss_pred hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCC
Confidence 22 3445555555
Q ss_pred cCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCC
Q 040398 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQ 249 (732)
Q Consensus 170 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~ 249 (732)
|.+....+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|.. +.++++|+
T Consensus 276 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--------------~~~l~~L~ 341 (844)
T 3j0a_A 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN--------------FYGLPKVA 341 (844)
T ss_dssp CCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCS--------------CSSCTTCC
T ss_pred CcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHH--------------hcCCCCCC
Confidence 5555544555555566666666666665555555555666666666666665544433 44555666
Q ss_pred eEEccCCcCcCCCCC
Q 040398 250 SLDLSYNNFTWQSPE 264 (732)
Q Consensus 250 ~LdLs~N~l~~~~p~ 264 (732)
.|+|++|++++.++.
T Consensus 342 ~L~L~~N~i~~~~~~ 356 (844)
T 3j0a_A 342 YIDLQKNHIAIIQDQ 356 (844)
T ss_dssp EEECCSCCCCCCCSS
T ss_pred EEECCCCCCCccChh
Confidence 666666666555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=267.72 Aligned_cols=241 Identities=18% Similarity=0.136 Sum_probs=194.9
Q ss_pred CCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 15 NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 15 ~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
.+++++.|++++|.++...+..+..+ +|++|+|++|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999996666667777 89999999999998888899999999999999999998778889999999999
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCC
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 173 (732)
+|++|.|++..+..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++.. +..+++|+.|++++|.+.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999555555799999999999999999999999999999999999999998653 344455555555555443
Q ss_pred -------------------CCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcch
Q 040398 174 -------------------NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLK 234 (732)
Q Consensus 174 -------------------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~ 234 (732)
..+... .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..
T Consensus 206 ~l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~------- 273 (597)
T 3oja_B 206 TLAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP------- 273 (597)
T ss_dssp EEECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGG-------
T ss_pred cccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHH-------
Confidence 332222 3579999999999986 467899999999999999999988864
Q ss_pred hhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcccc
Q 040398 235 FTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277 (732)
Q Consensus 235 ~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~ 277 (732)
++++++|+.|+|++|++++.++....+..+..|++.
T Consensus 274 -------~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls 309 (597)
T 3oja_B 274 -------FVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLS 309 (597)
T ss_dssp -------GTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECC
T ss_pred -------hcCccCCCEEECCCCCCCCCCcccccCCCCcEEECC
Confidence 556667777777777777665544444445444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=256.90 Aligned_cols=242 Identities=19% Similarity=0.190 Sum_probs=192.5
Q ss_pred cCCCCCCCCEEEcccCcCccccCccccccccceEecccccc-cccCCcccc-------CCCCCCEEecccccCCccCCcc
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRL-SGNIPSHLG-------NITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
.++.+++|++|++++|.+ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 355677899999999999 677766554 88999999999 456777666 7899999999999999888887
Q ss_pred c--cCCCCCCEEeCCCCcccccCCccccCC-----CCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc--CCc
Q 040398 84 L--GNLVNLETLRLSSNRLIGNLPMELVKL-----KNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP--IPP 154 (732)
Q Consensus 84 l--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~ 154 (732)
+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|++++..|..|+.+++|+.|+|++|++.+. ++.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 8899999999999999866 8778777 8999999999999888888999999999999999998765 333
Q ss_pred cc--cCccCCCeeeccCcCCCCC---CcccccCCCCccEEEcccccccCCcc-hhhcCCCCCcEEeCCCCcCcccCCCCC
Q 040398 155 SI--SALDKLNQLRISDLQGPNQ---TFPMLRNMTGLTRIILRNCNIAGEIP-EYIWGIKNLRFLDLSFNQLTGELPDVA 228 (732)
Q Consensus 155 ~~--~~l~~L~~L~ls~N~l~~~---~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 228 (732)
.+ ..+++|+.|++++|.++.. ....+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|...
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 44 7889999999999998843 23445678899999999999998775 45566889999999999998 666541
Q ss_pred ccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 229 VPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 229 ~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
. ++|+.|||++|+|++. |....+..+..|+
T Consensus 273 --------------~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~ 302 (312)
T 1wwl_A 273 --------------P--AKLSVLDLSYNRLDRN-PSPDELPQVGNLS 302 (312)
T ss_dssp --------------C--SEEEEEECCSSCCCSC-CCTTTSCEEEEEE
T ss_pred --------------c--CCceEEECCCCCCCCC-hhHhhCCCCCEEe
Confidence 1 5788999999999888 4444444444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=252.31 Aligned_cols=230 Identities=17% Similarity=0.186 Sum_probs=205.9
Q ss_pred CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
....++.+++.++ .+|..+. .++++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS-TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC-TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCCEEEeCCCCcC-cCCCCCC-CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 4678999999999 7776554 3699999999999988889999999999999999999977778999999999999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCC-CcCcCCccccCccCCCeeeccCcCCCCCC
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG-LEGPIPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
|+|++..+..|..+++|+.|+|++|.|+...+..|..+++|+.|+|++|+ +....+..|..+++|+.|+|++|.++.++
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 99996666689999999999999999998888899999999999999955 44444557999999999999999999765
Q ss_pred cccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCC
Q 040398 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYN 256 (732)
Q Consensus 177 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N 256 (732)
.+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|.. +.++++|+.|||++|
T Consensus 202 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------------~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 202 --NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA--------------FDNLQSLVEINLAHN 265 (440)
T ss_dssp --CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTS--------------STTCTTCCEEECTTS
T ss_pred --ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhh--------------hcCCCCCCEEECCCC
Confidence 5889999999999999999888999999999999999999999887765 667889999999999
Q ss_pred cCcCCCCCC
Q 040398 257 NFTWQSPEQ 265 (732)
Q Consensus 257 ~l~~~~p~~ 265 (732)
+|++.++..
T Consensus 266 ~l~~~~~~~ 274 (440)
T 3zyj_A 266 NLTLLPHDL 274 (440)
T ss_dssp CCCCCCTTT
T ss_pred CCCccChhH
Confidence 999888764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=247.18 Aligned_cols=216 Identities=19% Similarity=0.199 Sum_probs=196.3
Q ss_pred cCCcc-CCCCCCCCEEEcccCcCccc--cCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCC-c
Q 040398 8 TLPPQ-IVNLPYLETVDFAYNYLHGS--IPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP-R 82 (732)
Q Consensus 8 ~lP~~-l~~l~~L~~L~Ls~N~l~~~--~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~ 82 (732)
.+|+. +.++++|++|+|++|.++.. .|..+..+ +|++|+|++|.+. .+|..+..+++|++|+|++|++++..+ .
T Consensus 42 ~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~ 120 (306)
T 2z66_A 42 SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120 (306)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTT
T ss_pred ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccch
Confidence 46654 79999999999999999843 35555555 8999999999999 688889999999999999999995444 5
Q ss_pred cccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccc-cCCccccCCCCCCEEEcccCCCcCcCCccccCccC
Q 040398 83 ELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG-SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK 161 (732)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 161 (732)
.+..+++|++|+|++|.+++..+..+..+++|+.|++++|.+++ .+|..+..+++|+.|+|++|++++..|..+..+++
T Consensus 121 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 200 (306)
T 2z66_A 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200 (306)
T ss_dssp TTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCC
Confidence 78999999999999999998889999999999999999999986 68899999999999999999999888999999999
Q ss_pred CCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCC-CCcEEeCCCCcCcccC
Q 040398 162 LNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIK-NLRFLDLSFNQLTGEL 224 (732)
Q Consensus 162 L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~g~~ 224 (732)
|+.|++++|.+.......+..+++|++|+|++|++++..|..+..++ +|+.|+|++|++++..
T Consensus 201 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99999999999999988899999999999999999999999999985 9999999999999653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=257.96 Aligned_cols=231 Identities=18% Similarity=0.236 Sum_probs=196.4
Q ss_pred cCCccCCCCCCCCEEEcccCcCc-cccCcccc-------cc-ccceEecccccccccCCccc--cCCCCCCEEecccccC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLH-GSIPREWA-------SM-QLKYISVFANRLSGNIPSHL--GNITSLTYLDLEENQF 76 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~~-~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l 76 (732)
.+|+.+... |+.|+|++|.++ ..+|..+. .+ +|++|+|++|++++.+|..+ +.+++|++|+|++|++
T Consensus 56 ~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 133 (312)
T 1wwl_A 56 ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133 (312)
T ss_dssp CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBC
T ss_pred ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCC
Confidence 456655555 899999999994 46676664 44 89999999999999999887 8999999999999999
Q ss_pred CccCCccccCC-----CCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccccc--CCccc--cCCCCCCEEEcccCC
Q 040398 77 SGTIPRELGNL-----VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS--APDFI--QSWTQLNRLEIQGSG 147 (732)
Q Consensus 77 ~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~ 147 (732)
++. |..+..+ ++|++|+|++|+|++..|..+..+++|+.|+|++|++.+. .+..+ ..+++|+.|+|++|+
T Consensus 134 ~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 134 ATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp SSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred cch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 966 8888777 9999999999999988889999999999999999998765 34444 889999999999999
Q ss_pred CcC--cCC-ccccCccCCCeeeccCcCCCCCC-cccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 148 LEG--PIP-PSISALDKLNQLRISDLQGPNQT-FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 148 l~~--~~p-~~~~~l~~L~~L~ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
+++ .++ ..+..+++|+.|++++|.+.+.. ...+..+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++.
T Consensus 213 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp CCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC
T ss_pred CcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC
Confidence 983 222 34567899999999999999876 466778899999999999999 7888776 8999999999999976
Q ss_pred CCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcC
Q 040398 224 LPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 224 ~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~ 260 (732)
|. +..+++|+.|+|++|+|++
T Consensus 290 -p~---------------~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 290 -PS---------------PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -CC---------------TTTSCEEEEEECTTCTTTC
T ss_pred -hh---------------HhhCCCCCEEeccCCCCCC
Confidence 53 3456889999999999975
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=248.68 Aligned_cols=239 Identities=20% Similarity=0.222 Sum_probs=208.5
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 86 (732)
.+|..+. ++|++|+|++|++++..+..+..+ +|++|+|++|++++..|..|+++++|++|+|++|++++..+..+.+
T Consensus 45 ~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 122 (353)
T 2z80_A 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKP 122 (353)
T ss_dssp SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTT
T ss_pred ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCC
Confidence 3565554 489999999999997666688888 8999999999999877889999999999999999999444445899
Q ss_pred CCCCCEEeCCCCcccccCCc--cccCCCCCCEEEccCc-cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCC
Q 040398 87 LVNLETLRLSSNRLIGNLPM--ELVKLKNLTDFRINDN-NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 163 (732)
+++|++|+|++|+++ .+|. .+..+++|+.|++++| .+....+..+..+++|+.|++++|.+++..|..+..+++|+
T Consensus 123 l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 201 (353)
T 2z80_A 123 LSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201 (353)
T ss_dssp CTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEE
T ss_pred CccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCC
Confidence 999999999999999 5555 7899999999999999 57777788999999999999999999998899999999999
Q ss_pred eeeccCcCCCCCCcccccCCCCccEEEcccccccCC-------------------------------cchhhcCCCCCcE
Q 040398 164 QLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE-------------------------------IPEYIWGIKNLRF 212 (732)
Q Consensus 164 ~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-------------------------------~p~~l~~l~~L~~ 212 (732)
.|++++|.+...+...+..+++|++|+|++|++++. +|..+..+++|+.
T Consensus 202 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~ 281 (353)
T 2z80_A 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLE 281 (353)
T ss_dssp EEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCE
T ss_pred eecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCE
Confidence 999999999877776777899999999999999873 4567889999999
Q ss_pred EeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 213 LDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 213 L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
|+|++|+++ .+|... +.++++|+.|+|++|++++..|
T Consensus 282 L~Ls~N~l~-~i~~~~-------------~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 282 LEFSRNQLK-SVPDGI-------------FDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp EECCSSCCC-CCCTTT-------------TTTCTTCCEEECCSSCBCCCHH
T ss_pred EECCCCCCC-ccCHHH-------------HhcCCCCCEEEeeCCCccCcCC
Confidence 999999999 555431 4677899999999999986543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=274.45 Aligned_cols=261 Identities=18% Similarity=0.170 Sum_probs=197.2
Q ss_pred CCCCCEEEcccCcCccccCcccccc-ccceEecccccccccC-CccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 16 LPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNI-PSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 16 l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
.++|++|+|++|.+++..|..|..+ +|++|+|++|.+.+.+ |..|+++++|++|+|++|.|++..|..|.++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 3689999999999998889999999 8999999999776666 7889999999999999999998889999999999999
Q ss_pred eCCCCcccccCCcc--ccCCCCCCEEEccCccccccCC-ccccCCCCCCEEEcccCCCcCcCCccccCc--cCCCeeecc
Q 040398 94 RLSSNRLIGNLPME--LVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNRLEIQGSGLEGPIPPSISAL--DKLNQLRIS 168 (732)
Q Consensus 94 ~L~~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~ls 168 (732)
+|++|.+++.+|.. +.++++|+.|+|++|.+++..+ ..|+++++|+.|+|++|.+++..+..+..+ ++|+.|+++
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 99999999877665 9999999999999999987755 679999999999999999999999999888 899999999
Q ss_pred CcCCCCCCcccccCCCC------ccEEEcccccccCCcchhhcC------------------------------------
Q 040398 169 DLQGPNQTFPMLRNMTG------LTRIILRNCNIAGEIPEYIWG------------------------------------ 206 (732)
Q Consensus 169 ~N~l~~~~~~~l~~l~~------L~~L~Ls~N~l~~~~p~~l~~------------------------------------ 206 (732)
+|.+....+..+..+++ |+.|+|++|.+++.+|..+..
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence 99888766555544443 666666666555444433221
Q ss_pred --CCCCcEEeCCCCcCcccCCCCCc-cCcch-----hhH---H-HHHHhccCCCCeEEccCCcCcCCCCCC-ccccCCCC
Q 040398 207 --IKNLRFLDLSFNQLTGELPDVAV-PADLK-----FTQ---I-LMFIRGVYEHQSLDLSYNNFTWQSPEQ-PACREKPN 273 (732)
Q Consensus 207 --l~~L~~L~Ls~N~l~g~~p~~~~-~~~l~-----~~~---~-~~~~~~l~~L~~LdLs~N~l~~~~p~~-~~~~~~~~ 273 (732)
.++|+.|+|++|.+++..|.... ...+. ... + +..+.++++|+.|+|++|++++.+|.. ..+..+..
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 13455555555555544443211 00000 000 0 122667788888888888888776642 33344444
Q ss_pred ccc
Q 040398 274 LNL 276 (732)
Q Consensus 274 l~~ 276 (732)
|++
T Consensus 343 L~L 345 (844)
T 3j0a_A 343 IDL 345 (844)
T ss_dssp EEC
T ss_pred EEC
Confidence 443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-26 Score=261.32 Aligned_cols=125 Identities=26% Similarity=0.348 Sum_probs=99.7
Q ss_pred CCcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCc-cCC
Q 040398 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG-TIP 81 (732)
Q Consensus 4 ~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p 81 (732)
.+++..|.+|.++++|++|+|++|++++..|..|..+ +|++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|
T Consensus 63 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p 139 (562)
T 3a79_B 63 SISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVC 139 (562)
T ss_dssp CCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCC
T ss_pred CccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCch
Confidence 3555556799999999999999999998889999988 8999999999999 78876 89999999999999985 346
Q ss_pred ccccCCCCCCEEeCCCCcccccCCccccCCCCC--CEEEccCccc--cccCCccccC
Q 040398 82 RELGNLVNLETLRLSSNRLIGNLPMELVKLKNL--TDFRINDNNF--NGSAPDFIQS 134 (732)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~~~p~~~~~ 134 (732)
..|+++++|++|+|++|+|++. .+..+++| +.|++++|.+ ++..|..+..
T Consensus 140 ~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~ 193 (562)
T 3a79_B 140 KEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193 (562)
T ss_dssp GGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEE
T ss_pred HhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccc
Confidence 8999999999999999998742 33444444 6666666666 4444444433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=268.84 Aligned_cols=252 Identities=21% Similarity=0.231 Sum_probs=202.5
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|..+. ++|++|+|++|.+++..+..|..+ +|++|+|++|++++..|..++++++|++|+|++|++++..+..|.++
T Consensus 19 ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l 96 (680)
T 1ziw_A 19 VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96 (680)
T ss_dssp CCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred cccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccC
Confidence 454443 679999999999997777778888 79999999999998888889999999999999999984444478999
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCcccc--CccCCCee
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS--ALDKLNQL 165 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L 165 (732)
++|++|+|++|++++..|..+.++++|+.|++++|.+++..|..+.++++|+.|++++|.+++..+..+. .+++|+.|
T Consensus 97 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 176 (680)
T 1ziw_A 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176 (680)
T ss_dssp TTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEE
T ss_pred CCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEE
Confidence 9999999999999876677899999999999999999988888899999999999999999877776654 45889999
Q ss_pred eccCcCCCCCCcccccCC---------------------------CCccEEEcccccccCCcchhhcCCCC--CcEEeCC
Q 040398 166 RISDLQGPNQTFPMLRNM---------------------------TGLTRIILRNCNIAGEIPEYIWGIKN--LRFLDLS 216 (732)
Q Consensus 166 ~ls~N~l~~~~~~~l~~l---------------------------~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~Ls 216 (732)
++++|.+.+..+..+..+ ++|+.|+|++|.+++..|..+..++. |+.|+|+
T Consensus 177 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls 256 (680)
T 1ziw_A 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256 (680)
T ss_dssp ECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECT
T ss_pred ECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECC
Confidence 999999888777666544 45677777888888777777777654 8888888
Q ss_pred CCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC-CccccCCCCccc
Q 040398 217 FNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE-QPACREKPNLNL 276 (732)
Q Consensus 217 ~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~-~~~~~~~~~l~~ 276 (732)
+|++++.+|.. ++++++|+.|+|++|++++.+|. ...|..+..|++
T Consensus 257 ~n~l~~~~~~~--------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 303 (680)
T 1ziw_A 257 YNNLNVVGNDS--------------FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303 (680)
T ss_dssp TSCCCEECTTT--------------TTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEEC
T ss_pred CCCcCccCccc--------------ccCcccccEeeCCCCccCccChhhhcCCCCccEEec
Confidence 88888776654 56678888888888888887764 334444444443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=266.88 Aligned_cols=240 Identities=19% Similarity=0.205 Sum_probs=124.8
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCc--------------------cccCC
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPS--------------------HLGNI 63 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~--------------------~l~~l 63 (732)
+++.+|. +..+++|++|++++|.++ .+| .+..+ +|++|++++|++ +.+|. .++.+
T Consensus 274 ~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l 349 (606)
T 3vq2_A 274 FSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVAL 349 (606)
T ss_dssp CCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCC
T ss_pred ccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccC
Confidence 3444554 555555555555555554 333 33333 455555555555 24442 23344
Q ss_pred CCCCEEecccccCCcc--CCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCC-ccccCCCCCCE
Q 040398 64 TSLTYLDLEENQFSGT--IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNR 140 (732)
Q Consensus 64 ~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 140 (732)
++|++|+|++|++++. +|..+..+++|++|+|++|.++ .+|..+..+++|+.|++++|++.+..| ..+..+++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 4555555555554432 2444555555555555555554 244455555555555555555554444 44555555555
Q ss_pred EEcccCCCcCcCCccccCccCCCeeeccCcCCCC-CCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCc
Q 040398 141 LEIQGSGLEGPIPPSISALDKLNQLRISDLQGPN-QTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219 (732)
Q Consensus 141 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 219 (732)
|++++|.+++..|..+..+++|+.|++++|.+.+ ..+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 5555555555555555555555555555555554 234445555555555555555555555555555555555555555
Q ss_pred CcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 220 LTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 220 l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+++.+|.. +.++++|+.|||++|+|+..++
T Consensus 509 l~~~~~~~--------------~~~l~~L~~L~l~~N~l~~~p~ 538 (606)
T 3vq2_A 509 LLFLDSSH--------------YNQLYSLSTLDCSFNRIETSKG 538 (606)
T ss_dssp CSCEEGGG--------------TTTCTTCCEEECTTSCCCCEES
T ss_pred CCCcCHHH--------------ccCCCcCCEEECCCCcCcccCH
Confidence 55544432 4445556666666666654433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=263.58 Aligned_cols=266 Identities=22% Similarity=0.256 Sum_probs=186.3
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGN 86 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 86 (732)
+||+.+. ++|++|+|++|++++..|..+..+ +|++|+|++|++++..|..|+++++|++|+|++|++++..|..|++
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 96 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence 3555543 678999999999987778888877 7999999999998777788888999999999999998666666888
Q ss_pred CCCCCEEeCCCCcccc-cCCccccCCCCCCEEEccCccccccC-CccccCCCCCCEEEcccCCCcCcCCccccC------
Q 040398 87 LVNLETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFNGSA-PDFIQSWTQLNRLEIQGSGLEGPIPPSISA------ 158 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------ 158 (732)
+++|++|+|++|++++ ..|..+.++++|+.|++++|.+.+.+ +..+.++++|+.|++++|++++..|..+..
T Consensus 97 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 9999999999998885 35677888899999999988844344 467888888999999999888877777654
Q ss_pred ------------------ccCCCeeeccCcCCCCCCc---ccc-------------------------------------
Q 040398 159 ------------------LDKLNQLRISDLQGPNQTF---PML------------------------------------- 180 (732)
Q Consensus 159 ------------------l~~L~~L~ls~N~l~~~~~---~~l------------------------------------- 180 (732)
+++|+.|++++|.+.+... ...
T Consensus 177 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l 256 (549)
T 2z81_A 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256 (549)
T ss_dssp EEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEE
T ss_pred EecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccc
Confidence 4566667777776665310 000
Q ss_pred --------------------------------------------------cCCCCccEEEcccccccCCcchhh-cCCCC
Q 040398 181 --------------------------------------------------RNMTGLTRIILRNCNIAGEIPEYI-WGIKN 209 (732)
Q Consensus 181 --------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~ 209 (732)
..+++|+.|++++|++. .+|..+ ..+++
T Consensus 257 ~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~ 335 (549)
T 2z81_A 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS 335 (549)
T ss_dssp EEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTT
T ss_pred ccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCcc
Confidence 01124555555555555 455544 46888
Q ss_pred CcEEeCCCCcCcccCCCC----CccCcch--------hhHH---HHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCc
Q 040398 210 LRFLDLSFNQLTGELPDV----AVPADLK--------FTQI---LMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNL 274 (732)
Q Consensus 210 L~~L~Ls~N~l~g~~p~~----~~~~~l~--------~~~~---~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l 274 (732)
|+.|+|++|++++.+|.. .....++ ...+ ...+..+++|+.|||++|+|+..++....+..+..|
T Consensus 336 L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L 415 (549)
T 2z81_A 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFL 415 (549)
T ss_dssp CCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEE
T ss_pred ccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEE
Confidence 888888888888754311 0011111 1111 234778888888888888888665544444445445
Q ss_pred cc
Q 040398 275 NL 276 (732)
Q Consensus 275 ~~ 276 (732)
++
T Consensus 416 ~L 417 (549)
T 2z81_A 416 NL 417 (549)
T ss_dssp EC
T ss_pred EC
Confidence 44
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=263.93 Aligned_cols=128 Identities=19% Similarity=0.283 Sum_probs=95.0
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCc-cCCc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG-TIPR 82 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~ 82 (732)
+++..|.++.++++|++|+|++|++++..|..|..+ +|++|+|++|++++..|..++++++|++|+|++|.+++ .+|.
T Consensus 38 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 117 (549)
T 2z81_A 38 ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117 (549)
T ss_dssp CCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSC
T ss_pred cCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhh
Confidence 455567788888888888888888887777778777 78888888888886656668888888888888888875 3466
Q ss_pred cccCCCCCCEEeCCCCcccccCC-ccccCCCCCCEEEccCccccccCCccc
Q 040398 83 ELGNLVNLETLRLSSNRLIGNLP-MELVKLKNLTDFRINDNNFNGSAPDFI 132 (732)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~ 132 (732)
.+.++++|++|+|++|++.+.+| ..+.++++|+.|++++|++++..|..+
T Consensus 118 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168 (549)
T ss_dssp SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred hhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence 77788888888888877433443 466677777777777777766555444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-25 Score=233.64 Aligned_cols=226 Identities=18% Similarity=0.129 Sum_probs=173.2
Q ss_pred CEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCc
Q 040398 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNR 99 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 99 (732)
..++..+.+++ .+|..+. .+|++|+|++|++++..+..+.++++|++|+|++|++++..+..+.++++|++|+|++|+
T Consensus 10 ~~~~c~~~~l~-~ip~~l~-~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP-FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC-TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEEecCCCcc-ccCCCCC-CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 34566666666 5665443 268888888888886666678888888888888888885555678888888888888888
Q ss_pred ccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc-CCccccCccCCCeeeccCcCCCCCCcc
Q 040398 100 LIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP-IPPSISALDKLNQLRISDLQGPNQTFP 178 (732)
Q Consensus 100 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~~ 178 (732)
+++..+..+.++++|+.|++++|.+++..+..+..+++|+.|+|++|.+++. +|..+..+++|+.|++++|.++.+...
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 8877677788888888888888888876666788888888888888888763 578888888888888888888887777
Q ss_pred cccCCCCcc----EEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 179 MLRNMTGLT----RIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 179 ~l~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
.+..+++|+ .|+|++|++++..+. .....+|+.|+|++|++++.++.. +.++++|+.|+|+
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~-~~~~~~L~~L~L~~n~l~~~~~~~--------------~~~l~~L~~L~l~ 232 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLKELALDTNQLKSVPDGI--------------FDRLTSLQKIWLH 232 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTT-SSCSCCEEEEECCSSCCSCCCTTT--------------TTTCCSCCEEECC
T ss_pred HhhhhhhccccceeeecCCCcccccCcc-ccCCCcccEEECCCCceeecCHhH--------------hcccccccEEEcc
Confidence 777776666 889999999854444 444558999999999998665543 5667889999999
Q ss_pred CCcCcCCC
Q 040398 255 YNNFTWQS 262 (732)
Q Consensus 255 ~N~l~~~~ 262 (732)
+|++++..
T Consensus 233 ~N~~~c~c 240 (276)
T 2z62_A 233 TNPWDCSC 240 (276)
T ss_dssp SSCBCCCT
T ss_pred CCcccccC
Confidence 99887543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.41 Aligned_cols=215 Identities=14% Similarity=0.181 Sum_probs=191.4
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|+.+. ++|++|+|++|++++..+..+..+ +|++|+|++|++++..+..+.++++|++|+|++|.+++..+..+.++
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence 444433 479999999999997777788888 89999999999997777789999999999999999997777889999
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccccc-CCccccCCCCCCEEEcccCCCcCcCCccccCccCCC---
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN--- 163 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--- 163 (732)
++|++|++++|++++..+..+..+++|+.|++++|.+++. +|..+..+++|+.|+|++|++++..+..+..+++|+
T Consensus 100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ 179 (276)
T 2z62_A 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179 (276)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccc
Confidence 9999999999999977676899999999999999999864 699999999999999999999988788888888887
Q ss_pred -eeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 164 -QLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 164 -~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
.|++++|.+..++...+... +|++|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus 180 l~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 180 LSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp EEEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred eeeecCCCcccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 89999999998887766654 899999999999977677788999999999999999987664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=256.64 Aligned_cols=119 Identities=18% Similarity=0.196 Sum_probs=78.5
Q ss_pred ccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc-ccccCCCCccEEEcccccccCCcchhhcCCC
Q 040398 130 DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF-PMLRNMTGLTRIILRNCNIAGEIPEYIWGIK 208 (732)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 208 (732)
..+..+++|+.|++++|.+++..+ .+..+++|+.|++++|.+....+ ..+..+++|++|+|++|.+.+..|..+..++
T Consensus 367 ~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 445 (570)
T 2z63_A 367 QSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445 (570)
T ss_dssp HHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred ccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC
Confidence 334556777888888888774433 37777777777777777766544 4567777777777777777766777777777
Q ss_pred CCcEEeCCCCcCc-ccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 209 NLRFLDLSFNQLT-GELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 209 ~L~~L~Ls~N~l~-g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+|+.|+|++|.++ +.+|.. +..+++|+.|+|++|++++.+|
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~--------------~~~l~~L~~L~l~~n~l~~~~~ 487 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDI--------------FTELRNLTFLDLSQCQLEQLSP 487 (570)
T ss_dssp TCCEEECTTCEEGGGEECSC--------------CTTCTTCCEEECTTSCCCEECT
T ss_pred cCcEEECcCCcCccccchhh--------------hhcccCCCEEECCCCccccCCh
Confidence 7777777777776 455543 3344555555555555555544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=258.45 Aligned_cols=217 Identities=15% Similarity=0.134 Sum_probs=184.1
Q ss_pred CCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 15 NLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 15 ~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
.+++|++|+|++|.+++..|..+..+ +|++|+|++|.+++..| ++.+++|++|+|++|.|++ +| ..++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC----CCCCcCEE
Confidence 34489999999999998878888888 79999999999986665 8999999999999999983 33 23889999
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCcccc-CccCCCeeeccCcCC
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS-ALDKLNQLRISDLQG 172 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l 172 (732)
+|++|.|++..+. .+++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999865443 468899999999999988898999999999999999999988888876 789999999999999
Q ss_pred CCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEE
Q 040398 173 PNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLD 252 (732)
Q Consensus 173 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~Ld 252 (732)
++.+ .+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.|++ +|.. +..+++|+.|+
T Consensus 182 ~~~~--~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--------------l~~l~~L~~L~ 243 (487)
T 3oja_A 182 YDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA--------------LRFSQNLEHFD 243 (487)
T ss_dssp CEEE--CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT--------------CCCCTTCCEEE
T ss_pred cccc--ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchh--------------hccCCCCCEEE
Confidence 8773 34468999999999999996 55558899999999999999996 4543 45567899999
Q ss_pred ccCCcCc
Q 040398 253 LSYNNFT 259 (732)
Q Consensus 253 Ls~N~l~ 259 (732)
|++|+++
T Consensus 244 l~~N~l~ 250 (487)
T 3oja_A 244 LRGNGFH 250 (487)
T ss_dssp CTTCCBC
T ss_pred cCCCCCc
Confidence 9999887
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=257.57 Aligned_cols=251 Identities=17% Similarity=0.158 Sum_probs=194.6
Q ss_pred CCcccCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 4 SLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 4 ~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
.+.+.+|+.+..+++|++|++++|.++ .+|..+...+|++|++++|.+. .+|. ..+++|++|++++|.+.+..+.
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~- 343 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE- 343 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC-
T ss_pred hhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc-
Confidence 456778899999999999999999998 6777776669999999999998 7775 4678888888888887755554
Q ss_pred ccCCCCCCEEeCCCCcccccC--CccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCC-ccccCcc
Q 040398 84 LGNLVNLETLRLSSNRLIGNL--PMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIP-PSISALD 160 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~ 160 (732)
..+++|+.|++++|++++.. |..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+++..+ ..+..++
T Consensus 344 -~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 421 (570)
T 2z63_A 344 -VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421 (570)
T ss_dssp -CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCT
T ss_pred -ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCC
Confidence 67788888888888887543 66777888888888888888755444 7888888888888888876655 4677888
Q ss_pred CCCeeeccCcCCCCCCcccccCCCCccEEEccccccc-CCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHH
Q 040398 161 KLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIA-GEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239 (732)
Q Consensus 161 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~ 239 (732)
+|+.|++++|.+....+..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++.+|..
T Consensus 422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~------------ 489 (570)
T 2z63_A 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA------------ 489 (570)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT------------
T ss_pred CCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh------------
Confidence 8888888888888777777888888888888888886 467777888888888888888888776754
Q ss_pred HHHhccCCCCeEEccCCcCcCCCCCC-ccccCCCCcc
Q 040398 240 MFIRGVYEHQSLDLSYNNFTWQSPEQ-PACREKPNLN 275 (732)
Q Consensus 240 ~~~~~l~~L~~LdLs~N~l~~~~p~~-~~~~~~~~l~ 275 (732)
+.++++|+.|+|++|++++.+|.. ..|..+..|+
T Consensus 490 --~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 524 (570)
T 2z63_A 490 --FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524 (570)
T ss_dssp --TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred --hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEE
Confidence 556677888888888888877753 3444444443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-25 Score=254.18 Aligned_cols=115 Identities=18% Similarity=0.280 Sum_probs=73.0
Q ss_pred ccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCC
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVN 89 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 89 (732)
.+|.++++|++|+|++|+|++..|..|..+ +|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++
T Consensus 70 ~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~ 149 (635)
T 4g8a_A 70 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 149 (635)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTT
T ss_pred HHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcc
Confidence 356666666666666666665555566665 5666666666666444455666666666666666666444445666666
Q ss_pred CCEEeCCCCcccc-cCCccccCCCCCCEEEccCcccc
Q 040398 90 LETLRLSSNRLIG-NLPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 90 L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
|++|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 150 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 150 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred cCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence 6777776666654 34556666666666666666554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-25 Score=254.17 Aligned_cols=145 Identities=17% Similarity=0.284 Sum_probs=128.2
Q ss_pred CCCCcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccC
Q 040398 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTI 80 (732)
Q Consensus 2 l~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 80 (732)
|++||..|| +.+++|||++|+|++..|..|..+ +|++|+|++|+|++..|..|.++++|++|+|++|+|++..
T Consensus 43 l~~vP~~lp------~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~ 116 (635)
T 4g8a_A 43 FYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 116 (635)
T ss_dssp CSSCCSSSC------TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred cCccCCCCC------cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCC
Confidence 566666666 468999999999997777889988 8999999999999777788999999999999999999655
Q ss_pred CccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccc-cCCccccCCCCCCEEEcccCCCcCcC
Q 040398 81 PRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNG-SAPDFIQSWTQLNRLEIQGSGLEGPI 152 (732)
Q Consensus 81 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~ 152 (732)
+..|.++++|++|+|++|+|++..+..|+++++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++..
T Consensus 117 ~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 117 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp GGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred HHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccc
Confidence 5689999999999999999997667779999999999999999975 46888999999999999999886543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=243.85 Aligned_cols=220 Identities=15% Similarity=0.125 Sum_probs=182.0
Q ss_pred cCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
.+..+++|++|+|++|++++..|..+..+ +|++|+|++|++++..+ +..+++|++|+|++|+|+ .++ ..++|
T Consensus 29 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~-~l~----~~~~L 101 (317)
T 3o53_A 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELL----VGPSI 101 (317)
T ss_dssp HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE-EEE----ECTTC
T ss_pred HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc-ccc----CCCCc
Confidence 34556789999999999997777888888 79999999999986554 889999999999999988 333 34889
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccc-cCccCCCeeeccC
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSI-SALDKLNQLRISD 169 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~ 169 (732)
++|++++|+|++..+. .+++|+.|++++|++++..+..+..+++|+.|+|++|.+++..+..+ ..+++|+.|++++
T Consensus 102 ~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~ 178 (317)
T 3o53_A 102 ETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178 (317)
T ss_dssp CEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred CEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCC
Confidence 9999999999865443 36789999999999998888889999999999999999997777766 4789999999999
Q ss_pred cCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCC
Q 040398 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQ 249 (732)
Q Consensus 170 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~ 249 (732)
|.++..+ ....+++|++|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|.. +..+++|+
T Consensus 179 N~l~~~~--~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~--------------~~~l~~L~ 240 (317)
T 3o53_A 179 NFIYDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA--------------LRFSQNLE 240 (317)
T ss_dssp SCCCEEE--CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT--------------CCCCTTCC
T ss_pred CcCcccc--cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhH--------------hhcCCCCC
Confidence 9988773 33458899999999999984 55568889999999999999984 4543 45667899
Q ss_pred eEEccCCcCc
Q 040398 250 SLDLSYNNFT 259 (732)
Q Consensus 250 ~LdLs~N~l~ 259 (732)
.|+|++|+++
T Consensus 241 ~L~l~~N~~~ 250 (317)
T 3o53_A 241 HFDLRGNGFH 250 (317)
T ss_dssp EEECTTCCCB
T ss_pred EEEccCCCcc
Confidence 9999999987
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-25 Score=228.41 Aligned_cols=205 Identities=21% Similarity=0.271 Sum_probs=181.8
Q ss_pred cCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
++.++++|++|++++|+++ .+|..+. .++++|+|++|++++..+..|.++++|++|+|++|.|++ ++.. ..+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~-~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC-TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC-CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCC
Confidence 4778899999999999999 6666553 379999999999997778899999999999999999984 4433 7899999
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
+|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 788889999999999999999998888889999999999999999997777778899999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcc
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 222 (732)
++.++...|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 99888888889999999999999998 788888888899999999999874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-24 Score=223.58 Aligned_cols=202 Identities=21% Similarity=0.252 Sum_probs=133.9
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
+++++++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|+...+..+.++++|+.|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 3566666666666 4565443 466666776666664444466666667777777666664334445666677777777
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+..++...|..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 77766555566666777777777777776665666667777777777777777666666777777777777777777655
Q ss_pred chhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 201 PEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
+..+..+++|+.|+|++|++++..+.. +..+++|+.|+|++|+++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGA--------------FDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTT--------------TTTCTTCCEEECCSSCBC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHH--------------hccccCCCEEEecCCCee
Confidence 556777777777777777777544432 445567777777777664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=233.57 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=154.8
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|+ +.++++|++|+|++|.++. +| .+..+ +|++|+|++|+++ .++. +..+++|++|++++|.....+ ..+..+
T Consensus 81 ~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l 154 (347)
T 4fmz_A 81 ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNIS-DISP-LANLTKMYSLNLGANHNLSDL-SPLSNM 154 (347)
T ss_dssp CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCC-CCGG-GTTCTTCCEEECTTCTTCCCC-GGGTTC
T ss_pred chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCccc-Cchh-hccCCceeEEECCCCCCcccc-cchhhC
Confidence 444 8888899999999998884 44 46666 7899999988888 4444 778888888888888655333 347777
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeec
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 167 (732)
++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 228 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEc
Confidence 888888888887773322 6777777777777777764332 5566666666666666653322 555666666666
Q ss_pred cCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcch--------h-hHH
Q 040398 168 SDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLK--------F-TQI 238 (732)
Q Consensus 168 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~--------~-~~~ 238 (732)
++|.+..... +..+++|++|+|++|.+++ + ..+..+++|+.|++++|++++. |.......+. . ...
T Consensus 229 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGG
T ss_pred cCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcC
Confidence 6666655443 5555666666666666653 2 2355556666666666655542 2100000000 0 111
Q ss_pred HHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 239 LMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 239 ~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
+..+.++++|+.|+|++|++++.+| ...+..+..|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~ 339 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSAD 339 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEES
T ss_pred hhHhhccccCCEEEccCCccccccC-hhhhhccceee
Confidence 2336667777777777777777666 44444444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=241.14 Aligned_cols=221 Identities=20% Similarity=0.199 Sum_probs=182.1
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
..+..+..++++++|++|+|++|.+++ +| .+..+ +|++|+|++|++++ +| ++.+++|++|+|++|+|++ ++
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--
Confidence 445566788889999999999999995 45 56666 79999999999995 44 8899999999999999985 44
Q ss_pred ccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCC
Q 040398 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 163 (732)
++++++|++|+|++|++++ +| +..+++|+.|++++|++++. + ++.+++|+.|++++|...+.+ .+..+++|+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 173 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173 (457)
T ss_dssp CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence 8899999999999999985 44 88899999999999999864 3 788899999999999665555 477888999
Q ss_pred eeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHh
Q 040398 164 QLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243 (732)
Q Consensus 164 ~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~ 243 (732)
.|++++|.+++++ +..+++|+.|+|++|++++. .+..+++|+.|+|++|++++ +| ++
T Consensus 174 ~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip----------------~~ 230 (457)
T 3bz5_A 174 TLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID----------------VT 230 (457)
T ss_dssp EEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC----------------CT
T ss_pred EEECCCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC----------------cc
Confidence 9999999988865 77788899999999998864 37788899999999999887 44 23
Q ss_pred ccCCCCeEEccCCcCcCCCCC
Q 040398 244 GVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 244 ~l~~L~~LdLs~N~l~~~~p~ 264 (732)
.+++|+.|++++|+|++.++.
T Consensus 231 ~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 231 PLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp TCTTCSEEECCSSCCSCCCCT
T ss_pred ccCCCCEEEeeCCcCCCcCHH
Confidence 457888889999988887643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=222.55 Aligned_cols=206 Identities=22% Similarity=0.249 Sum_probs=185.5
Q ss_pred CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
.++.+++++++++ .+|..+. .+|++|+|++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|+|++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~-~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP-ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC-TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCCEEEccCCCCC-ccCCCCC-CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 5789999999999 6776554 3799999999999966667899999999999999999954445678999999999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF 177 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 177 (732)
|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|.+..++.
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 99997666778999999999999999998888889999999999999999997777779999999999999999999999
Q ss_pred ccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 178 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++...-+
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 899999999999999999997777778899999999999999986544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-24 Score=238.95 Aligned_cols=239 Identities=19% Similarity=0.203 Sum_probs=196.1
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+++ +| .+.++++|++|+|++|++++ +| +..+ +|++|+|++|++++ ++ ++++++|++|+|++|++++ +|
T Consensus 54 l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~-- 122 (457)
T 3bz5_A 54 ITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD-- 122 (457)
T ss_dssp CCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--
T ss_pred ccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--
Confidence 444 45 79999999999999999996 44 6666 79999999999996 44 8999999999999999995 55
Q ss_pred ccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCC
Q 040398 84 LGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLN 163 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 163 (732)
++.+++|++|++++|+|++ ++ +..+++|+.|++++|...+.+ .+..+++|+.|++++|++++ +| +..+++|+
T Consensus 123 ~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~ 194 (457)
T 3bz5_A 123 VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLN 194 (457)
T ss_dssp CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCC
T ss_pred CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCC
Confidence 8999999999999999996 43 889999999999999766566 48899999999999999996 45 88999999
Q ss_pred eeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHh
Q 040398 164 QLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243 (732)
Q Consensus 164 ~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~ 243 (732)
.|++++|.+++. .+..+++|++|+|++|++++ +| +..+++|+.|++++|++++..+... ..+... .-
T Consensus 195 ~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l--~~L~~L-----~l 261 (457)
T 3bz5_A 195 RLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL--SKLTTL-----HC 261 (457)
T ss_dssp EEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC--TTCCEE-----EC
T ss_pred EEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC--CCCCEE-----ec
Confidence 999999999987 37889999999999999997 66 8899999999999999998754321 111100 00
Q ss_pred ccCCCCeEEccCCcCcCCCCCCccccCCCCccc
Q 040398 244 GVYEHQSLDLSYNNFTWQSPEQPACREKPNLNL 276 (732)
Q Consensus 244 ~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~ 276 (732)
...+|+.|++++|++.+.+|. ..|..+..|++
T Consensus 262 ~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~L 293 (457)
T 3bz5_A 262 IQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDV 293 (457)
T ss_dssp TTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCC
T ss_pred cCCCCCEEECCCCccCCcccc-cccccCCEEEC
Confidence 113677888888888777763 45666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-24 Score=230.31 Aligned_cols=221 Identities=24% Similarity=0.365 Sum_probs=150.8
Q ss_pred ccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCcc----------
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT---------- 79 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---------- 79 (732)
+.+.++++|++|+|++|.+++ ++. +..+ +|++|++++|.....+ ..+..+++|++|++++|.+.+.
T Consensus 104 ~~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~ 180 (347)
T 4fmz_A 104 SALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTPIANLTDLY 180 (347)
T ss_dssp GGGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCS
T ss_pred hHHcCCCcCCEEECcCCcccC-chh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchhhccCCCCC
Confidence 357778888888888887774 333 4444 5666666666444222 2255555555555555555422
Q ss_pred -----------CCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCC
Q 040398 80 -----------IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL 148 (732)
Q Consensus 80 -----------~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 148 (732)
++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 181 ~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 255 (347)
T 4fmz_A 181 SLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255 (347)
T ss_dssp EEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCcc
Confidence 221 4444444444444444442222 6667777777777777764433 77788888888888888
Q ss_pred cCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCC
Q 040398 149 EGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVA 228 (732)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 228 (732)
++. ..+..+++|+.|++++|.+... +.+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|
T Consensus 256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--- 328 (347)
T 4fmz_A 256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--- 328 (347)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG---
T ss_pred CCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC---
Confidence 743 4677888888888888888776 457888889999999999988888888889999999999999887655
Q ss_pred ccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 229 VPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 229 ~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
+..+++|+.||+++|+|+
T Consensus 329 -------------~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 329 -------------LASLSKMDSADFANQVIK 346 (347)
T ss_dssp -------------GGGCTTCSEESSSCC---
T ss_pred -------------hhhhhccceeehhhhccc
Confidence 456789999999999985
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=226.89 Aligned_cols=221 Identities=17% Similarity=0.176 Sum_probs=176.6
Q ss_pred CCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
++..+++..+.+.... ....+ +|++|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECC
Confidence 3445566666665332 23334 6888888888887 343 47888889999999988884 3 478888889999999
Q ss_pred CCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCC
Q 040398 97 SNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 97 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
+|++++..+..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++|.+++.+
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 99888766667888889999999999988777777888889999999999888777777888889999999999888888
Q ss_pred cccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCC
Q 040398 177 FPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYN 256 (732)
Q Consensus 177 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N 256 (732)
+..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++.+..| +|+.|+++.|
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~---------------------~l~~l~~~~n 232 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP---------------------GIRYLSEWIN 232 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT---------------------TTHHHHHHHH
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc---------------------HHHHHHHHHH
Confidence 8888888899999999999988777778888999999999998886655 3567888888
Q ss_pred cCcCCCCCC
Q 040398 257 NFTWQSPEQ 265 (732)
Q Consensus 257 ~l~~~~p~~ 265 (732)
+++|.+|..
T Consensus 233 ~~~g~ip~~ 241 (272)
T 3rfs_A 233 KHSGVVRNS 241 (272)
T ss_dssp HTGGGBBCT
T ss_pred hCCCcccCc
Confidence 888888753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-24 Score=237.96 Aligned_cols=196 Identities=29% Similarity=0.383 Sum_probs=129.5
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+..+++|++|+|++|.+++..| +..+ +|++|+|++|++++. +. ++++++|++|+|++|.+++ ++. +.++++|+
T Consensus 64 ~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~ 137 (466)
T 1o6v_A 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TP-LANLTNLTGLTLFNNQITD-IDP-LKNLTNLN 137 (466)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCS
T ss_pred hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccC-hh-hcCCCCCCEEECCCCCCCC-ChH-HcCCCCCC
Confidence 6777788888888888774433 5555 677888877777743 33 7777777777777777773 332 66777777
Q ss_pred EEeCCCCcccccCC--------------------ccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc
Q 040398 92 TLRLSSNRLIGNLP--------------------MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP 151 (732)
Q Consensus 92 ~L~L~~N~l~~~~p--------------------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 151 (732)
+|+|++|.+++ ++ ..+.++++|+.|++++|.+++. ..+..+++|+.|++++|.+++.
T Consensus 138 ~L~l~~n~l~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 214 (466)
T 1o6v_A 138 RLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDI 214 (466)
T ss_dssp EEEEEEEEECC-CGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred EEECCCCccCC-ChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccc
Confidence 77777776653 22 1255667777777777777643 2366777777777777777654
Q ss_pred CCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 152 IPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 152 ~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
.| +..+++|+.|++++|.+... +.+..+++|++|+|++|.+++..+ +..+++|+.|++++|++++.
T Consensus 215 ~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 280 (466)
T 1o6v_A 215 TP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 280 (466)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC
T ss_pred cc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc
Confidence 44 55666777777777766654 345666666666666666664443 55666666666666666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-25 Score=253.42 Aligned_cols=184 Identities=16% Similarity=0.185 Sum_probs=145.5
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcccccc--------cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR--------QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..+.||+|+||.||+|+.. ++.+|+|+...... ...+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3568999999999999544 67888887543211 11345899999999999999997777777888889999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999843 5689999999999999996 999999999999999 999999999987755
Q ss_pred cCcee------eecccCccccccchhccc--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 670 EKTHI------STRVAGTIGYMAPEYALW--GYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 670 ~~~~~------~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
..... .....||+.|||||++.. ..|+..+|+||..+-.++-+.++.++.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 234679999999999986 567788999999999888887776653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=235.75 Aligned_cols=220 Identities=30% Similarity=0.440 Sum_probs=148.7
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCC----------
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP---------- 81 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p---------- 81 (732)
+.++++|++|+|++|.+++..+ +..+ +|++|+|++|++++ ++. +.++++|++|+|++|.+++ ++
T Consensus 86 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~ 160 (466)
T 1o6v_A 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISD-ISALSGLTSLQQ 160 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCSEEEEEEEEECC-CGGGTTCTTCSE
T ss_pred hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCC-ChH-HcCCCCCCEEECCCCccCC-ChhhccCCcccE
Confidence 7777788888888887775443 5555 67777777777773 333 6777777777777777663 22
Q ss_pred ----------ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCc
Q 040398 82 ----------RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGP 151 (732)
Q Consensus 82 ----------~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 151 (732)
..+.++++|+.|++++|++++ ++ .+..+++|+.|++++|.+++..| ++.+++|+.|++++|++++.
T Consensus 161 L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp EEEEESCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred eecCCcccCchhhccCCCCCEEECcCCcCCC-Ch-hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 125667788888888888873 33 47778888888888888876554 66677777777777777642
Q ss_pred CCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccC
Q 040398 152 IPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPA 231 (732)
Q Consensus 152 ~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~ 231 (732)
..+..+++|+.|++++|.+.+..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..|
T Consensus 237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~------ 304 (466)
T 1o6v_A 237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP------ 304 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG------
T ss_pred --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh------
Confidence 356677777777777777766554 6667777777777777775433 6667777777777777765433
Q ss_pred cchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 232 DLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 232 ~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+..+++|+.|+|++|++++.+|
T Consensus 305 ----------~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 305 ----------ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp ----------GGGCTTCSEEECCSSCCSCCGG
T ss_pred ----------hcCCCCCCEEECcCCcCCCchh
Confidence 2344455555555555555444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=234.98 Aligned_cols=232 Identities=17% Similarity=0.136 Sum_probs=192.9
Q ss_pred CCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 96 (732)
.++.++++.+.+...+...+... +|++|+|++|++++..|..+.++++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 46667777887775555555555 79999999999997777899999999999999999986554 9999999999999
Q ss_pred CCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCC
Q 040398 97 SNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 97 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
+|+|++ + ..+++|+.|++++|++++..+.. +++|+.|++++|++++..+..+..+++|+.|++++|.+....
T Consensus 89 ~n~l~~-l----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQE-L----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEE-E----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccc-c----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 999984 2 24589999999999998765543 688999999999999888889999999999999999999987
Q ss_pred cccc-cCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccC
Q 040398 177 FPML-RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSY 255 (732)
Q Consensus 177 ~~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~ 255 (732)
+..+ ..+++|++|+|++|.|++. +. ...+++|+.|+|++|++++.++. +..+++|+.|+|++
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~---------------~~~l~~L~~L~L~~ 223 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE---------------FQSAAGVTWISLRN 223 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG---------------GGGGTTCSEEECTT
T ss_pred HHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhh---------------hcccCcccEEECcC
Confidence 7766 4789999999999999954 43 33599999999999999965443 55678999999999
Q ss_pred CcCcCCCCCCccccCCCCccc
Q 040398 256 NNFTWQSPEQPACREKPNLNL 276 (732)
Q Consensus 256 N~l~~~~p~~~~~~~~~~l~~ 276 (732)
|+|+..++....+..+..|++
T Consensus 224 N~l~~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 224 NKLVLIEKALRFSQNLEHFDL 244 (317)
T ss_dssp SCCCEECTTCCCCTTCCEEEC
T ss_pred CcccchhhHhhcCCCCCEEEc
Confidence 999987665555555555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=220.16 Aligned_cols=202 Identities=20% Similarity=0.176 Sum_probs=179.4
Q ss_pred cccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCC
Q 040398 37 WASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT 115 (732)
Q Consensus 37 ~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 115 (732)
+..+ +++++++++|+++ .+|..+. ++|++|+|++|.|++..+..|.++++|+.|+|++|+|++. +.. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 4444 7999999999999 7887775 7999999999999977788999999999999999999954 433 7899999
Q ss_pred EEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEccccc
Q 040398 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCN 195 (732)
Q Consensus 116 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 195 (732)
.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++..++...|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 788889999999999999999997778889999999999999999999999999999999999999999
Q ss_pred ccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 196 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
|++..+..+..+++|+.|+|++|+|+ .+|.. +..+.+|+.|+|++|++.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~--------------~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKG--------------FFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTT--------------TTTTCCCSEEECCSCCBC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChh--------------hcccccCCeEEeCCCCcc
Confidence 99666667788999999999999999 55543 334568999999999775
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=222.60 Aligned_cols=205 Identities=22% Similarity=0.267 Sum_probs=185.7
Q ss_pred cCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
.+.++++|+.|++++|.++ .++. +..+ +|++|+|++|++++ + ..+..+++|++|+|++|.+++..+..+.++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~~~~-l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCC-CCTT-GGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCcc-cccc-cccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 4567889999999999998 4443 5556 89999999999995 3 479999999999999999997777778999999
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 170 (732)
++|+|++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 99999999999777777899999999999999999888888999999999999999999887888899999999999999
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCC
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDV 227 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 227 (732)
.+.+..+..+..+++|++|+|++|.+.+ .+++|+.|+++.|.++|.+|..
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCT
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCc
Confidence 9999999889999999999999999985 4567999999999999999975
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=243.23 Aligned_cols=208 Identities=17% Similarity=0.134 Sum_probs=180.0
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
+|++|+|++|++++..|..|+.+++|++|+|++|.|++..| +..+++|++|+|++|.|++. | ..++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-E----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-C----CCCCcCEEECc
Confidence 69999999999998778899999999999999999996655 99999999999999999843 2 34899999999
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCccccc-CCCCccEEEcccccccCC
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLR-NMTGLTRIILRNCNIAGE 199 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~ 199 (732)
+|.|++..+. .+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++..+..+. .+++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 9999976654 468899999999999998899999999999999999999998877775 799999999999999965
Q ss_pred cchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 200 IPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 200 ~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
|. +..+++|+.|+|++|+|++.+|. +..+++|+.|||++|+|++.++....+..+..|+
T Consensus 185 -~~-~~~l~~L~~L~Ls~N~l~~~~~~---------------~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~ 243 (487)
T 3oja_A 185 -KG-QVVFAKLKTLDLSSNKLAFMGPE---------------FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFD 243 (487)
T ss_dssp -EC-CCCCTTCCEEECCSSCCCEECGG---------------GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEE
T ss_pred -cc-cccCCCCCEEECCCCCCCCCCHh---------------HcCCCCccEEEecCCcCcccchhhccCCCCCEEE
Confidence 33 34699999999999999976553 5567899999999999998776655555444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=225.33 Aligned_cols=222 Identities=18% Similarity=0.188 Sum_probs=154.4
Q ss_pred CCCEEEcccCcCccccC----ccccccccceEecccccccccCCccc--cCCCCCCEEecccccCCccCC----ccccCC
Q 040398 18 YLETVDFAYNYLHGSIP----REWASMQLKYISVFANRLSGNIPSHL--GNITSLTYLDLEENQFSGTIP----RELGNL 87 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p----~~~~~~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 87 (732)
.++.|.+.++.++...- ..+...+|++|+|++|++.+..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 46777777776653211 11111258888888888887777777 778888888888888876544 344567
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccccc--C--CccccCCCCCCEEEcccCCCcCcCCc----cccCc
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS--A--PDFIQSWTQLNRLEIQGSGLEGPIPP----SISAL 159 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 159 (732)
++|++|+|++|++++..|..+..+++|+.|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 7888888888888766677777888888888888877542 1 233467788888888888886 2222 24667
Q ss_pred cCCCeeeccCcCCCCCCcccccCC---CCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhh
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNM---TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFT 236 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~ 236 (732)
++|++|+|++|.+.+..+..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~---------- 289 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ---------- 289 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC----------
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch----------
Confidence 788888888888877765555554 57888888888887 6676553 6888888888888753 21
Q ss_pred HHHHHHhccCCCCeEEccCCcCc
Q 040398 237 QILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 237 ~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
+..+++|+.|+|++|+|+
T Consensus 290 -----~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 290 -----PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp -----TTSCCCCSCEECSSTTTS
T ss_pred -----hhhCCCccEEECcCCCCC
Confidence 224467788888888775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-25 Score=244.97 Aligned_cols=246 Identities=19% Similarity=0.223 Sum_probs=198.9
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcc----cccc-ccceEecccc---cccccCCccc-------cCCCCCCEEecc
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPRE----WASM-QLKYISVFAN---RLSGNIPSHL-------GNITSLTYLDLE 72 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~----~~~~-~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~Ls 72 (732)
.++..+.++++|++|+|++|.++...+.. +..+ +|++|+|++| ++.+.+|..+ .++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 46778889999999999999999765544 4455 7999999995 5556667655 789999999999
Q ss_pred cccCCc----cCCccccCCCCCCEEeCCCCcccccCCcc----ccCC---------CCCCEEEccCcccc-ccCC---cc
Q 040398 73 ENQFSG----TIPRELGNLVNLETLRLSSNRLIGNLPME----LVKL---------KNLTDFRINDNNFN-GSAP---DF 131 (732)
Q Consensus 73 ~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~----l~~l---------~~L~~L~L~~N~l~-~~~p---~~ 131 (732)
+|.+++ .+|..+..+++|++|+|++|.|++..+.. +..+ ++|+.|+|++|+++ +.++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 999996 47888899999999999999997544433 4444 89999999999997 4455 46
Q ss_pred ccCCCCCCEEEcccCCCc--C---cCCccccCccCCCeeeccCcCCC----CCCcccccCCCCccEEEcccccccCC---
Q 040398 132 IQSWTQLNRLEIQGSGLE--G---PIPPSISALDKLNQLRISDLQGP----NQTFPMLRNMTGLTRIILRNCNIAGE--- 199 (732)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~~~~l~~l~~L~~L~Ls~N~l~~~--- 199 (732)
+..+++|+.|+|++|+++ | ..+..+..+++|+.|+|++|.++ ...+..+..+++|++|+|++|.|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 778999999999999998 3 34558899999999999999986 33455688899999999999999876
Q ss_pred -cchhhcC--CCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHH-hccCCCCeEEccCCcCcCCCC
Q 040398 200 -IPEYIWG--IKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFI-RGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 200 -~p~~l~~--l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~-~~l~~L~~LdLs~N~l~~~~p 263 (732)
++..+.. +++|+.|+|++|.+++. ....++..+ .++++|+.|+|++|++++..+
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~----------g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELD----------AVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHH----------HHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHH----------HHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 5677744 99999999999999852 011233334 668999999999999986653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.70 Aligned_cols=206 Identities=14% Similarity=0.128 Sum_probs=143.7
Q ss_pred cCccccCccccccccceEecccccccccCCccccCCCCCCEEeccccc-CCccCCccccCCCCCCEEeCCC-CcccccCC
Q 040398 28 YLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQ-FSGTIPRELGNLVNLETLRLSS-NRLIGNLP 105 (732)
Q Consensus 28 ~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p 105 (732)
.++ .+|. +.. +|++|+|++|++++..+..+.++++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+
T Consensus 22 ~l~-~ip~-~~~-~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 22 DIQ-RIPS-LPP-STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp SCS-SCCC-CCT-TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred Ccc-ccCC-CCC-cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 354 5555 222 67778888888775555577777888888888876 7644444677777888888877 77775555
Q ss_pred ccccCCCCCCEEEccCccccccCCccccCCCCCC---EEEcccC-CCcCcCCccccCccCCC-eeeccCcCCCCCCcccc
Q 040398 106 MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN---RLEIQGS-GLEGPIPPSISALDKLN-QLRISDLQGPNQTFPML 180 (732)
Q Consensus 106 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~~~~l 180 (732)
..|.++++|+.|++++|++++ +|. +..+++|+ .|++++| ++++..+..|..+++|+ .|++++|.++.++...+
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~ 176 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176 (239)
T ss_dssp TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT
T ss_pred HHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc
Confidence 677777788888888887775 555 77777777 7788877 77765566677777777 77777777776666556
Q ss_pred cCCCCccEEEccccc-ccCCcchhhcCC-CCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCC
Q 040398 181 RNMTGLTRIILRNCN-IAGEIPEYIWGI-KNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYN 256 (732)
Q Consensus 181 ~~l~~L~~L~Ls~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N 256 (732)
.. ++|++|+|++|+ +++..+..+..+ ++|+.|+|++|++++..+. .+.+|+.|++++|
T Consensus 177 ~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~-----------------~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 NG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK-----------------GLEHLKELIARNT 236 (239)
T ss_dssp TT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT-----------------TCTTCSEEECTTC
T ss_pred CC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh-----------------HhccCceeeccCc
Confidence 55 677788888874 775555667777 7788888888877743332 2356677777665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-22 Score=207.85 Aligned_cols=183 Identities=19% Similarity=0.195 Sum_probs=151.1
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
..++++++++.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4677888888888 6776665 578888888888887667778888888888888888887777778888888888888
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+..+++..|..+++|++|+|++|+|++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88888777777888888888888888888666666788888888888888888888878888889999999999999777
Q ss_pred chhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 201 PEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
+..+..+++|+.|+|++|++++..++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCCccc
Confidence 77888899999999999999876543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=230.59 Aligned_cols=215 Identities=18% Similarity=0.189 Sum_probs=113.3
Q ss_pred ccCCccCCCCCCCCEEEcccCcCccccCcccccc-c-------------cceEecccccccccCCccccCCCCCCEEecc
Q 040398 7 GTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-Q-------------LKYISVFANRLSGNIPSHLGNITSLTYLDLE 72 (732)
Q Consensus 7 g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~-------------L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 72 (732)
|+||++|++|++|++|++++|.+.+.+|..++.+ + +++|++++|+++ .+|.. .++|++|+|+
T Consensus 24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~---~~~L~~L~l~ 99 (454)
T 1jl5_A 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVAS 99 (454)
T ss_dssp ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECC
T ss_pred hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---cCCCCEEEcc
Confidence 5666666666666666666666666666666554 2 266666666666 34432 2456666666
Q ss_pred cccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcC
Q 040398 73 ENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPI 152 (732)
Q Consensus 73 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 152 (732)
+|.+++ +|.. +++|+.|++++|++++ +|.. .++|++|++++|++++ +| .++++++|++|++++|++++ +
T Consensus 100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l 168 (454)
T 1jl5_A 100 CNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-L 168 (454)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-C
T ss_pred CCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-c
Confidence 666663 4532 2455666666665552 2221 1456666666666654 44 35566666666666666653 3
Q ss_pred CccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCc
Q 040398 153 PPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPAD 232 (732)
Q Consensus 153 p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 232 (732)
|..+ ++|++|++++|.+.+++ .+..+++|++|++++|++++ +|.. .++|+.|++++|+++ .+|+
T Consensus 169 p~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp~------ 232 (454)
T 1jl5_A 169 PDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELPE------ 232 (454)
T ss_dssp CCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCCC------
T ss_pred CCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-cccc------
Confidence 4322 35566666666555532 35555666666666666553 3332 135555566655555 3442
Q ss_pred chhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 233 LKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 233 l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
++++++|+.|++++|++++.
T Consensus 233 ---------~~~l~~L~~L~l~~N~l~~l 252 (454)
T 1jl5_A 233 ---------LQNLPFLTTIYADNNLLKTL 252 (454)
T ss_dssp ---------CTTCTTCCEEECCSSCCSSC
T ss_pred ---------cCCCCCCCEEECCCCcCCcc
Confidence 34456667777777776654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=210.08 Aligned_cols=196 Identities=15% Similarity=0.170 Sum_probs=172.8
Q ss_pred CCCEEEcccCcCccccCcccccc-ccceEeccccc-ccccCCccccCCCCCCEEeccc-ccCCccCCccccCCCCCCEEe
Q 040398 18 YLETVDFAYNYLHGSIPREWASM-QLKYISVFANR-LSGNIPSHLGNITSLTYLDLEE-NQFSGTIPRELGNLVNLETLR 94 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 94 (732)
+|++|+|++|++++..+..|..+ +|++|+|++|+ ++...+..|.++++|++|+|++ |+|++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 79999999999997777788888 89999999997 8855566899999999999999 999966667899999999999
Q ss_pred CCCCcccccCCccccCCCCCC---EEEccCc-cccccCCccccCCCCCC-EEEcccCCCcCcCCccccCccCCCeeeccC
Q 040398 95 LSSNRLIGNLPMELVKLKNLT---DFRINDN-NFNGSAPDFIQSWTQLN-RLEIQGSGLEGPIPPSISALDKLNQLRISD 169 (732)
Q Consensus 95 L~~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 169 (732)
|++|++++ +|. +..+++|+ .|++++| ++++..+..|..+++|+ .|++++|+++ .+|......++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 99999995 776 88899998 9999999 99988888899999999 9999999999 5555444448999999999
Q ss_pred cC-CCCCCcccccCC-CCccEEEcccccccCCcchhhcCCCCCcEEeCCCCc
Q 040398 170 LQ-GPNQTFPMLRNM-TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQ 219 (732)
Q Consensus 170 N~-l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 219 (732)
|+ ++.++...|..+ ++|+.|+|++|+|+ .+|.. .+++|+.|+++++.
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC-
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCcc
Confidence 95 999888899999 99999999999999 45554 68899999998863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-22 Score=206.47 Aligned_cols=182 Identities=19% Similarity=0.193 Sum_probs=167.3
Q ss_pred CCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEc
Q 040398 64 TSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEI 143 (732)
Q Consensus 64 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 143 (732)
.+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..+.++++|+.|+|++|.|++..+..|..+++|+.|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 46789999999999 8888776 68999999999999888888999999999999999999988899999999999999
Q ss_pred ccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 144 QGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 144 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
++|++++..+..+..+++|+.|+|++|.++.++...|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999987788899999999999999999999998899999999999999999977777899999999999999999977
Q ss_pred CCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCC
Q 040398 224 LPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQS 262 (732)
Q Consensus 224 ~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 262 (732)
+|.. +.++++|+.|+|++|++++..
T Consensus 171 ~~~~--------------~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 171 PHGA--------------FDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CTTT--------------TTTCTTCCEEECCSCCBCTTS
T ss_pred CHHH--------------HhCCCCCCEEEeeCCceeCCc
Confidence 7654 567789999999999998654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=220.72 Aligned_cols=201 Identities=15% Similarity=0.146 Sum_probs=172.1
Q ss_pred CCCCCEEEcccCcCccccCccc--ccc-ccceEecccccccccCC----ccccCCCCCCEEecccccCCccCCccccCCC
Q 040398 16 LPYLETVDFAYNYLHGSIPREW--ASM-QLKYISVFANRLSGNIP----SHLGNITSLTYLDLEENQFSGTIPRELGNLV 88 (732)
Q Consensus 16 l~~L~~L~Ls~N~l~~~~p~~~--~~~-~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 88 (732)
+++|++|+|++|.+++..|..+ ..+ +|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..+..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4569999999999999999887 666 89999999999997665 4556799999999999999977788999999
Q ss_pred CCCEEeCCCCccccc--C--CccccCCCCCCEEEccCccccccCCc----cccCCCCCCEEEcccCCCcCcCCccccCc-
Q 040398 89 NLETLRLSSNRLIGN--L--PMELVKLKNLTDFRINDNNFNGSAPD----FIQSWTQLNRLEIQGSGLEGPIPPSISAL- 159 (732)
Q Consensus 89 ~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l- 159 (732)
+|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..+++|+.|+|++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 999999999998752 2 233478999999999999997 3333 35788999999999999998888888777
Q ss_pred --cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcc
Q 040398 160 --DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 160 --~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 222 (732)
++|+.|+|++|+++.++...+ ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLEQVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCCSCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCCchhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 699999999999997654432 7999999999999953 44 6789999999999999984
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=214.71 Aligned_cols=209 Identities=20% Similarity=0.306 Sum_probs=157.6
Q ss_pred EEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcc
Q 040398 22 VDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL 100 (732)
Q Consensus 22 L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 100 (732)
+.+..+.+++.++ ...+ +|++|++++|+++ .+| .+..+++|++|+|++|.++ .++. +..+++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcC
Confidence 3444555553222 2334 6888888888887 455 5778888888888888887 4444 88888888888888888
Q ss_pred cccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccc
Q 040398 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180 (732)
Q Consensus 101 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l 180 (732)
++ ++ .+..+++|+.|++++|++++. +. +..+++|+.|+|++|.+++..+ +..+++|+.|++++|.+.+... +
T Consensus 98 ~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 98 KN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp SC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 74 33 678888888888888888753 33 7888888888888888875433 7788888888888888887655 7
Q ss_pred cCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcC
Q 040398 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 181 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~ 260 (732)
..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~----------------l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP----------------LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG----------------GTTCTTCCEEEEEEEEEEC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc----------------ccCCCCCCEEEccCCeeec
Confidence 888889999999998885443 7788899999999998886543 4567888899999998876
Q ss_pred CC
Q 040398 261 QS 262 (732)
Q Consensus 261 ~~ 262 (732)
.+
T Consensus 232 ~~ 233 (308)
T 1h6u_A 232 QP 233 (308)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-25 Score=237.70 Aligned_cols=253 Identities=14% Similarity=0.154 Sum_probs=194.3
Q ss_pred CCCCcccCCccCCCCCCCCEEEcccCcCccccC----cccccc--ccceEecccccccccCCccccCC-----CCCCEEe
Q 040398 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIP----REWASM--QLKYISVFANRLSGNIPSHLGNI-----TSLTYLD 70 (732)
Q Consensus 2 l~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~~--~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~ 70 (732)
..+++|.+|+.+...++|++|+|++|.+++..+ ..+..+ +|++|+|++|++++..+..+..+ ++|++|+
T Consensus 7 ~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~ 86 (362)
T 3goz_A 7 LHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLN 86 (362)
T ss_dssp CCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred cccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEE
Confidence 357888888888888889999999999997666 555544 59999999999997777777665 9999999
Q ss_pred cccccCCccCCccc----cCC-CCCCEEeCCCCcccccCCcccc----C-CCCCCEEEccCccccccCC----ccccCCC
Q 040398 71 LEENQFSGTIPREL----GNL-VNLETLRLSSNRLIGNLPMELV----K-LKNLTDFRINDNNFNGSAP----DFIQSWT 136 (732)
Q Consensus 71 Ls~N~l~~~~p~~l----~~l-~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~L~~N~l~~~~p----~~~~~l~ 136 (732)
|++|.+++..+..+ ..+ ++|++|+|++|+|++..+..+. . .++|+.|+|++|.++...+ ..+..++
T Consensus 87 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 166 (362)
T 3goz_A 87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166 (362)
T ss_dssp CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred CcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCC
Confidence 99999986666544 444 8999999999999866554443 3 3699999999999985443 4445665
Q ss_pred -CCCEEEcccCCCcCcCCcccc----Cc-cCCCeeeccCcCCCCCCccc----ccC-CCCccEEEcccccccCCcch---
Q 040398 137 -QLNRLEIQGSGLEGPIPPSIS----AL-DKLNQLRISDLQGPNQTFPM----LRN-MTGLTRIILRNCNIAGEIPE--- 202 (732)
Q Consensus 137 -~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~ls~N~l~~~~~~~----l~~-l~~L~~L~Ls~N~l~~~~p~--- 202 (732)
+|+.|+|++|++++..+..+. .+ ++|+.|+|++|.+....... +.. .++|++|+|++|.|++..+.
T Consensus 167 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 246 (362)
T 3goz_A 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK 246 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHH
T ss_pred ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHH
Confidence 999999999999877665444 44 69999999999998854432 333 46899999999999976553
Q ss_pred -hhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 203 -YIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 203 -~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
.+..+++|+.|+|++|.+.+..++. ...+...+.++++|+.|||++|++...
T Consensus 247 ~~~~~l~~L~~L~L~~n~l~~i~~~~-------~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 247 LLKDSLKHLQTVYLDYDIVKNMSKEQ-------CKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HTTTTTTTCSEEEEEHHHHTTCCHHH-------HHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHhcCCCccEEEeccCCccccCHHH-------HHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3456799999999999976443321 123334456778899999999998755
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-22 Score=231.46 Aligned_cols=220 Identities=23% Similarity=0.271 Sum_probs=138.8
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
.||..+. ++|++|+|++|+|+ .+|. ...+|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+
T Consensus 54 ~lp~~l~--~~L~~L~L~~N~l~-~lp~--~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l 120 (622)
T 3g06_A 54 TLPDCLP--AHITTLVIPDNNLT-SLPA--LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LP 120 (622)
T ss_dssp CCCSCCC--TTCSEEEECSCCCS-CCCC--CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CC
T ss_pred ccChhhC--CCCcEEEecCCCCC-CCCC--cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CC
Confidence 4555554 68888999888888 5665 1227888888888888 5666 5688888888888887 4555 45
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCcccc-----------------CCCCCCEEEcccCCCcC
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQ-----------------SWTQLNRLEIQGSGLEG 150 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----------------~l~~L~~L~Ls~N~l~~ 150 (732)
++|+.|+|++|+|+ .+|.. +++|+.|+|++|++++ +|..+. .+++|+.|+|++|++++
T Consensus 121 ~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 121 SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC
T ss_pred CCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC
Confidence 67777777777777 45543 3677777777777764 332221 12555555555555552
Q ss_pred cCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCcc
Q 040398 151 PIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVP 230 (732)
Q Consensus 151 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 230 (732)
+|.. +++|+.|++++|.++.++. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+. +|.
T Consensus 196 -l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---- 258 (622)
T 3g06_A 196 -LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---- 258 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC----
T ss_pred -CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc----
Confidence 3322 2445555555555554332 23667777777777774 55 345777788888887773 343
Q ss_pred CcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 231 ADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 231 ~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
.+++|+.|+|++|+|+..|+....+..+..|+
T Consensus 259 -------------~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 259 -------------LPSGLLSLSVYRNQLTRLPESLIHLSSETTVN 290 (622)
T ss_dssp -------------CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEE
T ss_pred -------------ccccCcEEeCCCCCCCcCCHHHhhccccCEEE
Confidence 12567778888887775544444444444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-23 Score=215.86 Aligned_cols=195 Identities=22% Similarity=0.337 Sum_probs=171.7
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+.++++|++|++++|.++ .+| .+..+ +|++|+|++|+++ .++. +..+++|++|+|++|++++ ++ .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 456889999999999998 456 46666 8999999999999 4555 9999999999999999984 44 799999999
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
+|+|++|++++ ++ .+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++. +. +..+++|+.|++++|.
T Consensus 111 ~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCc
Confidence 99999999995 44 38999999999999999986544 89999999999999999954 33 8999999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
+.+... +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++.
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 998765 8899999999999999996553 88999999999999999864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-24 Score=228.76 Aligned_cols=202 Identities=17% Similarity=0.213 Sum_probs=124.0
Q ss_pred CCCCEEEcccCcCccccCccccccccceEeccccccccc-CCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGN-IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRL 95 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 95 (732)
++++.|++++|.+.+..+..+...+|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..+..+++|++|+|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 566666666666665555544333666666666666644 5666666666666666666666566666666666666666
Q ss_pred CCC-cccc-cCCccccCCCCCCEEEccCc-ccccc-CCccccCCC-CCCEEEcccC--CCc-CcCCccccCccCCCeeec
Q 040398 96 SSN-RLIG-NLPMELVKLKNLTDFRINDN-NFNGS-APDFIQSWT-QLNRLEIQGS--GLE-GPIPPSISALDKLNQLRI 167 (732)
Q Consensus 96 ~~N-~l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~l 167 (732)
++| .+++ .++..+.++++|+.|++++| .+++. ++..+..++ +|+.|+|++| .++ +.++..+..+++|+.|++
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l 229 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence 666 4554 24555666666666666666 66543 455566666 6666666666 343 344555566666666666
Q ss_pred cCcC-CCCCCcccccCCCCccEEEccccc-ccCCcchhhcCCCCCcEEeCCCC
Q 040398 168 SDLQ-GPNQTFPMLRNMTGLTRIILRNCN-IAGEIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 168 s~N~-l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~N 218 (732)
++|. +++..+..+..+++|++|+|++|. +.......+.++++|+.|+|++|
T Consensus 230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 6666 555555566666666666666664 22222224556666666666666
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=224.61 Aligned_cols=224 Identities=20% Similarity=0.204 Sum_probs=165.3
Q ss_pred CCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCC-------------CEEecccccCCcc
Q 040398 14 VNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSL-------------TYLDLEENQFSGT 79 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L-------------~~L~Ls~N~l~~~ 79 (732)
.+.++|++|++++|++ +.+|..++.+ +|++|++++|++.|.+|..++++++| ++|++++|.++ .
T Consensus 8 ~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~ 85 (454)
T 1jl5_A 8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85 (454)
T ss_dssp ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-C
T ss_pred cccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-c
Confidence 3568999999999999 6999999999 79999999999999999999999875 99999999999 5
Q ss_pred CCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCc
Q 040398 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159 (732)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 159 (732)
+|.. .++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. .++|++|++++|++++ +| .+..+
T Consensus 86 lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l 152 (454)
T 1jl5_A 86 LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNS 152 (454)
T ss_dssp CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTC
T ss_pred CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCC
Confidence 6652 3789999999999996 7754 4899999999999985 3322 2799999999999996 77 69999
Q ss_pred cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHH
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~ 239 (732)
++|++|++++|++++++. ...+|++|+|++|++++ +| .+..+++|+.|++++|++++ +|..
T Consensus 153 ~~L~~L~l~~N~l~~lp~----~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~------------ 213 (454)
T 1jl5_A 153 SFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL------------ 213 (454)
T ss_dssp TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC------------
T ss_pred CCCCEEECCCCcCcccCC----CcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC------------
Confidence 999999999999997543 23599999999999996 67 58999999999999999996 4432
Q ss_pred HHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcccc
Q 040398 240 MFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277 (732)
Q Consensus 240 ~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~ 277 (732)
..+|+.|++++|+++ .+|....+..+..|++.
T Consensus 214 -----~~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~ 245 (454)
T 1jl5_A 214 -----PLSLESIVAGNNILE-ELPELQNLPFLTTIYAD 245 (454)
T ss_dssp -----CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECC
T ss_pred -----cCcccEEECcCCcCC-cccccCCCCCCCEEECC
Confidence 147899999999999 45555555555555543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=210.48 Aligned_cols=165 Identities=18% Similarity=0.068 Sum_probs=129.2
Q ss_pred HHHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccc------------------cchHHHHHHHHHHhcC
Q 040398 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR------------------QGNREFLNEIGTISCL 567 (732)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l 567 (732)
+..+......|.+.+.||+|+||.||+|++.+|+.||+|+++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667778899999999999999997899999999864321 1245688999999999
Q ss_pred CCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCC
Q 040398 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATN 647 (732)
Q Consensus 568 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~N 647 (732)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.||++||+|||+.+ |+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 9 5 667765544 55699999999999998 411 124479999999999999986 9999999999
Q ss_pred eEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhccc----------CCCCCchhHHH
Q 040398 648 VLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW----------GYLTYKADVYS 703 (732)
Q Consensus 648 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~----------~~~~~k~DvwS 703 (732)
||++ ++.+||+|||+|+.. ..|+|||++.. ..+...+|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 999999999998632 25788998753 34555667664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-22 Score=224.01 Aligned_cols=183 Identities=22% Similarity=0.289 Sum_probs=153.6
Q ss_pred CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
+|+.|+|++|++++ +|..+. .+|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~-~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP-PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC-TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc-CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 89999999999985 776553 47999999999999 788 457999999999999995 787 665 899999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF 177 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 177 (732)
|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|.++.++.
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~ 197 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh
Confidence 99995 776 68999999999999986 665 57899999999999986 776 65 899999999999997665
Q ss_pred ccccCCCCc-------cEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCC
Q 040398 178 PMLRNMTGL-------TRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDV 227 (732)
Q Consensus 178 ~~l~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 227 (732)
+.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..
T Consensus 198 --~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 198 --VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp --CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred --HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 443 66 99999999999 68888888999999999999999877753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.8e-21 Score=217.84 Aligned_cols=214 Identities=22% Similarity=0.218 Sum_probs=158.9
Q ss_pred CCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
+++.|++++|.++ .+|..+. .+|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~-~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP-AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC-TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CCcEEEecCCCcC-ccChhhC-CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 5899999999999 7787665 58999999999999 6777 5799999999999998 6776 679999999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccc---cCc--------------c
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSI---SAL--------------D 160 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l--------------~ 160 (732)
|+|+ .+|. .+++|+.|++++|+|++ +|.. +++|+.|+|++|++++ +|..+ ..+ +
T Consensus 111 N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~ 181 (622)
T 3g06_A 111 NPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPS 181 (622)
T ss_dssp CCCC-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCT
T ss_pred CcCC-CCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCC
Confidence 9999 5665 57899999999999985 5553 4899999999999985 34322 222 4
Q ss_pred CCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHH
Q 040398 161 KLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240 (732)
Q Consensus 161 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~ 240 (732)
+|+.|++++|.++.++. .+++|+.|++++|.|+ .+|. .+++|+.|+|++|+|++ +|.
T Consensus 182 ~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~-~l~~---~~~~L~~L~Ls~N~L~~-lp~-------------- 238 (622)
T 3g06_A 182 GLQELSVSDNQLASLPT----LPSELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LPV-------------- 238 (622)
T ss_dssp TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS-SCCC---CCTTCCEEECCSSCCSC-CCC--------------
T ss_pred CCcEEECCCCCCCCCCC----ccchhhEEECcCCccc-ccCC---CCCCCCEEEccCCccCc-CCC--------------
Confidence 55555555555554332 1345666666666665 3443 23678888888888885 342
Q ss_pred HHhccCCCCeEEccCCcCcCCCCCCccccCCCCcccccc
Q 040398 241 FIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLF 279 (732)
Q Consensus 241 ~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~~~ 279 (732)
.+++|+.|+|++|+|+..++ .+..+..|++...
T Consensus 239 ---~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N 271 (622)
T 3g06_A 239 ---LPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRN 271 (622)
T ss_dssp ---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSS
T ss_pred ---CCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCC
Confidence 23689999999999996654 3455555655433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-23 Score=223.17 Aligned_cols=233 Identities=17% Similarity=0.177 Sum_probs=187.9
Q ss_pred EEEcccCcCccccCcccccc-ccceEecccccccccCC----ccccCCC-CCCEEecccccCCccCCccccCC-----CC
Q 040398 21 TVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIP----SHLGNIT-SLTYLDLEENQFSGTIPRELGNL-----VN 89 (732)
Q Consensus 21 ~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 89 (732)
.++|+.|.+++.+|..+... +|++|+|++|++++..+ ..+.+++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999998888777 59999999999996655 7788898 99999999999997777777664 99
Q ss_pred CCEEeCCCCcccccCCccc----cCC-CCCCEEEccCccccccCCcccc----C-CCCCCEEEcccCCCcCcCC----cc
Q 040398 90 LETLRLSSNRLIGNLPMEL----VKL-KNLTDFRINDNNFNGSAPDFIQ----S-WTQLNRLEIQGSGLEGPIP----PS 155 (732)
Q Consensus 90 L~~L~L~~N~l~~~~p~~l----~~l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~Ls~N~l~~~~p----~~ 155 (732)
|++|+|++|+|++..+..+ ..+ ++|+.|+|++|+|++..+..+. . .++|+.|+|++|.+++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997666644 444 8999999999999877665543 3 3699999999999986443 34
Q ss_pred ccCcc-CCCeeeccCcCCCCCCccccc----CC-CCccEEEcccccccCC----cchhhcC-CCCCcEEeCCCCcCcccC
Q 040398 156 ISALD-KLNQLRISDLQGPNQTFPMLR----NM-TGLTRIILRNCNIAGE----IPEYIWG-IKNLRFLDLSFNQLTGEL 224 (732)
Q Consensus 156 ~~~l~-~L~~L~ls~N~l~~~~~~~l~----~l-~~L~~L~Ls~N~l~~~----~p~~l~~-l~~L~~L~Ls~N~l~g~~ 224 (732)
+..++ +|+.|+|++|.++......+. .+ ++|++|+|++|.|++. ++..+.. .++|+.|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 999999999999988765444 44 5999999999999964 5556666 459999999999998654
Q ss_pred CCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 225 PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 225 p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
+. .+...+..+++|+.|+|++|+++...+
T Consensus 242 ~~----------~l~~~~~~l~~L~~L~L~~n~l~~i~~ 270 (362)
T 3goz_A 242 LE----------NLKLLKDSLKHLQTVYLDYDIVKNMSK 270 (362)
T ss_dssp HH----------HHHHTTTTTTTCSEEEEEHHHHTTCCH
T ss_pred HH----------HHHHHHhcCCCccEEEeccCCccccCH
Confidence 32 233446778899999999999765543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=190.67 Aligned_cols=174 Identities=21% Similarity=0.280 Sum_probs=95.1
Q ss_pred ceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCc
Q 040398 43 KYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122 (732)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 122 (732)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..+..+++|++|+|++|+|++..+..+..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 44555555555 445433 245666666666665433344555666666666666665443444555666666666666
Q ss_pred cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcch
Q 040398 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPE 202 (732)
Q Consensus 123 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 202 (732)
++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.++.++...+..+++|++|+|++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 6654444455556666666666666554444445555555555555555555444445555555555555555542
Q ss_pred hhcCCCCCcEEeCCCCcCcccCCC
Q 040398 203 YIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 203 ~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
.+++|+.|+++.|+++|.+|+
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~ 183 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRN 183 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBC
T ss_pred ---CCCCHHHHHHHHHhCCceeec
Confidence 234455555555555555554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-21 Score=189.64 Aligned_cols=182 Identities=20% Similarity=0.186 Sum_probs=157.3
Q ss_pred CCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSN 98 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 98 (732)
-+.++++++.++ .+|..+. .+|++|+|++|++++..+..+.++++|++|+|++|+|++..+..+..+++|++|+|++|
T Consensus 9 ~~~v~c~~~~l~-~~p~~~~-~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 9 GTTVECYSQGRT-SVPTGIP-AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TTEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCcc-CCCCCCC-CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 367889999888 5665442 27999999999999666667899999999999999999555556789999999999999
Q ss_pred cccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcc
Q 040398 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178 (732)
Q Consensus 99 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 178 (732)
+|++..+..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~----- 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD----- 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC-----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee-----
Confidence 999666666899999999999999999877788999999999999999999777777899999999999999765
Q ss_pred cccCCCCccEEEcccccccCCcchhhcCCCC
Q 040398 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKN 209 (732)
Q Consensus 179 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 209 (732)
..+++|++|+++.|+++|.+|+.++.++.
T Consensus 162 --~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 162 --CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp --CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred --cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 34678999999999999999998887765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.1e-21 Score=203.83 Aligned_cols=200 Identities=17% Similarity=0.137 Sum_probs=129.2
Q ss_pred CEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCc-cccCCCCCCE-EeCCC
Q 040398 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR-ELGNLVNLET-LRLSS 97 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~-L~L~~ 97 (732)
++++.++++++ .+|..+. .++++|+|++|+|+..-+..|.++++|++|+|++|++.+.+|. .|.++++|++ +.+++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~-~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC-TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC-CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 56777777777 5665442 2577777777777733334677777777777777777655553 5666766654 45556
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEccc-CCCcCcCCccccCcc-CCCeeeccCcCCCCC
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG-SGLEGPIPPSISALD-KLNQLRISDLQGPNQ 175 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~ 175 (732)
|+|+...|..|..+++|+.|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|++++|+++.+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i 169 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence 777765566677777777777777777765555566666677777754 455544444555554 566777777777766
Q ss_pred CcccccCCCCccEEEccc-ccccCCcc-hhhcCCCCCcEEeCCCCcCccc
Q 040398 176 TFPMLRNMTGLTRIILRN-CNIAGEIP-EYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 176 ~~~~l~~l~~L~~L~Ls~-N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
+...|. ..+|++|++++ |.++ .+| +.|..+++|+.|||++|+|+..
T Consensus 170 ~~~~f~-~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 170 HNSAFN-GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp CTTSST-TEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred Chhhcc-ccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCcc
Confidence 655553 34677777764 4455 444 4566777777777777777743
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.85 E-value=6.4e-24 Score=237.07 Aligned_cols=243 Identities=17% Similarity=0.185 Sum_probs=152.0
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCccccc-----c-ccceEeccccccccc----CCccccCCCCCCEEecccccCC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWAS-----M-QLKYISVFANRLSGN----IPSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----~-~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
.+|..+.++++|++|+|++|.+++..+..+.. . +|++|+|++|++++. ++..+..+++|++|+|++|.++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 45666777777777777777776544443332 1 477777777777653 3455566677777777777776
Q ss_pred ccCCcccc-----CCCCCCEEeCCCCccccc----CCccccCCCCCCEEEccCccccccC-----CccccCCCCCCEEEc
Q 040398 78 GTIPRELG-----NLVNLETLRLSSNRLIGN----LPMELVKLKNLTDFRINDNNFNGSA-----PDFIQSWTQLNRLEI 143 (732)
Q Consensus 78 ~~~p~~l~-----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L 143 (732)
+..+..+. .+++|++|+|++|.+++. ++..+..+++|+.|++++|.++... +..+..+++|+.|+|
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 44333332 255777777777777642 4566667777777777777775432 222335677777777
Q ss_pred ccCCCcCc----CCccccCccCCCeeeccCcCCCCCCcccccC-----CCCccEEEcccccccCC----cchhhcCCCCC
Q 040398 144 QGSGLEGP----IPPSISALDKLNQLRISDLQGPNQTFPMLRN-----MTGLTRIILRNCNIAGE----IPEYIWGIKNL 210 (732)
Q Consensus 144 s~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~-----l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L 210 (732)
++|.++.. ++..+..+++|+.|++++|.+.+.....+.. .++|++|+|++|.+++. ++..+..+++|
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 77777643 4566666777777777777766544333332 25777777777777755 45566667777
Q ss_pred cEEeCCCCcCcccCCCCCccCcchhhHHHHHHhc-cCCCCeEEccCCcCcC
Q 040398 211 RFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG-VYEHQSLDLSYNNFTW 260 (732)
Q Consensus 211 ~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~-l~~L~~LdLs~N~l~~ 260 (732)
+.|+|++|++++..+. .+...+.. .++|+.|+|++|+++.
T Consensus 344 ~~L~Ls~n~i~~~~~~----------~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 344 LELQISNNRLEDAGVR----------ELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp CEEECCSSBCHHHHHH----------HHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cEEEccCCccccccHH----------HHHHHHcCCCCceEEEECCCCCCCh
Confidence 7888877777643221 11112221 4567777777777663
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.9e-23 Score=224.02 Aligned_cols=217 Identities=19% Similarity=0.248 Sum_probs=180.8
Q ss_pred CCccCCCCCCCCEEEcccC---cCccccCccc-------ccc-ccceEecccccccc----cCCccccCCCCCCEEeccc
Q 040398 9 LPPQIVNLPYLETVDFAYN---YLHGSIPREW-------ASM-QLKYISVFANRLSG----NIPSHLGNITSLTYLDLEE 73 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~~-~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~ 73 (732)
++..+.++++|++|+|++| ++++.+|..+ ..+ +|++|+|++|++++ .+|..+.++++|++|+|++
T Consensus 52 l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 131 (386)
T 2ca6_A 52 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 131 (386)
T ss_dssp HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcC
Confidence 4456889999999999996 5556667655 444 79999999999997 4788899999999999999
Q ss_pred ccCCccCCcc----ccCC---------CCCCEEeCCCCccc-ccCC---ccccCCCCCCEEEccCcccc--c---cCCcc
Q 040398 74 NQFSGTIPRE----LGNL---------VNLETLRLSSNRLI-GNLP---MELVKLKNLTDFRINDNNFN--G---SAPDF 131 (732)
Q Consensus 74 N~l~~~~p~~----l~~l---------~~L~~L~L~~N~l~-~~~p---~~l~~l~~L~~L~L~~N~l~--~---~~p~~ 131 (732)
|.|++..+.. +..+ ++|++|+|++|+|+ +.+| ..+..+++|+.|+|++|+++ | ..+..
T Consensus 132 n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~ 211 (386)
T 2ca6_A 132 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211 (386)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHH
Confidence 9997543333 4344 89999999999998 4455 46778999999999999997 3 34558
Q ss_pred ccCCCCCCEEEcccCCCc----CcCCccccCccCCCeeeccCcCCCCCC----cccc--cCCCCccEEEcccccccC---
Q 040398 132 IQSWTQLNRLEIQGSGLE----GPIPPSISALDKLNQLRISDLQGPNQT----FPML--RNMTGLTRIILRNCNIAG--- 198 (732)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~ls~N~l~~~~----~~~l--~~l~~L~~L~Ls~N~l~~--- 198 (732)
+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.++... +..+ ..+++|+.|+|++|.|++
T Consensus 212 l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~ 291 (386)
T 2ca6_A 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291 (386)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHH
Confidence 899999999999999996 578889999999999999999998763 3344 338999999999999997
Q ss_pred -Ccchhh-cCCCCCcEEeCCCCcCcccCC
Q 040398 199 -EIPEYI-WGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 199 -~~p~~l-~~l~~L~~L~Ls~N~l~g~~p 225 (732)
.+|..+ .++++|+.|+|++|++++..|
T Consensus 292 ~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 292 RTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 488887 668999999999999997654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-21 Score=214.97 Aligned_cols=182 Identities=21% Similarity=0.270 Sum_probs=156.7
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
+|++|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 69999999999995 888774 89999999999999 788 557999999999999996 787 655 99999999
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|.++.++. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCC-ch
Confidence 999997 666 68999999999999996 666 67899999999999999666 55 89999999999999 77
Q ss_pred chhhcCCCCC-------cEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCC
Q 040398 201 PEYIWGIKNL-------RFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 201 p~~l~~l~~L-------~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
|. +.. +| +.|+|++|+|+ .+|.. +..+++|+.|+|++|+|++.+|.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~--------------l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPEN--------------ILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGG--------------GGGSCTTEEEECCSSSCCHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHH--------------HhcCCCCCEEEeeCCcCCCcCHH
Confidence 77 554 77 99999999999 45653 55688999999999999988764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.7e-22 Score=212.30 Aligned_cols=222 Identities=15% Similarity=0.200 Sum_probs=187.3
Q ss_pred CCCEEEcccCcCccccCcccccc---ccceEecccccccccCCccccCCCCCCEEecccccCCcc-CCccccCCCCCCEE
Q 040398 18 YLETVDFAYNYLHGSIPREWASM---QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT-IPRELGNLVNLETL 93 (732)
Q Consensus 18 ~L~~L~Ls~N~l~~~~p~~~~~~---~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L 93 (732)
.++.|++++|.+. |..+..+ +++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4889999999887 3444444 699999999999966555 67899999999999999865 88889999999999
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccCc-ccccc-CCccccCCCCCCEEEcccC-CCcCc-CCccccCcc-CCCeeecc
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRINDN-NFNGS-APDFIQSWTQLNRLEIQGS-GLEGP-IPPSISALD-KLNQLRIS 168 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~ls 168 (732)
+|++|++++..+..+..+++|+.|+|++| .+++. ++..+..+++|+.|+|++| .+++. ++..+..++ +|+.|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999888889999999999999999 67753 6777899999999999999 99864 577789999 99999999
Q ss_pred Cc--CCCC-CCcccccCCCCccEEEccccc-ccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhc
Q 040398 169 DL--QGPN-QTFPMLRNMTGLTRIILRNCN-IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG 244 (732)
Q Consensus 169 ~N--~l~~-~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~ 244 (732)
+| .++. ..+..+..+++|++|+|++|. +++..+..+..+++|+.|+|++|. +..+... ..+.+
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~-----------~~l~~ 270 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETL-----------LELGE 270 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGG-----------GGGGG
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHH-----------HHHhc
Confidence 99 4542 234457789999999999999 787888899999999999999996 2222211 12567
Q ss_pred cCCCCeEEccCC
Q 040398 245 VYEHQSLDLSYN 256 (732)
Q Consensus 245 l~~L~~LdLs~N 256 (732)
+++|+.|+|++|
T Consensus 271 ~~~L~~L~l~~~ 282 (336)
T 2ast_B 271 IPTLKTLQVFGI 282 (336)
T ss_dssp CTTCCEEECTTS
T ss_pred CCCCCEEeccCc
Confidence 899999999999
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=198.50 Aligned_cols=221 Identities=18% Similarity=0.188 Sum_probs=157.7
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCC-ccccCCCCCCE-EecccccCCccCCccccCCCCCCEE
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIP-SHLGNITSLTY-LDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p-~~l~~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
++|++|+|++|+|+...+..|..+ +|++|+|++|++.+.+| ..|.++++|++ +.++.|+|+...|..|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 568888888888885555577777 78888888888766665 45777877765 5666788886666778888888888
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccC-ccccccCCccccCCC-CCCEEEcccCCCcCcCCccccCccCCCeeeccC-c
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRIND-NNFNGSAPDFIQSWT-QLNRLEIQGSGLEGPIPPSISALDKLNQLRISD-L 170 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~-N 170 (732)
++++|+|++..+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+|+ .+|.......+|+.|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence 8888888865555666667777888865 566655556666654 5778888888888 4555555567788888864 6
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCe
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQS 250 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~ 250 (732)
.+..++...|..+++|++|+|++|+|+ .+|.. .+.+|+.|.+.++.--..+|. +.++++|+.
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~l~~lP~---------------l~~l~~L~~ 250 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLKKLPT---------------LEKLVALME 250 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTTCCCCCC---------------TTTCCSCCE
T ss_pred cccCCCHHHhccCcccchhhcCCCCcC-ccChh--hhccchHhhhccCCCcCcCCC---------------chhCcChhh
Confidence 777777778888888888888888888 44442 245566666555443335553 345677888
Q ss_pred EEccCC
Q 040398 251 LDLSYN 256 (732)
Q Consensus 251 LdLs~N 256 (732)
++++++
T Consensus 251 l~l~~~ 256 (350)
T 4ay9_X 251 ASLTYP 256 (350)
T ss_dssp EECSCH
T ss_pred CcCCCC
Confidence 888765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.83 E-value=7.3e-23 Score=228.48 Aligned_cols=184 Identities=14% Similarity=0.161 Sum_probs=77.2
Q ss_pred CCCCCCCEEEcccCcCccc----cCcccccc-ccceEecccccccccCCccc-cCCC----CCCEEecccccCCc----c
Q 040398 14 VNLPYLETVDFAYNYLHGS----IPREWASM-QLKYISVFANRLSGNIPSHL-GNIT----SLTYLDLEENQFSG----T 79 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~~-~L~~L~L~~n~l~~~~p~~l-~~l~----~L~~L~Ls~N~l~~----~ 79 (732)
..+++|++|+|++|.++.. ++..+... +|++|+|++|++....+..+ ..++ +|++|+|++|+++. .
T Consensus 25 ~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~ 104 (461)
T 1z7x_W 25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104 (461)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHH
Confidence 3444555555555554421 22333333 45555555555443222221 1122 35555555555442 2
Q ss_pred CCccccCCCCCCEEeCCCCcccccCCcccc-----CCCCCCEEEccCccccccC----CccccCCCCCCEEEcccCCCcC
Q 040398 80 IPRELGNLVNLETLRLSSNRLIGNLPMELV-----KLKNLTDFRINDNNFNGSA----PDFIQSWTQLNRLEIQGSGLEG 150 (732)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~ 150 (732)
++..+..+++|++|+|++|.+++..+..+. .+++|+.|++++|++++.. +..+..+++|+.|+|++|.++.
T Consensus 105 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcch
Confidence 344444555555555555554432222211 1234555555555444321 3333444455555555554443
Q ss_pred cCCcccc-----CccCCCeeeccCcCCCCCC----cccccCCCCccEEEccccccc
Q 040398 151 PIPPSIS-----ALDKLNQLRISDLQGPNQT----FPMLRNMTGLTRIILRNCNIA 197 (732)
Q Consensus 151 ~~p~~~~-----~l~~L~~L~ls~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~ 197 (732)
..+..+. ..++|+.|++++|.++... +..+..+++|++|+|++|.++
T Consensus 185 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 2222221 1334444455444444432 222333444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=195.04 Aligned_cols=191 Identities=18% Similarity=0.270 Sum_probs=134.1
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
+..+.+..+.+.+..+ +..+++|++|++++|.+. .++ .+..+++|++|+|++|++++. +. +..+++|+.|++++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCC
Confidence 4445555665553322 345677777777777776 444 366777777777777777743 33 77777777777777
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP 201 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 201 (732)
|.+++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|.++.. ..+..+++|+.|+|++|++++..|
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 77764 22 377777777777777777743 4577777788888888877776 567778888888888888886544
Q ss_pred hhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCC
Q 040398 202 EYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQS 262 (732)
Q Consensus 202 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 262 (732)
+..+++|+.|+|++|++++. |. +..+++|+.|+|++|+++..+
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l-~~---------------l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL-RA---------------LAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC-GG---------------GTTCTTCSEEEEEEEEEECCC
T ss_pred --hcCCCccCEEECCCCcCCCC-hh---------------hccCCCCCEEECcCCcccCCc
Confidence 77888888888888888753 21 456778888888888887543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.2e-20 Score=198.77 Aligned_cols=179 Identities=19% Similarity=0.152 Sum_probs=135.9
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcccc-CCCCCCEEeCCCCcccccCCccccCCCCCCEEEc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELG-NLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 119 (732)
.-+.+++++|+|+ .+|..+. ..|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|+.|+|
T Consensus 19 ~~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 19 ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp ETTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 3467778888877 6776554 4577888888888755555666 7888888888888888666667788888888888
Q ss_pred cCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccc---cCCCCccEEEcccccc
Q 040398 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML---RNMTGLTRIILRNCNI 196 (732)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l---~~l~~L~~L~Ls~N~l 196 (732)
++|+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+..++...| ..+++|+.|+|++|+|
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 8888877777778888888888888888887777778888888888888888887776666 5678888888888888
Q ss_pred cCCcchhhcCCCC--CcEEeCCCCcCcc
Q 040398 197 AGEIPEYIWGIKN--LRFLDLSFNQLTG 222 (732)
Q Consensus 197 ~~~~p~~l~~l~~--L~~L~Ls~N~l~g 222 (732)
++..+..+..+++ |+.|+|++|++..
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CccCHHHhhhccHhhcceEEecCCCccC
Confidence 8666667777776 4778888888874
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.5e-20 Score=210.92 Aligned_cols=189 Identities=21% Similarity=0.278 Sum_probs=109.4
Q ss_pred CCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
+..+.|..+.+...++ +..+ +|++|+|++|.+. .++ .+..+++|+.|+|++|+|++. +. +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~-~~-l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCC-GG-GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCC-hh-hccCCCCCEEECcC
Confidence 3334455555553322 2233 5666666666666 333 366666666666666666633 32 66666666666666
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF 177 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 177 (732)
|+|++ +| .+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+.+..+
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 66653 33 566666666666666666532 3456666666666666666643 455666666666666666655544
Q ss_pred ccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 178 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECC
T ss_pred --hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCC
Confidence 5566666666666666653 22 355666666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=188.28 Aligned_cols=188 Identities=22% Similarity=0.295 Sum_probs=155.2
Q ss_pred CEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCC
Q 040398 20 ETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSN 98 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 98 (732)
..+.+..+.+++..+ +..+ +|++|++++|.+. .++ .+..+++|++|+|++|++++ ++. +..+++|++|+|++|
T Consensus 27 ~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCC
Confidence 334555666653322 2344 7999999999998 454 48889999999999999984 444 889999999999999
Q ss_pred cccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcc
Q 040398 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178 (732)
Q Consensus 99 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 178 (732)
++++ +| .+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+.+..+
T Consensus 101 ~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 101 KVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred cCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 9984 44 488999999999999999853 4688899999999999999864 678899999999999999988765
Q ss_pred cccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 179 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
+..+++|+.|+|++|.|++ ++. +..+++|+.|++++|+++..
T Consensus 174 -l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEECC
T ss_pred -hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccCC
Confidence 8899999999999999995 554 88999999999999999853
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.8e-19 Score=178.97 Aligned_cols=154 Identities=16% Similarity=0.175 Sum_probs=84.7
Q ss_pred EEecccccCCccCCccccCCCCCCEEeCCCCcccccCC-ccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccC
Q 040398 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLP-MELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146 (732)
Q Consensus 68 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 146 (732)
++++++|.++ .+|..+. ..++.|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4444444444 3343332 223444444444443322 22444444555555555544444444555555555555555
Q ss_pred CCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccC
Q 040398 147 GLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGEL 224 (732)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 224 (732)
++++..+..|..+++|++|+|++|.+..+.+..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|++.+..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 555444444555555555555555555555555566667777777777777666777777888888888888877653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-20 Score=210.05 Aligned_cols=176 Identities=20% Similarity=0.309 Sum_probs=155.4
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+.+|++|+.|+|++|.+. .+| .+..+ +|++|+|++|+|++..| +..+++|+.|+|++|.|+ .+| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-CCh-hhccCCCCC
Confidence 567899999999999998 455 46666 89999999999995444 999999999999999998 455 799999999
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
.|+|++|+|++ + ..+..|++|+.|+|++|+|++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.
T Consensus 113 ~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 99999999995 4 4699999999999999999865 679999999999999999997666 9999999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcch
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPE 202 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 202 (732)
+.++ +.+..+++|+.|+|++|++.+....
T Consensus 187 i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 187 ISDL--RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp CCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred CCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence 9986 4689999999999999999864433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.2e-19 Score=177.66 Aligned_cols=153 Identities=16% Similarity=0.219 Sum_probs=82.0
Q ss_pred ceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCc
Q 040398 43 KYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122 (732)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 122 (732)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 44555555555 4444432 44555555555555333334444555555555555554444444444444444444444
Q ss_pred cccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcch
Q 040398 123 NFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPE 202 (732)
Q Consensus 123 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 202 (732)
+|+...+ ..|..+++|+.|+|++|.+..+.+..|..+++|+.|+|++|+|++..+.
T Consensus 91 ~l~~l~~------------------------~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 91 KITELPK------------------------SLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCccCH------------------------hHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 4443333 3344455555555555555555555555566666666667777655555
Q ss_pred hhcCCCCCcEEeCCCCcCcc
Q 040398 203 YIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 203 ~l~~l~~L~~L~Ls~N~l~g 222 (732)
.+..+++|+.|+|++|++..
T Consensus 147 ~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTCTTCCEEECCSSCEEC
T ss_pred HHhCCCCCCEEEeCCCCcCC
Confidence 66667777777777777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.3e-19 Score=177.62 Aligned_cols=152 Identities=22% Similarity=0.215 Sum_probs=128.2
Q ss_pred CCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSN 98 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 98 (732)
-+.+++++|.++ .+|..+. .+|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~-~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP-ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC-TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CCEEEcCCCCcC-cCCCccC-cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 368999999999 6776554 47999999999999777779999999999999999999878999999999999999999
Q ss_pred cccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCC
Q 040398 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQG 172 (732)
Q Consensus 99 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 172 (732)
+|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 99955555678899999999999999988888888888888888888888866666666666555555555544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=194.76 Aligned_cols=178 Identities=19% Similarity=0.162 Sum_probs=156.7
Q ss_pred CCEEEcccCcCccccCccccccccceEecccccccccCCcccc-CCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLG-NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
-+.+++++|+++ .+|..+.. .+++|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~~-~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLPS-YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCCT-TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCCC-CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 468999999999 67765432 589999999999977777787 999999999999999976677899999999999999
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccc---cCccCCCeeeccCcCCCC
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSI---SALDKLNQLRISDLQGPN 174 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~ 174 (732)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++|.+..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99997777789999999999999999998889999999999999999999995444445 679999999999999999
Q ss_pred CCcccccCCCC--ccEEEcccccccC
Q 040398 175 QTFPMLRNMTG--LTRIILRNCNIAG 198 (732)
Q Consensus 175 ~~~~~l~~l~~--L~~L~Ls~N~l~~ 198 (732)
++...+..++. |+.|+|++|.+.-
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 99888888887 4899999999974
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.5e-22 Score=226.15 Aligned_cols=125 Identities=18% Similarity=0.198 Sum_probs=100.9
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcc
Q 040398 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILR 192 (732)
Q Consensus 113 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls 192 (732)
.|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++++ .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp--~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc--ccCCCCCCcEEECC
Confidence 58888888888875 565 888888888888888888 77888888888888888888888754 78888899999999
Q ss_pred cccccCCc-chhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEc
Q 040398 193 NCNIAGEI-PEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDL 253 (732)
Q Consensus 193 ~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdL 253 (732)
+|+|++.. |..+..+++|+.|+|++|+|++.+|... ..+..+++|+.||+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~-----------~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE-----------RLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT-----------HHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH-----------HHHHHCcccCccCC
Confidence 99998776 8889999999999999999988776431 22455678888864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.2e-19 Score=176.99 Aligned_cols=158 Identities=14% Similarity=0.165 Sum_probs=118.1
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCC-ccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP-RELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 119 (732)
.-+++++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 12 ~~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 12 EGTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88 (220)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence 3457777777777 5666553 345777777777775434 34677777777777777777666667777778888888
Q ss_pred cCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCC
Q 040398 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE 199 (732)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 199 (732)
++|+|++..+..|..+++|++|+|++|++++..|..+..+++|+.|+|++|.++.+.+..|..+++|+.|+|++|.+...
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 88887777777777788888888888888777777788888888888888888887777788888888888888888765
Q ss_pred cc
Q 040398 200 IP 201 (732)
Q Consensus 200 ~p 201 (732)
.+
T Consensus 169 c~ 170 (220)
T 2v70_A 169 CY 170 (220)
T ss_dssp GG
T ss_pred Cc
Confidence 44
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-18 Score=174.82 Aligned_cols=157 Identities=22% Similarity=0.205 Sum_probs=103.1
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
..+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|+
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 4566777777776 6666553 677777777777776666677777777777777777764444556677777777777
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|+|++..+..|..+++|+.|+|++|+++ .+|..+..+ ++|+.|+|++|+|++..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l------------------------~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERL------------------------THLTHLALDQNQLKSIP 151 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGC------------------------TTCSEEECCSSCCCCCC
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccC------------------------CCCCEEECCCCcCCccC
Confidence 77777655566666777777777777666 455555444 45555556666666444
Q ss_pred chhhcCCCCCcEEeCCCCcCcccCC
Q 040398 201 PEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
+..+..+++|+.|+|++|++.+..+
T Consensus 152 ~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 152 HGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHHhCCCCCCEEEeeCCCccCCcc
Confidence 4556666677777777777665443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=174.40 Aligned_cols=153 Identities=18% Similarity=0.196 Sum_probs=106.5
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 170 (732)
+.+++++++++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44555555554 4444332 45555555555555555555555555555555555555444445566666666666666
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCe
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQS 250 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~ 250 (732)
.++.++...|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.. +..+++|+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~ 163 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA--------------FDRLSSLTH 163 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT--------------TTTCTTCCE
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH--------------HhCCCCCCE
Confidence 666666666777888999999999999 78999999999999999999999766543 567789999
Q ss_pred EEccCCcCcCC
Q 040398 251 LDLSYNNFTWQ 261 (732)
Q Consensus 251 LdLs~N~l~~~ 261 (732)
|+|++|++++.
T Consensus 164 L~l~~N~~~c~ 174 (229)
T 3e6j_A 164 AYLFGNPWDCE 174 (229)
T ss_dssp EECTTSCBCTT
T ss_pred EEeeCCCccCC
Confidence 99999988743
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-19 Score=173.14 Aligned_cols=154 Identities=19% Similarity=0.209 Sum_probs=102.6
Q ss_pred ccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCC
Q 040398 60 LGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN 139 (732)
Q Consensus 60 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 139 (732)
...+++|++|+|++|.++ .+| .+..+++|++|++++|.++ . +..+..+++|+.|++++|++++..+..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677888888888877 566 5777778888888877665 2 33677777777777777777766677777777777
Q ss_pred EEEcccCCCcCcCCccccCccCCCeeeccCcC-CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCC
Q 040398 140 RLEIQGSGLEGPIPPSISALDKLNQLRISDLQ-GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 140 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 218 (732)
.|+|++|++++..|..+..+++|+.|++++|. +..++ .+..+++|++|+|++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 77777777776666666666666666666665 44442 45566666666666666663 33 4555666666666666
Q ss_pred cCc
Q 040398 219 QLT 221 (732)
Q Consensus 219 ~l~ 221 (732)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=170.69 Aligned_cols=153 Identities=19% Similarity=0.276 Sum_probs=125.3
Q ss_pred ccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCE
Q 040398 38 ASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTD 116 (732)
Q Consensus 38 ~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 116 (732)
..+ +|++|++++|+++ .+| .+..+++|++|+|++|.++ . +..+..+++|++|+|++|++++..|..+..+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 444 6888899888888 667 6888889999999998776 3 347888889999999999998777888888999999
Q ss_pred EEccCccccccCCccccCCCCCCEEEcccCC-CcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEccccc
Q 040398 117 FRINDNNFNGSAPDFIQSWTQLNRLEIQGSG-LEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCN 195 (732)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 195 (732)
|++++|++++..|..+..+++|+.|+|++|+ ++ .+| .+..+++|+.|++++|.+.+.. .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 9999999988788888889999999999998 55 555 6888899999999999988765 68888999999999999
Q ss_pred ccC
Q 040398 196 IAG 198 (732)
Q Consensus 196 l~~ 198 (732)
|.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=181.62 Aligned_cols=168 Identities=18% Similarity=0.262 Sum_probs=103.5
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
++..+++++|.++ .++ .+..+++|++|+|++|.++ .++ .+..+++|+.|+|++|+|++ ++. +..+++|+.|+|+
T Consensus 20 ~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECC
Confidence 4667777777777 333 4667777777777777777 555 57777777777777777774 333 7777777777777
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|++++ +|.... ++|+.|+|++|++++. ..+..+++|+.|++++|++++++ .+..+++|++|+|++|+|++.
T Consensus 94 ~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch-
Confidence 777764 332222 6677777777776642 23555555555555555555442 355555555555555555533
Q ss_pred chhhcCCCCCcEEeCCCCcCccc
Q 040398 201 PEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
..+..+++|+.|+|++|++++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 3445555555555555555533
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-19 Score=213.33 Aligned_cols=222 Identities=19% Similarity=0.166 Sum_probs=121.3
Q ss_pred CCCCEEEcccCcCccccCcccccc-----ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-----QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-----~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
++++.|+|..|.+.......+..+ ++..++++.|++. ..|..+..+++|+.|+|++|.|. .+|..+.++++|+
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLT 250 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCS
T ss_pred CccceEEeeCCCCCcchhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCC
Confidence 568889999998885322333322 2444555556666 66788899999999999999998 8888888999999
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
+|+|++|+|+ .+|..+.+|++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|.
T Consensus 251 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 251 RLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred EEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 9999999999 88989999999999999999998 77989999999999999999997 778889999999999999999
Q ss_pred CCCCCcccccCCCC-ccEEEcccccccCCcchhhcCCCCCcEEeCCCC----cCcccCCCCCccCcchhhHHHHHHhccC
Q 040398 172 GPNQTFPMLRNMTG-LTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN----QLTGELPDVAVPADLKFTQILMFIRGVY 246 (732)
Q Consensus 172 l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N----~l~g~~p~~~~~~~l~~~~~~~~~~~l~ 246 (732)
+++..+..+..+.. +..|+|++|.+++.+|.. |..|+++.| ...|.+|... ...+.++.
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~----------~~~~~~l~ 391 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQST----------EHLATDLA 391 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------
T ss_pred cCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccc----------cchhhccc
Confidence 98877776655432 334788999998887764 455667766 3333333321 01133455
Q ss_pred CCCeEEccCCcCc
Q 040398 247 EHQSLDLSYNNFT 259 (732)
Q Consensus 247 ~L~~LdLs~N~l~ 259 (732)
.+....+++|-+.
T Consensus 392 ~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 392 KRTFTVLSYNTLC 404 (727)
T ss_dssp ----------CCC
T ss_pred ccceeeeeccccc
Confidence 5666777788664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.8e-19 Score=181.72 Aligned_cols=172 Identities=16% Similarity=0.249 Sum_probs=149.3
Q ss_pred CCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEE
Q 040398 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRL 141 (732)
Q Consensus 62 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 141 (732)
.+.+++.+++++|.++ .++ .+..+++|+.|++++|+|+ .+| .+..+++|+.|+|++|+|++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4677888999999998 455 6888999999999999998 666 78999999999999999996555 9999999999
Q ss_pred EcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 142 EIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 142 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
+|++|++++ +|.... ++|+.|++++|.+++. +.+..+++|+.|+|++|+|++ ++ .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCc
Confidence 999999985 444333 9999999999999986 368999999999999999995 44 6889999999999999999
Q ss_pred ccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCC
Q 040398 222 GELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQS 262 (732)
Q Consensus 222 g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 262 (732)
+. +. +..+++|+.|+|++|++++.+
T Consensus 164 ~~-~~---------------l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 164 NT-GG---------------LTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp BC-TT---------------STTCCCCCEEEEEEEEEECCC
T ss_pred ch-HH---------------hccCCCCCEEeCCCCcccCCc
Confidence 76 21 567789999999999998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9.3e-19 Score=179.65 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=107.0
Q ss_pred CCCcccceecccCceEEEEEEE-cCCeE--EEEEEccccccc------------------------chHHHHHHHHHHhc
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQL-TDGTI--IAVKLLSSKSRQ------------------------GNREFLNEIGTISC 566 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~ 566 (732)
.-|++.+.||+|+||.||+|+. .+|+. ||||+++..... ....+.+|++.+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999998 68999 999987543111 11367899999999
Q ss_pred CCCCce--eeeeeeEEeCCEEEEEEEecCC-C----chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCce
Q 040398 567 LQHPNL--VKLYGCCIEGDQLMLVYEYLEN-N----SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH-EESRFKI 638 (732)
Q Consensus 567 l~H~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-~~~~~~i 638 (732)
++|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.||+.||+||| +.+ |
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 988865 233332 346899999952 4 67665421 224456789999999999999 775 9
Q ss_pred EeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 639 VHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 639 iH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
+||||||+|||+++ .++|+|||+|....
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999999998 99999999997543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=5.6e-21 Score=217.79 Aligned_cols=185 Identities=14% Similarity=0.097 Sum_probs=139.2
Q ss_pred cCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCc-------------ccccCCccccCCCCCCEEE-ccCccccc
Q 040398 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNR-------------LIGNLPMELVKLKNLTDFR-INDNNFNG 126 (732)
Q Consensus 61 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~ 126 (732)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 44566666666666665 566666666666666665553 3445566666666666666 44443321
Q ss_pred cCCc------cccC--CCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccC
Q 040398 127 SAPD------FIQS--WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAG 198 (732)
Q Consensus 127 ~~p~------~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 198 (732)
++. .+.. ...|+.|+|++|+|++ +|. +..+++|+.|+|++|.++.+ +..+..+++|+.|+|++|+|++
T Consensus 425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCC-CGGGGGCTTCCEEECCSSCCCC
T ss_pred -hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccccc-chhhhcCCCCCEEECCCCCCCC
Confidence 110 0111 1359999999999995 676 99999999999999999955 5589999999999999999996
Q ss_pred CcchhhcCCCCCcEEeCCCCcCcccC-CCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCc
Q 040398 199 EIPEYIWGIKNLRFLDLSFNQLTGEL-PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQP 266 (732)
Q Consensus 199 ~~p~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~ 266 (732)
+| .+..+++|+.|+|++|+|++.+ |.. ++++++|+.|+|++|+|++.+|...
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~--------------l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQP--------------LVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGG--------------GGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHH--------------HhcCCCCCEEEecCCcCCCCccHHH
Confidence 77 8999999999999999999886 754 7788999999999999999987643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=163.23 Aligned_cols=120 Identities=21% Similarity=0.328 Sum_probs=63.5
Q ss_pred ceEecccccccccCCccccCCCCCCEEecccccCCccCCc-cccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 43 KYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPR-ELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
++|++++|+++ .+|..+.. +|++|+|++|+|++..+. .+..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 55666666664 55554432 556666666665533332 255555555555555555555555555555555555555
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCee
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 165 (732)
|+|++..+..|..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 55555555555555555555555555554444444444333333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-18 Score=203.44 Aligned_cols=184 Identities=22% Similarity=0.183 Sum_probs=129.1
Q ss_pred ccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccC
Q 040398 32 SIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVK 110 (732)
Q Consensus 32 ~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 110 (732)
..|..+..+ +|++|+|++|++. .+|..++++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..+.+
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 456777777 7999999999999 89998999999999999999999 99999999999999999999999 88999999
Q ss_pred CCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccC-CCeeeccCcCCCCCCcccccCCCCccEE
Q 040398 111 LKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDK-LNQLRISDLQGPNQTFPMLRNMTGLTRI 189 (732)
Q Consensus 111 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~~~~l~~l~~L~~L 189 (732)
|++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++..+. .|..|
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l 364 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFI 364 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C----
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------cccee
Confidence 999999999999997 77888999999999999999999999988876543 34588999999876654 56777
Q ss_pred Ecccc--------cccCCcchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 190 ILRNC--------NIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 190 ~Ls~N--------~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
+++.| .|.+..+..+..+.++....+++|.+.+...
T Consensus 365 ~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 365 EINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp -------------------------------------CCCGGGC
T ss_pred EeecccccccccCCccccccchhhcccccceeeeeccccccccC
Confidence 88877 4444455556677788888999999875443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.8e-18 Score=195.59 Aligned_cols=239 Identities=11% Similarity=0.081 Sum_probs=153.3
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCC-ccccCCCCCCEEecccccCC-ccCCccc
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIP-SHLGNITSLTYLDLEENQFS-GTIPREL 84 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~-~~~p~~l 84 (732)
..+..+..+++|+.|+++++... .+|..+..+ +|++|+|++|.+++... ..+.++++|++|+|+ |.+. +.++..+
T Consensus 261 ~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~ 338 (592)
T 3ogk_B 261 EKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLA 338 (592)
T ss_dssp TSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHH
T ss_pred HHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHH
Confidence 34455666666777766665333 556656555 68888888777664333 345677788888887 3333 2233344
Q ss_pred cCCCCCCEEeCC-----------CCccccc-CCccccCCCCCCEEEccCccccccCCccccC-CCCCCEEEcc----cCC
Q 040398 85 GNLVNLETLRLS-----------SNRLIGN-LPMELVKLKNLTDFRINDNNFNGSAPDFIQS-WTQLNRLEIQ----GSG 147 (732)
Q Consensus 85 ~~l~~L~~L~L~-----------~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~ 147 (732)
..+++|++|+|+ .|.+++. ++.....+++|+.|+++.|.+++..+..+.. +++|+.|+|+ .|.
T Consensus 339 ~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~ 418 (592)
T 3ogk_B 339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREER 418 (592)
T ss_dssp HHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSC
T ss_pred HhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcc
Confidence 567778888887 3566543 2222445778888888777777666666654 7788888885 566
Q ss_pred CcCc-----CCccccCccCCCeeeccCcC--CCCCCccccc-CCCCccEEEcccccccC-CcchhhcCCCCCcEEeCCCC
Q 040398 148 LEGP-----IPPSISALDKLNQLRISDLQ--GPNQTFPMLR-NMTGLTRIILRNCNIAG-EIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 148 l~~~-----~p~~~~~l~~L~~L~ls~N~--l~~~~~~~l~-~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N 218 (732)
+++. ++..+..+++|+.|+++.|. +++.....+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|
T Consensus 419 l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n 498 (592)
T 3ogk_B 419 ITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498 (592)
T ss_dssp CSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred ccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence 6643 33335667788888886433 4443333333 36778888888888875 34555667888888888888
Q ss_pred cCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 219 QLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 219 ~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
.+++.. +......+++|+.|+|++|+++..
T Consensus 499 ~l~~~~-------------~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 499 CFSERA-------------IAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CCBHHH-------------HHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCcHHH-------------HHHHHHhcCccCeeECcCCcCCHH
Confidence 876331 223355678888888888887644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=156.22 Aligned_cols=132 Identities=18% Similarity=0.258 Sum_probs=83.1
Q ss_pred CEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCc-cccCCCCCCEEEccCccccccCCccccCCCCCCEEEccc
Q 040398 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPM-ELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 67 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 145 (732)
++|++++|.|+ .+|..+.. +|++|+|++|+|++..+. .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777775 66665543 666777777766644332 256666666666666666655566666666666666666
Q ss_pred CCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 146 SGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 146 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
|++++..+. .|..+++|++|+|++|+|++.+|..+..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNK------------------------MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSS------------------------SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHH------------------------HhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 665544444 44455566666667777776667777777777777777777776543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=151.47 Aligned_cols=131 Identities=16% Similarity=0.172 Sum_probs=66.6
Q ss_pred CCCEEeCCCCccc-ccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeec
Q 040398 89 NLETLRLSSNRLI-GNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167 (732)
Q Consensus 89 ~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 167 (732)
+|+.|+|++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|++
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3444444444443 33444444444444444444444432 33444444444444444444434444444444444444
Q ss_pred cCcCCCCCCc-ccccCCCCccEEEcccccccCCcc---hhhcCCCCCcEEeCCCCcCc
Q 040398 168 SDLQGPNQTF-PMLRNMTGLTRIILRNCNIAGEIP---EYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 168 s~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~ 221 (732)
++|.+++.+. ..+..+++|+.|+|++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 4444444322 445556666666777777764443 35666777777777777665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-16 Score=150.21 Aligned_cols=131 Identities=22% Similarity=0.219 Sum_probs=59.8
Q ss_pred CCCCEEEcccCcCc-cccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEe
Q 040398 17 PYLETVDFAYNYLH-GSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLR 94 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~-~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 94 (732)
++|++|+|++|.++ +.+|..+..+ +|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 3444444444 455555555554422 4444445555555555555433444444444555555
Q ss_pred CCCCcccccC-CccccCCCCCCEEEccCccccccCC---ccccCCCCCCEEEcccCCCc
Q 040398 95 LSSNRLIGNL-PMELVKLKNLTDFRINDNNFNGSAP---DFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 95 L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 149 (732)
|++|+|++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555444211 1344444444444444444443322 23444444444444444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-17 Score=191.79 Aligned_cols=200 Identities=16% Similarity=0.127 Sum_probs=135.1
Q ss_pred CCCCCCEEEcccCcCccccCcccccc--c-cceEeccccc-ccc-cCCccccCCCCCCEEecccccCCcc----CCcccc
Q 040398 15 NLPYLETVDFAYNYLHGSIPREWASM--Q-LKYISVFANR-LSG-NIPSHLGNITSLTYLDLEENQFSGT----IPRELG 85 (732)
Q Consensus 15 ~l~~L~~L~Ls~N~l~~~~p~~~~~~--~-L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~ 85 (732)
++++|++|+|++|.+++..+..+... + |++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 78899999999998887777766654 4 9999998886 221 2233345788999999999988755 334456
Q ss_pred CCCCCCEEeCCCCccc----ccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCc---CcCCccccC
Q 040398 86 NLVNLETLRLSSNRLI----GNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE---GPIPPSISA 158 (732)
Q Consensus 86 ~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~ 158 (732)
++++|++|+|++|.++ +.++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.+... +..+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 7889999999999887 3455556778999999999998875 6677788888888888754322 233344555
Q ss_pred ccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc-hhhcCCCCCcEEeCC
Q 040398 159 LDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP-EYIWGIKNLRFLDLS 216 (732)
Q Consensus 159 l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls 216 (732)
+++|+.|+++++.. ...+..+..+++|++|+|++|.+++... ..+..+++|+.|+|+
T Consensus 269 ~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 269 PRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp CTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred cccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 56666666655422 2223345556666666666666554333 234556666666666
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=147.60 Aligned_cols=126 Identities=20% Similarity=0.258 Sum_probs=83.5
Q ss_pred ccceEeccccccc-ccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEc
Q 040398 41 QLKYISVFANRLS-GNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119 (732)
Q Consensus 41 ~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 119 (732)
+|++|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|+.|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 4677777777776 56666667777777777777777643 56667777777777777777556666666777777777
Q ss_pred cCcccccc-CCccccCCCCCCEEEcccCCCcCcCC---ccccCccCCCeeecc
Q 040398 120 NDNNFNGS-APDFIQSWTQLNRLEIQGSGLEGPIP---PSISALDKLNQLRIS 168 (732)
Q Consensus 120 ~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls 168 (732)
++|.+++. .+..+..+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 77777643 23566667777777777777664443 355666666666554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=149.36 Aligned_cols=127 Identities=19% Similarity=0.232 Sum_probs=62.2
Q ss_pred EEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCC
Q 040398 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG 147 (732)
Q Consensus 68 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 147 (732)
++++++|.|+ .+|..+. ++|++|+|++|+|+ .+|..+.++++|+.|+|++|.|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4444444444 4443332 34455555555554 444444444555555555554444444444444444444444444
Q ss_pred CcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcc
Q 040398 148 LEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 148 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 222 (732)
+++..+. .|..+++|++|+|++|+|+...+..+..+++|+.|+|++|++..
T Consensus 90 l~~i~~~------------------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPR------------------------TFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTT------------------------TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHH------------------------HhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 4433333 33344445555555555554334445566666666666666653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=149.16 Aligned_cols=126 Identities=21% Similarity=0.305 Sum_probs=90.0
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
-+++++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 456777777777 6676553 57788888888887 6777777788888888888888766666777888888888888
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
|+|++..|..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 137 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence 88877777778888888888888887774444445555554444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.5e-16 Score=146.02 Aligned_cols=128 Identities=20% Similarity=0.303 Sum_probs=67.3
Q ss_pred CCCCEEecccccCC-ccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEE
Q 040398 64 TSLTYLDLEENQFS-GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLE 142 (732)
Q Consensus 64 ~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 142 (732)
++|++|++++|.++ +.+|..+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 45555555666666666666665533 4455555555555555555544444444455555555
Q ss_pred cccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc---hhhcCCCCCcEEeCC
Q 040398 143 IQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP---EYIWGIKNLRFLDLS 216 (732)
Q Consensus 143 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls 216 (732)
+++|.+++. + .+..+..+++|++|+|++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~-~----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDL-S----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSH-H----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCCh-H----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555544421 0 11234444555555555555554433 345555566655554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=170.41 Aligned_cols=145 Identities=12% Similarity=0.115 Sum_probs=102.6
Q ss_pred HHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEccccccc--------------chHH--------HHHHHHHHh
Q 040398 508 QIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQ--------------GNRE--------FLNEIGTIS 565 (732)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~--------------~~~~--------~~~E~~~l~ 565 (732)
.+.....-|++.+.||+|++|.||+|...+|+.||||+++..... .... ...|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 333444458999999999999999999999999999987532110 0111 234556666
Q ss_pred cCCCCceeeeeeeEEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCC
Q 040398 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKA 645 (732)
Q Consensus 566 ~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp 645 (732)
++.+.++....-+... ..++||||++|++|..+.. . .....++.||+.+|.|||+.| ||||||||
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 6654443222112122 2379999999988876441 1 123568899999999999986 99999999
Q ss_pred CCeEEcCCCC----------eEEEeeecceeC
Q 040398 646 TNVLLDRDLN----------PKISDFGLAKLD 667 (732)
Q Consensus 646 ~NILl~~~~~----------~kL~DfGla~~~ 667 (732)
.|||+++++. +.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999988763 899999977543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-15 Score=144.62 Aligned_cols=67 Identities=16% Similarity=0.137 Sum_probs=35.8
Q ss_pred ccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 159 LDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 159 l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
+++|+.|+|++|.++..+...+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus 75 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 75 LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 3333333333333333333334445556666666666664444445666777777777777766544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=144.88 Aligned_cols=133 Identities=19% Similarity=0.217 Sum_probs=80.5
Q ss_pred CCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEccc
Q 040398 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 66 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 145 (732)
.+.+++++|+++ .+|..+. ++|+.|+|++|++++..+..+..+++|+.|++++|+|++..+..+..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 456666666666 4554333 4666666666666644444556666666666666666655555556666666666666
Q ss_pred CCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc
Q 040398 146 SGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP 201 (732)
Q Consensus 146 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 201 (732)
|++++..+..+..+++|+.|++++|.++.++...+..+++|++|+|++|.+.+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66665545555666666666666666666555555666666666666666665443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=9.8e-16 Score=162.97 Aligned_cols=250 Identities=14% Similarity=0.063 Sum_probs=134.4
Q ss_pred CcccCCccCCC--CCCCCEEEcccCcCccccCccccc-c-ccceEeccccccc--cc-----------------C-Cccc
Q 040398 5 LPGTLPPQIVN--LPYLETVDFAYNYLHGSIPREWAS-M-QLKYISVFANRLS--GN-----------------I-PSHL 60 (732)
Q Consensus 5 ~~g~lP~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~-~-~L~~L~L~~n~l~--~~-----------------~-p~~l 60 (732)
-+|+++..+.. +.+|+.|.++++ +.......+.. + +|++|||++|++. .. + +..|
T Consensus 11 ~~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF 89 (329)
T 3sb4_A 11 KPGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAF 89 (329)
T ss_dssp STTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTT
T ss_pred CCCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHh
Confidence 35666666654 667777777754 22111122222 3 5778888887776 11 1 2234
Q ss_pred cC--------CCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccc----cccC
Q 040398 61 GN--------ITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF----NGSA 128 (732)
Q Consensus 61 ~~--------l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~ 128 (732)
.+ +++|++|+|.+ .++..-+.+|.+|++|+.|+|++|.++...+..|..+.++..+.+..+.. ....
T Consensus 90 ~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~ 168 (329)
T 3sb4_A 90 SNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWE 168 (329)
T ss_dssp EEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTT
T ss_pred cccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccc
Confidence 44 55566666655 55523333455555566666655555544444455554444444443211 1111
Q ss_pred CccccCCCCCC-EEEc-------------------------ccCCCcCcCCccc-cCccCCCeeeccCcCCCCCCccccc
Q 040398 129 PDFIQSWTQLN-RLEI-------------------------QGSGLEGPIPPSI-SALDKLNQLRISDLQGPNQTFPMLR 181 (732)
Q Consensus 129 p~~~~~l~~L~-~L~L-------------------------s~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~~l~ 181 (732)
...|.++..|+ .+.+ .++-.. .....+ ..+++|+.|+|++|.++.++...|.
T Consensus 169 ~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~ 247 (329)
T 3sb4_A 169 HFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFA 247 (329)
T ss_dssp TSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTT
T ss_pred ccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhh
Confidence 11222222222 1111 111000 000000 1267788888888888888777888
Q ss_pred CCCCccEEEcccccccCCcchhhcCCCCCc-EEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcC
Q 040398 182 NMTGLTRIILRNCNIAGEIPEYIWGIKNLR-FLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 182 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~ 260 (732)
++++|+.|+|++| ++...+..|.++++|+ .|++.+ .++...+.. |.++.+|+.|++++|+++.
T Consensus 248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~a--------------F~~c~~L~~l~l~~n~i~~ 311 (329)
T 3sb4_A 248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGA--------------FMGCDNLRYVLATGDKITT 311 (329)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTT--------------TTTCTTEEEEEECSSCCCE
T ss_pred CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhh--------------hhCCccCCEEEeCCCccCc
Confidence 8888888888877 6645555777788887 888877 555333322 6677778888888888877
Q ss_pred CCCCCc-cccCCCC
Q 040398 261 QSPEQP-ACREKPN 273 (732)
Q Consensus 261 ~~p~~~-~~~~~~~ 273 (732)
..+..+ .|..+..
T Consensus 312 I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 312 LGDELFGNGVPSKL 325 (329)
T ss_dssp ECTTTTCTTCCCCE
T ss_pred cchhhhcCCcchhh
Confidence 766543 3444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-17 Score=162.27 Aligned_cols=144 Identities=16% Similarity=0.149 Sum_probs=71.9
Q ss_pred cccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCC
Q 040398 83 ELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKL 162 (732)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 162 (732)
.+..+++|++|+|++|+|++ +| .+..+++|+.|++++|.++ .+|..+..+++|+.|+|++|+++
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~------------- 106 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA------------- 106 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC-------------
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCC-------------
Confidence 44444445555555554442 33 4444445555555555444 33333333444444444444444
Q ss_pred CeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc-hhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHH
Q 040398 163 NQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP-EYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMF 241 (732)
Q Consensus 163 ~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 241 (732)
+++ .+..+++|++|+|++|++++..+ ..+..+++|+.|++++|++++.+|.... ........
T Consensus 107 -----------~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~----~~~~~~~~ 169 (198)
T 1ds9_A 107 -----------SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNA----TSEYRIEV 169 (198)
T ss_dssp -----------CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTT----HHHHHHHH
T ss_pred -----------cCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccc----hHHHHHHH
Confidence 321 34445556666666666663222 3566667777777777777665543100 00111234
Q ss_pred HhccCCCCeEEccCCcCcCC
Q 040398 242 IRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 242 ~~~l~~L~~LdLs~N~l~~~ 261 (732)
+..+++|+.|| +|+++..
T Consensus 170 ~~~l~~L~~Ld--~~~i~~~ 187 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVDVD 187 (198)
T ss_dssp HHHCSSCSEEC--CGGGTTT
T ss_pred HHhCCCcEEEC--CcccCHH
Confidence 56667777776 6666544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=154.72 Aligned_cols=221 Identities=11% Similarity=0.082 Sum_probs=156.4
Q ss_pred CCCCCEEEcccCcCc--------------------cccCccccc--------c-ccceEecccccccccCCccccCCCCC
Q 040398 16 LPYLETVDFAYNYLH--------------------GSIPREWAS--------M-QLKYISVFANRLSGNIPSHLGNITSL 66 (732)
Q Consensus 16 l~~L~~L~Ls~N~l~--------------------~~~p~~~~~--------~-~L~~L~L~~n~l~~~~p~~l~~l~~L 66 (732)
+++|++|||++|++. ...+..|.. + +|++|+|.+ +++..-+..|.+|++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 788999999999988 233446667 6 899999999 8885556789999999
Q ss_pred CEEecccccCCccCCccccCCCCCCEEeCCCCcc----cccCCccccCCCCCC-EEEcc---------------------
Q 040398 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRL----IGNLPMELVKLKNLT-DFRIN--------------------- 120 (732)
Q Consensus 67 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~p~~l~~l~~L~-~L~L~--------------------- 120 (732)
++|+|++|.+....+..|.++.++..+.+..+.. ...-...|.++.+|+ .+.+.
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 9999999999856666888888888888776432 112233444455554 33332
Q ss_pred ----CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCcc-EEEccccc
Q 040398 121 ----DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLT-RIILRNCN 195 (732)
Q Consensus 121 ----~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~-~L~Ls~N~ 195 (732)
++-...........+++|+.|+|++|+++...+..|.++++|+.|+|.+| +..+....|.++++|+ .|+|.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 21110000001113778888888888888666667888888888888887 7778888888888888 888888 6
Q ss_pred ccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEc
Q 040398 196 IAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDL 253 (732)
Q Consensus 196 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdL 253 (732)
++...+..|.++++|+.|++++|.++...+.. |.++++|+.|+.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~a--------------F~~~~~L~~ly~ 328 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDEL--------------FGNGVPSKLIYK 328 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTT--------------TCTTCCCCEEEC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhh--------------hcCCcchhhhcc
Confidence 76455678888888888888888888554433 666777777753
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.6e-15 Score=143.43 Aligned_cols=134 Identities=19% Similarity=0.278 Sum_probs=72.5
Q ss_pred ccCCCCCCEEecccccCCccCCccccCC-CCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCC
Q 040398 60 LGNITSLTYLDLEENQFSGTIPRELGNL-VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQL 138 (732)
Q Consensus 60 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 138 (732)
+.++.+|++|+|++|+++ .+|. +..+ ++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 444555666666666655 3333 3332 2555555555555532 345555555555555555554333334455555
Q ss_pred CEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchh----hcCCCCCcEEe
Q 040398 139 NRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEY----IWGIKNLRFLD 214 (732)
Q Consensus 139 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~ 214 (732)
+.|+|++|+++ .+|. ...+..+++|+.|+|++|.++ .+|.. +..+++|+.||
T Consensus 91 ~~L~L~~N~i~-~~~~----------------------~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld 146 (176)
T 1a9n_A 91 TELILTNNSLV-ELGD----------------------LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146 (176)
T ss_dssp CEEECCSCCCC-CGGG----------------------GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CEEECCCCcCC-cchh----------------------hHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeC
Confidence 55555555543 2222 123445566666667777766 44543 66777777777
Q ss_pred CCCCcCc
Q 040398 215 LSFNQLT 221 (732)
Q Consensus 215 Ls~N~l~ 221 (732)
+++|.+.
T Consensus 147 ~~~n~~~ 153 (176)
T 1a9n_A 147 FQKVKLK 153 (176)
T ss_dssp TEECCHH
T ss_pred CCcCCHH
Confidence 7777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=5.3e-15 Score=142.24 Aligned_cols=137 Identities=15% Similarity=0.180 Sum_probs=88.4
Q ss_pred CCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEE
Q 040398 110 KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRI 189 (732)
Q Consensus 110 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L 189 (732)
++++|+.|++++|+++ .+|......++|+.|+|++|.+++. ..+..+++|+.|++++|.++.+++..+..+++|++|
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3444444444444444 2232222222455555555555432 345555566666666666655555556777889999
Q ss_pred EcccccccCCcch--hhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCC
Q 040398 190 ILRNCNIAGEIPE--YIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 190 ~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~ 261 (732)
+|++|+|+ .+|. .+..+++|+.|+|++|+++. +|.. ....+..+++|+.||++.|.+...
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~----------~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHY----------RLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTH----------HHHHHHHCTTCSEETTEECCHHHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhH----------HHHHHHHCCccceeCCCcCCHHHH
Confidence 99999997 6776 88999999999999999984 3431 123477899999999999998654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-16 Score=157.12 Aligned_cols=136 Identities=19% Similarity=0.161 Sum_probs=91.8
Q ss_pred CCCCCEEeCCCCcccccCCc------cccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCcc
Q 040398 87 LVNLETLRLSSNRLIGNLPM------ELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD 160 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 160 (732)
...++.++++.|.+++.+|. .+..+++|+.|+|++|++++ +| .+..+++|+.|++++|.++ .+|
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~------- 86 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIE------- 86 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCS-------
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-ccc-------
Confidence 34455555555555544443 55566666666666666653 34 4555555555555555554 222
Q ss_pred CCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHH
Q 040398 161 KLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240 (732)
Q Consensus 161 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~ 240 (732)
..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..
T Consensus 87 -----------------~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~-------------~~ 134 (198)
T 1ds9_A 87 -----------------NLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGE-------------ID 134 (198)
T ss_dssp -----------------SHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHH-------------HH
T ss_pred -----------------chhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhH-------------HH
Confidence 234455788999999999995 66 68899999999999999984321 12
Q ss_pred HHhccCCCCeEEccCCcCcCCCCC
Q 040398 241 FIRGVYEHQSLDLSYNNFTWQSPE 264 (732)
Q Consensus 241 ~~~~l~~L~~LdLs~N~l~~~~p~ 264 (732)
.+..+++|+.|++++|++++.+|.
T Consensus 135 ~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 135 KLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHTTTTTCSEEEECSCHHHHHHHT
T ss_pred HHhcCCCCCEEEecCCcccccccc
Confidence 377889999999999999998776
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.8e-16 Score=179.78 Aligned_cols=203 Identities=12% Similarity=0.042 Sum_probs=106.1
Q ss_pred ccceEecccccccccCC-ccccCCCCCCEEecccccCCcc-CCccccCCCCCCEEeC---------CCCcccccCCcccc
Q 040398 41 QLKYISVFANRLSGNIP-SHLGNITSLTYLDLEENQFSGT-IPRELGNLVNLETLRL---------SSNRLIGNLPMELV 109 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L---------~~N~l~~~~p~~l~ 109 (732)
+|++|+|++|.+++... ..+.++++|++|+|++| +.+. ++.....+++|++|+| +.|.+++.....+.
T Consensus 290 ~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~ 368 (594)
T 2p1m_B 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368 (594)
T ss_dssp TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHH
T ss_pred CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHH
Confidence 56666666666553322 22445666666666665 3311 1112224566666666 23344432222222
Q ss_pred -CCCCCCEEEccCccccccCCcccc-CCCCCCEEEcc--c----CCCcCc-----CCccccCccCCCeeeccCcCCCCCC
Q 040398 110 -KLKNLTDFRINDNNFNGSAPDFIQ-SWTQLNRLEIQ--G----SGLEGP-----IPPSISALDKLNQLRISDLQGPNQT 176 (732)
Q Consensus 110 -~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~~ 176 (732)
.+++|+.|.+..|.+++.....+. .+++|+.|+|+ + |.++.. ++..+..+++|+.|+|++ .+++..
T Consensus 369 ~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred HhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 356666666666666544444443 46666666666 3 344411 111244556666666655 444433
Q ss_pred cccccC-CCCccEEEcccccccCCcchhh-cCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 177 FPMLRN-MTGLTRIILRNCNIAGEIPEYI-WGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 177 ~~~l~~-l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
...+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .....+++|+.|+|+
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~-------------~~~~~l~~L~~L~l~ 514 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL-------------ANASKLETMRSLWMS 514 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH-------------HTGGGGGGSSEEEEE
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH-------------HHHHhCCCCCEEeee
Confidence 344433 5666777777766655444444 4566677777776666422111 123345666777777
Q ss_pred CCcC
Q 040398 255 YNNF 258 (732)
Q Consensus 255 ~N~l 258 (732)
+|++
T Consensus 515 ~~~~ 518 (594)
T 2p1m_B 515 SCSV 518 (594)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 7665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=5.1e-13 Score=145.52 Aligned_cols=226 Identities=12% Similarity=0.044 Sum_probs=174.6
Q ss_pred cCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
+|.+. +|+.++|..| ++..-..+|...+|+.+.|.+ .++..-+..|.++++|+.++|++|+++ .++.....+++|+
T Consensus 131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~ 206 (401)
T 4fdw_A 131 AFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIE 206 (401)
T ss_dssp TTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCS
T ss_pred hcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccC
Confidence 56664 7999998876 775666778777899999986 777555678999999999999999998 5665444478999
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
.+.|.+| ++..-...|.++++|+.+.+.+| ++..-...|.+ .+|+.+.| .|.++..-...|.++++|+.+++.+|.
T Consensus 207 ~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 207 EVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGST 282 (401)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSC
T ss_pred EEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcc
Confidence 9999854 66555678889999999999875 56566677777 78999999 555665667889999999999998887
Q ss_pred CC-----CCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccC
Q 040398 172 GP-----NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVY 246 (732)
Q Consensus 172 l~-----~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~ 246 (732)
+. .+....|.++++|+.++|. |.++......|.++.+|+.|+|..| ++..-+.. |.++
T Consensus 283 ~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a--------------F~~~- 345 (401)
T 4fdw_A 283 FNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA--------------FNNT- 345 (401)
T ss_dssp CCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS--------------SSSS-
T ss_pred ccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh--------------CCCC-
Confidence 66 5677789999999999998 4577555668888999999999665 55322222 5667
Q ss_pred CCCeEEccCCcCcCCC
Q 040398 247 EHQSLDLSYNNFTWQS 262 (732)
Q Consensus 247 ~L~~LdLs~N~l~~~~ 262 (732)
+|+.|++++|.+....
T Consensus 346 ~L~~l~l~~n~~~~l~ 361 (401)
T 4fdw_A 346 GIKEVKVEGTTPPQVF 361 (401)
T ss_dssp CCCEEEECCSSCCBCC
T ss_pred CCCEEEEcCCCCcccc
Confidence 8999999999765433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-14 Score=167.23 Aligned_cols=126 Identities=13% Similarity=0.110 Sum_probs=54.6
Q ss_pred ccceEecccccccccCCcccc-CCCCCCEEecccc-cCCcc-CCccccCCCCCCEEeCCCCcccccCCcccc----CCCC
Q 040398 41 QLKYISVFANRLSGNIPSHLG-NITSLTYLDLEEN-QFSGT-IPRELGNLVNLETLRLSSNRLIGNLPMELV----KLKN 113 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~----~l~~ 113 (732)
+|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 455555555555544444443 3555555555555 33311 222333455555555555555433222222 3445
Q ss_pred CCEEEccCcc--ccc-cCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeee
Q 040398 114 LTDFRINDNN--FNG-SAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLR 166 (732)
Q Consensus 114 L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 166 (732)
|+.|++++|. +.. .++..+..+++|+.|+|++|...+.++..+..+++|+.|+
T Consensus 186 L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 241 (594)
T 2p1m_B 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241 (594)
T ss_dssp CCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEE
T ss_pred CcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcc
Confidence 5555555554 110 0111123345555555555521112333344444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-13 Score=129.50 Aligned_cols=106 Identities=21% Similarity=0.265 Sum_probs=65.0
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
..++|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3456666666666 4555442 566666666666665555566666666666666666664444445666666666666
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+|+|++..+..|..+++|+.|+|++|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 66666555555666666666666666655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-13 Score=128.28 Aligned_cols=107 Identities=21% Similarity=0.263 Sum_probs=59.9
Q ss_pred CCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEccc
Q 040398 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 66 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 145 (732)
.++|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 455666666665 4555443 5556666666666544455555555555555555555544444445555555555555
Q ss_pred CCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCC
Q 040398 146 SGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGE 199 (732)
Q Consensus 146 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 199 (732)
|+| +.++...|..+++|++|+|++|.+...
T Consensus 88 N~l------------------------~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQL------------------------KSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCC------------------------CCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred Ccc------------------------CEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 554 444444555566666777777777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.4e-13 Score=128.51 Aligned_cols=105 Identities=24% Similarity=0.320 Sum_probs=60.0
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccC
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 121 (732)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 345666666665 5555443 5666666666666655555566666666666666666643333345566666666666
Q ss_pred ccccccCCccccCCCCCCEEEcccCCCc
Q 040398 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 122 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
|+|++..+..|..+++|+.|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 6665444444555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=7.5e-13 Score=126.89 Aligned_cols=104 Identities=21% Similarity=0.310 Sum_probs=58.2
Q ss_pred CEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccC
Q 040398 67 TYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146 (732)
Q Consensus 67 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 146 (732)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 5555443 55666666666665544555555555555555555555443344444555555555555
Q ss_pred CCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEccccccc
Q 040398 147 GLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIA 197 (732)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 197 (732)
+| ..++...|..+++|++|+|++|.+.
T Consensus 92 ~l------------------------~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HL------------------------KSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CC------------------------CCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cc------------------------ceeCHHHhccccCCCEEEeCCCCcc
Confidence 44 4444444555666666777777776
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.7e-12 Score=138.71 Aligned_cols=224 Identities=11% Similarity=0.074 Sum_probs=176.4
Q ss_pred ccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCC
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVN 89 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 89 (732)
.+|.+ .+|+.+.|.. .++..-+..|..+ +|+.++|.+|+++ .++.......+|+.+.|.+| ++..-...|.++++
T Consensus 152 ~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~ 227 (401)
T 4fdw_A 152 MAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQ 227 (401)
T ss_dssp TTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTT
T ss_pred HhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCC
Confidence 35666 4799999986 7776777889887 7999999999999 56654444799999999955 76455568999999
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCc-----CcCCccccCccCCCe
Q 040398 90 LETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE-----GPIPPSISALDKLNQ 164 (732)
Q Consensus 90 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~ 164 (732)
|+.++|..| ++..-...|.+ .+|+.+.| .|.++......|.++++|+.+.+.+|.+. ...+..|..+++|+.
T Consensus 228 L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~ 304 (401)
T 4fdw_A 228 LKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLAR 304 (401)
T ss_dssp CCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCE
T ss_pred CCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCe
Confidence 999999975 55344556666 89999999 45677677889999999999999998875 355678999999999
Q ss_pred eeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhc
Q 040398 165 LRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG 244 (732)
Q Consensus 165 L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~ 244 (732)
++|. +.+..+....|.++++|+.|+|..| ++..-...|.++ +|+.|++++|.+....+.. +.+
T Consensus 305 l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~--------------F~~ 367 (401)
T 4fdw_A 305 FEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKV--------------WYG 367 (401)
T ss_dssp ECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSS--------------CCC
T ss_pred EEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccc--------------ccC
Confidence 9999 5588888999999999999999665 664556788889 9999999999887433322 233
Q ss_pred c-CCCCeEEccCCcC
Q 040398 245 V-YEHQSLDLSYNNF 258 (732)
Q Consensus 245 l-~~L~~LdLs~N~l 258 (732)
+ .+++.|.+..|.+
T Consensus 368 ~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 368 FPDDITVIRVPAESV 382 (401)
T ss_dssp SCTTCCEEEECGGGH
T ss_pred CCCCccEEEeCHHHH
Confidence 3 2566777665543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-14 Score=153.75 Aligned_cols=182 Identities=15% Similarity=0.157 Sum_probs=116.2
Q ss_pred ccceEecccccccccCCccc----c-CCCCCCEEecccccCCccCCccc-cCCCCCCEEeCCCCcccccCCccc-----c
Q 040398 41 QLKYISVFANRLSGNIPSHL----G-NITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMEL-----V 109 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l----~-~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~l-----~ 109 (732)
+|++|+|++|.++......+ . ..++|++|+|++|.|+......+ ..+++|+.|+|++|+|+......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 57777777777764333222 2 22678888888887764322222 234577888888888764333333 2
Q ss_pred CCCCCCEEEccCccccc----cCCccccCCCCCCEEEcccCCCcCc----CCccccCccCCCeeeccCcCCCCCCccc--
Q 040398 110 KLKNLTDFRINDNNFNG----SAPDFIQSWTQLNRLEIQGSGLEGP----IPPSISALDKLNQLRISDLQGPNQTFPM-- 179 (732)
Q Consensus 110 ~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~-- 179 (732)
..++|+.|+|++|.|+. .++..+..+++|++|+|++|.++.. ++..+...++|+.|+|++|.++......
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 35778888888888753 2344456777888888888887642 2455667778888888888887654333
Q ss_pred --ccCCCCccEEEcccccccCCcchhhcCCC--C---CcEEe--CCCCcCcc
Q 040398 180 --LRNMTGLTRIILRNCNIAGEIPEYIWGIK--N---LRFLD--LSFNQLTG 222 (732)
Q Consensus 180 --l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~--~---L~~L~--Ls~N~l~g 222 (732)
+...++|++|+|++|.|++.....+..+. . |+.+. +..|.++.
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~ 284 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE 284 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred HHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence 44568899999999999876666555432 2 77777 77777763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=6.9e-12 Score=128.44 Aligned_cols=148 Identities=12% Similarity=0.081 Sum_probs=115.6
Q ss_pred HHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEE
Q 040398 509 IRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 587 (732)
+....+.|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4455678888888998999999999755 6889999986532233346888999998884 6677889999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE---------------------------------- 633 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~---------------------------------- 633 (732)
||||++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999876411 112347888999999999981
Q ss_pred ----------------------CCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 634 ----------------------SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 634 ----------------------~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
.+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013489999999999998765567999998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.3e-14 Score=151.23 Aligned_cols=111 Identities=14% Similarity=0.132 Sum_probs=63.9
Q ss_pred CCCCCEEecccccCCccCCccc----c-CCCCCCEEeCCCCcccccCCccc-cCCCCCCEEEccCccccccCCccc----
Q 040398 63 ITSLTYLDLEENQFSGTIPREL----G-NLVNLETLRLSSNRLIGNLPMEL-VKLKNLTDFRINDNNFNGSAPDFI---- 132 (732)
Q Consensus 63 l~~L~~L~Ls~N~l~~~~p~~l----~-~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~~---- 132 (732)
+++|++|+|++|.|+......+ . +.++|+.|+|++|.|+......+ ..+++|+.|+|++|.|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3578888888888874333332 2 23678888888888764322222 235677788888887764433333
Q ss_pred -cCCCCCCEEEcccCCCcCc----CCccccCccCCCeeeccCcCCC
Q 040398 133 -QSWTQLNRLEIQGSGLEGP----IPPSISALDKLNQLRISDLQGP 173 (732)
Q Consensus 133 -~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 173 (732)
...++|+.|+|++|.++.. ++..+..+++|++|+|++|.+.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 2356677777777776531 2223344444555554444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=132.76 Aligned_cols=104 Identities=19% Similarity=0.209 Sum_probs=70.2
Q ss_pred ceEecccc-cccccCCccccCCCCCCEEeccc-ccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 43 KYISVFAN-RLSGNIPSHLGNITSLTYLDLEE-NQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 43 ~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
..++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 34566666 666 5666 77777777777775 77775555667777777777777777776666667777777777777
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 7777755555555554 667777666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=132.50 Aligned_cols=102 Identities=22% Similarity=0.214 Sum_probs=66.4
Q ss_pred EEecccc-cCCccCCccccCCCCCCEEeCCC-CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEccc
Q 040398 68 YLDLEEN-QFSGTIPRELGNLVNLETLRLSS-NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG 145 (732)
Q Consensus 68 ~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 145 (732)
.++++++ +|+ .+|. |..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 676 5676 77777777777775 777755556677777777777777777776666777777777777777
Q ss_pred CCCcCcCCccccCccCCCeeeccCcCC
Q 040398 146 SGLEGPIPPSISALDKLNQLRISDLQG 172 (732)
Q Consensus 146 N~l~~~~p~~~~~l~~L~~L~ls~N~l 172 (732)
|+|++..+..+..++ |+.|+|.+|.+
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~ 115 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPL 115 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCc
Confidence 777644444444333 44444444444
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.3e-11 Score=114.97 Aligned_cols=126 Identities=24% Similarity=0.327 Sum_probs=94.2
Q ss_pred eEEEecCCCeee-ecCceecCCCCCC--CCcceeeecCCCCceeccccCCCCCCccccccccccCCCCCchhhhcccccC
Q 040398 305 SLHINCGGGNVK-VNDSTFEGDAGVG--GGAATYHLLDGTNWGISSTGDFTDDDDEQNTNYIANSQSSGISELYNDARIS 381 (732)
Q Consensus 305 s~~i~c~~~~~~-~~~~~~~~~~~~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (732)
+..|||||+..+ ..+..|++|.... |++..+ + . . ..+ ....+....+|++||..
T Consensus 7 ~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~--------~--~--~----------~~~-~~~~~~~~~lY~TaR~~ 63 (174)
T 2jwp_A 7 IWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDY--------G--M--K----------LPI-LRSNPEDQVLYQTERYN 63 (174)
T ss_dssp EEEEEETSSSEEETTTEEECSSCSSTTCCCCCCC--------C--T--T----------SCC-SSSCHHHHHTTTCCCCC
T ss_pred EEEEECCCCCccCCCCCEEcCCcCcccCCccccc--------c--c--c----------eEe-cccCCCCchhhhhhccC
Confidence 678999999865 4456899997532 322211 0 0 0 000 11233457799999999
Q ss_pred ccceeEEEEeecCcceeEEEEeeEEEeeccccccccCceeeEEEecceecccccchhhhccCCCCceeeeeeeeeccce
Q 040398 382 PLSLTYIGYCLENGNYSVALHFAEIQFTNDKTYKTLGRRIFDIYIQDKLVEKDFNIEAEAHGVLKPVTRPFTANVSNHI 460 (732)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 460 (732)
|.+++|..-|..+|+|.|.|||+|+.+++ +|+|+|+|++++..+.++|+|.+++++ ..+..+.+...+.+..
T Consensus 64 ~~~~tY~f~v~~~G~Y~VrLhF~ei~~~~------~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~ 135 (174)
T 2jwp_A 64 EDSFGYDIPIKEEGEYVLVLKFAEVYFAQ------SQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGK 135 (174)
T ss_dssp CSCEEEEEECCSCEEEEEEEEEECCSCCC------SSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTE
T ss_pred CCCeEEEEEeCCCeEEEEEEEEeccccCC------CCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCc
Confidence 99999999999999999999999998753 799999999999999999999999876 5677777766654443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=3.8e-11 Score=122.39 Aligned_cols=140 Identities=15% Similarity=0.123 Sum_probs=101.8
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCce--eeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL--VKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~~~~lv~e 590 (732)
...+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.++ .+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445443333456669999998777888999997643 22456788998888865454 468888888788999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES------------------------------------ 634 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------------------------------------ 634 (732)
|++|.++. ... .. ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998884 210 11 2356778888888888642
Q ss_pred -------------------CCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 635 -------------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 635 -------------------~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
+..++|+|++|.||+++++..+.|+|||.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112899999999999987766779999987653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.4e-10 Score=120.20 Aligned_cols=68 Identities=16% Similarity=0.234 Sum_probs=40.9
Q ss_pred CCCCccEEEcccccccCCcchhhc---CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcC
Q 040398 182 NMTGLTRIILRNCNIAGEIPEYIW---GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNF 258 (732)
Q Consensus 182 ~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l 258 (732)
.+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++.-+. .+...+..+++|+.|+|++|.+
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~----------~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR----------LLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH----------HHHTTHHHHTTCSEEECCSBBC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH----------HHHhhcccCCcceEEECCCCcC
Confidence 356777777777777654444333 366777777777777643111 1122234567777777777766
Q ss_pred c
Q 040398 259 T 259 (732)
Q Consensus 259 ~ 259 (732)
+
T Consensus 320 ~ 320 (362)
T 2ra8_A 320 S 320 (362)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=3.1e-10 Score=118.83 Aligned_cols=187 Identities=18% Similarity=0.210 Sum_probs=122.4
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCce--eeeeeeEEeCC---EEEEEEEec
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNL--VKLYGCCIEGD---QLMLVYEYL 592 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~~---~~~lv~e~~ 592 (732)
++.++.|....||++. ..+++|+.... .....+.+|.++++.+. +..+ .+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999864 45888885432 33567889999998873 4333 34444333332 347899999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE--------------------------------------- 633 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~--------------------------------------- 633 (732)
+|.++.+... ..++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875431 2466777888888999888888862
Q ss_pred ----------------CCCceEeCCCCCCCeEEcC--CCCeEEEeeecceeCCccCceeee-------------cccCcc
Q 040398 634 ----------------SRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEEEKTHIST-------------RVAGTI 682 (732)
Q Consensus 634 ----------------~~~~iiH~Dlkp~NILl~~--~~~~kL~DfGla~~~~~~~~~~~~-------------~~~gt~ 682 (732)
.+..++|+|++|.||++++ ...+.|+||+.+...++...-... .+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1134799999999999998 455789999988754332110000 000001
Q ss_pred cccc-chhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 683 GYMA-PEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 683 ~y~A-PE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
++.. |+.... .....+.|+++.+++.+.+|+.+|-
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111 222211 1123689999999999999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-09 Score=116.58 Aligned_cols=144 Identities=16% Similarity=0.238 Sum_probs=106.6
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcc--ccc-ccchHHHHHHHHHHhcCCC--CceeeeeeeEEeC---CEEEEEE
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLS--SKS-RQGNREFLNEIGTISCLQH--PNLVKLYGCCIEG---DQLMLVY 589 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~---~~~~lv~ 589 (732)
.++.++.|.++.||+++..+ ..+++|+.. ... ......+.+|.++++.+.+ ..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46779999999999998764 578888765 321 1223567889999988874 4567888888766 4578999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES----------------------------------- 634 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~----------------------------------- 634 (732)
||++|..+.+.. ...++...+..++.+++++|..||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998775422 124678888899999999999999731
Q ss_pred --------------------CCceEeCCCCCCCeEEcCCCC--eEEEeeecceeCC
Q 040398 635 --------------------RFKIVHRDIKATNVLLDRDLN--PKISDFGLAKLDE 668 (732)
Q Consensus 635 --------------------~~~iiH~Dlkp~NILl~~~~~--~kL~DfGla~~~~ 668 (732)
+..++|+|+++.||++++++. +.|+||+.+...+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 246899999999999998753 6899999887543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.3e-10 Score=120.29 Aligned_cols=179 Identities=17% Similarity=0.213 Sum_probs=106.7
Q ss_pred ccCCCCCCEEecccccCC---------ccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCc
Q 040398 60 LGNITSLTYLDLEENQFS---------GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPD 130 (732)
Q Consensus 60 l~~l~~L~~L~Ls~N~l~---------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 130 (732)
+..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+......
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~ 211 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVE 211 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHH
Confidence 445566777766554321 123344556677777777776311 2232 3 267777887777776543333
Q ss_pred ccc--CCCCCCEEEccc--CCCcCc-----CCccc--cCccCCCeeeccCcCCCCCCcccc---cCCCCccEEEcccccc
Q 040398 131 FIQ--SWTQLNRLEIQG--SGLEGP-----IPPSI--SALDKLNQLRISDLQGPNQTFPML---RNMTGLTRIILRNCNI 196 (732)
Q Consensus 131 ~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~ls~N~l~~~~~~~l---~~l~~L~~L~Ls~N~l 196 (732)
.+. .+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+.....+ ..+++|+.|+|+.|.|
T Consensus 212 ~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 343 577788777753 221111 11122 246788888888887764322222 2578899999999999
Q ss_pred cCCc----chhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhc-cCCCCeEEccCCc
Q 040398 197 AGEI----PEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRG-VYEHQSLDLSYNN 257 (732)
Q Consensus 197 ~~~~----p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~-l~~L~~LdLs~N~ 257 (732)
++.. +..+..+++|+.|+|++|.|+...- ..+.. + ...+|++.|+
T Consensus 292 ~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~--------------~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK--------------KELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp BHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH--------------HHHHHHC--CSEEECCSBC
T ss_pred ChHHHHHHHhhcccCCcceEEECCCCcCCHHHH--------------HHHHHHc--CCEEEecCCc
Confidence 8643 3444567899999999998873311 11222 2 4568999988
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-07 Score=103.38 Aligned_cols=195 Identities=11% Similarity=0.076 Sum_probs=86.2
Q ss_pred CCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCC
Q 040398 13 IVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLE 91 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 91 (732)
|.++++|+.+.|..+- .......|... +|+.+.+..| ++..-...+.++..|+.+.+..+... +........+|+
T Consensus 158 F~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~ 233 (394)
T 4fs7_A 158 FATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVK 233 (394)
T ss_dssp TTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCC
T ss_pred hcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCc
Confidence 4444444444444322 11222333333 3444444333 22122334444444444444433221 222223334444
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 92 TLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 92 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
.+.+..+ ++..-...+..+.+|+.+.+..+... .....|..+..|+.+.+..+.+. ...+..+.+|+.+.+.++
T Consensus 234 ~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~- 307 (394)
T 4fs7_A 234 NIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS- 307 (394)
T ss_dssp EEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-
T ss_pred eEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-
Confidence 4444322 11122233444555555555544322 33444555555555554443321 234555556666665543
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCC
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 218 (732)
+..+....|.++.+|+.++|.++ ++..-...|.++.+|+.+++..|
T Consensus 308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 44455555666666666666533 44233345555666666666544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.69 E-value=3.9e-07 Score=98.89 Aligned_cols=84 Identities=13% Similarity=0.127 Sum_probs=38.4
Q ss_pred cCCCCCCCCEEEcccCc---CccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 12 QIVNLPYLETVDFAYNY---LHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~---l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+|.++++|+.+.+..|. ++..-..+|... +|+.+.+..+ ++..-...+..+.+|+.+.+..+. ...-...+.++
T Consensus 82 AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c 159 (394)
T 4gt6_A 82 AFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYC 159 (394)
T ss_dssp TTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTC
T ss_pred HhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceecc
Confidence 34555555555555442 332333344433 4554444332 332223445555566666665432 21223345555
Q ss_pred CCCCEEeCCC
Q 040398 88 VNLETLRLSS 97 (732)
Q Consensus 88 ~~L~~L~L~~ 97 (732)
.+|+.+.+..
T Consensus 160 ~~L~~i~~~~ 169 (394)
T 4gt6_A 160 YSLHTVTLPD 169 (394)
T ss_dssp TTCCEEECCT
T ss_pred cccccccccc
Confidence 5555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.55 E-value=3.8e-07 Score=98.93 Aligned_cols=197 Identities=12% Similarity=0.039 Sum_probs=150.2
Q ss_pred ccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCC
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVN 89 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 89 (732)
.++.++++|+.+++..| ++......|... .|+.+.+..+... +........+|+.+.+..+. +..-...+.++..
T Consensus 179 ~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~ 254 (394)
T 4fs7_A 179 GLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTD 254 (394)
T ss_dssp TTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSS
T ss_pred ccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eeccccccccccc
Confidence 35778899999999876 554555667766 6888888766544 44455566889999987643 3234457888999
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccC
Q 040398 90 LETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD 169 (732)
Q Consensus 90 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 169 (732)
|+.+.+..+..+ .....+..+..|+.+.+..+.+ ....|..+.+|+.+.+.++ ++..-..+|.++++|+.++|.+
T Consensus 255 l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 255 LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred ceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCC
Confidence 999999887654 5566788899999998877653 2456888999999999765 6545567799999999999975
Q ss_pred cCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCC
Q 040398 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 170 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 218 (732)
+ ++.+....|.++.+|+.+.|..| ++..-...|.++++|+.+++..|
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 4 77788888999999999999877 66455567888999999988654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.53 E-value=1.6e-06 Score=94.06 Aligned_cols=240 Identities=10% Similarity=0.090 Sum_probs=144.2
Q ss_pred ccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCC
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVN 89 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 89 (732)
.+|..+..|+.+.+..+ ++......|... +|+.+.+..+ +...-...+..+.+|+.+.+..+ +. .+........+
T Consensus 108 ~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~~~ 183 (394)
T 4gt6_A 108 QAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFTGTA 183 (394)
T ss_dssp TTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCC
T ss_pred hhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-ee-Eeccccccccc
Confidence 35667777877777654 443444556555 6888887643 33244556777777888777654 33 23332223355
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEccCcc------------------------------------ccccCCcccc
Q 040398 90 LETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN------------------------------------FNGSAPDFIQ 133 (732)
Q Consensus 90 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~------------------------------------l~~~~p~~~~ 133 (732)
|+.+.+..+-.. .-...+..+.+|+......+. ++..-...|.
T Consensus 184 l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~ 262 (394)
T 4gt6_A 184 LTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFD 262 (394)
T ss_dssp CSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTT
T ss_pred eeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceee
Confidence 666666544322 233344444444444332221 1112234577
Q ss_pred CCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEE
Q 040398 134 SWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFL 213 (732)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 213 (732)
++..|+.+.+.++..+ .....|.++++|+.+.+. +.+..+....|.++.+|+.++|..+ ++..-...|.++.+|+.+
T Consensus 263 ~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i 339 (394)
T 4gt6_A 263 SCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERI 339 (394)
T ss_dssp TCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred ecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEE
Confidence 7888888888766543 556678888888888885 4566677778888888888888765 553445577788888888
Q ss_pred eCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 214 DLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 214 ~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
.|..+ ++ .|.+ ..|.++.+|+.+++++|.... .....|..+..+.
T Consensus 340 ~ip~s-v~-~I~~-------------~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~ 384 (394)
T 4gt6_A 340 AIPSS-VT-KIPE-------------SAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLP 384 (394)
T ss_dssp EECTT-CC-BCCG-------------GGGTTCTTCCEEEESSCHHHH--HTCBCCCCC----
T ss_pred EECcc-cC-EEhH-------------hHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEE
Confidence 88654 44 2332 126777888888888886543 2234555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=2.6e-08 Score=96.05 Aligned_cols=92 Identities=21% Similarity=0.187 Sum_probs=46.0
Q ss_pred ccccCCCCCCEEecccc-cCCcc----CCccccCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCcccccc-
Q 040398 58 SHLGNITSLTYLDLEEN-QFSGT----IPRELGNLVNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFNGS- 127 (732)
Q Consensus 58 ~~l~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~- 127 (732)
..+...++|++|+|++| .|... +...+...++|++|+|++|+|.. .+...+...++|+.|+|++|.|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34445566666666666 55521 23344455566666666666653 1223334445566666666655422
Q ss_pred ---CCccccCCCCCCEEEc--ccCCCc
Q 040398 128 ---APDFIQSWTQLNRLEI--QGSGLE 149 (732)
Q Consensus 128 ---~p~~~~~l~~L~~L~L--s~N~l~ 149 (732)
+...+...++|+.|+| ++|.++
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2233444444555555 444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=5e-08 Score=94.02 Aligned_cols=124 Identities=14% Similarity=0.164 Sum_probs=69.7
Q ss_pred ccccCCCCCCEEEccCc-ccccc----CCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccc
Q 040398 106 MELVKLKNLTDFRINDN-NFNGS----APDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180 (732)
Q Consensus 106 ~~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l 180 (732)
..+...++|+.|+|++| .|... +...+...++|++|+|++|.+.......+ ...+
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l--------------------~~~L 89 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFAL--------------------AEML 89 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHH--------------------HHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHH--------------------HHHH
Confidence 34455666777777776 66422 22334445566666666666542111111 1123
Q ss_pred cCCCCccEEEcccccccCC----cchhhcCCCCCcEEeC--CCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 181 RNMTGLTRIILRNCNIAGE----IPEYIWGIKNLRFLDL--SFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 181 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L--s~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
...++|++|+|++|.|++. +...+...++|+.|+| ++|.|+... ...+...+...++|+.|+|+
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g----------~~~l~~~L~~n~~L~~L~L~ 159 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV----------EMEIANMLEKNTTLLKFGYH 159 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH----------HHHHHHHHHHCSSCCEEECC
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHH----------HHHHHHHHHhCCCcCEEecc
Confidence 3345667777777777643 3455566677777877 677776321 12334455666778888888
Q ss_pred CCcCc
Q 040398 255 YNNFT 259 (732)
Q Consensus 255 ~N~l~ 259 (732)
+|.+.
T Consensus 160 ~n~i~ 164 (185)
T 1io0_A 160 FTQQG 164 (185)
T ss_dssp CSSHH
T ss_pred CCCCC
Confidence 87764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1.3e-08 Score=103.43 Aligned_cols=105 Identities=21% Similarity=0.224 Sum_probs=58.8
Q ss_pred ecccccccccCC-ccccCCCCCCE--EecccccCCccCCc----cccCCCCCCEEeCCCCcccc--cCCccccCCCCCCE
Q 040398 46 SVFANRLSGNIP-SHLGNITSLTY--LDLEENQFSGTIPR----ELGNLVNLETLRLSSNRLIG--NLPMELVKLKNLTD 116 (732)
Q Consensus 46 ~L~~n~l~~~~p-~~l~~l~~L~~--L~Ls~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~ 116 (732)
..++|..++.+. +.+...+.|.. ++++.|... .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.
T Consensus 122 ~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~ 200 (267)
T 3rw6_A 122 SKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 200 (267)
T ss_dssp HHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCE
T ss_pred HhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCE
Confidence 333444443333 22444455555 566666433 2222 12356677777777777775 44555666777777
Q ss_pred EEccCccccccCCccccCCC--CCCEEEcccCCCcCcCC
Q 040398 117 FRINDNNFNGSAPDFIQSWT--QLNRLEIQGSGLEGPIP 153 (732)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 153 (732)
|+|++|+|++. ..+..+. +|+.|+|++|.+.+.+|
T Consensus 201 L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 201 LNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp EECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred EECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 77777777644 2233333 67777777777765444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.40 E-value=6.6e-06 Score=88.51 Aligned_cols=239 Identities=11% Similarity=0.057 Sum_probs=122.6
Q ss_pred cCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCC-ccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIP-SHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
+|.++++|+.++|..+ ++..-..+|...+|+.+.+..+ ++ .+. ..|.. .+|+.+++..+-.. .-...|.++ +|
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~-l~-~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~~-~l 137 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMER-VK-KFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYNS-SV 137 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTT-CC-EECTTTTTT-CCCSEEECCTTCCE-ECTTTTTTC-CC
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCce-ee-Eeccceecc-CCcccccCCCcccc-ccccccccc-ee
Confidence 5677777777777643 5544455666666666666533 44 233 33333 46777777654221 111222222 34
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccc-----------------------------------cccCCccccCC
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF-----------------------------------NGSAPDFIQSW 135 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l-----------------------------------~~~~p~~~~~l 135 (732)
+.+.+..+ ++..-...+..+.+|+.+.+..+.. .......+..+
T Consensus 138 ~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~ 216 (379)
T 4h09_A 138 KRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYG 216 (379)
T ss_dssp CEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTC
T ss_pred eeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccc
Confidence 44433322 1112223334444444444332211 01112234445
Q ss_pred CCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeC
Q 040398 136 TQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDL 215 (732)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 215 (732)
.+|+.+.+..+ ++......+..+.+|+.+.+.++ ++.+....|.++.+|+.+.+..+ +.......|..+.+|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 56666666444 23234455666777777777654 55566666777777777777544 44233445666777777777
Q ss_pred CCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCC-ccccCCCCcc
Q 040398 216 SFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQ-PACREKPNLN 275 (732)
Q Consensus 216 s~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~-~~~~~~~~l~ 275 (732)
.+|.++. |++. .|.++.+|+.++|..| ++...... ..|..+..+.
T Consensus 294 ~~~~i~~-I~~~-------------aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 294 DNSAIET-LEPR-------------VFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp CCTTCCE-ECTT-------------TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred cccccce-ehhh-------------hhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 7766662 2221 1556667777777544 44333332 3455555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3.4e-08 Score=100.34 Aligned_cols=64 Identities=23% Similarity=0.149 Sum_probs=35.9
Q ss_pred ccCCCCccEEEcccccccCCcchhhcCCC--CCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEE
Q 040398 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIK--NLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLD 252 (732)
Q Consensus 180 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~Ld 252 (732)
+..+++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|+. -......+..+++|+.||
T Consensus 192 ~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~-------~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 192 VQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQ-------STYISAIRERFPKLLRLD 257 (267)
T ss_dssp HHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSH-------HHHHHHHHHHCTTCCEES
T ss_pred HhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcc-------hhHHHHHHHHCcccCeEC
Confidence 34455666666666666543 2233333 6777777777777665531 012224466667777776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2e-06 Score=89.79 Aligned_cols=139 Identities=18% Similarity=0.185 Sum_probs=95.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCC---ceeeeeeeEE-eCCEEEEEEEecCC
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHP---NLVKLYGCCI-EGDQLMLVYEYLEN 594 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~~ 594 (732)
.+.++.|....||+. |..+++|+.. .......+.+|.++++.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899988 5668888843 223356788999999998753 2456666664 34567899999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE----------------------------------------- 633 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~----------------------------------------- 633 (732)
.++.+... ..++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876321 1234445555555566655555543
Q ss_pred ----------------CCCceEeCCCCCCCeEEcC---CCC-eEEEeeecceeCCc
Q 040398 634 ----------------SRFKIVHRDIKATNVLLDR---DLN-PKISDFGLAKLDEE 669 (732)
Q Consensus 634 ----------------~~~~iiH~Dlkp~NILl~~---~~~-~kL~DfGla~~~~~ 669 (732)
.+..++|+|+++.||+++. ++. +.|+||+.+...++
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 1234699999999999987 455 48999998876544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.1e-06 Score=86.38 Aligned_cols=137 Identities=15% Similarity=0.106 Sum_probs=97.5
Q ss_pred eecccCce-EEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 521 KIGEGGFG-PVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 521 ~LG~G~fg-~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...++.+. +--+.+++.++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35556555 69998765 4677899986532 3456778888888774 32356788999999999999999999888
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES------------------------------------------- 634 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------------------------------------------- 634 (732)
.+..... ......++.++++.|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7754211 1223356666777777777531
Q ss_pred ------------CCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 635 ------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 635 ------------~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
+..++|+|+.+.||++++++.+-|+||+.+...+
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 1237899999999999987767799999886543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2.9e-06 Score=90.51 Aligned_cols=80 Identities=6% Similarity=0.005 Sum_probs=54.1
Q ss_pred ccee-cccCceEEEEEEEc-------CCeEEEEEEccccc---ccchHHHHHHHHHHhcCC-C--CceeeeeeeEEeC--
Q 040398 519 MNKI-GEGGFGPVYKGQLT-------DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQ-H--PNLVKLYGCCIEG-- 582 (732)
Q Consensus 519 ~~~L-G~G~fg~Vy~a~~~-------~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~-- 582 (732)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999998754 26788999865432 101245677888887774 2 2456777776554
Q ss_pred -CEEEEEEEecCCCchh
Q 040398 583 -DQLMLVYEYLENNSLA 598 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~ 598 (732)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.09 E-value=4.6e-05 Score=81.85 Aligned_cols=136 Identities=13% Similarity=0.137 Sum_probs=102.3
Q ss_pred CccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCC
Q 040398 105 PMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMT 184 (732)
Q Consensus 105 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~ 184 (732)
...+..+.+|+.+.+..+ +.......+.++..|+.+.+..+ ++..-...|.++.+|+.+.+.. .+..+....|..+.
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceecccccccccc
Confidence 445666788888888755 44455667888999999999776 5545567788889999998865 46667777889999
Q ss_pred CccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 185 GLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 185 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
+|+.+.+.++.++..-...|.++.+|+.+.|..+ ++ .|.+. .|.++.+|+.+.|..| ++
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~-------------aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVY-------------AFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTT-------------TTTTCTTCCCCCCCTT-CC
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHH-------------HhhCCCCCCEEEECCc-cC
Confidence 9999999998888555668888999999999755 44 33332 2677788888888655 55
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.6e-05 Score=81.22 Aligned_cols=145 Identities=17% Similarity=0.209 Sum_probs=81.1
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCC--Cceeeeee------eEEeCCEEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH--PNLVKLYG------CCIEGDQLMLVYE 590 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~------~~~~~~~~~lv~e 590 (732)
.+.++.|..+.||++...+| .+++|+.... ..++..|.++++.+.. -.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677889999987655 4899988652 1233344444444421 12333332 2235677899999
Q ss_pred ecCCCchh--------------HHhhcC--CC--C-c-----ccCCHHHH------------------------------
Q 040398 591 YLENNSLA--------------HALFGG--EN--S-Q-----LKLNWSVR------------------------------ 616 (732)
Q Consensus 591 ~~~~gsL~--------------~~l~~~--~~--~-~-----~~l~~~~~------------------------------ 616 (732)
|++|..+. ..+|.. .. . . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986442 112211 00 0 0 01122211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 617 -QKICLGIARGLAFLHE----------ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 617 -~~i~~~i~~aL~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
..+...+.+++++|+. ..+..++|+|+++.||+++.++.+.|+||+.+....
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~ 254 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDL 254 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccCC
Confidence 1111234446667763 023469999999999999888889999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.4e-05 Score=84.78 Aligned_cols=75 Identities=15% Similarity=0.170 Sum_probs=49.4
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEcccccc-------cchHHHHHHHHHHhcCCC--Cce-eeeeeeEEeCCEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR-------QGNREFLNEIGTISCLQH--PNL-VKLYGCCIEGDQLML 587 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~nI-v~l~~~~~~~~~~~l 587 (732)
.+.+|.|..+.||+++.. +++.++||....... ....++..|.++++.+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999764 468899997653211 123456778888887742 333 345543 4455689
Q ss_pred EEEecCCC
Q 040398 588 VYEYLENN 595 (732)
Q Consensus 588 v~e~~~~g 595 (732)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=9.5e-05 Score=76.16 Aligned_cols=79 Identities=19% Similarity=0.269 Sum_probs=57.5
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCC-c--eeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHP-N--LVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~-n--Iv~l~~~~~~~~~~~lv~e 590 (732)
.....++.+|.|..+.||+.+..||+.|.+|+...........|.+|.+.|+.+.-. . +.+++++ .. -++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 345567889999999999999999999999987655444456688899988877422 2 3344443 22 368999
Q ss_pred ecCCCc
Q 040398 591 YLENNS 596 (732)
Q Consensus 591 ~~~~gs 596 (732)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=5e-06 Score=78.40 Aligned_cols=34 Identities=18% Similarity=0.260 Sum_probs=17.4
Q ss_pred CccEEEccccc-ccCCcchhhcCCCCCcEEeCCCC
Q 040398 185 GLTRIILRNCN-IAGEIPEYIWGIKNLRFLDLSFN 218 (732)
Q Consensus 185 ~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~N 218 (732)
+|++|+|++|. |++.--..+..+++|+.|+|+++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 45555555543 54444444455555555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.70 E-value=7.8e-06 Score=77.10 Aligned_cols=85 Identities=11% Similarity=0.187 Sum_probs=44.6
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEEcccCC-CcCcCCccccCc----cCCCeeeccCcC-CCCCCcccccCCCCc
Q 040398 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG-LEGPIPPSISAL----DKLNQLRISDLQ-GPNQTFPMLRNMTGL 186 (732)
Q Consensus 113 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~~~~~~~l~~l~~L 186 (732)
+|+.|+++++.++..--..+..+++|+.|+|++|. ++..--..+..+ ++|+.|+|++|. +++.....+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444433222334445555555555543 433222333332 356666666653 555555566677778
Q ss_pred cEEEccccc-cc
Q 040398 187 TRIILRNCN-IA 197 (732)
Q Consensus 187 ~~L~Ls~N~-l~ 197 (732)
++|+|+++. ++
T Consensus 142 ~~L~L~~c~~It 153 (176)
T 3e4g_A 142 KYLFLSDLPGVK 153 (176)
T ss_dssp CEEEEESCTTCC
T ss_pred CEEECCCCCCCC
Confidence 888888775 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=4.8e-05 Score=83.01 Aligned_cols=79 Identities=10% Similarity=0.051 Sum_probs=48.6
Q ss_pred CceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccC---CCCCchhHHHHHHHHHHHH
Q 040398 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG---YLTYKADVYSFGVVALEIV 712 (732)
Q Consensus 636 ~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvll~ell 712 (732)
..++|+|+++.||++++++ ++|+||+.+...++...-...-..-...|.+|+..... ......++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 99999998876443211100000001246666654321 1122345667888888877
Q ss_pred cCC
Q 040398 713 SGK 715 (732)
Q Consensus 713 tG~ 715 (732)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00042 Score=72.08 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=92.1
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCC---CCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 518 PMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ---HPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
..+.++.|....+|+... ++..+++|+.... ....+.+|.+.|+.+. ...+++++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346799999999999876 4677889986532 3566888988888774 35577888888888889999999998
Q ss_pred Cchh--------H---HhhcCCC-Cc-----------------ccCCHHHHH---HHHH----------------HHHHH
Q 040398 595 NSLA--------H---ALFGGEN-SQ-----------------LKLNWSVRQ---KICL----------------GIARG 626 (732)
Q Consensus 595 gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~----------------~i~~a 626 (732)
..+. . .+|.... .. ..-+|.... ++.. ++++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7542 1 2333211 10 012454321 1111 11111
Q ss_pred -HHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeee
Q 040398 627 -LAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFG 662 (732)
Q Consensus 627 -L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfG 662 (732)
.+.|.. ..++.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2245689999999999999887 8899984
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.27 E-value=7.2e-05 Score=71.84 Aligned_cols=65 Identities=14% Similarity=0.166 Sum_probs=32.7
Q ss_pred cCCCCCCEEecccc-cCCcc----CCccccCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCcccc
Q 040398 61 GNITSLTYLDLEEN-QFSGT----IPRELGNLVNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 61 ~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
.+-+.|++|+|++| +|... +...+..-+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|.|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33455666666653 55421 23344445556666666666652 22233334455666666666554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.27 E-value=5.3e-05 Score=72.77 Aligned_cols=109 Identities=17% Similarity=0.210 Sum_probs=70.3
Q ss_pred ccceEecccc-cccc----cCCccccCCCCCCEEecccccCCcc----CCccccCCCCCCEEeCCCCcccc----cCCcc
Q 040398 41 QLKYISVFAN-RLSG----NIPSHLGNITSLTYLDLEENQFSGT----IPRELGNLVNLETLRLSSNRLIG----NLPME 107 (732)
Q Consensus 41 ~L~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~ 107 (732)
.|++|+|++| +|.. .+...+..-+.|++|+|++|+|... +...+..-+.|++|+|++|.|++ .+...
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a 121 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 121 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence 4777888775 6652 2445566667888888888888733 33344456778888888888874 23334
Q ss_pred ccCCCCCCEEEccCc---cccc----cCCccccCCCCCCEEEcccCCCc
Q 040398 108 LVKLKNLTDFRINDN---NFNG----SAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 108 l~~l~~L~~L~L~~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+..-+.|+.|+|++| .+.. .+.+.+..-+.|+.|+++.|.+.
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 555567888888765 3321 23345566678888888776653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0019 Score=67.56 Aligned_cols=160 Identities=14% Similarity=0.097 Sum_probs=88.7
Q ss_pred ccHHHHHHHhCCCcc-----cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCc--eeeee
Q 040398 504 FTLKQIRAATSNFDP-----MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN--LVKLY 576 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~-----~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 576 (732)
.+.+.+..+...|.+ +..++ |....||++...+|+.+++|+..... .....+..|..+++.+.... +++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 444555544444432 34566 77789999887778789999986331 12345666777776664222 34444
Q ss_pred ee-----EEeCCEEEEEEEecCCCchh-----H------H---hhcC----CC-CcccCCHHHH----HHH---------
Q 040398 577 GC-----CIEGDQLMLVYEYLENNSLA-----H------A---LFGG----EN-SQLKLNWSVR----QKI--------- 619 (732)
Q Consensus 577 ~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~----~~-~~~~l~~~~~----~~i--------- 619 (732)
.. ....+..+++|+|++|..+. . . +|.. .. .....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 23356678999999885432 0 0 1210 00 0111222111 000
Q ss_pred ------HHHHHHHHHHHHh----CCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 620 ------CLGIARGLAFLHE----ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 620 ------~~~i~~aL~yLH~----~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
...+.+.++.+.. ..+..++|+|+++.||+++ + .+.|+||+.+...
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1111122333321 1234578999999999999 4 8999999877643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0036 Score=65.14 Aligned_cols=160 Identities=17% Similarity=0.153 Sum_probs=88.1
Q ss_pred ccHHHHHHHhCCCcc-----cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCc--eeeee
Q 040398 504 FTLKQIRAATSNFDP-----MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPN--LVKLY 576 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~-----~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 576 (732)
++.+++......|.. .+.++.|....+|++...+| .+++|+..... ....+..|+++++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445666666666654 34567788889999987665 58899876521 1234455666666553222 23333
Q ss_pred e------eEEeCCEEEEEEEecCCCchhH--------------HhhcC----CCCc-cc---CCHHHHHH----------
Q 040398 577 G------CCIEGDQLMLVYEYLENNSLAH--------------ALFGG----ENSQ-LK---LNWSVRQK---------- 618 (732)
Q Consensus 577 ~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~-~~---l~~~~~~~---------- 618 (732)
. +....+..+++|+|++|..+.. .+|.. .... .. ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 2 1233567789999999864311 11211 0000 00 11222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 619 --ICLGIARGLAFLHEE----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 619 --i~~~i~~aL~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+...+.+.++++++. .+..++|+|+.+.||+++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455565532 234589999999999999876568999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0014 Score=68.66 Aligned_cols=146 Identities=15% Similarity=0.119 Sum_probs=73.1
Q ss_pred cceecccCceE-EEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCC--CceeeeeeeEEeCCEEEEEEEecCCC
Q 040398 519 MNKIGEGGFGP-VYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH--PNLVKLYGCCIEGDQLMLVYEYLENN 595 (732)
Q Consensus 519 ~~~LG~G~fg~-Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~g 595 (732)
.+.|+.|.... +|+....+|+.+++|........ .+..|+++++.+.. -.+.+++.+..+.+ +++||++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~---~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG---DTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTTC---CSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc---cccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665554 66776544677778865443212 22345555555532 22445665533333 6899999876
Q ss_pred chhHHhhcCC---------------------CC-cccCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 040398 596 SLAHALFGGE---------------------NS-QLKLNWSVRQ-------K-------------ICLGIARGLAFLH-- 631 (732)
Q Consensus 596 sL~~~l~~~~---------------------~~-~~~l~~~~~~-------~-------------i~~~i~~aL~yLH-- 631 (732)
.+.+++.... .. ...++..... . ....+.+.++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654432110 00 0112211100 0 0011222233331
Q ss_pred -hCCCCceEeCCCCCCCeEEcCC----CCeEEEeeecceeCCc
Q 040398 632 -EESRFKIVHRDIKATNVLLDRD----LNPKISDFGLAKLDEE 669 (732)
Q Consensus 632 -~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DfGla~~~~~ 669 (732)
...+..++|||+.+.||+++.+ ..+.|+||+.+...+.
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 1123468999999999999875 6789999998875443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=68.19 Aligned_cols=142 Identities=12% Similarity=0.134 Sum_probs=75.7
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCce-eeeeeeEEeCCEEEEEEEec-CCCc
Q 040398 519 MNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL-VKLYGCCIEGDQLMLVYEYL-ENNS 596 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~gs 596 (732)
++.|+.|....+|++ +.+++|+........ ....+|..+++.+...++ .+++++ .++.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 677989999999998 458888876432211 122457777666643333 345443 344457899999 6544
Q ss_pred hhH------------------HhhcCCC-CcccCC-HHHHHHHHHH--------------HHHHH----HHHHh-CCCCc
Q 040398 597 LAH------------------ALFGGEN-SQLKLN-WSVRQKICLG--------------IARGL----AFLHE-ESRFK 637 (732)
Q Consensus 597 L~~------------------~l~~~~~-~~~~l~-~~~~~~i~~~--------------i~~aL----~yLH~-~~~~~ 637 (732)
+.. .+|.... ...... +.....+... +.+.+ +.+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 1122111 000011 1111111110 11111 12211 12345
Q ss_pred eEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 638 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 638 iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
++|+|+.+.||+ .+++.+.++||..+...++
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~ 205 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMNDP 205 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEECT
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCCCH
Confidence 799999999999 5667789999988765433
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00058 Score=74.55 Aligned_cols=73 Identities=18% Similarity=0.291 Sum_probs=49.3
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCce-eeeeeeEEeCCEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTD--------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL-VKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~ 589 (732)
++.|+.|-...||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4668888889999998753 578999988432 112455678888888754444 45665543 2 3899
Q ss_pred EecCCCch
Q 040398 590 EYLENNSL 597 (732)
Q Consensus 590 e~~~~gsL 597 (732)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0019 Score=68.98 Aligned_cols=143 Identities=18% Similarity=0.248 Sum_probs=83.5
Q ss_pred cceecccCceEEEEEEEc--------CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCce-eeeeeeEEeCCEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL-VKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~ 589 (732)
++.+..|-...+|++... +++.+.+|+.... ........+|.++++.+.-.++ .++++.+. + .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence 356777888899999864 3578999986432 2234556689888887743333 45665543 3 3899
Q ss_pred EecCCCchhH-----------------HhhcCCCC-cccC--CHHHHHHHHHHHHH-------------------HHHH-
Q 040398 590 EYLENNSLAH-----------------ALFGGENS-QLKL--NWSVRQKICLGIAR-------------------GLAF- 629 (732)
Q Consensus 590 e~~~~gsL~~-----------------~l~~~~~~-~~~l--~~~~~~~i~~~i~~-------------------aL~y- 629 (732)
||++|.+|.. .+|..... .... -|.++.++..++.. .++.
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865431 11222111 1112 24555555544322 2233
Q ss_pred ---HHhC-CCCceEeCCCCCCCeEEcCC----CCeEEEeeeccee
Q 040398 630 ---LHEE-SRFKIVHRDIKATNVLLDRD----LNPKISDFGLAKL 666 (732)
Q Consensus 630 ---LH~~-~~~~iiH~Dlkp~NILl~~~----~~~kL~DfGla~~ 666 (732)
|... .+..++|+|+.+.||+++++ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 23458899999999999876 6899999988864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=68.98 Aligned_cols=74 Identities=16% Similarity=0.136 Sum_probs=47.9
Q ss_pred cceecccCceEEEEEEEcC-CeEEEEEEcccccccchHHHHHHHHHHhcCCCCcee-eeeeeEEeCCEEEEEEEecCCCc
Q 040398 519 MNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV-KLYGCCIEGDQLMLVYEYLENNS 596 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~gs 596 (732)
++.|+.|-...+|++...+ +..+++|+......... ...+|..+++.+...+++ ++++.+ .+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4568888889999998775 57889998754322211 125788888888655554 566665 23 35999998754
Q ss_pred h
Q 040398 597 L 597 (732)
Q Consensus 597 L 597 (732)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.011 Score=62.08 Aligned_cols=33 Identities=30% Similarity=0.425 Sum_probs=28.4
Q ss_pred CceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 636 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 636 ~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
..++|+|+.+.||++++++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 468999999999999988889999998876543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.005 Score=54.94 Aligned_cols=36 Identities=14% Similarity=0.337 Sum_probs=16.8
Q ss_pred CCCEEEccCccccccCCccccCCCCCCEEEcccCCC
Q 040398 113 NLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL 148 (732)
Q Consensus 113 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 148 (732)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 344444444444433334444444555555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0049 Score=54.98 Aligned_cols=55 Identities=22% Similarity=0.312 Sum_probs=29.5
Q ss_pred EEecccccCC-ccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccc
Q 040398 68 YLDLEENQFS-GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNF 124 (732)
Q Consensus 68 ~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 124 (732)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5555555554 24444332 3466666666666533344455566666666666654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0039 Score=66.39 Aligned_cols=74 Identities=12% Similarity=0.180 Sum_probs=43.3
Q ss_pred cceecccCceEEEEEEEcC---------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCce-eeeeeeEEeCCEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTD---------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL-VKLYGCCIEGDQLMLV 588 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv 588 (732)
.+.++.|....+|++...+ ++.+++|+........ .....|.++++.+...++ .++++.. ++ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 3567778888999998654 2688899875432221 123567777776643333 3555443 33 689
Q ss_pred EEecCCCch
Q 040398 589 YEYLENNSL 597 (732)
Q Consensus 589 ~e~~~~gsL 597 (732)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.035 Score=60.05 Aligned_cols=142 Identities=12% Similarity=0.150 Sum_probs=83.3
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCce-eeeeeeEEeCCEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTD--------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNL-VKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~ 589 (732)
++.+..|-...+|++...+ ++.+++|+........ ....+|.++++.+.-.++ .++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4567778888999998753 5789999875432221 123567777777743333 3555432 33 6899
Q ss_pred EecCCCchhH-----------------HhhcCCC---------CcccCCHHHHHHHHHHH-------------------H
Q 040398 590 EYLENNSLAH-----------------ALFGGEN---------SQLKLNWSVRQKICLGI-------------------A 624 (732)
Q Consensus 590 e~~~~gsL~~-----------------~l~~~~~---------~~~~l~~~~~~~i~~~i-------------------~ 624 (732)
||++|.+|.. .+|.... ...+..|..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0121100 11112344444444322 2
Q ss_pred HHHHHHHh---------------------CCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 625 RGLAFLHE---------------------ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 625 ~aL~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+.+++|.+ ..+..++|+|+.+.||+ ++++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11235789999999999 7788899999988864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.06 E-value=0.41 Score=51.26 Aligned_cols=30 Identities=23% Similarity=0.385 Sum_probs=24.9
Q ss_pred ceEeCCCCCCCeEE------cCCCCeEEEeeeccee
Q 040398 637 KIVHRDIKATNVLL------DRDLNPKISDFGLAKL 666 (732)
Q Consensus 637 ~iiH~Dlkp~NILl------~~~~~~kL~DfGla~~ 666 (732)
.++|+|+.+.||++ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 3456799999988864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.50 E-value=0.5 Score=45.51 Aligned_cols=101 Identities=16% Similarity=0.097 Sum_probs=64.6
Q ss_pred chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHH-hCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCcee
Q 040398 596 SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH-EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHI 674 (732)
Q Consensus 596 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~~ 674 (732)
||.++|. ....+++++++|-++.|.+.+|.-+- ... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 8899884 34568999999999999999987662 111 1 1222346899999999987653 1110
Q ss_pred eecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCC
Q 040398 675 STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNN 717 (732)
Q Consensus 675 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P 717 (732)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122567888653 3556788999999999988754443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.15 E-value=0.72 Score=44.35 Aligned_cols=115 Identities=10% Similarity=0.126 Sum_probs=79.0
Q ss_pred CCCceeeeeeeEEeCCEEEEEEEecCCC-chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCC
Q 040398 568 QHPNLVKLYGCCIEGDQLMLVYEYLENN-SLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKAT 646 (732)
Q Consensus 568 ~H~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~ 646 (732)
.||++++. ..-.+++.+.+.++.-+.+ ++.. + ..++...+++++.+|+...++++. -+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888866 5666777777777755422 4433 2 256788999999999998866654 478889999
Q ss_pred CeEEcCCCCeEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 647 NVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 647 NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
||+++.++.+++.-.|+...+.+ . ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988876432222 1 11111223345567788888888775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.68 E-value=2.7 Score=40.50 Aligned_cols=83 Identities=13% Similarity=0.193 Sum_probs=62.1
Q ss_pred CCCceeeeeeeEEeCCEEEEEEEecCCC-chhHHhhcCCCCcccCCHHHHHHHHHHHHHHHH-HHHhCCCCceEeCCCCC
Q 040398 568 QHPNLVKLYGCCIEGDQLMLVYEYLENN-SLAHALFGGENSQLKLNWSVRQKICLGIARGLA-FLHEESRFKIVHRDIKA 645 (732)
Q Consensus 568 ~H~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~-yLH~~~~~~iiH~Dlkp 645 (732)
.||++ -...-.+++.+.+.++.-+++ ++.. + ..++...+++++.+|+...+ +++. -+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 67887 344446778888888865443 4443 3 25678899999999988777 5554 57888999
Q ss_pred CCeEEcCCCCeEEEeeecce
Q 040398 646 TNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 646 ~NILl~~~~~~kL~DfGla~ 665 (732)
+||++|.++.+++.-.|.-.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GGEEECTTCCEEESCCEETT
T ss_pred ceEEEeCCCcEEEEEcCCcc
Confidence 99999999999998888643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 732 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-64
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+IG G FG VYKG+ + + +++ + Q + F NE+G + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
G QL +V ++ E +SL H L E K I A+G+ +LH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEEEKTHISTRVAGTIGYMAPEYAL- 691
I+HRD+K+ N+ L DL KI DFGLA + +H +++G+I +MAPE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 692 --WGYLTYKADVYSFGVVALEIVSGK 715
++++DVY+FG+V E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 6e-63
Identities = 47/206 (22%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 512 ATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQH 569
+F+ ++++G G G V+K G ++A KL+ + + R + E+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P +V YG ++ + E+++ SL L ++ + K+ + + +GL +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTY 119
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
L + KI+HRD+K +N+L++ K+ DFG++ + GT YM+PE
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
+ + ++D++S G+ +E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 7/202 (3%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ ++G G FG V+ G T +AVK L + FL E + LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LY + + + ++ EY+EN SL L S +KL + + IA G+AF+ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+HRD++A N+L+ L+ KI+DFGLA+L E+ + I + APE +G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
T K+DV+SFG++ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHG 207
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-60
Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ + ++G G FG V G+ +A+K++ + EF+ E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LYG C + + ++ EY+ N L + L + + ++C + + +L +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK 119
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
+ +HRD+ A N L++ K+SDFGL++ +++ S + + PE ++
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 694 YLTYKADVYSFGVVALEIVS 713
+ K+D+++FGV+ EI S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
S + +IG G FG V+ G + +A+K + + +F+ E + L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LYG C+E + LV+E++E+ L+ L + +CL + G+A+L E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
++HRD+ A N L+ + K+SDFG+ + +++ ST + + +PE +
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
+ K+DV+SFGV+ E+ S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG 199
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-57
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 8/208 (3%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPN 571
+++ + IG G +G K + +DG I+ K L S + + ++E+ + L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 572 LVKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
+V+ Y I+ L +V EY E LA + G + L+ ++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 630 LHEESR--FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
H S ++HRD+K NV LD N K+ DFGLA++ + T + GT YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSP 183
Query: 688 EYALWGYLTYKADVYSFGVVALEIVSGK 715
E K+D++S G + E+ +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
++ + ++G+G FG VYK Q + + A K++ +KS + +++ EI ++ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
KL + L ++ E+ ++ + E L S Q +C L +LH+
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD- 128
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW- 692
KI+HRD+KA N+L D + K++DFG++ + + + GT +MAPE +
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCE 185
Query: 693 ----GYLTYKADVYSFGVVALEIVSGK 715
YKADV+S G+ +E+ +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-57
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 505 TLKQIRAATSNFDP------MNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREF 557
L+++R+ S DP KIG+G G VY + G +A++ ++ + +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 558 LNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQ 617
+NEI + ++PN+V + GD+L +V EYL SL +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIA 119
Query: 618 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR 677
+C + L FLH +++HRDIK+ N+LL D + K++DFG E++ ST
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 678 VAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
V GT +MAPE K D++S G++A+E++ G+
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-56
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 11/215 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHPNL 572
++D + +GEG +G V +AVK++ K E EI L H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
VK YG EG+ L EY L + + + Q+ + G+ +LH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYAL 691
I HRDIK N+LLD N KISDFGLA + + ++ GT+ Y+APE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 692 WG-YLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725
+ DV+S G+V +++G+ DS
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 7/202 (3%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ K+G+G FG V+ G T +A+K L FL E + L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
+LY + + +V EY+ SL L G + L + IA G+A++
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 634 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWG 693
R VHRD++A N+L+ +L K++DFGLA+L E+ + I + APE AL+G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 694 YLTYKADVYSFGVVALEIVSGK 715
T K+DV+SFG++ E+ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKG 211
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 3e-56
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 43/254 (16%)
Query: 490 VDPNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAV 543
++P L LE+ +N + + IGEG FG V++ + T++AV
Sbjct: 1 LNPKLLSLEY------------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV 48
Query: 544 KLLSSKSRQGNR-EFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF 602
K+L ++ + +F E ++ +PN+VKL G C G + L++EY+ L L
Sbjct: 49 KMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 108
Query: 603 G--------------------GENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRD 642
L+ + + I +A G+A+L E K VHRD
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 165
Query: 643 IKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADV 701
+ N L+ ++ KI+DFGL++ + + A I +M PE + T ++DV
Sbjct: 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 702 YSFGVVALEIVSGK 715
+++GVV EI S
Sbjct: 226 WAYGVVLWEIFSYG 239
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-56
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN---REFLNEIGTISCLQ 568
F + +IG G FG VY + + + ++A+K +S +Q N ++ + E+ + L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HPN ++ GC + LV EY ++ + L + G +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+LH ++HRD+KA N+LL K+ DFG A + + + GT +MAPE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 689 YALW---GYLTYKADVYSFGVVALEIVSGK 715
L G K DV+S G+ +E+ K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 8e-56
Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 492 PNLEGLEFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS 550
PN + E + + T+K +K+G G +G VY+G +AVK L +
Sbjct: 7 PNYDKWEMERTDITMK------------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 54
Query: 551 RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLK 610
+ EFL E + ++HPNLV+L G C ++ E++ +L L E ++ +
Sbjct: 55 MEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQE 111
Query: 611 LNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670
++ V + I+ + +L ++ +HRD+ A N L+ + K++DFGL++L +
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718
I + APE + + K+DV++FGV+ EI + +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-55
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ IG+G FG V G G +AVK + + + + FL E ++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 574 KLYGCCIEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
+L G +E L +V EY+ SL L + L K L + + +L
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
VHRD+ A NVL+ D K+SDFGL K E + + + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALRE 174
Query: 693 GYLTYKADVYSFGVVALEIVSGK 715
+ K+DV+SFG++ EI S
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFG 197
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (477), Expect = 1e-54
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 504 FTLKQIRAATSNFDP---------MNKIGEGGFGPVYKGQLT----DGTIIAVKLL-SSK 549
FT + A F IG G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 550 SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL 609
+ + R+FL+E + HPN++ L G + +M++ E++EN SL L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 610 KLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669
+ GIA G+ +L VHRD+ A N+L++ +L K+SDFGL++ E+
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 670 EKTHISTRVA----GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ + + A I + APE + T +DV+S+G+V E++S
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-54
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 520 NKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLY 576
+IG G F VYKG T+ +A L + ++ + F E + LQHPN+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 577 GCCIE----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
++LV E + + +L L + + V + C I +GL FLH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 633 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
+ I+HRD+K N+ + + KI D GLA L + V GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
Y DVY+FG+ LE+ + +
Sbjct: 187 EKY-DESVDVYAFGMCMLEMATSE 209
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 521 KIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCI 580
IG+G FG V++G+ G +AVK+ SS+ + + EI L+H N++
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 581 EGD----QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE--- 633
+ + QL LV +Y E+ SL L ++ + K+ L A GLA LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 634 --SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIS---TRVAGTIGYMAPE 688
+ I HRD+K+ N+L+ ++ I+D GLA + I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 689 YAL------WGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSNC 726
+AD+Y+ G+V EI + D
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-54
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
+F+ +G+G FG VY + I+A+K+L + E+ S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
PN+++LYG + ++ L+ EY ++ L K + +A L++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 121
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
H + +++HRDIK N+LL KI+DFG + + + GT+ Y+ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
K D++S GV+ E + GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 507 KQIRAATSNFDPMN-KIGEGGFGPVYKGQL---TDGTIIAVKLLSSKSRQGNRE-FLNEI 561
K++ N + ++G G FG V +G +A+K+L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 562 GTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICL 621
+ L +P +V+L G C + + LMLV E L L G ++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 622 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVA 679
++ G+ +L E+ VHRD+ A NVLL KISDFGL+K ++ +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS 713
+ + APE + + ++DV+S+GV E +S
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-53
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 520 NKIGEGGFGPVYKGQLTD---GTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHPNLVK 574
++G G FG V KG +AVK+L +++ E L E + L +P +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 575 LYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES 634
+ G C E + MLV E E L L + ++ ++ G+ +L E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 635 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTR--VAGTIGYMAPEYALW 692
VHRD+ A NVLL KISDFGL+K ++ + + + + APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 693 GYLTYKADVYSFGVVALEIVS 713
+ K+DV+SFGV+ E S
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFS 205
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSRQGNRE-FLNEIGTISC 566
+ +G G FG V + +AVK+L + RE ++E+ +S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 567 L-QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG--------------GENSQLKL 611
L H N+V L G C G +++ EY L + L E+ +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 612 NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEE 670
+ +A+G+AFL + +HRD+ A N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 671 KTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNM 718
+ + +MAPE T+++DV+S+G+ E+ S ++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 31/230 (13%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSKSRQGNRE-FLNEIGTIS- 565
N + +G G FG V +AVK+L K+ RE ++E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 CLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG-------------------GEN 606
H N+V L G C + L++EY L + L E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 665
L + +A+G+ FL + VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ + + + +MAPE G T K+DV+S+G++ EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 4e-51
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
++D ++G G FG V++ G A K + + EI T+S L+HP LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L+ + ++++++YE++ L + + K++ + + +GL +HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 634 SRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
VH D+K N++ + K+ DFGL + +++ T GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
+ Y D++S GV++ ++SG
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 6e-51
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKSRQGN-REFLNEIGTISCLQH 569
+F+ IG G FG VY G L D AVK L+ + G +FL E + H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 570 PNLVKLYGCCIEGD-QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
PN++ L G C+ + ++V Y+++ L + + N L +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMK 144
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEEEKTHISTRVAGTIGYM 685
FL + K VHRD+ A N +LD K++DFGLA+ E + H T + +M
Sbjct: 145 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVSGK 715
A E T K+DV+SFGV+ E+++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-51
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDGT-----IIAVKLLSSKSRQGNR-EFLNEIGTISCL 567
S IG G FG VYKG L + +A+K L + + R +FL E G +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
H N+++L G + +M++ EY+EN +L + + + GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGM 123
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYM 685
+L VHRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVSGK 715
APE + T +DV+SFG+V E+++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYG 210
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 16/217 (7%)
Query: 506 LKQIRAATSNFDPMNKIGEGGFGPVYKGQLTD-----GTIIAVKLLS-SKSRQGNREFLN 559
L+ ++ + F + +G G FG VYKG +A+K L + S + N+E L+
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 560 EIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKI 619
E ++ + +P++ +L G C+ + L+ + + L L + +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNW 116
Query: 620 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRV 678
C+ IA+G+ +L + ++VHRD+ A NVL+ + KI+DFGLAK L EEK + +
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 679 AGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
I +MA E L T+++DV+S+GV E+++
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 6e-50
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQ 568
+ IGEG FG V++G +A+K + + RE FL E T+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HP++VKL G E + + ++ E L L + L+ + ++ LA
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALA 122
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPE 688
+L + + VHRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 689 YALWGYLTYKADVYSFGVVALEIVSGK 715
+ T +DV+ FGV EI+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHG 206
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 8e-50
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSK---SRQGNREFLNEIGTISCL 567
+ + K+G+G FG V +G+ +AVK L + +F+ E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 568 QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
H NL++LYG + + +V E SL L + + + +A G+
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGM 124
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH--ISTRVAGTIGYM 685
+L + + +HRD+ A N+LL KI DFGL + + H + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVS 713
APE ++ +D + FGV E+ +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLTDG---TIIAVKLLS-SKSRQGNREFLNEIGTISCL-Q 568
++ + IGEG FG V K ++ A+K + S+ +R+F E+ + L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFG------------GENSQLKLNWSVR 616
HPN++ L G C L L EY + +L L ++ L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 617 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHIST 676
+ARG+ +L ++ + +HRD+ A N+L+ + KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 677 RVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ +MA E + T +DV+S+GV+ EIVS
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHP 570
+F +GEG F V + L A+K+L + E +S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
VKLY + ++L Y +N L + + + + I L +L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYL 124
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEEEKTHISTRVAGTIGYMAPEY 689
H + I+HRD+K N+LL+ D++ +I+DFG AK+ E K + GT Y++PE
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
+D+++ G + ++V+G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 3e-49
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+D + ++G G FG V++ G + K +++ NEI ++ L HP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L+ + +++L+ E+L L + K++ + GL +HE
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 634 SRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
IVH DIK N++ + KI DFGLA ++ T T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 201
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
+ + D+++ GV+ ++SG
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLS-SKSRQGNREFLNEIGTISC 566
++G+G FG VY+G T +A+K ++ + S + EFLNE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 567 LQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF------GGENSQLKLNWSVRQKIC 620
++V+L G +G +++ E + L L + S ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 621 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEEEKTHISTRVA 679
IA G+A+L+ K VHRD+ A N ++ D KI DFG+ + + E + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 680 GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ +M+PE G T +DV+SFGVV EI +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 3e-45
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSK---SRQGNREFLNEIGTISCLQ-- 568
+F IG GGFG VY + D G + A+K L K +QG LNE +S +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 569 -HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
P +V + D+L + + + L + L + + + + I GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGL 120
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAP 687
+H +V+RD+K N+LLD + +ISD GLA ++K H S GT GYMAP
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 174
Query: 688 EYALWG-YLTYKADVYSFGVVALEIVSGKNNM 718
E G AD +S G + +++ G +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 7e-45
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTI 564
KQ +D + +G G F V + ++A+K ++ K+ +G NEI +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIA 624
++HPN+V L G L L+ + + L + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVL 117
Query: 625 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEEEKTHISTRVAGT 681
+ +LH+ IVHRD+K N+L D D ISDFGL+K+ E+ + + GT
Sbjct: 118 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGT 172
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
GY+APE + D +S GV+A ++ G
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 9e-45
Identities = 41/205 (20%), Positives = 79/205 (38%), Gaps = 12/205 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV 573
+ +G G FG V++ + K + K EI ++ +H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 574 KLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEE 633
L+ ++L++++E++ + + S +LN + L FLH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 634 SRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
I H DI+ N++ + KI +FG A+ + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQ 176
Query: 692 WGYLTYKADVYSFGVVALEIVSGKN 716
++ D++S G + ++SG N
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKSRQGN-REFLNEIGTI 564
+GEG FG V + T +AVK+L S + + + + ++E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 565 SCL-QHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALF------------GGENSQLKL 611
+ +H N++ L G C + L ++ EY +L L N + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 612 NWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671
+ +ARG+ +L + K +HRD+ A NVL+ D KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 672 THISTRVA-GTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ T + +MAPE T+++DV+SFGV+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-44
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 9/204 (4%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPN 571
NF + KIGEG +G VYK + G ++A+K + +++ + EI + L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+VKL ++L LV+E+L + F ++ + + + + +GLAF H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
+++HRD+K N+L++ + K++DFGLA+ + V
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
Y + D++S G + E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-44
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE-FLNEIGTISCLQHP 570
+ ++ IGEG +G V + +A+K +S Q + L EI + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQL----KLNWSVRQKICLGIARG 626
N++ + + YL + L G + +L L+ I RG
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTH-----LMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 627 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGY 684
L ++H ++HRD+K +N+LL+ + KI DFGLA++ + + T T T Y
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 685 MAPEYALWG-YLTYKADVYSFGVVALEIVSGK 715
APE L T D++S G + E++S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 5e-44
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 9/203 (4%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPNL 572
+ + KIGEG +G VYK Q G A+K + + + EI + L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
VKLY +L+LV+E+L+ + + L + L + G+A+ H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
+++HRD+K N+L++R+ KI+DFGLA+ + +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 693 GYLTYKADVYSFGVVALEIVSGK 715
+ D++S G + E+V+G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 514 SNFDPMNKIGEGGFGPVYKG------QLTDGTIIAVKLLSSKSRQG-NREFLNEIGTIS- 565
+G G FG V + + +AVK+L + +R ++E+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 566 CLQHPNLVKLYGCCIE-GDQLMLVYEYLENNSLAHALFGGENSQLK------------LN 612
H N+V L G C + G LM++ E+ + +L+ L N + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 613 WSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672
+A+G+ FL K +HRD+ A N+LL KI DFGLA+ ++
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 673 HI-STRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG 714
++ + +MAPE T ++DV+SFGV+ EI S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 2e-43
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQH 569
+F + +G G FG V+ + +G A+K+L + + +E +S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P +++++G + Q+ ++ +Y+E L + V + + L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH + I++RD+K N+LLD++ + KI+DFG AK + + GT Y+APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
D +SFG++ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNRE---FLNEIGTIS-CLQH 569
+F +G+G FG V+ + A+K L + + + E +S +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
P L ++ + L V EYL L + + K + S I GL F
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQF 118
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
LH + IV+RD+K N+LLD+D + KI+DFG+ K + +T GT Y+APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGK 715
L + D +SFGV+ E++ G+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 4e-43
Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS---------SKSRQGNREFLNEIGTI 564
N++P +G G V + AVK++ + ++ L E+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 565 SCLQ-HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGI 623
+ HPN+++L LV++ ++ L L ++ L+ +KI +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 624 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIG 683
+ LH+ IVHRD+K N+LLD D+N K++DFG + + + V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 684 YMAPEYALWG------YLTYKADVYSFGVVALEIVSGK 715
Y+APE + D++S GV+ +++G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 519 MNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQG-----NREFLNEIGTISCLQHPNL 572
++ +GEG F VYK + I+A+K + R NR L EI + L HPN+
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
+ L + LV++++E + +++ L L S + L +GL +LH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 633 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL- 691
I+HRD+K N+LLD + K++DFGLAK + +V T Y APE
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFG 174
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
D+++ G + E++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 5e-42
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 14/213 (6%)
Query: 512 ATSNFDPMNKIGEGGFGPVYKGQ--LTDGTIIAVKLLSSKSRQGN--REFLNEIG---TI 564
A ++ + +IGEG +G V+K + G +A+K + ++ + + E+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 565 SCLQHPNLVKLYGCCIEGDQLMLVYEYL--ENNSLAHALFGGENSQLKLNWSVRQKICLG 622
+HPN+V+L+ C L E+ + + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTI 682
+ RGL FLH ++VHRD+K N+L+ K++DFGLA++ + T V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 683 GYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
Y APE L D++S G + E+ K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (384), Expect = 5e-42
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 17/210 (8%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS---SKSRQGNREFLNEIGTISCLQHPN 571
++ +G GG V+ + L +AVK+L ++ F E + L HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 572 LVKLYGCCIE----GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGL 627
+V +Y G +V EY++ +L + + ++ + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQAL 124
Query: 628 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEEEKTHISTRVAGTIGYM 685
F H+ I+HRD+K N+++ K+ DFG+A+ D + V GT Y+
Sbjct: 125 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVSGK 715
+PE A + ++DVYS G V E+++G+
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNR------EFLNEIGTISCLQ 568
+D ++G G F V K + + G A K + + + +R + E+ + +Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 569 HPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLA 628
HPN++ L+ ++L+ E + LF + L + I G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 629 FLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEEEKTHISTRVAGTIGY 684
+LH +I H D+K N++L P KI DFGLA + + GT +
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 685 MAPEYALWGYLTYKADVYSFGVVALEIVSGKN 716
+APE + L +AD++S GV+ ++SG +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (370), Expect = 5e-40
Identities = 46/224 (20%), Positives = 86/224 (38%), Gaps = 22/224 (9%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNL 572
++ +IGEG FG +++G L + +A+K +S + +E T L +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63
Query: 573 VKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE 632
+Y EG +LV + L + G K + + + +HE
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHE 119
Query: 633 ESRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEEEKTHI------STRVAGT 681
+ +V+RDIK N L+ R + + DFG+ K + T ++GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 682 IGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725
YM+ L + + D+ + G V + + G + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGN--REFLNEIGTISCLQHP 570
S ++ + KIG+G FG V+K + G +A+K + ++ + L EI + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 571 NLVKLYGCCIEGD--------QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
N+V L C + LV+++ E++ N +K S +++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEEEKTHISTRVA 679
+ GL ++H KI+HRD+KA NVL+ RD K++DFGLA+ L + + + T
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 680 GTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGK 715
T+ Y PE L D++ G + E+ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 1e-39
Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 20/216 (9%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYG-C 578
KIG G FG +Y G + G +A+KL K++ + E +Q + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKI 638
EGD ++V E L + F K + + + + ++H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 639 VHRDIKATNVL---LDRDLNPKISDFGLAKLDEEEKTHI------STRVAGTIGYMAPEY 689
+HRD+K N L + I DFGLAK + +TH + + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 690 ALWGYLTYKADVYSFGVVALEIVSGKNNMSYVPDSN 725
L + + D+ S G V + G + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 510 RAATSNFDPMNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKSRQGNREFLNEIGTISCLQ 568
R ++ IG G FG VY+ +L D G ++A+K + R NRE + + L
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLD 71
Query: 569 HPNLVKLYGCCIEGDQ------LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLG 622
H N+V+L + L LV +Y+ A Q L +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQ 130
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEEKTHISTRVAGT 681
+ R LA++H I HRDIK N+LLD D K+ DFG AK + ++S +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 185
Query: 682 IGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGK 715
Y APE T DV+S G V E++ G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 20/206 (9%)
Query: 521 KIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE------FLNEIGTISCLQ--HPN 571
+G GGFG VY G ++D +A+K + E E+ + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+++L D +L+ E E + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 632 EESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
++HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 691 L-WGYLTYKADVYSFGVVALEIVSGK 715
Y A V+S G++ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHP 570
+FD + +G+G FG V + G A+K+L + ++ + E + +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
L L D+L V EY L L + + + I L +L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYL 121
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
H +V+RDIK N++LD+D + KI+DFGL K + + T GT Y+APE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 691 LWGYLTYKADVYSFGVVALEIVSGK 715
D + GVV E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHPN 571
++ + KIGEG +G V+K + I+A+K + L EI + L+H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 572 LVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLH 631
+V+L+ +L LV+E+ + + + + + + + +GL F H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCH 118
Query: 632 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYAL 691
++HRD+K N+L++R+ K+++FGLA+ S V
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 692 WGYLTYKADVYSFGVVALEIVSGK 715
+ D++S G + E+ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAG 199
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 11/206 (5%)
Query: 514 SNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLL--SSKSRQGNREFLNEIGTISCLQHP 570
+ + + +G G +G V G +A+K L +S + E+ + ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 571 NLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
N++ L + L ++ G KL Q + + +GL ++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 631 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYA 690
H I+HRD+K N+ ++ D KI DFGLA+ + E T T Y APE
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY----VVTRWYRAPEVI 190
Query: 691 L-WGYLTYKADVYSFGVVALEIVSGK 715
L W T D++S G + E+++GK
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 43/203 (21%), Positives = 73/203 (35%), Gaps = 21/203 (10%)
Query: 522 IGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTIS-CLQHPNLVKLYGCC 579
+G G G V + A+K+L + E+ Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 74
Query: 580 ----IEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR 635
L++V E L+ L + + +I I + +LH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 636 FKIVHRDIKATNVLLDRDLNP---KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALW 692
I HRD+K N+L K++DFG AK + + T Y+APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 693 GYLTYKADVYSFGVVALEIVSGK 715
D++S GV+ ++ G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 2e-36
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 15/222 (6%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNRE 556
+F T Q A FD + +G G FG V + G A+K+L + ++
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 557 ---FLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNW 613
LNE + + P LVKL + L +V EY+ + L + +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSE 140
Query: 614 SVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673
+ I +LH +++RD+K N+L+D+ +++DFG AK +
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
Query: 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
+ GT +APE L D ++ GV+ E+ +G
Sbjct: 198 LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-34
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 18/229 (7%)
Query: 498 EFQASSFTLKQIRAATSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLS----SK 549
E + ++ T + NF+ + +G G +G V+ + G + A+K+L +
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 550 SRQGNREFLNEIGTISCLQH-PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQ 608
+ E + ++ P LV L+ +L L+ +Y+ L L + +
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQR 123
Query: 609 LKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668
+ Q I L LH+ I++RDIK N+LLD + + ++DFGL+K
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 669 EEKTHISTRVAGTIGYMAPEYALWGYLTY--KADVYSFGVVALEIVSGK 715
++T + GTI YMAP+ G + D +S GV+ E+++G
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-33
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS--SKSRQGNREFLNEIGTISCLQHPN 571
+ + IG G G V +A+K LS +++ + E+ + C+ H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 572 LVKLYGCCI------EGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIAR 625
++ L E + LV E ++ N + Q++L+ + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLC 130
Query: 626 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYM 685
G+ LH I+HRD+K +N+++ D KI DFGLA+ T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 185
Query: 686 APEYALWGYLTYKADVYSFGVVALEIVSGK 715
APE L D++S G + E+V K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 11/207 (5%)
Query: 513 TSNFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLS--SKSRQGNREFLNEIGTISCLQH 569
+ ++ +G G +G V G +AVK LS +S + E+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
N++ L L + L A KL Q + I RGL +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
+H I+HRD+K +N+ ++ D KI DFGLA+ ++E T T Y APE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEI 189
Query: 690 AL-WGYLTYKADVYSFGVVALEIVSGK 715
L W + D++S G + E+++G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 2e-32
Identities = 41/207 (19%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 515 NFDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNL 572
++ + K+G G + V++ +T+ + VK+L ++ + EI + L+ PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 573 VKLYGCCIE--GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFL 630
+ L + LV+E++ N L + I + L +
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC 145
Query: 631 HEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEY 689
H I+HRD+K NV++D + ++ D+GLA+ + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 690 AL-WGYLTYKADVYSFGVVALEIVSGK 715
+ + Y D++S G + ++ K
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 7e-26
Identities = 40/215 (18%), Positives = 80/215 (37%), Gaps = 18/215 (8%)
Query: 516 FDPMNKIGEGGFGPVYKGQ-LTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVK 574
+ + K+G G F V+ + + + T +A+K++ + +EI + + + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 575 LYGCCIEGD-QLMLVYEYLENNSLAHALFGGENSQLKL-----------NWSVRQKICLG 622
+L+ + + N + + + L ++I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 623 IARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEEEKTHISTR-VAG 680
+ GL ++H R I+H DIK NVL++ D + +A L
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 681 TIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK 715
T Y +PE L AD++S + E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 2e-22
Identities = 29/156 (18%), Positives = 49/156 (31%), Gaps = 21/156 (13%)
Query: 520 NKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR----------QGNREFLNEIGTISCLQH 569
+GEG V+ VK G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 570 PNLVKLYGCCIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAF 629
L KL G + VY + N L + E ++++ ++ I +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118
Query: 630 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665
+ IVH D+ NVL+ + I DF +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 5e-18
Identities = 49/301 (16%), Positives = 87/301 (28%), Gaps = 16/301 (5%)
Query: 18 YLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFS 77
+L V + L +P++ + + N+++ N+ +L L L N+ S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP-DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 78 GTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQ 137
P LV LE L LS N+L L+ L S + +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 138 LNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIA 197
+ A + +L + N T LT + L I
Sbjct: 129 VELGTNPLKSS----GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKIT 184
Query: 198 GEIPEYIWGIKNLRFLDLSFNQLTGELPD---------VAVPADLKFTQILMFIRGVYEH 248
+ G+ NL L LSFN ++ + K ++ +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
Query: 249 QSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFGVFPCT-NNFTCHRYWHSLH 307
Q + L NN + + S N + + F C ++
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
Query: 308 I 308
+
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.4 bits (158), Expect = 5e-12
Identities = 32/226 (14%), Positives = 78/226 (34%), Gaps = 12/226 (5%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQ-LKYISVFANRLSGNIPSHLG 61
+ P L LE + + N L + ++Q L+ ++ ++ + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
+ + L + SG + L +R++ + +P L +LT+ ++
Sbjct: 125 QMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDG 180
Query: 122 NNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLR 181
N ++ L +L + + + S++ L +L +++ + +
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL-A 239
Query: 182 NMTGLTRIILRNCNIAG------EIPEYIWGIKNLRFLDLSFNQLT 221
+ + + L N NI+ P Y + + L N +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 1e-15
Identities = 41/211 (19%), Positives = 73/211 (34%), Gaps = 37/211 (17%)
Query: 15 NLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEEN 74
L LE++ N + P L +S+ N+L L ++T+LT LDL N
Sbjct: 195 KLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 75 QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQS 134
Q S P L L L L+L +N++ P+ + + N I +
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI----SPISN 305
Query: 135 WTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNC 194
L L + + + P + ++T L R+ N
Sbjct: 306 LKNLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFANN 339
Query: 195 NIAGEIPEYIWGIKNLRFLDLSFNQLTGELP 225
++ + + N+ +L NQ++ P
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 5e-12
Identities = 26/112 (23%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 11 PQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLD 70
+ L L ++ N I L Y++++ N +S P + ++T L L
Sbjct: 279 SPLAGLTALTNLELNENQ-LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 71 LEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
N+ S L NL N+ L N++ P L L +T +ND
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 4e-11
Identities = 43/205 (20%), Positives = 76/205 (37%), Gaps = 28/205 (13%)
Query: 59 HLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFR 118
L +T+L L NQ S P + NL+ L L+ N+L L L NLTD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 119 INDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178
+ +N + AP + T+L L++ + + P + + +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDIS 301
Query: 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQI 238
+ N+ LT + L NI+ P + + L+ L + N+++ V + T I
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD------VSSLANLTNI 353
Query: 239 LMFIRGVYEHQSLDLSYNNFTWQSP 263
L +N + +P
Sbjct: 354 ----------NWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 42/266 (15%), Positives = 81/266 (30%), Gaps = 34/266 (12%)
Query: 58 SHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDF 117
+ + +LT ++ NQ + P L NL L + +++N++ P+ +
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 118 RINDNNFNGSAPDFIQSW---------TQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
N + + ++ L S + ++ L L L
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 169 DLQGPNQTFPMLR----NMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGEL 224
+ + +T L +I N I+ P I NL L L+ NQL
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233
Query: 225 PDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFRSSSV 284
+ + + LDL+ N + +P + L L + S++
Sbjct: 234 --------------IGTLASLTNLTDLDLANNQISNLAPLSGLTKLT-ELKLGANQISNI 278
Query: 285 ENNFGVFPCTNNFTCHRYWHSLHINC 310
G+ TN +
Sbjct: 279 SPLAGLTALTNLELNENQLEDISPIS 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 8e-14
Identities = 61/268 (22%), Positives = 88/268 (32%), Gaps = 19/268 (7%)
Query: 3 FSLPGTLPPQIVNLPYLETVDFA--YNYLHGSIPREWASMQLKYISVFANRLSGNIPSHL 60
P +P + NLPYL + N + P QL Y+ + +SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
I +L LD N SGT+P + +L NL + NR+ G +P L
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180
N + + + DK Q +
Sbjct: 182 SRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240
L + LRN I G +P+ + +K L L++SFN L GE+P
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF------- 293
Query: 241 FIRGVYEHQSLDLSYNNFTWQSPEQPAC 268
+ N SP PAC
Sbjct: 294 --------DVSAYANNKCLCGSP-LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 9e-09
Identities = 59/275 (21%), Positives = 95/275 (34%), Gaps = 48/275 (17%)
Query: 41 QLKYISVFANRLSGN--IPSHLGNITSLTYLDLEEN-QFSGTIPRELGNLVNLETLRLSS 97
++ + + L IPS L N+ L +L + G IP + L L L ++
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSIS 157
+ G +P L ++K L + N +G+ P I S L + G+ + G IP S
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 158 ALDKL--------NQLRISDLQGPNQTFPMLRNM---------------TGLTRIILRNC 194
+ KL N+L ++ T+ I
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 195 NIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254
N + KNL LDL N++ G LP + + SL++S
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ--------------GLTQLKFLHSLNVS 276
Query: 255 YNNFTWQSPEQPACREKPNLNLNLFRSSSVENNFG 289
+NN + P+ NL F S+ NN
Sbjct: 277 FNNLCGEIPQ--------GGNLQRFDVSAYANNKC 303
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 6e-11
Identities = 36/214 (16%), Positives = 60/214 (28%), Gaps = 29/214 (13%)
Query: 10 PPQIVNLPYLETVDFAYNYLHGSI-PREWASMQLKYISVFANRLSGNIPSHLGNITSLTY 68
P L L T+ L L+Y+ + N L ++ +LT+
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 69 LDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSA 128
L L N+ S R L +L+ L L NR+ P L L + NN +
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 129 PDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTR 188
+ + L L + N L +
Sbjct: 218 TEALAPLRALQYLRLND-----------------NPWVCD--------CRARPLWAWLQK 252
Query: 189 IILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
+ + +P+ + L+ N L G
Sbjct: 253 FRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 7e-10
Identities = 49/281 (17%), Positives = 94/281 (33%), Gaps = 23/281 (8%)
Query: 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHL 60
L ++P +P + N + + + L + + +N L+ +
Sbjct: 23 LQAVPVGIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 61 GNITSLTYLDLEENQFSGTI-PRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRI 119
+ L LDL +N ++ P L L TL L L P L L +
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 120 NDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPM 179
DN D + L L + G+ + + L L++L + + +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239
R++ L + L N++ E + ++ L++L L+ N + + A L
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL------ 250
Query: 240 MFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLNLFR 280
Q S + P++ A R+ L N +
Sbjct: 251 ---------QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 31/217 (14%), Positives = 66/217 (30%), Gaps = 12/217 (5%)
Query: 21 TVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG-T 79
T+D LH + S + + + + H + ++DL + T
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVST 62
Query: 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT--DFRINDNNFNGSAPDFIQSWTQ 137
+ L L+ L L RL + L K NL + + + S ++
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 138 LNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRI-------I 190
L+ L + ++ + +L G + T + R +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 191 LRNCNIAGEIPEYIWGIKNLRFLDLSF-NQLTGELPD 226
+ + + + + + L+ L LS + E
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 2e-08
Identities = 29/186 (15%), Positives = 50/186 (26%), Gaps = 24/186 (12%)
Query: 56 IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLT 115
+P L T L L EN L L L L L + +
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGL--------------------EGPIPPS 155
D N + + T L+ + + L +PP
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 156 ISALDKLNQLRISDLQGPNQTFP-MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLD 214
+ + + +L + L ++L+ ++ IP+ +G L F
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 215 LSFNQL 220
L N
Sbjct: 202 LHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 18/77 (23%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 26 YNYLHGSIPREWASMQLKYISVFA-NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL 84
N L P A N L+ L + +L L L+EN TIP+
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 85 GNLVNLETLRLSSNRLI 101
L L N +
Sbjct: 192 FGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 32/217 (14%), Positives = 58/217 (26%), Gaps = 20/217 (9%)
Query: 61 GNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120
+ S ++ ++ + +P +L + L LS N L L+ LT ++
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180
D L + ++ AL L+ P L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILM 240
+ L + P + L L L+ N LT +
Sbjct: 124 GELQELYLKGNELKTL---PPGLLTPTPKLEKLSLANNNLTELPAGL------------- 167
Query: 241 FIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLNLN 277
+ G+ +L L N+ P L+
Sbjct: 168 -LNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLH 203
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 21/89 (23%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 37 WASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96
+L+ + + N L P L L L L N + L L NL+TL L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 97 SNRLIGNLPMELVKLKNLTDFRINDNNFN 125
N L +P L ++ N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLT 67
T+ + L + +D ++N L P A L+ + N L N+ L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA--NLPRLQ 68
Query: 68 YLDLEENQFSGT-IPRELGNLVNLETLRLSSNRL--IGNLPMELVKL 111
L L N+ + + L + L L L N L + L ++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 6/103 (5%)
Query: 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGS 127
L L T+ L L+ + L LS NRL P L L+ L + +DN
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 128 APDFIQSWTQLNRLEIQGSGLEG-PIPPSISALDKLNQLRISD 169
Q L + + L+ + + +L L +
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 99
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 8/120 (6%)
Query: 52 LSGN---IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMEL 108
L+ + HL + +T+LDL N+ P L L LE L+ S N L +
Sbjct: 5 LAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVAN 63
Query: 109 VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQG---SGLEGPIPPSISALDKLNQL 165
+ N +A + S +L L +QG EG L ++ +
Sbjct: 64 LPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 23/173 (13%), Positives = 50/173 (28%), Gaps = 12/173 (6%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV 109
+ S + S+ + + + L N+ L L+ N+L
Sbjct: 32 KKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI-----K 84
Query: 110 KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISD 169
L NL + + N + + I + + ++
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144
Query: 170 LQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
L + + L + I+ +P + G+ L+ L LS N ++
Sbjct: 145 KITDITVLSRLTKL---DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 15/41 (36%), Positives = 18/41 (43%), Gaps = 2/41 (4%)
Query: 57 PSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97
L +T L L L +N S R L L NL+ L L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 21/160 (13%), Positives = 40/160 (25%), Gaps = 18/160 (11%)
Query: 155 SISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNI----AGEIPEYIWGIKNL 210
I +LD + +SD + P+L+ + L +C + +I + L
Sbjct: 3 DIQSLD-IQCEELSD-ARWAELLPLLQQ---CQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 211 RFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACRE 270
L+L N+L + + + Q L L T +
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKI---------QKLSLQNCCLTGAGCGVLSSTL 108
Query: 271 KPNLNLNLFRSSSVENNFGVFPCTNNFTCHRYWHSLHINC 310
+ L S +
Sbjct: 109 RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 148
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 8e-06
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 55 NIPSHLGNITSLTYLDLEENQFSGT----IPRELGNLVNLETLRLSSNRLIGNLPMELVK 110
+ L L L + S + + L +L L LS+N L ++LV+
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 111 -----LKNLTDFRINDNNFNGSAPDFIQSWTQLN 139
L + D ++ D +Q+ +
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 8e-06
Identities = 15/85 (17%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 65 SLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRL----IGNLPMELVKLKNLTDFRI 119
+ LD++ + S EL L + +RL L ++ L L + +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 120 NDNNFNGSAPDFIQSWTQLNRLEIQ 144
N + Q +IQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 16/82 (19%), Positives = 26/82 (31%), Gaps = 9/82 (10%)
Query: 40 MQLKYISVFANRLSGN----IPSHLGNITSLTYLDLEENQFSGTIPRELG-----NLVNL 90
L+ + + +S + + + L SL LDL N +L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 91 ETLRLSSNRLIGNLPMELVKLK 112
E L L + L L+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 11/91 (12%)
Query: 19 LETVDFAYNYLHGSIPREWASM--QLKYISVFANRLSG----NIPSHLGNITSLTYLDLE 72
++++D L + E + Q + + + L+ +I S L +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 73 ENQFSGTIPRELG-----NLVNLETLRLSSN 98
N+ + ++ L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 19/102 (18%), Positives = 40/102 (39%), Gaps = 15/102 (14%)
Query: 179 MLRNMTGLTRIILRNCNI----AGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLK 234
+ + + L + L +C++ + + +LR LDLS N L V + +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 235 FTQILMFIRGVYEHQSLDLSYNNFTWQSPE--QPACREKPNL 274
+L + L L ++ + + Q ++KP+L
Sbjct: 424 PGCLL---------EQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 13/78 (16%), Positives = 27/78 (34%), Gaps = 5/78 (6%)
Query: 39 SMQLKYISVFANRLSGNIPSHL-GNITSLTYLDLEENQFSG----TIPRELGNLVNLETL 93
S+ ++ + + LS + L + + L++ + I L L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 94 RLSSNRLIGNLPMELVKL 111
L SN L +++
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)
Query: 89 NLETLRLSSNRL----IGNLPMELVKLKNLTDFRINDNNFNGSAPDFI-----QSWTQLN 139
L L L+ + +L L+ +L + +++N + + Q L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 140 RLEIQGSGLEGPIPPSISALDKLN-QLRI 167
+L + + + AL+K LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 7e-06
Identities = 26/114 (22%), Positives = 37/114 (32%), Gaps = 9/114 (7%)
Query: 26 YNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELG 85
+L S +L + N S I S SL L++ N+ +P
Sbjct: 246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 304
Query: 86 NLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN 139
LE L S N L +P +NL + N PD +S L
Sbjct: 305 ---RLERLIASFNHL-AEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 7e-06
Identities = 16/57 (28%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 40 MQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS 96
+L + N++S P L ++ +L + L+ NQ S P L N NL + L+
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 27/190 (14%), Positives = 56/190 (29%), Gaps = 20/190 (10%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELV 109
+ ++ + ++ +T L + TI + L NL L L N++ P++ +
Sbjct: 29 SNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNL 84
Query: 110 KLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL---- 165
+ N + T ++ L
Sbjct: 85 TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI 144
Query: 166 ----------RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDL 215
+S L N++ LT + + I+ P + + NL + L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202
Query: 216 SFNQLTGELP 225
NQ++ P
Sbjct: 203 KNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 57 PSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTD 116
+ L N++ LT L ++N+ S P L +L NL + L +N++ P L NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 117 FRIND 121
+ +
Sbjct: 222 VTLTN 226
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 27/169 (15%), Positives = 48/169 (28%), Gaps = 26/169 (15%)
Query: 51 RLSGNI---PSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPME 107
+L+ + + N LDL + I L + + S N +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 60
Query: 108 LVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRI 167
L+ L +N+N Q+ L L + + L + LD L L
Sbjct: 61 --LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASL-- 111
Query: 168 SDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLS 216
+ T+ + N I+ + +R LD
Sbjct: 112 -----KSLTYLCILRN--------PVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 35/205 (17%), Positives = 64/205 (31%), Gaps = 22/205 (10%)
Query: 65 SLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKL-KNLTDFRINDNN 123
T +D IPR++ + L L+ N L L +L + N
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNM 183
G P+ + + + L++ + ++ L +L L + D Q ++
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 184 TGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR 243
LT + L + W + LR L+ P+ ++ QI
Sbjct: 126 NSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARC-----GAPSKVRDVQIK---- 175
Query: 244 GVYEHQSLDLSYNNFTWQSPEQPAC 268
DL ++ F S C
Sbjct: 176 --------DLPHSEFKCSSENSEGC 192
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 8e-04
Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 8/173 (4%)
Query: 50 NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPREL-GNLVNLETLRLSSNRLIGNLPMEL 108
L IP + T L L +N+ L G L +L L L N+L G P
Sbjct: 18 RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74
Query: 109 VKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRIS 168
++ + ++ +N + QL L + + + +P S L+ L L ++
Sbjct: 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 169 DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221
N + L + L P +++++ DL ++
Sbjct: 135 S-NPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 12/97 (12%)
Query: 37 WASMQLKYISVFANRLSGNIPSHLGNI------TSLTYLDLEENQFSGTIPREL-----G 85
+ L+ + + LS + + + L L L+ N+ R L
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 86 NLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122
+ +L L L+ NR + +++ + R
Sbjct: 300 KMPDLLFLELNGNR-FSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 9/63 (14%), Positives = 20/63 (31%), Gaps = 5/63 (7%)
Query: 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSG----TIPRELGNLVNLETLRLSS 97
LK ++ ++ + L S+ + L N + + + +LE S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 98 NRL 100
Sbjct: 69 IFT 71
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 9/79 (11%), Positives = 17/79 (21%)
Query: 26 YNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELG 85
+ + N L + LD+ + L
Sbjct: 163 NGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222
Query: 86 NLVNLETLRLSSNRLIGNL 104
NL L + + + L
Sbjct: 223 NLKKLRARSTYNLKKLPTL 241
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 23/177 (12%), Positives = 51/177 (28%), Gaps = 22/177 (12%)
Query: 62 NITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIND 121
+ L + + T+ + +L + TL+ I ++ + L NLT ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG-IKSID-GVEYLNNLTQINFSN 71
Query: 122 NNFNGSA----------------PDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165
N + + I + N
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTG 222
R+ L +T L ++ + + P + + L LD+S N+++
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.4 bits (85), Expect = 0.003
Identities = 27/164 (16%), Positives = 48/164 (29%), Gaps = 14/164 (8%)
Query: 64 TSLTYLDLEENQFSGTIPR------ELGNLVNLETLRLSSNRL--IGNLPMELVKLKNLT 115
S+ + E+ + G IP L L + L LS+N + I +L + L+ L+
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLS-GMENLRILS 76
Query: 116 DFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALD-KLNQLRISDLQGPN 174
R S ++ L N++
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 175 QTFPMLRNM----TGLTRIILRNCNIAGEIPEYIWGIKNLRFLD 214
L ++ L N + E + + NL+ LD
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 21/157 (13%), Positives = 39/157 (24%), Gaps = 26/157 (16%)
Query: 70 DLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAP 129
+L+ Q + + + L L +LV ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLR 58
Query: 130 DFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRI 189
++ +L L L+ R+ L + N L +
Sbjct: 59 IIEENIPELLSLN-------------------LSNNRLYRLDDMSSIVQKAPN---LKIL 96
Query: 190 ILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226
L + E L L L N L+ D
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 732 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.2 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.77 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.06 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.23 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=373.35 Aligned_cols=203 Identities=30% Similarity=0.439 Sum_probs=176.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999986 79999999987543 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.+++. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999984 3457899999999999999999999996 999999999999999999999999999876443
Q ss_pred Cc-eeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 671 KT-HISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 671 ~~-~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
.. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 22 23345689999999999988765 678999999999999999999997533
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=372.96 Aligned_cols=198 Identities=28% Similarity=0.484 Sum_probs=179.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999975 79999999988665556778999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998743 35899999999999999999999996 99999999999999999999999999987654332
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 23456799999999999999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=367.16 Aligned_cols=198 Identities=28% Similarity=0.459 Sum_probs=177.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 357999999999999999999986 7899999998643 233457789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|....
T Consensus 85 mEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999843 346899999999999999999999996 9999999999999999999999999997654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 322 2346799999999999999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=371.48 Aligned_cols=208 Identities=27% Similarity=0.449 Sum_probs=169.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEe--CCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIE--GDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 587 (732)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999976 79999999987542 3345678999999999999999999999875 456899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCC--CceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESR--FKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
||||+++|+|.+++.........+++..++.++.||+.||+|||+++. .+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986544455679999999999999999999998641 249999999999999999999999999998
Q ss_pred eCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
....... ......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 7654322 233467999999999999999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=368.59 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=175.7
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++.+.||+|+||.||+|+++ +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 7999999998643 2334577999999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999884 3456899999999999999999999996 99999999999999999999999999987654
Q ss_pred cC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 32 2233456799999999999999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=369.50 Aligned_cols=201 Identities=28% Similarity=0.480 Sum_probs=177.6
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
+.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999999999999986 78999999998766666788999999999999999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999998743 2346899999999999999999999996 99999999999999999999999999976533221
Q ss_pred eeeecccCccccccchhcc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYAL-----WGYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 223467999999999984 456889999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=376.78 Aligned_cols=200 Identities=24% Similarity=0.450 Sum_probs=176.5
Q ss_pred HhCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
..++|++++.||+|+||+||+|++. +|+.||+|+++... ....+++.+|++++++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 79999999987643 344567899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++.. ...+++..++.++.||++||+|||+++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999853 346899999999999999999999741 399999999999999999999999999975433
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. .....+||+.|+|||++.+.+++.++||||+||++|||++|+.||..
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 22346899999999999999999999999999999999999999964
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=361.63 Aligned_cols=200 Identities=30% Similarity=0.521 Sum_probs=166.4
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999989999999987543 345789999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+|+|.+++.. ....+++..+..++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999998854 3346889999999999999999999986 999999999999999999999999999876554444
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSG-KNNMSY 720 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG-~~P~~~ 720 (732)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 44456789999999999999999999999999999999995 555543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-43 Score=367.16 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=180.0
Q ss_pred HHhCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
...++|++.+.||+|+||.||+|+++ +|+.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888999999999999999986 68999999987543 34678999999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999998643 2356899999999999999999999986 99999999999999999999999999987665
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
..........|++.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 55444445568899999999999999999999999999999999877764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-42 Score=369.27 Aligned_cols=200 Identities=25% Similarity=0.432 Sum_probs=179.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 7999999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC--CCCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DfGla~~~~~ 669 (732)
|++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999998843 2346899999999999999999999996 999999999999964 57899999999987655
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 333 2345799999999999999999999999999999999999999964
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=361.23 Aligned_cols=200 Identities=35% Similarity=0.536 Sum_probs=175.2
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|++++++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 45788899999999999999999988999999987543 345789999999999999999999998754 5678999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+++... ....+++..+.+|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999987432 2345899999999999999999999986 99999999999999999999999999998765554
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 44455679999999999999999999999999999999999665543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-42 Score=368.27 Aligned_cols=200 Identities=25% Similarity=0.404 Sum_probs=179.6
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 7999999998876655667889999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc--CCCCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DfGla~~~~~ 669 (732)
|++|+|.+.+.. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999987732 3446899999999999999999999986 99999999999998 568899999999987765
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 332 2345799999999999999999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=367.54 Aligned_cols=200 Identities=28% Similarity=0.377 Sum_probs=179.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++++.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|++++++++||||+++++++.+++.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999985 7999999998753 233457789999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||||++|+|.+++. ....+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999884 3456899999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 3322 23456799999999999999999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=359.23 Aligned_cols=200 Identities=34% Similarity=0.556 Sum_probs=167.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|+.+ ..||||+++.. .....+.|.+|++++++++|||||++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467888999999999999999865 35999998754 3445678999999999999999999999875 456899999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+++|+|.++++.. ...+++..+..++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999543 346899999999999999999999986 999999999999999999999999999765433
Q ss_pred Cc-eeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 671 KT-HISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 671 ~~-~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 22 23345679999999999864 35789999999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-43 Score=365.32 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=161.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.+.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999986 78999999987543 2334668899999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc---CCCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DfGla~~~ 667 (732)
||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999943 456899999999999999999999996 99999999999994 5788999999999865
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 4422 22346799999999999999999999999999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-42 Score=363.46 Aligned_cols=197 Identities=26% Similarity=0.442 Sum_probs=177.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
.++|++.+.||+|+||.||+|+++ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 357999999999999999999985 7999999998643 233457889999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999884 3446788899999999999999999986 9999999999999999999999999998765
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ...+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 422 346799999999999999999999999999999999999999964
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=351.99 Aligned_cols=201 Identities=26% Similarity=0.484 Sum_probs=180.5
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecC
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLE 593 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 593 (732)
++|++.++||+|+||.||+|++++++.||||+++.... ..++|.+|++++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999999899999999876433 45789999999999999999999999999999999999999
Q ss_pred CCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce
Q 040398 594 NNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH 673 (732)
Q Consensus 594 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~ 673 (732)
+|+|.+++.. ....+++..+.+++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999998743 3456889999999999999999999986 999999999999999999999999999876554444
Q ss_pred eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 674 ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 674 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 4445679999999999999999999999999999999998 89999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=352.59 Aligned_cols=195 Identities=31% Similarity=0.451 Sum_probs=168.0
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe----CCEEEEEE
Q 040398 517 DPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE----GDQLMLVY 589 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 589 (732)
+..++||+|+||+||+|++. +++.||+|++... .....+.+.+|++++++++|||||++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999986 7899999998654 33445679999999999999999999999875 35689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEc-CCCCeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DfGla~~~~ 668 (732)
||+++|+|.+++.. ...+++..++.++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999843 346899999999999999999999874 3499999999999996 57899999999998654
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... ....+||+.|||||++.+ +++.++|||||||++|||++|+.||..
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 432 234679999999998865 689999999999999999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=361.34 Aligned_cols=194 Identities=29% Similarity=0.481 Sum_probs=171.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
.|+.++.||+|+||.||+|++. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4889999999999999999875 789999999875432 334678999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
||++|+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987663 2346899999999999999999999996 999999999999999999999999999765432
Q ss_pred CceeeecccCccccccchhccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALW---GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 23579999999999864 4689999999999999999999999964
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=361.37 Aligned_cols=202 Identities=31% Similarity=0.512 Sum_probs=163.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CC---eEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DG---TIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|++.+.||+|+||.||+|+++ ++ ..||||++... .....++|.+|++++++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677889999999999999875 33 36899988654 344557899999999999999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
||||++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998853 2346899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCce----eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 669 EEKTH----ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 669 ~~~~~----~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 43221 1122457899999999999999999999999999999998 89999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=355.12 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=176.8
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc------ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS------RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.+.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999985 79999999986432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC----CeEEEee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF 661 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~Df 661 (732)
++|||||++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999843 346899999999999999999999996 99999999999998876 4999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+|........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 99987654322 2345799999999999999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=351.88 Aligned_cols=201 Identities=29% Similarity=0.470 Sum_probs=172.5
Q ss_pred CCCcccc-eecccCceEEEEEEEc---CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMN-KIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|.+.+ +||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999764 45689999987543 3446789999999999999999999999865 568899
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998743 3346899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 669 EEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 669 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 44332 2223568999999999999999999999999999999998 99999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-41 Score=361.69 Aligned_cols=196 Identities=25% Similarity=0.353 Sum_probs=176.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 589 (732)
++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 7999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEE 669 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~ 669 (732)
||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999998843 346899999999999999999999996 99999999999999999999999999987654
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 22 245799999999999999999999999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=349.48 Aligned_cols=194 Identities=31% Similarity=0.453 Sum_probs=165.3
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEecCC
Q 040398 520 NKIGEGGFGPVYKGQLT---DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYLEN 594 (732)
Q Consensus 520 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 594 (732)
++||+|+||.||+|.++ +++.||||+++... ....++|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 35789999986542 3345689999999999999999999999865 457899999999
Q ss_pred CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCce-
Q 040398 595 NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKTH- 673 (732)
Q Consensus 595 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~~- 673 (732)
|+|.+++.. ...+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999853 346899999999999999999999986 999999999999999999999999999876544332
Q ss_pred -eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 040398 674 -ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYV 721 (732)
Q Consensus 674 -~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~ 721 (732)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 2234568999999999999999999999999999999998 89999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-41 Score=359.94 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHH---HHHHHHhcCCCCceeeeeeeEEeCCEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFL---NEIGTISCLQHPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~ 585 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ......+. +|+++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999986 79999999986431 22223333 457778888999999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecce
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 665 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~ 665 (732)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999843 456789999999999999999999996 9999999999999999999999999998
Q ss_pred eCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 666 LDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 666 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 665432 234579999999999874 5689999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=356.47 Aligned_cols=207 Identities=30% Similarity=0.465 Sum_probs=174.1
Q ss_pred hCCCcccceecccCceEEEEEEEcC------CeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTD------GTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++.. ...||+|++... .......+.+|++++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678899999999999999998642 236999988654 334557889999999998 89999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC-------------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCC
Q 040398 585 LMLVYEYLENNSLAHALFGGEN-------------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKA 645 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp 645 (732)
.++|||||++|+|.++++.... ....+++..++.++.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965432 2245899999999999999999999986 99999999
Q ss_pred CCeEEcCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 646 TNVLLDRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 646 ~NILl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865443322 2334568999999999999999999999999999999998 899997543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=351.80 Aligned_cols=199 Identities=30% Similarity=0.446 Sum_probs=174.8
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc---cccchHHHHHHHHHHh-cCCCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK---SRQGNREFLNEIGTIS-CLQHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|++.+.||+|+||+||+|+++ +|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999986 7999999998753 2334456677777665 68999999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCC
Q 040398 589 YEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 668 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~ 668 (732)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999994 3446889999999999999999999996 9999999999999999999999999997554
Q ss_pred ccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 3322 23346799999999999999999999999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=349.41 Aligned_cols=200 Identities=32% Similarity=0.496 Sum_probs=167.7
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEec
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEYL 592 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 592 (732)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3578899999999999999999988888999998754 334578999999999999999999999985 45678999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.+.+... ....++|.++..++.||++||+|||+++ |+||||||+|||+|+++.+||+|||+|+.......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999988542 2335899999999999999999999986 99999999999999999999999999987655444
Q ss_pred eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 673 HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 673 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
.......||+.|+|||++..+.++.++|||||||++|||+||..|+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 44445679999999999999999999999999999999999766654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.2e-41 Score=345.88 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=168.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc---ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----E
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS---RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----Q 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 584 (732)
.++|++.+.||+|+||.||+|++. +|+.||||+++... ....+++.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 79999999987543 233467899999999999999999999988754 4
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.++||||+++++|.+++. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 799999999999999884 3446899999999999999999999986 999999999999999999999999998
Q ss_pred eeCCccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
........ ......+||+.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 75433222 223346799999999999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=349.87 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=176.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||+||+|+++ +|+.||||+++.... ....+.+|++++++++|||||++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999986 789999999976533 345688999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC--CCeEEEeeecceeCCc
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD--LNPKISDFGLAKLDEE 669 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DfGla~~~~~ 669 (732)
|++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999943 2346899999999999999999999996 9999999999999854 4799999999987654
Q ss_pred cCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 670 EKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 670 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
... .....+|+.|+|||...+..++.++||||+||++|+|++|+.||..
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 332 2335689999999999999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-40 Score=341.77 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=175.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc---------cchHHHHHHHHHHhcCC-CCceeeeeeeEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR---------QGNREFLNEIGTISCLQ-HPNLVKLYGCCIE 581 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 581 (732)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|++++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 799999999865421 12346889999999997 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
++..++|||||++|+|.+++. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 999999999999999999994 3446899999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCceeeecccCccccccchhccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALW------GYLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
|+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus 155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 99987655332 234679999999999863 35688999999999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-41 Score=346.49 Aligned_cols=200 Identities=31% Similarity=0.475 Sum_probs=165.4
Q ss_pred CCCcccceecccCceEEEEEEEcC-C----eEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTD-G----TIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~-g----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
+.|+..+.||+|+||.||+|.+++ + ..||||++.... .....+|.+|++++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 467888999999999999998753 2 479999987543 3345679999999999999999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+.++++.+.+.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999987743 3346899999999999999999999986 999999999999999999999999999865
Q ss_pred CccCc--eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 668 EEEKT--HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 668 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 44322 22234568999999999999999999999999999999999766654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=342.39 Aligned_cols=203 Identities=28% Similarity=0.393 Sum_probs=163.3
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
.++|++.+.||+|+||.||+|++. .+..||||.++... ....+.|.+|++++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 457889999999999999999864 24578999886543 334567999999999999999999999985 567899
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998743 3346899999999999999999999996 999999999999999999999999999876
Q ss_pred CccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 668 EEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
............||+.|+|||++.+..++.++|||||||++|||+| |++||....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 5444444445678999999999999999999999999999999998 899997643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=347.85 Aligned_cols=196 Identities=22% Similarity=0.279 Sum_probs=169.2
Q ss_pred hCCCcccc-eecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhc-CCCCceeeeeeeEEe----CCEE
Q 040398 513 TSNFDPMN-KIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISC-LQHPNLVKLYGCCIE----GDQL 585 (732)
Q Consensus 513 ~~~f~~~~-~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~ 585 (732)
.++|+++. .||+|+||.||+|++. +++.||||+++. .+.+.+|++++.+ .+|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 5999999999999975 799999999853 3557789988655 489999999999876 4678
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEeee
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFG 662 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DfG 662 (732)
|+|||||+||+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999642 2346899999999999999999999996 999999999999986 4569999999
Q ss_pred cceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 663 LAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 663 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
+|+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 9987654332 2346799999999999999999999999999999999999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=346.40 Aligned_cols=202 Identities=30% Similarity=0.532 Sum_probs=168.2
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe----EEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT----IIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 587 (732)
++|++++.||+|+||.||+|++. +|+ +||+|+++.. .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 454 6899988653 344567899999999999999999999999875 4677
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
++||+.+|+|.+.+.. ....+++..+.+++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998754 3456899999999999999999999986 999999999999999999999999999876
Q ss_pred CccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 668 EEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 543332 2334568999999999999999999999999999999998 788987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-40 Score=343.47 Aligned_cols=195 Identities=29% Similarity=0.402 Sum_probs=165.4
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEEccccccc-----chHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 518 PMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQ-----GNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 518 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
.+++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999975 7999999998754221 235688999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+.++++..+. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988777665 23456888899999999999999999996 9999999999999999999999999997654433
Q ss_pred ceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ....+||+.|+|||++... .++.++|||||||++|||+||+.||..
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 22 2345799999999998754 679999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=340.95 Aligned_cols=200 Identities=29% Similarity=0.448 Sum_probs=169.3
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++++.||+|+||+||+|++. +|+.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 79999999986543 2346789999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
|+.++.+.... . .....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~~~~~~-~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHH-H--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhh-h--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765444333 2 23346899999999999999999999996 999999999999999999999999999765433
Q ss_pred CceeeecccCccccccchhcccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGY-LTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
.. ......||+.|+|||...... ++.++||||+||++|+|++|+.||..
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 22 223457999999999877654 68899999999999999999999964
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-40 Score=342.84 Aligned_cols=207 Identities=29% Similarity=0.478 Sum_probs=175.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccccc-cchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSKSR-QGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
-.++|++.+.||+|+||.||+|+++ +++.||||+++.... ...++|.+|++++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4678999999999999999999864 457899999876533 345679999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC--------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 040398 585 LMLVYEYLENNSLAHALFGGE--------------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIK 644 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlk 644 (732)
.++||||+++|+|.++++... .....+++..+..|+.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999986432 12235899999999999999999999986 9999999
Q ss_pred CCCeEEcCCCCeEEEeeecceeCCccC-ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC-CCCCCC
Q 040398 645 ATNVLLDRDLNPKISDFGLAKLDEEEK-THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK-NNMSYV 721 (732)
Q Consensus 645 p~NILl~~~~~~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~-~P~~~~ 721 (732)
|+|||+|.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 999999999999999999997554332 22333467899999999999999999999999999999999996 567643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=334.05 Aligned_cols=198 Identities=32% Similarity=0.501 Sum_probs=164.4
Q ss_pred hCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEEEEEEe
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLMLVYEY 591 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~ 591 (732)
.++|++.+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++||||++++++|.+ ++.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356788899999999999999986 789999999653 345789999999999999999999999865 4568999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+++|+|.++++.. ....+++..+++|+.||++||.|||+.+ |+||||||+|||++.++.+|++|||+++......
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999998532 2335899999999999999999999985 9999999999999999999999999997644322
Q ss_pred ceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSYVP 722 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~~~ 722 (732)
....+|..|+|||++.+..+++++|||||||++|||+| |+.||....
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 23457889999999999999999999999999999998 788887543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=335.77 Aligned_cols=198 Identities=23% Similarity=0.360 Sum_probs=169.0
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccc------cchHHHHHHHHHHhcCC--CCceeeeeeeEEeCC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSR------QGNREFLNEIGTISCLQ--HPNLVKLYGCCIEGD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~ 583 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ....++.+|++++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 799999999864321 11244678999999986 899999999999999
Q ss_pred EEEEEEEecCC-CchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCC-CCeEEEee
Q 040398 584 QLMLVYEYLEN-NSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDF 661 (732)
Q Consensus 584 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~Df 661 (732)
..++||||+.+ +++.+++. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 57777773 3456899999999999999999999996 9999999999999855 78999999
Q ss_pred ecceeCCccCceeeecccCccccccchhcccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYL-TYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9998654432 234679999999999987654 6779999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-39 Score=334.46 Aligned_cols=199 Identities=29% Similarity=0.419 Sum_probs=171.3
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEEe
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYEY 591 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 591 (732)
++|+++++||+|+||+||+|++++|+.||||++.... ....+++.+|+.++++++||||+++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999987643 33467899999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccC
Q 040398 592 LENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEK 671 (732)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~ 671 (732)
+.++.+..+. .....+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887777665 23457999999999999999999999986 9999999999999999999999999997644322
Q ss_pred ceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 672 THISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 672 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 2 1223468999999999875 4679999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=338.66 Aligned_cols=207 Identities=27% Similarity=0.390 Sum_probs=165.1
Q ss_pred HHhCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 511 AATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 511 ~~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.-.++|++.++||+|+||.||+|++. +++.||||+++.. .....+.+.+|++.+.++ +|+||+++++++.++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33568999999999999999999853 3578999998754 334456788888888777 689999999988765
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeE
Q 040398 583 -DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 649 (732)
Q Consensus 583 -~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NIL 649 (732)
...++|||||++|+|.++++.... ....+++..+..++.||++||+|||+++ ||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 468999999999999999965322 2345899999999999999999999986 999999999999
Q ss_pred EcCCCCeEEEeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC-CCCCC
Q 040398 650 LDRDLNPKISDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK-NNMSY 720 (732)
Q Consensus 650 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~-~P~~~ 720 (732)
+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999865443332 233467999999999999999999999999999999999975 56764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=334.42 Aligned_cols=200 Identities=27% Similarity=0.457 Sum_probs=162.6
Q ss_pred CCCcccceecccCceEEEEEEEc--CC--eEEEEEEcccc---cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT--DG--TIIAVKLLSSK---SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLM 586 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 586 (732)
++|++.+.||+|+||.||+|++. ++ ..||||++... .....++|.+|++++++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56889999999999999999864 23 46899988754 23345689999999999999999999999965 4678
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
+||||+++|++.+.+.. ....+++..+..++.|||+||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999987743 3346899999999999999999999986 99999999999999999999999999987
Q ss_pred CCccCce--eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 667 DEEEKTH--ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 6544332 2233567889999999999999999999999999999998 8999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=335.69 Aligned_cols=202 Identities=30% Similarity=0.476 Sum_probs=169.9
Q ss_pred CCCcccceecccCceEEEEEEEc-CCe--EEEEEEcccc-cccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGT--IIAVKLLSSK-SRQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQLMLV 588 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 588 (732)
++|++.++||+|+||.||+|+++ +|. .||||++... .....++|.+|++++.++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999876 555 4777877543 334556899999999998 799999999999999999999
Q ss_pred EEecCCCchhHHhhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCe
Q 040398 589 YEYLENNSLAHALFGGE------------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 656 (732)
Q Consensus 589 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 656 (732)
|||+++|+|.++++... .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999996542 23467899999999999999999999986 9999999999999999999
Q ss_pred EEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCC-CCCC
Q 040398 657 KISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKN-NMSY 720 (732)
Q Consensus 657 kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~-P~~~ 720 (732)
||+|||+|+........ ....||..|+|||.+.++.++.++|||||||++|||++|.. ||..
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 99999999765442222 23468999999999999999999999999999999999764 6754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=334.53 Aligned_cols=200 Identities=27% Similarity=0.446 Sum_probs=166.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-C-CeEEEEEEccccc--ccchHHHHHHHHHHhcC---CCCceeeeeeeEEe----
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-D-GTIIAVKLLSSKS--RQGNREFLNEIGTISCL---QHPNLVKLYGCCIE---- 581 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 581 (732)
.++|++++.||+|+||+||+|++. + ++.||||+++... ......+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 6789999986532 22234456677766655 89999999999864
Q ss_pred -CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEe
Q 040398 582 -GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 660 (732)
Q Consensus 582 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 660 (732)
....+++|||++++.+..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 246899999999887765442 23456889999999999999999999996 99999999999999999999999
Q ss_pred eecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 661 FGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 661 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
||.++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 99987654432 23346799999999999999999999999999999999999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=332.22 Aligned_cols=202 Identities=31% Similarity=0.381 Sum_probs=163.0
Q ss_pred CCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----EEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----QLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~ 589 (732)
.+|...+.||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566788999999999999987 489999999864322 1222344556667889999999999998754 689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
|||++|+|.++++. ..++|..+.+++.|+|.||+|+|+.+ ..+|+||||||+|||+++++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999953 35899999999999999999999741 236999999999999999999999999999
Q ss_pred eeCCccCce---eeecccCccccccchhcccC------CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 665 KLDEEEKTH---ISTRVAGTIGYMAPEYALWG------YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 665 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
+........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 865433222 22346799999999998754 25678999999999999999998886533
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=333.36 Aligned_cols=205 Identities=27% Similarity=0.464 Sum_probs=176.0
Q ss_pred hCCCcccceecccCceEEEEEEE------cCCeEEEEEEccccc-ccchHHHHHHHHHHhcC-CCCceeeeeeeEEeCCE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQL------TDGTIIAVKLLSSKS-RQGNREFLNEIGTISCL-QHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 584 (732)
.++|++.+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+++++++ +|||||++++++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788899999999999999975 246789999997643 34456789999999999 69999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCC--------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 585 LMLVYEYLENNSLAHALFGGEN--------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
.++|||||++|+|.++++.... ....+++..+.+++.||++||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999865431 3346899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+| |++||..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 9999999999999987654433 33344678999999999999999999999999999999999 5555544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=328.98 Aligned_cols=196 Identities=30% Similarity=0.416 Sum_probs=167.8
Q ss_pred cceecccCceEEEEEEEcC----CeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEe-CCEEEEEEEec
Q 040398 519 MNKIGEGGFGPVYKGQLTD----GTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-GDQLMLVYEYL 592 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~ 592 (732)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|++++++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999998753 236899998753 44456789999999999999999999999876 46899999999
Q ss_pred CCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCccCc
Q 040398 593 ENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEEKT 672 (732)
Q Consensus 593 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~~~ 672 (732)
++|+|.++++. .....++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998854 3345678889999999999999999986 99999999999999999999999999986544322
Q ss_pred e---eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 673 H---ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 673 ~---~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2 22235689999999999999999999999999999999998888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=331.45 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=170.9
Q ss_pred hCCCcccceecccCceEEEEEEEc--------CCeEEEEEEcccccc-cchHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT--------DGTIIAVKLLSSKSR-QGNREFLNEIGTISCL-QHPNLVKLYGCCIEG 582 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 582 (732)
.++|++.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 457888999999999999999753 235799999976543 3457788999999888 899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEE
Q 040398 583 DQLMLVYEYLENNSLAHALFGGEN------------SQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 650 (732)
Q Consensus 583 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl 650 (732)
+..++||||+++|+|.+++..... ....+++.++++++.||++||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 2356899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEEeeecceeCCccCc-eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 040398 651 DRDLNPKISDFGLAKLDEEEKT-HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVS-GKNNMSY 720 (732)
Q Consensus 651 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~ellt-G~~P~~~ 720 (732)
+.++.+||+|||+++....... .......||+.|+|||.+.++.+++++|||||||++|||++ |+.||..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999986544322 22334678999999999999999999999999999999998 6888864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=332.71 Aligned_cols=206 Identities=28% Similarity=0.390 Sum_probs=175.8
Q ss_pred HhCCCcccceecccCceEEEEEEEc------CCeEEEEEEcccc-cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCE
Q 040398 512 ATSNFDPMNKIGEGGFGPVYKGQLT------DGTIIAVKLLSSK-SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQ 584 (732)
Q Consensus 512 ~~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 584 (732)
..++|++.+.||+|+||.||+|+++ +++.||||+++.. .......|.+|++++++++|||||++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3467888999999999999999763 3578999999754 33344678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC------CCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 585 LMLVYEYLENNSLAHALFGGE------NSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
.++||||+++|+|.++++... .....+++..+.+++.|+|+||.|||+++ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999885421 22245789999999999999999999985 999999999999999999999
Q ss_pred EeeecceeCCccCce-eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCC-CCCCC
Q 040398 659 SDFGLAKLDEEEKTH-ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGK-NNMSY 720 (732)
Q Consensus 659 ~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~-~P~~~ 720 (732)
+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 999999865443332 233456899999999999999999999999999999999985 67764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=327.98 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=167.9
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEe--------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIE-------- 581 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 581 (732)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999985 7999999998654 33456788999999999999999999998865
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEee
Q 040398 582 GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 661 (732)
Q Consensus 582 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~Df 661 (732)
++..++||||++++.+.... .....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 34689999999887766554 33456889999999999999999999986 999999999999999999999999
Q ss_pred ecceeCCccCce---eeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 662 GLAKLDEEEKTH---ISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 662 Gla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|++......... .....+||+.|+|||++.+. .+++++||||+||++|||++|+.||..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 999765433221 22235699999999998765 689999999999999999999999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-37 Score=322.44 Aligned_cols=201 Identities=24% Similarity=0.305 Sum_probs=171.5
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCC-CceeeeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQH-PNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++..... .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999976 799999998865432 2456788889988865 899999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC-----CCCeEEEeeecce
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLNPKISDFGLAK 665 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DfGla~ 665 (732)
|+ +++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 68999988532 346899999999999999999999996 999999999999974 5679999999998
Q ss_pred eCCccCc------eeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 666 LDEEEKT------HISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 666 ~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
....... .......||+.|||||++.+..+++++|||||||++|||+||+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 6543221 12234679999999999999999999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=331.95 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=167.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc-ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC----EEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS-RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD----QLM 586 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 586 (732)
+++|++++.||+|+||+||+|+++ +|+.||||++.... ....+++.+|++++++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999875 89999999987543 344568899999999999999999999987653 234
Q ss_pred EEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 587 LVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 587 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999843 36899999999999999999999996 99999999999999999999999999986
Q ss_pred CCccCce--eeecccCccccccchhcc-cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTH--ISTRVAGTIGYMAPEYAL-WGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~--~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... .....+||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 6443322 233467999999999885 45678999999999999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-38 Score=329.36 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=174.4
Q ss_pred hCCCcccceecccCceEEEEEEEc----CCeEEEEEEccccc----ccchHHHHHHHHHHhcCCC-CceeeeeeeEEeCC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT----DGTIIAVKLLSSKS----RQGNREFLNEIGTISCLQH-PNLVKLYGCCIEGD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~ 583 (732)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999852 58999999986532 2335678899999999976 89999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.||+|+|+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999843 345678899999999999999999986 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWG--YLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
++..............|++.|+|||.+.+. .++.++|||||||++|||+||+.||....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 987655444444456799999999998754 57889999999999999999999997543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=330.54 Aligned_cols=195 Identities=26% Similarity=0.413 Sum_probs=164.4
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccc--cccchHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSK--SRQGNREFLNEIGTISCLQHPNLVKLYGCCIEGD------ 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 583 (732)
.++|++++.||+|+||+||+|++. +|+.||||+++.. .....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 7999999999754 2334567899999999999999999999998754
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
++++||||+ +.+|..+.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 567877763 346899999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
|+...... +...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 98665432 34579999999999876 4678999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=330.07 Aligned_cols=196 Identities=29% Similarity=0.363 Sum_probs=163.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCceeeeeeeEEeC------CEEEE
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLVKLYGCCIEG------DQLML 587 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 587 (732)
+|+..++||+|+||+||+|++. +|+.||||++...... +.+|++++++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999986 7999999998754322 34699999999999999999998653 35799
Q ss_pred EEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeeccee
Q 040398 588 VYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKL 666 (732)
Q Consensus 588 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~ 666 (732)
||||++++.+.... ........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999876444333 22234557899999999999999999999986 99999999999999775 899999999986
Q ss_pred CCccCceeeecccCccccccchhccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 667 DEEEKTHISTRVAGTIGYMAPEYALW-GYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 667 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 654332 234579999999998875 4789999999999999999999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-37 Score=317.66 Aligned_cols=198 Identities=24% Similarity=0.381 Sum_probs=173.4
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeCCEEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 590 (732)
++|++++.||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999985 78999999986543 3345788999999999999999999999999999999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecceeCCcc
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEEE 670 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~~~~ 670 (732)
++.++++..++. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988774 3456789999999999999999999986 999999999999999999999999999876543
Q ss_pred CceeeecccCccccccchhcccCC-CCCchhHHHHHHHHHHHHcCCCCCC
Q 040398 671 KTHISTRVAGTIGYMAPEYALWGY-LTYKADVYSFGVVALEIVSGKNNMS 719 (732)
Q Consensus 671 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvll~elltG~~P~~ 719 (732)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||.
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 322 22345788999999887654 6899999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-36 Score=322.00 Aligned_cols=193 Identities=21% Similarity=0.348 Sum_probs=168.0
Q ss_pred CCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeC--CEEEEEE
Q 040398 514 SNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEG--DQLMLVY 589 (732)
Q Consensus 514 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~ 589 (732)
++|+++++||+|+||+||+|++. +|+.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999985 7999999998643 3467889999999995 99999999999854 5689999
Q ss_pred EecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCC-CeEEEeeecceeCC
Q 040398 590 EYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDE 668 (732)
Q Consensus 590 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DfGla~~~~ 668 (732)
||+++++|.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999998754 25899999999999999999999996 99999999999998765 59999999998765
Q ss_pred ccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 040398 669 EEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSYV 721 (732)
Q Consensus 669 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~~ 721 (732)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 4332 2345789999999998765 5799999999999999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-36 Score=316.34 Aligned_cols=201 Identities=25% Similarity=0.316 Sum_probs=166.2
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCCCCcee-eeeeeEEeCCEEEEEEE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV-KLYGCCIEGDQLMLVYE 590 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e 590 (732)
.++|++.+.||+|+||.||+|++. +|+.||||++..... .+++.+|+++++.++|+|++ .+..++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999975 789999998775432 34578899999999877655 45566677889999999
Q ss_pred ecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcC---CCCeEEEeeecceeC
Q 040398 591 YLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLD 667 (732)
Q Consensus 591 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DfGla~~~ 667 (732)
|++ +++.+.+.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+|+..
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 566665532 3346899999999999999999999996 999999999999853 457999999999875
Q ss_pred CccCce------eeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 040398 668 EEEKTH------ISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSYVP 722 (732)
Q Consensus 668 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~~~ 722 (732)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 443221 2234679999999999999999999999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-36 Score=321.92 Aligned_cols=196 Identities=25% Similarity=0.339 Sum_probs=160.1
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEe------CC
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIE------GD 583 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 583 (732)
.++|+++++||+|+||+||+|++. +|+.||||++.... ....+++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999986 79999999987542 3345678999999999999999999999864 36
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeec
Q 040398 584 QLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 663 (732)
Q Consensus 584 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGl 663 (732)
..|+||||+.++.+. .+. ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 889999999765544 442 35789999999999999999999996 99999999999999999999999999
Q ss_pred ceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 664 AKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 664 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++...... ......||+.|+|||++.+..+++++||||+||++|||++|+.||..
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 87554422 23345799999999999999999999999999999999999999963
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=320.96 Aligned_cols=196 Identities=27% Similarity=0.380 Sum_probs=165.3
Q ss_pred hCCCcccceecccCceEEEEEEEc-CCeEEEEEEccccc--ccchHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CE
Q 040398 513 TSNFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKS--RQGNREFLNEIGTISCLQHPNLVKLYGCCIEG-----DQ 584 (732)
Q Consensus 513 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 584 (732)
.++|++++.||+|+||+||+|++. +|+.||||++.... ....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 567999999999999999999975 79999999997543 33456789999999999999999999998643 34
Q ss_pred EEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEEEeeecc
Q 040398 585 LMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 664 (732)
Q Consensus 585 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla 664 (732)
.+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4667788889999998842 35899999999999999999999996 999999999999999999999999998
Q ss_pred eeCCccCceeeecccCccccccchhcccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 665 KLDEEEKTHISTRVAGTIGYMAPEYALWG-YLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 665 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
....... ....|++.|+|||...+. .++.++||||+||++|+|++|+.||..
T Consensus 169 ~~~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 169 RHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp -CCTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 7544322 235689999999987665 568999999999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=5.1e-31 Score=282.79 Aligned_cols=198 Identities=22% Similarity=0.274 Sum_probs=158.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEEcccccccchHHHHHHHHHHhcCC-----------CCceeeeeeeEEe-
Q 040398 515 NFDPMNKIGEGGFGPVYKGQLT-DGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-----------HPNLVKLYGCCIE- 581 (732)
Q Consensus 515 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~- 581 (732)
+|+++++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5899999999999999999985 799999999975432 3456788888888775 5789999988764
Q ss_pred -CCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCC-----
Q 040398 582 -GDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN----- 655 (732)
Q Consensus 582 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~----- 655 (732)
....+++|+++..+........ ......+++..++.++.||++||+|||+.. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 4567777777766543332211 123456788999999999999999999832 4999999999999986653
Q ss_pred -eEEEeeecceeCCccCceeeecccCccccccchhcccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 040398 656 -PKISDFGLAKLDEEEKTHISTRVAGTIGYMAPEYALWGYLTYKADVYSFGVVALEIVSGKNNMSY 720 (732)
Q Consensus 656 -~kL~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvll~elltG~~P~~~ 720 (732)
++++|||.+....... ...+||+.|+|||++....++.++||||+||++++|++|+.||..
T Consensus 170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 8999999987554322 345799999999999999999999999999999999999999974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=5.5e-31 Score=276.67 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=178.4
Q ss_pred CCCCEEEcccCcCcc--ccCcccccc-ccceEeccc-ccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCE
Q 040398 17 PYLETVDFAYNYLHG--SIPREWASM-QLKYISVFA-NRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLET 92 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~--~~p~~~~~~-~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 92 (732)
.+++.|+|++|.+.+ .+|..++.+ +|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 367778888887776 467777777 688888875 6777778877888888888888888887777777777778888
Q ss_pred EeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCC-CEEEcccCCCcCcCCccccCccCCCeeeccCcC
Q 040398 93 LRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQL-NRLEIQGSGLEGPIPPSISALDKLNQLRISDLQ 171 (732)
Q Consensus 93 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 171 (732)
++++.|++.+.+|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++.+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 8888887777777778888888888888888877777777777665 677778888877777777766544 57777777
Q ss_pred CCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeE
Q 040398 172 GPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSL 251 (732)
Q Consensus 172 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~L 251 (732)
..+..+..+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+|+|.+|+. ++++++|++|
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~--------------l~~L~~L~~L 273 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG--------------LTQLKFLHSL 273 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG--------------GGGCTTCCEE
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH--------------HhCCCCCCEE
Confidence 777777777777778888888888776554 4667777888888888888777765 6667778888
Q ss_pred EccCCcCcCCCCCCcccc
Q 040398 252 DLSYNNFTWQSPEQPACR 269 (732)
Q Consensus 252 dLs~N~l~~~~p~~~~~~ 269 (732)
||++|+|+|.+|+...+.
T Consensus 274 ~Ls~N~l~g~iP~~~~L~ 291 (313)
T d1ogqa_ 274 NVSFNNLCGEIPQGGNLQ 291 (313)
T ss_dssp ECCSSEEEEECCCSTTGG
T ss_pred ECcCCcccccCCCcccCC
Confidence 888888887777654433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.8e-30 Score=267.81 Aligned_cols=241 Identities=27% Similarity=0.422 Sum_probs=222.4
Q ss_pred Ccc--cCCccCCCCCCCCEEEccc-CcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccC
Q 040398 5 LPG--TLPPQIVNLPYLETVDFAY-NYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTI 80 (732)
Q Consensus 5 ~~g--~lP~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 80 (732)
++| +||++|++|++|++|+|++ |+++|.+|..+..+ +|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+
T Consensus 62 l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~ 141 (313)
T d1ogqa_ 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141 (313)
T ss_dssp CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred CCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccC
Confidence 455 6999999999999999997 89999999999999 8999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCEEeCCCCcccccCCccccCCCCC-CEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCc
Q 040398 81 PRELGNLVNLETLRLSSNRLIGNLPMELVKLKNL-TDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159 (732)
Q Consensus 81 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 159 (732)
|..+.+++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+
T Consensus 142 p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~ 220 (313)
T d1ogqa_ 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSD 220 (313)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTT
T ss_pred chhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 9999999999999999999999999999999886 899999999999999999888655 79999999999999999999
Q ss_pred cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHH
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQIL 239 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~ 239 (732)
++|+.|++++|.+.+.. +.+..+++|+.|+|++|+++|.+|+.++++++|++|+|++|+|+|.+|+
T Consensus 221 ~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~------------- 286 (313)
T d1ogqa_ 221 KNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ------------- 286 (313)
T ss_dssp SCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-------------
T ss_pred ccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-------------
Confidence 99999999999997754 4688899999999999999999999999999999999999999999996
Q ss_pred HHHhccCCCCeEEccCCc-CcCCC
Q 040398 240 MFIRGVYEHQSLDLSYNN-FTWQS 262 (732)
Q Consensus 240 ~~~~~l~~L~~LdLs~N~-l~~~~ 262 (732)
++++.+|+.+++++|+ ++|.|
T Consensus 287 --~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 287 --GGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp --STTGGGSCGGGTCSSSEEESTT
T ss_pred --cccCCCCCHHHhCCCccccCCC
Confidence 3456789999999998 55543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-24 Score=223.68 Aligned_cols=200 Identities=20% Similarity=0.224 Sum_probs=96.6
Q ss_pred EEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCC-CCcc
Q 040398 22 VDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLS-SNRL 100 (732)
Q Consensus 22 L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~N~l 100 (732)
++.++++++ .+|..+. ..+++|+|++|+|+...+..|.++++|++|++++|++....+..+.++..++.++.. .|.+
T Consensus 16 v~c~~~~L~-~iP~~ip-~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp EECCSSCCS-SCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EEcCCCCCC-ccCCCCC-CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 344444444 3343221 134555555555543223345555555555555555554444444444455554432 3334
Q ss_pred cccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccc
Q 040398 101 IGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180 (732)
Q Consensus 101 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l 180 (732)
+...|..+.++++|+.|++++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|++++|++..++...|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 43334445555555555555555544444444445555555555555554334444455555555555555555544555
Q ss_pred cCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 181 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
..+++|++|++++|++++..|..|..+++|+.|++++|++.+.
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~ 216 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ccccccchhhhhhccccccChhHhhhhhhcccccccccccccc
Confidence 5555555555555555544455555555555555555555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=9.1e-24 Score=220.16 Aligned_cols=230 Identities=19% Similarity=0.269 Sum_probs=143.4
Q ss_pred CCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 9 LPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 9 lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
||+.|. +.|++|+|++|+|+...+..|..+ +|++|++++|.+....|..|.++++|++|+|++|+|+ .+|..+.
T Consensus 25 lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~-- 99 (305)
T d1xkua_ 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-- 99 (305)
T ss_dssp CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--
T ss_pred cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh--
Confidence 444442 579999999999996555678887 8999999999999777888999999999999999998 6776543
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccc--ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCee
Q 040398 88 VNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN--GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQL 165 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 165 (732)
..|+.|++.+|.+.+..+..+.....+..+++..|... ...+..+..+++|+.+++++|.++ .+|..+ +++|+.|
T Consensus 100 ~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L 176 (305)
T d1xkua_ 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 176 (305)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEE
T ss_pred hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEE
Confidence 57888888888887544434444455555555555332 223344555555555555555554 233322 3455555
Q ss_pred eccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhcc
Q 040398 166 RISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGV 245 (732)
Q Consensus 166 ~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l 245 (732)
++++|.........|..++.++.|++++|.+.+..+..+..+++|+.|+|++|+|+ .+|+. +.++
T Consensus 177 ~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~--------------l~~l 241 (305)
T d1xkua_ 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG--------------LADH 241 (305)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT--------------TTTC
T ss_pred ECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc--------------cccc
Confidence 55555555555555555555555555555555444555555555555555555555 22322 3344
Q ss_pred CCCCeEEccCCcCcCC
Q 040398 246 YEHQSLDLSYNNFTWQ 261 (732)
Q Consensus 246 ~~L~~LdLs~N~l~~~ 261 (732)
++|+.|+|++|+|+..
T Consensus 242 ~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 242 KYIQVVYLHNNNISAI 257 (305)
T ss_dssp SSCCEEECCSSCCCCC
T ss_pred cCCCEEECCCCccCcc
Confidence 5555555555555543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.8e-24 Score=220.03 Aligned_cols=216 Identities=19% Similarity=0.216 Sum_probs=194.6
Q ss_pred CCCCcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecc-cccCCcc
Q 040398 2 LFSLPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLE-ENQFSGT 79 (732)
Q Consensus 2 l~~~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls-~N~l~~~ 79 (732)
|++||..|| +.+++|+|++|+|+...+..|..+ +|++|++++|++....+..+.++..++.++.. .|.++..
T Consensus 23 L~~iP~~ip------~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l 96 (284)
T d1ozna_ 23 LQAVPVGIP------AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96 (284)
T ss_dssp CSSCCTTCC------TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCC
T ss_pred CCccCCCCC------CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence 455555555 458999999999997666788888 79999999999998888888999999999875 5677766
Q ss_pred CCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCc
Q 040398 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159 (732)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 159 (732)
.+..+.++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++..+..|..+
T Consensus 97 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l 176 (284)
T d1ozna_ 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176 (284)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred cchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccc
Confidence 67789999999999999999987777788889999999999999998778889999999999999999998888999999
Q ss_pred cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCccc
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 223 (732)
++|+.+++++|++..+.+..|..+++|++|++++|++.+..+..+..+++|+.|+|++|++.+.
T Consensus 177 ~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 9999999999999999999999999999999999999988889999999999999999999865
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-23 Score=214.58 Aligned_cols=202 Identities=22% Similarity=0.261 Sum_probs=149.2
Q ss_pred CCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEE
Q 040398 14 VNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 14 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 93 (732)
.+...+.+++.++++|+ .+|..+. .++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp-~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC-TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC-cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 45566777788888887 5666543 25788888888887544567778888888888888887 454 35677788888
Q ss_pred eCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCC
Q 040398 94 RLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGP 173 (732)
Q Consensus 94 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 173 (732)
+|++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+|+.|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 88888887 45667777788888888888877666777777778888888888777666666677777777777777777
Q ss_pred CCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 174 NQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 174 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
.+++..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 777777777777777777777777 67776667777777777777765
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.5e-23 Score=212.45 Aligned_cols=198 Identities=21% Similarity=0.177 Sum_probs=177.3
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
.+.+++.++++|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .+..+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 4677899999999 7898775 68999999999999555578999999999999999998 555 45789999999999
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEI 200 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 200 (732)
+|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.+..++...+..+++|+.|++++|+|++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 99998 45778999999999999999999888888999999999999999999999999999999999999999999888
Q ss_pred chhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCc
Q 040398 201 PEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 201 p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
+..+..+++|+.|+|++|+|+ .+|+. +..+.+|+.|+|++|++.
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~--------------~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKG--------------FFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTT--------------TTTTCCCSEEECCSCCBC
T ss_pred ccccccccccceeecccCCCc-ccChh--------------HCCCCCCCEEEecCCCCC
Confidence 888999999999999999999 67764 345678999999999653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=2.4e-21 Score=207.77 Aligned_cols=164 Identities=23% Similarity=0.310 Sum_probs=89.6
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeee
Q 040398 87 LVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLR 166 (732)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 166 (732)
+++++.+++++|.+++..| +..+++|+.|++++|+++. + ..+..+++|+.|++++|.+++.. .+..+++|+.|+
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 3445555555555543222 2334556666666665552 2 24555666666666666665432 255556666666
Q ss_pred ccCcCCCCCCc--------------------ccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 167 ISDLQGPNQTF--------------------PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 167 ls~N~l~~~~~--------------------~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
+++|++..... ..+..+++++.|+|++|++++..+ +..+++|+.|+|++|+|++ +|.
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~~ 346 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSS 346 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CGG
T ss_pred ccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Chh
Confidence 66665544321 224455566666666666664322 5566666666666666653 221
Q ss_pred CCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCCCCccccCCCCcc
Q 040398 227 VAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSPEQPACREKPNLN 275 (732)
Q Consensus 227 ~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~ 275 (732)
+.++++|+.|+|++|+|++.+| ...+.++..|+
T Consensus 347 ---------------l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~ 379 (384)
T d2omza2 347 ---------------LANLTNINWLSAGHNQISDLTP-LANLTRITQLG 379 (384)
T ss_dssp ---------------GGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEE
T ss_pred ---------------HcCCCCCCEEECCCCcCCCChh-hccCCCCCEee
Confidence 4566777777777777776654 33344444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.86 E-value=6.9e-21 Score=198.05 Aligned_cols=244 Identities=22% Similarity=0.270 Sum_probs=205.0
Q ss_pred ccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 11 PQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
+..+++ .++.++-++++++ .+|..+. .++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|
T Consensus 5 p~~c~c-~~~~~~C~~~~L~-~lP~~l~-~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L 81 (305)
T d1xkua_ 5 PFRCQC-HLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81 (305)
T ss_dssp CTTCEE-ETTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCCCEe-cCCEEEecCCCCC-ccCCCCC-CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence 334443 5788999999999 7777653 379999999999994434579999999999999999997668889999999
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCc--CcCCccccCccCCCeeecc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLE--GPIPPSISALDKLNQLRIS 168 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls 168 (732)
+.|++++|+|+ .+|..+ ...|+.|++.+|.+.+..+..+.....+..+++..|... ...+..+..+++|+.++++
T Consensus 82 ~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~ 158 (305)
T d1xkua_ 82 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158 (305)
T ss_dssp CEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccc
Confidence 99999999999 677554 468999999999999877778888999999999988664 3446678899999999999
Q ss_pred CcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCC
Q 040398 169 DLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEH 248 (732)
Q Consensus 169 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L 248 (732)
+|.+..++... +++|+.|++++|.+.+..+..+..++.++.|++++|.+++..|.. +.++++|
T Consensus 159 ~n~l~~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~--------------~~~l~~L 221 (305)
T d1xkua_ 159 DTNITTIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS--------------LANTPHL 221 (305)
T ss_dssp SSCCCSCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT--------------GGGSTTC
T ss_pred cCCccccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccc--------------ccccccc
Confidence 99998775443 578999999999999999999999999999999999999877754 6678999
Q ss_pred CeEEccCCcCcCCCCCCccccCCCCcccc
Q 040398 249 QSLDLSYNNFTWQSPEQPACREKPNLNLN 277 (732)
Q Consensus 249 ~~LdLs~N~l~~~~p~~~~~~~~~~l~~~ 277 (732)
++|+|++|+|+..++....+..+..|++.
T Consensus 222 ~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 222 RELHLNNNKLVKVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp CEEECCSSCCSSCCTTTTTCSSCCEEECC
T ss_pred eeeecccccccccccccccccCCCEEECC
Confidence 99999999999876666666666666543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.1e-22 Score=196.88 Aligned_cols=163 Identities=20% Similarity=0.137 Sum_probs=119.6
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEcccccc------------------cchHHHHHHHHHHhcCCCCceeeeeee
Q 040398 517 DPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSR------------------QGNREFLNEIGTISCLQHPNLVKLYGC 578 (732)
Q Consensus 517 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 578 (732)
.+.++||+|+||.||+|+..+|+.||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999998999999998753211 011334568889999999999887765
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCCeEEcCCCCeEE
Q 040398 579 CIEGDQLMLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 658 (732)
Q Consensus 579 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 658 (732)
. . .+++|||+++..+.+ ++.....+++.|++++++|||+.+ |+||||||+|||++++ .++|
T Consensus 83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred c--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 2 2 278999998865443 233445689999999999999996 9999999999999975 5899
Q ss_pred EeeecceeCCccCceeeecccCcccccc------chhcccCCCCCchhHHHHHHHH
Q 040398 659 SDFGLAKLDEEEKTHISTRVAGTIGYMA------PEYALWGYLTYKADVYSFGVVA 708 (732)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~~k~DvwSlGvll 708 (732)
+|||+|......... .|.. .|.. .+.++.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999765432221 1211 1111 35678899999976544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=4.9e-20 Score=197.41 Aligned_cols=253 Identities=25% Similarity=0.305 Sum_probs=166.4
Q ss_pred CcccCCccCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCcc
Q 040398 5 LPGTLPPQIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRE 83 (732)
Q Consensus 5 ~~g~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 83 (732)
+++.++ ...+.+|++|++++|+|+. +. .+..+ +|++|+|++|+|+ .+|. ++++++|++|+|++|++++ ++ .
T Consensus 34 ~~~~~~--~~~l~~l~~L~l~~~~I~~-l~-gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~-i~-~ 105 (384)
T d2omza2 34 VTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIAD-IT-P 105 (384)
T ss_dssp TTSEEC--HHHHTTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-G
T ss_pred CCCccC--HHHhCCCCEEECCCCCCCC-cc-ccccCCCCCEEeCcCCcCC-CCcc-ccCCccccccccccccccc-cc-c
Confidence 444443 3467789999999999984 43 45666 7999999999999 4553 9999999999999999984 44 4
Q ss_pred ccCCCCCCEEeCCCCcccccC-----------------------------------------------------------
Q 040398 84 LGNLVNLETLRLSSNRLIGNL----------------------------------------------------------- 104 (732)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~----------------------------------------------------------- 104 (732)
+.++++|+.|++++|.+++..
T Consensus 106 l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (384)
T d2omza2 106 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 185 (384)
T ss_dssp GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 889999999999988876311
Q ss_pred ----CccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccc
Q 040398 105 ----PMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPML 180 (732)
Q Consensus 105 ----p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l 180 (732)
...+..+++++.|++++|.+++..| +..+++|+.|++++|.++. + ..+..+++|+.|++++|.+++.. .+
T Consensus 186 ~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~ 259 (384)
T d2omza2 186 KVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PL 259 (384)
T ss_dssp CCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred ccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cc
Confidence 1234456778888888888875543 4566788888888888874 2 35777888888888888877654 36
Q ss_pred cCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcc-----h---hhHHHHHHhccCCCCeEE
Q 040398 181 RNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADL-----K---FTQILMFIRGVYEHQSLD 252 (732)
Q Consensus 181 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l-----~---~~~~~~~~~~l~~L~~Ld 252 (732)
..+++|+.|++++|++++..+ +..++.++.++++.|.+++... ......+ . ...+ ..+..+++|+.|+
T Consensus 260 ~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~~~-~~~~~~l~~L~ls~n~l~~l-~~l~~l~~L~~L~ 335 (384)
T d2omza2 260 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDI-SPVSSLTKLQRLF 335 (384)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCC-GGGGGCTTCCEEE
T ss_pred cccccCCEeeccCcccCCCCc--cccccccccccccccccccccc-cchhcccCeEECCCCCCCCC-cccccCCCCCEEE
Confidence 777888888888888874332 3344445555555554443210 0000000 0 0000 0145566777777
Q ss_pred ccCCcCcCCCCCCccccCCCCccc
Q 040398 253 LSYNNFTWQSPEQPACREKPNLNL 276 (732)
Q Consensus 253 Ls~N~l~~~~p~~~~~~~~~~l~~ 276 (732)
|++|+|+.. +....|..+..|++
T Consensus 336 L~~n~l~~l-~~l~~l~~L~~L~l 358 (384)
T d2omza2 336 FANNKVSDV-SSLANLTNINWLSA 358 (384)
T ss_dssp CCSSCCCCC-GGGGGCTTCCEEEC
T ss_pred CCCCCCCCC-hhHcCCCCCCEEEC
Confidence 777777653 34444555544443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=9.7e-19 Score=173.49 Aligned_cols=204 Identities=20% Similarity=0.291 Sum_probs=151.2
Q ss_pred CCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
+..++++.+++++.+ ....+ +|++|++.+|+|+ .++ .+.++++|++|+|++|++++.. .+..+++|+.|++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccc
Confidence 344566666666433 33445 6888888888888 453 5888888888888888887433 378888888888888
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF 177 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 177 (732)
|.++ .++ .+..+++|+.|++++|.+.+. ..+...+.++.+.++.+.+... ..+..+++|+.|++++|.+....
T Consensus 95 n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~- 167 (227)
T d1h6ua2 95 NPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT- 167 (227)
T ss_dssp CCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-
T ss_pred cccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch-
Confidence 8887 444 577888888888888887643 3366778888888888887643 34667788888888888876543
Q ss_pred ccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 178 PMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 178 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
.+..+++|++|+|++|++++ ++. +.++++|+.|+|++|+|++..| +.++++|+.|+|+
T Consensus 168 -~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~----------------l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 -PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP----------------LANTSNLFIVTLT 225 (227)
T ss_dssp -GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG----------------GTTCTTCCEEEEE
T ss_pred -hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc----------------cccCCCCCEEEee
Confidence 37788888888888888874 443 7788888888888888885432 5567788888886
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=2.7e-19 Score=172.76 Aligned_cols=175 Identities=19% Similarity=0.210 Sum_probs=84.9
Q ss_pred EEecccccCCccCCccccCCCCCCEEeCCCCcccccC-CccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccC
Q 040398 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNL-PMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGS 146 (732)
Q Consensus 68 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 146 (732)
+++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+....+..+..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444444444 3443332 33444444444443222 223344444444444444444444444444444444444444
Q ss_pred CCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 147 GLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
+|+...+..|.++++|+.|+|++|+++.+++..|..+++|++|+|++|.+...... ..-...++.+.+..|.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh
Confidence 44444444444455555555555555555555555555666666666666533221 11112345556677777766554
Q ss_pred CCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCCC
Q 040398 227 VAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQSP 263 (732)
Q Consensus 227 ~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~p 263 (732)
. +..++.+||+.|+|+...+
T Consensus 168 ~-----------------l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 168 K-----------------VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp T-----------------TTTSBGGGSCTTTCCCCCC
T ss_pred h-----------------hcCCEeeecCHhhCcCCCC
Confidence 3 2345567778887764443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.7e-18 Score=169.23 Aligned_cols=190 Identities=21% Similarity=0.288 Sum_probs=160.6
Q ss_pred cCCCCCCCCEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCC
Q 040398 12 QIVNLPYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNL 90 (732)
Q Consensus 12 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 90 (732)
.+..|++|+.|++.+|+|+ .++ .+..+ +|++|+|++|++++..| +..+++|++|++++|.++ .++ .+..+++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L 109 (227)
T d1h6ua2 36 TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSI 109 (227)
T ss_dssp CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTC
T ss_pred CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccc
Confidence 3456789999999999999 454 46667 89999999999995433 899999999999999998 554 68899999
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCc
Q 040398 91 ETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDL 170 (732)
Q Consensus 91 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 170 (732)
+.+++++|...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.++.. ..+.++++|+.|++++|
T Consensus 110 ~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n 183 (227)
T d1h6ua2 110 KTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDN 183 (227)
T ss_dssp CEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred ccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCC
Confidence 9999999998743 3467789999999999998743 3477899999999999999743 34889999999999999
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCC
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 217 (732)
+++++. .+..+++|++|+|++|+|++ ++. +.++++|+.|+|++
T Consensus 184 ~l~~l~--~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 184 KISDIS--PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCCG--GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred ccCCCh--hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 998764 48899999999999999995 443 88999999999974
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.7e-18 Score=165.72 Aligned_cols=179 Identities=20% Similarity=0.331 Sum_probs=94.9
Q ss_pred ecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCcccc
Q 040398 46 SVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 46 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
++..+.+++.++. ..+.+|++|++++|.++ .++ .+..+++|++|+|++|+|++ ++ .+..+++|+.|++++|+|+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 4444444433332 23445555555555555 222 24555555555555555553 22 2445555555555555555
Q ss_pred ccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhc
Q 040398 126 GSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIW 205 (732)
Q Consensus 126 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 205 (732)
+ +| .+..+++|+.|++++|.+.. ...+..+++|+.+++++|.+++. ..+..+++|+.+++++|++++ ++. +.
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~-l~ 175 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP-LA 175 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG-GT
T ss_pred c-cc-cccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccc-ccc-cc
Confidence 2 22 35555556666665555542 23455555666666666655442 234455666666666666663 332 56
Q ss_pred CCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEcc
Q 040398 206 GIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLS 254 (732)
Q Consensus 206 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs 254 (732)
++++|+.|+|++|+|+. +|. +.++++|+.|+|+
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~~---------------l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LRA---------------LAGLKNLDVLELF 208 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CGG---------------GTTCTTCSEEEEE
T ss_pred CCCCCCEEECCCCCCCC-Chh---------------hcCCCCCCEEEcc
Confidence 66666666666666653 221 4455666666665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=5.3e-18 Score=169.61 Aligned_cols=200 Identities=14% Similarity=0.095 Sum_probs=100.6
Q ss_pred CEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCC-ccccCCCCCCEEeCC-C
Q 040398 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIP-RELGNLVNLETLRLS-S 97 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~-~ 97 (732)
+.++.++++++ .+|..+- .++++|+|++|+|+...+..|.++++|++|+|++|.+...++ ..|.+++++++|.+. .
T Consensus 11 ~~i~c~~~~l~-~iP~~l~-~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC-SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCC-CcCCCCC-CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 45556655555 4444331 245666666666653223345566666666666665554333 245556666666554 2
Q ss_pred CcccccCCccccCCCCCCEEEccCccccccCC-ccccCCCCCCEEEcccCCCcCcCCccccCcc-CCCeeeccCcCCCCC
Q 040398 98 NRLIGNLPMELVKLKNLTDFRINDNNFNGSAP-DFIQSWTQLNRLEIQGSGLEGPIPPSISALD-KLNQLRISDLQGPNQ 175 (732)
Q Consensus 98 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~ 175 (732)
|++....+..|.++++|+.|++++|.+....+ ..+..+..|..+..+++.+....+..+..++ .++.|++++|+++.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 45554555555666666666666666542222 1223344444444455555543344444443 455555555555554
Q ss_pred CcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCc
Q 040398 176 TFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLT 221 (732)
Q Consensus 176 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 221 (732)
....+.....++.+++++|+|+...+..|.++++|+.|+|++|+|+
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 4444433222233344555555322334555566666666666655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.1e-18 Score=170.48 Aligned_cols=199 Identities=14% Similarity=0.086 Sum_probs=158.0
Q ss_pred CCCCEEEcccCcCccccCcccccc-ccceEecccccccccCC-ccccCCCCCCEEeccc-ccCCccCCccccCCCCCCEE
Q 040398 17 PYLETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIP-SHLGNITSLTYLDLEE-NQFSGTIPRELGNLVNLETL 93 (732)
Q Consensus 17 ~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L 93 (732)
+.+++|+|++|+|+...+..|..+ +|++|+|++|.+...++ ..|.+++++++|++.. |++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 579999999999996556678887 89999999999986554 5788999999999875 77886777889999999999
Q ss_pred eCCCCcccccCC-ccccCCCCCCEEEccCccccccCCccccCCC-CCCEEEcccCCCcCcCCccccCccCCCe-eeccCc
Q 040398 94 RLSSNRLIGNLP-MELVKLKNLTDFRINDNNFNGSAPDFIQSWT-QLNRLEIQGSGLEGPIPPSISALDKLNQ-LRISDL 170 (732)
Q Consensus 94 ~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~ls~N 170 (732)
++++|+++...+ ..+..+..|..+...++.+....+..+..++ .++.|++++|+++.. +....+.+++.. +++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i-~~~~~~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNCAFNGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTTTTTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc-ccccccchhhhcccccccc
Confidence 999999974322 2345567777778888888867677777765 799999999999954 444444555554 467889
Q ss_pred CCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCC
Q 040398 171 QGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLS 216 (732)
Q Consensus 171 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 216 (732)
+++.++...|..+++|++|+|++|+|+...+..+.++++|+.|++.
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 9999998899999999999999999995445556677777666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.6e-18 Score=165.75 Aligned_cols=176 Identities=17% Similarity=0.245 Sum_probs=110.5
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccccCCccC-CccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTI-PRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
.++++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 445666666666 5565543 46666666666665433 3345666666666666666665666666666666666666
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCc-ccccCCCCccEEEcccccccCC
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTF-PMLRNMTGLTRIILRNCNIAGE 199 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~ 199 (732)
+|+|+...++.|.++++|+.|+|++|+|++..+..|..+++|++|+|++|.+..... ..+ ...++.+.+..|.++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeC
Confidence 666666666666666666666666666665556666666666666666666654321 111 12355566777887766
Q ss_pred cchhhcCCCCCcEEeCCCCcCcccCC
Q 040398 200 IPEYIWGIKNLRFLDLSFNQLTGELP 225 (732)
Q Consensus 200 ~p~~l~~l~~L~~L~Ls~N~l~g~~p 225 (732)
.|.. +..++.++|+.|.+....+
T Consensus 165 ~p~~---l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 165 APSK---VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp SSTT---TTTSBGGGSCTTTCCCCCC
T ss_pred CChh---hcCCEeeecCHhhCcCCCC
Confidence 6654 5567778999999886544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=163.51 Aligned_cols=181 Identities=23% Similarity=0.326 Sum_probs=151.1
Q ss_pred EEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCc
Q 040398 21 TVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNR 99 (732)
Q Consensus 21 ~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 99 (732)
..++..+.+++.++. ..+ +|++|++++|.++ .++ .+..+++|++|+|++|+|++ ++ .+.++++|+.|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccc
Confidence 345666777765543 234 7999999999998 444 48889999999999999984 44 47899999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCccc
Q 040398 100 LIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPM 179 (732)
Q Consensus 100 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 179 (732)
|+ .+| .+..+++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++.++. .
T Consensus 102 i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~ 173 (210)
T d1h6ta2 102 VK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--P 173 (210)
T ss_dssp CC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred cc-ccc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--c
Confidence 98 455 58899999999999999863 3 468889999999999999974 346788999999999999998754 4
Q ss_pred ccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCC
Q 040398 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSF 217 (732)
Q Consensus 180 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 217 (732)
+.++++|+.|+|++|+|+ .+| .+..+++|++|+|++
T Consensus 174 l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 889999999999999998 465 589999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.6e-17 Score=159.50 Aligned_cols=165 Identities=19% Similarity=0.292 Sum_probs=101.6
Q ss_pred eEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCcc
Q 040398 44 YISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNN 123 (732)
Q Consensus 44 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 123 (732)
.+.++.+.+++.++ ...+.+|++|++++|.++ .++ .+..+++|++|+|++|+|++ ++ .+.++++|+.|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~-~l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-cc-cccCCcccccccccccc
Confidence 34555555554332 234566666666666666 332 45666667777777766663 22 26666667777777666
Q ss_pred ccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchh
Q 040398 124 FNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEY 203 (732)
Q Consensus 124 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 203 (732)
+.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|.+... +.+..+++|++|++++|++++ ++ .
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~-l~-~ 167 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD-LK-P 167 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-G
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC-Cc-c
Confidence 652 22 356666777777766666532 3355666777777777766543 246667777777777777764 33 2
Q ss_pred hcCCCCCcEEeCCCCcCcc
Q 040398 204 IWGIKNLRFLDLSFNQLTG 222 (732)
Q Consensus 204 l~~l~~L~~L~Ls~N~l~g 222 (732)
+.++++|+.|++++|++++
T Consensus 168 l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC
T ss_pred ccCCCCCCEEECCCCCCCC
Confidence 6677777777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.4e-17 Score=161.55 Aligned_cols=178 Identities=24% Similarity=0.371 Sum_probs=129.3
Q ss_pred CEEEcccCcCccccCcccccc-ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCC
Q 040398 20 ETVDFAYNYLHGSIPREWASM-QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSN 98 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 98 (732)
..+.++.+.+++.++. ..+ ++++|++++|+++ .+. .+..+++|++|+|++|+|++ ++ .+.++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~-~l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-cc-cccCCccccccccccc
Confidence 3445666666654332 234 6888888888887 443 47778888888888888874 33 3788888888888888
Q ss_pred cccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcc
Q 040398 99 RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFP 178 (732)
Q Consensus 99 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 178 (732)
.+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|.++++.
T Consensus 95 ~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-- 166 (199)
T d2omxa2 95 QIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-- 166 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--
T ss_pred ccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--
Confidence 876 444 477888888888888877642 347778888888888888863 3 35777888888888888887654
Q ss_pred cccCCCCccEEEcccccccCCcchhhcCCCCCcEE
Q 040398 179 MLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFL 213 (732)
Q Consensus 179 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 213 (732)
.+.++++|++|+|++|+|++ ++ .+..+++|+.|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 37788888888888888874 44 46777877765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.71 E-value=3.8e-16 Score=164.26 Aligned_cols=56 Identities=27% Similarity=0.381 Sum_probs=36.1
Q ss_pred CCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcC
Q 040398 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 183 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~ 260 (732)
+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|+. +.+|+.|+|++|+|+.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~-----------------~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL-----------------PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC-----------------CTTCCEEECCSSCCSS
T ss_pred CCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc-----------------cCCCCEEECcCCcCCC
Confidence 356777777777776 5554 2566777777777776 34432 2457777777777763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.60 E-value=4.1e-14 Score=148.38 Aligned_cols=198 Identities=26% Similarity=0.303 Sum_probs=131.0
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCC
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNL 87 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 87 (732)
+||+. +++|++|+|++|+|+ .+|..+. +|++|++++|+++ .++.- .+.|++|+|++|.+. .+|. ++.+
T Consensus 52 ~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~--~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l 119 (353)
T d1jl5a_ 52 SLPEL---PPHLESLVASCNSLT-ELPELPQ--SLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNS 119 (353)
T ss_dssp CCCSC---CTTCSEEECCSSCCS-SCCCCCT--TCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTC
T ss_pred CCCCC---CCCCCEEECCCCCCc-ccccchh--hhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhh
Confidence 35643 357888888888888 6676533 5778888888777 44431 145888888888887 5663 5678
Q ss_pred CCCCEEeCCCCcccccC------------------CccccCCCCCCEEEccCccccccC------------------Ccc
Q 040398 88 VNLETLRLSSNRLIGNL------------------PMELVKLKNLTDFRINDNNFNGSA------------------PDF 131 (732)
Q Consensus 88 ~~L~~L~L~~N~l~~~~------------------p~~l~~l~~L~~L~L~~N~l~~~~------------------p~~ 131 (732)
++|+.|++++|.++... +..+..++.++.|++++|.+.... ...
T Consensus 120 ~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~ 199 (353)
T d1jl5a_ 120 SFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199 (353)
T ss_dssp TTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCC
T ss_pred ccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccc
Confidence 88888888887765211 122344556667777766554211 012
Q ss_pred ccCCCCCCEEEcccCCCcCcC----------------------C----------------------------------cc
Q 040398 132 IQSWTQLNRLEIQGSGLEGPI----------------------P----------------------------------PS 155 (732)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~~----------------------p----------------------------------~~ 155 (732)
+..++.|+.+++++|...... + ..
T Consensus 200 ~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 279 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL 279 (353)
T ss_dssp CTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccc
Confidence 334566666666655432100 0 00
Q ss_pred ccCccCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCC
Q 040398 156 ISALDKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPD 226 (732)
Q Consensus 156 ~~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 226 (732)
...+++|++|+|++|++..++. .+++|+.|+|++|+|+ .+|+. +++|+.|+|++|+|+ .+|+
T Consensus 280 ~~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 280 CDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred cccCCCCCEEECCCCccCcccc----ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 0113689999999999987653 3679999999999999 67753 568999999999998 5665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.59 E-value=1.1e-16 Score=168.78 Aligned_cols=243 Identities=16% Similarity=0.145 Sum_probs=177.9
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccCcccc----cc-ccceEecccccccc---c-------CCccccCCCCCCEEecc
Q 040398 8 TLPPQIVNLPYLETVDFAYNYLHGSIPREWA----SM-QLKYISVFANRLSG---N-------IPSHLGNITSLTYLDLE 72 (732)
Q Consensus 8 ~lP~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----~~-~L~~L~L~~n~l~~---~-------~p~~l~~l~~L~~L~Ls 72 (732)
.+..++.+.+.|++|+|++|.+...-...++ .. +|+.|+++++.... . +...+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3456677789999999999998754433333 33 69999998875431 1 23445678999999999
Q ss_pred cccCCcc----CCccccCCCCCCEEeCCCCcccccCCc-------------cccCCCCCCEEEccCcccccc----CCcc
Q 040398 73 ENQFSGT----IPRELGNLVNLETLRLSSNRLIGNLPM-------------ELVKLKNLTDFRINDNNFNGS----APDF 131 (732)
Q Consensus 73 ~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~-------------~l~~l~~L~~L~L~~N~l~~~----~p~~ 131 (732)
+|.++.. +...+..+++|++|++++|.++..-.. .....+.|+.|.+++|++... +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 9999753 334456789999999999988631111 123467899999999998632 3344
Q ss_pred ccCCCCCCEEEcccCCCcCc-----CCccccCccCCCeeeccCcCCCCCC----cccccCCCCccEEEcccccccCCcch
Q 040398 132 IQSWTQLNRLEIQGSGLEGP-----IPPSISALDKLNQLRISDLQGPNQT----FPMLRNMTGLTRIILRNCNIAGEIPE 202 (732)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~~p~ 202 (732)
+..++.|+.|+|++|.++.. +...+..+++|+.|+|++|.++... ...+..+++|++|+|++|.|++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 66789999999999998742 3456778899999999999986543 23467889999999999999865333
Q ss_pred h----hcC--CCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHh-ccCCCCeEEccCCcCcC
Q 040398 203 Y----IWG--IKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIR-GVYEHQSLDLSYNNFTW 260 (732)
Q Consensus 203 ~----l~~--l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~-~l~~L~~LdLs~N~l~~ 260 (732)
. +.. .+.|+.|++++|+|+.. ....+...+. +.++|+.|+|++|+++.
T Consensus 262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~----------~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 262 AVVDAFSKLENIGLQTLRLQYNEIELD----------AVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHH----------HHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHhhhccCCCCCEEECCCCcCChH----------HHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 3 333 46799999999998733 1233444453 67899999999999963
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=6.3e-15 Score=137.19 Aligned_cols=87 Identities=20% Similarity=0.240 Sum_probs=47.0
Q ss_pred ccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCC
Q 040398 60 LGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLN 139 (732)
Q Consensus 60 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 139 (732)
+.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .+..+++|+.|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 445556666666666665 44544455666666666666665 332 355555555555555555543333344444555
Q ss_pred EEEcccCCCc
Q 040398 140 RLEIQGSGLE 149 (732)
Q Consensus 140 ~L~Ls~N~l~ 149 (732)
.|++++|+++
T Consensus 91 ~L~L~~N~i~ 100 (162)
T d1a9na_ 91 ELILTNNSLV 100 (162)
T ss_dssp EEECCSCCCC
T ss_pred cceecccccc
Confidence 5555444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.1e-15 Score=156.54 Aligned_cols=222 Identities=15% Similarity=0.170 Sum_probs=126.5
Q ss_pred CEEEcccCcCccccCccccccccceEecccccccccCCccccCCCCCCEEecccccCCcc-CCccccCCCCCCEEeCCCC
Q 040398 20 ETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGT-IPRELGNLVNLETLRLSSN 98 (732)
Q Consensus 20 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N 98 (732)
++|||+++.+.......+....+..+.++...+... ........+|++|||+++.+++. +...+.++++|++|+|++|
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHTTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCchHHHHHHhccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 367777776653222222222345555555555422 22233456777777777766533 3344566777777777777
Q ss_pred cccccCCccccCCCCCCEEEccCc-ccccc-CCccccCCCCCCEEEcccC-CCcCc-CCccccC-ccCCCeeeccCc--C
Q 040398 99 RLIGNLPMELVKLKNLTDFRINDN-NFNGS-APDFIQSWTQLNRLEIQGS-GLEGP-IPPSISA-LDKLNQLRISDL--Q 171 (732)
Q Consensus 99 ~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~ls~N--~ 171 (732)
.+++..+..+..+++|+.|++++| .++.. +.....++++|+.|+|+++ .++.. +...+.. .++|+.|+++++ .
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 776666666777777777777774 44421 1222345677777777774 33321 1122222 356777777654 2
Q ss_pred CCCCCccc-ccCCCCccEEEcccc-cccCCcchhhcCCCCCcEEeCCCC-cCcccCCCCCccCcchhhHHHHHHhccCCC
Q 040398 172 GPNQTFPM-LRNMTGLTRIILRNC-NIAGEIPEYIWGIKNLRFLDLSFN-QLTGELPDVAVPADLKFTQILMFIRGVYEH 248 (732)
Q Consensus 172 l~~~~~~~-l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L 248 (732)
++...... ...+++|++|+|++| .+++..+..+.++++|++|+|+++ .+++.... .++++++|
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~--------------~L~~~~~L 227 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL--------------ELGEIPTL 227 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGG--------------GGGGCTTC
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHH--------------HHhcCCCC
Confidence 33322222 345677777777765 466666667777777777777774 45432221 14556777
Q ss_pred CeEEccCC
Q 040398 249 QSLDLSYN 256 (732)
Q Consensus 249 ~~LdLs~N 256 (732)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 77777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=9.4e-15 Score=129.47 Aligned_cols=102 Identities=28% Similarity=0.393 Sum_probs=57.6
Q ss_pred ceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCc
Q 040398 43 KYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDN 122 (732)
Q Consensus 43 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 122 (732)
|+|+|++|+++ .++ .+.++++|++|+|++|+|+ .+|..++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 35566666665 343 2555666666666666665 45555666666666666666665 333 3555666666666666
Q ss_pred cccccC-CccccCCCCCCEEEcccCCCc
Q 040398 123 NFNGSA-PDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 123 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+|+... ...+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 665322 134555556666666666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=4.1e-15 Score=138.53 Aligned_cols=122 Identities=16% Similarity=0.171 Sum_probs=81.6
Q ss_pred ccceEecccccccccCCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 41 QLKYISVFANRLSGNIPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 41 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
++++|+|++|+|+ .++..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+|+...+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 6777777777777 55665666777777777777777 453 46777778888888887774444445667788888888
Q ss_pred CccccccCC-ccccCCCCCCEEEcccCCCcCcCCc----cccCccCCCeee
Q 040398 121 DNNFNGSAP-DFIQSWTQLNRLEIQGSGLEGPIPP----SISALDKLNQLR 166 (732)
Q Consensus 121 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 166 (732)
+|+|+.... ..+..+++|+.|++++|.++ ..|. .+..+++|+.||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 887763321 35667777777777777775 2332 345555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=9e-15 Score=149.57 Aligned_cols=228 Identities=17% Similarity=0.223 Sum_probs=165.3
Q ss_pred CCEEEcccCcCccccCccccccccceEeccccccccc-CCccccCCCCCCEEecccccCCccCCccccCCCCCCEEeCCC
Q 040398 19 LETVDFAYNYLHGSIPREWASMQLKYISVFANRLSGN-IPSHLGNITSLTYLDLEENQFSGTIPRELGNLVNLETLRLSS 97 (732)
Q Consensus 19 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 97 (732)
+..+.++.+.+.......+...+|++|+|++|.+... +...+.++++|++|+|+++.+++..+..++.+++|++|+|++
T Consensus 25 ~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 5566776666654444445555899999999998754 455678899999999999999888888899999999999999
Q ss_pred C-ccccc-CCccccCCCCCCEEEccCc-ccccc-CCcccc-CCCCCCEEEcccC--CCcCc-CCccccCccCCCeeeccC
Q 040398 98 N-RLIGN-LPMELVKLKNLTDFRINDN-NFNGS-APDFIQ-SWTQLNRLEIQGS--GLEGP-IPPSISALDKLNQLRISD 169 (732)
Q Consensus 98 N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~-~l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~ls~ 169 (732)
+ .++.. +...+..+++|+.|+++++ .++.. +...+. ..++|+.|+++++ .++.. +.....++++|+.|++++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 5 67632 2333467899999999986 34321 222233 3578999999875 34432 233346789999999998
Q ss_pred cC-CCCCCcccccCCCCccEEEcccc-cccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCC
Q 040398 170 LQ-GPNQTFPMLRNMTGLTRIILRNC-NIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYE 247 (732)
Q Consensus 170 N~-l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~ 247 (732)
|. +++.....+..+++|++|+|++| .+++.....+.++++|+.|+++++ ++ +. .+......+++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~----d~---------~l~~l~~~lp~ 250 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP----DG---------TLQLLKEALPH 250 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC----TT---------CHHHHHHHSTT
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC----HH---------HHHHHHHhCcc
Confidence 64 67777788899999999999995 688777788899999999999887 33 21 01122233444
Q ss_pred CCeEEccCCcCcCCCC
Q 040398 248 HQSLDLSYNNFTWQSP 263 (732)
Q Consensus 248 L~~LdLs~N~l~~~~p 263 (732)
|++..++++...+
T Consensus 251 ---L~i~~~~ls~~~~ 263 (284)
T d2astb2 251 ---LQINCSHFTTIAR 263 (284)
T ss_dssp ---SEESCCCSCCTTC
T ss_pred ---ccccCccCCCCCC
Confidence 5567888887644
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=4.9e-14 Score=124.77 Aligned_cols=77 Identities=26% Similarity=0.374 Sum_probs=39.9
Q ss_pred EEecccccCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCC
Q 040398 68 YLDLEENQFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSG 147 (732)
Q Consensus 68 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 147 (732)
+|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|+. +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4556666665 333 3555555666666666555 445555555555555555555542 22 24444444444444444
Q ss_pred Cc
Q 040398 148 LE 149 (732)
Q Consensus 148 l~ 149 (732)
++
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=8.4e-15 Score=159.31 Aligned_cols=68 Identities=19% Similarity=0.289 Sum_probs=43.1
Q ss_pred CccCCCCCCCCEEEcccCcCccc----cCccccc--cccceEeccccccccc----CCccccCCCCCCEEecccccCC
Q 040398 10 PPQIVNLPYLETVDFAYNYLHGS----IPREWAS--MQLKYISVFANRLSGN----IPSHLGNITSLTYLDLEENQFS 77 (732)
Q Consensus 10 P~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~--~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 77 (732)
+..+..+++|++|||++|+|+.. +...+.. .+|++|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 48 ~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 48 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 44566777788888877777532 1122221 2577888887777632 3456677777888888777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=3.1e-15 Score=144.32 Aligned_cols=144 Identities=16% Similarity=0.172 Sum_probs=78.1
Q ss_pred CCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCc
Q 040398 80 IPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISAL 159 (732)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 159 (732)
++..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~---------- 106 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA---------- 106 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC----------
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc----------
Confidence 3344555555555555555555 333 3555555555555555554 23333333334444444444443
Q ss_pred cCCCeeeccCcCCCCCCcccccCCCCccEEEcccccccCCcc--hhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhH
Q 040398 160 DKLNQLRISDLQGPNQTFPMLRNMTGLTRIILRNCNIAGEIP--EYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQ 237 (732)
Q Consensus 160 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~ 237 (732)
.+ +.+..+++|+.|+|++|+|+ .++ ..+..+++|+.|+|++|++....+..... ...
T Consensus 107 --------------~l--~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~----~~~ 165 (198)
T d1m9la_ 107 --------------SL--SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNAT----SEY 165 (198)
T ss_dssp --------------CH--HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTH----HHH
T ss_pred --------------cc--ccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccch----hhH
Confidence 32 22445566777777777776 333 35677888888888888877655543111 011
Q ss_pred HHHHHhccCCCCeEEccCCcCc
Q 040398 238 ILMFIRGVYEHQSLDLSYNNFT 259 (732)
Q Consensus 238 ~~~~~~~l~~L~~LdLs~N~l~ 259 (732)
....+..+++|+.|| +.+++
T Consensus 166 r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 166 RIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHCSSCCEES--SGGGT
T ss_pred HHHHHHHCCCcCEeC--CccCC
Confidence 223467788888887 56554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=2.7e-14 Score=150.24 Aligned_cols=213 Identities=18% Similarity=0.225 Sum_probs=158.7
Q ss_pred ccCCCCCCCCEEEcccCcCcc---ccCcc-------cccc-ccceEeccccccccc----CCccccCCCCCCEEeccccc
Q 040398 11 PQIVNLPYLETVDFAYNYLHG---SIPRE-------WASM-QLKYISVFANRLSGN----IPSHLGNITSLTYLDLEENQ 75 (732)
Q Consensus 11 ~~l~~l~~L~~L~Ls~N~l~~---~~p~~-------~~~~-~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~ 75 (732)
+.+...++|+.|+++++.... ..|.. +... +|++|+|++|.+... +...+...++|++|+|++|.
T Consensus 53 ~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~ 132 (344)
T d2ca6a1 53 ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 132 (344)
T ss_dssp HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC
T ss_pred HHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccc
Confidence 457888999999999876542 22222 2222 699999999999753 34455678999999999998
Q ss_pred CCccCC----cc---------ccCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCcccccc-----CCcccc
Q 040398 76 FSGTIP----RE---------LGNLVNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFNGS-----APDFIQ 133 (732)
Q Consensus 76 l~~~~p----~~---------l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~ 133 (732)
+...-. .. ....+.|+.|++++|+++. .+...+..++.|+.|+|++|+|... +...+.
T Consensus 133 l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~ 212 (344)
T d2ca6a1 133 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 212 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGG
T ss_pred ccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhc
Confidence 862111 11 1356789999999999873 2344466789999999999998632 345577
Q ss_pred CCCCCCEEEcccCCCcCc----CCccccCccCCCeeeccCcCCCCCCcccc----c--CCCCccEEEcccccccCC----
Q 040398 134 SWTQLNRLEIQGSGLEGP----IPPSISALDKLNQLRISDLQGPNQTFPML----R--NMTGLTRIILRNCNIAGE---- 199 (732)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~l----~--~l~~L~~L~Ls~N~l~~~---- 199 (732)
.+++|+.|+|++|.++.. +...+..+++|++|+|++|.+++.....+ . ..+.|++|+|++|+|+..
T Consensus 213 ~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~ 292 (344)
T d2ca6a1 213 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292 (344)
T ss_dssp GCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred chhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHH
Confidence 899999999999998643 44567889999999999999887654443 2 246799999999999754
Q ss_pred cchhhc-CCCCCcEEeCCCCcCccc
Q 040398 200 IPEYIW-GIKNLRFLDLSFNQLTGE 223 (732)
Q Consensus 200 ~p~~l~-~l~~L~~L~Ls~N~l~g~ 223 (732)
+...+. +.++|+.|+|++|++...
T Consensus 293 l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 293 LKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHHccCCCCCEEECCCCcCCCc
Confidence 334443 578999999999999743
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=2.4e-14 Score=137.99 Aligned_cols=121 Identities=18% Similarity=0.170 Sum_probs=80.3
Q ss_pred cCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcccCCCcCcCCccccCccCCCeeeccCcCCCCCCcccccC
Q 040398 103 NLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQGSGLEGPIPPSISALDKLNQLRISDLQGPNQTFPMLRN 182 (732)
Q Consensus 103 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~l~~ 182 (732)
.++..+..+++|+.|+|++|+|+ .++ .+..+++|+.|+|++|.+ +.++ ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i------------------------~~i~-~~~~~ 91 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLI------------------------KKIE-NLDAV 91 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEE------------------------CSCS-SHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccc------------------------cccc-ccccc
Confidence 33445555666666666666655 222 244455555555555544 4332 12333
Q ss_pred CCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcCcCCC
Q 040398 183 MTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNFTWQS 262 (732)
Q Consensus 183 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 262 (732)
+++|++|++++|+|+. ++ .+..+++|+.|+|++|+++.. ++ ...+..+++|+.|+|++|+++...
T Consensus 92 ~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~-~~------------~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNW-GE------------IDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCH-HH------------HHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccccccccc-cc-cccccccccccccccchhccc-cc------------cccccCCCccceeecCCCccccCc
Confidence 4579999999999984 44 478899999999999999832 10 123678899999999999998877
Q ss_pred CCC
Q 040398 263 PEQ 265 (732)
Q Consensus 263 p~~ 265 (732)
+..
T Consensus 157 ~~~ 159 (198)
T d1m9la_ 157 KEN 159 (198)
T ss_dssp CTT
T ss_pred ccc
Confidence 654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.5e-12 Score=118.41 Aligned_cols=83 Identities=22% Similarity=0.176 Sum_probs=36.3
Q ss_pred CCEEecccccCCccCCccccCCCCCCEEeCCCC-cccccCCccccCCCCCCEEEccCccccccCCccccCCCCCCEEEcc
Q 040398 66 LTYLDLEENQFSGTIPRELGNLVNLETLRLSSN-RLIGNLPMELVKLKNLTDFRINDNNFNGSAPDFIQSWTQLNRLEIQ 144 (732)
Q Consensus 66 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 144 (732)
.+.++.+++.+. .+|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 334444444444 33444444444444444333 2442223334444444444444444444444444444444444444
Q ss_pred cCCCc
Q 040398 145 GSGLE 149 (732)
Q Consensus 145 ~N~l~ 149 (732)
+|+|+
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 44444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.8e-11 Score=112.61 Aligned_cols=106 Identities=19% Similarity=0.174 Sum_probs=73.6
Q ss_pred cceEecccccccccCCccccCCCCCCEEecccc-cCCccCCccccCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcc
Q 040398 42 LKYISVFANRLSGNIPSHLGNITSLTYLDLEEN-QFSGTIPRELGNLVNLETLRLSSNRLIGNLPMELVKLKNLTDFRIN 120 (732)
Q Consensus 42 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 120 (732)
.+.++.+++++. ..|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 455666777666 56667777777888887655 4664444567777788888888888876666677778888888888
Q ss_pred CccccccCCccccCCCCCCEEEcccCCCc
Q 040398 121 DNNFNGSAPDFIQSWTQLNRLEIQGSGLE 149 (732)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 149 (732)
+|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 888774444444443 5777888777774
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=1.3e-12 Score=141.52 Aligned_cols=89 Identities=21% Similarity=0.216 Sum_probs=61.2
Q ss_pred CCCCCCCCEEEcccCcCccc----cCcccccc-ccceEeccccccccc----CCccccC-CCCCCEEecccccCCcc---
Q 040398 13 IVNLPYLETVDFAYNYLHGS----IPREWASM-QLKYISVFANRLSGN----IPSHLGN-ITSLTYLDLEENQFSGT--- 79 (732)
Q Consensus 13 l~~l~~L~~L~Ls~N~l~~~----~p~~~~~~-~L~~L~L~~n~l~~~----~p~~l~~-l~~L~~L~Ls~N~l~~~--- 79 (732)
+..+++|++|+|++|.++.. +...+... +|++|+|++|+|+.. +...+.. ..+|++|+|++|++++.
T Consensus 23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~ 102 (460)
T d1z7xw1 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102 (460)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccc
Confidence 34567888888888888742 23333344 688899988888631 2333332 35788999998888743
Q ss_pred -CCccccCCCCCCEEeCCCCccc
Q 040398 80 -IPRELGNLVNLETLRLSSNRLI 101 (732)
Q Consensus 80 -~p~~l~~l~~L~~L~L~~N~l~ 101 (732)
++..+..+++|++|+|++|.|+
T Consensus 103 ~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 103 VLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCH
T ss_pred cccchhhccccccccccccccch
Confidence 4556778888999999888874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=1.6e-07 Score=93.24 Aligned_cols=151 Identities=12% Similarity=0.089 Sum_probs=104.6
Q ss_pred HHHHHHhCCCcccceecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCC-CCceeeeeeeEEeCCEE
Q 040398 507 KQIRAATSNFDPMNKIGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQ-HPNLVKLYGCCIEGDQL 585 (732)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 585 (732)
+++......|+..+..+.++.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 566777788887776555555789998654 5667788876554444445677888877663 33356788888888999
Q ss_pred EEEEEecCCCchhHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 040398 586 MLVYEYLENNSLAHALFGGENSQLKLNWSVRQKICLGIARGLAFLHEES------------------------------- 634 (732)
Q Consensus 586 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------------------------------- 634 (732)
++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998876544111 112334556666666666421
Q ss_pred -------------------------CCceEeCCCCCCCeEEcCCCCeEEEeeecceeC
Q 040398 635 -------------------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 667 (732)
Q Consensus 635 -------------------------~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~~ 667 (732)
+..++|+|+.|.||+++++..+-|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123789999999999998766779999987643
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=5.5e-09 Score=96.17 Aligned_cols=70 Identities=19% Similarity=0.045 Sum_probs=35.6
Q ss_pred ccCCCCccEEEcccccccCCcchhhcCCCCCcEEeCCCCcCcccCCCCCccCcchhhHHHHHHhccCCCCeEEccCCcC
Q 040398 180 LRNMTGLTRIILRNCNIAGEIPEYIWGIKNLRFLDLSFNQLTGELPDVAVPADLKFTQILMFIRGVYEHQSLDLSYNNF 258 (732)
Q Consensus 180 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~l~~L~~LdLs~N~l 258 (732)
+..+++|+.|+|++|.|+...+-......+|+.|++++|+++....+. .......+..+++|+.|| ++++
T Consensus 87 ~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~-------~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ-------STYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSH-------HHHHHHHHTTSTTCCEET--TEEC
T ss_pred HhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccc-------hhHHHHHHHHCCCCCEEC--cCCC
Confidence 334455555555555555322222233445666677777666443321 122334455667777766 5554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=9.4e-09 Score=94.59 Aligned_cols=30 Identities=17% Similarity=0.130 Sum_probs=15.5
Q ss_pred CccEEEcccccccCCcc-------hhhcCCCCCcEEe
Q 040398 185 GLTRIILRNCNIAGEIP-------EYIWGIKNLRFLD 214 (732)
Q Consensus 185 ~L~~L~Ls~N~l~~~~p-------~~l~~l~~L~~L~ 214 (732)
+|+.|+|++|.+..... ..+..+|+|+.||
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 45555555555553332 1244566777664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=8.6e-06 Score=79.75 Aligned_cols=131 Identities=16% Similarity=0.152 Sum_probs=84.7
Q ss_pred eecccCc-eEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCC--ceeeeeeeEEeCCEEEEEEEecCCCch
Q 040398 521 KIGEGGF-GPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHP--NLVKLYGCCIEGDQLMLVYEYLENNSL 597 (732)
Q Consensus 521 ~LG~G~f-g~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~~~~lv~e~~~~gsL 597 (732)
.+..|.. +.||+....++..+++|....... ..+..|.+.++.+... -+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 689999888888899998654432 2356677777666432 355778888888889999999988655
Q ss_pred hHHhhcCCCCcccCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 040398 598 AHALFGGENSQLKLNWSVRQKICLGIARGLAFLHE--------------------------------------------- 632 (732)
Q Consensus 598 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~--------------------------------------------- 632 (732)
.+.. ... ...+.++++.|+-||+
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3311 000 0112223333333332
Q ss_pred ------C----CCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 633 ------E----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 633 ------~----~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
. .+..++|+|+.|.||+++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112379999999999999876678999998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.77 E-value=4.2e-06 Score=76.67 Aligned_cols=86 Identities=10% Similarity=0.074 Sum_probs=41.2
Q ss_pred CCCCCEEecccc-cCCcc----CCccccCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEccCcccccc----CC
Q 040398 63 ITSLTYLDLEEN-QFSGT----IPRELGNLVNLETLRLSSNRLIG----NLPMELVKLKNLTDFRINDNNFNGS----AP 129 (732)
Q Consensus 63 l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p 129 (732)
.++|++|+|+++ .++.. +...+...+.|++|+|++|.++. .+...+...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 455666666652 34321 22334455556666666666652 1122333445566666666655422 11
Q ss_pred ccccCCCCCCEEEcccCCC
Q 040398 130 DFIQSWTQLNRLEIQGSGL 148 (732)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l 148 (732)
..+...+.|+.|+|++|.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2233444455555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.69 E-value=7.3e-06 Score=74.99 Aligned_cols=40 Identities=13% Similarity=0.273 Sum_probs=19.2
Q ss_pred CCCCCCEEeCCCC-ccccc----CCccccCCCCCCEEEccCcccc
Q 040398 86 NLVNLETLRLSSN-RLIGN----LPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 86 ~l~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 3455666666653 34321 2223344455555555555553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.00012 Score=76.41 Aligned_cols=77 Identities=13% Similarity=0.132 Sum_probs=48.4
Q ss_pred cceecccCceEEEEEEEcC-CeEEEEEEccccc-------ccchHHHHHHHHHHhcCC-C--CceeeeeeeEEeCCEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTD-GTIIAVKLLSSKS-------RQGNREFLNEIGTISCLQ-H--PNLVKLYGCCIEGDQLML 587 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l 587 (732)
.+.+|.|....||+++..+ ++.++||.-.... +....+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998764 6789999643211 112344566777777652 2 234455544 4556688
Q ss_pred EEEecCCCch
Q 040398 588 VYEYLENNSL 597 (732)
Q Consensus 588 v~e~~~~gsL 597 (732)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.06 E-value=5.2e-05 Score=68.96 Aligned_cols=64 Identities=14% Similarity=0.141 Sum_probs=30.7
Q ss_pred CCCCCCEEeccc-ccCCcc----CCccccCCCCCCEEeCCCCccccc----CCccccCCCCCCEEEccCcccc
Q 040398 62 NITSLTYLDLEE-NQFSGT----IPRELGNLVNLETLRLSSNRLIGN----LPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 62 ~l~~L~~L~Ls~-N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
+.++|++|+|++ +.++.. +...+...++|++|+|++|.++.. +...+...++|+.|++++|.+.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 445566666655 334321 222334455566666666655421 1222334455555555555553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.03 E-value=5.5e-05 Score=68.75 Aligned_cols=41 Identities=20% Similarity=0.148 Sum_probs=19.8
Q ss_pred cCCCCCCEEeCCC-Cccccc----CCccccCCCCCCEEEccCcccc
Q 040398 85 GNLVNLETLRLSS-NRLIGN----LPMELVKLKNLTDFRINDNNFN 125 (732)
Q Consensus 85 ~~l~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 125 (732)
.+.++|++|+|++ |.|+.. +-..+...++|+.|+|++|.++
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 3455666666665 344321 1222334455555555555553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.82 E-value=0.0015 Score=65.81 Aligned_cols=136 Identities=15% Similarity=0.113 Sum_probs=77.8
Q ss_pred eEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCCcee-----ee--eeeEEeCCEEEEEEEecCCCchh--
Q 040398 528 GPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV-----KL--YGCCIEGDQLMLVYEYLENNSLA-- 598 (732)
Q Consensus 528 g~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-----~l--~~~~~~~~~~~lv~e~~~~gsL~-- 598 (732)
-.||+++.++|+.|++|+.... ....+++..|...+..+....+. .. -..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999997643 23346677787777666432221 11 12344567788999999874221
Q ss_pred ----------------HHhhcCC-CCcccCCHH-------------------HHHHHHHHHHHHHHHHH----hCCCCce
Q 040398 599 ----------------HALFGGE-NSQLKLNWS-------------------VRQKICLGIARGLAFLH----EESRFKI 638 (732)
Q Consensus 599 ----------------~~l~~~~-~~~~~l~~~-------------------~~~~i~~~i~~aL~yLH----~~~~~~i 638 (732)
....... ......++. .+..+...+.+.++.+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111110 011111111 11112222222333332 2224568
Q ss_pred EeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 639 VHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 639 iH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
||+|+.+.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.40 E-value=0.0023 Score=66.41 Aligned_cols=73 Identities=18% Similarity=0.284 Sum_probs=48.6
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEEcccccccchHHHHHHHHHHhcCCCCcee-eeeeeEEeCCEEEEEE
Q 040398 519 MNKIGEGGFGPVYKGQLTD--------GTIIAVKLLSSKSRQGNREFLNEIGTISCLQHPNLV-KLYGCCIEGDQLMLVY 589 (732)
Q Consensus 519 ~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~ 589 (732)
++.|+.|-.-.+|++...+ ++.|.+++.-.. .......+|.++++.+.-.+++ ++++++. + .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEE
Confidence 4678888888999998653 356777776532 2233456788888877533444 6666653 2 6789
Q ss_pred EecCCCch
Q 040398 590 EYLENNSL 597 (732)
Q Consensus 590 e~~~~gsL 597 (732)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.23 E-value=0.015 Score=57.82 Aligned_cols=160 Identities=15% Similarity=0.043 Sum_probs=83.3
Q ss_pred ccHHHHHHHhCCCcccce-----ecccCceEEEEEEEcCCeEEEEEEcccccccchHHHHHHHHHHhcCCCC-----cee
Q 040398 504 FTLKQIRAATSNFDPMNK-----IGEGGFGPVYKGQLTDGTIIAVKLLSSKSRQGNREFLNEIGTISCLQHP-----NLV 573 (732)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~-----LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~-----nIv 573 (732)
.+.+++.....+|.+.+. |..|---..|+.+..+|+ +++|++..... .++...|++++..+... ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 456778888888876433 345555788999877654 89999865322 23334455555555322 222
Q ss_pred eee---eeEEeCCEEEEEEEecCCCchhH--------------Hhhc----C--CCCccc-----------------CCH
Q 040398 574 KLY---GCCIEGDQLMLVYEYLENNSLAH--------------ALFG----G--ENSQLK-----------------LNW 613 (732)
Q Consensus 574 ~l~---~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~--~~~~~~-----------------l~~ 613 (732)
+.. .+.........++.++.+..... .++. . ...... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 12233556677777776642210 0000 0 000000 000
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCCeEEcCCCCeEEEeeeccee
Q 040398 614 SVRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 666 (732)
Q Consensus 614 ~~~~~i~~~i~~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DfGla~~ 666 (732)
......+..+...+.-.+. ..+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111222222233333322 2244699999999999999887778999998863
|